cell_line_id,drug_id,response
BT 328,12003241,0.43959296828198
HSC-4,262093,2.780665409693215
BT 333,439501,-2.413365908020449
JHUEM-7,12003241,-3.5765771521887246
TE-15,73707398,1.075655915251324
NCI-H2342,sirolimus-bortezomib (250-1 mol-mol),2.0659171352443204
8505C,439501,-2.435831139874658
D283 Med,12003241,-3.4539176227720794
HCC2279,12003241,-1.0560673565017786
KMS-34,100016,4.459610626448404
SNU-1214,262093,2.99372726902227
Li-7,44491742,3.4427957124518325
ST486,sirolimus-bortezomib (250-1 mol-mol),-0.4662724333620547
SNU-182,11455910,3.5316691934445372
HCC2108,3689413,-1.830632797435868
SF126,6852167,3.245971174452026
HuP-T3,73707398,1.153693297692098
SW1271,9903786,4.005340236032604
JVM-3,49766530,-1.001889961758068
NCI-H2172,135421197,1.3346129669572484
SNU-466,637858,1.1868535051803475
Hs 683,11455910,0.4733989942514576
KMH-2,tanespimycin-bortezomib (250-1 mol-mol),-0.7573218655291942
RS4;11,tanespimycin-bortezomib (250-1 mol-mol),-0.3918084072183652
SNU-478,9927531,5.143977185818116
IGR-37,9903786,4.593363058361211
BT-474,135421197,1.065092434126716
MOLM-6,135999136,3.668986326514268
KMS-21-BM,9903786,1.778157023990249
BL-41,44491742,3.779286328341323
KMRC-2,tanespimycin-bortezomib (250-1 mol-mol),2.039285304893744
GDM-1,135999136,4.09510969720496
DMS 53,439501,-4.4060490975057105
BT 504,439501,-3.1394850364876907
HT-29,637858,2.6707335870409272
Panc 08.13,73707398,1.0210763814613335
NCI-H1792,375860,-0.209110690878502
Kelly,375860,-0.4375766322385214
SNU-C5,44491742,3.683316121476328
BL-70,11396600,2.443517551582617
WSU-DLCL2,49766530,-5.110358860052542
TM-31,439501,-2.1329770748027426
NCI-H460,11455910,1.4134750909778395
UO-31,637858,2.23783587214263
BT 333,5460769,4.50385990816769
PL-21,100016,4.334695208074886
M059K,637858,2.9375709273015533
HuH-1,6852167,3.503691591551823
KP-N-SI9s,6852167,2.328525910487029
KCL-22,5460769,3.17116063608923
LXF 289,46907787,-0.1426698074457199
HEC-1-B,selumetinib-JQ-1 (4-1 mol-mol),-0.661425337744121
MKN74,3689413,0.9993219534405752
KMH-2,100016,3.8705403745512017
NCI-H1869,135999136,1.6552462790975504
BHT-101,439501,-2.3771581779378828
QGP-1,10231331,-2.309455655415662
YD-38,444795,4.9688300992603
BT 330,12003241,-0.9920089469814386
OCI-M1,49766530,0.2650302716544968
JeKo-1,5460769,3.2700758729193526
WM983B,135421197,2.3980917008752725
Hs 934.T,46907787,4.0299623363215975
LN-18,375860,-0.7642172179373815
C2BBe1,44491742,3.6465315929226967
TUHR10TKB,selumetinib-JQ-1 (4-1 mol-mol),2.5341436510751754
HOP-92,tanespimycin-bortezomib (250-1 mol-mol),0.1347275198729775
Hs 888.T,12003241,-1.970204906844497
HSC-4,439501,-1.7709622187792924
HOP-92,sirolimus-bortezomib (250-1 mol-mol),1.0049376292822905
NCI-H1703,73707398,0.963485701318702
OCI-Ly10,11455910,3.348747046731681
GOS-3,100016,7.242262816552233
Rh30,135421197,2.937313489864044
NCI-H2170,136227331,4.269339943775955
NCI-H660,136227331,5.940989847463471
KMH-2,49766530,-1.67617119568669
HEC-108,100016,6.393272881400893
BT 159,262093,2.588782521087668
P31/FUJ,168313016,4.690131242833582
Calu-1,tanespimycin-bortezomib (250-1 mol-mol),-0.0246421056522193
NCI-H1869,11396600,4.813854369313605
DMS 53,3689413,-1.7302649812310384
T98G,9903786,3.9737183240681153
TOV-112D,UNC0638-navitoclax (1-1 mol-mol),4.5564386353746125
SNU-201,241158,5.535356896703898
OVCAR-5,637858,2.2396981147097903
LoVo,11396600,2.965288622606591
DEL,UNC0638-navitoclax (1-1 mol-mol),2.6998299925711127
HT-29,6852167,4.147335972225288
MHH-CALL-3,5460769,1.3871224464271157
MOTN-1,sirolimus-bortezomib (250-1 mol-mol),-0.1578046305827232
BT 340,3689413,0.410444406671797
TF-1,tanespimycin-bortezomib (250-1 mol-mol),0.3682708588950815
MG-63,46907787,1.9915589638341744
M059K,444795,5.032881715947493
BT-12,9903786,4.28961947380918
SNU-119,26596,2.579410873890194
SNU-1079,49766530,-2.354055789977545
CCK-81,6852167,2.8199787349778553
Hep-G2,444795,7.091940765135057
Caki-1,12003241,-1.8863162536101896
COV362,3689413,0.2449279899544521
KNS-81,UNC0638-navitoclax (1-1 mol-mol),0.7140378637358435
SF539,9927531,4.183842431586729
SU-DHL-1,100016,4.0163007651424945
CAL-148,3689413,0.1534272524825109
Daoy,444795,5.1441333345807685
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
SNU-1077,selumetinib-JQ-1 (4-1 mol-mol),1.9000830670563744
AGS,135999136,4.507616922311627
NH-6,3689413,-2.319645843981955
SNU-738,11455910,-0.0360600662579626
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
Pfeiffer,637858,0.795813698485305
Kelly,637858,1.5339565907917991
NCI-H2085,241158,1.210910612126421
MDST8,107970,2.8941750874079744
HEC-265,241158,3.756877585285286
Daudi,73707398,-0.7942959168982594
MOLT-13,375860,-0.4970846647186875
LN-229,12003241,-0.983315383516156
SET-2,44491742,3.5989743077742387
AGS,10231331,1.2929786798210765
TE-8,107970,2.3283260801611916
WSU-DLCL2,11455910,-0.3356389260792345
NCI-H2085,12003241,-2.8100927731995924
CAL-33,tanespimycin-bortezomib (250-1 mol-mol),0.6625956930764642
A2780,11396600,2.9320615716687564
Mel Ho,73707398,0.8984627578429711
TE-9,107970,2.565385085972178
HCC4006,11455910,0.2919573550060502
CMK,12003241,0.0052049395185332
JM-1,11396600,1.6173586604508372
LCLC-97TM1,135421197,1.517750954289076
Hs 822.T,3689413,-2.285857937794557
BT 248,11396600,1.9236183524788075
WM983B,135398744,6.927047773444745
NCI-H1339,12003241,0.6707609457385758
Hs 822.T,11455910,5.717819116017218
LN-18,637858,2.819183546851971
NCI-H460,439501,-2.362377537788676
8305C,46907787,-0.7427270894161048
WM88,10231331,-4.286644172681502
NCI-H520,107970,2.0234591709207397
AU565,9927531,4.912755977802547
Lu-99,sirolimus-bortezomib (250-1 mol-mol),1.6973589425418654
EM-2,9927531,3.4413075859413556
U-118MG,9903786,4.127288494791117
HCC1143,12003241,-0.0421467164139253
NCI-H2286,10231331,3.958797115295856
NCI-H1694,3689413,-2.758320209596303
CAL-12T,439501,-3.605636550997873
SNU-1077,12003241,-1.4220834787906382
NCI-H292,3689413,1.7536313837601494
HEL 92.1.7,5460769,3.8355782077499248
HSC-2,73707398,1.5445224580033434
RPMI-8402,262093,1.1284769386432876
PLC/PRF/5,tanespimycin-bortezomib (250-1 mol-mol),-0.763786349552494
SNU-685,10231331,4.963116273787337
DAN-G,11455910,0.9235983275094882
HCC1500,9903786,4.21203406645071
OVISE,241158,2.9923875981017134
BT 330,107970,1.6746237285504426
BT 145,11396600,1.7169241977244534
Hs 936.T,241158,4.073902447809716
JVM-3,6852167,1.039296799861209
JMSU-1,12003241,-3.06340831413481
HEC-151,11455910,-0.546024976491568
P12-Ichikawa,6852167,1.2288649311061628
JIMT-1,241158,4.281994950904064
NCI-H1395,44491742,3.9607165302769514
SNU-1033,135421197,1.1443309651958211
MOR/CPR,637858,2.5605522078351854
SNU-840,262093,3.393401871162564
SNU-216,selumetinib-JQ-1 (4-1 mol-mol),1.428202673212368
Mel JuSo,135999136,4.320625379627876
TOV-112D,49766530,0.7305238585252054
EB1,3689413,-2.432787849324627
A-375,241158,3.5865598480759413
JVM-2,12003241,-4.468160768320854
Detroit 562,168313016,4.3016363208247235
TT,439501,-2.411064207621025
HCC1419,262093,3.0653031319463624
Jurkat,135421197,1.0042206438045034
HCC38,262093,3.049385257949274
RPMI-6666,UNC0638-navitoclax (1-1 mol-mol),3.657204919876549
NCI-H810,637858,0.7916088156813487
MV4-11,selumetinib-JQ-1 (4-1 mol-mol),-3.212734853192351
PK-1,3689413,-0.025358625846968
647V,sirolimus-bortezomib (250-1 mol-mol),0.3544770314623594
SK-UT-1,241158,3.8222099850046054
KNS-81,73707398,1.6579800817235788
WM115,73707398,1.178086440828875
Hs 766T,44491742,4.434347985078199
SK-HEP-1,3689413,-2.4602386660304143
MDA-MB-453,44491742,4.088527945953042
IGROV-1,71466445,2.3758001916617797
MOLM-13,637858,0.5048034575879493
GI-1,5460769,1.3544320917610908
Fu97,tanespimycin-bortezomib (250-1 mol-mol),-2.3506071651033733
786-O,73707398,1.0800079367026778
SUP-T11,46907787,1.0254127656245202
UM-UC-3,241158,3.872560584721575
RS4;11,9927531,3.90062082158746
SK-MEL-24,9903786,3.6296294578661494
SEM,selumetinib-JQ-1 (4-1 mol-mol),-1.6081049960911422
Peer,168313016,3.2061836639817094
Hep-G2,107970,2.033740391106035
SU-DHL-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6950122900269923
NCI-H1975,tanespimycin-bortezomib (250-1 mol-mol),-1.468609028011694
RCH-ACV,168313016,3.0928889111886337
EHEB,6852167,1.7579387732994172
JHOC-5,46907787,0.6133782496345309
TC-71,3689413,0.4216372127873143
NCI-H650,107970,2.390821588287009
KMS-26,100016,3.884140356330727
SW48,6852167,2.2630322871527913
OAW28,11455910,2.4986666790908583
SW1990,10231331,2.104617413508516
SUIT-2,11396600,4.33113824085374
GB-1,439501,-2.3945114258909532
MHH-ES-1,262093,2.803376777339923
EPLC-272H,44491742,4.296380741364786
NCI-H460,9903786,4.057661845653794
CAL-120,9877608,5.792965508852075
HCC1419,5460769,4.36793897247466
BFTC-909,107970,2.2861723254681774
YD-38,tanespimycin-bortezomib (250-1 mol-mol),-0.8254079071300491
HH [Human lymphoma],444795,0.0461881419908549
NU-DUL-1,44491742,3.737315333639921
PaTu 8988s,UNC0638-navitoclax (1-1 mol-mol),1.233216645790841
MDA-MB-453,241158,3.8848602363142697
AN3-CA,tanespimycin-bortezomib (250-1 mol-mol),-2.8889708448552196
BT 330,tanespimycin-bortezomib (250-1 mol-mol),-1.5657589280340811
DK-MG,375860,-0.3429837018274142
L-363,12003241,0.3787290467646389
OCI-Ly3,3689413,-2.743608446400997
HD-MY-Z,135421197,1.63491304477545
SW948,11455910,0.6774609071475187
Sq-1,439501,0.4738250943054584
Pfeiffer,439501,-3.463410019597594
MOLP-2,73707398,0.4787083071687479
MHH-CALL-4,11396600,2.799931622192491
TCCSUP,262093,2.756857712955527
Namalwa,5460769,2.4239066035753054
KATO III,12003241,-4.840637368540689
KU-19-19,135421197,1.2163789616721166
JVM-2,107970,1.541422040439992
VCaP,44491742,3.83752183909955
YAPC,73707398,1.1307339717786768
BT 232,sirolimus-bortezomib (250-1 mol-mol),1.5892274515835794
Mel Ho,3689413,0.6432726542837045
NCI-H1694,5460769,2.288070088951681
Detroit 562,100016,6.391000104824681
PF-382,5460769,-0.5383889446594711
Ri-1,107970,1.039511049799593
A-172,3689413,-0.4114318334262174
SNU-1,selumetinib-JQ-1 (4-1 mol-mol),-0.6922648212512231
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906
MES-SA,241158,4.170875918540907
PE/CA-PJ34 (clone C12),46907787,4.066257221145479
SW1990,262093,3.247926984778252
SNG-M,49766530,1.2190782800499038
NCI-H1184,11396600,3.277329955302312
SH-4,439501,-2.6634763397724033
BT 286,selumetinib-JQ-1 (4-1 mol-mol),-1.4917661989890287
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
CCK-81,9929138,5.48307425077135
KE-37,tanespimycin-bortezomib (250-1 mol-mol),-0.6256036553504546
SW1271,135999136,4.614562085611917
NCI-H226,9927531,4.418189277296578
NCI-H358,107970,2.533765359070406
RCM-1 [Human rectal adenocarcinoma],168313016,4.590367789402496
OS-RC-2,241158,5.89413073451188
Hs 611.T,73707398,-1.1602307486634975
KHM-1B,241158,2.5921165995346565
BT 112,11396600,2.640188999201151
KYM-1,46907787,-0.5999039132788315
LOX-IMVI,168313016,4.96467141821942
SNU-1105,10231331,2.3119647781894272
SCC-9,135421197,2.7056920215811293
COR-L105,100016,7.1590039780101895
PaTu 8988t,439501,-3.4446792284706347
MCAS,selumetinib-JQ-1 (4-1 mol-mol),0.5693027943347815
GB-1,11455910,1.6376110278947926
HCC4006,49766530,-3.027931972438472
HSC-2,439501,-2.499396675496898
BICR 31,439501,-2.4499261286992007
T3M-10,sirolimus-bortezomib (250-1 mol-mol),0.4109261861139289
ECC12,637858,2.8438650239378793
SNU-398,3689413,0.8860664930016563
HDQ-P1,12003241,-0.8789475866858393
Hs 852.T,26596,-1.3645726938327003
ESS-1,6852167,2.0941643944902055
EHEB,9903786,1.657877258917439
KMS-21-BM,11455910,-0.3641448488710944
HPB-ALL,44491742,4.0686707496415835
RKN,11455910,3.815213247766997
MOR/CPR,6852167,3.3580650919838537
KMS-28BM,107970,1.6529733654048155
OCI-M1,46907787,-0.947970936826993
BT 416,10231331,-2.083820485023427
SNU-478,sirolimus-bortezomib (250-1 mol-mol),0.1595579698583019
Hs 895.T,selumetinib-JQ-1 (4-1 mol-mol),4.223259606319089
IGR-37,46907787,3.599816729005436
KE-39,71466445,5.518940973386278
HCC1143,100016,7.122041956726765
NCI-H1184,135999136,3.0982974136589143
A-498,73707398,1.745059470984177
TE-5,49766530,-3.388201082645815
KMS-26,26596,-2.3246210028506873
BT-474,11396600,4.260974029786902
BT 112,selumetinib-JQ-1 (4-1 mol-mol),2.692883041543946
253J,12003241,-2.2004462353623775
MSTO-211H,241158,2.290519528489604
CJM [Human melanoma],135999136,4.708181973943208
EJM,26596,-3.57565028157041
TT2609-C02,107970,2.997655912505065
CAL-51,241158,3.781489879449518
NCI-H520,6852167,1.505656389836919
HOP-62,637858,3.261273294662145
BT 482,tanespimycin-bortezomib (250-1 mol-mol),-0.9105363094795508
Rh30,11396600,3.5985518110360997
BICR 56,637858,2.3725324595184185
OCI-Ly3,6852167,1.562357091312624
COV362,136227331,5.836047268415018
PK-1,9903786,5.672212413868687
LCLC-97TM1,71466445,2.7974721848465025
COLO 829,12003241,-1.833925982592443
SCC-25,5460769,1.2990848940221191
Panc 02.03,262093,3.467425891303458
BT 359,3689413,-0.0229882443129298
U2OS,107970,2.3283737537932514
Mono-Mac-1,262093,2.3689622956108107
OPM-2,49766530,-3.767684481967312
SR,6852167,3.3054095897845777
BT-474,12003241,-0.1629967020972257
SW1271,selumetinib-JQ-1 (4-1 mol-mol),-0.3516238001186607
CHP-126,5460769,0.9651768958989126
EFO-21,375860,0.3291343721988856
MOR/CPR,135421197,2.970176340421023
NCI-H1944,26596,-1.3994203937624
MPP 89,100016,6.902779011713528
BFTC-905,UNC0638-navitoclax (1-1 mol-mol),2.7149212585440083
VMRC-LCD,71466445,3.0345394698478647
TE-4,10231331,0.3803992395266883
BT 187,sirolimus-bortezomib (250-1 mol-mol),0.4911829416060825
DK-MG,12003241,0.4512209867473665
LXF 289,135398744,6.087135496005038
KG-1-C,46907787,0.4611136549096399
CAL-148,9929138,4.85675773122561
SK-LMS-1,44491742,4.239159149665423
SUP-B15,71466445,3.754478245783766
Hs 940.T,12003241,-1.8353600585061816
HCT 15,tanespimycin-bortezomib (250-1 mol-mol),-0.1755556188950918
SNU-449,375860,2.655390537146391
K-562,3689413,1.0071697658281389
RT-112,9929138,6.4480300033203095
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
KYSE-510,26596,-0.7866712659714874
SET-2,6852167,2.1824189534016556
NCI-H1869,46907787,2.861559973778754
BT 416,44491742,4.3969888889672415
SW1088,644241,2.51934073419526
DLD-1,439501,-1.8196175209339427
SK-MEL-5,262093,3.0272532373657848
SK-ES-1,9927531,4.061932878113416
PSN1,44491742,3.787418780270154
Kasumi-2,5460769,1.467216518279754
GSS,262093,2.371550442394459
Hs 852.T,444795,5.030337936357497
LN-18,3689413,-0.4753252169993508
U2OS,10231331,1.781161622423505
SH-4,107970,1.9075532691951709
NCI-H2172,241158,6.148791775116968
697,71466445,1.5576237887375004
SF295,439501,-2.4386536619135137
SK-ES-1,11455910,-0.125480247265252
COLO 684,3689413,-2.2674920306130764
SR,135421197,1.9567356952392363
HMC-1-8,46907787,0.1330345715933646
HT,71466445,4.097100218112886
Peer,selumetinib-JQ-1 (4-1 mol-mol),-0.7186159888699871
CAL-54,9927531,5.326263652959217
P12-Ichikawa,9927531,3.8027198390435792
HCC1438,11455910,1.641191029153792
NCI-H1975,637858,1.41679582909573
MES-SA,tanespimycin-bortezomib (250-1 mol-mol),-2.9811279867981635
KHM-1B,107970,1.817903354032074
CAL-29,9927531,5.397915625533194
MOLT-13,9903786,1.350785557130732
PE/CA-PJ15,5460769,-0.4178373813349113
P31/FUJ,3689413,-2.495432751898851
TE 617.T,9927531,4.756324122053051
JHH-4,262093,3.0993355303406305
SNU-478,135421197,1.3858416930524595
RS4;11,11396600,2.516092176764727
BT 147,tanespimycin-bortezomib (250-1 mol-mol),-3.7345384366794665
TOV-112D,46907787,4.171399533980788
SNU-503,5460769,2.419581709530207
KMS-21-BM,135421197,0.9217420053482288
BT 271,46907787,2.4034092441644597
KYSE-410,UNC0638-navitoclax (1-1 mol-mol),2.9728532369388425
HMCB,26596,-1.2966092010554455
Ishikawa (Heraklio) 02 ER-,637858,2.5781304421684847
BT 228,6852167,4.103615495734906
NCI-H196,sirolimus-bortezomib (250-1 mol-mol),1.900922719750797
JHH-1,375860,-0.0865260995882469
JHH-5,11396600,2.359739892843467
SW1710,46907787,3.5885429995487073
HuCC-T1,135999136,-3.733945692205328
GSU,3689413,3.217966232949248
OCUM-1,9903786,1.5374110288154037
NCI-H2228,sirolimus-bortezomib (250-1 mol-mol),2.3578690583328887
COLO 678,3689413,0.0140701655611088
KATO III,11455910,0.859891525831657
SKM-1,241158,1.623725861036911
COR-L105,11455910,0.425998653780944
NCI-H2087,11455910,0.3125785540763442
JHH-1,6852167,3.051302168376451
KE-97,12003241,-1.757079073884842
JHUEM-7,5460769,0.024222502884872
Hs 895.T,11396600,3.5595368141538297
Calu-6,107970,2.3483200205763106
BT 159,46907787,3.605654998165969
SNU-478,5460769,1.0103147308873888
CAL-54,637858,1.3720795157109595
BT 359,100016,6.547217450499836
Caki-1,73707398,2.0691913303307023
TE-11,135421197,3.0798207714757906
HEC-6,selumetinib-JQ-1 (4-1 mol-mol),0.8521985876067439
CAMA-1,sirolimus-bortezomib (250-1 mol-mol),0.4180423517556048
KMH-2,73707398,0.2398101632779203
Panc 08.13,135421197,2.5362535902354932
M-07e,135421197,0.940164437961766
BICR 6,439501,-3.4433349442086234
NCI-H841,5460769,2.2001101436907984
Panc 10.05,262093,2.3686778047262327
ALL-SIL,UNC0638-navitoclax (1-1 mol-mol),-1.2077799570565213
HEY A8,49766530,-2.2509342663740566
647V,135421197,1.6081071378201617
NCI-H2023,9903786,4.254062749563359
TYK-nu,10231331,1.3626302869635751
HGC-27,6852167,0.8540634851742253
MG-63,3689413,-2.4336894587390323
COV644,sirolimus-bortezomib (250-1 mol-mol),0.1029805647741307
Hs 683,26596,-1.91567083647516
COLO 741,135999136,4.637543658362488
BDCM,135421197,0.954440132345953
Hs 294T,241158,3.871652959751704
Hs 852.T,241158,3.502588858838865
PE/CA-PJ15,12003241,-2.2005242909151668
SNU-601,71466445,5.5588944397471085
CMK,49766530,1.0776761429399353
SW982,262093,3.11351394040104
GaMG,sirolimus-bortezomib (250-1 mol-mol),1.2428919572047608
BT 359,439501,-2.266223118686084
RERF-LC-MS,10231331,0.9954911948227504
NCI-H1355,73707398,1.7830398779702854
KMS-34,3689413,-2.478307053017587
G-402,9903786,2.6546356785146084
NCI-H526,5460769,4.454179309152686
SW1417,439501,0.2964546756721697
FaDu,73707398,1.881650223785896
NCI-H1869,375860,1.5517292037743613
BT 428,10231331,-0.1978015197872311
COR-L51,11455910,-0.1708653149441187
OCI-AML-5,5460769,2.0028479546764664
VM-CUB-1,46907787,-0.1808741907084093
BT 440,262093,2.750742554492899
TALL-1 [Human adult T-ALL],9927531,3.369458546084366
HuP-T4,135999136,4.980263470840169
KYO-1,46907787,-0.6673337091305744
SK-MES-1,11455910,0.6501278721551685
HCC202,107970,1.9120205179375371
MOTN-1,selumetinib-JQ-1 (4-1 mol-mol),0.9467345984879016
ESS-1,11455910,0.1046831634026344
HT115,sirolimus-bortezomib (250-1 mol-mol),0.8189257476447475
MG-63,135999136,4.46138735599139
HuCC-T1,6852167,2.8530776188641926
ECC12,26596,-1.2680544811101384
HCC4006,135421197,1.321900660308596
SNU-886,439501,-0.6078207224909147
TALL-1 [Human adult T-ALL],UNC0638-navitoclax (1-1 mol-mol),-2.996993812021711
HT-1197,6852167,3.650905767737215
DU145,selumetinib-JQ-1 (4-1 mol-mol),3.7436181665569137
HCC1143,262093,2.740628946324062
SH-10-TC,11455910,0.8075465879192946
LCLC-97TM1,107970,2.3018486004849907
HT-1197,262093,2.0088485136907575
MHH-CALL-4,sirolimus-bortezomib (250-1 mol-mol),0.7403590273968818
SH-10-TC,73707398,1.591598537302804
RL,107970,2.2198714391244088
OVISE,439501,-2.343202219776273
Hs 578T,439501,-3.2814601954597915
BT 232,11396600,3.2918989092466813
IGROV-1,46907787,2.182756719431072
P12-Ichikawa,UNC0638-navitoclax (1-1 mol-mol),-0.6602743849013243
RVH-421,6852167,3.1482110171534297
ONCO-DG-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1798955899961833
SNU-308,6852167,3.364672579284096
MFE-296,637858,1.569825687785107
Becker,selumetinib-JQ-1 (4-1 mol-mol),4.188822961792769
KYSE-410,11396600,3.754375595740645
HSC-3,100016,6.558832951826536
JMSU-1,241158,1.9095752467633784
HCC1833,262093,2.988096800875125
5637,637858,2.0145403224080347
LN-18,135999136,4.29684161962908
L-428,selumetinib-JQ-1 (4-1 mol-mol),0.3703912930912235
KLE,10231331,5.289162464767698
Hs 944.T,444795,6.517214631419411
LOX-IMVI,135398744,6.429324407359154
HEL,5460769,3.63888115942649
JHH-4,49766530,0.9310698609536
KYSE-150,135999136,4.969581445777764
DV-90,637858,1.0178013462705249
HEL 92.1.7,241158,3.844440784956009
KYSE-410,3689413,0.6720370091874901
PK-45H,637858,3.525714653404077
COR-L47,9903786,1.6785820828918676
BT 245,136227331,4.251360717375094
IST-Mes1,12003241,-1.7187710036837192
NCI-H2291,73707398,1.387885298831554
HEC-59,9903786,2.2541518083702172
JK-1,107970,0.6168366370340178
A-549,168313016,6.463391576466817
MKN74,6852167,3.3368691353125604
KALS-1,107970,3.013495125773725
KMRC-2,135999136,5.684896477141993
U-BLC1,135421197,1.4306901409483936
NCI-H1573,644241,1.7880619305370915
SU-DHL-1,6852167,2.266746993939426
RVH-421,3689413,0.478404210346996
SK-LMS-1,12003241,-1.0710207153229787
NCI-H1838,sirolimus-bortezomib (250-1 mol-mol),2.042115006385595
KP-2,168313016,4.4737072284411115
BT 416,135398744,7.827037669937473
HCC1500,selumetinib-JQ-1 (4-1 mol-mol),2.938993597127826
KP-2,6852167,2.748552445152737
HCC1143,73707398,0.6963565440176983
HuNS1,262093,2.5146440588932397
NCI-H1623,375860,-0.2497324332058591
JHH-4,107970,2.219436256549423
HCC2218,3689413,-1.7582350299108729
BT 245,46907787,3.440577921160999
BT 159,10231331,4.0293232500193845
KYSE-30,11396600,3.6948052468539654
MOLT-13,107970,2.070591581633897
EFM-192A,sirolimus-bortezomib (250-1 mol-mol),-0.607233737838293
PC-3,135421197,2.1784840639419154
SW1417,10231331,-0.4605053540659229
OCI-AML-2,241158,3.3676277073160237
JHUEM-2,439501,-3.5756847183572704
NCI-H2228,73707398,2.430231026946045
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
BT 139,72967,3.761856387021038
NCI-H1869,12003241,-1.5114527115730307
RPMI-8402,46907787,-0.930500865109614
SNU-C2A,46907787,-0.3001977853137419
KM12,26596,0.910782273652732
SW1783,46907787,3.9046818317286944
WM266-4,sirolimus-bortezomib (250-1 mol-mol),0.2916280413347675
NCI-H747,168313016,4.938874545890276
RL95-2,71466445,3.2305855648631647
NCI-H508,46907787,0.2508579246977522
Hs 578T,3689413,-0.3709013801718254
WM88,12003241,-2.725037582616198
HCC1143,439501,-0.7374061663212956
SNU-C4,637858,2.223101229415045
PC-3,selumetinib-JQ-1 (4-1 mol-mol),5.329469318289121
SK-MEL-31,46907787,2.8803714607156707
Rh18,11396600,3.2185471746223975
PaTu 8988s,100016,6.475282567189534
SUP-B15,168313016,4.060589167875257
TE-8,444795,5.184133125926738
GMS-10,selumetinib-JQ-1 (4-1 mol-mol),2.191227396741531
MDA-MB-361,9927531,5.403888941869855
BT 172,tanespimycin-bortezomib (250-1 mol-mol),-3.8739618006203655
Sq-1,9903786,4.063753255024067
LXF 289,262093,3.4150141342974605
TE-11,100016,3.880053912311749
Sq-1,tanespimycin-bortezomib (250-1 mol-mol),0.5619260521481989
HOP-62,46907787,2.3496891847816905
OV-90,6852167,4.1070875772110185
HuG1-N,107970,2.023608678167257
RPMI-6666,9929138,7.502464828843475
KMS-28BM,3689413,-2.3321976244932134
DU145,73707398,3.2547142234589126
LK-2,tanespimycin-bortezomib (250-1 mol-mol),-0.1134545910607498
COLO 320,375860,0.3995752770957879
SNU-C2A,439501,-1.0520759407127591
SNU-C4,135421197,3.0670219235957914
Ki-JK,9903786,1.8002187553993072
TE-5,5460769,-0.4523281217111792
Becker,49766530,0.5239013848654858
MCF-7,168313016,4.48999133855647
MKN74,637858,2.2619901111682768
MCAS,44491742,4.8173197109659
A-375,selumetinib-JQ-1 (4-1 mol-mol),1.0912668350631578
NCI-H226,9903786,4.103639248775795
CAL-12T,11455910,1.8992809146905865
HT-1080,3689413,-2.4389842103983583
Ku812,selumetinib-JQ-1 (4-1 mol-mol),-3.4448372792658857
JHH-2,46907787,3.1927291980316506
JHUEM-3,11455910,0.589239225317042
KE-97,11396600,3.2423162434671293
NCI-H1793,644241,1.969414301495338
TE-15,46907787,0.2449943729998491
SK-N-AS,49766530,0.7065822517646133
BT 333,6852167,3.960179900726511
BICR 16,637858,2.469326044218029
IGR-1,73707398,1.4805521909749868
HEC-6,46907787,0.920887915413934
SNU-387,107970,2.231476947099596
KYO-1,439501,-2.3318531278707555
JJN-3,6852167,2.0043505861675706
SNU-840,46907787,4.423017532961323
SNU-213,439501,-0.6838743591109449
Karpas-422,73707398,0.5334637120665475
WM793,107970,2.3599025930331368
NCI-H2122,12003241,-0.1228144224546952
NH-6,375860,-0.5773523787871093
8305C,3689413,-2.5688983672154575
F-36P,135398744,6.4039586130062505
NCI-H358,9927531,4.779825407302033
CFPAC-1,135421197,3.4833112622431357
KYSE-30,637858,2.0597026776790544
JL-1,107970,3.007452583664889
HCC1569,444795,4.941392474524884
EFM-192A,71466445,2.8191232050659463
SNU-1066,107970,2.4636875537817433
SW948,12003241,-1.7903806895013192
SH-4,10231331,-1.6536047980695794
NCI-H2196,selumetinib-JQ-1 (4-1 mol-mol),3.899366542869125
Panc 10.05,12003241,0.2449442349226892
SW48,9903786,0.6824641791663469
HCC1833,3689413,0.395553245761409
TUHR4TKB,107970,3.061138054610261
LNCaP clone FGC,73707398,1.3422598428306614
RERF-LC-A1,5460769,2.531170153978
SNU-449,46907787,4.480861537403045
LS180,5460769,0.3293841533128088
RPMI-8226,12003241,-0.708602453849348
SUP-HD1,100016,7.0046366432620735
SaOS-2,UNC0638-navitoclax (1-1 mol-mol),2.2506963685809676
NCI-H1568,3689413,-2.0602171008804935
TUHR4TKB,6852167,3.6957006227457168
BT-12,5460769,4.230264663253868
BT 172,262093,2.689184232302602
AsPC-1,49766530,-1.5554439905221051
MDA-MB-468,135421197,1.1227139239966792
HeLa,26596,-2.0330393314508868
HuCC-T1,11455910,0.6774191240252393
KO52,71466445,2.839981960673523
JK-1,444795,3.5125605826433244
PF-382,26596,-2.06856872789975
CMK,637858,2.2570785394012014
SW982,135421197,2.997806489210206
OAW42,439501,-3.627774271274344
HOP-62,selumetinib-JQ-1 (4-1 mol-mol),-0.1175997595945407
HT115,10231331,0.3575794941006647
A-375,637858,2.049731474801189
HCC1428,49766530,1.5674588812368278
ONS-76,6852167,3.4771955261396252
NCO2,46907787,-1.209980225717052
JHH-5,UNC0638-navitoclax (1-1 mol-mol),0.713308672539544
MOLM-6,UNC0638-navitoclax (1-1 mol-mol),-2.357780415242804
UM-UC-3,637858,2.079800276505731
DMS 114,tanespimycin-bortezomib (250-1 mol-mol),-0.0529426000704769
ESS-1,73707398,0.9452333213652502
SNU-601,49766530,0.5786542106679428
CAL-148,262093,2.3702009846471928
23132/87,135421197,1.295481545457509
HDLM-2,selumetinib-JQ-1 (4-1 mol-mol),1.4826251454250057
HuG1-N,375860,-0.3915682925509006
Ki-JK,3689413,-3.396353931218892
OPM-2,9903786,2.6412283094975657
BT 172,9927531,4.926572000473132
BT 147,9927531,5.037418148394567
SK-MEL-3,11396600,4.278325283702902
SUP-B15,135421197,1.049763554342806
TE-15,375860,-0.9577501669745316
MOLM-6,49766530,0.2890752826418397
NCI-H2087,168313016,4.712660554948847
LCLC-103H,73707398,1.1679839843019937
Ishikawa (Heraklio) 02 ER-,sirolimus-bortezomib (250-1 mol-mol),0.8957919072189129
JHH-2,135999136,4.591945581603726
SUP-T1,107970,1.556646477102781
HCC1833,637858,1.485454068401974
BT-20,44491742,4.162819949257598
SR,168313016,4.7863861467417514
8305C,439501,-2.556096692618791
MDA-MB-453,49766530,3.3081056054922064
MOLP-8,444795,3.9342801961368417
HCC1806,135421197,3.3559114199150697
MKN45,sirolimus-bortezomib (250-1 mol-mol),2.222344728894145
HCC1937,135999136,4.749692180944621
NCI-H1563,46907787,3.500140375056612
DAN-G,107970,2.4101634443904727
RCM-1 [Human rectal adenocarcinoma],11455910,0.3019920512168372
SW1990,54596490,5.639139126471044
JeKo-1,444795,4.544640897314401
BT 239,3689413,-0.6991113979789645
LCLC-97TM1,11455910,0.6647050862050086
NCI-H1184,73707398,0.6283107907901586
SW620,9903786,1.7872370567942188
RT-4,262093,3.3301279648450985
ONS-76,100016,6.019166856387977
SNU-5,73707398,1.5532401180341584
NH-6,26596,-2.8225281366091375
Jurkat,5460769,1.807388363251775
Hs 822.T,UNC0638-navitoclax (1-1 mol-mol),1.6925354489393756
Pfeiffer,135999136,1.352929794196776
Daoy,49766530,-2.465455878883475
T24,11396600,3.350791028009117
SK-BR-3,sirolimus-bortezomib (250-1 mol-mol),-3.644794085557173
BHT-101,tanespimycin-bortezomib (250-1 mol-mol),1.2601290483730383
SW1990,135421197,2.4673652362446887
OS-RC-2,6852167,2.6750903805779833
B-CPAP,tanespimycin-bortezomib (250-1 mol-mol),1.6177879591056448
SNU-869,3689413,-0.5659806105186423
ECC10,11396600,2.3430961684425133
LS1034,selumetinib-JQ-1 (4-1 mol-mol),-0.292584359399862
Ki-JK,6852167,1.5180827510613648
NCI-H2141,9927531,4.975438094968349
OE33,107970,1.9682278614825048
K-562,11396600,3.7562155275673415
MFE-319,135999136,3.968795924273322
JURL-MK1,46907787,-0.3234597989905174
SK-MES-1,9903786,1.5074557756101594
KYSE-520,73707398,1.862286341397532
Mel Ho,375860,-0.1475069462998833
JHUEM-2,5460769,-3.615295030871829
TT,selumetinib-JQ-1 (4-1 mol-mol),1.1402175654992766
HCC15,11396600,3.725702968544969
NCI-H2081,26596,-1.5856459484869678
HuP-T3,12003241,-0.2833744856936582
RMG-I,241158,3.956223740645626
COR-L88,selumetinib-JQ-1 (4-1 mol-mol),1.7913504777641114
EM-2,644241,-5.5059587558621965
NCI-H2196,262093,1.390749456679199
TE-8,11396600,3.483213709023348
THP-1,71466445,1.634612281146758
SUIT-2,3689413,0.4029780891432681
SNU-1079,10231331,-1.013778330631948
KLE,241158,1.9293702793301108
SF539,sirolimus-bortezomib (250-1 mol-mol),0.2813071974909388
AN3-CA,262093,3.1058426937478036
NCI-H1869,71466445,5.354012834432668
NCI-H2122,135421197,1.54063176818906
MeWo,46907787,2.7349600019242963
HCC1195,sirolimus-bortezomib (250-1 mol-mol),1.8421532111980472
NCI-N87,637858,1.7879892218708664
HPB-ALL,11455910,0.3446196457259795
GI-1,100016,6.475829804009189
NCI-H1651,637858,3.1417577804963375
Hs 729.T,UNC0638-navitoclax (1-1 mol-mol),2.435241393916189
Reh,26596,-2.983938152417055
CAL-78,135999136,4.505947344605436
TALL-1 [Human adult T-ALL],selumetinib-JQ-1 (4-1 mol-mol),-0.8847007543917196
CMK,241158,3.7264216380116193
SK-UT-1,3689413,-2.3572164451465105
OVTOKO,6852167,2.7499655001384995
A4/Fukuda,10231331,-0.0070700765814584
SNU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9967147031928247
TE-11,46907787,3.0827761276743346
NCI-N87,11396600,3.282772907192936
NCI-H1650,637858,1.5493828729258998
TTC-709,107970,1.8845253707265144
EBC-1,3689413,0.3969440473796213
COLO 684,9927531,4.094715698749933
NCI-H1339,100016,8.285361450373896
SNU-886,UNC0638-navitoclax (1-1 mol-mol),-7.5974579555081725
MPP 89,637858,1.2560615658967635
TE-1,262093,3.2367135010578134
PC-14,73707398,2.0324483303809666
HuH-1,100016,6.427674645277276
BT 428,439501,-3.4900182991978936
8305C,49766530,-2.6247792402938086
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849
TC-71,71466445,3.509629418813805
GP2d,262093,3.014356837300259
NCI-H1694,46907787,-1.0476402710384092
A2058,107970,2.3458450243640026
KP-2,46907787,4.229874958784046
BT 359,11396600,2.03647677274721
UACC-257,3689413,2.9773275321267945
HEL,3689413,-2.191477482826257
HCC1833,46907787,1.8265768936236628
AML-193,262093,1.541807961893536
DB,9927531,3.16097275010185
HEL,selumetinib-JQ-1 (4-1 mol-mol),-0.6322408734916383
Hs 683,135999136,4.01183659290713
COLO 320,241158,3.262543389019309
SNU-C1,71466445,4.306904502290324
KMS-11,135421197,1.6070380180755417
PL-21,9903786,1.6725311379491856
HuG1-N,11396600,3.640105128263337
TUHR4TKB,26596,-1.9685779873935287
Yamato-SS,46907787,0.3625913303778602
JMSU-1,439501,-3.223216777280016
Hs 934.T,49766530,-2.9625051950902455
HEC-108,9903786,3.9980769668892706
TUHR10TKB,3689413,0.0025132381526345
Hs 294T,44491742,3.9125649468331383
HCC1833,9927531,4.651328537031639
HLF,3689413,-1.4235179966835771
Hs 683,sirolimus-bortezomib (250-1 mol-mol),1.0884212532476678
Toledo,selumetinib-JQ-1 (4-1 mol-mol),4.9688453289491115
MHH-CALL-4,444795,3.2572985338765084
NOMO-1,73707398,0.2786764614411772
8505C,tanespimycin-bortezomib (250-1 mol-mol),0.1990697698035682
NCI-H446,12003241,-2.472170144252885
KYSE-510,6852167,3.606040413694624
MOLP-8,168313016,3.7646553629166304
EFO-27,6852167,4.289895730200754
OCI-M1,tanespimycin-bortezomib (250-1 mol-mol),0.2831250626591589
HEC-59,tanespimycin-bortezomib (250-1 mol-mol),0.4869715963462457
IGR-37,135421197,1.178661342091473
42-MG-BA,sirolimus-bortezomib (250-1 mol-mol),1.266614497912793
SW948,49766530,-0.6875988061214425
NCI-H1703,375860,-0.6025431335029626
23132/87,107970,2.492254606799978
Rh41,439501,-3.728538784636516
SUIT-2,241158,4.373615531607702
HCC78,135999136,4.338544211633957
MKN1,637858,2.106169799801537
SW1417,241158,4.352874922061946
GCT,UNC0638-navitoclax (1-1 mol-mol),2.4775147083922
Kasumi-2,11396600,2.2579616248243495
Hs 683,262093,3.4514070525670295
Kasumi-2,9927531,4.453654232617923
KATO III,135421197,1.1737614873683315
NCI-H1650,11455910,2.7994234029229372
NCI-H1693,5460769,1.1417796185034783
G-361,46907787,-0.7380617933880704
LP-1,262093,1.1866363383040155
2004,sirolimus-bortezomib (250-1 mol-mol),0.3524960836924493
MOLT-16,135421197,0.9266017011835492
K-562,262093,3.1056763935044813
RS4;11,selumetinib-JQ-1 (4-1 mol-mol),0.0937059974096374
ALL-SIL,135421197,0.8278001934093618
RD,135421197,3.4107276707770864
ECC10,44491742,3.5514188140431644
DEL,12003241,1.2715450206031036
COLO 829,73707398,1.647067774146123
Peer,375860,-1.18299630263261
DLD-1,44491742,4.025001948780805
Hs 895.T,3689413,-2.343534689562226
U-BLC1,375860,-0.0684909455881561
NCI-H747,637858,1.7302074070773383
F-36P,135421197,1.230502256000523
EKVX,135421197,0.902433297386992
Mono-Mac-6,6852167,2.351301964226235
Namalwa,241158,1.6214493925930429
SW1088,135999136,4.543955103595509
HEC-6,9929138,7.579418638994079
BT 159,sirolimus-bortezomib (250-1 mol-mol),0.8786451932311966
SKM-1,135421197,1.6359213938027426
NCI-H2126,11396600,4.817248126603388
TE-15,6852167,2.5993041449635794
SNU-423,107970,2.9468491759606303
MIA PaCa-2,12003241,-0.7993036743010778
U266B1,375860,-0.8204266898735075
U-937,71466445,2.7910445117106515
BICR 56,241158,3.5079507073020153
BT 187,135999136,1.2876624032070751
NU-DHL-1,100016,6.7557445252971355
NMC-G1,439501,-2.0387411188020024
NCI-H358,135999136,4.377326657668253
Mel JuSo,11455910,0.951920968650534
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821
Malme-3M,136227331,3.99929328678972
SNU-878,73707398,1.334014436236399
RD,10231331,0.5766168645235544
IGROV-1,107970,2.287061680908213
TE-9,sirolimus-bortezomib (250-1 mol-mol),1.65156532299436
NCI-H1623,selumetinib-JQ-1 (4-1 mol-mol),2.0981342871867903
SJSA-1,9927531,4.886165341408575
KMBC-2,46907787,3.4975434896929674
HCC95,3689413,2.984270072976439
KHM-1B,262093,0.9728016968076376
NCI-H1563,439501,-2.9827403425963492
U-BLC1,5460769,1.2363713333826207
BT 333,11396600,2.8942593651334567
TCC-Pan2,439501,-0.269334901836468
Hs 294T,5460769,3.362841605128932
JURL-MK1,9927531,3.9851065784934945
A4/Fukuda,26596,-3.7061252239164553
HuH-6,11455910,0.6602078622110275
COLO 205,73707398,1.5350438237256383
HCC78,sirolimus-bortezomib (250-1 mol-mol),1.3217046818023197
KYSE-150,11455910,1.1327678102936536
BFTC-909,644241,3.062866082016443
HD-MY-Z,100016,6.5820470291511555
LCLC-97TM1,644241,3.02487415997038
BHY,168313016,5.174584951343697
WM1799,selumetinib-JQ-1 (4-1 mol-mol),-1.4889485752316562
NCI-H322,sirolimus-bortezomib (250-1 mol-mol),2.3812461676498144
TOV-112D,6852167,3.8380412423876353
QGP-1,262093,3.244803388046988
ECC10,644241,2.643631790579766
BT 145,439501,-4.642543329116397
SNU-216,637858,1.4153180245301518
SNU-C1,9903786,1.6227295920089169
VMRC-RCZ,135999136,4.588924618132249
KNS-42,9927531,5.582016236081196
LS180,selumetinib-JQ-1 (4-1 mol-mol),-1.4901017430136672
LS180,12003241,-0.6460664270988897
Mono-Mac-1,439501,-2.692243954974466
COV644,49766530,0.2349932620082565
U-BLC1,selumetinib-JQ-1 (4-1 mol-mol),-1.24963956980548
NCI-H929,46907787,-2.2229329095691495
RT-112,3689413,0.3015272221175239
JHUEM-1,644241,3.1376628194237446
SNU-503,73707398,2.541804283502416
NCI-H1385,44491742,3.386868498663753
AGS,241158,4.254131157773437
COLO 668,9927531,4.694789725560254
SNU-8,9903786,3.356408381726989
GCT,11396600,3.3936538094375317
ECC10,selumetinib-JQ-1 (4-1 mol-mol),0.1905940904726353
RD,375860,-0.3090206369308591
NCI-H508,6852167,2.6729418239485128
HEY A8,11396600,3.7173618063092246
IGR-37,44491742,4.84582247034579
HEC-59,637858,1.9276997282278596
TE 617.T,135421197,0.8388775868881587
NCI-H1155,135421197,0.9372585927098024
LOU-NH91,100016,8.416108067142021
NCI-H510A,9927531,4.438228286684184
HCC2218,262093,2.308676672701105
HCC2279,135421197,3.588174017039921
HPB-ALL,644241,3.355304143351822
HCC1419,107970,2.3261217172500306
5637,11396600,4.421550522360851
A101D,439501,-0.9695989482214274
KYM-1,135421197,2.2292481943308906
GSU,46907787,1.9668852323778605
SK-UT-1,135999136,1.6451873526214251
Daudi,49766530,-5.535187194073846
BT 504,9903786,2.1257740171546717
A2780,46907787,0.387414270491788
SNU-213,262093,3.638008939275064
HDQ-P1,3689413,0.8200542052424229
SNU-8,tanespimycin-bortezomib (250-1 mol-mol),1.1303799126997314
DU4475,135421197,0.912129000759155
Ri-1,71466445,1.3498732213426647
JVM-3,637858,0.8696003861837296
Karpas-620,135421197,3.2232508043122587
KMS-34,375860,-1.1418796151741155
Panc 03.27,6852167,2.678417934109474
Karpas-422,sirolimus-bortezomib (250-1 mol-mol),-8.407469772088508
BFTC-909,46907787,2.3649992203474515
PLC/PRF/5,44491742,4.0953370325315355
A2058,73707398,1.8585898108228869
TCC-Pan2,3689413,-0.1350455546392483
KMS-18,6852167,1.1752786516202087
MKN7,sirolimus-bortezomib (250-1 mol-mol),1.1357480366001242
SK-LU-1,241158,4.950718472920296
JM-1,444795,2.4559914793227597
HSC-2,selumetinib-JQ-1 (4-1 mol-mol),1.4656219122240142
BT 131,UNC0638-navitoclax (1-1 mol-mol),1.908727174025509
LS123,3689413,-2.2814901809462467
DK-MG,439501,-2.8000262894493653
NCI-H28,10231331,1.6918864459680945
LS513,375860,-0.922608188487365
YD-8,46907787,3.160935680087681
SW579,sirolimus-bortezomib (250-1 mol-mol),0.6765835324099176
MCF-7,9903786,3.2865331154211743
Hs 839.T,3689413,-2.374647409552807
ONCO-DG-1,375860,-0.8365182552714027
HT-29,3689413,-0.0079740382830798
OC 314,54596490,6.227091932870461
MHH-NB-11,11455910,-0.4373414457289755
NCI-H1573,10231331,0.5929302495217658
NU-DHL-1,135421197,0.761695548293036
OCI-Ly10,100016,6.418038918193145
MG-63,439501,-2.9607530024491515
NCI-H1184,tanespimycin-bortezomib (250-1 mol-mol),-0.120544891510118
PE/CA-PJ49,9903786,3.1609136015972847
L3.3,439501,-0.248470622878828
LS180,3689413,1.3392854552239355
KYSE-510,73707398,1.7707709875360005
HCC4006,262093,2.439333720308208
KMS-26,46907787,-2.97816119814664
CCK-81,71466445,2.0404974765306085
BT 271,439501,-3.3712164407205916
DU145,49766530,-0.0443271676579987
KE-39,12003241,0.559414259019648
KYSE-140,49766530,-0.5324613674424623
Mel Ho,71466445,3.8263355015421503
U-BLC1,11396600,3.266285635126102
Pfeiffer,sirolimus-bortezomib (250-1 mol-mol),-8.074968240863114
MV4-11,444795,-2.88363162511681
COR-L105,9927531,5.197941564874311
DU4475,26596,-2.6903175915045305
Hs 940.T,6852167,2.7181130284574793
MeWo,tanespimycin-bortezomib (250-1 mol-mol),1.6748762379833977
NCI-H526,637858,1.1191066667687413
HCT 15,241158,4.134051598727554
PE/CA-PJ15,100016,6.230779358531284
SNU-478,444795,4.74563569018297
NCI-H322,637858,2.9009451409256273
NCI-H1703,135999136,4.447228934762928
NCI-H2110,54596490,5.001361284562202
SNU-840,241158,4.028396774971829
NCI-H211,637858,1.4615716709012136
AsPC-1,49766530,-1.5554439905221051
AsPC-1,637858,2.8111542457272605
COR-L95,135421197,1.4504202802892363
CJM [Human melanoma],3689413,-1.0332065150817793
NCI-H2170,46907787,3.956167889910436
Daoy,26596,-2.0962215675601024
YD-15,71466445,5.119296595757631
NCI-H1435,439501,-0.9104784538070396
UACC-257,46907787,5.925125259909612
DB,tanespimycin-bortezomib (250-1 mol-mol),-0.1936867614029041
ST486,135421197,0.3717374472748143
Lu-99,10231331,1.318316273900534
EFM-192A,262093,3.3016365369190614
JURL-MK1,168313016,3.946784557441632
D283 Med,selumetinib-JQ-1 (4-1 mol-mol),1.653180962560337
SUP-M2,637858,0.6632556191760942
SEM,135421197,0.5141119166667375
KP-3,107970,2.4048716428801677
HuH-6,439501,-1.8507525220603604
SNU-16,3689413,-2.4569670929316656
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284
COLO 205,262093,3.276906461196508
253J,375860,-0.8253978695794215
NCI-H2444,46907787,3.4332033911522126
NCI-H2009,12003241,-1.6852069192913937
HCC1438,168313016,6.342901339897561
BT 422,12003241,1.9442582460098417
OV-90,135421197,1.209947389883954
253J-BV,241158,5.2277807850188
KYSE-30,262093,2.7328983938102693
TTC-709,sirolimus-bortezomib (250-1 mol-mol),0.2718728202081833
SNU-16,71466445,2.4496252530891525
786-O,107970,3.015534830895647
RD,46907787,1.7054026101917616
Panc 08.13,241158,4.606670048460817
TE 441.T,6852167,2.229580798352396
A2780,26596,-4.32263985415392
HCC1419,selumetinib-JQ-1 (4-1 mol-mol),4.191406953790356
NCI-H838,26596,-1.3070884520917134
BT 340,11396600,2.9184379115774375
TT2609-C02,136227331,4.484463069653878
A-673,UNC0638-navitoclax (1-1 mol-mol),0.924898873011094
ONCO-DG-1,439501,-2.5478488812484015
Kasumi-2,11455910,-0.3707966959989963
KO52,135421197,1.227280721989531
MES-SA,12003241,-0.7503338761579216
DB,selumetinib-JQ-1 (4-1 mol-mol),0.9497259010838596
COV434,444795,5.643905455381125
MHH-CALL-3,9903786,1.8198372830428096
HuP-T4,241158,4.238157785514265
NCI-H1838,49766530,5.619169884682744
SCaBER,73707398,1.3236589923807338
LOU-NH91,UNC0638-navitoclax (1-1 mol-mol),-2.1290518505040854
Jurkat,9903786,1.902939896932713
KYSE-150,439501,-2.052967446367251
TE-5,3689413,-3.902523210420284
LAMA-84,100016,4.28644111913654
COLO 792,107970,1.4461618436680284
GA-10,44491742,3.5610264108230365
HGC-27,11455910,-0.7196123988614116
Panc 10.05,73707398,0.9040448931915048
Kasumi-1,135999136,3.6917766554725175
SNU-466,49766530,-2.375695720565105
SNU-1079,46907787,-3.0889383409725992
U-118MG,439501,-2.7971615553970675
KMS-11,168313016,3.7893432463065713
NUGC-4,49766530,-0.8370280457407315
Ki-JK,262093,2.27215883158064
SF268,107970,1.9571800308435767
JeKo-1,3689413,-2.4394197066593835
A-549,49766530,0.1688758689952186
TCC-Pan2,9929138,7.681781953750215
JHOC-5,637858,2.3474009196061973
DV-90,135421197,0.8587381868219376
HEC-1-B,12003241,-1.9447585975595445
SNU-601,26596,-1.2729418504176535
PL-21,135398744,6.318867550173511
P12-Ichikawa,3689413,-1.803795844399087
NCI-H1155,44491742,3.896429855213272
HuH-1,11455910,4.282125665148122
MOLM-13,3689413,-2.8005667715254017
PaTu 8988t,selumetinib-JQ-1 (4-1 mol-mol),1.6621315506186802
COR-L88,439501,-1.6986263045412435
HMCB,262093,2.6900614407313355
C2BBe1,72967,3.7345422437876254
A-204,6852167,1.599589382352186
MIA PaCa-2,9927531,4.662028210048159
GA-10,136227331,3.9402947188121793
Aska-SS,135999136,2.4639426582272796
LMSU,73707398,1.6424339360302744
MFE-296,375860,0.0283845052081567
OE33,selumetinib-JQ-1 (4-1 mol-mol),2.2373751377171938
Capan-1,107970,3.0385955558587434
L-540,107970,2.1674122993429252
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633
HEL 92.1.7,12003241,-0.5838184983387604
JIMT-1,73707398,1.677314809441859
RPMI-8402,selumetinib-JQ-1 (4-1 mol-mol),1.0607904490994169
A101D,637858,2.3382819963464967
BT 359,6852167,4.533677121834974
MIA PaCa-2,44491742,3.8709962970987464
Karpas-299,107970,1.6107801137995834
PF-382,168313016,4.6371186800984745
TALL-1 [Human adult T-ALL],73707398,0.2643947199828666
MDA-MB-157,6852167,3.8998726158787007
NU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),-0.9508883032540202
MG-63,262093,3.0447141305088614
MV4-11,9903786,0.7441932169203459
MOLT-16,3689413,-0.0606324778239056
Sq-1,12003241,-0.6972908416742193
NB4,375860,-1.341920340962159
SCC-25,100016,6.900174579464034
TUHR10TKB,637858,1.682299707905914
HEC-1-B,637858,2.0958235368347293
BL-70,100016,3.880189960258483
M-07e,135999136,1.658429474822417
OE33,sirolimus-bortezomib (250-1 mol-mol),0.234198569818553
NCI-H23,9903786,3.588944874892838
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
TE-9,375860,-0.8213044409878748
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014
YD-10B,3689413,2.253033530854965
Karpas-422,26596,-1.4945297758647662
NCI-H1105,11396600,3.854794582402416
NU-DUL-1,6852167,0.3945833512314752
OE33,5460769,3.7320924588923465
Karpas-299,11396600,2.5931923649102804
Jurkat,73707398,0.9750698244222464
BT 179,262093,3.0912681706054492
LMSU,241158,4.2548793295703025
MOLP-8,12003241,-1.4499361325619826
OE33,637858,2.678273035808489
T24,sirolimus-bortezomib (250-1 mol-mol),0.798518469796891
MHH-CALL-4,73707398,0.4741930113136588
T84,375860,-1.0611721246965713
KYO-1,selumetinib-JQ-1 (4-1 mol-mol),0.0180906147444378
NCI-H2122,6852167,2.6058424993180247
NCI-H2023,5460769,4.150302713550692
KMS-34,sirolimus-bortezomib (250-1 mol-mol),-7.371271931180508
Hs 611.T,9903786,0.3508528062947837
NCI-H1915,46907787,2.8693661385266
HDLM-2,46907787,1.6560945810392764
BT 422,135999136,1.6828969655433983
SW1271,637858,1.8302889918552376
MDA-MB-453,9927531,3.885109165752666
Detroit 562,selumetinib-JQ-1 (4-1 mol-mol),1.562753151865237
HCC1428,11455910,0.3865695172976586
LP-1,107970,1.8011925115015095
MDA-MB-453,637858,1.2138352699902215
8-MG-BA,3689413,0.0230588346989354
DBTRG-05MG,439501,-1.6362214385175518
EFO-21,54596490,5.632352941512187
DMS 273,71466445,2.157471967137961
SUP-M2,44491742,3.782473940408551
LC-1F,sirolimus-bortezomib (250-1 mol-mol),1.5648585655869938
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585
COV644,168313016,4.295385194423968
KMS-34,UNC0638-navitoclax (1-1 mol-mol),-1.1659764168057434
Rh30,9903786,2.553175737800522
BT 164,11455910,0.017477073320278
TC-71,135421197,1.432077175902578
AsPC-1,3689413,-2.062701377390924
JIMT-1,6852167,4.253888723725077
OAW28,46907787,2.388022074777516
RERF-LC-A1,637858,2.1829548820407165
Panc 04.03,44491742,4.30815140156182
SK-LU-1,49766530,-1.2707580776234786
Daudi,241158,1.9180708700138325
MHH-CALL-3,3689413,-1.9959162007922513
SK-MEL-1,6852167,3.260361139868282
THP-1,10231331,-2.0055855111768697
HCC1171,241158,3.854682403921552
BT-20,644241,2.7102093275988133
NH-6,135999136,3.2691781476001744
BV-173,9929138,5.5371919710520325
BT 159,selumetinib-JQ-1 (4-1 mol-mol),1.6689047126090906
OVCAR-4,49766530,-2.103044081091216
Hs 578Bst,637858,1.5469526457433171
IGR-1,9903786,4.216869468062427
SK-MES-1,168313016,3.674631178203009
L-540,136227331,3.8428800907354983
CL-11,selumetinib-JQ-1 (4-1 mol-mol),-3.72089292117095
FaDu,135421197,1.369051763273762
KALS-1,241158,1.844994871137429
RPMI-7951,9927531,5.17840544344631
IA-LM,168313016,4.257474229118996
JeKo-1,11396600,2.6042135230770325
COV434,sirolimus-bortezomib (250-1 mol-mol),-0.3799222121291876
TE-14,135421197,1.7423329869648043
TYK-nu,tanespimycin-bortezomib (250-1 mol-mol),-0.3612776377127862
DMS 273,49766530,-1.3487399530522592
P3HR-1,444795,4.927433768581791
HCC2279,sirolimus-bortezomib (250-1 mol-mol),1.5842839132976092
L-363,168313016,3.838439815056608
A3/Kawakami,3689413,-2.523189913009787
BT 320,439501,-1.927418392306892
SNU-1214,selumetinib-JQ-1 (4-1 mol-mol),-0.4737134364925926
MDA-MB-157,135421197,1.265960780615991
HCC1954,71466445,4.2589101297816
OVCAR-8,sirolimus-bortezomib (250-1 mol-mol),1.6177185023966834
SNU-466,6852167,4.01396121923117
TE-10,439501,-2.523220580930317
OE21,5460769,0.0529032243874579
BT 271,5460769,1.6664418058692942
BFTC-905,44491742,3.9351753124000073
SNU-398,135421197,1.394943523979563
NCI-H1734,6852167,1.6616243857794395
NCI-H23,107970,2.3320218632275096
BICR 18,73707398,1.6642895703320195
2004,5460769,0.3983589325904631
SNU-503,9927531,6.946018069076572
5637,100016,5.253062593048346
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
Kasumi-1,3689413,-0.2693105089834908
L-540,12003241,-2.1812715398766844
SK-N-SH,444795,4.912607426917253
PE/CA-PJ34 (clone C12),selumetinib-JQ-1 (4-1 mol-mol),1.4884609912866928
KYSE-30,73707398,1.0667429400266626
OCI-Ly3,12003241,-1.5890645032871102
Detroit 562,26596,-2.098444949143179
SK-LU-1,9903786,1.4733207164642357
Calu-1,9927531,5.244935764908175
NCI-H508,135999136,4.354641124621475
A-375,6852167,3.704250523230319
UO-31,11396600,1.978530758998764
LNCaP clone FGC,71466445,3.001006325551692
SNU-46,262093,2.777218393099506
PE/CA-PJ15,44491742,3.9025986426144934
NCI-H1563,sirolimus-bortezomib (250-1 mol-mol),2.9865151808582615
NCI-H1435,135398744,6.3008870427516115
WM983B,5460769,5.3340527249808005
ALL-SIL,637858,0.2842777242368783
OCI-AML-2,26596,-2.6744696757916215
PF-382,71466445,1.9189761436188
DU145,selumetinib-JQ-1 (4-1 mol-mol),3.7436181665569137
U-251MG,selumetinib-JQ-1 (4-1 mol-mol),5.468916065595192
NCI-H524,375860,-1.0954179632346426
MV4-11,6852167,0.3226146559681107
BT 179,6852167,5.751557945891216
TOV-112D,73707398,1.216080457841962
Panc 04.03,5460769,2.0457621674825224
SIG-M5,49766530,0.6577937335718277
SU-DHL-10,375860,-0.3702588226637646
NOMO-1,135421197,1.2386186938920458
HT,262093,2.3474073826292265
NCI-H889,637858,1.600777353937621
WM1799,637858,1.7330510519637692
G-361,3689413,0.7888420983212308
697,3689413,-4.592685729606217
Tm87-16,135421197,2.3570280625350057
SNU-685,135999136,4.652702404642394
GCT,637858,1.0385345002534945
KNS-60,107970,2.476032725637248
MOLT-3,135421197,0.6925394528870177
SNU-8,11455910,1.7503640063904615
THP-1,44491742,3.722381012581274
WM1799,6852167,3.2210767792178827
RL,12003241,-0.503691110401914
NCI-H1435,135421197,1.75045264737253
DMS 114,9929138,6.976557704238316
OCI-AML-3,6852167,1.22318237293595
Sq-1,UNC0638-navitoclax (1-1 mol-mol),-0.0941415801553838
PL-21,12003241,-0.83006256212438
MDA-MB-468,107970,1.7140259838975702
Peer,46907787,-0.6755973461446936
BT 232,107970,1.965995572624395
NCI-H1563,11396600,3.5189077710115244
Hs 888.Lu,9903786,2.210543303670434
NCI-H838,71466445,4.919843327137771
EJM,11396600,3.800195279839431
Raji,100016,6.465762715187829
RS4;11,375860,-1.0420029340567167
A2058,135421197,3.1634124303989273
LOU-NH91,241158,4.097895358021133
BT 428,tanespimycin-bortezomib (250-1 mol-mol),-1.9102610894463772
NCI-H520,46907787,1.4915843927881316
Jurkat,135999136,1.446686093818366
KP-4,73707398,1.2219624501401705
FTC-238,44491742,5.664145193267726
EHEB,73707398,0.3528380726382398
IGR-39,107970,3.0190333972500913
BT 164,375860,0.1283909632199744
TT2609-C02,637858,3.064237161486694
SW1353,3689413,-1.8577928934605696
Calu-1,637858,1.6711749737628838
NU-DHL-1,6852167,1.5672236440525231
UACC-62,637858,3.1015028924179164
SNU-213,3689413,0.5464532854962126
TE 617.T,6852167,3.448270243983474
SNU-668,262093,3.825984415177203
KU-19-19,135999136,4.912207411852192
SCC-4,5460769,3.1702887923440466
UM-UC-3,6852167,1.955849338539072
BL-70,241158,1.7812102764916156
NCI-H520,637858,1.8177885969386705
BICR 18,selumetinib-JQ-1 (4-1 mol-mol),2.0446383498260534
WM115,5460769,2.9023963298546507
EM-2,44491742,3.7753697950117897
LC-1/sq-SF,637858,3.634884010371685
KMS-18,375860,0.187704093925913
ME-1 [Human leukemia],73707398,0.5585508807159069
MOLP-8,71466445,1.892906464336944
COR-L51,11396600,3.4123493157330027
KMS-21-BM,26596,-2.3391795645360403
Rh30,241158,3.625038807076232
TE 617.T,11396600,3.161779711193339
KMS-12-BM,26596,-3.7364157309734822
MOLT-13,sirolimus-bortezomib (250-1 mol-mol),-0.8755495405790606
HEY A8,637858,2.557883541626409
TOV-112D,100016,6.758334848108728
KMS-28BM,439501,-2.813687034658713
SNU-1196,49766530,-0.055725374284701
JHUEM-3,241158,4.29308217340487
Hs 944.T,selumetinib-JQ-1 (4-1 mol-mol),-1.1784399840398554
CMK,sirolimus-bortezomib (250-1 mol-mol),0.3522446092805081
BT 422,136227331,4.344086098247262
YD-38,9903786,2.8631306213752103
KMS-27,241158,2.104620669820106
RERF-LC-Ad1,49766530,-0.8755533009144216
WT2-iPS,tanespimycin-bortezomib (250-1 mol-mol),-2.960139188693383
GB-1,tanespimycin-bortezomib (250-1 mol-mol),0.6130587014327358
COV362,135421197,3.17227725861234
HeLa,439501,-2.848382287027866
Detroit 562,tanespimycin-bortezomib (250-1 mol-mol),-0.6563279140280487
BHY,12003241,-1.9102935005607824
TE-4,tanespimycin-bortezomib (250-1 mol-mol),-0.9407472033022316
SK-MEL-1,3689413,2.3373069635982495
HuH-28,11396600,3.662277898501366
NOMO-1,439501,-2.35226533453039
REC-1,9927531,3.800278065681949
PaTu 8988t,135421197,1.788370067257354
697,11455910,-1.5843121483230655
PANC-1,241158,4.756219321498369
HCC2218,168313016,4.988518158983073
HuH-6,107970,0.8073577315762971
KP-3,49766530,-2.4187443119050904
MCAS,73707398,1.1782781305000984
NCI-H1838,73707398,0.6541596314038816
Calu-6,73707398,1.205682955793124
MOLM-6,selumetinib-JQ-1 (4-1 mol-mol),-0.8995054444130357
SNU-C1,5460769,4.252440714424883
Caov-3,3689413,1.9135377903432256
PE/CA-PJ34 (clone C12),375860,-0.361568415532625
UO-31,6852167,2.94948623576417
Caov-3,sirolimus-bortezomib (250-1 mol-mol),1.7880451090258302
HLF,71466445,3.5325302047070295
GSS,9877608,3.923769598981982
KMS-12-BM,135999136,1.7056569950210811
Jurkat,sirolimus-bortezomib (250-1 mol-mol),-2.067381581487011
Yamato-SS,439501,-2.9542074712794517
HEC-151,9929138,7.082890356746388
SNG-M,9929138,6.049726158148494
UACC-62,241158,4.23511002277846
OCI-AML-2,sirolimus-bortezomib (250-1 mol-mol),0.9467040078581898
Jurkat,6852167,1.7593049967611742
SNU-466,439501,-2.48566817429276
GP2d,168313016,5.68534337088213
BT 231,73707398,1.611870726926167
SNU-738,135421197,2.9898433759416396
HEC-6,262093,2.3423105964881414
GA-10,135999136,3.782942361648187
A-549,44491742,4.437272986024
MIA PaCa-2,136227331,4.243512473772355
LC-1/sq-SF,sirolimus-bortezomib (250-1 mol-mol),0.7549261124626822
OCI-M1,sirolimus-bortezomib (250-1 mol-mol),0.0784730767185344
TE-1,135421197,1.2529610572902146
SNU-175,637858,-0.1007556152188427
TT,637858,2.8122907208600676
BT 228,11455910,0.8628346849534536
TCC-Pan2,selumetinib-JQ-1 (4-1 mol-mol),-2.1073076371814667
SNU-1077,49766530,-1.9738465664800544
KMS-11,11396600,1.6057835101589155
HL-60,262093,1.12595796571635
ALL-SIL,5460769,0.8731159867521163
Caov-3,637858,1.6331589021286677
SCaBER,637858,2.007494552130968
HCC366,262093,3.5189758741975905
EB1,49766530,-2.446229475307264
HT-144,637858,2.176874063733469
REC-1,44491742,3.8136752597353953
H-STS,12003241,-1.720451684377523
THP-1,637858,1.002288461822537
L3.3,262093,4.054875705556861
KYSE-510,11455910,0.588334409452975
EBC-1,UNC0638-navitoclax (1-1 mol-mol),3.6336601547096503
EPLC-272H,11455910,1.2178341739631082
OE21,10231331,0.7094072975995727
P12-Ichikawa,44491742,4.234271740927445
Kasumi-1,6852167,0.8999296873470045
HH [Human lymphoma],selumetinib-JQ-1 (4-1 mol-mol),0.1451973449780448
CAMA-1,selumetinib-JQ-1 (4-1 mol-mol),1.6036689260374652
MHH-CALL-3,135398744,6.205129646453742
HEC-1-A,46907787,1.2689818779824844
MOTN-1,9903786,1.5262783813128549
Fu97,6852167,1.3919958052442372
SNU-1079,168313016,1.9938843500812935
MV4-11,10231331,-0.0666057003982483
NCI-H1755,6852167,2.94649587469227
HuP-T4,6852167,1.1747824212222648
CAMA-1,262093,3.184417935809398
NCI-H226,107970,3.317033859610873
BT 271,644241,2.5391465532485564
RKN,73707398,1.136221501718042
OAW28,49766530,-0.5315014966120291
A-204,262093,2.2081126884410764
NCI-H28,9927531,4.6016482528028515
DMS 454,selumetinib-JQ-1 (4-1 mol-mol),2.137011851517838
SNU-387,selumetinib-JQ-1 (4-1 mol-mol),0.6613396146104882
HuP-T3,9903786,4.0743016574038915
JJN-3,tanespimycin-bortezomib (250-1 mol-mol),-0.8037062174146113
CCF-STTG1,135999136,5.41297640167708
EB1,12003241,-4.025525342770554
OCI-AML-3,637858,0.7817011573177973
P-STS,135999136,4.20452870640474
ALL-SIL,262093,0.6753795238054565
KM12,5460769,1.9442092441204395
DMS 53,6852167,2.392011330045594
COR-L51,135999136,4.175528591862206
NCI-H1568,439501,-2.6831567396736022
NCI-H1568,241158,1.943489424131273
LS1034,262093,2.9969405069392963
DMS 454,46907787,-0.5101535213897416
BT 271,selumetinib-JQ-1 (4-1 mol-mol),0.8721966521481374
REC-1,46907787,4.0420421547178975
SK-HEP-1,73707398,1.730256970360003
KE-97,168313016,4.176662787294865
SW620,262093,2.830381572601645
MOLT-3,5460769,-0.5989426440895276
ChaGo-K-1,UNC0638-navitoclax (1-1 mol-mol),3.3725673517370662
SIG-M5,sirolimus-bortezomib (250-1 mol-mol),0.1286056255448012
DB,49766530,-1.6801310295102778
LOU-NH91,136227331,3.865245001267085
HCC4006,9927531,5.0093588349321125
NCI-H522,375860,-0.630771500248647
Hs 688(A).T,644241,2.0149750049986452
SW579,241158,3.28708470010344
NCI-H226,tanespimycin-bortezomib (250-1 mol-mol),2.419002105970759
MOLT-16,100016,4.920795787487072
COR-L95,9927531,5.207677506691081
NCI-H1734,sirolimus-bortezomib (250-1 mol-mol),-0.1121283938952372
Kelly,selumetinib-JQ-1 (4-1 mol-mol),0.3130303472508387
GP2d,46907787,2.1457899624672296
SK-MEL-3,sirolimus-bortezomib (250-1 mol-mol),0.3038157322659797
HEC-1-B,107970,2.166435384493281
NCI-H1838,100016,6.459213557236613
SNU-601,168313016,4.9872270729910255
B-CPAP,12003241,-1.7111954205398938
MFE-319,26596,-1.024111788947852
Li-7,71466445,3.6770078176216536
P3HR-1,tanespimycin-bortezomib (250-1 mol-mol),1.2081674914796665
NCI-H522,135999136,4.552466214525868
HCC78,tanespimycin-bortezomib (250-1 mol-mol),1.9748974265856916
NCI-H716,241158,3.477027636615277
SIG-M5,9903786,1.9849552317824917
MOLM-13,9927531,3.44947203831576
SK-N-BE(2),10231331,-2.0949368191083466
BT-16,12003241,-1.8198494997272787
Granta-519,3689413,-2.6080640580656977
KMRC-3,262093,3.093643058080816
HEY A8,107970,2.371695678258084
BT 147,135398744,6.518001641470466
SW982,241158,3.5394445387006948
JMSU-1,46907787,1.0426197937359232
U2OS,3689413,0.3310874452746708
SIG-M5,168313016,4.915391806280637
HuG1-N,11455910,1.8248856097934676
Kelly,73707398,0.4225318745477273
SNU-216,262093,2.2180002949269793
NCI-H1373,selumetinib-JQ-1 (4-1 mol-mol),1.3695812893088852
KYSE-450,262093,3.266752988649651
BT 416,46907787,1.2743651659496544
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997
8-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),0.0897901825982692
SW948,107970,1.650733689507072
COR-L47,26596,-5.5673450877852995
MDA-MB-361,100016,6.5281042722822145
U266B1,241158,2.766625072392717
Raji,71466445,2.2613596218999295
SF539,UNC0638-navitoclax (1-1 mol-mol),2.2023146643666323
HLF,5460769,2.8126856105883355
OAW42,73707398,1.7425852441434224
SNG-M,73707398,0.9251887702431444
TUHR10TKB,sirolimus-bortezomib (250-1 mol-mol),1.3489758983524096
BT 172,26596,1.567138444115151
HOP-92,54596490,4.357567293340528
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163
HuP-T4,107970,2.3366903299299935
Hs 822.T,637858,3.031541188164114
MEC-1,26596,-1.4944057602934653
HeLa,6852167,3.9174873228525353
TE-6,107970,2.2926230294608776
JHH-2,439501,-1.6705307194191004
VMRC-RCZ,49766530,0.1680653140003736
WM88,49766530,-2.7931642846980336
DU145,54596490,4.798915584619797
HPAF-II,439501,-2.2531231348817715
LXF 289,107970,2.2922723928752307
IM95,439501,-2.2673196662301933
Hs 578Bst,73707398,1.3431993476303796
NB4,6852167,1.4864413822511506
NCI-H211,9927531,3.644928626875117
Peer,12003241,-2.4634872028083015
NCI-H841,71466445,4.53794934837107
BICR 31,9903786,2.10396775229317
JHH-1,135999136,4.28736281530391
Peer,UNC0638-navitoclax (1-1 mol-mol),-1.4165935954052693
NCI-H2342,241158,4.482197649882829
23132/87,tanespimycin-bortezomib (250-1 mol-mol),-3.0777539592464227
IGROV-1,49766530,-0.195540678413639
HuP-T4,135421197,1.5998853236041033
HCC1395,73707398,1.348655515938351
NB1,107970,2.3226504043825287
BT-474,49766530,-0.1663339170498422
RL,135999136,1.4689449879319691
EFO-27,5460769,4.47484627366887
DK-MG,5460769,1.2841485986218522
UO-31,44491742,3.8837342350027377
KMS-11,9903786,1.9090096011276083
TM-31,12003241,-1.3961411648113156
BFTC-905,12003241,-0.5086689742708943
HCC1500,135421197,1.2704457907642457
SUP-HD1,439501,-1.483428569132062
BT 340,10231331,4.137603645680791
BT 112,26596,-1.3919420546275056
KMS-21-BM,10231331,-2.04952218948576
OAW28,44491742,4.754653012158477
LN-229,439501,-1.7560244035844634
OCI-Ly19,26596,-2.6757237263114875
OC 314,UNC0638-navitoclax (1-1 mol-mol),2.3317167150978584
NCI-H446,11396600,2.9015736046433607
NCI-H2029,26596,-1.020700117051714
JHH-2,sirolimus-bortezomib (250-1 mol-mol),0.503615314024041
KMRC-3,26596,-1.545617580729079
Calu-3,tanespimycin-bortezomib (250-1 mol-mol),0.4939757205414833
NCI-H226,11396600,3.8487542891861697
HuG1-N,135398744,6.4115232793077235
Ku812,9929138,4.0796690015060095
TOV-112D,12003241,-0.8504182456561812
NCI-H2009,49766530,0.9767616789625324
KMRC-2,444795,5.142588115774172
SNU-1,135421197,1.7958722609417297
OV56,262093,3.284870427010587
OE21,11396600,3.3249407167750284
T98G,46907787,2.563671389341863
A4/Fukuda,9903786,0.7546004224414102
CGTH-W-1,241158,3.697852979444439
NUGC-3,637858,1.9360146170624208
Mino,71466445,1.235748115046604
SNU-489,12003241,-0.3449149032803904
G-292 clone A141B1,10231331,4.526878083033799
BT 131,444795,4.929583132306808
NCI-H841,439501,-5.095559559459305
LS411N,73707398,1.3643081745247092
NCI-H810,135398744,5.260119762115652
RL,3689413,-2.4285945149334185
BT 482,262093,2.2810025470588102
CAL-33,135999136,4.312581278342569
Hep-G2,46907787,3.3643071732848
TE-8,73707398,0.912270343350113
TOV-112D,26596,-2.3004297516066927
BT 482,135999136,2.0696310473297768
KYSE-70,selumetinib-JQ-1 (4-1 mol-mol),2.626623407119128
CAL-51,6852167,2.546662292056567
KMH-2,11455910,1.2516447842889498
PaTu 8988s,6852167,3.1010868108448832
Hs 683,73707398,1.2895938784946597
NALM-6,241158,2.1531208223375
TF-1,3689413,-2.3947116127493797
HuNS1,selumetinib-JQ-1 (4-1 mol-mol),0.1641694525405924
CMK,375860,-0.825698439326878
RPMI-7951,9903786,2.3675771120862485
Jurkat,46907787,-0.5839129118288405
HCC1833,241158,3.043564904971582
P-STS,73707398,-0.0870893043837352
COV434,71466445,1.9159359610911857
CMK,tanespimycin-bortezomib (250-1 mol-mol),0.1761627875965655
HMCB,100016,6.123582467992384
NCI-H1155,26596,-2.1815551982286885
SW1417,5460769,5.65335320943634
SNU-1196,46907787,4.641039727024587
KALS-1,136227331,4.320673828023345
Mel Ho,5460769,6.181973204258103
P31/FUJ,9903786,1.0734919883099745
JK-1,46907787,0.9440267753612736
8505C,9929138,7.301174384982561
BT 340,135421197,2.5749512763200824
SNU-466,375860,0.3319976998596873
SJSA-1,100016,7.674645652371816
SNU-119,10231331,4.363406465804169
NCI-H28,135421197,1.3178315366428714
KHM-1B,9903786,1.5275790345873377
KMS-28BM,46907787,-0.0548327067626499
HEC-6,tanespimycin-bortezomib (250-1 mol-mol),0.7644617965871396
BT-549,135421197,3.4062158650675265
SK-MEL-3,241158,4.338095980194072
NCI-H1755,3689413,1.3270015579538552
GA-10,71466445,1.994023479253392
BT 340,107970,2.016731313243945
COV644,tanespimycin-bortezomib (250-1 mol-mol),2.484857024985863
SNU-8,439501,-2.494664293068585
F-36P,9903786,0.2788806994422486
MOLP-2,6852167,2.4581845144067853
PC-3,444795,5.089315637194618
NCI-H292,135999136,4.360218039072087
NCI-H1869,5460769,3.405523512527605
RKO,5460769,5.660789679983863
KYM-1,UNC0638-navitoclax (1-1 mol-mol),2.797768732363665
Rh41,UNC0638-navitoclax (1-1 mol-mol),0.2843737570532182
SUP-T11,100016,5.673603064365157
SKM-1,5460769,2.732858525958475
MIA PaCa-2,3689413,-2.455927464924985
HD-MY-Z,44491742,3.754375539988437
CAL-12T,375860,0.2281009293347852
PaTu 8988s,selumetinib-JQ-1 (4-1 mol-mol),0.3498739449396179
JK-1,71466445,1.5365502092012424
KNS-60,439501,-2.666798913296539
HCC1428,54596490,5.919134315186448
SNU-1033,11455910,1.238389627301748
OAW28,49766530,-0.5315014966120291
SNU-1033,46907787,1.4215977745383968
TE-9,637858,2.7560592782365454
JHOM-1,135999136,4.389225693013997
SK-ES-1,6852167,1.4651919042879715
NCI-H1869,49766530,-0.032716755694371
SNU-8,49766530,-3.645853792041198
OE33,3689413,1.522493576982794
Yamato-SS,11455910,2.3027203497268327
ESS-1,444795,3.9723378710264985
JURL-MK1,100016,3.373338788856286
FaDu,46907787,3.7880775071647377
NB1,375860,-0.2400015719415603
OCI-Ly3,44491742,3.926689861618192
BT 131,9927531,5.2651806903181235
DAN-G,46907787,4.341199528724315
KPL-1,3689413,3.184676645737856
NCI-H1092,UNC0638-navitoclax (1-1 mol-mol),0.7964927017699627
KCL-22,73707398,1.053432785971903
SNU-1,262093,3.13624265052581
KMS-26,262093,1.018601177342637
JHH-1,262093,3.2882358665123426
JeKo-1,241158,1.9415728140254451
KLE,3689413,-1.503166424361693
SUP-B15,selumetinib-JQ-1 (4-1 mol-mol),0.3382807042409725
Karpas-422,selumetinib-JQ-1 (4-1 mol-mol),-0.3387810810596827
NCI-H520,11396600,3.7776798770198594
JHH-6,49766530,1.0695229920160838
Calu-6,sirolimus-bortezomib (250-1 mol-mol),1.0438055867495408
NCI-H1092,11455910,0.2647471022018075
PC-3,11455910,0.8033042289278307
MHH-NB-11,26596,-2.2895666937918673
NCI-H838,439501,-0.7442992299750818
KNS-60,tanespimycin-bortezomib (250-1 mol-mol),1.2079185483503194
HCC1588,375860,-1.1262838478639452
MDA-MB-157,71466445,-0.8161407888171323
MCF-7,6852167,1.253402776787036
JHOC-5,135421197,3.377612264303829
KMRC-20,439501,-2.469138258710991
IGR-1,637858,2.3337050705342453
HMCB,9903786,3.962700823971229
HPB-ALL,UNC0638-navitoclax (1-1 mol-mol),-0.420170411701019
L-1236,sirolimus-bortezomib (250-1 mol-mol),1.403422736729983
MM1.S,3689413,-0.3922685663675629
J82,tanespimycin-bortezomib (250-1 mol-mol),2.212384566230415
Hs 578Bst,136227331,4.283595415699579
SU-DHL-1,637858,0.6782178889909583
NUGC-3,71466445,2.3864279046881673
SET-2,241158,3.0184145193600807
U266B1,9903786,3.1119057024478094
G-361,sirolimus-bortezomib (250-1 mol-mol),0.933443297731252
A-673,46907787,1.1836850249017303
NCI-H929,3689413,-2.331613234092956
CAL-54,tanespimycin-bortezomib (250-1 mol-mol),2.1097630424969593
SU-DHL-4,10231331,4.353604499482432
MDA-MB-361,9903786,4.233301337396568
Kelly,71466445,1.8588223340604555
KMRC-20,12003241,-0.2043728031762648
Kuramochi,9927531,6.027141313400392
SK-MEL-5,sirolimus-bortezomib (250-1 mol-mol),0.9353591049866828
BICR 31,135421197,2.236076370585341
EN,241158,4.188243340516178
NU-DHL-1,135398744,6.409233084142903
SK-CO-1,241158,4.831010946536929
K029AX,135421197,2.4286138926915175
GMS-10,9903786,4.533895537186943
CGTH-W-1,3689413,-0.6568714259027654
BFTC-905,637858,2.2129577853608757
WM266-4,11396600,1.7325332738125347
YKG-1,375860,0.0929787084961373
HPB-ALL,168313016,3.5981845776520047
BT-20,107970,2.153530404894493
BT 444,9927531,5.530041138420047
OC 314,11455910,0.0768833443632768
DMS 273,135421197,2.3407622077730035
HEC-1-B,241158,4.361747370873768
SNU-1076,26596,-1.989905852137358
SK-UT-1,100016,6.311695779547894
ChaGo-K-1,6852167,1.9816298194521569
NCI-H1155,100016,6.5684025185087505
SR,375860,-0.3204889716997534
L-540,9903786,1.612072273929478
TE-4,46907787,0.034405481319533
YD-15,439501,-2.3800052899031985
D283 Med,sirolimus-bortezomib (250-1 mol-mol),0.1311503224086672
SW948,439501,-2.1692174321648174
MHH-CALL-4,26596,-1.7349356502662407
SNU-61,selumetinib-JQ-1 (4-1 mol-mol),-2.0822040932557564
SK-N-FI,sirolimus-bortezomib (250-1 mol-mol),0.1232342384365411
LS1034,tanespimycin-bortezomib (250-1 mol-mol),0.2308030361348307
BT 498,136227331,4.544114350665722
QGP-1,73707398,1.9620866624858488
NCI-H810,tanespimycin-bortezomib (250-1 mol-mol),0.3768886958286864
LS513,selumetinib-JQ-1 (4-1 mol-mol),-1.0778434179028742
JHOM-1,107970,2.565801555569848
HEC-151,73707398,0.6503268944686523
JHUEM-3,selumetinib-JQ-1 (4-1 mol-mol),0.3995235416963141
IPC-298,5460769,5.755627361996784
EFO-21,sirolimus-bortezomib (250-1 mol-mol),2.2010900590086595
CL-11,644241,1.6397301100186843
Karpas-299,26596,-3.8097040773311246
KYO-1,44491742,4.154466430935869
VMRC-RCZ,241158,4.939048140887211
ST486,3689413,-2.784671548878338
ZR-75-30,12003241,0.0052055629667129
LK-2,375860,-0.3436710653987513
VMRC-LCD,100016,6.5149453048399515
HMC-1-8,107970,2.4556526925315754
MOLM-13,100016,3.967621300341963
SNU-1079,44491742,4.118848224044972
JeKo-1,135999136,1.7054412351562194
DMS 114,sirolimus-bortezomib (250-1 mol-mol),-2.6988548245768387
HCC1833,168313016,5.722800305180265
SK-MEL-1,71466445,4.292797719025509
SNU-478,49766530,0.8968210676937323
BT 131,135421197,1.356520545497568
Jurkat,262093,2.316034624316645
KYSE-520,3689413,3.1364277290203986
SW1417,sirolimus-bortezomib (250-1 mol-mol),0.2535776257809292
AN3-CA,11455910,0.3745394880525272
KYSE-180,3689413,3.064535959483158
TALL-1 [Human adult T-ALL],9929138,6.59900307589284
NCI-H647,439501,-1.4518848962069395
OVK18,71466445,3.037286239647414
SEM,UNC0638-navitoclax (1-1 mol-mol),-2.575766799282578
NCI-H441,73707398,1.0117211394398191
G-292 clone A141B1,375860,0.1163688023411329
SIG-M5,262093,1.2071251684519244
Rh30,tanespimycin-bortezomib (250-1 mol-mol),0.9800677460463127
CAL-85-1,5460769,4.15135857015067
SNU-410,107970,2.3255659679492378
MG-63,selumetinib-JQ-1 (4-1 mol-mol),3.254737197001595
Lu-65,637858,2.878442664173332
HCC1395,135421197,5.533531628940142
EoL-1,135999136,4.026118373456707
KE-37,49766530,-2.520266355553242
Hs 611.T,136227331,5.417316134562269
NCI-H2405,3689413,-0.5066399807315675
EN,6852167,3.8351993338589496
SNU-1033,3689413,-2.6391429266703015
OAW28,11455910,2.4986666790908583
HCC1806,sirolimus-bortezomib (250-1 mol-mol),1.669162775720282
NCI-H358,637858,1.9740293300552516
SET-2,135999136,1.840217367729006
Mono-Mac-1,168313016,3.482496352370787
TT,9927531,4.594242153757871
SW948,375860,-0.5776308885037049
NCI-H2405,tanespimycin-bortezomib (250-1 mol-mol),-0.894001775676426
JHH-2,637858,0.9882525447375544
MSTO-211H,49766530,-4.866552298919663
NCI-H1435,tanespimycin-bortezomib (250-1 mol-mol),-3.816394464229111
RMG-I,46907787,1.7853253377364269
G-402,46907787,0.192686346076504
JJN-3,11396600,3.2077193233266375
Namalwa,11396600,2.5581294543218616
CAL-33,439501,-2.9579708224622423
VCaP,100016,6.449384825808392
HCC15,135999136,4.472611779685761
WT2-iPS,135421197,2.4533231744799235
HEC-59,135421197,2.778714880666289
NCI-H716,6852167,2.05149641213453
GA-10,100016,3.803284916821312
Hs 936.T,9903786,5.166198075920313
MPP 89,44491742,4.112850541914658
WM88,168313016,5.2919128740723265
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958
Hep 3B2.1-7,71466445,5.312056535197058
KYSE-180,46907787,3.816228061036196
VMRC-RCZ,sirolimus-bortezomib (250-1 mol-mol),0.0993693702457471
SNU-1196,3689413,-1.8376731206647552
PE/CA-PJ15,262093,3.193957949465754
Sq-1,49766530,-3.572585466463728
KYSE-520,5460769,2.8497133103495713
OV-90,sirolimus-bortezomib (250-1 mol-mol),0.2139978702426217
LS411N,44491742,5.693616041532359
U-BLC1,9929138,7.10057481888197
OE33,11455910,2.709307324033481
JeKo-1,9903786,1.7626830163965443
BT 172,135999136,1.8952925369851452
BT 216,135999136,1.3001577329115062
OVTOKO,tanespimycin-bortezomib (250-1 mol-mol),0.5504148489500027
OE19,12003241,0.3915460727280876
LN-18,439501,-2.51749540441962
NCI-H1105,9927531,4.896971855718655
HOS,9927531,4.717123870748892
NCI-H2196,6852167,2.8747705894098488
TALL-1 [Human adult T-ALL],439501,-2.6089794339614256
RMG-I,135999136,4.313972565447826
LS513,10231331,-1.4270487616040106
HT-29,sirolimus-bortezomib (250-1 mol-mol),1.8819281446300895
JHH-2,107970,2.452158222323847
WM266-4,5460769,5.368369623882124
HOS,135999136,1.413572307289402
HCC4006,12003241,-2.6394477245029355
CAL-12T,135421197,3.5670485271085868
NCI-H460,107970,2.752075604137296
KMS-20,11396600,3.251276500206743
SBC-5,262093,2.1741934315953726
L-428,73707398,0.6270222273710352
KMS-20,11455910,0.7957422642794928
A3/Kawakami,9903786,0.9564213610990896
NCI-H2196,5460769,6.02637664184288
YKG-1,tanespimycin-bortezomib (250-1 mol-mol),0.0684440375972302
A-253,6852167,4.173153374285914
HuG1-N,sirolimus-bortezomib (250-1 mol-mol),-0.2161746161621927
BT 159,107970,1.8106388402335116
IGR-39,262093,3.5414544189999035
HCC38,49766530,0.1078777234170871
HDQ-P1,tanespimycin-bortezomib (250-1 mol-mol),3.130731084653335
NCC-StC-K140,375860,-0.6581555419852907
SNU-886,selumetinib-JQ-1 (4-1 mol-mol),2.185309080254947
WM115,44491742,3.78432787650886
TTC-709,6852167,1.9849494908807752
A-375,12003241,-1.2978704743837648
NCI-H146,107970,1.621489555747201
IPC-298,168313016,4.989251523592668
TC-71,UNC0638-navitoclax (1-1 mol-mol),4.936257961765979
MHH-CALL-3,49766530,-2.9861059393678766
SU-DHL-8,sirolimus-bortezomib (250-1 mol-mol),-6.359979517729665
NUGC-3,262093,3.0230092898812484
SNU-466,10231331,4.3204156342714715
NCI-H1395,9927531,4.9557176619227015
769-P,12003241,-0.850847726914325
IGROV-1,375860,0.7731558163124775
SW1417,6852167,3.2987198824651105
HCC1500,439501,-1.4156205398968564
MOLM-13,444795,-0.8871401586886155
WM793,11396600,4.503186389543736
42-MG-BA,12003241,-1.3085155086024562
HOP-92,6852167,3.546901057497169
COLO 205,439501,-0.8424951249003566
KM12,71466445,5.496348766161868
JHH-6,375860,3.732925459637326
CA46,26596,-3.5845712744961324
HGC-27,UNC0638-navitoclax (1-1 mol-mol),1.547939825071545
CHP-212,71466445,1.0770121742472976
U-CH1,241158,4.570202527341932
SU.86.86,tanespimycin-bortezomib (250-1 mol-mol),0.1396013159425142
MCF-7,241158,3.9263571249685874
SK-ES-1,49766530,-2.1156842470602037
M059K,135999136,4.281587930141844
ONS-76,49766530,-0.8397126534273769
TF-1,241158,3.865318341041154
SNU-878,11455910,0.0025920112250637
HCC-56,11396600,3.807461388056502
PL-21,375860,-0.8908022550999798
F-36P,135999136,1.2589377775362909
Kasumi-1,71466445,1.0139160827846212
SK-N-MC,136227331,5.402807013617019
HCC44,6852167,0.644523823911665
BFTC-909,6852167,2.133526407129769
HEC-151,tanespimycin-bortezomib (250-1 mol-mol),0.2767790074283919
SNU-1079,5460769,0.9743779178913314
HCC2108,9903786,2.237017286795856
NCI-H1184,sirolimus-bortezomib (250-1 mol-mol),-1.8985096784471465
KM12,262093,3.385023533358405
MOLT-13,11455910,1.8534554613452228
SNU-601,tanespimycin-bortezomib (250-1 mol-mol),0.586889084570332
NCI-H520,107970,2.0234591709207397
SK-MEL-2,tanespimycin-bortezomib (250-1 mol-mol),2.677378887587516
NCI-H2141,44491742,3.797452560506029
BT 239,135999136,1.6386300110242584
DMS 454,UNC0638-navitoclax (1-1 mol-mol),-2.3468627747637685
MHH-NB-11,3689413,1.2467762283849737
HEC-108,73707398,1.5484357778063762
HCC1143,9903786,3.3387804215378885
KYSE-30,6852167,3.4266052993567775
NCI-H1734,439501,-2.4852115396408436
TM-31,49766530,-2.5083427606022037
Daoy,11396600,3.83670374909926
CAL-51,49766530,0.4609697007955676
BT 145,49766530,-0.5681033515253969
MIA PaCa-2,439501,-4.331404793236993
Aska-SS,11396600,4.186494523446212
ST486,9927531,3.885019702146961
NCI-H69,9903786,3.032908802365876
Hs 746.T,44491742,3.728027076014932
Hs 888.Lu,135999136,4.915312211386622
GP2d,439501,-1.2526235353612607
JHH-1,46907787,3.3100024597454674
SNU-869,46907787,4.403742227184192
EKVX,12003241,-0.995524269330736
SU-DHL-10,sirolimus-bortezomib (250-1 mol-mol),0.6200641507940263
SUP-HD1,26596,-3.617348161498389
TC-71,637858,2.1337665442095664
NH-6,46907787,3.739922386901546
Kasumi-1,tanespimycin-bortezomib (250-1 mol-mol),0.2568876868109762
KMS-21-BM,9877608,6.031837359251096
NCI-H2081,135421197,1.057518505455496
MDA-MB-468,12003241,1.1497525105309832
SaOS-2,135421197,3.6760992974277817
NCI-H2110,11455910,0.8455410267883708
U-937,5460769,3.0065623514388298
TE 441.T,73707398,2.754590712931621
HCC827,637858,1.7740818571247208
BT 286,9903786,1.725049982792706
COV434,107970,1.1877633129771374
YAPC,selumetinib-JQ-1 (4-1 mol-mol),3.639146337556592
LNCaP clone FGC,107970,2.7706506032666067
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128
OCI-AML-2,375860,-0.4546682587094939
SUP-B15,100016,6.907261874504965
ME-1 [Human leukemia],241158,1.6111961137085613
SNU-61,3689413,-2.128463404187725
HSC-3,107970,2.329842902304128
JURL-MK1,637858,1.598414572100692
P31/FUJ,49766530,-2.577046245506879
KP-3,135421197,0.5862918255078794
HCC1588,262093,3.0584960901544833
AN3-CA,439501,-3.229124904343767
ZR-75-1,5460769,4.241529452507845
MHH-ES-1,637858,1.480038374938484
DV-90,71466445,2.3382409396535384
SK-CO-1,168313016,6.229837204453753
TF-1,11396600,2.862627725963247
KO52,9927531,4.721929704585103
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021
JL-1,9903786,5.3673726170242455
MOTN-1,54596490,5.846399797637999
SNU-761,selumetinib-JQ-1 (4-1 mol-mol),-0.3894007965128778
SW1271,444795,4.935671262335122
CML-T1,644241,-4.543158274485358
THP-1,12003241,-0.95805458474302
A-549,168313016,6.463391576466817
NCI-H1339,71466445,4.88090882012996
MDA-MB-231,9927531,7.115369189993137
COLO 684,54596490,4.5333934619605
BT 187,241158,4.303810925937258
NCI-H441,637858,1.9230137221665495
SK-LMS-1,71466445,5.876102346203037
Hs 895.T,136227331,4.438273380824898
LNCaP clone FGC,11455910,0.1396389722474823
KALS-1,tanespimycin-bortezomib (250-1 mol-mol),0.1032603454372563
RD,73707398,0.8861107206817521
COLO 741,26596,-0.5200940435510158
EM-2,73707398,-0.1284556019091807
MOLT-16,46907787,-0.6616446970476906
2004,49766530,-2.057712290576902
KMS-12-BM,UNC0638-navitoclax (1-1 mol-mol),-0.7236362684252565
MES-SA,439501,-2.264210619464941
NCI-H1339,135421197,3.8934160378835054
NCI-H1581,262093,2.2413159684739905
NCI-H2023,100016,7.201065180404722
GDM-1,26596,-2.9755879350812964
HCC2935,sirolimus-bortezomib (250-1 mol-mol),0.5945661645124948
CAL-27,73707398,1.0723780770878542
Hs 934.T,selumetinib-JQ-1 (4-1 mol-mol),3.438166448048175
A-498,3689413,-0.327867250415736
GI-1,49766530,-2.6650453503199776
COLO 800,73707398,1.0528249782433163
NCI-H2122,73707398,2.514369766982023
Mino,444795,1.9878842537418735
NCI-H1755,UNC0638-navitoclax (1-1 mol-mol),-2.483337609520519
BT 147,135999136,2.0385519129868443
DMS 53,UNC0638-navitoclax (1-1 mol-mol),-1.494402322167808
GDM-1,3689413,-2.3976693518494208
NCI-H1299,10231331,4.726273361560379
HT-55,637858,2.07232626492922
HCC1833,73707398,0.9424461947301042
BICR 22,241158,4.423333712203234
SK-MES-1,637858,1.374960774456644
T-47D,sirolimus-bortezomib (250-1 mol-mol),1.0675161294174855
SK-N-BE(2),637858,0.7979005670073629
FaDu,5460769,4.852166639687207
G-401,262093,2.911602765721858
KG-1-C,9903786,3.898193715125589
BT 179,135999136,1.6190851622776896
SNU-C2A,26596,-0.6540146277819451
HSC-3,26596,-1.4868403003967878
LP-1,44491742,3.686326414227543
BT 139,6852167,2.565632709988516
769-P,10231331,6.35987842726323
RMG-I,637858,1.5920986883450186
HT-1080,46907787,3.15683670670671
DBTRG-05MG,262093,3.4066291906537645
SW1417,selumetinib-JQ-1 (4-1 mol-mol),-0.4291556100825567
FTC-238,9927531,3.762159625160711
HT-29,135421197,2.624845390114819
HCC95,5460769,4.4862905703550355
CAL-12T,5460769,3.2968044881057734
BxPC-3,12003241,-1.7282705692868598
Hs 934.T,439501,-2.1837618207890808
NCI-H1734,49766530,-2.088624168616933
HT-144,12003241,-2.1434131709855215
NCI-H1651,3689413,1.2718647351965997
SNU-1214,9903786,2.1258190574569955
T98G,107970,3.0789596512237978
YD-8,6852167,2.601588502277786
Hs 578T,9903786,3.085679401941195
BT 440,6852167,5.5047187061926035
DMS 273,444795,4.3404236236698495
JURL-MK1,11396600,3.824773747794518
CAL-78,11455910,2.8056640629270766
HCC1428,12003241,3.752026929973328
HCC78,11455910,2.0518993583639182
KP-2,262093,3.513459327352711
Panc 05.04,73707398,0.929289426406569
SNU-119,9927531,4.042335314323924
CAMA-1,637858,2.0184779682033094
NCI-H1341,10231331,3.946004914876153
JHUEM-1,26596,-1.2940313289426515
BHY,3689413,1.273700268174745
COLO 205,sirolimus-bortezomib (250-1 mol-mol),2.1268339041997457
OVK18,107970,2.305543981399572
SW1353,107970,3.000498774882463
JURL-MK1,135999136,1.3235312555861445
CAL-120,439501,-2.2295565318957955
KYSE-520,tanespimycin-bortezomib (250-1 mol-mol),-1.1109729915268285
A3/Kawakami,UNC0638-navitoclax (1-1 mol-mol),3.0447804722614764
THP-1,selumetinib-JQ-1 (4-1 mol-mol),-3.8600862118998553
BT-12,375860,0.1600757407844332
YKG-1,26596,0.9408189524000934
JL-1,100016,8.572446789328106
COLO 829,10231331,-1.138980901640988
BL-41,sirolimus-bortezomib (250-1 mol-mol),1.1503434998526136
COLO 205,100016,5.963233409359241
RD,6852167,2.8800606360455228
OVK18,262093,2.4244937883691287
Sq-1,444795,5.017643579289032
OE33,6852167,2.347290735103793
HEL 92.1.7,selumetinib-JQ-1 (4-1 mol-mol),0.8853993447032109
NCI-H1869,168313016,4.348765145343562
SK-N-DZ,26596,-3.5191168188453603
LNCaP clone FGC,12003241,-1.977151768552247
JHOS-2,637858,2.236950440158482
CAL-51,12003241,-1.2189714227076325
AMO1,241158,1.849274294802101
OAW28,44491742,4.754653012158477
TCC-Pan2,71466445,3.915793713203546
SNU-478,46907787,0.0593244213587615
CAL-54,UNC0638-navitoclax (1-1 mol-mol),2.525711366860768
SF268,73707398,1.033344286819735
MEC-1,5460769,1.3276972601062724
BT 232,54596490,5.37904940780473
JM-1,73707398,-0.8556338999048841
42-MG-BA,9929138,6.505508084195067
Ri-1,6852167,-0.591407289651703
NCI-H2009,5460769,1.3316086312624285
KYM-1,sirolimus-bortezomib (250-1 mol-mol),0.1122184014552232
HOS,262093,1.0531886567175572
GOS-3,26596,5.630360863540023
SNU-1214,11396600,3.7056462791365847
NCI-H2087,100016,6.366125554898137
TUHR14TKB,135421197,2.206090635498825
HCC1954,3689413,-1.9966165648344365
SK-MEL-3,5460769,5.404359476176559
Karpas-299,9903786,1.3697827730065784
MKN74,11455910,0.5314790476879293
SU-DHL-8,11396600,1.8138091107788987
CAL-27,241158,4.222061028231435
HEC-6,3689413,-0.7278233112149324
HCC1833,71466445,4.001049080223579
NU-DUL-1,26596,-3.721309412327892
TCC-Pan2,10231331,-1.6197179286660257
REC-1,49766530,2.1728933829794395
SNU-1,9903786,3.1259833622650315
2004,12003241,-2.052412032835344
ECC10,sirolimus-bortezomib (250-1 mol-mol),-0.7952118818560531
NCI-H1568,selumetinib-JQ-1 (4-1 mol-mol),2.397330498930178
SK-N-SH,6852167,2.0581991902600913
HCC1937,49766530,-0.8756565380330879
NCI-H2023,6852167,3.239571554271464
Reh,sirolimus-bortezomib (250-1 mol-mol),0.0012430835565731
SNU-C2A,100016,6.499335908465164
SCC-25,637858,1.5386898989204256
CJM [Human melanoma],46907787,4.250483968066917
YKG-1,46907787,4.9363681806831075
MV4-11,637858,-0.472794507161154
NCI-H441,6852167,5.036797338049703
MDA-MB-157,3689413,-1.567220624306923
JJN-3,UNC0638-navitoclax (1-1 mol-mol),2.7939555874700845
MHH-ES-1,73707398,0.6255428046106257
LXF 289,637858,2.285720521187594
KP-4,444795,4.300956807365333
SIG-M5,44491742,3.8291239619503905
KMS-26,168313016,2.9457781921447146
DAN-G,439501,-2.2705852872142236
Panc 03.27,9927531,5.182143526242967
Kasumi-2,375860,-0.7090394918812726
SUP-T11,sirolimus-bortezomib (250-1 mol-mol),0.9294161353730758
RCH-ACV,26596,-2.407585357799557
Calu-6,11396600,3.718739877278185
SUP-M2,26596,-3.767571298105125
MOTN-1,135421197,1.3703744240022513
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885
BL-70,71466445,1.4229248120179192
PLC/PRF/5,5460769,4.572267252029585
OVCAR-5,5460769,4.389197007102137
NCI-H647,12003241,-2.504495302724225
GCT,3689413,-2.349685112754086
A-375,444795,4.8572215879040925
SK-MES-1,107970,1.6078502223677542
NCI-H2106,UNC0638-navitoclax (1-1 mol-mol),-0.2261787168491973
U-87MG ATCC,637858,3.3817655791628294
HuCC-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.370448841464423
8505C,135999136,4.3130615236691545
NOMO-1,46907787,-1.215006340822028
L-540,135421197,1.2106932508822246
CAL-62,6852167,2.7968041616377457
WM983B,135999136,4.467967668661813
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
COLO 684,135421197,1.6241995142011054
NU-DUL-1,10231331,-2.9477670322701885
Panc 10.05,135999136,4.645706759436588
LMSU,135999136,4.828023886470807
PK-45H,tanespimycin-bortezomib (250-1 mol-mol),-0.8772986942389263
NCI-H23,3689413,-2.6057234529472098
SW1271,11396600,3.626770708484224
NCI-H292,73707398,0.96137499748578
P31/FUJ,73707398,-0.9687174770786582
NCI-H2110,168313016,5.8271641700116215
HT-29,selumetinib-JQ-1 (4-1 mol-mol),2.436079004945063
NCI-H1693,637858,1.99563162890805
SIG-M5,375860,-0.3879584489386603
8-MG-BA,9903786,3.978061546376923
NCI-H1915,49766530,3.459700063272212
SK-HEP-1,135999136,5.290710201924687
HuT 78,46907787,-2.3061129610788833
DU145,637858,2.575359401469111
SNU-423,135999136,4.547106106138672
2004,135398744,6.587609936981218
NCI-H1693,tanespimycin-bortezomib (250-1 mol-mol),0.5051860079997127
SK-MEL-3,439501,-0.9323794711246036
SNU-423,11396600,4.403909661334611
IMR-32,selumetinib-JQ-1 (4-1 mol-mol),0.7090363184607439
SK-N-MC,637858,1.08432841840482
COLO 829,9927531,5.213552390265391
CAL-51,439501,-2.444412450902406
KMH-2,375860,-0.9905938635036066
OVK18,12003241,-0.5661348884613613
OCI-Ly10,9903786,3.2654189555082493
Detroit 562,9903786,2.622976915424344
NCI-H1915,644241,1.9378779435175135
NCI-H716,73707398,1.3705255443510411
LS180,262093,3.1953995116592826
BT 504,3689413,0.2401102984502228
DU4475,262093,2.0152969052094725
BHT-101,135421197,3.464281402199008
IM95,12003241,-0.6158272527459553
ZR-75-1,11455910,1.4286794272371928
8-MG-BA,135999136,1.4343313230693755
NCI-H1355,26596,0.1615668606609613
HEC-1-A,12003241,-1.9132267433224897
HCC1395,375860,-0.7550225265126825
KE-39,439501,-0.0752815835977172
JHH-5,10231331,1.5048057077981425
SNU-398,375860,0.3424290745203647
PE/CA-PJ41 (clone D2),5460769,2.5777137088305184
KMRC-3,49766530,-1.4126043666581272
MOLM-13,262093,0.9014616367149992
SK-MEL-30,637858,2.477374564987187
SEM,12003241,-3.075217153076431
KMS-18,100016,3.3973864073508864
SK-BR-3,selumetinib-JQ-1 (4-1 mol-mol),2.4200828967398995
JURL-MK1,49766530,-0.182637071574771
SNU-886,10231331,-0.2281959370366189
AN3-CA,selumetinib-JQ-1 (4-1 mol-mol),3.4953796840918763
LS123,107970,2.423370198781075
SW1353,46907787,-0.2143520062248116
SK-N-FI,tanespimycin-bortezomib (250-1 mol-mol),-0.0515208796010249
SR,26596,-2.2070280953319283
TUHR10TKB,135421197,3.595491301203154
FaDu,sirolimus-bortezomib (250-1 mol-mol),0.8335893601460954
KNS-62,241158,4.309841254636907
BT 328,11455910,1.1431162062454217
Hs 578T,46907787,2.2226344570292915
BxPC-3,3689413,-0.056748072256038
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798
BxPC-3,375860,-1.018881063070817
GDM-1,12003241,-2.0828988572069487
PaTu 8988t,3689413,2.4784022576221836
HH [Human lymphoma],439501,-4.820803116801483
OCI-Ly3,26596,-3.73515804460265
SNU-C1,107970,1.526415841578502
SCaBER,439501,-1.925365534311937
HCC1428,73707398,2.0353997361879625
BxPC-3,107970,2.2592769610294448
A-673,262093,2.1198375376891705
BT 145,168313016,5.801537598068537
HCC1833,12003241,-0.598038454038546
MOTN-1,637858,0.888223152245666
PK-1,168313016,5.489792964329215
BT 147,73707398,1.4314799151310398
COLO 792,439501,-2.3600745539186994
KMRC-3,135421197,4.3103204050054345
A-498,637858,3.4757595298108974
PC-3,100016,6.704789318152335
NCI-H2085,9903786,1.6610112484663062
KMS-20,71466445,3.065213582457146
SNU-1041,6852167,3.3738029338506093
LAMA-84,375860,-0.4537383385412094
Mino,107970,1.374067690004091
JHH-6,tanespimycin-bortezomib (250-1 mol-mol),2.875959809379233
EoL-1,9903786,-0.1437472034571408
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196
NUGC-4,9927531,4.1074548867853045
KP-3,sirolimus-bortezomib (250-1 mol-mol),1.5261353801171291
NCI-H841,6852167,3.0459288620836964
DU4475,100016,3.3182611876021157
SNU-878,sirolimus-bortezomib (250-1 mol-mol),1.804977895321967
AML-193,sirolimus-bortezomib (250-1 mol-mol),0.7759141374550513
COV362,262093,3.3118588999816008
SK-N-BE(2),100016,5.117046374692038
SNU-449,3689413,-2.168376107627999
T24,11455910,0.9790559747688146
769-P,73707398,1.168379286742932
BT-474,selumetinib-JQ-1 (4-1 mol-mol),0.4588027273781878
P12-Ichikawa,tanespimycin-bortezomib (250-1 mol-mol),0.3962036190597272
L-363,11396600,3.444833933433015
FU-OV-1,9903786,2.8592788804010936
MPP 89,sirolimus-bortezomib (250-1 mol-mol),1.5945655725799224
MDA-MB-157,49766530,-2.405889714389838
Jurkat,107970,2.2627318872269733
H-STS,135999136,1.636218584553822
NCI-H1694,262093,1.281080897473335
DB,9903786,1.8629742307315609
BICR 6,3689413,-0.1381327952499849
SW982,11455910,2.7333702343206547
KNS-42,11396600,3.114434674778827
CAL-148,12003241,2.7249507328526015
KHM-1B,73707398,-0.6689954941559422
NCI-H929,9903786,1.9183912305018265
ESS-1,9903786,1.7886366060040666
CAL-51,168313016,5.819136604546001
A-673,12003241,-2.2168793422392103
DU145,12003241,-2.0135691280208876
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084
EKVX,11455910,2.049892638783207
CJM [Human melanoma],9927531,5.046484804612069
ALL-SIL,11396600,2.960335319566646
VMRC-LCD,46907787,0.5475756209741912
Panc 10.05,11455910,2.05873127969748
SCaBER,6852167,2.743013640713377
KMS-18,10231331,3.978934052597739
NCI-H650,71466445,5.7475497080688065
MSTO-211H,12003241,-2.79016034960529
NCI-H1915,73707398,1.0384692664501904
LS1034,12003241,0.7423322156732435
HEC-1-A,439501,-2.768971793153046
SK-MEL-1,135421197,3.405543423729856
639V,3689413,3.093093365439167
KYSE-70,3689413,0.9447440025313596
OCI-AML-2,107970,2.189664943492832
Lu-99,44491742,4.467729937048073
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277
EFE-184,262093,3.462409565200508
KCL-22,46907787,-0.6577650451757896
HEC-151,3689413,0.5850952885102259
SNU-1077,46907787,0.7852146377897988
BT 159,44491742,4.231002554874911
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903
G-401,135421197,1.4306754302223277
NCI-H1299,6852167,2.875213655534043
SCC-4,46907787,0.5455328261501977
ME-1 [Human leukemia],135999136,4.558571069428398
MDA-MB-435S,11396600,4.912452343589747
Hs 729.T,375860,0.4901141915771287
RPMI-6666,9903786,1.3063050389166864
NCI-H1563,5460769,4.309223313184859
MEC-1,49766530,-2.6442058003130806
U266B1,71466445,2.059013324665234
RPMI-7951,637858,1.6619998861158691
SU-DHL-8,241158,1.5578201018770153
BT 164,3689413,-2.3779302902052444
EM-2,107970,2.208998012653241
BICR 31,107970,2.625018410874988
MDA-MB-468,439501,-1.8794738155702295
AU565,6852167,0.824199435407992
IST-Mes1,73707398,1.324483483158502
DV-90,3689413,0.3888446743511712
CCK-81,375860,-0.7586959822706537
NCI-H2170,100016,6.477443817994488
KYO-1,26596,-1.5121743902030458
BT 333,135421197,2.652327815352438
786-O,26596,-1.1841737668988108
Jurkat,tanespimycin-bortezomib (250-1 mol-mol),0.7517275719467844
A-673,444795,4.685959151928419
SET-2,tanespimycin-bortezomib (250-1 mol-mol),0.2740236023779227
SW948,241158,4.5321951743877005
ALL-SIL,375860,-1.552794194023853
NCI-H28,46907787,-0.1803088776787751
C2BBe1,10231331,5.91991778505206
SK-MEL-2,11455910,1.0662653811839238
PaTu 8902,107970,2.826401466277882
NCI-H322,44491742,4.376212292863665
HCC2279,26596,-1.3902688555824585
BT 164,49766530,-0.4702645034832948
FTC-133,3689413,-0.3036251064519336
SNU-869,100016,6.487538118719535
A-375,73707398,0.8320576726433225
MHH-CALL-3,11455910,1.7272986441128235
NCI-H647,11455910,1.3155768042278373
BT 164,5460769,1.5184738603275272
8505C,selumetinib-JQ-1 (4-1 mol-mol),0.2956990111735152
HCC1833,6852167,3.1486831435900164
SNU-886,241158,1.2144772988451973
OAW42,11455910,0.9169740584979637
RERF-LC-Ad1,107970,2.434538597740863
KYSE-140,selumetinib-JQ-1 (4-1 mol-mol),2.3172835703962686
KP-2,135999136,5.367391673563159
MSTO-211H,439501,-1.1644309958543906
KP-N-SI9s,135398744,6.4391278360731246
SNU-407,637858,1.71460298771488
IST-Mes1,135421197,1.925463420817299
COLO 741,439501,-2.122340896395585
RPMI-8226,26596,-3.5550255900749623
NCI-H2085,107970,2.2340000781597844
KYSE-510,49766530,3.99865541167158
HCC366,375860,-0.8525905799274879
SJSA-1,637858,2.1617157587953133
LS411N,46907787,0.8939335106347707
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776
CML-T1,9927531,3.1672020542525674
EN,9903786,3.730384858671513
OCI-Ly3,168313016,4.115265738534389
NCI-H747,73707398,1.0948410901239818
UM-UC-3,5460769,6.395850795756177
NCI-H1944,439501,-2.342776450648639
Caov-3,168313016,5.0841231575962
BICR 56,168313016,4.673512744968894
CCK-81,439501,-0.4641982207624705
SNU-449,262093,3.0394524195162766
CA46,11396600,2.515122226404857
SR,107970,1.7321639087061549
EN,46907787,5.476162929897771
KM12,9927531,4.5473811141762965
Hs 294T,selumetinib-JQ-1 (4-1 mol-mol),1.603608430454955
HuT 78,UNC0638-navitoclax (1-1 mol-mol),0.0082226538693411
NCI-H2081,11396600,3.4950774921622174
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
BT 172,12003241,-0.4866452668331515
RT-4,12003241,-1.8542714118634884
NCI-H1355,46907787,3.837327934735341
U-937,11455910,-0.571974283584222
OPM-2,3689413,-4.501811354570108
RPMI-7951,12003241,-0.9511728924240472
GI-1,11455910,0.5064796295845606
OCI-Ly10,637858,2.6828928934608176
TE-8,46907787,2.122097927546814
NCI-H1339,3689413,0.3064961832206241
TCC-Pan2,sirolimus-bortezomib (250-1 mol-mol),2.6812327412010095
NCI-H1693,100016,7.64063251702684
JMSU-1,26596,-1.1755063311173417
A-375,5460769,3.311565919469283
NCI-H841,241158,3.877248650806591
HCC1569,262093,2.630898961991999
OCI-Ly10,UNC0638-navitoclax (1-1 mol-mol),0.9404785966426684
NCI-H1581,46907787,2.054614673663103
HCC2218,439501,-2.1463275405716495
PE/CA-PJ41 (clone D2),107970,2.3655447470564774
HCC202,262093,3.36035713735401
EoL-1,sirolimus-bortezomib (250-1 mol-mol),-9.043460932568856
NCI-H1915,11455910,3.6924393637334703
OVSAHO,444795,4.551054343981997
NB4,9903786,1.7786072365174606
JIMT-1,100016,6.5721980857327935
EJM,241158,2.554123806651753
CAL-27,375860,-0.618101771298289
P3HR-1,71466445,2.8786541215857264
SNU-761,9929138,6.284127493402678
A-549,637858,3.117280931983567
RPMI-8402,49766530,0.2151937728897686
HDQ-P1,9927531,5.7159143296477115
A-549,637858,3.117280931983567
BICR 6,11455910,1.839661874011414
JHH-1,637858,3.237981035954196
HCC202,3689413,-1.588009861739516
NCI-H2286,11455910,3.2712794680477173
MKN74,439501,-1.7547166912858625
NCI-H1435,262093,2.8121009793990046
WSU-DLCL2,135999136,1.771587640268099
M-07e,sirolimus-bortezomib (250-1 mol-mol),-0.1751510828449014
Mel JuSo,135421197,1.941691146031138
ECC10,3689413,0.143670384150019
WM88,9927531,4.19876481787408
HCC1954,selumetinib-JQ-1 (4-1 mol-mol),2.098282008016861
SK-MEL-28,107970,3.16887671769628
NCI-H2085,3689413,-0.2448228197387998
WSU-DLCL2,100016,5.8333868406138585
NCI-H522,439501,-5.784929410118117
NCI-H1666,tanespimycin-bortezomib (250-1 mol-mol),-4.94228815381926
BT-474,6852167,2.8360260364208707
BT 286,11455910,-0.3413435906946745
EM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.8534548568665049
H-STS,73707398,1.2106724937411937
COR-L105,107970,2.936160881286492
RPMI-8402,241158,3.030815815171316
SNU-1105,sirolimus-bortezomib (250-1 mol-mol),1.4785919320575531
HT-55,tanespimycin-bortezomib (250-1 mol-mol),-1.2155769519281892
RT-112,375860,-0.4271930456025025
KMS-34,9903786,0.5468687794140459
OVK18,241158,3.4460864967100195
HGC-27,3689413,-1.6532214726359813
OCI-AML-3,9927531,5.116735976562035
NCI-H1573,46907787,2.7163703210354178
NB1,135421197,1.388835024026268
IGROV-1,107970,2.287061680908213
CAL-27,3689413,-0.5192231908073464
ME-1 [Human leukemia],selumetinib-JQ-1 (4-1 mol-mol),-1.5743329708103595
NU-DUL-1,135421197,1.0938833376467747
U266B1,46907787,1.9154344054077848
BT-16,107970,2.1571455528855665
SF126,262093,2.7341205400396418
YAPC,6852167,3.757016833172803
L-1236,49766530,-2.927530009447525
NU-DHL-1,44491742,4.098367852004394
OV56,637858,2.2925900158017747
SNU-1076,439501,-2.344859624762999
SNU-216,241158,4.2881581162179305
SK-HEP-1,selumetinib-JQ-1 (4-1 mol-mol),3.7826975046986697
BT-20,46907787,4.606441667420873
MOLM-6,46907787,0.3486946401183053
Hep-G2,sirolimus-bortezomib (250-1 mol-mol),1.7771755554565365
ECC10,UNC0638-navitoclax (1-1 mol-mol),-3.3170539937927876
SW1710,6852167,3.088497738849751
COR-L95,375860,0.21091681928276
BT 328,135398744,6.520469371663204
SK-UT-1,44491742,5.121507877742128
MDA-MB-435S,375860,0.073459033352106
SNU-878,selumetinib-JQ-1 (4-1 mol-mol),-0.4766929338153627
TOV-112D,10231331,5.961074518530357
WM266-4,UNC0638-navitoclax (1-1 mol-mol),4.921786401804959
TF-1,100016,6.442708110888471
LUDLU-1,44491742,3.9054426641243873
Hs 888.Lu,100016,7.863224005148367
T24,135421197,1.5767187843599464
RPMI-6666,107970,2.181327963925534
NCI-N87,241158,3.56045646229574
LAMA-84,168313016,3.970773961757139
ECC12,11455910,2.320558491794217
SNU-620,100016,4.241219903285237
BT 416,135421197,2.461654603646364
RERF-LC-A1,11455910,0.7727825040667291
JHH-1,73707398,1.6871204848292365
NCI-H2286,9903786,1.3981147995547691
SNU-C5,136227331,4.384397979730017
WM88,9903786,2.087799458877892
RERF-LC-Ad2,6852167,2.3505226801926686
A-375,49766530,-0.2051662663719206
HT-144,262093,3.242537447174441
OVCAR-4,3689413,-2.062187861989016
Hs 895.T,6852167,1.764938958894413
NUGC-3,107970,2.2870652507466156
L-428,9903786,1.2681458902985745
RERF-LC-A1,262093,2.373838000571716
HuH-28,5460769,2.112533024093989
HCC44,49766530,3.18026268339199
COLO 699,12003241,-1.6460659518938752
BT 245,sirolimus-bortezomib (250-1 mol-mol),0.5347503794304393
Hep 3B2.1-7,637858,2.0545585773513517
SU-DHL-1,3689413,-2.511818154735677
MFE-296,135421197,4.335521235356187
BT 172,637858,1.9723791445737595
SK-MEL-3,637858,2.888806865252382
HEC-1-A,10231331,6.402874161063355
Tm87-16,5460769,0.8511670833811608
CJM [Human melanoma],107970,2.889297820732489
NCI-H522,135421197,1.9700795220087195
MOLM-6,73707398,0.517152915565168
NU-DHL-1,9927531,5.134600574788464
SF126,241158,3.967394683714564
YD-8,3689413,-2.153430400522153
IGROV-1,637858,1.814476597989254
VMRC-RCW,439501,-1.1623161811429144
KYSE-150,44491742,4.452704490333977
KYSE-140,46907787,2.8487460555393453
U-118MG,selumetinib-JQ-1 (4-1 mol-mol),4.036114633188371
EFO-21,3689413,0.1102098212077115
NCI-H2196,tanespimycin-bortezomib (250-1 mol-mol),0.7510452056774047
U-118MG,26596,0.614033451908362
DK-MG,168313016,4.410305787145771
OCI-AML-2,10231331,-3.616941439793987
OCI-Ly19,tanespimycin-bortezomib (250-1 mol-mol),0.3425077317029711
SK-LU-1,135999136,3.760067607406658
SK-MEL-24,UNC0638-navitoclax (1-1 mol-mol),3.0441510128296456
CHP-212,46907787,-1.3675859090756428
MKN7,262093,2.224966476841938
UACC-257,6852167,4.471876231491938
BT 239,11396600,1.7772646645104542
RERF-LC-A1,9903786,4.61839139463389
DK-MG,3689413,-2.444320741118214
SNU-878,9903786,2.6270705473192644
NCI-H1793,3689413,2.3725709733273663
TE-5,9927531,4.466928464790859
KMRC-2,12003241,-1.7913952791170802
KYSE-30,44491742,4.262990240897069
CJM [Human melanoma],439501,-2.3505582983790076
BHT-101,12003241,-0.6402723165837827
KPL-1,107970,2.5494857724802813
JM-1,46907787,-1.9243382261841309
Hs 746.T,10231331,1.9624435442246329
NCI-H1563,49766530,0.5577612729828542
WM793,selumetinib-JQ-1 (4-1 mol-mol),1.649848066078306
GOS-3,49766530,-1.0492623989714644
JHOM-1,12003241,-1.2744243269669069
NUGC-3,100016,7.160996607387645
T84,100016,6.649554415164183
LoVo,26596,-4.043483931746528
Hep 3B2.1-7,73707398,1.151761195316654
Kelly,10231331,5.16242002724797
A-549,3689413,0.7236603744186211
GA-10,49766530,-5.511762261884949
OVCAR-4,637858,2.0846250774170167
SNU-16,11396600,2.12862636556111
L-540,3689413,0.298858834558217
CGTH-W-1,selumetinib-JQ-1 (4-1 mol-mol),1.2775145909700567
NCI-H1694,135421197,1.1346758741878853
Hs 578Bst,3689413,-1.7241892879585388
SF126,644241,2.527931632106116
NCI-H522,262093,3.0660845932794656
SU.86.86,11396600,3.58919118666286
SK-N-MC,71466445,2.7140492776165916
Mono-Mac-1,6852167,1.1013775883292647
TC-71,241158,3.671280815212322
786-O,46907787,3.0733456424852914
WSU-DLCL2,375860,-1.1401457482447963
G-402,100016,6.451749665500501
GOS-3,241158,4.584939515140501
SH-4,sirolimus-bortezomib (250-1 mol-mol),0.5100564849810528
U-118MG,12003241,-0.1852675851464418
NU-DUL-1,135999136,1.5798926430352824
HEC-1-A,6852167,2.216892801119106
OE19,135421197,2.291572889832539
UO-31,100016,6.129898752942045
Ki-JK,135999136,4.148473540945428
HCC1954,5460769,3.202561874283659
EB1,241158,1.457261035728942
Calu-3,sirolimus-bortezomib (250-1 mol-mol),-0.667685459302334
NCI-H2196,9927531,4.117400803944708
BT 482,107970,1.7416732658347511
MKN74,5460769,3.534639533895065
TUHR14TKB,11455910,2.317206369851234
HDQ-P1,73707398,1.4216828244439217
GSU,tanespimycin-bortezomib (250-1 mol-mol),-0.9312032825444012
SBC-5,46907787,3.799315463541784
NALM-6,637858,-0.2798518560160861
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055
SNU-478,637858,1.5237047093622371
NCI-H1703,46907787,1.9618105089969164
NCI-H1395,439501,0.2163751108150007
MDA-MB-435S,sirolimus-bortezomib (250-1 mol-mol),0.878398861878788
SNU-216,100016,6.2010021575017085
MPP 89,107970,1.974109057124115
NUGC-4,439501,-0.6746997916086527
SK-MEL-1,9903786,3.576716533884559
NCC-StC-K140,9927531,5.259562635251384
EC-GI-10,5460769,0.497898829273519
Caki-2,49766530,0.634494181094052
CAL-33,637858,2.2822409220674085
JeKo-1,12003241,-2.1711036059300963
NCI-H2106,sirolimus-bortezomib (250-1 mol-mol),0.8781181431398268
697,5460769,1.383858776744359
NCI-H727,168313016,5.705554517808247
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
HT,26596,-2.1592273986948394
VM-CUB-1,26596,-2.0768458829121745
Hs 611.T,135999136,3.4823204763051487
NCI-H1693,9927531,4.77981113730065
ACHN,selumetinib-JQ-1 (4-1 mol-mol),5.066584749922726
CL-11,9903786,2.342392371257784
MPP 89,12003241,-0.4822573033051652
NCI-H2023,107970,2.443634681904435
WM793,49766530,-0.085641441031448
NCI-H1339,26596,-1.3893901381267089
BT-549,637858,2.0216713295762614
ME-1 [Human leukemia],135421197,1.4857901642413922
MOTN-1,tanespimycin-bortezomib (250-1 mol-mol),0.3345366577649379
Yamato-SS,73707398,1.2225276782354235
BT 504,12003241,-1.3815102310326015
Namalwa,375860,-0.654511262615756
TE-10,6852167,2.690583082482836
HCC1428,sirolimus-bortezomib (250-1 mol-mol),2.58650359596758
NCI-H2196,107970,1.7459552506758529
MeWo,selumetinib-JQ-1 (4-1 mol-mol),0.1566106193221408
TCCSUP,637858,2.4470905671949996
YD-15,9903786,1.471025688701345
SNU-46,637858,2.6211038154237833
Hs 611.T,262093,0.9776083871947168
HT-55,135421197,1.3327520491863434
KMS-11,73707398,0.4989267515733416
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175
VCaP,439501,-3.1099303166106087
BT 112,439501,-2.896282798681624
Peer,11396600,1.9228051784431397
Capan-1,5460769,0.8848211247496085
TE 617.T,sirolimus-bortezomib (250-1 mol-mol),0.0331781036900695
KNS-62,12003241,3.5800547148534165
ACHN,49766530,-1.8563203862098
KNS-62,49766530,5.605619598661556
ALL-SIL,73707398,-0.324762560862376
HEC-1-B,6852167,2.27935850479613
Calu-3,135421197,0.9816420613117603
KLE,6852167,2.751103786046217
SCC-4,tanespimycin-bortezomib (250-1 mol-mol),-0.6950216335747628
CCF-STTG1,selumetinib-JQ-1 (4-1 mol-mol),4.9623301985248265
SW948,5460769,-0.6640669541383749
MOTN-1,375860,-0.5275856656168855
697,107970,1.291277302319886
WM115,3689413,-0.1044392328624619
JM-1,5460769,0.6255065324989537
SNU-C4,sirolimus-bortezomib (250-1 mol-mol),0.5711150121168962
DBTRG-05MG,107970,3.006907268796323
JHOC-5,241158,4.073008861380035
SW948,444795,4.960330673315111
OCI-Ly19,100016,6.584850236816641
SK-MEL-3,9927531,5.047514354060135
NUGC-3,439501,-0.8687930764506365
HGC-27,439501,-3.477587502070629
U-118MG,107970,2.261669486619066
MKN1,selumetinib-JQ-1 (4-1 mol-mol),4.262768356267428
NCI-H358,644241,2.2506762746858144
OCI-Ly3,5460769,0.7293331267323642
JHOC-5,6852167,3.0537905244245813
HCT 8,439501,1.4071558312094663
U-CH1,sirolimus-bortezomib (250-1 mol-mol),-0.0071193636307831
T24,71466445,5.710927088014398
NCI-H2170,9903786,3.56987053348202
MeWo,6852167,2.944495368954562
SU-DHL-4,241158,2.7367495479709194
PL-21,241158,4.28297897809028
TE-15,11396600,3.8567248680954056
PaTu 8988t,637858,2.5993481939897314
EFE-184,107970,2.9508712394784826
SNU-1041,107970,2.962273906034501
Ri-1,49766530,-2.264065529315868
SYO-1,375860,-0.5330917141994846
HuT 78,71466445,0.6237805812301164
PE/CA-PJ34 (clone C12),135999136,4.2559270335643955
HEC-265,439501,-2.385481236661946
NCI-H1734,9877608,5.725584045619203
Tm87-16,71466445,3.970710704905261
ST486,11396600,2.643350967918509
MOLP-8,73707398,-1.5200522985211378
NCI-H1915,136227331,4.393848466029563
JeKo-1,71466445,3.0601358929071605
TT2609-C02,241158,6.14247238841205
TE-6,168313016,5.611200236172772
HCC1438,selumetinib-JQ-1 (4-1 mol-mol),3.080440327517642
BT 139,9903786,4.553274987644657
Panc 04.03,49766530,1.2448845141630578
KALS-1,11396600,3.671510042060093
253J-BV,439501,-2.3122827098315515
BFTC-905,10231331,1.5129291743987272
SUP-B15,135999136,1.810963396419892
HSC-2,241158,3.065705859569923
Ku812,107970,1.4051912271786118
CL-11,6852167,3.2346326297754833
SET-2,375860,-0.3203156821570778
SK-MEL-3,49766530,1.022989661604762
SK-LU-1,6852167,4.189762356624802
HCC1569,9929138,7.033632026458537
Daudi,5460769,0.2326576177581661
HMC-1-8,9903786,2.873770542760651
OAW42,selumetinib-JQ-1 (4-1 mol-mol),3.6330242229616694
SU-DHL-10,135421197,2.145200655725533
SW1353,73707398,1.600430045495041
NCI-H2110,5460769,2.6451142093153326
SNU-685,5460769,1.3668159641558515
SNU-C1,375860,0.032690159170556
SU.86.86,107970,2.3526522734553685
SK-MEL-3,3689413,0.509275079548213
SNU-886,644241,2.771156867357371
HCC4006,375860,-0.093838404315139
NUGC-3,375860,-0.2148572525752654
Hep-G2,168313016,5.1281820641860545
HEC-108,tanespimycin-bortezomib (250-1 mol-mol),0.6287218196429517
NCI-H1092,73707398,1.109051456829637
DU4475,9929138,2.965218723675565
NCI-H747,262093,2.550683117249541
MCAS,11455910,0.7655577193657753
T84,9929138,6.3577776039121465
HuCC-T1,439501,-1.791859675505955
Mel JuSo,73707398,1.4621510495455972
SNU-61,10231331,-0.1396530061474971
L-540,9929138,3.361491533267478
Kelly,100016,6.527674974645037
B-CPAP,49766530,-2.4408790709837396
BT 248,44491742,4.160095989296475
BT 231,UNC0638-navitoclax (1-1 mol-mol),5.638389329843739
ONCO-DG-1,46907787,0.8121949091079932
NCI-H2023,3689413,4.096769539099316
Peer,44491742,1.9885349932687044
TOV-112D,135421197,1.1317975787010155
TALL-1 [Human adult T-ALL],6852167,1.670387367472753
SK-N-SH,168313016,5.308215001668749
HOS,12003241,-0.4852200240623472
SNU-81,46907787,-1.0582449369350613
NU-DUL-1,11396600,2.3602642092623753
Pfeiffer,49766530,-5.33360369117745
BICR 16,9903786,3.9167102075651785
NCI-H211,71466445,2.8294314838648473
JK-1,644241,-7.211964985196522
HCC827,100016,4.431453048958875
Rh30,73707398,0.839071257859524
TOV-112D,3689413,0.2430902307838531
SNU-387,9927531,5.201038765097566
YH-13,sirolimus-bortezomib (250-1 mol-mol),0.2727627020521754
EFE-184,tanespimycin-bortezomib (250-1 mol-mol),1.3257452416243327
LUDLU-1,11396600,3.511011158799078
VMRC-RCZ,11396600,4.06764978038785
HCT 8,5460769,4.645297134954857
JHUEM-7,49766530,-0.0352390480057696
DMS 273,44491742,3.7307306463602545
SCaBER,12003241,-1.3613478880946173
NCO2,644241,3.59504052771079
TYK-nu,262093,2.9110323710045285
SNU-1272,6852167,2.886842068916118
CAL-51,46907787,3.297361866649883
EKVX,9927531,4.418248493855361
HEL 92.1.7,9927531,3.309303309112431
NCI-H196,11455910,1.326317749713535
COLO 800,135999136,4.366247169448385
JJN-3,11455910,0.8680436077837121
SK-HEP-1,5460769,6.10306620405049
SNU-668,135421197,2.8470371844107274
LOX-IMVI,439501,-2.207275092585139
SCC-4,439501,-2.9533139403217397
KU-19-19,12003241,-0.0608702413973226
M-07e,11396600,2.6873765044270463
KP-3,tanespimycin-bortezomib (250-1 mol-mol),-0.1312023090499479
U266B1,selumetinib-JQ-1 (4-1 mol-mol),0.6265067373447608
NCI-H661,168313016,5.326553105852446
Panc 08.13,9903786,3.5519515597880646
SCC-4,sirolimus-bortezomib (250-1 mol-mol),1.5371967281247725
JHOM-1,439501,-1.2372155535522604
JJN-3,10231331,5.266258686816633
SNU-16,9929138,2.9075870655199836
VCaP,168313016,4.030935975123804
KO52,selumetinib-JQ-1 (4-1 mol-mol),-1.2096541805376022
ECC12,439501,0.4068206161036775
PaTu 8988s,439501,-3.8776790772528864
BT 330,10231331,3.9874659396467793
NCI-H1915,11396600,3.355120861633073
NCI-H2286,11396600,3.697851476409739
BL-70,12003241,-2.1974938808167477
KLE,11455910,3.332048563725763
BT 330,439501,-3.680620250809701
SiMa,9927531,3.724506882989752
SW579,54596490,4.948848003277673
HCC1833,49766530,-1.3796186102265957
Namalwa,9903786,1.5886639412240358
BICR 6,11396600,3.532608369106794
SUP-HD1,44491742,5.1977387021810255
DB,135999136,3.730789319227476
BICR 22,44491742,3.912327775797625
J82,107970,2.424996826844534
YD-10B,selumetinib-JQ-1 (4-1 mol-mol),-1.9634991051981487
HCC2108,135999136,4.648622110630223
8-MG-BA,6852167,4.146273302746602
LCLC-97TM1,73707398,0.638027637531153
NCI-H524,3689413,-3.856889937044058
HCC2935,71466445,4.339835405663117
SNU-201,selumetinib-JQ-1 (4-1 mol-mol),2.2194070686066936
QGP-1,637858,2.459344583911319
Hs 944.T,12003241,-1.584632945920027
RERF-LC-MS,262093,3.104487938727744
MOLT-3,107970,1.5374571301913311
NCI-H647,44491742,3.8006488884614527
LN-229,135999136,5.508952384522358
HH [Human lymphoma],sirolimus-bortezomib (250-1 mol-mol),-8.470809124767328
TE-14,46907787,0.3694296946140285
Mono-Mac-6,11396600,3.7802987218854898
253J,49766530,0.1673174329767313
KP-4,6852167,2.7219764725227753
ChaGo-K-1,44491742,3.5931231049771126
SNU-387,73707398,1.5803373697858054
H-STS,26596,-2.569417697964928
COR-L51,135421197,2.6598803683271965
ECC10,26596,-3.5060948128404874
NCI-H1869,49766530,-0.032716755694371
SW1783,9927531,4.46381053918724
SNU-738,tanespimycin-bortezomib (250-1 mol-mol),1.4501924886201147
Hs 888.Lu,5460769,5.202141251599371
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677
HCC827,168313016,6.229726215184129
KP-N-SI9s,439501,-2.735040326022903
SNU-C1,241158,4.295259005445246
HEC-151,10231331,4.832109833959945
NCI-H23,49766530,-2.8295631960670735
8505C,241158,4.029404542619069
NCI-H1568,5460769,1.1324377767406906
P3HR-1,11396600,3.8940986796449946
MOLT-16,sirolimus-bortezomib (250-1 mol-mol),-5.402934760182518
RD,selumetinib-JQ-1 (4-1 mol-mol),0.3868599896227363
Calu-3,9903786,3.8990782508172495
HEL 92.1.7,439501,-2.540174469055436
NCI-H1838,46907787,3.3230363809861667
PK-1,637858,2.636074428434348
DU4475,136227331,3.920684597845916
Fu97,439501,-2.2730678806091924
Ci-1,375860,-0.2191044108092374
NCI-H1694,168313016,4.033797833146115
SNU-668,11455910,1.1110208427049713
TC-71,100016,6.681443396825605
SNU-620,107970,2.1644257311198936
NCI-H446,135999136,1.8364057437274477
HCC1806,26596,-2.125787428122878
SNU-61,135421197,1.1046098427392648
EoL-1,5460769,1.0165285119643896
CAL-85-1,sirolimus-bortezomib (250-1 mol-mol),-0.0188849543206935
SNU-886,375860,-0.100716733121392
DEL,3689413,-2.5284347391762583
HT-144,49766530,0.4974871030439343
Karpas-620,3689413,-2.001578563648977
PC-3,168313016,4.45670900548214
BT 216,439501,-3.37474066613204
BT-474,11455910,3.140407546934709
CFPAC-1,135999136,4.179535980060787
NCI-H1299,6852167,2.875213655534043
BICR 6,sirolimus-bortezomib (250-1 mol-mol),1.9744607450620832
COR-L88,tanespimycin-bortezomib (250-1 mol-mol),-0.4696067896304535
JK-1,selumetinib-JQ-1 (4-1 mol-mol),-0.917900524349044
PF-382,135999136,1.3874167482573283
NCI-N87,375860,-0.928197184659684
RPMI-8226,135999136,1.3758652810772145
CW-2,73707398,1.0711790511285473
TE-11,9903786,1.6089543664279713
Pfeiffer,tanespimycin-bortezomib (250-1 mol-mol),-0.0267896609776724
MES-SA,135999136,1.8012434168872604
DMS 454,168313016,5.4433694832060775
HOS,73707398,3.147958849673515
MFE-319,9903786,4.166499809230756
NCI-H508,44491742,4.239299300064597
RPMI-6666,12003241,-3.2897330659592705
BT 482,UNC0638-navitoclax (1-1 mol-mol),2.1366376160225227
KMS-27,26596,-2.324040117520084
Hs 852.T,10231331,1.8356181415822297
TTC-709,5460769,-2.125391207652167
SU-DHL-8,73707398,0.7589420989008208
UO-31,3689413,-5.037713706278837
IM95,644241,4.4124367091719865
HCC1195,12003241,-0.4871999069137717
SH-10-TC,3689413,0.5157614607297105
42-MG-BA,5460769,1.54562912999154
NCI-H2110,12003241,-0.2811614102315782
IM95,71466445,4.20194665159327
NB1,439501,-2.2993360738685604
TALL-1 [Human adult T-ALL],11455910,0.0661503545953694
TUHR10TKB,UNC0638-navitoclax (1-1 mol-mol),-2.6605756335280297
BICR 18,5460769,1.6305268231033057
BT 498,262093,3.072055867790356
M-07e,100016,5.065678373530031
EFM-192A,49766530,1.9106564421036225
ECC10,168313016,3.3239878993756684
HEC-1-A,UNC0638-navitoclax (1-1 mol-mol),1.5450110805841195
RVH-421,262093,2.8806904491125
RPMI-7951,241158,3.4568590473726273
OCI-M1,selumetinib-JQ-1 (4-1 mol-mol),-0.1559464569185333
HPAC,12003241,0.9185778330779416
NCI-H1755,11455910,1.1406081050587142
TE 441.T,selumetinib-JQ-1 (4-1 mol-mol),4.709536906442107
CAL-148,sirolimus-bortezomib (250-1 mol-mol),-6.661160669337239
MOTN-1,6852167,1.1725623710698938
KMH-2,selumetinib-JQ-1 (4-1 mol-mol),-2.0810705685207265
RERF-LC-MS,9903786,2.6182355767545213
Hs 746.T,439501,-2.632583453917954
EFO-21,5460769,5.67589124107342
SW948,selumetinib-JQ-1 (4-1 mol-mol),-0.7293969321677569
HCC38,6852167,2.687362191349945
RPMI-7951,26596,-1.730558618097036
KNS-81,11455910,2.3157999192593888
COLO 201,135999136,4.934648698657588
NCI-H1355,9903786,1.6922210610733373
SK-MEL-31,11455910,3.802034948643962
KE-39,12003241,0.559414259019648
KMRC-3,241158,4.146314213470915
MKN74,12003241,-0.9650452844715884
GSU,9903786,4.148563338701872
SNU-308,3689413,0.3406956707675037
AsPC-1,135999136,4.3448843965381965
A-549,135421197,2.4799819746704075
SK-MM-2,444795,-2.647397105058285
JIMT-1,selumetinib-JQ-1 (4-1 mol-mol),2.8828877731679667
CAL-12T,241158,3.629471544675429
8305C,375860,-0.9705370224824008
DLD-1,11455910,2.1228676329479397
KMS-21-BM,9927531,3.894276575541364
MOLT-3,26596,-3.757190091597864
DOV13,262093,2.5740309324045327
KE-39,262093,2.516325504276674
NCI-H322,5460769,4.726933223287107
Namalwa,26596,-3.71974803891978
SU.86.86,49766530,0.3418469510818301
BV-173,107970,2.273734627744329
MeWo,241158,3.9599252474346502
BT 286,241158,3.931607244311501
YD-38,73707398,1.113777458655618
JHOM-1,73707398,2.0512902795527856
SK-OV-3,6852167,3.0870556066687076
KP-2,375860,1.4529528337868778
TE-11,10231331,4.736086886941046
NCI-H2126,107970,2.363943051390716
SNU-899,10231331,-0.5861041210807778
Pfeiffer,6852167,-0.1757451201496154
NCI-H1373,135999136,5.970731564912955
HCC95,6852167,2.584252401921641
SNU-C2A,3689413,1.145907285408548
HMCB,439501,-1.1140754693945072
OC 314,tanespimycin-bortezomib (250-1 mol-mol),-1.1782334155710066
BT 482,12003241,-1.3288470463834767
BICR 22,71466445,3.433479198461154
RPMI-8226,11455910,-0.3031686531040117
GSU,100016,6.3262103117900805
NCI-H1792,73707398,2.4293633915980535
SCC-9,9927531,5.254709651648818
COR-L105,UNC0638-navitoclax (1-1 mol-mol),1.0855753959105363
NCI-H727,9903786,3.725485605999375
SCC-25,selumetinib-JQ-1 (4-1 mol-mol),-1.3511560119840642
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034
HEL 92.1.7,71466445,0.5664416443041054
KMS-26,44491742,3.93722038391691
UACC-257,selumetinib-JQ-1 (4-1 mol-mol),-0.3941335857847879
CHP-212,selumetinib-JQ-1 (4-1 mol-mol),-3.8376268074181312
OVCAR-5,73707398,1.79782058395096
LNCaP clone FGC,100016,6.505127339133147
B-CPAP,9903786,2.2781712830719316
CAL-29,262093,2.679093479440611
BT 232,12003241,0.7689860927775146
NCI-H508,637858,2.102679611900147
SUIT-2,107970,2.9350948745745966
VCaP,637858,1.896853411256556
8505C,444795,4.497569251932835
KMM-1,3689413,1.9155128689282703
SNU-1,71466445,4.2359794223935054
CCF-STTG1,135999136,5.41297640167708
SIG-M5,UNC0638-navitoclax (1-1 mol-mol),1.9019832326670536
NCI-H446,11455910,-0.4036414129969405
NCI-H1155,11396600,2.7094100495435165
SU.86.86,637858,2.2457554549288714
COV362,6852167,2.529860049737666
OVCAR-8,135999136,4.416830472376433
HuP-T4,637858,2.2191803891242987
COLO 201,9929138,6.828783569682717
HD-MY-Z,6852167,3.895273061647595
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448
A-204,71466445,3.8139873570598497
RERF-LC-Ad1,3689413,-1.7788688033713365
Rh30,135398744,6.322590827161508
SW1710,439501,-1.6962022164368444
Kasumi-2,12003241,-2.245419673861097
THP-1,5460769,3.8427937277030497
WM793,sirolimus-bortezomib (250-1 mol-mol),1.012836657947069
RPMI-6666,tanespimycin-bortezomib (250-1 mol-mol),-0.2887832089561175
SNU-668,9903786,2.616887117986772
U-251MG,439501,-1.7120275668154334
MCF-7,3689413,0.894647662863142
U-BLC1,9903786,1.0981923916711085
JK-1,135999136,1.835652515578062
SNU-407,46907787,-0.6820147293264143
SK-MM-2,241158,3.139397646648939
JHUEM-1,44491742,3.7957056019779345
EoL-1,10231331,-2.1863910131139326
NCI-H1869,100016,6.8338343579730285
8305C,262093,3.034489216194041
NU-DHL-1,12003241,-2.4677988287748915
NCI-H520,375860,-0.3875820486223135
AU565,26596,-1.0644098452654434
COLO 741,3689413,2.799435260821197
BL-70,46907787,0.0819976049687394
HCC1171,637858,2.0193293251273587
RERF-LC-Ad1,selumetinib-JQ-1 (4-1 mol-mol),3.573516405475977
NCI-H2342,73707398,3.0796988460505044
SK-MM-2,11455910,-0.2856161246837256
CAS-1,9927531,5.442580925984542
YH-13,73707398,1.2587835012572517
OVCAR-8,10231331,5.783202418816481
G-402,tanespimycin-bortezomib (250-1 mol-mol),-2.2331450772750285
T3M-10,46907787,3.0112486695528085
TE-8,262093,2.355811133795261
TE-10,73707398,0.9916706156447608
SF539,12003241,-2.026733754371074
CHP-212,11396600,2.9941835804811507
HPB-ALL,49766530,-0.2881554297817815
PLC/PRF/5,439501,-1.8160204684239925
RKN,135999136,4.319110081529012
UO-31,241158,4.2784384777828866
NCI-H929,100016,3.8135603062591
OVK18,26596,-0.4420601425641566
SF126,26596,2.229943441766346
KLE,12003241,-1.9975693903430911
A-549,selumetinib-JQ-1 (4-1 mol-mol),1.5948722522654506
AML-193,tanespimycin-bortezomib (250-1 mol-mol),-1.641441169090329
JVM-3,UNC0638-navitoclax (1-1 mol-mol),0.2477073978511914
SK-MEL-2,444795,5.015543431579257
BT 330,444795,4.463557334125424
HLF,12003241,-1.5273612308967348
SK-MEL-24,9927531,5.248971858061216
SK-MEL-5,tanespimycin-bortezomib (250-1 mol-mol),1.5988116818939204
KP-4,46907787,2.8983323327312185
NCI-H2030,sirolimus-bortezomib (250-1 mol-mol),1.8055328698484328
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887
NCI-H1734,73707398,0.7636447310811201
HuH-6,9929138,4.876929493574036
DMS 114,168313016,4.429758921545856
KMRC-1,selumetinib-JQ-1 (4-1 mol-mol),4.265974961239561
769-P,71466445,4.666274253577678
MHH-NB-11,5460769,0.1822518013387546
MOLT-13,11396600,2.919023807687231
SNU-C1,11396600,2.8735657781270003
SNU-216,439501,-2.844909600692544
CAL-51,44491742,5.152478206660974
SNU-61,375860,-0.3575080218905608
SNU-C1,44491742,3.3879999967260717
Jurkat,12003241,-1.1785607025510931
NCI-H1373,100016,4.430083600999957
SNU-C2A,selumetinib-JQ-1 (4-1 mol-mol),1.4067421274631011
NCI-H727,241158,6.115461447477091
FaDu,44491742,4.0645501932383095
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
COLO 699,135999136,4.420900898288184
TCC-Pan2,107970,2.8606881993885738
COLO 320,136227331,6.064515235330745
AML-193,11455910,0.2037712262055268
DEL,644241,2.6875101037764892
BT 504,selumetinib-JQ-1 (4-1 mol-mol),2.8147645186457964
MDA-MB-453,135999136,4.2113637134750395
5637,262093,4.0544390012856235
JM-1,168313016,3.8541200519849017
OE33,168313016,4.477619540995002
Granta-519,375860,-0.9367901929922506
RT-4,10231331,3.499380927126235
MeWo,136227331,4.002976901142853
NCI-H2106,46907787,3.0584015724155904
BT 239,9903786,2.77679173166366
SUP-M2,tanespimycin-bortezomib (250-1 mol-mol),-1.1687996119846569
ES-2,12003241,0.0508402342945085
OAW28,46907787,2.388022074777516
NU-DUL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.4841470415007147
CAS-1,44491742,3.9814120844096386
HT115,439501,-2.40828737906019
A2780,6852167,1.374383856311773
FTC-133,selumetinib-JQ-1 (4-1 mol-mol),3.749238444437789
TE-6,44491742,4.129891650576595
COLO 205,135421197,2.4843493589992125
KE-39,9929138,5.605001473491643
A-549,637858,3.117280931983567
SK-UT-1,107970,2.916039273405532
NCI-H2081,6852167,2.954622232439069
Panc 03.27,54596490,4.426950175549895
MHH-NB-11,135421197,1.028464988751559
HCC2935,44491742,3.357572958697748
NCO2,12003241,-5.3551857747003
SW579,UNC0638-navitoclax (1-1 mol-mol),1.075742965744335
KP-2,241158,4.417297726606118
NCI-H929,439501,-2.3111413664478513
HuP-T4,73707398,0.9905638319288622
CCF-STTG1,12003241,0.9586959919868534
Karpas-422,UNC0638-navitoclax (1-1 mol-mol),0.995215523956661
A-172,selumetinib-JQ-1 (4-1 mol-mol),3.279588036343396
OVSAHO,637858,1.8290217705007763
TALL-1 [Human adult T-ALL],100016,4.020437007073488
NCI-N87,73707398,0.9429301881187698
HPAC,3689413,3.007667333136724
MOLP-2,46907787,3.434010090351403
MCAS,10231331,-0.2141548705956653
786-O,100016,5.342252836782742
MOTN-1,49766530,-1.5651845787849432
HEC-151,100016,5.913951457428463
NCI-H2009,135999136,4.285465393980956
NCI-H211,46907787,-1.4290062563896933
OCI-AML-3,49766530,-3.0415372602627375
CAL-85-1,11396600,3.0340075631394248
WM793,168313016,5.214677912138177
42-MG-BA,11455910,2.2214845082540813
CW-2,5460769,1.6725505189692909
MeWo,100016,6.619977613887792
JM-1,11455910,-0.0097968256607179
HCC95,11455910,1.9982111231876976
YH-13,11455910,2.765771134789071
NCI-H1703,71466445,5.673513655932656
NCI-H2170,11455910,0.541639462195205
OCI-Ly10,44491742,5.232515428740167
NCI-H889,6852167,5.2304269420890535
FaDu,241158,4.6777977803464745
OVK18,sirolimus-bortezomib (250-1 mol-mol),-3.215952535759779
NCI-H1693,644241,2.15020513902518
FU-OV-1,73707398,1.0047751906041116
Rh30,439501,-1.3281255322499272
Daoy,3689413,-2.377724406680773
NCI-H2087,107970,0.9807530000225162
EBC-1,11455910,1.3767667984766183
LC-1/sq-SF,5460769,2.491763650512152
Ki-JK,tanespimycin-bortezomib (250-1 mol-mol),-1.1406777464208224
EJM,UNC0638-navitoclax (1-1 mol-mol),1.2280431327330104
NCI-H841,selumetinib-JQ-1 (4-1 mol-mol),3.1374958176608603
ES-2,11396600,4.145090695204245
KMS-27,73707398,0.1300509584750546
SR,439501,-3.204976665793822
NCI-H358,10231331,-2.127257720605189
TOV-21G,selumetinib-JQ-1 (4-1 mol-mol),-0.6067316586875464
LP-1,11455910,0.2365094775897044
MDA-MB-361,375860,2.2561583319189773
SK-LMS-1,6852167,3.2249832474571893
HCT 8,11455910,0.923477323038918
HCC1588,100016,6.591658390404969
SF539,5460769,-0.1125532875886319
TTC-709,tanespimycin-bortezomib (250-1 mol-mol),0.5220611379237968
KPL-1,73707398,1.7074726811570569
SK-UT-1,tanespimycin-bortezomib (250-1 mol-mol),-0.7154967018113316
NCI-H1581,444795,4.04311509968713
KE-39,11455910,-0.1151631297895284
KO52,107970,1.5787465596439585
JHUEM-1,46907787,1.7226050110198932
SEM,135398744,6.34358667151958
DMS 114,6852167,2.821069829391007
L-428,107970,1.6404690434145903
NUGC-3,26596,-0.5443807488000636
CAL-51,26596,-1.4638590943230956
ME-1 [Human leukemia],135398744,6.466274911980868
Kuramochi,637858,2.821656022109006
NCI-H211,262093,1.1438689543119294
NCI-H2081,sirolimus-bortezomib (250-1 mol-mol),-0.0413699313219798
A-375,73707398,0.8320576726433225
KMS-28BM,444795,2.369177528845911
CL-11,10231331,-1.8481941267603217
Kasumi-2,241158,2.967162139629707
SW1573,135421197,1.3915330004591782
GSU,10231331,1.2076140731561538
HCC1588,107970,2.234641750507031
NCI-N87,135421197,1.227136310912881
Rh41,11455910,-0.4442712184273157
SW620,100016,5.873144490676751
CHP-126,262093,1.44556631123722
RCH-ACV,11455910,1.239951006790748
BICR 16,selumetinib-JQ-1 (4-1 mol-mol),2.075716785292983
SW1417,9927531,5.165268920139929
TM-31,selumetinib-JQ-1 (4-1 mol-mol),3.4065119528708148
MM1.S,26596,-1.4234323398175248
MPP 89,selumetinib-JQ-1 (4-1 mol-mol),2.3199890701471295
CHP-126,26596,-2.268724327317824
NCI-H2087,9927531,4.212541441573842
PC-3,sirolimus-bortezomib (250-1 mol-mol),0.5730469414273184
A4/Fukuda,100016,4.8831896191852096
BT 320,11396600,4.5560356349666
BT 245,168313016,5.350977355116985
RCC10RGB,107970,3.009214725762471
CJM [Human melanoma],241158,4.277707149827287
KP-N-YN,73707398,1.440636079440376
YD-15,135421197,2.516828006554414
TE-5,241158,3.735323756350085
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028
Panc 10.05,49766530,2.44365810580744
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823
JK-1,3689413,-0.5403816328590246
HEC-251,9903786,4.825179909690824
HT-144,73707398,1.5512400088188414
Hs 294T,UNC0638-navitoclax (1-1 mol-mol),3.1993320257548796
MG-63,12003241,-0.4675070550973023
TE-14,73707398,2.073714083306327
BT 145,135421197,2.030859989245954
Panc 02.03,3689413,0.2165954212360822
ME-1 [Human leukemia],49766530,-2.233463718889399
CAS-1,107970,2.1962069806486326
HT,49766530,-2.438744411324034
BT 328,tanespimycin-bortezomib (250-1 mol-mol),-1.4953584261079875
Kasumi-1,644241,-2.415467387593779
SNU-407,3689413,0.4751617374249986
BFTC-905,11455910,3.497810765417644
OV-90,107970,2.0662633791311635
NCI-H2291,107970,2.284745408670311
AsPC-1,10231331,1.7826677656602696
A2780,136227331,3.7351205807719863
SK-ES-1,73707398,-0.3273653393975521
TT,5460769,2.0834356012703155
SK-MEL-5,44491742,4.058095878540579
P31/FUJ,46907787,-0.8407426122417735
P12-Ichikawa,241158,2.9729795131964063
PE/CA-PJ34 (clone C12),9903786,2.211143495082886
KNS-42,44491742,4.252498617041353
KMS-18,9903786,2.604638475406196
DAN-G,11396600,4.828113333823666
HCC1500,241158,4.347158152842418
A-204,644241,0.4255610904978891
SUP-B15,73707398,0.0543063600854058
JVM-3,241158,1.7213635489720556
KMH-2,9903786,1.3660293069385576
NU-DHL-1,11455910,-0.2130419418137634
KCL-22,375860,-0.4876859015099881
SW1710,12003241,-1.2750404815852618
BT 216,49766530,0.8435993289862541
SNU-423,241158,3.874082799654454
Granta-519,49766530,-2.591856607816134
JHUEM-7,375860,-0.5506223236134746
NCI-H2228,49766530,-0.2388260531706088
OE21,26596,-3.6158126221637823
NCI-H69,11396600,3.636933869724233
CGTH-W-1,135421197,2.895305047489035
U2OS,11396600,3.835959810142159
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935
SW620,439501,-1.8970460757593473
SNU-C5,sirolimus-bortezomib (250-1 mol-mol),1.5938355123050036
HEL 92.1.7,tanespimycin-bortezomib (250-1 mol-mol),0.3488899515335228
HCC-56,3689413,0.2080037745541134
HCC2108,100016,5.291323338255078
SKM-1,637858,0.6023395164344832
OC 314,107970,2.3630132830347343
OVCAR-8,46907787,2.826813590962943
HCC44,262093,3.638344184210184
GSS,49766530,0.909441474448473
SNU-1272,9903786,4.921324329124853
OE33,tanespimycin-bortezomib (250-1 mol-mol),-0.7700127207654934
Rh30,6852167,1.7191526949253222
PSN1,135421197,2.7573404072547327
HCC2279,5460769,5.144403730026711
KE-39,637858,2.1285067674718374
MPP 89,5460769,6.230455153292042
NCI-H1755,637858,1.863634433373937
CGTH-W-1,637858,2.9183826473094125
JHH-2,73707398,1.105649662692389
AsPC-1,135999136,4.3448843965381965
NCI-H2052,5460769,4.5383671359434254
CML-T1,135421197,0.9317392273651705
T84,9927531,3.2336753080400933
HuNS1,9903786,1.9338093787028072
OAW42,444795,4.960287089839776
Hs 683,637858,2.5544628931589166
DMS 114,135398744,6.443015881513616
A2780,100016,4.757543521992015
GI-1,375860,-0.0355977916209161
HCC1419,3689413,0.4398043880767979
Hs 944.T,3689413,0.6165521340275051
A-204,selumetinib-JQ-1 (4-1 mol-mol),1.7277465059670114
BCP-1,26596,-2.6141791098451934
PC-3,439501,-3.5165301870607903
KMBC-2,11455910,1.9151529363040984
SNU-C4,375860,0.622805119835088
U-251MG,3689413,0.7299892089467567
RCH-ACV,5460769,1.517415725106548
HEC-1-B,3689413,0.3558591242375798
Panc 04.03,73707398,1.757833710000806
COLO 205,637858,2.2798809149356223
RCC10RGB,44491742,5.1484686760969645
SK-MEL-31,49766530,-1.960215058686701
IMR-32,11455910,-0.0063621760742968
RPMI-8402,11455910,1.2135317922717286
SNU-308,100016,6.582722131637771
PF-382,44491742,5.368678247108403
BFTC-905,644241,3.603531566552796
253J-BV,262093,3.2913693796929713
UACC-257,tanespimycin-bortezomib (250-1 mol-mol),0.2764764402822645
EoL-1,168313016,2.0659145537185792
VMRC-LCD,3689413,-0.1897073669297062
SNB-75,sirolimus-bortezomib (250-1 mol-mol),1.678317962717081
SK-LMS-1,11455910,0.8292842204783425
SNU-878,637858,2.041946688300655
ES-2,439501,-2.264854435064497
AN3-CA,9903786,1.5268103297033566
DMS 114,11396600,3.971117414652232
Reh,107970,1.8822362327686308
DU145,5460769,5.167808415466422
BL-70,5460769,4.3376670104082455
SF126,107970,2.3765754029032773
NCI-H69,71466445,3.7482174156628263
SK-MEL-1,73707398,1.2021958708063876
Hs 611.T,49766530,-2.7427307114148545
EPLC-272H,11396600,3.8096472633651106
JMSU-1,49766530,0.5298615958954185
GOS-3,135421197,1.697146176044067
MDA-MB-468,9903786,1.7748497481459855
NCI-H2110,6852167,2.8025502977558165
KMS-28BM,11396600,2.8366519547889357
SNU-398,637858,1.1142411159722052
SNG-M,107970,2.3024806168242224
RCM-1 [Human rectal adenocarcinoma],73707398,2.4695798871265473
CJM [Human melanoma],11455910,2.204115994538186
NCI-H441,241158,4.194222979464958
Hs 294T,26596,-0.6328702993813093
Li-7,375860,-0.9891534259719538
SNU-1066,135421197,3.020792561550821
VMRC-LCD,11455910,1.1166938549694674
SNU-1076,73707398,1.2464040742464415
SW1990,sirolimus-bortezomib (250-1 mol-mol),0.2169201029218291
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
MOLT-16,12003241,-1.273061825596023
WM1799,107970,2.5287793754876464
L-540,10231331,4.825518632225075
NCI-H889,12003241,4.506379405890452
U-118MG,tanespimycin-bortezomib (250-1 mol-mol),0.2197944792007267
RD,439501,-3.401030731559912
BT 231,46907787,1.384655777142133
OCI-AML-2,71466445,1.8267840663953585
BT-12,11455910,1.8698034646141068
MKN74,44491742,4.321441779997771
TT2609-C02,10231331,2.507453069849083
SNU-1105,selumetinib-JQ-1 (4-1 mol-mol),2.4835806832746035
TT,262093,3.6842052963276406
LCLC-103H,12003241,-0.4608233539243975
Kelly,5460769,2.22696841800341
KYSE-30,3689413,-2.4041486305877497
TC-71,26596,-3.193308290167961
BT 131,44491742,4.605626488786133
5637,375860,-1.1046178739161925
HDLM-2,3689413,0.2567400255605154
NH-6,73707398,1.0742164546750694
HCC4006,46907787,3.5860575166232933
LS513,49766530,0.4821695528273116
KP-4,3689413,-2.736369445880075
Hs 944.T,241158,3.718025513554267
HCT 116,selumetinib-JQ-1 (4-1 mol-mol),4.796768877675462
OV7,6852167,2.904721816278503
SK-MEL-30,168313016,6.2335475928263255
A-673,44491742,3.844993574977925
ECC12,sirolimus-bortezomib (250-1 mol-mol),1.6381290256709142
ECC12,5460769,2.2219131741447913
NCI-H2030,9903786,2.824655549380346
BT 428,12003241,-1.1639537703903158
SNU-407,262093,2.588557756768625
SK-OV-3,3689413,0.6002437290843657
DMS 114,12003241,-1.1763340491850245
Daudi,44491742,3.5549145676591314
DOV13,sirolimus-bortezomib (250-1 mol-mol),0.9080087228698384
Ki-JK,168313016,2.304395905335515
MOR/CPR,439501,-2.2142939555112484
NCI-H2286,71466445,4.093392952146547
TYK-nu,sirolimus-bortezomib (250-1 mol-mol),0.7718318576607361
HCT 116,sirolimus-bortezomib (250-1 mol-mol),1.7104818148268468
SH-10-TC,tanespimycin-bortezomib (250-1 mol-mol),1.41172754635421
IGR-1,46907787,-0.5222417136929179
SNU-1033,11396600,3.651423781511848
UO-31,tanespimycin-bortezomib (250-1 mol-mol),0.458183553535823
BDCM,12003241,-3.7863516552935415
SK-HEP-1,241158,4.116654148222159
OVCAR-5,selumetinib-JQ-1 (4-1 mol-mol),-2.399030765208003
SW1417,11455910,2.2970669346586168
MOLM-6,26596,-3.738191164501696
BT 359,135999136,1.778359502307078
VMRC-RCW,135398744,6.359457324257638
Ci-1,262093,2.7870589391035443
NCI-H522,73707398,0.7434005611154502
COLO 741,10231331,0.6549411878869091
SaOS-2,6852167,2.181246544986129
Hs 944.T,71466445,4.831797191006342
L3.3,11455910,1.84757483649511
SH-10-TC,262093,3.640204599057082
CAL-51,9903786,2.1849161121493847
HSC-2,12003241,-2.7433654243875214
EoL-1,UNC0638-navitoclax (1-1 mol-mol),-2.9986936858021616
Panc 04.03,11455910,2.454958233695195
WM793,12003241,-0.659721194491695
SU-DHL-10,3689413,-0.1067642786236739
BT 239,10231331,1.4016139195268935
BT 187,11455910,1.1160186893710065
AN3-CA,6852167,1.7401945713297349
HuH-6,UNC0638-navitoclax (1-1 mol-mol),1.0136391182455402
IMR-32,71466445,2.852327940242344
SNU-175,439501,-1.724461019506839
IGROV-1,3689413,-0.3633634632064185
KM12,44491742,3.983947326566667
KNS-62,11455910,1.837200886780492
SNU-761,637858,1.643402740657157
NCI-H1944,107970,2.5235329939917155
Granta-519,9903786,1.2937892753152922
TT2609-C02,439501,-1.3899506791900362
NCI-H1944,637858,3.157092426362052
RERF-LC-Ad2,9927531,7.758899930646885
SK-MEL-28,637858,2.5948993681356276
KP-4,9927531,4.133132471869078
BT 440,11396600,2.3245110777445728
Daoy,12003241,1.232177667394707
Panc 05.04,107970,2.819973093119505
KMS-26,439501,-2.394060102049288
NCI-H661,3689413,0.5447440822016135
SK-MEL-1,439501,-2.4358325657169035
Mel JuSo,12003241,-0.8749256028494242
JHH-4,3689413,0.1617777803735524
NCI-H1341,sirolimus-bortezomib (250-1 mol-mol),-0.2391500871709352
KYSE-410,12003241,-2.1155115062785805
KE-39,3689413,-1.8420159541718293
SUIT-2,241158,4.373615531607702
NCI-H1435,5460769,2.24942337838163
KYO-1,136227331,5.147481927043426
A4/Fukuda,6852167,0.513003696591474
IGR-1,UNC0638-navitoclax (1-1 mol-mol),0.937988062527938
ONCO-DG-1,49766530,-2.0037340634863
Granta-519,12003241,-2.1147517064841925
OV56,73707398,1.090209453559451
RCH-ACV,selumetinib-JQ-1 (4-1 mol-mol),-0.4227837844361623
SK-N-BE(2),3689413,-2.1106889399644273
F-36P,107970,1.5167035192895906
UACC-257,44491742,4.3075324328228275
HCC1395,637858,2.957827547978506
IMR-32,375860,-2.054219262250898
Rh41,11396600,2.905636505661568
23132/87,5460769,0.87100881863978
Kasumi-2,135421197,0.8154486687594628
KYSE-180,5460769,3.044274290576871
EFE-184,sirolimus-bortezomib (250-1 mol-mol),0.9563190078492846
SW1990,49766530,-0.1486325613650474
LS180,439501,-1.9142457865624176
BT-16,135421197,1.2495545603041716
U-BLC1,439501,-3.0504776234222035
NCI-H146,3689413,0.5626872136369616
CCK-81,637858,1.7536647831614909
SCC-4,107970,2.410783645873977
Hs 934.T,241158,5.288609584609173
CAL-85-1,241158,4.439596779386476
NCI-H1339,11396600,3.0711399080961934
SNU-201,9903786,3.5619464236544336
SNU-175,73707398,0.569469638672086
G-361,selumetinib-JQ-1 (4-1 mol-mol),-0.122250953270649
HCC1171,6852167,6.381123013085841
KMRC-20,44491742,5.411645351023098
NU-DHL-1,46907787,-1.3567156835247356
ESS-1,12003241,-1.211695248693708
HeLa,100016,5.8653655502295
SNU-81,10231331,-2.370371712203436
SNU-886,262093,3.428603865365944
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122
HCC1833,9903786,4.187003338939228
BT-16,11396600,4.325514003074736
KP-2,444795,5.129804419457869
PE/CA-PJ34 (clone C12),3689413,1.240876822848384
HCC95,sirolimus-bortezomib (250-1 mol-mol),1.734022258386224
DEL,262093,1.2345626785360508
COV434,11455910,1.492860778557748
TE-9,439501,-2.406207557642534
IST-Mes1,107970,2.9610434925705773
BEN,439501,-2.2680431594189727
HL-60,444795,2.82308006165913
KMS-20,107970,1.4633641977001968
SK-N-DZ,3689413,-4.934308383981231
KLE,UNC0638-navitoclax (1-1 mol-mol),-2.745432149551299
GSU,107970,2.406623240528259
Pfeiffer,135421197,0.665786429706454
PC-3,5460769,3.04554817499368
KYSE-510,44491742,4.7429938042096245
DU4475,selumetinib-JQ-1 (4-1 mol-mol),-2.9281799022987234
SW1990,9903786,3.346032701157222
TE 441.T,46907787,3.123657521861764
JeKo-1,9927531,3.3417502019075473
Hep-G2,241158,4.703758837360285
VM-CUB-1,135999136,4.744134082695585
HEC-1-A,44491742,4.152626069309694
TCCSUP,9903786,3.558837088709428
TT2609-C02,9927531,6.514577910597335
PL-21,637858,1.6083768268340104
A-375,5460769,3.311565919469283
JM-1,9927531,4.0230036766634125
SW1417,12003241,-2.0835943723769184
CAL-29,241158,5.118479967388945
G-402,sirolimus-bortezomib (250-1 mol-mol),0.1655413434951251
EB1,UNC0638-navitoclax (1-1 mol-mol),1.198480968859453
A-204,439501,-3.495173266920804
KYSE-410,9903786,4.00816844948711
CAL-148,selumetinib-JQ-1 (4-1 mol-mol),-1.2852398724483811
CCF-STTG1,100016,6.985278157575169
COR-L51,sirolimus-bortezomib (250-1 mol-mol),0.5050478913341053
BT-16,71466445,5.064611089812396
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
P3HR-1,444795,4.927433768581791
KMS-18,44491742,4.313842675965846
IM95,26596,-1.182221472210093
LAMA-84,46907787,-0.5709891402685436
NALM-6,439501,-2.425379213431436
HMC-1-8,sirolimus-bortezomib (250-1 mol-mol),1.238114753866591
BT 232,46907787,4.9227176505536665
BT 248,135999136,1.3787773380664552
NCI-H1755,44491742,6.2867569407900215
SK-MEL-2,241158,4.163944752728283
KO52,6852167,2.1234945146220645
JK-1,439501,-2.3094568759097265
SW948,3689413,-2.2648112033429824
SUP-M2,selumetinib-JQ-1 (4-1 mol-mol),2.7498429004871765
RPMI-8402,26596,-2.3009998991377274
Ishikawa (Heraklio) 02 ER-,26596,-0.9802171650937824
CAL-51,6852167,2.546662292056567
Rh18,6852167,1.9644324701038989
NCI-H23,135421197,1.340316450445973
NCI-H1155,71466445,4.659482632283621
BV-173,46907787,-0.9372629276794407
NCI-H23,selumetinib-JQ-1 (4-1 mol-mol),-0.1845846084913472
NCI-H441,100016,5.015174861435744
T84,sirolimus-bortezomib (250-1 mol-mol),0.444201231826254
KYSE-30,241158,4.2154926555372
NCI-H1734,5460769,-3.3513439751679983
CW-2,3689413,0.3628565855877684
HCC202,637858,1.2638902875992883
COLO 205,26596,-2.0120712396922475
Ri-1,selumetinib-JQ-1 (4-1 mol-mol),-0.2329470107135907
SU-DHL-6,9903786,1.8029536633965553
HCC202,73707398,1.13633679828289
Hs 936.T,10231331,-0.3842903211878899
HCC1395,12003241,-2.06138866466857
NCI-H28,5460769,-1.4379241893426098
KNS-60,selumetinib-JQ-1 (4-1 mol-mol),2.416041251074975
B-CPAP,444795,4.737983928137852
PSN1,71466445,5.775525837190175
SK-CO-1,71466445,5.862416915369376
U-87MG ATCC,107970,2.4278638259024965
MDA-MB-453,54596490,5.641262539800198
RMG-I,3689413,-2.168245992738919
NCI-H2009,71466445,2.5164920571758036
BT 224,262093,3.775565066976983
Panc 08.13,tanespimycin-bortezomib (250-1 mol-mol),-2.574326454795975
Karpas-620,135398744,5.497457460597933
JK-1,49766530,-2.0838340114086047
PE/CA-PJ49,tanespimycin-bortezomib (250-1 mol-mol),-1.0553859212416536
SNU-175,26596,-1.9837379159345812
VMRC-LCD,168313016,5.458908786396005
HCC1419,637858,3.7204958327098416
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
M-07e,444795,0.671881702750201
NCI-H1694,444795,3.723692799249934
SYO-1,26596,-1.7250044942499454
NCI-H2029,46907787,2.4460673221548443
HuG1-N,3689413,0.3289715107360669
HCC78,selumetinib-JQ-1 (4-1 mol-mol),3.3730165762035567
SU-DHL-8,6852167,1.4339874618826112
TE-1,241158,4.508480195004466
KMS-34,444795,1.6495761438437055
NCI-H1693,46907787,2.3875684863362445
TF-1,UNC0638-navitoclax (1-1 mol-mol),0.2455241341736459
NCI-H1155,644241,2.1023649798666937
NCI-H1650,tanespimycin-bortezomib (250-1 mol-mol),-0.4838646802432306
SK-MM-2,375860,0.1183568668528984
KM12,6852167,3.682699732019613
TE-15,5460769,-0.6910051691918724
A2058,tanespimycin-bortezomib (250-1 mol-mol),-0.4864507990371403
HEC-151,6852167,1.7550927798186455
HCC2218,selumetinib-JQ-1 (4-1 mol-mol),1.4456076234612698
NALM-6,12003241,-1.6085171342218008
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433
KYSE-510,5460769,1.9314900427321815
RERF-LC-A1,sirolimus-bortezomib (250-1 mol-mol),0.1484412834683056
Hs 766T,10231331,-1.1212004968621416
U-118MG,sirolimus-bortezomib (250-1 mol-mol),0.338671350803902
DMS 114,262093,2.4519702544281436
HCC1833,107970,2.3243441845600517
A2058,375860,-0.1531874219729508
Granta-519,644241,4.377614733152813
SaOS-2,46907787,1.5905885991562354
BEN,6852167,3.945016619736351
HT,46907787,-0.9086366382873644
Rh18,49766530,-3.897407053636511
DBTRG-05MG,73707398,1.7792481673131717
BT 498,135999136,3.3192669973744273
BT 245,44491742,4.161467905313556
NH-6,11396600,3.28881859897494
PLC/PRF/5,49766530,1.3653713216930163
Ku812,49766530,-2.390671573618507
A-673,11455910,-0.0977898825280259
697,439501,-3.82474204489092
HCC1500,49766530,0.4188049276678212
Hs 688(A).T,49766530,-1.7217170265307382
Yamato-SS,135421197,2.276835379752713
WM266-4,selumetinib-JQ-1 (4-1 mol-mol),-0.7959266829016844
SNU-398,9903786,4.103035354116066
MHH-ES-1,375860,-0.6305847513048299
IGR-1,10231331,1.9861104383183457
MDA-MB-453,439501,-3.002845657836036
Jurkat,9929138,6.106641752412507
SUP-B15,UNC0638-navitoclax (1-1 mol-mol),-1.2738444623015683
COLO 680N,135999136,4.301915358812356
COLO 205,49766530,-2.229597593802736
GB-1,644241,3.285062000536014
PE/CA-PJ15,tanespimycin-bortezomib (250-1 mol-mol),-3.0373663834156943
HCC2108,71466445,4.412506412183148
PE/CA-PJ41 (clone D2),11455910,-0.0174306689930347
LOU-NH91,637858,2.168731257760998
NCI-H508,26596,-1.5060721880179218
T24,107970,2.9745778553622952
SiMa,26596,-2.340944971406374
8305C,10231331,2.2947891246385983
YD-10B,73707398,1.1278990449683126
A2058,46907787,1.6965919931363946
EM-2,439501,-2.360437246727397
CAL-29,644241,2.799007464040423
Karpas-620,46907787,4.212982028495631
BT 422,46907787,4.821420374408007
YD-8,44491742,4.162245932134171
HCC44,11455910,-0.4907181791415154
DV-90,136227331,3.915454108317936
NU-DHL-1,107970,1.0254507421459336
TM-31,375860,0.1832837483799453
Kasumi-2,168313016,3.99242446715415
Daoy,9903786,4.877795508066272
SU.86.86,11455910,1.5020597787375292
RS4;11,49766530,-2.8590033120735767
BT 416,9903786,2.244954394725016
EBC-1,135421197,2.252820006275089
SNU-886,107970,2.7037771874608034
PANC-1,46907787,0.0989885994051276
HOP-92,11455910,1.423553791437778
CAL-85-1,71466445,4.774774705188815
AGS,11455910,2.3599070102743274
HSC-4,46907787,5.727789952108257
MOR/CPR,11396600,4.52695838854887
SU-DHL-6,46907787,-0.6700724490980451
TALL-1 [Human adult T-ALL],637858,1.0149454438397798
OCI-Ly19,6852167,0.0969280373931757
SK-MEL-1,sirolimus-bortezomib (250-1 mol-mol),1.7691939182804728
Rh18,3689413,-2.3361578419795843
Mino,UNC0638-navitoclax (1-1 mol-mol),-2.2285256214754647
KE-39,44491742,3.945663107977575
CAL-27,262093,3.248965473833737
HD-MY-Z,71466445,5.190152829485737
NCI-H69,sirolimus-bortezomib (250-1 mol-mol),0.0331466406346395
NCI-H889,241158,3.896556371812661
SNU-840,sirolimus-bortezomib (250-1 mol-mol),-1.042474975863496
SK-CO-1,3689413,1.2567954519757167
Hep 3B2.1-7,6852167,2.3004574615198656
A-673,11396600,2.723776149104898
769-P,11396600,4.3298717315530935
Yamato-SS,6852167,0.5276701137747644
Karpas-620,644241,2.657067982766826
Ri-1,12003241,-5.9425936829646435
SBC-5,11396600,3.6683316442381617
Capan-2,637858,2.3526238536580224
HCC2935,3689413,-0.3223376962809587
OCI-AML-5,9903786,1.179944382770948
SH-4,49766530,3.958821770259228
MKN74,107970,1.5556994313686008
BT 504,26596,-1.373211017914528
PSN1,3689413,-0.2980036400640658
TM-31,44491742,6.007028920174117
NCI-H1341,3689413,-3.76878307288409
SNU-16,439501,-4.306216522257499
A4/Fukuda,9927531,3.7257201794253776
PE/CA-PJ41 (clone D2),6852167,3.048314493941667
KE-39,107970,2.31854003043047
RPMI-7951,71466445,5.865470046063986
ACC-MESO-1,135421197,1.1131712845559925
KYSE-510,9927531,4.748041591600806
U266B1,637858,0.9424663085199376
HPB-ALL,46907787,1.131077875050485
Panc 03.27,262093,3.23349895733636
HCC78,6852167,3.0692566285368157
Hs 944.T,10231331,-1.2019051656889153
MDA-MB-435S,26596,0.461113315638288
JHOC-5,tanespimycin-bortezomib (250-1 mol-mol),0.5504047070747966
BT-16,6852167,2.8490153723252227
TUHR4TKB,12003241,-0.5778416487283387
PE/CA-PJ49,46907787,3.401972170810614
BT 159,439501,-3.0773792715975685
NCI-H522,54596490,4.410611853984333
COR-L95,107970,2.0048060228155333
NCI-H2452,9927531,4.529523169776047
NCI-H661,9903786,4.646166413465223
KPL-1,9929138,5.414616490149542
LUDLU-1,11455910,1.2851880169886276
COLO 699,11396600,3.859625290158775
ECC10,375860,-0.309694131426854
KMH-2,12003241,-0.520398442259763
U-BLC1,26596,-0.9383285983925695
HuH-6,tanespimycin-bortezomib (250-1 mol-mol),0.4881830883702249
VCaP,46907787,-0.7712669618246023
UM-UC-3,sirolimus-bortezomib (250-1 mol-mol),1.1405696257506746
BFTC-905,439501,-2.3282671970513524
HOS,11396600,2.933584432278509
BT 248,135421197,1.5349499708791383
SK-N-AS,107970,1.6101479775889769
CHP-212,26596,-3.74720846369554
NCI-H2196,11396600,3.4925760347357
NCI-H1385,644241,1.6107924420900666
WM1799,11396600,3.8068565686639273
LOX-IMVI,selumetinib-JQ-1 (4-1 mol-mol),0.1243957473600749
Ishikawa (Heraklio) 02 ER-,107970,3.1744092198805136
HOP-62,262093,4.19078744138027
SNU-1196,selumetinib-JQ-1 (4-1 mol-mol),3.366894097169684
SNU-878,107970,2.6977452614918507
HGC-27,54596490,4.386231335265865
NCI-H2030,135421197,3.075513669205883
COLO 201,71466445,2.22674921872856
8305C,11396600,4.152403523001879
JeKo-1,100016,6.219930850058466
NCI-H1693,107970,1.7337077857992298
RKO,26596,-1.341584325458414
NU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-2.039060237587124
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316
CMK,135421197,2.3308084532247935
HeLa,73707398,1.5466980684371698
KATO III,sirolimus-bortezomib (250-1 mol-mol),0.9695085232942704
HuT 78,3689413,-1.8719775604380453
A-498,11455910,2.747308138802023
BT 139,439501,-2.1565169223075062
COLO 684,sirolimus-bortezomib (250-1 mol-mol),-6.565635252448311
AML-193,637858,1.3897000366082406
HEY A8,selumetinib-JQ-1 (4-1 mol-mol),1.3172129019958227
HMC-1-8,3689413,0.9110162890999955
ACC-MESO-1,selumetinib-JQ-1 (4-1 mol-mol),2.43285066252002
M059K,46907787,1.4659082225415776
NCI-H1105,selumetinib-JQ-1 (4-1 mol-mol),4.102386120760642
NCI-H508,107970,2.3621486723726126
MDA-MB-231,73707398,1.1644092904893582
Capan-1,11455910,2.2189515930780312
KATO III,107970,2.4596354159707827
NCI-H661,5460769,1.0320957244219937
HuH-1,73707398,2.2911867225031712
COLO 320,UNC0638-navitoclax (1-1 mol-mol),2.1878312985182604
OPM-2,135421197,1.341685947169011
HCT 15,135421197,1.319827384864071
AMO1,26596,-3.5101711689538155
SNU-685,71466445,4.2836215001071185
HuH-28,49766530,-2.3300741099072937
GI-1,73707398,0.9512925339176724
RERF-LC-A1,73707398,1.0933643071146293
Karpas-620,9927531,5.121600131108068
TE-5,262093,1.0368633823540545
BT 359,107970,2.0114219051470887
TT2609-C02,12003241,-1.0431647024866548
Rh41,9903786,2.3999141751709763
DAN-G,sirolimus-bortezomib (250-1 mol-mol),0.114309742904921
B-CPAP,9929138,3.6088246512600457
HT115,9877608,5.791889645309291
Hep-G2,637858,2.4710681435790747
C2BBe1,UNC0638-navitoclax (1-1 mol-mol),0.9522227757619474
BxPC-3,73707398,1.0061551215696194
PSN1,26596,-0.5365301326145567
2004,73707398,0.939674633435561
HOP-92,11396600,3.514379135780385
HEC-6,135421197,3.631820052963688
SCC-9,12003241,-1.125345709331217
BT 224,100016,6.546386559669457
JHUEM-3,107970,1.8006750209945723
HH [Human lymphoma],637858,0.9741155601767478
Reh,5460769,-1.7090111602799842
CAL-12T,100016,6.470654025405006
SNU-C2A,73707398,0.9848565358771032
YD-15,5460769,-2.912025087128814
C2BBe1,49766530,1.671103573384802
JVM-2,439501,-2.3079985652377633
A-673,73707398,-0.4228078892765429
NCI-H1666,9927531,4.532813040549954
697,11396600,1.1442486142510078
HEL 92.1.7,UNC0638-navitoclax (1-1 mol-mol),-1.3520489193994385
DMS 273,107970,2.226748766743483
L-540,637858,1.6045529162646237
697,49766530,-5.010660235197008
TE-14,tanespimycin-bortezomib (250-1 mol-mol),-1.657648162906329
KP-4,375860,-0.9518603940694028
PLC/PRF/5,71466445,4.409191653894859
SNU-719,73707398,1.6522942539342995
Granta-519,6852167,2.2648312753409887
KMRC-2,UNC0638-navitoclax (1-1 mol-mol),2.5258787536181515
MG-63,6852167,1.3458734698302683
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308
DU145,107970,2.74634542230273
HCC1395,6852167,3.6940482841079647
NCI-H647,sirolimus-bortezomib (250-1 mol-mol),1.438565345282899
CHP-212,9903786,1.1399886841606115
MPP 89,tanespimycin-bortezomib (250-1 mol-mol),-0.3809360105117337
SK-OV-3,637858,3.830307013284548
Fu97,sirolimus-bortezomib (250-1 mol-mol),-0.4373916466224739
SCC-4,637858,1.987717752873236
SW48,100016,6.031440310304127
OVCAR-8,9903786,3.64408364733759
MG-63,11396600,3.547749871707555
NCI-H1568,375860,-0.3746562160702436
PC-3,3689413,-2.1836829404040157
Hs 839.T,100016,7.045878686884313
JHUEM-7,26596,-1.8551798961299688
MHH-CALL-4,100016,6.461754156645112
SNU-8,71466445,3.518025690097915
Daoy,241158,3.1399206167097966
Pfeiffer,11396600,1.1420767199469808
NCI-H2452,12003241,-1.7557808561862691
COLO 320,637858,0.981357097050842
BT 179,11396600,2.8965915614229036
HCC202,selumetinib-JQ-1 (4-1 mol-mol),2.9874459844488315
JHH-6,637858,3.376480637337269
NCI-H747,6852167,2.2192552845643148
WM115,11396600,2.8854117577089378
KMS-34,6852167,-0.2545428449161299
NCI-H1623,3689413,0.664737487618683
EBC-1,12003241,0.7952037321943549
IGROV-1,73707398,0.8848064516600974
SK-N-SH,11455910,2.5268556232530868
SNU-761,11396600,3.454843575520041
SNU-119,sirolimus-bortezomib (250-1 mol-mol),1.5818216209728622
MKN7,135999136,6.1524703702506915
WM793,73707398,0.9042820542427616
SNU-489,6852167,4.263249412846992
MFE-319,11455910,1.7600877604233616
OAW42,644241,1.8292706332656063
MHH-CALL-3,selumetinib-JQ-1 (4-1 mol-mol),2.581245013728603
BHT-101,5460769,1.8781791917401816
GSS,71466445,1.4608073960696302
WM266-4,9903786,4.44287748208762
SNU-899,tanespimycin-bortezomib (250-1 mol-mol),0.5360677802944718
NCI-H1373,12003241,-0.7849764131433078
JHOM-1,sirolimus-bortezomib (250-1 mol-mol),0.2834615362224199
EFE-184,11455910,1.1766265020277265
THP-1,375860,-0.8916673896492482
OCI-Ly3,375860,-1.0546671004791963
NCI-H446,9903786,1.878824600883621
COV434,9929138,5.510182738323978
SW948,11396600,3.556168564723583
THP-1,135421197,0.9721009186640236
NCI-H1092,tanespimycin-bortezomib (250-1 mol-mol),0.328880127360426
Hep 3B2.1-7,107970,2.24352532481949
Rh30,46907787,2.5511013191395913
LC-1/sq-SF,6852167,3.913772365452576
A-549,135421197,2.4799819746704075
NCI-H1184,selumetinib-JQ-1 (4-1 mol-mol),1.001947758259214
GSU,637858,2.527068624581838
NCI-H526,241158,3.603489043441015
NCI-H1155,439501,-2.4258947741424572
DMS 273,11455910,0.4737958394902512
HCC44,100016,5.500199899639815
SNU-1079,9903786,0.8372132722803839
EC-GI-10,439501,-3.666361132208791
CAL-120,11455910,1.9217151174360485
EFO-27,100016,6.711163327148508
NCI-H1838,12003241,-1.140669133543194
SK-MEL-24,439501,0.5144696508733063
T-47D,tanespimycin-bortezomib (250-1 mol-mol),1.663799380230643
HeLa,5460769,5.484643109222549
Caki-2,selumetinib-JQ-1 (4-1 mol-mol),4.273304003635038
SNU-478,3689413,0.4137881438833174
TUHR14TKB,3689413,-1.483434528636918
SNU-1196,637858,2.876047341050798
KNS-60,644241,2.4844336494007706
NCI-H292,11455910,1.285235050416197
NCI-H1734,71466445,2.259055905852919
A2780,444795,1.1255727490438436
HPAC,135421197,1.2085727097221448
HL-60,6852167,1.3769451533529364
SUP-HD1,3689413,-2.4864416841895727
SKM-1,sirolimus-bortezomib (250-1 mol-mol),0.3833247137434921
PK-1,135421197,2.4270856926792947
ST486,637858,0.4034485852671179
DMS 114,3689413,-0.1355634310043713
Calu-6,135999136,4.2599356901260865
DK-MG,100016,7.056187444773538
RS4;11,262093,0.7375601612159237
COLO 699,241158,2.9243499322437554
EB1,135999136,3.88645183006867
Peer,26596,-2.3725099322734193
NCI-H520,136227331,4.183046250285636
CL-11,136227331,4.347611231682629
HuG1-N,439501,-1.480081510168686
TM-31,tanespimycin-bortezomib (250-1 mol-mol),0.6359976993745172
Panc 08.13,637858,1.5616639635325589
CHP-212,135999136,3.677189987225608
BDCM,selumetinib-JQ-1 (4-1 mol-mol),0.9833737053487288
LAMA-84,26596,-2.1995969037049936
NCI-H522,9927531,4.749051096908956
OPM-2,262093,0.5720462757198622
TYK-nu,11396600,3.490673589764442
RD,12003241,-0.8502341845781216
CGTH-W-1,46907787,2.2159861154913516
KMS-27,9929138,5.026853283311406
SU-DHL-1,135999136,4.730243036337901
MEC-1,12003241,-2.6195126554486223
HOP-92,49766530,-2.5153256499879517
TE-14,selumetinib-JQ-1 (4-1 mol-mol),0.562522938991472
K029AX,73707398,1.096607124396172
A-172,11455910,2.3992948402654095
SUP-T11,73707398,0.4533846882446893
EC-GI-10,375860,-0.5151206248138002
KG-1-C,selumetinib-JQ-1 (4-1 mol-mol),-0.1781764139854267
SUP-B15,10231331,2.8012447297266907
EM-2,444795,-0.7982281742747948
YKG-1,44491742,4.005192115909779
NCI-H2452,136227331,4.192235498443636
HCT 8,selumetinib-JQ-1 (4-1 mol-mol),0.8650339041398372
RCC10RGB,49766530,-1.6086406954404375
CAL-120,262093,3.3293434401415847
LP-1,135421197,1.2171511840038625
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526
BT 416,107970,2.292868528252604
Li-7,3689413,2.782987463580999
SCC-25,49766530,-2.1571219685765195
OVISE,637858,1.8122421616924396
Hs 895.T,sirolimus-bortezomib (250-1 mol-mol),2.0562146171637723
TALL-1 [Human adult T-ALL],46907787,-0.546067260060498
P31/FUJ,262093,1.035147161622815
SNU-601,9903786,4.302030389769322
NCI-H2228,9927531,4.856676083567804
22Rv1,49766530,0.7330336721208812
COLO 829,135999136,4.936325381606469
MDA-MB-415,637858,2.2956366108360204
CCF-STTG1,10231331,5.780092265996196
Ri-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1783875799681585
SNU-C1,tanespimycin-bortezomib (250-1 mol-mol),-0.731545490498155
PF-382,46907787,-1.0517755055208098
NCI-H929,637858,-0.3950607584941885
MEC-1,135421197,0.4740815920241465
SNU-449,54596490,5.440438718305218
NCI-H2081,3689413,-0.989992552174664
JHH-2,44491742,4.07921218281707
MFE-319,46907787,6.309736161106018
MKN74,12003241,-0.9650452844715884
KE-97,107970,2.319431088510128
BT 139,tanespimycin-bortezomib (250-1 mol-mol),-4.226590067496966
T98G,135421197,2.3831918060045663
BT 112,10231331,5.608675026595674
DND-41,444795,3.8247123815588817
TF-1,71466445,1.6305537519060282
SUP-B15,46907787,-0.2691985239437229
VM-CUB-1,241158,3.308698579389838
NCI-H211,5460769,0.8923450706014173
T98G,tanespimycin-bortezomib (250-1 mol-mol),-0.015927454797827
A-204,12003241,-1.8688427044932845
OUMS-23,selumetinib-JQ-1 (4-1 mol-mol),2.2362069327324128
SK-UT-1,73707398,0.9883439046575164
BT 248,5460769,4.810999932000391
HD-MY-Z,73707398,1.0247944682443757
COLO 684,UNC0638-navitoclax (1-1 mol-mol),2.88576239527898
HCC15,49766530,0.5190445493569186
HuG1-N,135999136,4.33659793669441
BT 139,168313016,5.38709248356601
HCC1395,26596,-1.834868374404667
HCC2218,135421197,0.9685735875874713
SNU-216,3689413,1.0802163076061988
SK-MEL-1,9927531,4.509159168037888
NCI-H1755,241158,2.7309585381924024
OCI-Ly10,selumetinib-JQ-1 (4-1 mol-mol),0.8556530157943396
BCP-1,46907787,-0.5507438894309143
IPC-298,sirolimus-bortezomib (250-1 mol-mol),0.7212424962654913
KG-1-C,241158,4.3112514697697355
ZR-75-30,9903786,5.791062866548605
NCI-H2286,5460769,0.0147592339119179
NCI-H2286,135999136,4.916000985263414
HDQ-P1,6852167,3.4525559906926793
NCI-H1734,12003241,-3.2634619258307644
Lu-65,3689413,-0.1410308041132627
OCI-Ly10,241158,3.5075111900011664
LUDLU-1,49766530,4.558190853315777
SH-10-TC,12003241,1.4218324467353134
PK-1,439501,-1.8745947720441176
NCI-H2196,73707398,1.0531590450327926
RKN,selumetinib-JQ-1 (4-1 mol-mol),2.2117221190324323
SNU-503,12003241,-0.772187364196845
TE-4,637858,2.2506365452063295
MDA-MB-435S,241158,4.325248822766316
COR-L95,6852167,3.112371536345172
SW1417,3689413,1.8157284329768
HCC1500,3689413,-1.6712109221216571
WT2-iPS,46907787,4.256789061062823
CAL-51,135421197,1.6266864976107616
Hs 888.T,5460769,6.095978340264565
IA-LM,439501,-4.16745845294267
SNU-C5,tanespimycin-bortezomib (250-1 mol-mol),0.6015716530365237
COLO 680N,241158,5.284652832624782
SK-ES-1,9903786,1.417242629772361
BT 224,73707398,1.7036083579889874
KMBC-2,5460769,1.880103554481412
647V,12003241,-0.2300893498058843
A-673,71466445,2.638210082463498
CAL-148,46907787,0.1974742055175984
DEL,107970,2.0685567869118486
Namalwa,9927531,3.1365070733929663
COLO 678,135421197,1.7545986410246563
NCI-H1838,11455910,2.7014431026549386
MM1.S,135421197,1.5136201913497214
TUHR10TKB,tanespimycin-bortezomib (250-1 mol-mol),1.8838456132179628
HCC1954,135421197,1.006556252272656
RMG-I,5460769,4.854195851393806
L-363,73707398,0.3951176028003356
NCI-H2106,6852167,4.160945846818268
HCT 15,3689413,1.3698068653375808
BT 428,637858,2.1785026029472454
Karpas-620,262093,2.9084914265438164
SK-MEL-5,637858,2.5788242810991537
OVCAR-5,136227331,3.878676395565833
KMRC-3,3689413,-1.603340065722176
YD-15,sirolimus-bortezomib (250-1 mol-mol),1.709895595212298
OCI-AML-5,3689413,0.2797126247075585
DMS 273,168313016,5.378851860414917
HPAC,107970,2.120634105202459
G-361,10231331,-1.1139259320348027
Hs 578T,637858,1.2517408441018556
DU4475,439501,-1.9980477376201553
KMS-20,241158,1.964058176771948
CAMA-1,135421197,1.145586441403014
HCC-56,637858,2.8571937872562407
RCC10RGB,262093,2.8343922904091134
RS4;11,100016,4.815282587104974
NCI-H358,sirolimus-bortezomib (250-1 mol-mol),1.7482633742638032
ESS-1,selumetinib-JQ-1 (4-1 mol-mol),2.1651949829821353
BxPC-3,26596,-1.629746525957504
SK-N-MC,46907787,0.041820408065543
MV4-11,241158,1.6741528155317085
SNU-449,135398744,6.632733291537939
Fu97,107970,1.6491316920896912
YD-38,637858,1.9824428087241075
NCI-H1666,241158,3.305487854480141
Hs 839.T,73707398,2.753670018006987
Fu97,11396600,5.862463296841975
TE 617.T,375860,-0.5164864785345091
MOLM-6,sirolimus-bortezomib (250-1 mol-mol),0.6452652216759648
LOX-IMVI,107970,2.2116293322990264
NB4,sirolimus-bortezomib (250-1 mol-mol),0.8498736120929098
A-375,262093,2.9970202931790046
KP-4,5460769,4.107177099702386
UACC-62,136227331,3.8337503750077175
KYSE-450,selumetinib-JQ-1 (4-1 mol-mol),2.8795541061049104
RPMI-6666,637858,1.2318801416926508
PL-21,3689413,-0.2817982428361766
RS4;11,10231331,6.472547503473555
ES-2,135398744,8.06870751291861
647V,3689413,-0.9737590954891844
MIA PaCa-2,sirolimus-bortezomib (250-1 mol-mol),0.2138092716811536
RCH-ACV,375860,-0.3160075920060057
A-253,9927531,5.71272933596785
Granta-519,135999136,4.28714374371566
NCI-H1975,12003241,-2.295585009641022
L-540,26596,-2.7361292622141806
MOLP-2,sirolimus-bortezomib (250-1 mol-mol),0.2890446382441622
NCO2,sirolimus-bortezomib (250-1 mol-mol),-0.0508749295611852
COR-L51,12003241,-0.3418570343381517
CAMA-1,9877608,5.870182576067418
CW-2,444795,4.148366741515224
CHP-212,11455910,-0.0664645017636666
BT 340,135999136,1.7458658328692
RPMI-8226,100016,4.270983790022636
OV-90,637858,2.6658344204605275
RMG-I,11455910,3.4870876000849704
Calu-3,439501,-2.024926202935107
SNU-478,26596,-1.226862251098003
MM1.S,tanespimycin-bortezomib (250-1 mol-mol),-0.3747840615026737
KALS-1,selumetinib-JQ-1 (4-1 mol-mol),1.151640151549291
AsPC-1,107970,2.236934549480267
L-428,tanespimycin-bortezomib (250-1 mol-mol),0.8418435976707451
SNU-1105,73707398,1.718813701968452
TT2609-C02,46907787,0.4476463508004357
BT 224,135398744,6.495060752655371
5637,5460769,-1.549780285334619
OVCAR-5,107970,2.223801029553332
PC-3,tanespimycin-bortezomib (250-1 mol-mol),1.8125784159372291
NCC-StC-K140,44491742,3.703030524506224
NCI-H1703,262093,3.0674943510667334
NCI-H1105,444795,4.226557988602367
EFO-27,11396600,3.826824277303455
YAPC,135999136,4.461108174764027
RCM-1 [Human rectal adenocarcinoma],241158,4.470658456064693
HCC827,241158,3.909716950172797
JHH-1,44491742,4.550943997135646
A-172,49766530,0.1361021615856843
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251
Hs 578Bst,sirolimus-bortezomib (250-1 mol-mol),2.6578506949502416
Toledo,107970,3.124947759529639
A101D,3689413,0.2698790344581709
HCT 8,46907787,1.4188037679805106
SNU-16,54596490,4.1031320340534485
COLO 678,49766530,0.1111976795656789
L-540,6852167,1.4633456510076597
NALM-6,UNC0638-navitoclax (1-1 mol-mol),-0.3986406964147952
T3M-10,UNC0638-navitoclax (1-1 mol-mol),0.7914868615478301
SNU-466,262093,-0.0016542197274145
Li-7,9927531,4.31523724383209
KMS-11,241158,1.7607069914757574
KE-39,3689413,-1.8420159541718293
KE-39,135421197,0.9510973278490732
NCI-H1581,241158,3.097187487045549
CHP-126,375860,-0.7056712843598286
SaOS-2,9927531,5.410264314347966
SK-MES-1,9927531,5.425786603716899
JVM-2,9903786,-0.0734034903257133
Rh41,100016,7.167579216403683
CAL-51,262093,2.862241975448649
HL-60,9903786,1.6430909188137364
MKN1,sirolimus-bortezomib (250-1 mol-mol),0.957329263001516
HCC38,107970,1.6777687706047888
NCI-H1299,selumetinib-JQ-1 (4-1 mol-mol),1.4480114642409152
KYSE-140,3689413,0.0626395685413909
OS-RC-2,sirolimus-bortezomib (250-1 mol-mol),1.663291645677193
SNU-C2A,UNC0638-navitoclax (1-1 mol-mol),4.411481357734303
NCI-H2342,262093,3.257524790305271
JeKo-1,26596,-2.667287216238713
SET-2,135421197,1.735218850040683
OVSAHO,3689413,-0.988138970272714
NU-DUL-1,selumetinib-JQ-1 (4-1 mol-mol),-1.3712165783966237
TE-11,11455910,1.33460610412381
SNU-16,262093,3.1289538389821248
PSN1,107970,2.763803123998224
Aska-SS,tanespimycin-bortezomib (250-1 mol-mol),-0.5241440221117086
CGTH-W-1,6852167,2.088295658936421
TE-4,9927531,4.138970102101572
G-402,11455910,-0.05437779259868
SF539,637858,1.5175949767978318
MFE-296,26596,-0.907337078157821
J82,5460769,3.931927319993056
HMC-1-8,135421197,3.069266594691258
KO52,262093,1.2878327274871448
DU145,262093,3.2967412726475187
TE-6,439501,-2.719069941795036
ONS-76,637858,2.646425044184718
DU145,107970,2.74634542230273
NCI-H1651,44491742,4.212944602241969
MV4-11,9927531,4.708512628737502
WM983B,46907787,1.5249847323988268
MCAS,46907787,1.67067233253558
OCI-AML-5,107970,2.8114256045372
EB1,644241,2.100204883262369
IPC-298,3689413,3.077795295387571
NCI-H2029,49766530,1.603997264455234
NCI-H1573,selumetinib-JQ-1 (4-1 mol-mol),-2.008096563094489
LS1034,637858,1.918496292413477
AML-193,644241,1.8416137938925805
RERF-LC-MS,49766530,0.7744144603938863
Capan-1,49766530,2.9089609583789535
HCC1395,439501,-2.37120422712219
A2058,241158,4.224104807378981
SK-MEL-31,439501,1.7901681191985463
A101D,9903786,4.417171452040311
TT,107970,2.344052320065365
SNU-466,241158,0.9825949083572648
HCC2108,262093,2.915848941362045
KP-N-YN,637858,1.0855268631392891
BT 428,9927531,4.812195201637174
SNU-C4,5460769,4.699419094889071
LS513,tanespimycin-bortezomib (250-1 mol-mol),-1.0041137629262296
HD-MY-Z,241158,3.745964403533247
SNU-869,11396600,4.186989660644326
LMSU,11396600,3.695024866246392
Panc 10.05,44491742,3.75595275347319
HCC44,5460769,-1.4878647509683542
SW1990,9927531,5.3345214594202695
OVSAHO,168313016,5.470935278602615
HT,241158,2.254595813400616
VCaP,sirolimus-bortezomib (250-1 mol-mol),0.185191058575781
KMS-20,375860,-0.5673020428522673
F-36P,49766530,-1.869404688444432
HDLM-2,6852167,1.8499669564369137
TE-10,637858,2.2669165845620887
BT 330,241158,3.9809433714442166
LS180,637858,2.1359320280537704
NCI-H460,73707398,3.251551904382877
JJN-3,439501,-3.1655591002540864
Panc 04.03,3689413,0.3957464459941977
Hs 888.T,49766530,-2.634429263371643
G-292 clone A141B1,9903786,2.9519846446825277
TALL-1 [Human adult T-ALL],262093,1.1652608151765906
22Rv1,135421197,1.1830541259797036
22Rv1,3689413,0.3571323215452703
HCC1428,selumetinib-JQ-1 (4-1 mol-mol),2.208240466064499
Daudi,135999136,4.063293138043838
BICR 56,12003241,-1.3308187474558526
OCI-AML-3,UNC0638-navitoclax (1-1 mol-mol),2.252668799817522
KNS-60,46907787,3.1008858460670905
KNS-81,11396600,3.683177466862877
NCI-N87,5460769,3.352422042402732
SNU-601,135999136,4.32642211604744
EB1,11396600,2.2409379442223134
MFE-296,73707398,0.7695687331901435
HuG1-N,49766530,-0.3535010251675565
MOTN-1,5460769,0.7518419346698605
TE-5,12003241,-1.2234174090075007
COLO 320,9903786,-0.1996043978745841
SET-2,107970,1.5950786133470078
Panc 05.04,10231331,1.446733345878993
JHH-5,tanespimycin-bortezomib (250-1 mol-mol),-2.9889336169985454
769-P,135421197,1.1178294524098082
KYSE-30,135999136,4.4123994381842415
HEL,107970,2.2652057864285893
T-47D,135421197,1.1997772280694294
HT115,73707398,0.748734542291225
TTC-709,3689413,-2.3273701449747985
Hs 839.T,49766530,-2.6127392720366296
BT 440,439501,-2.9388364994679614
COLO 320,selumetinib-JQ-1 (4-1 mol-mol),3.547549690422233
B-CPAP,sirolimus-bortezomib (250-1 mol-mol),1.6590312282318416
TCCSUP,439501,-2.3382973857263893
DMS 273,439501,-3.5888564067388633
NCI-H1155,9903786,2.7353298872083984
NCI-H358,241158,3.665424345382122
G-361,6852167,3.18294861196672
ALL-SIL,44491742,3.700418914769662
EFM-192A,3689413,0.6464751811970497
KYSE-140,262093,3.0131352463234906
SW1088,262093,4.334823497952687
PSN1,375860,-0.0527401494130232
U-CH1,selumetinib-JQ-1 (4-1 mol-mol),2.130676998880085
SW620,selumetinib-JQ-1 (4-1 mol-mol),-2.137275886686104
NCI-H841,44491742,3.87806302811964
23132/87,6852167,2.0137400124986713
HuCC-T1,71466445,-5.737741283929361
LMSU,44491742,4.063120482610564
MG-63,49766530,-2.6108444064120686
SK-N-AS,UNC0638-navitoclax (1-1 mol-mol),2.763969623467532
SF268,sirolimus-bortezomib (250-1 mol-mol),0.3840315084108963
A2058,439501,-1.4813488072157313
Mono-Mac-1,UNC0638-navitoclax (1-1 mol-mol),0.713076461951265
SF268,241158,3.9832812003151834
NCI-H1299,439501,-2.475221299124019
NCI-H1184,439501,-1.2905593318516702
OVCAR-5,12003241,-2.4332289606556903
Becker,107970,3.0116017692585406
SNU-5,6852167,3.310074767427802
PaTu 8988s,644241,1.4748860636178889
CAL-33,12003241,-0.8317301463564554
MDA-MB-468,5460769,3.9216030050456023
NCI-H889,107970,2.493650179224298
HuT 78,73707398,-1.0733102034167783
HPAF-II,10231331,1.5877031286420482
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737
TCC-Pan2,5460769,4.19565263219897
SNU-16,6852167,2.2118089271790033
PK-45H,107970,2.275385985235783
KYO-1,tanespimycin-bortezomib (250-1 mol-mol),0.6215111489817027
DLD-1,262093,2.7792650333384072
GP2d,73707398,1.3305042715968274
SNU-685,439501,-2.253643843124453
647V,444795,4.052159403101229
OUMS-23,49766530,1.123776679749195
OC 314,262093,2.2402315645095054
ST486,100016,6.384120256869386
PK-45H,73707398,3.18492419186588
TUHR14TKB,49766530,-0.541882480263748
WM88,262093,2.979155040217876
KMS-20,135398744,7.132407790781497
NCI-H1915,71466445,2.9548789565379576
TE-9,135421197,3.747020112935066
Mono-Mac-1,444795,3.2832788866841573
KCL-22,439501,-2.3189522381647194
MOLT-16,11455910,-0.4766797538258427
HSC-4,11455910,0.337268703123225
BFTC-909,44491742,4.0640318167931255
OCI-M1,135421197,1.730627187910493
OCI-M1,439501,-2.6275325883029135
SU-DHL-10,637858,1.1094204456021386
OV-90,46907787,3.848595934568226
NCI-H1435,3689413,0.9860334604053864
SF268,262093,3.1286411170758113
NCI-H358,49766530,1.9873941918959552
LOU-NH91,26596,-0.8372049149458933
SNU-475,49766530,3.8108218409500063
SUP-M2,5460769,0.4100409038325726
PC-3,241158,4.501131440200892
Rh41,637858,1.4614866227185788
KCL-22,644241,-4.057206367955216
KALS-1,10231331,5.286218838371379
SNU-C1,11455910,1.0435411312145502
TF-1,selumetinib-JQ-1 (4-1 mol-mol),-0.1446879756721995
EKVX,tanespimycin-bortezomib (250-1 mol-mol),1.3495515941174134
NCI-H358,262093,2.755416882784921
HCC38,73707398,0.9482703589784276
SNU-1066,sirolimus-bortezomib (250-1 mol-mol),1.8149944261171216
NCI-H1373,49766530,-0.1297725913169194
SNU-449,107970,2.557902386411369
BT 422,73707398,0.9682269368808664
HD-MY-Z,49766530,-2.787165933045758
OE19,73707398,1.8381430425163503
TUHR4TKB,selumetinib-JQ-1 (4-1 mol-mol),2.4543426930881647
BT 231,12003241,-1.271590527231957
NCI-H661,12003241,-1.8871798966926587
SUP-T11,11396600,2.6585567591139245
HCC202,49766530,0.0708249995809799
TE-11,11396600,4.3576491196249565
HCC2935,46907787,3.142856350749045
Caov-3,tanespimycin-bortezomib (250-1 mol-mol),-1.0739653599444468
NCI-H1792,136227331,4.237356132647452
TE-5,100016,6.463093527046919
HEC-151,9903786,2.765131251863377
HL-60,12003241,-0.948434817183572
AsPC-1,44491742,4.429887143828186
253J-BV,11396600,3.6309884615301953
Lu-99,644241,2.5747874241134476
BT 139,262093,2.8481987129285256
MSTO-211H,6852167,2.890925130180435
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025
NUGC-4,selumetinib-JQ-1 (4-1 mol-mol),-2.3807316373780716
OE33,9903786,4.225835285233996
OAW42,12003241,1.2884936123543242
MOLM-16,9903786,-0.0890634921772537
BT 428,444795,3.9327551144919584
UACC-812,11396600,4.679415745859403
JHH-4,135421197,2.467716742231404
CL-11,3689413,0.4065181450870009
SW1990,46907787,4.845912107981417
BT 416,9929138,7.415658440710529
GP2d,375860,-0.4187362187145614
OCI-AML-3,tanespimycin-bortezomib (250-1 mol-mol),-0.5201119154164948
KP-N-SI9s,5460769,-0.2609459312778176
Ri-1,135999136,4.203993475326129
NCI-H146,selumetinib-JQ-1 (4-1 mol-mol),0.7874306910270304
BT 164,100016,6.2228733531949505
NCI-H28,sirolimus-bortezomib (250-1 mol-mol),0.5571270031367631
MKN7,46907787,4.340343416812888
769-P,637858,2.2738014282368324
RL,46907787,-0.3277939634463202
SK-MES-1,46907787,1.4035137131204831
PC-14,9927531,4.079128694018213
NCI-H1581,107970,2.3968187314483145
NCI-H1105,44491742,3.93837449237457
DMS 454,11396600,3.1958001986957143
SNU-C1,selumetinib-JQ-1 (4-1 mol-mol),-2.6335235217626702
JVM-2,6852167,-1.0712990514737957
ESS-1,9927531,5.52249907084491
COLO 699,26596,-1.9597259723317009
SU-DHL-8,168313016,3.815239771277497
NCI-H1184,6852167,1.6538062359818173
GP2d,107970,1.8153419418648105
MC116,9903786,4.909292458120856
MES-SA,375860,0.0274489129930107
DMS 53,241158,3.9946484898477936
PaTu 8988t,375860,0.0559535091713014
Calu-1,11455910,4.249423837752583
BT 239,262093,1.5843139145133054
NCI-H2052,12003241,-1.5616837194527835
L-428,54596490,5.475491625110064
ECC12,135999136,4.487232125219349
NCI-H2110,135999136,4.378229186440323
NU-DHL-1,637858,-0.1721952663561851
AML-193,73707398,0.1090219362628487
SF539,444795,3.755252396278318
TE-4,sirolimus-bortezomib (250-1 mol-mol),1.0624472113387091
SCC-4,9927531,4.977228114447549
MSTO-211H,100016,4.243846732059744
MOLT-16,49766530,-2.0330031999498255
A-375,439501,-2.387181275139254
U-BLC1,UNC0638-navitoclax (1-1 mol-mol),0.3786430687179207
NCI-H747,100016,6.898929440027426
SNU-1214,100016,6.334633199659308
SW579,10231331,4.122750326545354
COLO 741,11455910,3.212603536123838
DMS 79,3689413,-2.460389219665011
BV-173,12003241,-5.971697113356734
Daoy,73707398,0.9018089005014748
Mono-Mac-1,selumetinib-JQ-1 (4-1 mol-mol),0.1381126547939459
KP-N-SI9s,241158,3.863624288459924
G-402,644241,3.1791014891654457
MDA-MB-415,71466445,4.189951151964875
SK-LMS-1,9927531,4.694028683387814
NCI-H196,439501,-2.4399998682634023
MOLT-16,selumetinib-JQ-1 (4-1 mol-mol),0.56687932569694
NCI-H1650,262093,3.0085408028309786
Karpas-620,9929138,4.250879016380974
NCI-H211,168313016,4.627432995908626
IPC-298,439501,-1.1668969195749603
VM-CUB-1,5460769,-0.9631116017936964
PF-382,9927531,5.462558018035092
RERF-LC-MS,439501,-1.3704502050640626
OV7,9927531,3.7573149322821937
LNCaP clone FGC,168313016,4.233748238876194
HPB-ALL,3689413,0.032224825554501
KYO-1,107970,2.531973304775865
A-549,100016,7.181380121169662
JHUEM-2,6852167,1.1461018937250853
LUDLU-1,9927531,4.97566245035899
IM95,135999136,4.354179315277477
HL-60,26596,-1.7556952568708522
EFO-27,241158,4.165561573655071
KYSE-450,439501,-3.185322034462323
OV56,49766530,0.3841868356522632
IPC-298,241158,3.61817079796593
BT 359,11455910,0.3970564809620578
IGR-1,135421197,2.0618404907412473
NCI-H226,11455910,1.847807065010321
SW1353,5460769,4.513460705614206
SK-N-FI,selumetinib-JQ-1 (4-1 mol-mol),1.2619141801436582
DMS 53,5460769,5.120342551697822
8505C,46907787,1.2029484173632825
RKO,73707398,0.9128481241529548
BV-173,sirolimus-bortezomib (250-1 mol-mol),-2.492930235496017
2004,107970,1.5686946490439204
HCT 15,439501,-2.431117301372995
NCI-H446,100016,4.920277084242614
Mono-Mac-1,sirolimus-bortezomib (250-1 mol-mol),-0.8446882860578903
LAMA-84,12003241,-5.010316876482206
BT-12,135421197,1.7013160656627575
HMCB,107970,2.4632765451158356
K029AX,selumetinib-JQ-1 (4-1 mol-mol),0.2286983759000624
Lu-99,tanespimycin-bortezomib (250-1 mol-mol),-2.7467052265090723
Panc 04.03,10231331,4.944041434313903
Hs 688(A).T,3689413,-1.8044012386941577
KALS-1,UNC0638-navitoclax (1-1 mol-mol),2.8792786842803673
SNU-1,9927531,3.402077148066899
WM88,5460769,5.637392858071443
G-361,71466445,3.559474212214759
SK-CO-1,439501,-2.410857533331093
NCI-H716,262093,3.1268134242095735
GI-1,135421197,1.6519040465788966
IGROV-1,6852167,1.5305143027352028
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332
A3/Kawakami,5460769,1.7157310456182762
SUIT-2,6852167,4.156327087057675
NCI-H1573,168313016,4.64136690416913
RCM-1 [Human rectal adenocarcinoma],637858,2.624063294513633
Rh41,12003241,-2.564539347057637
U-251MG,73707398,1.5280990364669664
UACC-62,135999136,5.678520185449006
Panc 02.03,241158,4.402915180139186
CAL-12T,9903786,2.474655504914218
HuCC-T1,262093,2.7118122084105374
SUP-M2,241158,1.5646629177764024
NCI-H747,9927531,5.010482166224782
KMS-12-BM,100016,3.5545657198194873
NCI-H2110,9927531,4.774812830583443
OVTOKO,sirolimus-bortezomib (250-1 mol-mol),1.6633585904908004
SNU-503,sirolimus-bortezomib (250-1 mol-mol),1.3381896958753263
P3HR-1,71466445,2.8786541215857264
LAMA-84,73707398,0.8554564674159427
Karpas-422,241158,2.526232566496073
MG-63,107970,2.132030955920877
HuP-T3,44491742,4.372770131484514
MDA-MB-453,168313016,4.163913885489913
COV434,168313016,4.745616441578848
CA46,12003241,-2.799565618947511
GA-10,241158,1.1347612436603682
Rh41,262093,2.4502999940067225
Mono-Mac-6,637858,-0.2655990256126367
HCC1143,3689413,0.0716522323698814
OCI-AML-3,168313016,3.888373508395693
LK-2,71466445,4.119295136707602
HCC38,46907787,0.4227430281894037
HCC-56,168313016,4.911744541698628
ChaGo-K-1,9903786,4.114689259573735
SBC-5,135421197,2.079587314097717
HuP-T4,135398744,7.1369518257480475
L-363,6852167,1.3812859143740928
BFTC-909,26596,-1.7437210940555867
RPMI-6666,selumetinib-JQ-1 (4-1 mol-mol),0.5297817690201579
NCI-H1693,11455910,0.7254587825692573
TUHR4TKB,439501,-2.4659071378458544
HLF,44491742,4.796533392480472
Hs 888.T,262093,2.531155754559327
A-375,12003241,-1.2978704743837648
NCI-H2029,71466445,4.409186865297714
SUP-HD1,tanespimycin-bortezomib (250-1 mol-mol),-0.2470989811885863
HLF,sirolimus-bortezomib (250-1 mol-mol),0.7648448061241114
COLO 792,135421197,2.064004994537627
HPB-ALL,tanespimycin-bortezomib (250-1 mol-mol),1.0478674895496405
KMRC-3,9903786,5.172590154682236
HEC-251,3689413,-0.622023028283223
769-P,26596,-0.9592747509105644
786-O,sirolimus-bortezomib (250-1 mol-mol),0.3515124224328601
RERF-LC-Ad1,262093,3.285321037103647
T84,6852167,2.3607700783512686
HOP-62,6852167,3.1179431190301226
COLO 800,107970,2.383898658325272
SNU-503,selumetinib-JQ-1 (4-1 mol-mol),0.4592551090177056
Kasumi-2,439501,-3.441659601561783
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
BT 139,107970,1.8298356347130915
RD,71466445,3.6816034975249474
8505C,3689413,-3.9181742012691143
A2780,9927531,3.2712332494904226
SNU-5,12003241,2.4960585201420247
NCI-H1355,3689413,0.7312644846226123
GB-1,3689413,-2.42348697309168
NCI-H2009,107970,2.2954238398166344
IGROV-1,44491742,4.406671418311328
C2BBe1,637858,2.175277981120109
NCI-H1092,107970,1.8386309101568237
JHH-1,9903786,3.3314474186941987
SK-MEL-5,71466445,2.1269711311282373
AGS,135421197,2.7162637897993123
SF539,44491742,4.105649274647132
B-CPAP,107970,2.366266521836174
GCT,444795,4.405029687815304
SW1463,439501,-0.3046644173954531
WM115,71466445,4.303064097958205
HCC1500,11455910,0.2448151005088887
Ishikawa (Heraklio) 02 ER-,100016,6.479675962630039
MKN1,9927531,4.774967251580727
EJM,9927531,5.060130602494636
MDA-MB-157,375860,0.0174110406826079
SNG-M,3689413,1.102237357506899
WT2-iPS,9903786,4.00311264543886
MM1.S,sirolimus-bortezomib (250-1 mol-mol),-3.4112466986615475
T-47D,11455910,1.56267041367126
MES-SA,49766530,3.67980126905318
CHP-212,644241,2.544720169894308
P31/FUJ,637858,0.7903103947120294
CAL-27,107970,2.069516948439653
EoL-1,9929138,2.1880692859665984
CCK-81,26596,-1.410251638303959
NCI-H1385,444795,4.446664518945096
COV362,selumetinib-JQ-1 (4-1 mol-mol),4.077044084854786
HCC2218,100016,5.089450081937329
TE-15,selumetinib-JQ-1 (4-1 mol-mol),0.3530631195710951
NCI-H1869,5460769,3.405523512527605
MKN1,44491742,4.1588945650125355
NCI-H1915,637858,1.260114577354328
Tm87-16,49766530,0.8637146059158625
NCI-H2170,11396600,3.579707270807188
A-549,9903786,1.8644448309659765
HuT 78,9903786,-0.2471360619469426
CHP-212,sirolimus-bortezomib (250-1 mol-mol),-0.2954884064996527
TYK-nu,241158,3.931158179587867
TALL-1 [Human adult T-ALL],241158,1.7102872988706168
Calu-1,12003241,-0.3445186674692038
COR-L51,9927531,4.484495617917877
NCI-H2172,3689413,0.3383001060602208
HEL 92.1.7,sirolimus-bortezomib (250-1 mol-mol),0.1862867514845364
GP2d,11455910,0.6533370320075141
CCF-STTG1,100016,6.985278157575169
A-673,3689413,-2.493408888485536
PaTu 8988t,12003241,-0.7673639150441187
ME-1 [Human leukemia],3689413,-2.217252079013703
CML-T1,107970,1.8137988275945616
DMS 53,sirolimus-bortezomib (250-1 mol-mol),0.155507409478016
HEY A8,73707398,1.040881676923852
DB,439501,-2.823022710491889
UACC-62,107970,2.9897447341876764
BT 232,262093,2.843383638859083
8505C,262093,2.08540105499643
LS180,26596,-1.3053249122689552
RL,selumetinib-JQ-1 (4-1 mol-mol),0.7569589634428372
ECC10,tanespimycin-bortezomib (250-1 mol-mol),1.1222379258321835
JHH-4,12003241,-1.7562385090138668
HSC-3,12003241,-1.4285198417789524
KE-97,11455910,0.2852885194409614
EPLC-272H,5460769,1.6244755024215547
RPMI-8226,135421197,1.9475796731003323
ECC12,73707398,1.5263893558271446
JHOS-2,44491742,4.089494767364973
LUDLU-1,5460769,4.034100561481378
BxPC-3,11455910,2.77826122800999
HMC-1-8,12003241,-0.3368702938294806
VMRC-RCW,637858,1.774740761381287
SUP-T1,135999136,2.1938595349455885
HGC-27,tanespimycin-bortezomib (250-1 mol-mol),-1.4262734798711498
BT 440,selumetinib-JQ-1 (4-1 mol-mol),1.436759754366273
BICR 6,10231331,5.678935014467026
MEC-1,637858,0.8953416902336931
Karpas-422,tanespimycin-bortezomib (250-1 mol-mol),-0.3820258248934754
TE-5,9903786,3.304893690679265
WM88,11396600,2.133090606668807
SNU-1033,439501,-2.7458935942411085
KMRC-2,439501,-1.138228475309333
NCI-H1092,sirolimus-bortezomib (250-1 mol-mol),0.4958114346992872
HEY A8,12003241,-2.767500133031125
SW1271,73707398,1.637161284255629
MFE-296,selumetinib-JQ-1 (4-1 mol-mol),3.490518746009096
NCI-H661,439501,-2.903837615768139
NCI-H358,73707398,1.1537520848201694
KYSE-30,46907787,3.978537949893093
SK-N-AS,46907787,2.030774624984343
BT 172,241158,4.245378972557845
NCI-H1373,135398744,6.356905852078599
P31/FUJ,selumetinib-JQ-1 (4-1 mol-mol),-1.737174960648273
HPAC,tanespimycin-bortezomib (250-1 mol-mol),-0.5212433601902327
U266B1,49766530,0.1325204149265123
F-36P,9927531,3.277951098444252
YH-13,12003241,-0.7443010060517422
PC-3,637858,2.713540293531518
SCC-25,12003241,-2.271238083973026
NCI-H2452,135999136,4.5117873079445205
F-36P,sirolimus-bortezomib (250-1 mol-mol),0.0498711406572633
SNU-878,135421197,4.562979063002288
ECC12,6852167,3.3957553977851194
T3M-10,selumetinib-JQ-1 (4-1 mol-mol),1.5480323853814495
HCT 116,262093,3.0489861047493525
YKG-1,10231331,5.270675851444794
L3.3,26596,-0.871586326159775
OE21,439501,-2.897438407377833
BT 216,5460769,4.97858517740557
NCI-H1693,3689413,-3.280819080207211
RPMI-7951,49766530,-2.0352614049405178
Hs 936.T,selumetinib-JQ-1 (4-1 mol-mol),1.8156081078118131
KU-19-19,5460769,4.3332822587900255
ONS-76,10231331,-2.145918525616272
HMC-1-8,tanespimycin-bortezomib (250-1 mol-mol),-0.5086629381230219
KMS-18,sirolimus-bortezomib (250-1 mol-mol),0.6867934925830966
HD-MY-Z,selumetinib-JQ-1 (4-1 mol-mol),0.9792895483914368
UM-UC-3,107970,2.392496715008541
BEN,selumetinib-JQ-1 (4-1 mol-mol),2.435867815788394
MOTN-1,9927531,4.434768269129304
SUP-B15,6852167,2.250730006351081
SNU-475,6852167,2.5801440708134193
RPMI-8402,6852167,1.2289989467414018
DEL,5460769,1.5827510666329687
RT-112,26596,-1.382463026117804
Hs 294T,262093,3.0816217922662146
HCC1588,46907787,1.4873763939478983
8-MG-BA,49766530,-0.054737716744796
JHUEM-1,sirolimus-bortezomib (250-1 mol-mol),0.1143622651277921
KYSE-70,637858,2.812350468450961
COV434,100016,6.159872289007743
KYSE-450,73707398,1.7321370562114622
TE-6,46907787,1.386672545327742
EFE-184,444795,6.4127463450250355
THP-1,6852167,0.7768028422680426
OCI-AML-5,71466445,1.573445404531825
ECC10,9927531,3.415986585333862
HEC-1-A,26596,-0.4494032602178983
NCI-H716,135421197,1.426114705682071
LS123,637858,0.8552062768357409
KO52,UNC0638-navitoclax (1-1 mol-mol),-2.0411974213550965
KP-4,241158,1.8280076583022216
DB,46907787,-0.5328399527377402
WM266-4,44491742,3.776227470260235
IGROV-1,9903786,1.7387584479757865
HDLM-2,5460769,4.226839303780804
MHH-CALL-3,107970,2.3840240428143034
SF295,3689413,-1.7224429364651286
YD-8,107970,2.31722941739338
LOU-NH91,12003241,-1.4006618643370652
KO52,168313016,6.361073320142098
KP-N-SI9s,3689413,-0.3839516560951015
UO-31,107970,1.930629959385541
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448
SNU-407,9903786,2.2079678485918977
SW579,11455910,0.492813014431951
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
SH-10-TC,26596,-1.1215294696679303
NCI-H1184,241158,3.551679636073963
PC-14,637858,2.799364880868444
GSS,11396600,2.8148513524153005
HuH-6,46907787,2.171713572401701
JL-1,12003241,-1.4801638152381718
SU-DHL-6,241158,1.5794519300851928
B-CPAP,11396600,0.7084279408075309
SNU-1066,selumetinib-JQ-1 (4-1 mol-mol),2.1861844384259377
NCI-H2023,11396600,4.497397906995783
SKM-1,6852167,1.599440768743568
ST486,12003241,-0.1204499968223502
Daudi,3689413,-4.376822515219121
OVK18,6852167,1.7942608404325415
HMC-1-8,100016,5.583587343649554
HuT 78,6852167,0.2624976594092375
SF126,tanespimycin-bortezomib (250-1 mol-mol),0.701676185557571
SHP-77,375860,-1.0648061224217071
T3M-10,44491742,3.8541069254264566
647V,6852167,2.725026978750747
EM-2,135421197,1.083301811797457
SNG-M,sirolimus-bortezomib (250-1 mol-mol),0.843195777913948
JHUEM-2,12003241,-3.1995756847172108
HCT 8,12003241,1.3953140594908418
Ci-1,11396600,2.9258292979253744
NCI-H2405,73707398,2.099759783776834
HOP-62,9927531,4.3195662996069855
BT 228,73707398,1.4280479826464054
MHH-CALL-4,5460769,0.3846301145612474
Kasumi-2,637858,0.3812755763700117
L-428,375860,-0.9643395664590056
GaMG,3689413,4.2258406300802145
RD,637858,1.496545007024156
JHUEM-2,100016,5.904304927611702
LS1034,107970,1.4253135653766993
SNU-668,637858,2.2358105014096914
HCC2279,6852167,3.124713547621625
BICR 56,10231331,4.370706281036396
NCI-H841,49766530,-1.6257988824506011
LOU-NH91,73707398,1.1540810865513749
EFE-184,6852167,4.373196332667482
HCC1833,100016,6.427561679501585
SNU-1,12003241,-2.3799966933109262
HEC-1-B,262093,2.9636053597230916
U-937,9927531,3.434526864785126
KLE,439501,-2.1797784747958477
TE-14,637858,2.3337222437177454
SNU-685,135421197,3.6677204832747976
SNU-C4,tanespimycin-bortezomib (250-1 mol-mol),0.700839751007814
BT-549,262093,3.1295246575488354
OAW28,12003241,-0.542287488877267
IA-LM,71466445,4.189377103287156
NCI-H2141,tanespimycin-bortezomib (250-1 mol-mol),0.6080837341051074
LoVo,6852167,1.8421975016001388
KP-N-SI9s,10231331,1.7797766908392143
MKN7,selumetinib-JQ-1 (4-1 mol-mol),3.0805078817781366
SNU-601,5460769,-0.8674559843471038
SK-MEL-28,3689413,3.3385356968233744
IPC-298,107970,3.0209130478833477
U-251MG,262093,3.13898838464472
Karpas-422,44491742,3.8079113446891424
CCK-81,100016,4.4296308435579554
JJN-3,selumetinib-JQ-1 (4-1 mol-mol),-0.4237843202351842
COLO 684,73707398,1.0044196671057204
UM-UC-1,241158,4.206004961628962
JeKo-1,73707398,1.0235026447845044
YAPC,11455910,1.8317787914833017
BT 498,135421197,2.801881228152874
Hs 294T,12003241,-1.502620378279095
BL-70,439501,-3.7904230490472623
MOLM-6,135421197,0.9867364446858986
HSC-3,sirolimus-bortezomib (250-1 mol-mol),1.8734787499367431
BT 112,49766530,0.144276899282749
WM983B,73707398,1.4395905386733596
SF539,375860,-0.4378698388059482
HCC1569,12003241,1.6977916939082411
Panc 05.04,439501,0.2716766298535532
NCI-H1651,46907787,3.508622378093426
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557
CFPAC-1,73707398,2.9085605361845213
RCC10RGB,46907787,5.224507823938942
RERF-LC-MS,135999136,4.400683337930441
Hs 766T,73707398,0.9103087119029484
BC-3C,241158,4.191862782565103
ACC-MESO-1,100016,6.4652465436588775
Caov-3,9903786,2.8083030393929276
L3.3,44491742,6.349276489474054
TE 441.T,444795,4.4291459900533185
M-07e,12003241,-1.0456216878354962
MIA PaCa-2,5460769,2.8270884799697833
OE19,tanespimycin-bortezomib (250-1 mol-mol),-3.057865430510972
SUP-HD1,11396600,3.836607370981288
BT 172,135421197,1.393069790953409
BT 187,73707398,1.309358111635466
TE-9,5460769,0.3621954570930285
BT 164,10231331,4.691772823179407
JL-1,135999136,4.159644444432376
Yamato-SS,49766530,-1.529274305649153
PE/CA-PJ34 (clone C12),73707398,0.9457530769963428
HT-1376,73707398,3.190908649969745
HCC1419,49766530,1.3909719340179874
Reh,135421197,0.7565283422785475
OC 314,136227331,3.341110019421027
Panc 10.05,444795,4.847688722639358
RL,71466445,2.5949033766521037
CHP-212,241158,4.019379918122575
LS123,sirolimus-bortezomib (250-1 mol-mol),1.3187092506497549
MDA-MB-361,73707398,0.9595895200292788
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
HuT 78,107970,1.6472037116063474
NCI-H1573,12003241,0.8925202340822594
NCI-H2444,6852167,3.117687231513562
SW620,3689413,1.1437224923774536
A2058,6852167,3.6639698934564175
T84,10231331,0.9685449870961756
NCI-H1944,9903786,2.6495499411680785
NCI-H2085,49766530,1.4049840507927902
UO-31,11455910,0.6340600347677866
CCK-81,11455910,1.1979404959065163
SF126,135999136,1.802588488381459
SNU-1105,107970,3.082321397183302
SK-N-DZ,375860,-1.0583156634000266
LOX-IMVI,12003241,-2.813518393614124
BT 416,6852167,0.3489067839841118
CCF-STTG1,3689413,0.3028996084806184
SW1710,9929138,6.751654764196259
SW1088,49766530,2.123366462001536
T84,135421197,1.1926800486380174
NCO2,selumetinib-JQ-1 (4-1 mol-mol),-1.9216061314069743
Sq-1,107970,2.3768765562541527
Hs 578Bst,6852167,5.521965568866905
HuH-6,6852167,2.719206575723939
EHEB,637858,1.5977612521222773
SNU-489,sirolimus-bortezomib (250-1 mol-mol),1.5186743345934282
TCC-Pan2,241158,4.391584480851977
NCI-N87,444795,4.906796024963376
HCC2279,3689413,-1.8306201481389968
KYSE-140,637858,2.3149924463818534
HCC78,12003241,-1.0292430450952663
KLE,107970,2.4969694624001546
KMS-21-BM,637858,0.4852193372876609
U-937,11396600,2.847104167418143
BT 228,49766530,0.5150432807946567
NCI-H1395,135999136,4.46612092216275
MV4-11,262093,1.4019245337963713
GA-10,9929138,4.091985168387067
NCC-StC-K140,439501,-3.4454248624947437
CAL-27,26596,-1.6130291256541474
SaOS-2,241158,3.6917409878316136
PE/CA-PJ49,241158,3.9020503625286698
HOP-62,241158,4.371363298737313
ONCO-DG-1,168313016,4.429383977943416
NCI-H2087,375860,0.2532519276094911
HCC1588,135421197,1.0846790192354827
HT-1197,tanespimycin-bortezomib (250-1 mol-mol),-0.7318651528628731
NCI-H520,168313016,4.384348437846953
MHH-CALL-3,tanespimycin-bortezomib (250-1 mol-mol),0.530639980340651
Panc 08.13,11396600,4.2902573182297665
SCaBER,9903786,2.6079380846248568
TCCSUP,444795,5.142441230913875
2004,135421197,1.2984734830690137
HT115,100016,5.804685245268015
HCC1954,44491742,3.88484853713588
SK-MEL-5,6852167,3.3711794080976594
NCI-H1915,241158,4.528319937628717
IGR-39,6852167,3.2260385180997044
SK-BR-3,6852167,1.9054876714905489
TYK-nu,100016,5.6630271022409495
MHH-CALL-3,46907787,0.253800682048371
NCI-H2106,73707398,-1.2347656307302788
SK-MEL-24,135421197,2.6941455652105852
HCC15,439501,0.3030845703669018
SNU-601,44491742,3.984168627416036
NCI-H526,26596,-1.5534394961181943
HCC4006,11396600,3.4330968627911425
Daoy,11455910,0.1226016368388986
BC-3C,tanespimycin-bortezomib (250-1 mol-mol),1.3285525848592783
SNU-626,135421197,2.600343807362106
SNU-182,3689413,-3.9177675224777406
NCI-H2291,selumetinib-JQ-1 (4-1 mol-mol),-0.7266625306171108
NCI-H292,selumetinib-JQ-1 (4-1 mol-mol),0.7417417133593783
CHP-126,11396600,3.667072533638785
HOS,9903786,4.58127571794388
NU-DHL-1,135999136,3.842512591140382
JM-1,49766530,-3.0151701370453794
BT 498,3689413,1.8744771197995864
Detroit 562,3689413,-1.858060179976838
CL-11,49766530,-0.1976824475741571
23132/87,73707398,1.3488452767175056
PLC/PRF/5,selumetinib-JQ-1 (4-1 mol-mol),3.8128877630515614
KO52,637858,1.0718331271712598
HT-1080,375860,-0.4805820776579086
L-540,375860,-0.5429152411185477
Pfeiffer,3689413,-4.622184503253435
DND-41,5460769,0.7297318325246287
SUP-T1,5460769,2.284635628978783
DAN-G,637858,2.982118454285325
HEC-1-A,241158,4.656372705051137
NCI-H2030,439501,-1.2331748188079374
DOV13,11396600,3.62542872436994
Panc 08.13,46907787,-0.8528546674908809
TE-6,73707398,1.658809664747792
RS4;11,168313016,4.934593266436089
HGC-27,49766530,-2.870861488456396
KYSE-510,tanespimycin-bortezomib (250-1 mol-mol),-1.5212875758875433
WM1799,10231331,-0.6781881841650482
CW-2,9927531,5.678325078717316
DMS 53,637858,1.231022213456641
CW-2,26596,-0.0212695413567751
EB1,tanespimycin-bortezomib (250-1 mol-mol),-0.3360954254075145
HL-60,135421197,1.9226353151764572
HEL 92.1.7,168313016,4.428707161449081
Malme-3M,6852167,4.778936783077254
SK-MM-2,637858,0.0064684499737818
BT-12,637858,1.7766399417002317
SNU-423,262093,3.077382051759327
WT2-iPS,73707398,1.5963579815560645
Aska-SS,46907787,-0.8953027920417477
SNU-1,439501,-3.7780257252431126
HCC1195,9927531,5.131359962593503
BT 498,241158,4.164187123770961
SNU-410,3689413,1.1161257107979303
Daoy,375860,-0.1320421153214505
CW-2,262093,1.6035183288099986
Panc 10.05,sirolimus-bortezomib (250-1 mol-mol),0.3447430037578218
Hs 578T,6852167,0.7100294177326232
Ishikawa (Heraklio) 02 ER-,6852167,3.9423721034653423
PE/CA-PJ15,135421197,1.0415253026449975
Raji,46907787,-0.4930919590495862
GSS,375860,-0.7667011218707456
KE-97,selumetinib-JQ-1 (4-1 mol-mol),-2.3334311692640184
COR-L95,UNC0638-navitoclax (1-1 mol-mol),-0.3776689942774316
EFO-21,107970,3.0231101472169186
PK-1,5460769,3.319049240944118
COV644,71466445,5.298867896385173
JIMT-1,439501,-2.416769885537428
NCO2,73707398,-1.0010123602704273
COR-L95,73707398,1.0347493154641954
NCI-H1355,tanespimycin-bortezomib (250-1 mol-mol),-4.485986367397168
LN-18,262093,3.730786897618696
Peer,262093,1.208995800009143
OV-90,tanespimycin-bortezomib (250-1 mol-mol),-2.825248650811712
Panc 08.13,12003241,-0.6066963298008116
TE-14,439501,-3.001573063863178
D283 Med,9927531,3.2144716566788745
SNG-M,12003241,-1.3269427590967688
GP2d,6852167,0.7851862344848514
HCC2935,107970,1.7323238719492455
G-402,262093,2.972927806454912
NCI-H1341,100016,3.8327529210726903
NCI-H1793,UNC0638-navitoclax (1-1 mol-mol),-2.4732230487504148
SUP-HD1,71466445,3.198564934424997
CAL-51,168313016,5.819136604546001
SUP-M2,9927531,2.443296482682693
OCI-M1,26596,-2.6046335322938927
Tm87-16,9929138,6.73537704561969
SF539,3689413,-2.2250008276513107
HSC-4,644241,2.6183127396598262
SNU-1272,637858,3.0444768805463465
JHH-2,26596,-0.057413924712861
HGC-27,9903786,1.5115157472800849
OVCAR-5,44491742,4.010152953024954
OCI-AML-5,26596,-1.736130608355082
TT,73707398,1.721245202435463
JHUEM-1,135999136,1.801917523699696
WM1799,49766530,-0.3108809621459331
DMS 273,11396600,2.9821670224503025
BT 504,tanespimycin-bortezomib (250-1 mol-mol),-4.273282009198175
SK-N-SH,sirolimus-bortezomib (250-1 mol-mol),0.20777860601932
VMRC-RCW,3689413,-0.2709078941714827
KYSE-30,100016,6.190453384433256
Kelly,135398744,7.079466503802849
GOS-3,73707398,2.285638026393688
BICR 6,selumetinib-JQ-1 (4-1 mol-mol),1.6625006001600495
U-CH1,439501,-1.675454590298179
HT-1197,9903786,4.0222787047996915
YD-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6090982455977105
DEL,241158,1.6743881940862215
LOX-IMVI,44491742,5.895851784959737
SW620,107970,2.8176179958695053
NCI-H1838,241158,4.182638843798734
OVTOKO,107970,2.3329176858745164
Daudi,71466445,1.7957550148901065
SNU-1272,241158,4.382370259171122
AsPC-1,6852167,3.622461858977091
LP-1,444795,7.002761969822617
Panc 02.03,5460769,1.6540560754425335
KP-2,12003241,-1.0131753515014823
PSN1,6852167,6.331825232579055
Detroit 562,262093,3.439277279464399
CAL-54,135421197,1.5931766951689923
Hep 3B2.1-7,439501,-1.9738642324779276
HCC1569,73707398,0.8159586298539813
TE-11,tanespimycin-bortezomib (250-1 mol-mol),-2.7748536147542167
KNS-81,tanespimycin-bortezomib (250-1 mol-mol),2.206166956375568
RMG-I,12003241,-2.7782598646997414
Mono-Mac-1,11396600,1.2647728617805982
Kuramochi,73707398,1.772910417031626
U-CH1,637858,2.937039052046479
Mono-Mac-1,49766530,-2.16205133655403
KMS-34,46907787,-0.9505734854402896
SNU-398,12003241,3.2060207303790924
HCC202,135398744,6.455993552330763
RCC10RGB,selumetinib-JQ-1 (4-1 mol-mol),3.398592660488386
NCI-H810,9927531,3.2474997445381693
SK-LMS-1,241158,4.676834411951693
JHUEM-1,444795,5.327264163388397
KYM-1,selumetinib-JQ-1 (4-1 mol-mol),-0.2216165227125683
MDA-MB-361,UNC0638-navitoclax (1-1 mol-mol),1.8233267611349624
Hs 839.T,439501,-1.1818140450451011
253J,168313016,4.386063736521232
KYSE-70,26596,-1.4453873864890578
LS411N,6852167,3.3651093558735035
Mono-Mac-1,9903786,0.9536797288397608
BICR 6,375860,-0.3964511389825882
NU-DUL-1,UNC0638-navitoclax (1-1 mol-mol),-0.5183888778396748
SK-MEL-28,46907787,3.835105129876131
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266
RS4;11,73707398,0.131215442193938
U266B1,135398744,6.53135676756175
PK-45H,241158,4.308454696287406
YD-8,9903786,2.667696713101927
22Rv1,9903786,3.2246012387786536
NCI-H1339,sirolimus-bortezomib (250-1 mol-mol),1.1828252918019528
Mino,100016,3.8828597807205023
HT-1197,3689413,0.4105522735593818
LUDLU-1,9903786,3.064378057627616
LMSU,637858,2.7447242272748924
P-STS,UNC0638-navitoclax (1-1 mol-mol),-1.327662119160444
KP-4,26596,-2.006035898797214
NCI-H1563,9927531,5.123884061924823
CW-2,241158,3.8389238376142822
MeWo,9927531,4.558706173548934
2004,136227331,4.391518238587266
UACC-257,11396600,3.5466245418165743
SW1088,tanespimycin-bortezomib (250-1 mol-mol),0.2648421366318154
Mono-Mac-6,selumetinib-JQ-1 (4-1 mol-mol),-2.958594774349443
MES-SA,sirolimus-bortezomib (250-1 mol-mol),0.1069072940558757
DLD-1,5460769,4.378806727859053
ACC-MESO-1,6852167,4.128939666891623
DoHH2,26596,-2.141975510207564
EFO-21,100016,8.032262329904976
Rh41,71466445,3.306687548235661
BT 187,262093,2.657149541546316
253J-BV,135999136,-5.377455212980044
OCI-AML-3,3689413,-2.4390268193517275
OUMS-23,3689413,0.7829309194563772
COLO 800,sirolimus-bortezomib (250-1 mol-mol),0.359649452523933
JHH-5,11455910,0.7201597489902917
MDA-MB-468,sirolimus-bortezomib (250-1 mol-mol),0.2787318869708576
KMS-27,3689413,0.1610585283674763
VMRC-LCD,241158,4.61265608430858
D283 Med,5460769,1.125938178392905
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884
PE/CA-PJ15,6852167,2.545538398770599
CFPAC-1,46907787,2.402933014882264
KMS-12-BM,637858,0.99115660334439
Mel JuSo,375860,0.1137765747437233
FTC-133,135398744,6.510037604259866
Kasumi-1,selumetinib-JQ-1 (4-1 mol-mol),-0.6942072614799009
BICR 6,tanespimycin-bortezomib (250-1 mol-mol),-0.3653020091427266
NCI-H2087,444795,4.628154500266454
NCI-H2087,6852167,3.953337173011455
EN,439501,-3.211149849796052
HOP-92,107970,1.9922027058608
Daudi,262093,0.7533038243356376
Ki-JK,439501,-2.4258748646441624
YH-13,375860,-0.5335760796053879
SaOS-2,637858,1.716758511666406
KMS-27,49766530,0.6819698946698491
HCC366,26596,-1.6336746121015082
MOLT-13,6852167,1.1565895599380966
COLO 668,637858,1.0989795984996742
HCC2218,44491742,3.8267338846087497
BT 231,6852167,2.464272024157972
SF539,107970,2.309030481029931
EPLC-272H,sirolimus-bortezomib (250-1 mol-mol),-1.4049400380442874
YD-38,107970,2.360175771455579
G-402,9927531,4.821419019473558
SNU-466,3689413,-2.151085855485809
HDQ-P1,135421197,5.294865947723562
JJN-3,3689413,0.1640237934246712
HCC1428,11396600,5.584589218980949
NCI-H2126,9903786,3.129084376626642
JHH-1,tanespimycin-bortezomib (250-1 mol-mol),1.1160802698150678
KNS-60,26596,-3.4190498423081026
A-253,tanespimycin-bortezomib (250-1 mol-mol),-0.0985571483289859
PaTu 8988s,9903786,1.8009975173036927
HCT 15,44491742,3.7262724808810295
Lu-99,100016,4.341210602126273
NCI-H1693,UNC0638-navitoclax (1-1 mol-mol),1.0366545937598326
KMS-27,135421197,2.249002810195298
MDA-MB-157,44491742,3.772080854170876
SNU-899,71466445,4.515368703204169
BV-173,9903786,1.323242877126727
ALL-SIL,9903786,1.532435199339551
HSC-2,11455910,0.978871234646886
LS1034,9903786,3.887461634575776
BT 444,3689413,2.494766939004703
NCI-H1869,9903786,3.8309501172404734
OPM-2,5460769,4.223891374112808
G-401,637858,0.5800115670130345
SU-DHL-1,439501,-2.3864560258185916
SNU-1214,6852167,3.35319741255355
HuG1-N,262093,3.534679932173412
ESS-1,10231331,5.566440371270769
TUHR4TKB,9903786,3.6038306258320425
HEC-108,26596,-0.981636576627464
Panc 03.27,49766530,0.7469851659716551
PaTu 8988s,135999136,4.429569126789119
HCC2108,selumetinib-JQ-1 (4-1 mol-mol),3.0515246299931205
JJN-3,375860,-0.479807677724239
HCC1500,44491742,3.6723474636183537
HEC-1-A,107970,2.315887402815249
NCI-H211,444795,1.3932572861204826
NALM-6,49766530,-2.146531352978819
SK-MES-1,UNC0638-navitoclax (1-1 mol-mol),1.0494999959319211
G-361,241158,1.6882284990551055
PF-382,11455910,1.1839598995526908
MOLT-13,100016,6.122983577816604
Panc 02.03,selumetinib-JQ-1 (4-1 mol-mol),2.589155616289617
CAS-1,sirolimus-bortezomib (250-1 mol-mol),2.076174664589587
MOLM-6,100016,5.4880920806856865
Hs 888.T,100016,7.920695284419831
BICR 22,135421197,2.0438055763788556
HDLM-2,UNC0638-navitoclax (1-1 mol-mol),-2.911208376881327
Karpas-422,3689413,0.6826110279753447
NCI-H647,46907787,2.2999063461602716
HT-144,tanespimycin-bortezomib (250-1 mol-mol),-0.8683575179427937
COR-L51,26596,-2.461438053418328
SW1088,5460769,2.7590684048589025
SK-N-DZ,11455910,0.8503332996504234
BT 147,135421197,1.4134853513564778
JL-1,49766530,2.587242207366064
SNU-C4,6852167,3.429186893177276
MOLT-16,241158,2.157657324299802
2004,tanespimycin-bortezomib (250-1 mol-mol),0.7644529480942643
253J-BV,9903786,4.2891414604158395
MM1.S,11455910,0.7825849388460823
KNS-62,UNC0638-navitoclax (1-1 mol-mol),3.437270318122968
EM-2,637858,1.4868695241377077
KMRC-20,46907787,3.5898907650473855
SNU-475,3689413,0.7678171361213897
Daudi,UNC0638-navitoclax (1-1 mol-mol),1.2047563677281543
SH-10-TC,241158,4.192657349891415
NU-DUL-1,107970,1.631619301271972
Ki-JK,10231331,4.443580343542006
NH-6,135421197,0.8889429247891555
RPMI-8402,135398744,6.9217830210823434
TE-11,selumetinib-JQ-1 (4-1 mol-mol),1.5412110979956997
RERF-LC-MS,241158,4.36087401910034
ESS-1,49766530,-0.3205579652733103
SW1417,tanespimycin-bortezomib (250-1 mol-mol),-2.5738545143684064
KO52,11455910,0.9067852842316652
NCI-H1703,637858,1.360095781311221
HCC1954,10231331,3.3840036108796525
NCI-N87,135999136,4.294797881105147
NCI-H1299,12003241,-0.9760038754339474
SK-MEL-24,10231331,-1.7228498103629468
LS513,73707398,0.9593843362718174
MHH-NB-11,135999136,1.0169938700078396
GDM-1,135398744,6.258827934702185
P3HR-1,637858,1.45691685095597
HEC-251,241158,3.0567288983724135
LNCaP clone FGC,sirolimus-bortezomib (250-1 mol-mol),-6.240208819655782
TT,12003241,-1.2151389854631975
HEL 92.1.7,46907787,-0.7435733597095894
NALM-6,5460769,0.3419650871663187
DMS 114,135999136,2.324166381403774
BT 112,3689413,-2.4519950955667764
HCC44,637858,1.942113190267318
NCI-H2452,46907787,3.091101876271566
NCI-H2286,12003241,-2.840007028807547
TT2609-C02,44491742,4.381647170405731
HuH-6,71466445,1.898975323859935
HCC1395,9903786,3.009593050669707
JHH-5,6852167,3.2228194351334674
BT-549,6852167,2.654575121453327
SNU-1079,637858,2.1328198031741494
HDLM-2,444795,4.905725806732837
SNU-81,5460769,-2.0941921209529575
KYSE-410,selumetinib-JQ-1 (4-1 mol-mol),1.899201390217913
CAL-29,6852167,1.5867412061088535
JHH-1,241158,4.182258020404446
NCI-H2444,637858,2.7890642864609525
RT-112,11396600,5.757660560625734
BT 179,selumetinib-JQ-1 (4-1 mol-mol),2.623374795423357
COV362,107970,1.7647317871906374
KATO III,637858,2.9571239735822696
SW620,135421197,1.4472362766412623
YAPC,9929138,5.651296587688524
BT 428,73707398,0.9802493689904498
BL-70,49766530,-0.8526727850489186
TE-11,3689413,2.9978037995561126
EBC-1,107970,2.1957803762133725
EN,262093,3.594484397034306
KMRC-1,375860,0.0373834100132385
JHUEM-7,9903786,1.8726211891462523
KNS-42,sirolimus-bortezomib (250-1 mol-mol),0.2435231832120803
NCI-H520,9903786,3.332228860924169
U-87MG ATCC,3689413,-0.5776108875278053
HCC95,135999136,5.011624687002968
SW1783,11396600,4.918648417758992
RL95-2,12003241,-0.4521887729146946
BT 444,439501,-3.015846554822595
JMSU-1,375860,-0.8562191900715512
JIMT-1,sirolimus-bortezomib (250-1 mol-mol),1.70536390931118
NCI-H1568,UNC0638-navitoclax (1-1 mol-mol),3.297813275168301
SNU-119,tanespimycin-bortezomib (250-1 mol-mol),0.9832561237476752
EoL-1,6852167,-0.9141942843071824
CAL-33,selumetinib-JQ-1 (4-1 mol-mol),1.717482821229556
MFE-319,11396600,2.9869741461400956
SNU-1196,73707398,2.467226592979981
SNU-5,sirolimus-bortezomib (250-1 mol-mol),-0.1680239232280146
NCI-H2444,49766530,-1.881288849348997
WM983B,49766530,2.209591976361656
AML-193,46907787,-0.6702200808347925
IGR-39,26596,-2.1240544281705955
AsPC-1,3689413,-2.062701377390924
BT 320,107970,2.3152930812829497
U-118MG,241158,4.2243210279093
SNU-C1,26596,-0.0671330439663034
LoVo,10231331,-0.6826574775964468
SU-DHL-10,439501,-2.5547095883933975
NCI-H1339,selumetinib-JQ-1 (4-1 mol-mol),2.2666299614605143
Sq-1,46907787,2.10826946873895
CA46,107970,1.651382626144423
EB1,100016,6.112181525197604
BICR 16,12003241,-0.754422743943259
NCI-H2286,49766530,-2.3239391037136654
OAW28,637858,2.2776250733597085
HEC-1-A,9927531,4.872071430147468
SW620,73707398,1.7654578320686287
BICR 6,26596,-1.5869658496484045
SNG-M,11396600,4.011470573491779
EPLC-272H,9903786,1.2271384419186997
BT 245,11455910,0.6053339220870597
KM12,73707398,1.4036404190350429
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422
CAL-62,375860,-0.9840760104927472
NCI-H526,375860,-1.1255684965626964
EBC-1,selumetinib-JQ-1 (4-1 mol-mol),-0.5998354334946902
NU-DUL-1,375860,-1.5029992457223036
OCI-M1,UNC0638-navitoclax (1-1 mol-mol),1.3490882330999483
LS1034,11396600,3.6253356993405266
WM266-4,6852167,2.43484592020926
BT 245,644241,2.053411949495115
SNU-387,UNC0638-navitoclax (1-1 mol-mol),1.7391468001573358
CAL-27,9903786,1.9830233496778105
SNU-738,sirolimus-bortezomib (250-1 mol-mol),1.9846643128257275
Karpas-299,5460769,1.8174425760442317
U-118MG,9929138,7.614097012433896
DoHH2,46907787,0.1864391937598248
HOS,375860,-0.0507320978080906
NCI-H1435,11396600,4.531231464370408
EHEB,5460769,-1.3281679410072365
F-36P,5460769,6.312488647887553
Panc 03.27,3689413,-0.1085312900774309
YD-15,10231331,1.0782876966297934
KM12,439501,-0.9697085854354284
NCI-H1355,439501,-2.6186321377113955
SW1353,375860,-0.9837699886394528
TYK-nu,5460769,2.633431315912765
NCI-H1915,262093,3.400332041553307
HEC-265,tanespimycin-bortezomib (250-1 mol-mol),-1.1174681512441365
22Rv1,107970,2.2797965792288815
UM-UC-1,11455910,0.1775144921107808
253J,sirolimus-bortezomib (250-1 mol-mol),1.7518558579799193
HT-1080,135999136,2.188985981446395
FTC-133,241158,4.091507154193835
IMR-32,26596,-3.972445110403932
NCI-H1734,11396600,3.6622911845899817
SUP-M2,10231331,0.1284921122273066
GA-10,73707398,-0.3686666371597158
NCI-H2228,3689413,-0.2908814661872257
SNU-16,168313016,4.402991610313933
OCI-M1,168313016,4.404992087327789
Jurkat,439501,-2.365566126578654
Caov-3,6852167,1.75620045611788
CAL-148,100016,6.461133409351435
Namalwa,3689413,-2.4943268400148715
SK-MEL-3,44491742,3.867059457044452
KYM-1,54596490,5.194094726606244
CAL-120,tanespimycin-bortezomib (250-1 mol-mol),1.8647047986889285
BICR 6,9927531,3.2709369283144674
TUHR14TKB,107970,2.3416804561478464
MDA-MB-468,135999136,4.546911980308586
Hs 852.T,73707398,0.5669652099288242
KCL-22,11396600,5.105155728417937
JHUEM-7,439501,-3.5721158792487646
MOR/CPR,sirolimus-bortezomib (250-1 mol-mol),1.9515018462114049
BC-3C,644241,2.777421268835519
MHH-NB-11,9927531,4.251740517213762
Hs 611.T,3689413,-2.7004104072546133
GCT,11455910,0.2932583767108606
SEM,5460769,-1.0690415880949575
SK-ES-1,3689413,-2.1650070700779582
LOX-IMVI,71466445,3.3061273768946737
MSTO-211H,107970,1.929708493397844
BT 179,3689413,2.324623273227175
Rh18,71466445,2.179125629800487
PE/CA-PJ49,49766530,3.753784618730391
Kelly,12003241,2.7454811269637145
CAL-78,9903786,2.899593269782219
MEC-1,375860,-0.4118266375234574
NCI-H2171,selumetinib-JQ-1 (4-1 mol-mol),1.3266542460733022
SNU-503,3689413,0.9941235992839832
MFE-319,73707398,1.6772690272757178
CCF-STTG1,6852167,4.451400297706149
Sq-1,73707398,0.934201736655557
SCaBER,49766530,0.3491318819905442
RL,100016,6.4335673885856135
LOX-IMVI,73707398,0.9274850481113778
OVTOKO,49766530,-2.319379422934269
SU.86.86,44491742,4.316349403220542
HPB-ALL,9927531,5.02886546731598
NCI-H1651,262093,4.029586538433741
HCT 15,262093,3.178837249101228
T-47D,439501,-2.5781176863157524
Pfeiffer,444795,1.9683094418573817
OVCAR-5,49766530,-1.816533160659826
Lu-99,9927531,4.1215148534256105
A-204,135999136,4.389692456038631
RS4;11,3689413,-2.3954384764538528
GA-10,tanespimycin-bortezomib (250-1 mol-mol),-0.5876436517522915
WT2-iPS,12003241,-2.3723982156624057
HCC-56,375860,-0.2290653983773377
GaMG,9903786,4.966976399953102
RCC10RGB,72967,3.7162805539485775
DOV13,107970,2.938310681769946
BT 444,tanespimycin-bortezomib (250-1 mol-mol),-3.2528888157944684
SK-LMS-1,26596,1.8216060443410544
Calu-3,644241,2.2382913836957576
NCI-H647,6852167,1.3113478854499263
HGC-27,46907787,1.268146898786742
MHH-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.9882924076413532
HEL 92.1.7,6852167,2.2795499395639536
UO-31,375860,-0.3911745062364136
BT 224,9927531,6.091778203420535
JHUEM-2,26596,-3.440401418336309
COV644,selumetinib-JQ-1 (4-1 mol-mol),0.9606383383342412
MSTO-211H,26596,-0.5653018529577997
KYSE-150,11396600,3.904935557523132
LS180,46907787,-0.2837252988913812
L-540,135999136,4.377146973519388
ONS-76,12003241,-1.3579895274230906
MKN1,262093,2.3312380194672353
PK-59,241158,4.280180443060871
RL,135421197,1.8322990483714552
RVH-421,5460769,4.814862206766451
SNU-685,262093,3.0570612245027027
AN3-CA,11396600,4.58709626361668
SK-MEL-1,241158,3.5443731206675646
SU-DHL-8,46907787,-0.7946943870210552
MOLM-13,11396600,-0.7885098330267027
SNU-620,439501,-2.3713510132267923
HT115,135421197,2.47112158690729
MHH-ES-1,71466445,3.4244975863031755
LS123,selumetinib-JQ-1 (4-1 mol-mol),1.505935551015269
KP-N-YN,selumetinib-JQ-1 (4-1 mol-mol),4.653792080901046
COR-L105,10231331,1.4114577114599935
NCI-H211,selumetinib-JQ-1 (4-1 mol-mol),-1.7857534849869647
HT115,241158,4.681808490608726
SNU-C1,3689413,-0.1776191587992591
Hs 729.T,100016,6.726636381823557
KMBC-2,9927531,4.40438479738659
EKVX,3689413,-1.7429314171810966
SNU-449,241158,4.010766929552104
SNG-M,135421197,2.4480650600360705
SNU-1,241158,3.738411168906105
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157
BT 179,10231331,5.820683667863652
LS411N,10231331,0.2083934704449227
BT 286,6852167,3.4826351863854295
Lu-99,11455910,-0.2189814587074641
NCI-H647,9927531,5.004225610104877
MM1.S,6852167,1.3787685421812157
VCaP,262093,1.994503008869617
OPM-2,71466445,2.165442844786418
NCI-H1339,637858,2.289025775873357
SK-MEL-5,375860,0.3634288608432608
NMC-G1,6852167,3.88532849006431
VMRC-RCW,262093,3.5147146159266174
HCC15,644241,2.326085716096255
KMBC-2,3689413,-0.0193871140642154
BT 333,136227331,5.5959520749391904
EPLC-272H,46907787,-0.1418313335798283
SNU-761,444795,4.765225896641203
NCI-H211,26596,-3.016523907085459
SU.86.86,UNC0638-navitoclax (1-1 mol-mol),3.1579288284093683
JHH-4,46907787,3.5638190245783687
SH-10-TC,637858,3.386044080916751
SF126,11396600,4.209455624849945
Caki-2,637858,3.3027688951039953
A-253,637858,1.2237702609484895
OVTOKO,3689413,-2.3162270386238735
RL,tanespimycin-bortezomib (250-1 mol-mol),0.0166541585574005
ChaGo-K-1,12003241,1.029111103028103
HT115,26596,-1.779298311907341
HOP-62,100016,6.313498249886369
AsPC-1,6852167,3.622461858977091
BT 179,5460769,5.470437683574026
KYSE-180,44491742,6.4799420322622305
OV56,3689413,-0.2367136689985935
CAL-51,9877608,5.917079709597661
SF126,9927531,4.99089280929888
23132/87,selumetinib-JQ-1 (4-1 mol-mol),1.331252033045766
IPC-298,135421197,1.9910993623388888
8-MG-BA,107970,3.159598521099513
OC 314,3689413,-2.4202845950234466
BT-20,11455910,1.5364398716433951
RPMI-7951,73707398,0.5772291594495476
NCI-H358,selumetinib-JQ-1 (4-1 mol-mol),-0.8434190935752972
SK-MEL-30,6852167,4.680001158379356
G-292 clone A141B1,5460769,2.9316291773021095
VMRC-LCD,637858,1.7836003197528063
HuH-6,444795,4.76302166283974
PE/CA-PJ49,71466445,3.0052586534681645
KE-39,11455910,-0.1151631297895284
COR-L88,sirolimus-bortezomib (250-1 mol-mol),1.8944526230025216
HGC-27,26596,-3.243081069551806
AMO1,439501,-2.703410930799938
NCI-H446,107970,2.2153976675650777
JK-1,168313016,3.280810167382389
A-673,selumetinib-JQ-1 (4-1 mol-mol),0.7422634242763538
JHH-6,9927531,5.6306250844291075
SNU-8,375860,-0.8346021123643971
TE-11,26596,-1.418568182466745
MDA-MB-157,637858,0.0650158223638603
ChaGo-K-1,49766530,-1.5426741425236086
SNU-1077,439501,-0.9206139201693064
AML-193,135999136,1.7506715164272186
KMS-26,444795,3.741445044808976
KYO-1,644241,-6.264819027230071
NCI-H1105,71466445,2.8775637842759583
KYSE-30,9927531,4.7729245028370055
PE/CA-PJ41 (clone D2),44491742,4.176291442698054
MFE-319,241158,3.887445302538144
SF539,9903786,2.8297220739955993
BC-3C,3689413,4.931170730107947
SYO-1,241158,4.09537808941347
NCI-H2081,73707398,0.6809572071185331
CAL-78,107970,2.506185199590124
MJ,26596,-3.924273415415616
HH [Human lymphoma],135421197,1.0671301978035626
Hs 683,tanespimycin-bortezomib (250-1 mol-mol),-2.2425112205370388
GI-1,46907787,1.730990455077524
AML-193,10231331,0.6322489911417504
RT-4,9903786,1.1299984693284726
HL-60,241158,3.40829183459634
TUHR4TKB,11455910,2.848253003917055
A3/Kawakami,107970,2.2225148018694254
DLD-1,tanespimycin-bortezomib (250-1 mol-mol),0.5980844777691691
MOLM-13,26596,-2.2068545341754295
HCC1937,11396600,3.939286660836918
JeKo-1,sirolimus-bortezomib (250-1 mol-mol),0.3610522952079053
J82,44491742,4.20149606168553
L-540,sirolimus-bortezomib (250-1 mol-mol),-4.16248218477803
Ku812,241158,2.509231607325934
BT 147,107970,1.8049375369032488
A-549,6852167,2.2085984360403663
COLO 680N,637858,2.3166033820088368
BT-20,9903786,4.2067479925704925
NUGC-3,selumetinib-JQ-1 (4-1 mol-mol),2.244150108489299
BT 112,6852167,2.8502822773493315
MOLP-2,375860,-0.2269367011336988
GCT,26596,-0.460153915776305
CHP-126,49766530,-2.0764650765443817
KALS-1,9929138,7.477924351122795
A101D,241158,4.125404634521497
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148
BT 231,sirolimus-bortezomib (250-1 mol-mol),0.2590844427623678
COLO 800,168313016,4.811042364024057
42-MG-BA,241158,3.541250292338109
T24,262093,3.3703165306256353
YD-38,3689413,0.3954861349850884
SNU-8,46907787,1.495459042873151
P31/FUJ,11396600,3.188193103342261
Li-7,5460769,-0.8720138445783291
BT 286,26596,0.1662425719802319
NCI-H1915,12003241,-2.138789855422618
DMS 53,136227331,3.826104197881878
MCAS,9929138,6.918248380879042
NCI-H1703,10231331,6.407882764214753
M059K,262093,3.1968962336594644
NB4,3689413,-2.3833174829698085
H-STS,100016,5.985929376611731
B-CPAP,135421197,1.178862358485884
KE-97,6852167,1.7981479981592747
OCI-AML-3,644241,1.351301385486736
Pfeiffer,73707398,0.9124583373506832
SYO-1,135421197,1.7778335849280964
SNU-1214,10231331,0.2722984048431807
KALS-1,46907787,2.274678241554836
GSS,11455910,-0.448056775545068
JHUEM-2,49766530,-1.5038121113070972
DLD-1,12003241,-0.215038024432674
EBC-1,375860,-0.2967621546856999
786-O,168313016,4.441158744193567
RPMI-6666,375860,-0.292497445502028
OS-RC-2,107970,2.550901736917197
JVM-3,26596,-2.348515642559758
SNU-489,49766530,0.3539258431489716
SW620,10231331,-3.895026934403506
BT 187,tanespimycin-bortezomib (250-1 mol-mol),-2.6862986394516453
RMG-I,11396600,4.055852766131107
ECC10,73707398,0.3199143694659382
NCI-H146,135999136,1.6477982136645704
KE-37,71466445,2.2362370567819863
COR-L95,9903786,3.7357721387912513
BICR 22,9903786,3.2901982519836213
KP-N-YN,5460769,4.0809724038992705
EN,12003241,3.248318270429482
SNU-840,44491742,6.442056780348467
SK-N-BE(2),135421197,1.0059955397340807
HuH-6,3689413,1.6433341745909646
RERF-LC-A1,selumetinib-JQ-1 (4-1 mol-mol),1.0639220525759086
TE-1,107970,2.027205986063941
TE-10,9903786,3.070607136357089
SNU-C4,135999136,6.328379982006613
CAL-148,5460769,1.0209449875435856
HCC366,241158,4.236615889952433
NUGC-3,10231331,2.721945968034159
SK-N-MC,sirolimus-bortezomib (250-1 mol-mol),-0.0028242639035691
DMS 53,tanespimycin-bortezomib (250-1 mol-mol),0.0429262611809588
MOLM-6,3689413,0.3128747542373787
IGR-39,46907787,4.8604904570412915
JM-1,135421197,0.410328587733175
NCI-N87,262093,3.0008468279122607
COR-L88,49766530,3.4984546409835016
KMS-26,375860,-1.2821443043959098
SW982,439501,-3.0027408627821934
KYSE-410,sirolimus-bortezomib (250-1 mol-mol),0.4997693160347982
LN-229,3689413,-2.3108318382356248
TE-1,selumetinib-JQ-1 (4-1 mol-mol),3.3703910260827374
NCI-H2081,UNC0638-navitoclax (1-1 mol-mol),0.8615686531760992
SNU-685,9903786,5.039547940758868
JHH-4,sirolimus-bortezomib (250-1 mol-mol),0.3887655009012536
KMRC-3,11396600,3.674088989428189
Daudi,107970,1.216737596928884
CMK,6852167,2.302921040135064
G-292 clone A141B1,73707398,0.1616989889265252
BT 498,11455910,2.7063920015971084
CL-34,12003241,-1.25604782594079
HCC1500,11396600,2.707080690171913
HEC-251,439501,-2.223367930628925
KYSE-30,107970,2.3754255446432935
NCI-H838,262093,3.692579673956935
HCC366,12003241,-0.2149977364985454
SNU-C4,11396600,4.202175701473822
RL95-2,selumetinib-JQ-1 (4-1 mol-mol),-1.1090222735998203
SNU-899,107970,2.6525131600787293
NCI-H2228,262093,3.7725646248304447
SU-DHL-10,73707398,0.8499866155658562
HEC-251,637858,1.281363109758873
SK-N-DZ,6852167,3.0525681043394055
A-673,5460769,1.3883868162718005
Ishikawa (Heraklio) 02 ER-,241158,3.6664689500376353
NUGC-4,107970,2.3784134624007436
SK-N-FI,135999136,4.105674452216523
NCI-H810,100016,4.22640705156995
SNU-449,49766530,-0.9876450445747244
RERF-LC-A1,135999136,1.9235315107843012
PE/CA-PJ49,6852167,2.2001528743044094
DU4475,637858,0.6789447912072304
SNU-398,11396600,3.339240330685363
MV4-11,tanespimycin-bortezomib (250-1 mol-mol),-4.482772377599296
L-363,sirolimus-bortezomib (250-1 mol-mol),-5.312309266116436
VMRC-RCZ,9927531,5.06353509308392
OAW28,11396600,3.5740319462685535
L3.3,9903786,3.5860218860878263
CL-11,46907787,0.9755252779091432
MJ,tanespimycin-bortezomib (250-1 mol-mol),-0.74419356352866
MOLM-13,10231331,1.9024628033326092
JURL-MK1,tanespimycin-bortezomib (250-1 mol-mol),-1.9568027387357825
DU145,49766530,-0.0443271676579987
RPMI-8402,11396600,3.4463493734861186
KP-2,135398744,6.663666573534304
KHM-1B,135999136,4.388497598108013
SNU-878,241158,4.120703520920855
DV-90,12003241,-1.148500998331207
OVSAHO,49766530,-1.4771294887146182
Lu-99,5460769,-0.1107532404571854
A-172,tanespimycin-bortezomib (250-1 mol-mol),0.1851985294738919
IGROV-1,44491742,4.406671418311328
SK-N-AS,9903786,2.5201816871089653
BCP-1,439501,-3.5020472552151904
NCI-H446,sirolimus-bortezomib (250-1 mol-mol),0.5863083212438859
TM-31,262093,3.077046279014693
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361
A-375,100016,6.005492870785018
HSC-2,100016,6.282703144403752
NCI-H1734,selumetinib-JQ-1 (4-1 mol-mol),-1.5307267440702577
SCC-25,11455910,2.801880341049824
TYK-nu,6852167,3.6852222689466223
HEC-6,100016,5.931518422248653
EBC-1,6852167,1.79353662478517
VCaP,9927531,5.412919809162458
SW948,10231331,-0.4116197219649379
HT-144,644241,2.394177436899907
BT 340,11455910,0.6869107925797121
YD-8,644241,2.56753139102049
Mel Ho,439501,-2.4053312201946055
NCI-H2110,10231331,4.807632795755959
SK-N-DZ,UNC0638-navitoclax (1-1 mol-mol),1.0761547272216332
NCI-H2170,71466445,3.990901852662392
JHUEM-1,637858,1.3497979097457864
GCT,selumetinib-JQ-1 (4-1 mol-mol),4.034111871238951
MIA PaCa-2,10231331,2.934704407633453
23132/87,12003241,-0.6974968916735146
HCC1806,49766530,4.996924493962182
IM95,637858,1.184914734198418
MOLT-3,444795,4.052546401379371
YD-15,selumetinib-JQ-1 (4-1 mol-mol),1.1872540503704618
HSC-2,sirolimus-bortezomib (250-1 mol-mol),0.058005047365845
Hs 895.T,73707398,1.8635773546339192
KMS-18,49766530,-2.077336380213563
HeLa,5460769,5.484643109222549
NCI-H810,241158,3.83353914911485
GI-1,sirolimus-bortezomib (250-1 mol-mol),0.2030703478127671
NCI-H446,49766530,-2.3059028658542116
KMS-34,168313016,2.8504854607247743
KM12,9903786,1.2751766913602836
ECC10,49766530,-0.6021024707846206
BT-16,11455910,0.4164616318960097
WM88,241158,3.766898171789964
MIA PaCa-2,637858,1.1483651516118356
Kasumi-2,135999136,3.771420948620172
DU145,135421197,3.2080942542888056
UACC-62,11455910,0.399778260959969
M-07e,241158,4.092457424530606
RPMI-6666,241158,2.9721894035721546
MEC-1,11455910,-0.0965490267087482
PC-3,136227331,4.235931729378205
SNU-489,73707398,1.821217019007182
BT 428,46907787,0.0171893573997719
COLO 320,44491742,4.01582606797262
WSU-DLCL2,73707398,0.2530088858784944
HT-55,135999136,4.374145297422013
NCI-H322,9927531,5.259442104255536
NU-DUL-1,262093,1.0561136959498525
IGR-37,9929138,7.412799255181445
BT 340,selumetinib-JQ-1 (4-1 mol-mol),3.1298101289788223
EPLC-272H,135999136,5.477096530832568
BT 504,262093,2.380431698547906
Sq-1,11455910,0.8534874445635723
NCI-H1341,5460769,4.302850791572325
HEL,241158,3.370113308144609
EFO-21,49766530,0.1419770754491262
769-P,49766530,-0.8828677111325465
A3/Kawakami,100016,3.999978023882096
SNU-668,6852167,2.3843814312201603
FU-OV-1,selumetinib-JQ-1 (4-1 mol-mol),-0.403195367038434
OVCAR-4,9903786,4.586941705699431
L-363,100016,4.553463106890726
BT 131,3689413,-1.953613680223501
KP-3,11455910,1.1515388808863225
Namalwa,12003241,-3.0032452893334596
Reh,439501,-2.4165922655956407
SW1088,6852167,3.083915220127574
BT 482,439501,-3.1816156321337186
VMRC-LCD,26596,-2.205960208364449
LS513,6852167,2.449303940636612
COLO 684,637858,1.1934197712616614
MFE-319,444795,3.938376988705715
CMK,71466445,1.4196244832729643
SU.86.86,135999136,4.173280321668127
SNU-81,selumetinib-JQ-1 (4-1 mol-mol),-1.924488986117384
SNU-1033,tanespimycin-bortezomib (250-1 mol-mol),-1.1601474483832803
HuH-6,selumetinib-JQ-1 (4-1 mol-mol),2.3851782535908628
HEC-251,262093,2.9573459973674985
DMS 79,49766530,-1.9641825285331105
SK-N-AS,12003241,-1.4595382352216486
MJ,49766530,1.2980181747447994
HOS,tanespimycin-bortezomib (250-1 mol-mol),0.2321152572283642
NCI-H1694,241158,2.045684471014548
Karpas-422,11396600,4.033756538148708
MDA-MB-231,sirolimus-bortezomib (250-1 mol-mol),1.1512355372843297
MOLM-13,11455910,-0.3133362084586128
Hs 940.T,3689413,0.3650733663514719
NCI-H2023,439501,-1.9243866702684376
Calu-6,375860,0.1574070397224094
EHEB,12003241,-2.0597430880681062
SNU-5,135421197,2.4308176065595672
JHH-6,439501,-0.5793275995059294
KYSE-140,135421197,1.0055598212916683
MIA PaCa-2,26596,-1.1158295610303952
MKN74,241158,4.664529497930215
OCI-Ly10,5460769,4.307631470824749
PF-382,135421197,0.9667662585436329
AM-38,375860,-0.397083991918632
SK-N-AS,439501,-3.01819280603901
BT 440,12003241,-2.6320772698218793
MKN45,73707398,3.4688255593209596
UM-UC-3,135999136,3.953178744040034
KMS-21-BM,44491742,3.2404662940088205
HCC1395,9929138,7.007797451102856
Lu-65,9903786,2.0553359532496875
CAL-54,11396600,3.3062490005536467
HT-144,5460769,5.183826263672234
HuH-1,selumetinib-JQ-1 (4-1 mol-mol),2.1726097433834557
HEC-151,49766530,-0.2709325293810298
SNU-245,439501,-2.452660264273032
L-428,6852167,2.25091130507535
647V,9903786,2.919786568637495
ONCO-DG-1,11396600,3.950887665043145
DBTRG-05MG,637858,2.5619452660939146
COLO 684,9903786,4.137443964220156
A-673,135999136,4.231524255529223
KMS-28BM,644241,0.6061929880948521
MCAS,26596,-1.466898780296629
BT 330,selumetinib-JQ-1 (4-1 mol-mol),4.150840661532534
OVK18,375860,0.1054743479549769
OVTOKO,637858,2.365004868994971
BT 328,73707398,2.390014521827579
ACC-MESO-1,135999136,6.41791740965286
LMSU,tanespimycin-bortezomib (250-1 mol-mol),0.1689419151943554
SCLC-21H,439501,-2.4331226834497612
SNG-M,375860,-0.2212162005851632
IMR-32,73707398,0.5521746080508468
LS411N,12003241,-0.0946051023392001
KALS-1,6852167,3.6016350818751097
Hs 611.T,11396600,2.963461604358696
BT 359,26596,-1.128901879166228
SK-MEL-2,262093,3.2801506390546225
AML-193,6852167,1.3321437801414788
HCC38,5460769,2.8026336362460307
BT 224,12003241,-0.3430722292852487
NCI-H2342,11396600,5.770432473059626
Pfeiffer,selumetinib-JQ-1 (4-1 mol-mol),-0.1055669472599887
Hs 944.T,107970,2.3124347415373983
Hs 746.T,637858,1.1882246907154543
HT-1376,sirolimus-bortezomib (250-1 mol-mol),1.0351777976040455
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
NCI-H1395,107970,2.4345825548290265
NCI-H1792,sirolimus-bortezomib (250-1 mol-mol),1.8777414374963155
M-07e,107970,1.522491308202342
JHUEM-7,11455910,0.2186713515547739
SYO-1,49766530,0.9236587906089132
RPMI-7951,tanespimycin-bortezomib (250-1 mol-mol),-3.2107041108384524
NCI-H2405,sirolimus-bortezomib (250-1 mol-mol),-0.6741915043369825
SK-BR-3,637858,1.5595701631801446
GSS,3689413,-0.0459197992618788
NCI-H1734,46907787,-1.0284147677545927
BHT-101,241158,3.8603827087696105
RPMI-8226,9903786,1.7655422214301637
COR-L88,100016,6.409850176158066
FU-OV-1,439501,-0.5556149973103641
AsPC-1,5460769,5.795061807453513
SiMa,selumetinib-JQ-1 (4-1 mol-mol),0.2044088203598688
NCI-H1299,selumetinib-JQ-1 (4-1 mol-mol),1.4480114642409152
Hs 578T,tanespimycin-bortezomib (250-1 mol-mol),0.2448774923200065
COLO 320,73707398,1.0538483346288248
MHH-CALL-3,444795,2.920512667470236
Rh41,tanespimycin-bortezomib (250-1 mol-mol),-0.5617508290284754
HT-55,11455910,0.5022530474255873
ZR-75-1,sirolimus-bortezomib (250-1 mol-mol),-0.944196489916664
SNU-668,3689413,0.4740443403911467
BT 224,sirolimus-bortezomib (250-1 mol-mol),0.3912560811158826
CAMA-1,73707398,1.6048081837673416
MDA-MB-435S,9903786,3.3965750050470356
OVCAR-8,637858,2.245893424159101
RVH-421,selumetinib-JQ-1 (4-1 mol-mol),-0.1901819182148017
KMS-11,selumetinib-JQ-1 (4-1 mol-mol),-2.59830306895456
RERF-LC-Ad1,6852167,4.2610431072057695
A3/Kawakami,9929138,3.117210627279925
FU-OV-1,46907787,-0.0188806347407138
Kasumi-2,UNC0638-navitoclax (1-1 mol-mol),-2.8195604802601197
COR-L88,11396600,3.064115551453064
HT115,9903786,1.6808315283009525
SK-N-MC,5460769,1.627780458373646
BT-12,6852167,4.120873835163926
SEM,375860,-0.9031870337732496
OE21,54596490,5.298200205444942
FaDu,136227331,3.76397674876245
SK-LU-1,3689413,-0.1029638587908799
MeWo,262093,2.898334268827345
NCI-H508,73707398,1.2275898465257518
Capan-2,11396600,4.3940876054708005
SK-MEL-30,241158,4.095934000449828
A-204,11396600,3.09168738174324
HL-60,11455910,0.6593265039247426
DU4475,UNC0638-navitoclax (1-1 mol-mol),0.9737803597054544
BFTC-909,375860,-1.1901103647211757
F-36P,262093,1.6746033026960565
L-428,UNC0638-navitoclax (1-1 mol-mol),-0.1190030333689591
NCI-H1395,168313016,6.368341181188219
HEC-6,168313016,4.325832160543922
NCI-H2171,9903786,1.7901794952315444
253J-BV,5460769,4.4338655315193325
SK-N-FI,71466445,2.6055268332428563
A4/Fukuda,241158,1.407426277414268
BT 498,UNC0638-navitoclax (1-1 mol-mol),2.7043329045361393
NCI-H1341,135999136,1.7699629004652555
KNS-42,637858,2.408422862210767
GSS,73707398,1.0095081490958464
DBTRG-05MG,49766530,0.0162384250619963
HCC2218,49766530,-1.6679502221604972
SK-UT-1,49766530,-1.8212556826920157
P31/FUJ,241158,2.9181679480161997
WM115,6852167,1.3860811523021286
HSC-3,444795,5.012644187656376
TT2609-C02,49766530,0.6648763661012455
NCI-H1373,3689413,-0.1033910947263759
SK-N-DZ,73707398,0.4769509189536381
REC-1,107970,3.403139793728704
NB1,46907787,2.2087209713335736
HSC-3,9903786,2.4966748748730025
NB4,135421197,1.336242233620032
NCI-H2170,49766530,5.350715427478364
HCC4006,71466445,3.4609882866554695
EFO-27,12003241,-1.7336155023360622
HSC-4,3689413,2.5472025828962055
GP2d,12003241,-2.636823152177336
BT 239,444795,5.138852816460672
BICR 16,26596,-0.6914049107649834
EoL-1,11396600,0.6541827154317742
NCI-H929,12003241,-1.2414676879861424
SNU-899,5460769,1.25373521066823
GI-1,9927531,5.508249375264951
KE-39,439501,-0.0752815835977172
G-361,444795,4.573428611348007
BT-20,6852167,1.899729475222497
RD,3689413,-1.0823038646320762
BT 131,439501,-2.852207869991737
HCT 116,107970,2.9696327154664126
NCI-H196,135999136,4.3823476311898855
BT 145,3689413,-2.1573583471040827
EPLC-272H,tanespimycin-bortezomib (250-1 mol-mol),-0.4152033872226455
OVCAR-8,375860,0.3753702766146815
SNU-1214,241158,4.530958895072107
KO52,sirolimus-bortezomib (250-1 mol-mol),0.090002603096776
HCC78,241158,5.586971952243853
JHH-4,selumetinib-JQ-1 (4-1 mol-mol),1.29938759958363
REC-1,6852167,4.364510532165473
OCI-Ly19,5460769,1.4066182919474557
BT 239,49766530,0.6116447613594903
NCI-H69,637858,1.6270818041098434
SUP-B15,375860,-0.4986384951202697
JHH-1,3689413,-2.4023532817808304
RL95-2,73707398,0.505219001940243
NCI-H2342,135421197,1.9083443664668167
MOTN-1,44491742,2.9342913777963555
CAL-51,9903786,2.1849161121493847
BT 179,637858,3.293610867259511
LK-2,3689413,0.6891361192494543
P3HR-1,262093,1.7726417290278578
SYO-1,439501,-5.087995993751375
BEN,46907787,0.3993513147154109
U-937,6852167,1.5283780064526906
SIG-M5,241158,3.2994951506114827
HSC-2,444795,4.293399719152513
RPMI-7951,375860,-1.2606970188300772
WM793,11455910,1.0189470974054349
SNU-61,12003241,0.1572719330395487
GaMG,6852167,2.8661941087752445
Caki-2,12003241,-1.799336945217181
JM-1,637858,0.5231851777275447
JM-1,selumetinib-JQ-1 (4-1 mol-mol),0.3812013730118292
KYSE-140,241158,3.465086029728998
DMS 273,241158,3.177272786345067
Ci-1,46907787,3.828892244852044
SNU-423,3689413,-2.448438848320713
PLC/PRF/5,6852167,3.832431058074985
D283 Med,46907787,-0.0797634926932206
MKN74,5460769,3.534639533895065
Hs 895.T,262093,3.3540332653039195
GCT,6852167,2.315251879365214
KE-37,5460769,2.542918791182312
Hs 944.T,637858,1.7134302577668823
HT-1197,5460769,3.9110228695560223
KATO III,9927531,6.301212923475331
A2058,3689413,3.023224690588694
HCC44,439501,-2.457856090784354
TTC-709,241158,3.209768010669518
JeKo-1,selumetinib-JQ-1 (4-1 mol-mol),2.6629730147631587
DMS 114,44491742,4.749496559747659
SK-MEL-5,11455910,0.3432757840716531
NCI-H1573,UNC0638-navitoclax (1-1 mol-mol),2.6425968514400715
BEN,637858,3.568953434975905
HEC-251,5460769,6.090602801092177
EN,444795,5.084994921875901
TCC-Pan2,11455910,2.002854110835051
JMSU-1,135421197,1.367458661118936
TE-9,6852167,3.2217086715952488
Mino,3689413,-3.624730843514525
BT-16,selumetinib-JQ-1 (4-1 mol-mol),4.014507447561005
COLO 320,135421197,0.8671243277775497
NCI-H1666,selumetinib-JQ-1 (4-1 mol-mol),-3.72613020395203
KMS-18,UNC0638-navitoclax (1-1 mol-mol),-0.0148454242506128
BT 245,selumetinib-JQ-1 (4-1 mol-mol),1.4299884719020757
JHUEM-7,selumetinib-JQ-1 (4-1 mol-mol),0.2978252775763586
OV-90,262093,3.163621030526785
HuG1-N,100016,5.877444193140431
QGP-1,135999136,1.7470686183555435
UACC-62,selumetinib-JQ-1 (4-1 mol-mol),-0.661389948081571
COLO 201,439501,-0.4470167142560104
JHUEM-3,10231331,1.902547404227762
Malme-3M,sirolimus-bortezomib (250-1 mol-mol),2.279282073181017
NCI-H446,637858,1.65759101648935
EHEB,49766530,-1.6427312921557593
Ri-1,9903786,-0.2937603570790111
Caov-3,12003241,-2.5094220970195136
HEC-265,107970,2.6838155458007753
A2780,UNC0638-navitoclax (1-1 mol-mol),1.9262711606440108
KE-37,262093,1.3419761733864255
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585
NCI-H1395,3689413,-2.5246792207692073
NCI-H1694,11396600,2.3248952404491976
BT 216,UNC0638-navitoclax (1-1 mol-mol),1.86314072706696
Mel Ho,637858,1.519372506019662
ONS-76,439501,-2.2755976390662163
BT-20,tanespimycin-bortezomib (250-1 mol-mol),2.8367182462251788
TE-14,44491742,4.678720015809428
HCC202,71466445,5.615992482141614
ST486,5460769,4.068144147085423
NCI-H1869,11455910,2.924449694106302
BT 498,107970,2.860609306082874
Panc 05.04,135421197,1.7241772934352249
MHH-ES-1,46907787,0.0189081093783337
SW1353,selumetinib-JQ-1 (4-1 mol-mol),1.7746405965747805
SNU-C1,12003241,0.2452706417287593
23132/87,375860,-0.9015552167310936
NCI-H1792,262093,4.0169185554275915
BT 428,11455910,0.0710771584645227
COLO 680N,73707398,1.0530287264392622
BT 131,135999136,1.5410915865018433
KYSE-140,9903786,2.4605743135261653
HT,6852167,0.7668896132234709
JHH-2,12003241,-2.42929005443543
NCI-H1573,11455910,2.1224271669039902
Kasumi-1,375860,-0.4619360100102614
OAW28,6852167,2.294169410796982
ZR-75-30,637858,1.9303975734710028
PE/CA-PJ49,637858,1.923825301062206
Hs 936.T,107970,2.841992044005918
GMS-10,637858,1.9088173452974475
SNU-46,6852167,4.045709050144237
NCI-H2170,73707398,2.2436003573271046
RCH-ACV,6852167,1.1883730851322674
CL-11,71466445,3.717903191169583
MDA-MB-453,107970,2.0242856345207834
JHH-5,9929138,4.293254911583093
LXF 289,100016,7.121965810949268
CL-11,11396600,3.643774231055674
U-87MG ATCC,49766530,-0.4723901829194296
Granta-519,135421197,0.2234065586927925
KMRC-1,6852167,3.0099217565414693
CL-11,5460769,2.817673582837802
NCI-H2106,644241,2.236152490037656
LMSU,135398744,6.91211293627059
HT-1080,241158,3.7241913217305873
HD-MY-Z,107970,2.364477587314304
COV434,241158,3.2094796403534875
NCI-H650,135999136,1.5977473869198309
RT-4,135999136,6.151607962032574
OV56,135999136,4.60647934251061
PE/CA-PJ34 (clone C12),262093,3.186494210920842
HT-55,439501,3.0049152055175377
BT 286,136227331,4.205096233968031
CGTH-W-1,12003241,-0.9249574155092228
KHM-1B,6852167,0.7581222087853566
HGC-27,644241,1.74526015473942
HT-1197,135421197,1.673772932436652
NCI-H1666,107970,1.4066957803626672
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
253J,6852167,1.19495327792042
K-562,107970,1.9304513771469212
KE-39,44491742,3.945663107977575
KE-97,9929138,4.212063934652932
HEC-251,73707398,0.8821727990853683
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815
HEC-6,11396600,6.108645448487235
LN-18,12003241,2.3352832275998927
SK-MEL-2,6852167,4.028362425471942
RERF-LC-MS,168313016,4.277512101574917
8-MG-BA,241158,4.128580176104645
EBC-1,439501,-0.4192565995990754
SU.86.86,9927531,4.197811757313418
BT 320,11455910,4.86644863423661
BT 245,11396600,2.7099317658056927
IGR-37,6852167,3.6803333790062767
OCI-Ly10,26596,-0.6290463214568307
SNU-738,262093,2.5728208753018285
SEM,tanespimycin-bortezomib (250-1 mol-mol),-2.121594680168012
BEN,135421197,5.032233949916212
CAL-33,135421197,1.5184759141231294
BT 340,439501,-2.6874072240019617
AU565,12003241,-0.6235660341918571
NCI-H2029,5460769,4.253529576580681
RKO,10231331,2.816804700080647
A2780,selumetinib-JQ-1 (4-1 mol-mol),-1.37978583005038
NCI-H2170,375860,0.3943136214520606
BICR 18,11455910,2.028324794320248
HEL,73707398,1.0006953763352662
OCI-Ly19,46907787,-0.6661147236567055
SiMa,12003241,-0.7003588791224504
BT 482,6852167,2.974571022555702
FTC-133,46907787,3.491897677971775
TYK-nu,444795,4.785149640817898
NCI-H2342,444795,5.031719559259329
GaMG,selumetinib-JQ-1 (4-1 mol-mol),2.933911727916489
PE/CA-PJ15,9903786,2.2611792207171484
Hs 611.T,tanespimycin-bortezomib (250-1 mol-mol),0.1632190347218379
KMS-20,135421197,1.5361253797366796
KP-3,262093,2.764663205540099
T98G,439501,-1.9696613143180952
HuT 78,444795,-1.7173791831946914
COLO 678,637858,2.34286662480737
DEL,439501,-2.407341543091591
UACC-62,262093,0.8846336077087198
BT 444,11396600,3.072900716227824
HEC-151,135421197,1.9024476201303135
BT 444,46907787,3.76954091799178
DMS 454,644241,1.5281678593249242
TC-71,sirolimus-bortezomib (250-1 mol-mol),0.6072005287356511
COLO 829,9903786,4.931323632089431
SNU-C4,44491742,4.387584080211158
SK-OV-3,9903786,2.611217845094376
NCI-H1563,UNC0638-navitoclax (1-1 mol-mol),0.5431037192141
BT 245,26596,-1.3254238494846824
RT-112,439501,-0.757801709231946
CAL-78,73707398,0.878307672243771
HT-1376,3689413,2.4091899536551264
JHH-5,49766530,-2.9566039137212137
SHP-77,241158,1.951017341248196
786-O,637858,2.2863883731736667
BICR 22,3689413,1.1307119933583345
DMS 454,107970,1.7006864411159697
NCI-H1975,26596,-2.5930273814391196
HT,107970,2.098069233579563
FTC-238,135421197,2.4336090665615115
SBC-5,11455910,0.8715920005264659
5637,9929138,6.240532566215687
CAL-54,46907787,-1.4297052290573224
LXF 289,11455910,1.909862916296106
LOU-NH91,6852167,3.2671273023515934
Detroit 562,sirolimus-bortezomib (250-1 mol-mol),0.7815437350354109
SF268,11455910,0.3275538615735771
G-361,11455910,0.6100431250643066
KM12,11396600,3.711398908201269
HuCC-T1,12003241,-1.0945393222434805
NCI-H1792,135421197,1.9377775784144329
MOLM-6,5460769,2.737785033090413
Reh,12003241,0.0982187894519585
LMSU,26596,2.3008598244356935
MDA-MB-453,9929138,5.862527790185705
OVK18,3689413,-2.4624871166851965
SK-N-MC,44491742,4.171908823838076
HSC-4,selumetinib-JQ-1 (4-1 mol-mol),3.950475054879744
NCI-H2106,44491742,3.3894720811903976
BICR 6,46907787,3.814885233730211
PE/CA-PJ49,375860,-0.7510752719204733
QGP-1,12003241,-0.3742156649429844
HGC-27,5460769,1.1785967516378393
NCI-H2052,73707398,1.348162665971746
T84,12003241,-0.2889439900128532
MDA-MB-361,439501,-3.0458993456169168
SK-MEL-28,11455910,1.7343524639503471
TE 441.T,3689413,-1.0112421393817166
U-BLC1,49766530,0.1451945306283898
NCI-H2172,6852167,4.795805811514927
NCI-H2081,9903786,1.5566694513779922
SW579,439501,-3.952222233094387
OAW28,168313016,5.164256635335989
SNU-C2A,tanespimycin-bortezomib (250-1 mol-mol),-0.6320265615754446
RPMI-7951,644241,2.388085399534529
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
OCUM-1,168313016,4.182572572603023
CMK,444795,5.729401774716638
NCI-H1793,262093,3.818681600610628
SYO-1,selumetinib-JQ-1 (4-1 mol-mol),-0.4471349364002282
CAL-85-1,136227331,4.603192424436066
HPAC,6852167,3.682014733747655
OVISE,135999136,4.426271635938179
Tm87-16,11455910,1.895109547469087
NCI-H1915,3689413,1.3727527679359948
2004,11396600,3.4880760696639417
SNU-46,135999136,5.748534430136229
NCI-H2172,637858,5.647730401907311
OAW42,9903786,3.91324183381597
TE-5,11396600,3.2450913131710957
HCC1171,107970,2.4719782408323385
NCI-H522,5460769,0.5614535105182378
BC-3C,sirolimus-bortezomib (250-1 mol-mol),0.3697062841938496
253J,439501,-2.369438844197353
HuH-28,46907787,0.1056590544791841
42-MG-BA,49766530,-1.7138070922942703
COV644,11396600,3.2739624799588505
Mono-Mac-6,3689413,-1.766017033423464
U-251MG,tanespimycin-bortezomib (250-1 mol-mol),-1.2552870435525063
HDLM-2,71466445,2.6757992406645505
G-401,9927531,4.9703255494446035
MOLT-3,100016,3.7727587478901734
NCI-H2126,444795,5.146791036292057
HuP-T3,11455910,1.0919804440303738
NCI-H841,46907787,3.457668599276525
A4/Fukuda,73707398,-0.4328093310020208
DMS 79,439501,-2.1979819291914224
NCI-H2342,9903786,5.089610325302681
LS1034,49766530,4.046854400664645
NCI-H1666,73707398,0.9789960895675976
KHM-1B,439501,-2.4289183886287535
Hs 766T,12003241,-1.434019858151168
L3.3,100016,6.042484334243821
BT 232,49766530,1.9852556236627383
HuT 78,10231331,-3.0866153075416376
NCI-H2030,44491742,2.996823060755576
ChaGo-K-1,selumetinib-JQ-1 (4-1 mol-mol),2.371471699435725
MHH-CALL-3,262093,1.7879800250632032
NCI-H1944,136227331,3.877742239943195
Hs 746.T,9903786,3.9786506562957857
SNU-738,9903786,3.5811355233288773
MOLM-13,375860,-1.005106987112833
BT 248,644241,1.8454939937856112
Hs 746.T,3689413,-1.6439550226846966
SNU-449,637858,2.172600125936458
ME-1 [Human leukemia],439501,-0.373146825712067
KM12,sirolimus-bortezomib (250-1 mol-mol),1.529989038741449
HCC1937,107970,2.351096424930394
HSC-2,375860,-0.5964846661669698
SNU-899,9903786,2.4739971743095497
MOLP-2,5460769,4.105160520991768
BICR 22,5460769,-1.4539525700949456
KYM-1,6852167,2.766391322477695
DEL,73707398,-0.3093051259140468
JVM-3,168313016,3.652022261873428
KHM-1B,3689413,-2.4012228391908783
F-36P,46907787,-0.7684715218448218
JMSU-1,262093,2.8828462460891444
Hs 888.Lu,49766530,-2.122811696802074
HT-1080,73707398,1.432665893023954
Hs 852.T,71466445,3.0340826390115985
MDA-MB-435S,100016,6.42664314163943
HCC1806,168313016,5.712077143573756
COR-L105,262093,2.940873643596252
SEM,9903786,1.5227669871926164
U266B1,12003241,-0.5113173834247196
EBC-1,444795,4.731018118480506
MOLM-13,selumetinib-JQ-1 (4-1 mol-mol),-6.008931443997215
NCC-StC-K140,11396600,-1.2265429504727747
HuH-28,241158,2.528595827749566
THP-1,49766530,-1.885819657206308
SCC-9,637858,3.7694424070181127
NCI-H28,tanespimycin-bortezomib (250-1 mol-mol),-3.05578817250867
SNU-5,9929138,6.321300531012286
GSU,6852167,3.634612073118843
K-562,168313016,4.482960220744853
U-CH1,44491742,4.471385772399255
COLO 800,selumetinib-JQ-1 (4-1 mol-mol),-0.1854936037479787
NCI-H1299,262093,2.920458315101783
NOMO-1,637858,1.0893367728071195
SNU-410,11396600,6.23981949111421
SK-BR-3,46907787,0.432844981405334
OC 314,12003241,-2.177807668538587
HCC1438,100016,5.852637802531623
Granta-519,262093,1.5974758737964725
SNU-886,sirolimus-bortezomib (250-1 mol-mol),1.314176922115052
Hs 766T,107970,2.2032041411618652
NCI-H322,107970,2.347963530024278
NCI-H508,tanespimycin-bortezomib (250-1 mol-mol),-0.2037245877334007
HCC15,71466445,3.952377160133232
CA46,3689413,-3.563387503989764
EJM,46907787,1.3360205419537388
IGR-1,9927531,6.184289140362073
SNU-119,5460769,2.8404840787101593
NCI-H1341,tanespimycin-bortezomib (250-1 mol-mol),-2.8449301183923756
Mono-Mac-1,135999136,5.618936483472871
NCI-H2030,selumetinib-JQ-1 (4-1 mol-mol),3.0704561739948737
NU-DHL-1,375860,-1.1724229979544771
CFPAC-1,49766530,5.350694813461272
KYSE-70,9903786,2.353212274658888
MSTO-211H,46907787,2.574686905184434
HCC1428,71466445,3.8149114243044817
HCC15,10231331,4.227224330005602
BT-20,637858,1.5317212374288376
NCI-H1435,6852167,1.616991513664108
BT 159,11455910,0.815831828499024
SNU-387,12003241,-1.416188991629313
JMSU-1,107970,2.4999599660448664
HuH-1,107970,2.4748588505404534
NCI-H1666,9903786,3.302889272478758
SK-ES-1,444795,4.571799247087775
OV7,sirolimus-bortezomib (250-1 mol-mol),0.4269208814409986
EPLC-272H,637858,1.4524809101407783
NCI-H69,12003241,2.7316245717871572
HCC2218,9927531,0.7764965952119703
HCC1500,UNC0638-navitoclax (1-1 mol-mol),-0.3841073877308503
Rh41,444795,-0.0086850409743929
HCC2218,5460769,-0.600250204778271
8-MG-BA,12003241,-0.0474192028844215
TTC-709,46907787,1.4773024325483866
Mel JuSo,26596,-0.7227371785697827
HCT 116,73707398,3.627883589581251
HSC-3,selumetinib-JQ-1 (4-1 mol-mol),1.0715718666689311
LN-18,107970,2.3088219916705857
SK-MEL-31,sirolimus-bortezomib (250-1 mol-mol),1.406107901853138
YD-8,241158,4.108189803137544
P31/FUJ,100016,5.4217002529902185
Ki-JK,637858,0.6675155607453573
ST486,71466445,2.0454820833353704
NCI-H526,439501,-2.4772740458578983
SNU-201,44491742,4.436109231936613
NCI-H1623,241158,4.3681147628536445
KE-39,136227331,5.536038659908766
EFO-27,UNC0638-navitoclax (1-1 mol-mol),3.21943648938414
SH-10-TC,6852167,3.183522893329415
LS513,3689413,-0.047571492296106
IGR-1,selumetinib-JQ-1 (4-1 mol-mol),-0.1009850774874795
MCAS,135398744,6.37399282177603
HCC2279,9927531,4.656852539502924
U-937,49766530,0.8721430649798465
NCI-H1869,107970,2.0096354902950178
CAL-27,sirolimus-bortezomib (250-1 mol-mol),0.4239769214934303
NCI-H660,3689413,-1.4753207784543096
SK-MEL-1,100016,6.470813601542051
NH-6,11455910,0.8097778679046014
PLC/PRF/5,73707398,1.7771083987685936
EBC-1,9903786,3.237672392939453
LAMA-84,241158,2.9700972782798636
SCC-4,11396600,3.496408170179274
OUMS-23,100016,6.512546818056364
COR-L105,3689413,-2.1605707630353708
SUP-HD1,46907787,0.5577023982990558
IGROV-1,5460769,1.6083174601829917
NCI-H929,444795,0.5078215400494521
BT 416,73707398,1.2000065788427186
G-402,44491742,3.86820580626592
Rh18,sirolimus-bortezomib (250-1 mol-mol),0.7964593742547511
KYSE-140,439501,-2.2036133964389446
SW48,241158,3.5185545260205364
NUGC-4,tanespimycin-bortezomib (250-1 mol-mol),-1.8387633895820632
IMR-32,9903786,1.34691800492683
NCI-H1944,100016,8.062523558454052
SNU-886,tanespimycin-bortezomib (250-1 mol-mol),0.3789441066781652
KMRC-1,46907787,3.729545872280723
MOTN-1,71466445,1.6583879973363078
GSU,sirolimus-bortezomib (250-1 mol-mol),1.8357391099692455
OE21,selumetinib-JQ-1 (4-1 mol-mol),-0.1930020472631329
L-1236,107970,3.0094874946662165
22Rv1,375860,-0.0627055235915324
NCI-H1703,26596,-2.7803694480879857
KHM-1B,26596,-2.1296194509234576
EJM,71466445,3.872070794685453
TE-1,tanespimycin-bortezomib (250-1 mol-mol),-1.7455027047349927
EB1,637858,0.8330107296865988
SU-DHL-8,100016,4.106875584244309
Hs 940.T,439501,-3.345771956263442
BICR 16,100016,8.634217681257812
NCI-H2106,168313016,4.030575020699663
LS513,12003241,-0.5342180043119649
SK-MES-1,49766530,1.8908947653330492
253J-BV,9927531,5.275278966830564
SNU-423,11455910,2.439649543978504
WM1799,241158,3.9311325613420394
HuH-1,26596,4.2639260913768755
SH-4,637858,1.8209494990164508
TYK-nu,107970,2.1879195811758683
SEM,46907787,-3.1211446232519178
RERF-LC-Ad2,107970,2.022505659566407
G-401,44491742,3.951665256591854
CAL-85-1,168313016,5.825760446908126
HH [Human lymphoma],9929138,3.344278516856126
A4/Fukuda,12003241,-4.192136354440014
BT 239,selumetinib-JQ-1 (4-1 mol-mol),1.637299005229072
KMRC-20,selumetinib-JQ-1 (4-1 mol-mol),2.987450194991694
TE-14,262093,3.712272001874861
SNU-201,439501,0.2163207704150155
ACC-MESO-1,3689413,0.4162012666414902
JVM-2,10231331,-1.0631945813970318
Jurkat,444795,4.645488476926674
OCI-AML-2,49766530,-2.1429855478008975
DBTRG-05MG,6852167,3.083762878407909
MCF-7,46907787,-0.1248384989436528
KCL-22,selumetinib-JQ-1 (4-1 mol-mol),-1.213906386428174
A-549,10231331,2.044831055629592
EJM,selumetinib-JQ-1 (4-1 mol-mol),1.9175380074632984
YH-13,10231331,5.93947704147761
COLO 668,73707398,0.8001176213586483
Panc 05.04,71466445,2.9988870085628165
MG-63,9903786,3.648237948966595
HuH-1,9903786,2.716851853041897
JM-1,10231331,5.343116821873739
SK-LMS-1,135421197,1.8226321341170344
OE19,6852167,3.959491189600183
KPL-1,UNC0638-navitoclax (1-1 mol-mol),2.89421490403249
CW-2,375860,1.657135931795828
H-STS,107970,1.855553720240211
NCI-H526,262093,1.015946009419874
COLO 668,selumetinib-JQ-1 (4-1 mol-mol),2.177290778736977
PF-382,375860,-0.9454794315487792
COR-L95,49766530,-0.268325836176492
ESS-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8573739995038356
Hs 944.T,136227331,3.8800196533098847
YD-10B,5460769,-2.041920161211882
KP-3,241158,4.0882665535753375
GI-1,44491742,3.8147677768435497
A3/Kawakami,637858,1.0589616094349
HCC4006,637858,1.3165870232425092
HCT 15,sirolimus-bortezomib (250-1 mol-mol),0.2078755227007766
EoL-1,71466445,0.1992433528179963
HL-60,selumetinib-JQ-1 (4-1 mol-mol),-1.2129549912844606
JHH-6,3689413,0.376454666699167
SF295,73707398,1.6695998936889058
NCI-H2052,637858,2.2400258514896967
CAMA-1,107970,2.77221313938515
22Rv1,9929138,6.22160850617875
LOX-IMVI,73707398,0.9274850481113778
NB4,10231331,-1.99869835268962
Hs 578Bst,UNC0638-navitoclax (1-1 mol-mol),2.7234983149900964
DU4475,9903786,2.594571624962549
MOTN-1,168313016,3.9664362294048954
DK-MG,107970,2.306444626900634
NCI-H358,100016,4.0854531303861155
AU565,3689413,0.8257687517728082
Toledo,11396600,3.3426369304139825
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716
NUGC-3,73707398,0.756281056203992
786-O,3689413,-2.4095930887688546
A-253,73707398,2.5977351568738825
GSS,26596,-1.5813697443428234
NCI-H1650,6852167,3.0026725356195336
KYSE-180,6852167,3.0076808179282213
HCC1419,sirolimus-bortezomib (250-1 mol-mol),0.331590407982584
Calu-6,135398744,6.4194279820254465
BT 159,6852167,3.668845452982651
LCLC-103H,selumetinib-JQ-1 (4-1 mol-mol),2.2778723422083886
RVH-421,11455910,0.1784528957020075
MES-SA,11455910,-0.2253675731239214
HL-60,439501,-2.5264411138407836
SF268,71466445,4.871894724490201
LP-1,26596,-1.5638632087078823
KNS-81,262093,3.063139326584166
UACC-257,10231331,-1.074340029980585
OCI-AML-3,71466445,1.081217761566199
SK-MES-1,11396600,3.1861183641425823
Hs 294T,tanespimycin-bortezomib (250-1 mol-mol),0.0201287487075006
AsPC-1,73707398,2.3690176063372888
KMS-27,12003241,-0.3161890721272481
T24,73707398,1.720352175395374
HCC2279,262093,2.5944321390006397
BT 231,11455910,0.2900866749520439
HT-55,241158,4.257763680370867
SF268,46907787,2.334109792042798
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786
BT 359,sirolimus-bortezomib (250-1 mol-mol),0.4069320029327686
RCH-ACV,136227331,3.661348982396994
SH-4,100016,6.480724052638794
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
NCI-H1581,49766530,-2.147039743069074
SK-MES-1,241158,4.574622502408226
HL-60,46907787,-0.5362964011669514
NCI-H2085,sirolimus-bortezomib (250-1 mol-mol),0.8300546394702069
MOLT-3,UNC0638-navitoclax (1-1 mol-mol),-1.1342008169918747
KYO-1,3689413,-0.0705408923087068
NCI-H146,439501,-3.5641402563292393
JeKo-1,11455910,-0.102644590273409
LN-229,44491742,4.497083507897472
JHH-1,12003241,2.181152294070196
Jurkat,44491742,-1.1697965410945943
Becker,3689413,0.4493271202500121
SK-LU-1,tanespimycin-bortezomib (250-1 mol-mol),1.5987534653894475
MOLP-8,375860,-0.9263291950812266
SNU-201,tanespimycin-bortezomib (250-1 mol-mol),1.2194348373634587
HCC1143,107970,2.31840177997234
SNU-308,107970,2.9327058246303483
BICR 18,10231331,4.6040196689650905
CAL-54,44491742,4.012557158379019
MOLP-8,6852167,0.8455390099609336
ACC-MESO-1,sirolimus-bortezomib (250-1 mol-mol),1.905625687431691
SNU-685,3689413,-2.422498805139559
LXF 289,241158,4.717778097263283
SH-10-TC,135999136,5.659373349051974
VMRC-RCZ,73707398,3.8485182497894472
Panc 10.05,54596490,4.364006655792474
U-937,375860,-0.6351957865306692
23132/87,100016,5.572734576179291
NU-DHL-1,3689413,-2.5727806443741836
OCI-AML-3,11455910,-0.2153245710553746
T-47D,135999136,4.653802376085038
ZR-75-1,71466445,5.023248156123476
JHUEM-7,11396600,4.730722840017514
A3/Kawakami,sirolimus-bortezomib (250-1 mol-mol),-6.300755370161075
BV-173,tanespimycin-bortezomib (250-1 mol-mol),-0.4619705859834364
MOLP-2,241158,2.025769717996406
PE/CA-PJ15,136227331,4.888188791536357
MHH-ES-1,168313016,4.916028116367523
SEM,9927531,4.847523560791686
COLO 829,49766530,1.364396620526625
AM-38,3689413,-2.9608439081613387
OE33,12003241,0.2230817721074321
SUP-T11,439501,-2.327064015434822
SYO-1,168313016,4.463038136814232
NCI-H1568,12003241,-1.4870303892505918
NCI-H1944,241158,4.952217480031954
SH-4,241158,4.950630413385666
PE/CA-PJ15,11455910,0.2163871462693647
NCI-H1105,46907787,2.551008749749465
NCI-H1373,637858,2.695780471176255
BT 232,10231331,3.6027232306656933
HCC1195,selumetinib-JQ-1 (4-1 mol-mol),2.3126527462305955
SNU-119,73707398,0.7345911888158907
THP-1,73707398,0.2816477508362379
OVCAR-5,10231331,0.2169812398707243
NCI-H526,71466445,3.4428380122826736
BT 228,44491742,3.950846154014159
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996
LCLC-97TM1,9927531,5.703886109604247
A-204,241158,3.4037902568157823
PC-3,72967,3.800120867156137
JM-1,6852167,1.3157742507093588
SK-N-MC,3689413,-2.3816652298923873
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088
Karpas-299,241158,1.626419354952072
P-STS,71466445,2.7514602087039792
SK-N-AS,5460769,4.709590087634428
COR-L88,46907787,2.262713166355046
UM-UC-3,73707398,1.0664316005493033
KYSE-180,107970,2.4041035075192196
KMRC-20,73707398,1.7254732299327342
L3.3,selumetinib-JQ-1 (4-1 mol-mol),7.047753882053292
Kuramochi,sirolimus-bortezomib (250-1 mol-mol),2.121194092694626
Raji,439501,-2.4044549184869872
GA-10,439501,-3.812594537001909
TE-10,11396600,3.9393585387483334
HT-1080,11455910,0.1997315897525516
ES-2,9903786,4.393151500832027
M059K,12003241,-0.3753342750649466
CMK,5460769,4.702047832953649
COV362,26596,-1.9019545485387068
BT-20,sirolimus-bortezomib (250-1 mol-mol),0.9050670682088444
WM1799,262093,3.074804588152201
Ci-1,11455910,-0.0933169767027184
COLO 792,6852167,0.7381788864541688
BT 179,11455910,0.244595682570849
Rh18,73707398,1.1064316951658733
KYSE-450,72967,3.7351940397417023
CAL-29,439501,-2.337192610313779
HuH-6,9903786,2.683606252138214
SK-N-AS,100016,6.379811774246359
HOP-62,73707398,1.728110403283316
HEL 92.1.7,100016,4.201358504841771
BT 228,10231331,4.437777613633079
KMRC-20,9903786,3.936421872110463
786-O,262093,3.537658086729407
8305C,168313016,5.620124632794436
BICR 56,selumetinib-JQ-1 (4-1 mol-mol),1.4514445246280927
KMS-18,73707398,0.4352882147281803
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805
SNU-1079,6852167,2.2180229891841723
NCI-H1693,sirolimus-bortezomib (250-1 mol-mol),0.2355785626536786
Fu97,375860,-0.1420045444279083
LOX-IMVI,selumetinib-JQ-1 (4-1 mol-mol),0.1243957473600749
NCI-H727,12003241,-0.657143782776601
HEC-151,637858,1.4744237971842309
Rh18,168313016,4.6958558766338045
TTC-709,637858,0.9125312609404584
SUP-T11,644241,2.523966392128261
22Rv1,100016,5.084356097831624
KG-1-C,107970,2.049328219906487
ACHN,439501,-3.3245140147129684
HCC1937,262093,4.048076592606387
JHOS-2,73707398,4.073232258082221
SNU-407,444795,5.198512423866144
ALL-SIL,9929138,4.286241964174987
NCI-H2291,11396600,4.122894095421017
NCI-H2196,46907787,3.906560872378596
OC 314,26596,-2.5716994048265964
LUDLU-1,107970,2.246008658957212
LXF 289,selumetinib-JQ-1 (4-1 mol-mol),1.3410904156119008
NCI-H2030,637858,2.3348665143276843
Malme-3M,49766530,0.5606234787009209
COLO 800,10231331,-1.3489383760666889
NCI-H1563,73707398,1.563728239277783
RERF-LC-A1,46907787,1.7386055738310746
HGC-27,168313016,4.744843210420601
BT 416,3689413,-0.9545304181237728
RPMI-8226,107970,2.2987962420855617
CHP-212,5460769,-1.533156489217473
Pfeiffer,71466445,3.089335098136117
YH-13,3689413,-1.970237829798131
SK-N-BE(2),UNC0638-navitoclax (1-1 mol-mol),-0.3828461387565847
Mino,168313016,3.695449207711372
U-87MG ATCC,sirolimus-bortezomib (250-1 mol-mol),1.5742671980534302
OVISE,11396600,4.241731433198166
DMS 114,375860,-0.2775891558908802
Kuramochi,241158,6.3295579427674475
NCI-H2122,135398744,6.485849720689022
BT 112,135999136,1.34167975240954
KE-97,sirolimus-bortezomib (250-1 mol-mol),0.1118131766190663
PL-21,46907787,0.2459511356880181
NCI-H2087,sirolimus-bortezomib (250-1 mol-mol),0.3308566581243162
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015
CGTH-W-1,10231331,5.198794225249042
BT-20,12003241,1.693784137841815
SNU-503,637858,3.226228036596522
J82,135421197,1.0520459695592828
NCI-H841,3689413,-2.418219785730911
SHP-77,6852167,3.706975834295729
NCI-H1869,9927531,5.985290716685452
NCI-H23,26596,-3.72229415651004
DU145,136227331,5.067250261949365
NCI-H1341,135421197,1.8518080327886164
SNU-719,selumetinib-JQ-1 (4-1 mol-mol),-1.673282940163647
JVM-3,12003241,-2.550977818363364
NCI-H2228,10231331,2.0160637465796256
NCI-H2291,49766530,-0.0984213660928805
Sq-1,44491742,3.879734584111586
DND-41,UNC0638-navitoclax (1-1 mol-mol),-0.950622126966266
BICR 18,46907787,0.7190687661680963
TE 617.T,135999136,4.164047799222283
Karpas-620,71466445,4.078861741332925
KE-39,135999136,4.6219900849735325
HH [Human lymphoma],100016,3.957825935624259
GB-1,12003241,-0.733058723008687
KNS-60,9927531,4.453206768801637
M059K,439501,-3.0131166353991703
HEL,11455910,0.7002369428142345
LS411N,637858,2.7012095970179635
BC-3C,11455910,1.805675194715763
RPMI-8226,11396600,2.661670578170676
23132/87,46907787,1.8335794476282232
RERF-LC-MS,135421197,1.554065103888189
NCI-H1944,644241,1.8482480993300487
PLC/PRF/5,9927531,3.33785239114395
GI-1,6852167,2.008297234106824
DOV13,439501,-2.3645646799051754
AGS,46907787,1.8516291073486968
NCI-H838,selumetinib-JQ-1 (4-1 mol-mol),5.188205394228317
RERF-LC-A1,241158,3.4003643660710714
SNU-182,10231331,3.169558165272788
EFM-192A,73707398,1.3646305784605928
KP-4,49766530,-2.33091907235806
PE/CA-PJ34 (clone C12),107970,2.3192518543827476
AU565,54596490,4.681317358630495
RPMI-6666,26596,-1.6823570129437355
CAL-85-1,9903786,2.154153676778314
DMS 273,26596,-2.1961333269229173
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728
SCC-4,168313016,4.773775305844119
MOLT-13,637858,0.5697042946883438
A-375,6852167,3.704250523230319
RERF-LC-A1,49766530,-2.6105960143319487
SUP-T1,9903786,2.605502996973438
HGC-27,135999136,4.659278272182858
HCC44,73707398,1.5654778950043116
MOLT-13,241158,1.68385615274184
NCI-H2029,100016,6.638892611020326
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305
BT 271,12003241,-0.5875601678545488
COR-L95,46907787,3.807595772412777
SW579,644241,1.6147011533525324
NCI-H1793,73707398,3.767957109023464
TE-1,168313016,5.403982565301054
TC-71,12003241,0.7010514965491693
EFM-192A,9903786,5.377742197319564
TT2609-C02,3689413,0.4383684388125656
YD-8,49766530,-2.0839194852213976
SNU-719,3689413,0.5380163789509392
BHY,637858,2.0345881350811297
RCM-1 [Human rectal adenocarcinoma],10231331,1.8254668182041616
BT-12,241158,4.014999342891219
Panc 08.13,3689413,2.756509749646428
BT 216,sirolimus-bortezomib (250-1 mol-mol),0.2946031494778452
MOLM-16,241158,1.7712175579783012
LS1034,375860,0.3009760561874473
KYO-1,9927531,4.747865514161547
SNU-1,44491742,4.0790825455255195
SNU-620,168313016,4.089156987985177
IGR-1,6852167,3.681437464404636
NCI-H1944,tanespimycin-bortezomib (250-1 mol-mol),-2.853694695712997
BT 145,sirolimus-bortezomib (250-1 mol-mol),-0.145853867426896
HCC-56,11455910,0.944400073561266
EC-GI-10,71466445,5.620190449625078
PK-59,637858,1.5777202295297317
L-540,44491742,3.302641301804856
NCI-N87,11455910,1.6652699053284308
SW620,46907787,4.128718909991831
Caov-3,135999136,5.456324561190912
HEC-151,sirolimus-bortezomib (250-1 mol-mol),0.8769904812641561
HCC1438,73707398,1.5624217708956756
NCI-H1915,135421197,1.7136891979004163
TT2609-C02,tanespimycin-bortezomib (250-1 mol-mol),-2.374986906427309
BICR 16,73707398,1.1623092103049966
BV-173,3689413,-0.0500702145216063
OCI-AML-5,135421197,2.371407792163204
Capan-1,tanespimycin-bortezomib (250-1 mol-mol),1.8501996853499856
HMC-1-8,241158,5.5321321838758335
SU-DHL-8,5460769,1.8345696055083096
EBC-1,168313016,3.7421502425797386
RERF-LC-A1,3689413,-2.1513750225162114
NCI-H2286,136227331,5.6980309243628
NCI-H810,135421197,1.5773346723196464
D283 Med,3689413,-5.066385831563446
A4/Fukuda,49766530,-0.1813275565198268
NCI-H1792,439501,0.6605330204311965
NCI-H2342,71466445,4.327526370836878
SNB-75,3689413,0.0039373561000733
A-549,107970,2.6370788506586345
CAL-27,439501,-1.3320445705497543
SYO-1,9903786,1.9235940661883033
KMS-27,11396600,3.3340163467465573
HMC-1-8,26596,-1.609914747159897
NCI-H1792,selumetinib-JQ-1 (4-1 mol-mol),1.508077627842721
697,46907787,-2.1488861965501327
KMS-21-BM,71466445,2.8050552373531694
SNU-738,107970,3.0367586938493756
EC-GI-10,11455910,2.357666913009647
DMS 273,9927531,4.953960158421894
BT 172,136227331,3.9802920608276886
RKO,637858,2.400395947377078
SF126,sirolimus-bortezomib (250-1 mol-mol),1.2366353132911738
TE 617.T,5460769,-1.488012889612994
JHH-5,73707398,1.459059572393258
DU145,136227331,5.067250261949365
NCI-H1568,9903786,2.4011050725962115
Daoy,sirolimus-bortezomib (250-1 mol-mol),0.3965851996199208
NCI-H1435,selumetinib-JQ-1 (4-1 mol-mol),2.795744930742413
WM266-4,tanespimycin-bortezomib (250-1 mol-mol),-3.087265381880702
NCI-N87,100016,7.118039999797619
TC-71,49766530,1.0136455106007916
JHUEM-1,375860,-0.7048271059992764
JIMT-1,3689413,-1.7375587293018775
CAL-51,439501,-2.444412450902406
DU145,262093,3.2967412726475187
Sq-1,100016,4.274424361552861
NCI-H1341,71466445,1.3364768956830928
HCC44,9903786,0.5279756391305372
LN-18,49766530,0.2968190625783926
SYO-1,sirolimus-bortezomib (250-1 mol-mol),0.8994859794760022
KE-39,9929138,5.605001473491643
JHH-1,49766530,-0.2614910303747365
NCI-H1563,12003241,-2.3981612742304614
LXF 289,11396600,4.152956454399736
TUHR10TKB,9903786,1.579233705567475
SW1710,11396600,4.154390829572998
HCC2935,12003241,-0.8324751754872037
HCC15,UNC0638-navitoclax (1-1 mol-mol),-0.269925552433359
G-361,168313016,4.401717934816135
NUGC-4,11455910,2.097041344071872
SR,46907787,0.4720796190205829
OV-90,135999136,4.339682590853578
CGTH-W-1,73707398,1.5502915494771807
NCI-H1975,6852167,1.190480480339929
Hs 934.T,107970,1.693270868560192
T84,637858,0.2956840752422291
CAL-85-1,tanespimycin-bortezomib (250-1 mol-mol),0.6735355915529317
SH-4,tanespimycin-bortezomib (250-1 mol-mol),0.1503763926907838
WM1799,439501,-0.7778279608408036
COLO 205,107970,2.370802122352658
A4/Fukuda,135999136,4.178898868342667
HCC1954,439501,-2.308794181663851
NCI-H526,selumetinib-JQ-1 (4-1 mol-mol),1.4934874607418576
ZR-75-30,3689413,-2.2209436804776805
NUGC-3,135999136,4.702707449703542
OAW42,375860,0.01569674815874
GOS-3,135999136,4.682109520485855
SW1783,44491742,3.6997355499837217
HCC1195,tanespimycin-bortezomib (250-1 mol-mol),0.0531375858676879
SYO-1,107970,2.1888093094332217
CML-T1,241158,2.0968023336421227
SW1783,3689413,0.540292166648154
A-549,46907787,5.023259811787708
SNU-C5,439501,-1.612847853644416
BT-12,72967,5.032821091249338
NCI-H1563,selumetinib-JQ-1 (4-1 mol-mol),4.213181825361553
SUP-T1,135421197,0.9840092633419462
OAW42,tanespimycin-bortezomib (250-1 mol-mol),2.1968698973757257
BT 139,sirolimus-bortezomib (250-1 mol-mol),1.2497154154601016
BT 271,73707398,1.1660432005744914
M-07e,11455910,0.9135610826931194
SU.86.86,9903786,4.655147385880342
KE-37,11455910,-0.4991335198758184
SNU-1079,3689413,-2.2789240635037182
IPC-298,100016,6.58023685235314
AsPC-1,262093,3.2992304028365926
SNU-869,44491742,4.0762801195520675
HeLa,3689413,0.6540693787829278
GOS-3,168313016,4.456848917287458
SF295,46907787,3.23145207595968
HOS,49766530,0.1670768985244303
Karpas-299,9929138,6.330957122742023
MOLT-16,UNC0638-navitoclax (1-1 mol-mol),-0.9307408191355994
CAL-27,6852167,2.441121376612338
HCC2218,73707398,1.2835282527544178
HCC4006,135999136,5.063143439586622
NCI-H1650,12003241,-2.181878019620055
SNU-620,73707398,1.5869525584401722
A4/Fukuda,375860,-1.1918610484687095
Kelly,168313016,4.119393264383737
SK-N-MC,444795,4.620519937789042
NCI-H1651,selumetinib-JQ-1 (4-1 mol-mol),4.513797591593027
EC-GI-10,3689413,0.4203199772849357
MKN1,46907787,2.3395662903789236
Hs 688(A).T,selumetinib-JQ-1 (4-1 mol-mol),5.275991754201655
DU145,9927531,4.922928089289864
253J,11455910,0.0349890570981946
BV-173,644241,-5.8284711205476025
Hep 3B2.1-7,262093,2.5027011818139964
SNU-C2A,9903786,2.8672741986738193
HCC366,9903786,2.568010100247165
HuH-28,selumetinib-JQ-1 (4-1 mol-mol),0.7023038761063913
NCI-H2009,73707398,1.4628489872410333
NUGC-3,3689413,0.9569280148265664
A4/Fukuda,637858,0.8198578842358093
8505C,11396600,3.6355990729160306
HEC-1-B,46907787,-1.260685398577055
SK-N-SH,73707398,0.8722989575210444
NB1,637858,1.5809621716939124
OV56,100016,6.603582199202106
HSC-3,73707398,1.0290894823159855
SNU-878,10231331,1.1758793721918113
SNU-308,9903786,2.008516122429012
COLO 829,107970,2.955971944277627
NCI-H1573,6852167,3.160970212714405
KMBC-2,sirolimus-bortezomib (250-1 mol-mol),0.4292158066242218
OC 314,73707398,0.9395818266377978
SHP-77,12003241,2.3628262056689384
BT 232,135999136,1.8601306956722656
Kasumi-1,262093,0.9096443237318556
HCT 15,107970,1.6751321182254142
PK-1,12003241,-0.8622642153841519
Caov-3,selumetinib-JQ-1 (4-1 mol-mol),1.5904337767004495
PC-14,sirolimus-bortezomib (250-1 mol-mol),1.4531465186128956
HCC1569,5460769,3.8365065781624255
5637,selumetinib-JQ-1 (4-1 mol-mol),-0.7167442987429579
Daoy,135421197,1.0307479494466607
Mono-Mac-1,26596,-2.0508737654950036
PE/CA-PJ41 (clone D2),9903786,4.971136415817363
SNU-1,5460769,1.879573497334996
NCI-H322,3689413,3.1405279208224086
SK-MES-1,6852167,2.1535089151807796
SJSA-1,107970,2.367498196024735
BT 139,3689413,1.1435542954681734
KYM-1,3689413,0.9025287359400416
MOLT-3,11455910,-0.1695088627496582
SK-MEL-28,262093,2.757579366484628
YH-13,107970,3.012104980277858
T84,46907787,1.7674761870685007
PE/CA-PJ15,241158,3.6544935074881586
Hs 578T,375860,-0.1045522991963771
OCUM-1,9927531,5.3600518663523244
PaTu 8988s,11455910,0.872430488696118
HT-144,10231331,-0.8863158661659762
NCI-H1355,644241,1.8672307897255656
Rh18,11455910,-0.2112753889424844
L-363,375860,-0.3038992932321046
NCI-H2141,3689413,-3.646913366295815
U266B1,11455910,1.3573355580969808
SNU-407,9929138,5.973449763391868
BT 216,selumetinib-JQ-1 (4-1 mol-mol),3.07268372456456
U-251MG,136227331,3.886496175618068
SNU-601,11396600,4.148994335946169
SNU-719,10231331,-1.4600362678469236
SK-MES-1,135421197,1.0053632050719472
DLD-1,107970,2.55803516550686
HT-55,262093,2.6396601461162588
BT 239,tanespimycin-bortezomib (250-1 mol-mol),-2.6769003708706594
NCI-H747,11396600,2.4515221760153603
EN,644241,6.348339111845882
NCI-H2023,637858,3.168017601469802
SK-N-FI,100016,6.445734787344034
BFTC-905,262093,2.3947823917937017
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736
GMS-10,6852167,2.636274185388478
SNU-213,637858,2.227184287849749
B-CPAP,439501,-2.790842155958922
MHH-CALL-4,9903786,1.9013313990407976
RD,sirolimus-bortezomib (250-1 mol-mol),0.3715826338530998
OCI-Ly3,9903786,0.6513092256101434
BT 172,100016,6.450201924949107
JVM-2,375860,-0.3585152251232266
U-118MG,3689413,-0.7349249104266066
TE 441.T,12003241,-1.1939319008466374
HEC-6,49766530,-2.047471555214632
BT 216,71466445,4.739477596582892
UM-UC-3,375860,0.617293660275221
EFE-184,44491742,4.212174395306579
JJN-3,168313016,4.2235817825732225
SF295,637858,2.706804834358429
A2780,5460769,-5.6757466443406575
RT-112,sirolimus-bortezomib (250-1 mol-mol),0.4814883462366654
JVM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.7253415150610979
HT-55,9903786,2.6159451586769156
HCC1195,637858,2.3009547057481137
NCI-H2009,46907787,0.5680124512944033
U-CH1,tanespimycin-bortezomib (250-1 mol-mol),-2.1423466451005524
SU-DHL-8,UNC0638-navitoclax (1-1 mol-mol),2.2079034151849246
PaTu 8988s,12003241,-0.9111494781164662
HCC1195,439501,-1.494120316453499
MHH-NB-11,44491742,4.127844347820601
F-36P,439501,-3.1981830153040223
NCI-H358,11396600,3.567926614566842
TOV-112D,136227331,4.785922428339521
SNU-407,73707398,0.6647043766298382
TOV-112D,selumetinib-JQ-1 (4-1 mol-mol),2.629482004155843
Hs 766T,11396600,4.535282068757712
RD,100016,6.5954800872388155
HuP-T3,135421197,1.625440100707307
BT 232,73707398,1.7633386245847071
TE-10,375860,-0.0930494370017834
LK-2,73707398,1.838459164463507
NCI-H2052,selumetinib-JQ-1 (4-1 mol-mol),-0.7577963848142586
ECC10,6852167,1.422945191083627
COV434,6852167,2.2026969386230397
NCI-H2122,71466445,3.71055721858648
NUGC-3,46907787,3.024654204411081
Capan-1,selumetinib-JQ-1 (4-1 mol-mol),1.4038636121829502
BT 164,73707398,0.8970000363309636
EPLC-272H,241158,3.6471551151035135
SK-MEL-5,9903786,4.335376265950657
K-562,73707398,1.1020172598138147
OCI-AML-2,439501,-2.945157705835344
Calu-3,100016,7.471917827082483
MHH-ES-1,5460769,-1.13601039501847
YH-13,135421197,2.4430977346174165
SK-MEL-1,11396600,3.732963338182352
CFPAC-1,selumetinib-JQ-1 (4-1 mol-mol),1.2285601106700188
BT 139,73707398,1.451350595417811
Mono-Mac-1,100016,3.734497226962008
MDA-MB-453,11455910,-0.0078824359576409
HEL 92.1.7,3689413,-2.453708704317935
LAMA-84,selumetinib-JQ-1 (4-1 mol-mol),-1.7222369046637322
LAMA-84,9903786,1.7036046577565669
NALM-6,262093,0.7865180544621748
A-549,9929138,6.139762216307962
Lu-65,tanespimycin-bortezomib (250-1 mol-mol),-1.7851341397947351
KMH-2,262093,2.330746095077634
G-402,10231331,3.752227949163232
NCI-H1869,439501,-1.575584272947446
Mono-Mac-6,107970,2.698784426617558
P-STS,tanespimycin-bortezomib (250-1 mol-mol),0.1209880905816519
P-STS,439501,-3.4977273473127632
HCC-56,49766530,0.5665552829970477
HCC95,9903786,2.343121552943665
HOS,637858,2.229714845567401
OCI-AML-5,46907787,-0.4591254686274671
RT-112,5460769,3.4890381868117712
Hs 936.T,73707398,1.47923152976858
JURL-MK1,439501,-2.5160318205813432
769-P,100016,6.594067506922387
OVK18,100016,6.632788488948234
HCC1438,107970,2.4795556192047874
MDA-MB-435S,3689413,-2.4980053098555404
HCC1395,49766530,0.1887726422432668
RPMI-8402,168313016,3.4100232859139465
COLO 829,sirolimus-bortezomib (250-1 mol-mol),0.4169423726863133
BT 330,49766530,-1.7517349908544686
DMS 53,9927531,3.323341915494568
PE/CA-PJ41 (clone D2),10231331,2.737757357175731
EN,107970,2.920021617709282
PE/CA-PJ34 (clone C12),sirolimus-bortezomib (250-1 mol-mol),0.9308222519351572
SF126,selumetinib-JQ-1 (4-1 mol-mol),2.532720151276387
U-BLC1,135999136,4.0618059262308615
DMS 273,6852167,2.1769146352356707
WM115,241158,3.4880777915567496
KE-39,UNC0638-navitoclax (1-1 mol-mol),0.4083822928083427
OCI-AML-2,11396600,1.0789992022533794
KMS-27,262093,2.820550232220946
AN3-CA,135999136,1.6085173592108284
8505C,135421197,0.9629586989681284
SCC-4,375860,-0.9454138707762751
NCI-H1755,sirolimus-bortezomib (250-1 mol-mol),0.7810995530072428
IGROV-1,262093,3.169376516915595
NCI-H2171,135421197,2.0026019926205185
YD-10B,135421197,0.9932980294986136
NCI-H1694,sirolimus-bortezomib (250-1 mol-mol),0.6427280207840891
P3HR-1,5460769,3.3454995233869957
PE/CA-PJ15,73707398,0.9467877501744384
TOV-112D,11455910,-0.1683002015136989
BT 248,11455910,-0.0312737668402554
Hep-G2,3689413,1.297693127771037
KYM-1,11455910,1.0218934269529627
HCC1395,107970,2.2035026306442616
HCC15,44491742,4.47716804785037
C2BBe1,6852167,2.3555235675705934
HSC-2,11396600,2.2102241778250757
PK-45H,3689413,-1.0199295796729335
RCH-ACV,49766530,-4.0327200092354305
KYSE-510,135999136,4.6232522957296736
HCC38,439501,-2.3943608626526536
RPMI-8402,3689413,0.0751031286751058
MKN74,262093,3.405035629450505
SUP-M2,11455910,-0.9872443510940216
HCC366,73707398,2.815770937960961
FTC-238,135999136,6.041478317142046
TM-31,11396600,3.128698302220667
SK-N-SH,439501,-1.8318448964157588
Ki-JK,241158,1.7863530369263578
SUP-T11,UNC0638-navitoclax (1-1 mol-mol),1.5876304129762722
A-172,46907787,3.7359554398784978
KCL-22,168313016,4.264267423573641
NCI-H1650,439501,-0.6894352308557807
2004,9903786,1.8272851025318924
JL-1,3689413,-0.3699196862305292
253J,46907787,2.2087478748262597
SKM-1,46907787,-1.5658410471483666
SF126,11455910,2.6986445536104138
SU-DHL-8,135421197,1.0706680615676138
MEC-1,73707398,0.8269388558464501
MEC-1,262093,1.0111827141937222
EJM,262093,1.353461350978494
PE/CA-PJ34 (clone C12),10231331,3.045773235767836
BT 286,637858,1.913556569209282
NCI-H522,136227331,5.948504593030567
COLO 668,5460769,2.9607897533404244
KYO-1,73707398,0.4233642273318134
22Rv1,11396600,4.6208981896393215
NCI-H838,sirolimus-bortezomib (250-1 mol-mol),0.8112840650122598
CAL-51,5460769,1.3780575552768597
MeWo,135421197,1.5459550604441452
ESS-1,241158,3.69128431914065
COLO 678,sirolimus-bortezomib (250-1 mol-mol),2.474512114208449
Pfeiffer,100016,6.236222400968574
NCI-H1092,71466445,6.1929235006275585
NCI-H1944,73707398,2.546148379079913
Mino,262093,1.013010854269816
Peer,71466445,1.396276268518125
UACC-257,9903786,4.920300978966239
SU-DHL-10,6852167,0.7392191200589763
ECC10,11455910,0.1106794798283132
SW1990,3689413,-1.271257676680656
Karpas-299,3689413,-1.6709269792656412
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482
22Rv1,sirolimus-bortezomib (250-1 mol-mol),-5.664247196474798
RVH-421,10231331,1.0693585699310195
RD,135999136,4.200113448993708
ECC12,107970,2.974178840344196
MKN74,439501,-1.7547166912858625
ZR-75-30,100016,8.126082181881081
BT 224,439501,-1.0305399865987015
NCI-H1184,375860,0.2561611360303955
NCI-H508,9903786,0.5730721211303239
Caki-1,262093,3.8219578030465033
Granta-519,11396600,3.399615682634249
Namalwa,selumetinib-JQ-1 (4-1 mol-mol),0.0869925670736783
MHH-ES-1,11455910,0.3888631975426587
U266B1,439501,-2.1640561417805686
TE-6,637858,2.4061460425592203
LoVo,11455910,2.8170443999319574
OCI-AML-5,11455910,0.2167444305252664
Rh41,44491742,3.4583513797459537
SNU-738,selumetinib-JQ-1 (4-1 mol-mol),5.597755741731593
NCI-H747,135999136,4.34177986775996
SNU-407,sirolimus-bortezomib (250-1 mol-mol),0.8562288670922468
COLO 320,46907787,2.462485637898589
COLO 320,135398744,6.463011253269961
SNU-5,9927531,5.646839183086857
SNU-1076,100016,6.986031941643801
M-07e,9903786,0.8629482504426611
CAL-51,46907787,3.297361866649883
HGC-27,73707398,0.4589955363470999
KLE,46907787,0.6768942529427939
KE-37,44491742,3.673383181125235
OV-90,12003241,-0.4315626967505086
LCLC-97TM1,3689413,0.1289764847745495
Hs 683,6852167,1.768664782954411
T98G,637858,3.480538395341526
TE-4,11455910,0.4087808216227429
MV4-11,49766530,-2.278829084327519
JeKo-1,375860,-0.4106112996091592
C2BBe1,3689413,0.1296061414739377
TUHR4TKB,135421197,2.8220761476999665
OCI-M1,637858,1.0895726887378772
BT 416,9927531,5.009885250018842
AML-193,135421197,0.7876033807150744
Peer,tanespimycin-bortezomib (250-1 mol-mol),-0.7923610578586646
SW620,11455910,-0.2228085222725968
NCI-H1581,44491742,3.702285088658523
NU-DUL-1,241158,0.4554147177079873
SU.86.86,sirolimus-bortezomib (250-1 mol-mol),0.3340737576471567
A3/Kawakami,11396600,1.9424572968751193
HGC-27,44491742,3.7914350891371114
Hs 766T,3689413,1.3725594081850794
DMS 53,9929138,3.8205898252518393
SNU-869,135421197,2.4475958723974944
NCI-H661,135421197,1.0600684669241136
BT 145,5460769,1.52442130287449
OCUM-1,375860,-0.572394584794254
HPAC,71466445,3.833476052590533
NCI-H647,9903786,3.1378024767973827
SK-LMS-1,439501,-2.6023396475730967
NCI-H441,12003241,-0.5712831750055372
SNU-466,11396600,3.3990634673304707
Mono-Mac-1,107970,1.267448776766495
JM-1,71466445,1.831003524042788
NCI-H1573,44491742,3.554417916622067
Hs 852.T,375860,0.1239369223393283
HCC4006,100016,6.421907923076987
BT 112,100016,6.504213631006025
MHH-ES-1,439501,-2.339727963154972
JeKo-1,6852167,1.633510922803868
KP-N-YN,11455910,2.456468445716411
RT-4,9929138,7.578104590024713
AN3-CA,107970,2.2532094276604115
NCI-H2029,9903786,4.7445314067007
GSS,46907787,-0.800523617648134
KCL-22,100016,3.971728515649248
ME-1 [Human leukemia],sirolimus-bortezomib (250-1 mol-mol),1.2847340597652257
BL-70,135421197,0.854508793534898
SaOS-2,439501,-2.8243657156627724
BICR 56,tanespimycin-bortezomib (250-1 mol-mol),-1.185151115756176
Hs 688(A).T,262093,2.411815084878299
Hs 936.T,71466445,3.3475399187974384
A-375,3689413,-0.7182003405560186
JIMT-1,49766530,-0.5672366381322033
SET-2,9927531,4.801393694643548
OAW42,100016,6.607597097790758
2004,262093,1.3904438006170303
BV-173,11455910,0.1396519641049683
NCI-H1581,135421197,1.183263993717128
BICR 6,6852167,3.11548661722106
DV-90,9903786,1.7610541097937376
JHUEM-2,241158,3.3547536689663904
CAL-120,46907787,4.080879277011309
OV-90,10231331,-0.2658989715006121
UM-UC-1,46907787,1.9790385116010816
NCI-H1568,26596,-1.690126811671561
LS123,46907787,4.6171834590437015
HDLM-2,sirolimus-bortezomib (250-1 mol-mol),0.137697197491076
BT 112,637858,1.3708104354326625
HCC1438,3689413,-0.4859764672187859
HEC-108,107970,2.8725679938480817
RL95-2,11396600,6.018951630956894
G-402,3689413,-2.398883611420732
KMS-20,26596,-2.568893435013116
NCI-H1651,9929138,6.746067047112118
OAW28,73707398,1.2451215877479735
Lu-99,46907787,0.2214274327488097
MOLM-6,tanespimycin-bortezomib (250-1 mol-mol),0.1329164696894222
NCI-H2085,selumetinib-JQ-1 (4-1 mol-mol),1.6728919652680674
NCI-H838,44491742,4.734730430776703
Hs 888.T,135421197,-0.1341748338568028
Rh41,3689413,-2.4330549607978984
COLO 668,100016,7.809114037996309
LoVo,5460769,-2.1468642890382412
NCI-H661,637858,2.3544841299222927
G-401,11455910,1.3171347053017213
PF-382,262093,0.5149344400111652
SNU-5,439501,-2.355283147047071
VM-CUB-1,tanespimycin-bortezomib (250-1 mol-mol),-0.9212762336148834
Hs 936.T,375860,0.6750085464565785
PK-1,sirolimus-bortezomib (250-1 mol-mol),1.545806469698299
AML-193,444795,4.361597558982522
NCI-H1395,selumetinib-JQ-1 (4-1 mol-mol),2.8235760807369177
TUHR4TKB,49766530,-1.753828688422756
SK-N-SH,3689413,0.7530548018951405
ECC12,135421197,3.3964396494270357
JJN-3,100016,3.8434142095984303
SNU-213,6852167,2.322505898014435
NCI-H446,10231331,4.291786486557435
BICR 22,UNC0638-navitoclax (1-1 mol-mol),4.356226198213725
HuT 78,44491742,3.833204810123411
HCC2108,439501,-2.3356100476768145
KMS-11,sirolimus-bortezomib (250-1 mol-mol),-4.474522876358157
GA-10,135421197,0.1177808721156358
NCI-H211,135999136,4.1735993115728505
NCI-H2110,262093,4.10340668622513
Karpas-620,107970,3.3214718336794484
HCC1419,9927531,5.21935192048334
BT 245,100016,6.42627295768896
COV434,26596,-1.4572205446145876
LAMA-84,135999136,1.3679633920686491
A4/Fukuda,3689413,-1.7998697854540155
EB1,71466445,3.091644056319097
T3M-10,637858,3.395991608767305
BT 330,262093,1.7469148441543585
Kasumi-2,107970,1.3663131605888186
KE-39,135421197,0.9510973278490732
SUP-T11,tanespimycin-bortezomib (250-1 mol-mol),1.9096696973942504
LOX-IMVI,9903786,2.476339692878584
Karpas-422,6852167,0.067435343224215
Lu-65,262093,3.3965218788249407
JHOS-2,100016,8.119351788295337
NCI-H1650,49766530,-2.350106011815308
GI-1,tanespimycin-bortezomib (250-1 mol-mol),0.3009698031973534
LUDLU-1,135421197,2.9427726224498274
TCCSUP,sirolimus-bortezomib (250-1 mol-mol),0.3356822516851041
PL-21,73707398,0.3528693898804576
SNU-423,49766530,-2.309056121887604
ESS-1,135421197,2.603718676668537
MOLM-13,135421197,0.945680487717708
SUP-T1,11396600,2.9540043474610287
SNU-478,375860,-0.8852245456595869
KYM-1,12003241,1.54362271248318
786-O,selumetinib-JQ-1 (4-1 mol-mol),3.8790698958118006
UM-UC-1,11396600,1.80390855748595
Yamato-SS,241158,3.6414110842673386
NCI-H2009,439501,-2.087429471182781
DMS 273,9903786,1.811418424711566
Hep-G2,135421197,1.3335693407455125
SNU-620,12003241,1.204190065135074
COLO 320,135999136,4.1679659514892435
KP-4,644241,3.5135167482418703
SU-DHL-1,107970,1.234326472603969
Karpas-620,637858,2.7118075848946583
T3M-10,241158,4.470503510456402
U-118MG,9927531,5.792159501722103
CAL-51,375860,-0.3577134594482877
REC-1,12003241,3.6312404592907614
KMS-20,100016,6.235059528000449
KE-37,46907787,-1.1788296839402306
NCI-H2444,9903786,4.235157669098579
NU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.2455773179911887
UM-UC-1,selumetinib-JQ-1 (4-1 mol-mol),0.4959207195366699
Hs 888.Lu,241158,5.055408917933412
NCI-H2029,6852167,3.404847034659949
HCC38,26596,-1.4255018531390269
MFE-319,54596490,4.465210230923051
WSU-DLCL2,12003241,-3.4791532779073373
NCI-H1869,46907787,2.861559973778754
TOV-112D,375860,-0.3825926571920917
OCI-AML-3,375860,-0.5721607544660736
MKN74,168313016,4.440025368788847
SK-N-FI,262093,0.9859061166754924
BL-70,375860,-0.623761093700038
LAMA-84,9929138,5.193234250593021
HCC1954,sirolimus-bortezomib (250-1 mol-mol),-8.401031472525755
NCI-H2110,637858,3.1754566169961005
RCC10RGB,9903786,5.708919982977709
Hep 3B2.1-7,tanespimycin-bortezomib (250-1 mol-mol),-0.3332537957884871
8505C,644241,2.1327575450913727
KMS-27,439501,-2.6111087383065597
JIMT-1,375860,-0.7058390896374014
HCT 15,71466445,5.362396254264255
UM-UC-1,637858,2.9353042937749745
PE/CA-PJ41 (clone D2),9927531,5.176178802230399
Hs 578T,168313016,4.885965287193478
HT-1080,168313016,5.65627248206995
NCI-H1869,73707398,1.8797199164844864
NCI-H661,46907787,3.1119891404607083
SNU-840,9903786,4.945950711370254
BT 330,6852167,3.461733809833727
SUP-M2,49766530,-5.163044789903349
SNU-16,644241,1.522235534594242
GSS,tanespimycin-bortezomib (250-1 mol-mol),-1.8015851395784044
HeLa,26596,-2.0330393314508868
KMRC-2,11396600,3.609897485717139
SNU-61,73707398,0.7144154314829279
HT115,71466445,3.3438481038223133
MHH-CALL-4,selumetinib-JQ-1 (4-1 mol-mol),-0.4835284848569625
DEL,11396600,2.9496069557825155
SNU-16,637858,0.5041964685707029
BC-3C,9927531,5.131139518306293
HuP-T4,100016,6.7159168289197915
RCM-1 [Human rectal adenocarcinoma],11396600,4.9998303274937115
KCL-22,135999136,1.6425661350334857
HDLM-2,168313016,4.65822549892325
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476
NCI-H1581,12003241,-3.141909657100737
JHUEM-1,5460769,1.70749298340363
BT 328,100016,6.778172011931934
JHUEM-2,71466445,5.178747074886277
SNU-1272,107970,2.7088030141342383
MOTN-1,135999136,4.458023817111403
MPP 89,241158,4.038106348888228
NCI-H358,44491742,4.317463726649291
HCC38,selumetinib-JQ-1 (4-1 mol-mol),2.765272906318856
TALL-1 [Human adult T-ALL],12003241,-0.6623785293924347
SNU-216,9927531,4.928854217015946
MOLT-16,73707398,0.2866580301768925
MOLM-13,73707398,-1.293008226929777
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798
NCI-H2228,44491742,4.2440053782675555
BT 422,107970,1.7481064478345374
Calu-6,11455910,2.638834676965617
NCI-H2030,12003241,-1.1383124397984303
SUP-B15,54596490,4.39372018561384
CL-11,439501,-1.1528361936308975
OCI-Ly19,439501,-4.390923092151438
T24,49766530,-0.3473877754234792
TC-71,375860,-0.373501612035207
ZR-75-30,6852167,2.8121433098983037
OVTOKO,439501,-1.8305159910800708
HCC1419,241158,4.325671093419114
HCC827,107970,2.348665730800901
KMRC-3,12003241,-2.293511180564156
KMS-12-BM,375860,-0.7808796284755947
NB4,107970,2.06414667273963
HPAC,439501,-1.2049246371580666
KYM-1,44491742,4.6632878215143405
Hs 729.T,136227331,4.519931514074803
LOX-IMVI,12003241,-2.813518393614124
ACC-MESO-1,637858,3.0332515622117016
HT-55,12003241,-0.758438477023311
CAL-27,135421197,2.124038194027939
A-172,135421197,2.0454281917849357
HSC-4,6852167,2.6632521076475446
BHT-101,73707398,1.5852766214934897
COLO 205,44491742,4.914749097396915
SNU-46,107970,2.926961098317302
647V,UNC0638-navitoclax (1-1 mol-mol),4.619302704924987
LNCaP clone FGC,tanespimycin-bortezomib (250-1 mol-mol),-2.6061183463030138
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992
HSC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.9764630835173828
NCI-H2444,262093,2.966539403917491
RCH-ACV,135999136,3.734219341327072
Hs 822.T,107970,2.3652889622874405
WM115,selumetinib-JQ-1 (4-1 mol-mol),-1.8046253833707984
MDA-MB-435S,12003241,-1.2560113103811834
Kasumi-1,11396600,3.073022183075244
TE-11,5460769,-1.6571855134906777
G-292 clone A141B1,439501,-3.0998279845902723
BT 139,637858,2.313744051526735
SK-N-BE(2),9903786,2.0499315562907627
JHOS-2,6852167,3.022922211254124
HCC78,5460769,-0.5347925527973022
Yamato-SS,tanespimycin-bortezomib (250-1 mol-mol),-1.0267358122656502
BT 159,3689413,0.7549791540054046
FTC-238,444795,4.083922601699021
CCK-81,sirolimus-bortezomib (250-1 mol-mol),0.9757763076184672
TUHR4TKB,637858,2.0327500822977154
WM266-4,135421197,2.204314792506349
NCI-H520,168313016,4.384348437846953
HCC1954,26596,-1.6295363665710343
NCI-H1092,44491742,3.604656167614849
SNU-61,637858,1.6436621136217924
Panc 08.13,selumetinib-JQ-1 (4-1 mol-mol),-0.0835546726356045
COLO 668,46907787,2.3006610001201584
NCI-H2052,100016,6.8923960055757805
DoHH2,439501,-2.792554896141067
JHOC-5,12003241,-1.1087899100302334
KMS-21-BM,135999136,1.2444015260094663
WM266-4,135999136,1.7774722318734697
FU-OV-1,49766530,-1.0180111021842635
A-549,107970,2.6370788506586345
KMBC-2,439501,-3.686477603107828
Pfeiffer,9927531,3.43317918273791
OV-90,100016,6.511633470460193
TE-14,sirolimus-bortezomib (250-1 mol-mol),0.5600865408130824
NCI-H1573,9903786,2.787588976876453
COR-L51,46907787,1.7446417299481616
COLO 201,637858,2.4512804408988393
OV56,sirolimus-bortezomib (250-1 mol-mol),0.4454120384496641
BV-173,375860,-0.7007170100715804
MDA-MB-435S,73707398,0.6150300416812977
KNS-81,439501,-1.422452321432204
CCK-81,135421197,1.1239650919721589
SW1088,136227331,5.532811982625497
NCI-H1944,9927531,4.180597511578871
SNU-738,9927531,4.827507825762818
RCH-ACV,444795,3.203280801108019
SCC-25,71466445,2.1328221809706336
MOLM-6,375860,-0.9334754341312836
Kasumi-2,3689413,-2.6905586087263043
NCI-H1666,135421197,0.9962315776177934
SNU-119,644241,2.7771526168962084
HT-1197,11396600,2.8973650572318213
NCI-H929,49766530,-2.4737600180853385
KYSE-150,262093,2.5847717064108657
SNU-1077,11396600,4.998092576249027
KYSE-450,135999136,4.777760732357945
KYSE-450,100016,6.589468110151047
JHUEM-1,136227331,3.9088223702445526
JK-1,241158,1.4435433616658495
UO-31,selumetinib-JQ-1 (4-1 mol-mol),1.0804888438509763
BT 498,selumetinib-JQ-1 (4-1 mol-mol),4.316550369510256
U-937,73707398,0.2560795072809404
42-MG-BA,262093,4.0294491331177715
LN-229,9929138,5.025043627599637
KYO-1,10231331,0.1625334489701108
OCI-Ly3,11455910,-0.0789783968306418
SNU-1,11455910,-0.8370004146214793
SNU-423,439501,-3.458666497477645
NCI-H1581,sirolimus-bortezomib (250-1 mol-mol),0.461020209130116
EJM,tanespimycin-bortezomib (250-1 mol-mol),-0.1920922307802734
G-292 clone A141B1,tanespimycin-bortezomib (250-1 mol-mol),-0.2188717779378038
BT 147,UNC0638-navitoclax (1-1 mol-mol),1.916043415549889
NCI-H2029,107970,1.7716424657793448
Rh18,135421197,3.2073141034499577
253J-BV,12003241,-1.283652626050959
KMS-34,10231331,3.91366971805432
SCaBER,135999136,5.810928777589949
SIG-M5,11396600,3.2448183238044255
NCI-H2126,12003241,2.692479485403981
CAL-78,UNC0638-navitoclax (1-1 mol-mol),-0.0060343846048504
BT 286,9927531,5.383522650777723
HOS,11455910,0.0895853773471224
PL-21,6852167,0.788666382413097
TE-8,9927531,4.6696791278322625
BV-173,100016,4.070459829867503
NCI-H1299,73707398,1.237381568912588
SNU-410,selumetinib-JQ-1 (4-1 mol-mol),4.312736206352891
K-562,9927531,3.3022164605184763
Mel Ho,241158,4.052373465177995
BT-20,100016,6.680150665921765
786-O,44491742,5.035169002663678
HCC1806,tanespimycin-bortezomib (250-1 mol-mol),-1.018724698872974
MDA-MB-361,12003241,-1.091645986643679
YD-10B,tanespimycin-bortezomib (250-1 mol-mol),-2.1326183945103807
SNU-478,71466445,3.1088351292941776
KMS-27,168313016,5.514189836939729
SNU-423,26596,-1.230407332735001
CW-2,9903786,2.9588284510461733
RCH-ACV,46907787,-0.324822109365263
Hs 888.Lu,6852167,2.0167944321765914
HT-29,73707398,3.199725729582929
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
VCaP,73707398,0.7017253624246395
SUP-B15,3689413,-0.2664359486303652
BL-41,135421197,4.0056146501146195
Hs 746.T,12003241,0.0057336203254279
TE-14,3689413,2.902593123647125
SCC-9,9903786,2.6448761987997917
SNU-449,439501,-4.772752939359215
YD-10B,100016,5.941622042216757
Lu-99,241158,3.0745673307990375
Mono-Mac-6,135421197,1.2337860408769474
KYSE-70,439501,-1.7979650249976522
Namalwa,439501,-2.8468436546580524
A-375,262093,2.9970202931790046
SNU-1214,46907787,-0.1476900319760525
NCI-H1339,46907787,4.303951587914797
JVM-3,71466445,1.609611139863367
TUHR4TKB,tanespimycin-bortezomib (250-1 mol-mol),0.8308277028090468
JHUEM-3,135421197,1.4304571308518408
RPMI-7951,44491742,3.876790810560562
COLO 741,sirolimus-bortezomib (250-1 mol-mol),1.7364314358901989
MOLM-13,49766530,-2.4914272268054107
COR-L95,12003241,2.921570030601445
KNS-81,9927531,4.88247851361275
786-O,375860,-0.1367440745191159
CHP-126,71466445,1.938697583088702
LS1034,11455910,0.6573376137938117
SEM,71466445,-0.7002004774951326
MKN45,selumetinib-JQ-1 (4-1 mol-mol),3.727544641794376
SET-2,26596,-1.642607786787168
BT 504,11455910,0.316004589079872
NH-6,5460769,1.427769870137193
NCI-H1184,135421197,-1.5924558307630432
SK-UT-1,11455910,0.1513173468225572
RPMI-8402,71466445,1.5277227120720451
HT-1080,12003241,-0.8718791582683669
JIMT-1,135999136,4.503963053903458
Hs 888.Lu,44491742,4.101401149351862
CW-2,46907787,1.2539554927641257
SW1573,49766530,-2.79322841384178
NCI-H1395,9903786,3.8864807174358984
MFE-296,44491742,4.423113386396404
SNU-182,444795,4.399798471090252
Lu-65,10231331,-0.1827270457349836
HEC-151,44491742,3.809390131450424
SNU-478,12003241,-2.4220393479516025
BT 440,100016,6.480442369798277
OVCAR-8,100016,5.760214455598188
OAW28,107970,2.4537130721494105
SNU-1105,9903786,3.6171667561714056
253J,241158,3.97219194312285
HEC-6,439501,-1.45021451422316
LMSU,sirolimus-bortezomib (250-1 mol-mol),0.3355197835459403
KYSE-140,6852167,2.934032084850076
BT-474,UNC0638-navitoclax (1-1 mol-mol),3.2058314272138477
HEC-1-A,sirolimus-bortezomib (250-1 mol-mol),1.0212510715684435
HuNS1,6852167,0.9722710028853416
NCI-H1693,selumetinib-JQ-1 (4-1 mol-mol),1.8964870202087152
WM266-4,637858,1.0594560796680337
H-STS,3689413,-4.4758570940331515
MDA-MB-361,tanespimycin-bortezomib (250-1 mol-mol),-3.253650081939563
Hs 839.T,262093,3.079390898816523
SNU-398,sirolimus-bortezomib (250-1 mol-mol),0.7620432052454496
KMS-18,26596,-1.560934239345236
JMSU-1,selumetinib-JQ-1 (4-1 mol-mol),2.396136909676299
KYSE-30,sirolimus-bortezomib (250-1 mol-mol),0.2847397172348017
HEC-151,644241,2.1605297615214716
SF268,UNC0638-navitoclax (1-1 mol-mol),2.2886187579463426
SK-ES-1,375860,-0.8114646343622277
SK-CO-1,46907787,4.316773762169295
PSN1,439501,-2.156746892791343
NCI-H1793,107970,2.8613850617942114
HCT 15,46907787,0.7050921153051607
HDQ-P1,UNC0638-navitoclax (1-1 mol-mol),2.4376644367097917
BT 179,439501,-2.97680380093877
IPC-298,6852167,2.465275757698449
SKM-1,26596,-4.237929506963809
NCI-H1581,644241,2.2407150929255453
COR-L88,3689413,0.2810588861379679
DMS 53,49766530,-0.8601617685974926
42-MG-BA,46907787,2.9371087072278983
ONCO-DG-1,6852167,2.562401229910015
SNU-620,6852167,2.296006256931868
SNU-16,135421197,0.9463670972041712
NCI-H1385,439501,-0.294435314613152
NCI-H226,262093,3.882477305073409
TALL-1 [Human adult T-ALL],11396600,2.6371175707819887
NCC-StC-K140,444795,2.80174580023504
NCI-H1734,375860,-1.150619884530698
RT-4,71466445,5.089577793908251
ChaGo-K-1,136227331,4.028131370047934
COR-L105,241158,4.618729119434587
AGS,sirolimus-bortezomib (250-1 mol-mol),0.9913550717108452
ONS-76,241158,4.846225597872182
H-STS,9927531,5.457961831541725
NCI-H2228,135999136,4.356643456755604
T-47D,3689413,-1.6434373642176223
MDA-MB-453,135421197,0.8806711164351635
HEC-108,selumetinib-JQ-1 (4-1 mol-mol),4.622936143310662
SNU-1077,sirolimus-bortezomib (250-1 mol-mol),1.9799689406124936
NCI-H2009,6852167,1.9075911063810396
Ci-1,3689413,-2.5186366363641293
L-1236,3689413,-0.1223462388223707
BT 172,sirolimus-bortezomib (250-1 mol-mol),0.9880201722030184
NCI-H2170,3689413,3.058757672919766
A-673,6852167,1.8255345198368305
MOLM-13,12003241,-3.578107028375036
RPMI-8402,375860,-0.8555405736756128
NCI-H2087,46907787,0.6289755590874684
HCC1500,54596490,4.413271545106012
CAL-78,439501,-1.7848444921283717
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555
Becker,241158,3.23499622526182
Mono-Mac-6,tanespimycin-bortezomib (250-1 mol-mol),4.2631567174447556
5637,6852167,1.734170154500971
SCC-25,44491742,4.077227537084196
HMC-1-8,6852167,2.3465845176332953
CAS-1,6852167,2.849454489855759
HEL,637858,1.821308587756956
EHEB,135999136,1.8833962574329148
A4/Fukuda,135421197,1.440002399326734
CAL-51,73707398,0.7053044464230985
DMS 454,135421197,0.7906856651766786
NCI-H69,3689413,-1.5363030352959728
PE/CA-PJ41 (clone D2),262093,3.3360750662244443
CAL-12T,637858,2.037009471526232
DV-90,44491742,3.389036842154366
SU-DHL-4,26596,-1.8970615023372663
OCI-Ly3,439501,-3.305238194936377
BT 416,UNC0638-navitoclax (1-1 mol-mol),-0.0804251161714488
Mel Ho,168313016,6.032250687681012
NCI-H1838,262093,3.1825262883222836
BT 145,100016,5.857999875396141
MHH-CALL-4,3689413,-0.1881082259185382
BICR 6,135421197,2.188693589086808
H-STS,11455910,0.6438795438543947
Panc 04.03,selumetinib-JQ-1 (4-1 mol-mol),2.1482953038113286
Hs 888.T,9903786,1.8376079408341344
HEY A8,3689413,-2.2125181580464592
BT 179,sirolimus-bortezomib (250-1 mol-mol),0.6409612230554944
BT 159,12003241,-1.7931625060077818
FTC-238,241158,3.997303742735551
MFE-296,tanespimycin-bortezomib (250-1 mol-mol),-0.069191081241384
HCC15,168313016,4.627209757330862
SW948,44491742,3.910317363967626
SUP-T11,26596,-3.766256771827544
NCI-H211,9903786,1.4038112191361545
U-BLC1,10231331,-1.9285312072374636
NCI-H650,49766530,-1.7972837938587842
OVCAR-5,tanespimycin-bortezomib (250-1 mol-mol),0.8786451228856517
LS180,44491742,4.531352051294965
QGP-1,241158,4.306884420889986
CAL-78,11396600,3.713466274420595
DEL,71466445,3.114463975482827
SNU-601,100016,6.491707225104745
MEC-1,107970,1.5620945400659931
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512
Hs 578Bst,49766530,-2.7319147514875124
T84,9903786,2.2055003104833553
NCI-H2170,tanespimycin-bortezomib (250-1 mol-mol),-1.8178915881298592
NCI-H661,UNC0638-navitoclax (1-1 mol-mol),4.1455150469586535
COLO 741,107970,2.647977331260038
BHY,tanespimycin-bortezomib (250-1 mol-mol),-0.455078005089977
Caov-3,100016,5.7781449283056645
KMH-2,5460769,1.5529919827376786
YAPC,107970,2.510985201601563
Pfeiffer,107970,1.4317635231254673
BT 164,135999136,1.3864420097377277
D283 Med,135999136,3.641764348590375
KE-37,9903786,1.3543500174719385
IGR-1,71466445,1.9675328649104085
SNU-626,46907787,1.3860019611329613
SW1573,12003241,-0.6702221198842615
SNU-C2A,10231331,2.052823285789936
SNU-1196,107970,2.4988255258778764
CJM [Human melanoma],135421197,2.95523092671823
Rh30,sirolimus-bortezomib (250-1 mol-mol),1.125854390557578
SNU-398,73707398,0.6638278244633883
SNU-81,439501,-1.707157001292212
Daudi,11396600,1.6595042173405945
CGTH-W-1,71466445,5.8893630337243446
TCC-Pan2,73707398,1.5554372616502647
BT-20,73707398,2.7146143235712747
HuCC-T1,44491742,4.260801380076742
A2780,9929138,3.988043631552867
COLO 205,3689413,0.2425510566398385
NCI-H929,10231331,2.673485705852421
Panc 03.27,637858,2.5511694826514204
SK-MEL-30,10231331,-2.3294138551278643
SUP-HD1,5460769,1.3370486215581097
RERF-LC-Ad2,11396600,4.594180065221676
LS1034,439501,-2.506043270280418
U-118MG,46907787,5.471659204774231
OCI-Ly10,46907787,0.036156791402413
MPP 89,9903786,4.435706117930943
Hs 294T,100016,6.337209257885702
TT2609-C02,135999136,6.167464859374325
EFO-21,9927531,5.470218663007946
OV-90,73707398,1.9025325058972111
42-MG-BA,107970,2.2671831149956807
BV-173,135398744,4.1083578998819945
KMS-21-BM,9929138,2.832243377547389
SJSA-1,3689413,0.2987109884776379
HCC1806,439501,-1.846359042641554
NCI-H929,44491742,4.424394304638718
GCT,241158,3.529930254107966
L-428,135421197,0.7073965487557408
L3.3,12003241,-0.3315333583144895
U-118MG,44491742,3.985342348777434
Kasumi-1,12003241,-2.8903721425855284
NCI-H1734,10231331,0.3591189863863598
Capan-1,135421197,1.617926303344926
KMRC-20,241158,6.296391412542069
OCI-Ly3,tanespimycin-bortezomib (250-1 mol-mol),-0.0739277067008881
THP-1,46907787,-2.1979745776426385
Calu-6,26596,-4.0671398242119965
DV-90,11455910,-0.2128562796551693
Capan-2,sirolimus-bortezomib (250-1 mol-mol),0.8521756904723038
LS1034,sirolimus-bortezomib (250-1 mol-mol),1.3157999694585985
MHH-CALL-4,262093,0.5666969129517823
DV-90,107970,1.4314124171332838
NCI-H1792,135999136,5.2433356507887785
SK-HEP-1,439501,-2.4482777943885856
Hs 578T,5460769,5.961368196562113
A-253,439501,-2.336084390723404
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054
NCI-H2106,71466445,4.59533809692137
HCC44,375860,-0.7535444730887934
PC-14,11455910,0.0459407670906722
DMS 79,135421197,1.224509473614064
JIMT-1,46907787,4.113382124971396
SNU-81,UNC0638-navitoclax (1-1 mol-mol),0.5211429629753735
HSC-4,9903786,4.262681016067309
MES-SA,73707398,1.87604618350638
HCT 8,3689413,3.2270836788045054
NCI-H1184,26596,-3.790175824084468
SNU-886,49766530,-1.8017914460493445
Kelly,3689413,-0.2906048821836837
L-540,selumetinib-JQ-1 (4-1 mol-mol),1.2043338237829615
BICR 18,375860,-0.1292020331481549
KMS-20,9903786,1.7377090782754483
BT 172,107970,1.9169413056630975
HT115,107970,2.245334342149862
DLD-1,637858,1.8547650248451624
NCI-H841,107970,1.8401087857571516
A-549,49766530,0.1688758689952186
OPM-2,439501,-4.648238189793765
U-251MG,UNC0638-navitoclax (1-1 mol-mol),2.869129939531875
Pfeiffer,12003241,-4.957665380544675
NCI-H2029,44491742,3.631304430303769
HuT 78,49766530,-1.6423396691241603
SK-BR-3,375860,-0.5619604471367267
RERF-LC-Ad2,sirolimus-bortezomib (250-1 mol-mol),2.075251911083675
SW1088,11396600,6.290027933724405
NALM-6,168313016,4.005992246679482
Mono-Mac-6,73707398,-1.419752522473527
JHH-5,375860,-0.2056318076209378
OCI-Ly19,135999136,4.140438011573843
Detroit 562,71466445,4.974965129813821
NCI-H2126,sirolimus-bortezomib (250-1 mol-mol),2.4996087284391493
TE 617.T,12003241,-2.151805000440827
YD-10B,6852167,1.0320503365922948
SK-UT-1,26596,0.4182972999713699
NCI-H2110,tanespimycin-bortezomib (250-1 mol-mol),-2.8330652513678274
OCI-Ly3,262093,0.61539030331268
KATO III,46907787,3.3838937790978165
BT 228,tanespimycin-bortezomib (250-1 mol-mol),0.2023623064786018
Becker,11396600,4.49881996506653
ECC10,9903786,0.6869958735378703
SH-4,selumetinib-JQ-1 (4-1 mol-mol),-0.5199709312425982
PC-3,135398744,6.536880900821883
NCI-H747,5460769,2.4677950435240814
Hep-G2,71466445,2.837099504530813
RKO,107970,2.3673735748138265
T84,241158,3.6074169392609665
KM12,135421197,2.2620714252127336
HCC-56,107970,2.461083510474252
KNS-60,637858,1.3304723346285807
SYO-1,637858,1.9757755479199952
SUP-B15,241158,3.019550409629665
Rh30,selumetinib-JQ-1 (4-1 mol-mol),0.2603507581444004
KE-39,9927531,6.019185228760376
RERF-LC-A1,26596,-2.038549310603685
NCI-H526,9929138,5.368953521226413
U266B1,3689413,0.1413723785410366
JHUEM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.535997961075801
SNG-M,6852167,3.692235384021515
KE-37,6852167,0.1803339767594556
RT-112,637858,2.10625188542633
BICR 6,262093,3.032842470666603
NCI-H146,375860,0.4213004900992469
Mino,12003241,-3.278689335869641
Mel JuSo,9929138,7.586814417068839
MES-SA,selumetinib-JQ-1 (4-1 mol-mol),3.9352065939881538
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179
BxPC-3,6852167,2.5268139587107754
BT 504,73707398,1.4743566299164823
HOP-62,107970,2.340316246371355
MOLP-8,UNC0638-navitoclax (1-1 mol-mol),1.623066033495539
TOV-21G,11455910,0.2385703250097463
Panc 04.03,UNC0638-navitoclax (1-1 mol-mol),4.190054196085194
SUP-HD1,135421197,1.0608859931865553
HGC-27,12003241,-2.439316929165163
SNU-878,tanespimycin-bortezomib (250-1 mol-mol),-0.1499782135858746
MOLP-8,135421197,1.7506124789909805
PE/CA-PJ49,sirolimus-bortezomib (250-1 mol-mol),0.2701469855669
BT-12,73707398,0.9835944574465368
LN-229,262093,3.033286890634207
NCI-H1355,12003241,-2.4294292569102436
SNU-1076,tanespimycin-bortezomib (250-1 mol-mol),1.399348377657982
IGROV-1,637858,1.814476597989254
NCI-H358,3689413,0.3269344418253172
COLO 320,11396600,2.8347180367361235
TE-15,168313016,4.315144290531877
HDLM-2,439501,-2.3355243460723747
U-251MG,sirolimus-bortezomib (250-1 mol-mol),1.1740336487454477
JK-1,375860,-0.5573981919442687
OE19,135999136,4.619564705221119
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
OCI-AML-2,9929138,5.333806393496855
MCAS,241158,4.420825214389376
Kasumi-1,49766530,0.877947367225252
BICR 56,9903786,4.170821075739504
TE-10,12003241,-0.2960597839275556
FaDu,11455910,0.0548486967941132
HuG1-N,12003241,-0.7398422629882291
HEC-59,439501,-0.4694388725326887
LP-1,375860,-0.2769324190070452
YD-8,9927531,5.007831795650313
GB-1,241158,3.739869791827646
BT 131,5460769,2.20262518629684
SNU-61,44491742,3.859456688826312
BICR 22,439501,-2.4052901035443
SNU-182,9903786,3.6716358007160546
CJM [Human melanoma],6852167,2.90088058805864
HuG1-N,selumetinib-JQ-1 (4-1 mol-mol),2.3210955713963672
BT 245,73707398,1.0043109985849346
KYM-1,11396600,3.5240556474022737
SNU-620,9929138,5.350432849489577
786-O,135421197,1.9891121265690648
Calu-3,46907787,0.7618212572232562
SNU-1,3689413,0.5302948396087109
SNU-C2A,262093,2.4515351463373807
NCI-H28,49766530,-2.0478449077556826
Li-7,9903786,1.4917500852360135
MOLM-13,6852167,0.0474303723036755
OVCAR-8,73707398,1.0104900888646875
TE-4,375860,-0.3741121439305557
UM-UC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0032411460887714
A-253,selumetinib-JQ-1 (4-1 mol-mol),3.3006041735860476
ONCO-DG-1,26596,-2.0057166886721625
FTC-133,107970,3.2744864550719126
COR-L105,71466445,5.452991683251573
GDM-1,10231331,4.684523654952728
Rh30,5460769,3.928559830912204
A-204,26596,-0.948226132815995
MDA-MB-468,selumetinib-JQ-1 (4-1 mol-mol),2.286033970917834
OCI-AML-3,46907787,-4.468250501398446
MIA PaCa-2,644241,2.2485281362376677
KE-39,637858,2.1285067674718374
PSN1,73707398,1.4306111569949278
KMRC-2,46907787,4.616997253710001
KMBC-2,135421197,1.90199423292403
GA-10,46907787,-1.6483994380715643
PK-59,9903786,2.9850600541065764
JHUEM-7,100016,7.782886537779513
BT 422,3689413,0.8456322118691856
SNU-886,6852167,1.7356740395835049
EFO-27,9927531,5.387402639259967
L-540,11455910,-0.1938391362250027
SNU-407,6852167,2.953427937237118
RCM-1 [Human rectal adenocarcinoma],49766530,0.9963320873999868
OE33,439501,-1.244619642300935
KP-2,sirolimus-bortezomib (250-1 mol-mol),1.2004115712626864
SaOS-2,54596490,5.687426160237218
SNU-182,241158,3.9105215752620457
NU-DUL-1,sirolimus-bortezomib (250-1 mol-mol),-5.630775475246084
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251
RPMI-8402,73707398,0.6686223698322713
Calu-6,439501,-0.8430638577007564
BT 320,6852167,5.054396580410171
Capan-2,9927531,4.988385726182681
ME-1 [Human leukemia],UNC0638-navitoclax (1-1 mol-mol),-2.6124434437691892
MHH-CALL-4,135421197,1.0493029833886585
SNU-C5,375860,0.3015760011094635
SNU-478,10231331,-0.4380556767393462
WM115,136227331,3.7917327546536983
Hs 611.T,241158,2.625430045012582
JK-1,12003241,-7.790720782549377
NCI-H196,107970,2.3706951810586068
CAL-12T,6852167,2.1618229054744997
23132/87,26596,-1.073494997011525
SNU-182,73707398,0.3756320577757861
U266B1,11396600,3.5687128062577447
TOV-112D,44491742,4.330645914345901
HCC15,73707398,1.6988346513711203
JJN-3,241158,1.8370439799329683
OCI-AML-5,375860,-0.4377067020305437
NCI-H1339,11455910,0.5713481488212533
U-251MG,107970,2.2965569009527536
NCI-H1869,168313016,4.348765145343562
KYM-1,168313016,6.440512642028005
2004,6852167,1.0282813099290709
UACC-257,73707398,1.7013992717994288
TM-31,6852167,4.4813408273382
LC-1F,selumetinib-JQ-1 (4-1 mol-mol),2.237558763845896
TE-6,tanespimycin-bortezomib (250-1 mol-mol),-0.454134198851735
HCC15,46907787,1.7788170946404287
GCT,73707398,0.6993687906747118
C2BBe1,444795,6.194271713784543
LOU-NH91,46907787,1.567116016960845
2004,241158,4.247713330929997
HPAC,73707398,1.2360196797474063
RD-ES,439501,-2.2858768035402623
BT 248,241158,3.909930885156875
PE/CA-PJ49,10231331,4.972087269175424
BL-70,107970,1.6369787903687438
ESS-1,439501,-2.0978778954241215
JK-1,9929138,4.47533502757398
CMK,168313016,3.8240747199409975
NCI-H23,6852167,1.7818977710975086
TE-5,644241,2.2121287177414444
HEC-151,26596,-1.920762353069635
TT,46907787,1.4494674694967729
SK-N-DZ,sirolimus-bortezomib (250-1 mol-mol),0.4176185816300255
Hep-G2,262093,4.425755335049499
NCI-H1734,637858,1.7593522393628591
NCI-H1341,46907787,0.7086470221827516
NCI-H716,46907787,-0.166954561973427
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055
M-07e,6852167,2.1940541155208098
OAW28,168313016,5.164256635335989
RCC10RGB,3689413,-2.0864832427963336
TCCSUP,100016,6.5110410318476575
NCI-H358,375860,-0.8161593688614527
Li-7,49766530,4.425008044849751
HuG1-N,168313016,4.445071492240178
Kelly,49766530,-2.0439406855810356
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
G-401,3689413,-2.428789331956376
OCUM-1,6852167,3.0808075947415237
DV-90,241158,4.253592582656695
HCT 8,107970,2.7615178304694386
BT-12,11396600,3.9879207117312943
Peer,135421197,0.5765613346520675
RCH-ACV,241158,1.6371386561823098
MM1.S,46907787,-0.8682718758201811
NCI-H661,135999136,1.375733620998009
SNU-1214,135999136,5.40108770784267
TT2609-C02,selumetinib-JQ-1 (4-1 mol-mol),-0.0768064994283236
U2OS,49766530,3.607044221214865
DEL,sirolimus-bortezomib (250-1 mol-mol),-0.5963284229759003
Ri-1,439501,-2.801888786170529
NCI-H358,26596,-1.6094838950604715
HSC-2,49766530,-2.22152995059399
COLO 792,tanespimycin-bortezomib (250-1 mol-mol),-2.234001402971202
TE-6,11396600,3.777010025535689
VCaP,49766530,-0.3741263874855742
LS180,6852167,2.255231171645259
HCC827,6852167,2.3379035713359904
BT 245,10231331,3.905394007999992
TE 617.T,tanespimycin-bortezomib (250-1 mol-mol),-1.7403863885968738
SNU-407,tanespimycin-bortezomib (250-1 mol-mol),0.2441686883353643
JHH-2,11396600,2.878978251675123
CAL-148,444795,5.084246191247904
TE-8,168313016,5.127856732185798
HCC366,3689413,-0.7247636162337553
NCI-H522,107970,1.611650854248594
Becker,135999136,4.331325475055123
IST-Mes1,9903786,2.7623614356082458
HDLM-2,241158,2.746701613084659
TUHR4TKB,73707398,1.120933989488566
SNU-1272,49766530,0.1675221070029884
639V,637858,2.8155963626279767
JHUEM-1,9929138,5.0527545997933085
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164
HDLM-2,26596,-1.5696156753174118
AMO1,46907787,-0.6708551712557594
SNU-1,49766530,2.1666853303349245
NCI-H810,44491742,3.3983932232685756
AML-193,12003241,-1.5379973109398848
BICR 56,107970,3.0717922125106405
BT 482,sirolimus-bortezomib (250-1 mol-mol),0.6907201532102293
NCI-H2286,107970,2.345269043808208
Panc 03.27,135421197,1.6982326506072338
SK-MM-2,UNC0638-navitoclax (1-1 mol-mol),-2.9286271637501806
DEL,100016,3.851368536137221
NCI-H2170,107970,2.6189429155295585
BT 245,107970,1.8345714144721337
A-204,46907787,0.8434762218045947
BT 245,439501,-4.061461225365729
YD-8,262093,2.4929271706284433
Mono-Mac-1,11455910,1.2371744705316827
NCI-H1105,439501,-2.509690538840725
MDA-MB-435S,262093,2.2230696932896
HT,637858,1.2510770253025525
NUGC-4,375860,-0.1996539544596114
RL,6852167,1.9852892386197472
AU565,73707398,1.1644887368044523
A-375,9929138,5.4250105922665375
JHUEM-2,9903786,1.0264930895087971
BT 145,375860,-0.1157906952672005
HCC1395,11396600,4.211353464920311
COLO 320,444795,4.368203032924048
A-204,375860,0.2477180197304712
M059K,26596,-1.203189408299565
SNU-478,241158,3.0431805013253252
KMRC-2,637858,2.4993405738331216
CML-T1,262093,1.3151134240668207
MHH-ES-1,12003241,-1.3957716684214538
NU-DHL-1,5460769,0.1990382783266381
BT 164,11396600,2.523887599451015
GA-10,UNC0638-navitoclax (1-1 mol-mol),1.4796624390436783
NCI-H1869,262093,3.2234761574881485
Hs 934.T,12003241,-1.701018905102148
HEC-1-A,54596490,4.808755296997763
NUGC-3,11455910,1.6597314376827883
SK-LU-1,107970,2.349132829745335
697,135999136,1.259492439714956
SNU-407,439501,-0.9775272958011642
NCI-H2106,637858,1.632566617574699
LAMA-84,tanespimycin-bortezomib (250-1 mol-mol),-0.5777887932469495
BT 248,444795,4.817055384579841
NCI-H2126,637858,2.592215073021411
DV-90,10231331,-0.8799349916089758
WM793,241158,3.83369214528036
FTC-238,6852167,3.2631212459606864
EHEB,tanespimycin-bortezomib (250-1 mol-mol),-0.1449440337171298
NCI-H520,11396600,3.7776798770198594
U266B1,sirolimus-bortezomib (250-1 mol-mol),0.0143822479563884
NCI-H1563,107970,2.7821488570698176
NCI-H460,262093,3.3627537421549314
SNU-1214,11455910,3.3877834337363124
BT 147,644241,1.928241008057233
COV434,9903786,2.975082903645508
NCI-H1693,375860,0.3039564435298386
SUP-B15,439501,-4.354200278672526
A4/Fukuda,439501,-3.252400391503616
KNS-42,tanespimycin-bortezomib (250-1 mol-mol),0.1852378636050138
MM1.S,375860,-0.3099552941005813
RERF-LC-Ad2,12003241,0.07971757119013
KMS-18,tanespimycin-bortezomib (250-1 mol-mol),0.4216929170783136
Rh30,107970,2.354219446763589
KU-19-19,49766530,0.1366302187334878
Ishikawa (Heraklio) 02 ER-,375860,-0.5414643002476628
SK-MM-2,49766530,-2.0965316269775816
NCI-H2023,241158,4.443142725107179
SK-HEP-1,12003241,-1.7510835313415607
SK-MES-1,644241,1.6292140413735792
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
Jurkat,49766530,-1.3206088246448346
P3HR-1,selumetinib-JQ-1 (4-1 mol-mol),3.656805781248008
A4/Fukuda,107970,1.5574682195612295
Lu-65,26596,-0.6076566338784338
NUGC-4,46907787,-1.879898884008335
MCF-7,9927531,5.854182634805009
NCI-H2141,49766530,-3.0033448616594174
KMH-2,6852167,2.5301856007997348
OCI-M1,375860,-0.3208113625803119
BT 216,100016,6.740671439747835
Hs 895.T,644241,2.271304651362579
PaTu 8988t,262093,3.2462588578894587
5637,241158,3.580140863644883
NCI-H1341,26596,-1.5435661996164969
Karpas-299,100016,4.52969889794102
Mono-Mac-1,9927531,4.461355065468675
B-CPAP,5460769,4.36425483182296
697,9929138,3.2982563407186447
Ishikawa (Heraklio) 02 ER-,3689413,0.6231985481364082
ECC12,9903786,2.9866335342643953
COLO 668,6852167,2.8709029977726717
DV-90,135999136,4.944237509825111
EJM,73707398,0.7642029358076543
KYSE-180,375860,-0.0718407094344544
Hs 940.T,sirolimus-bortezomib (250-1 mol-mol),2.1873747359763613
BICR 18,tanespimycin-bortezomib (250-1 mol-mol),-0.1167236068858008
MOLM-13,44491742,3.7695621371445975
VMRC-LCD,262093,2.9924485884433496
CAL-148,6852167,2.1626646060240367
NCI-H460,73707398,3.251551904382877
UM-UC-3,selumetinib-JQ-1 (4-1 mol-mol),4.140497449686447
KYO-1,9903786,1.1587901811719317
NCI-H69,5460769,3.1019087351608037
SJSA-1,sirolimus-bortezomib (250-1 mol-mol),0.9111785812193088
SBC-5,444795,4.741830288065925
CA46,71466445,1.6737757590775906
CJM [Human melanoma],9903786,6.367293868352352
8505C,135398744,7.128245503588914
LUDLU-1,6852167,2.262101031306484
CJM [Human melanoma],sirolimus-bortezomib (250-1 mol-mol),0.403265479261487
HCC2935,644241,2.068249364643198
IPC-298,selumetinib-JQ-1 (4-1 mol-mol),-2.676817535219498
LS411N,3689413,2.701640891749041
SNU-869,262093,3.5484440490505738
LoVo,168313016,4.599216339831628
NCI-H1581,tanespimycin-bortezomib (250-1 mol-mol),0.5752068727797862
NCI-H2405,6852167,3.038556010393465
LC-1/sq-SF,135421197,3.695638130955798
NCI-H211,644241,1.4591617185883057
KMRC-1,135421197,2.781168744821282
JHOC-5,100016,4.009706795291197
BT 428,6852167,2.9431146688699275
LMSU,5460769,3.9630418347665857
KP-4,637858,2.2303750130637163
RPMI-6666,46907787,0.0524007873085762
HEC-1-A,637858,1.7638389780998065
HEC-59,5460769,4.548370162463851
LS411N,selumetinib-JQ-1 (4-1 mol-mol),-0.8055713738039206
OUMS-23,637858,2.1150816031372655
JHUEM-3,sirolimus-bortezomib (250-1 mol-mol),0.3977209679383447
DEL,6852167,2.99985019228043
HuCC-T1,UNC0638-navitoclax (1-1 mol-mol),3.2626901265646127
TE 617.T,44491742,3.9684227449531697
Karpas-422,5460769,4.127517160029383
MOLP-2,49766530,-0.7894264806393523
HCC1588,9927531,4.588881343798492
ACC-MESO-1,9903786,5.156493229165983
NCI-H520,9903786,3.332228860924169
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783
GB-1,107970,2.4736997234599234
KYSE-150,71466445,6.21700221694018
SNU-899,73707398,1.7017712409022585
BT 271,11455910,0.6743644259938443
SNU-489,9903786,5.534401948294785
SNU-899,168313016,4.812796828917726
JMSU-1,6852167,1.4853357753609204
Hs 766T,tanespimycin-bortezomib (250-1 mol-mol),-1.398950675536224
COLO 320,3689413,-1.9916072658639432
8505C,sirolimus-bortezomib (250-1 mol-mol),0.1276397939018833
BL-70,UNC0638-navitoclax (1-1 mol-mol),1.3205011863889164
GSS,637858,1.823205693461285
G-361,439501,-0.9249859922186838
LS513,9903786,1.9994254947829608
SK-LMS-1,637858,2.4121207019199074
JHUEM-2,637858,1.722532316890112
NCI-H2122,sirolimus-bortezomib (250-1 mol-mol),1.792709807177603
EC-GI-10,44491742,4.525033675313585
JHH-4,11455910,0.4294886649556081
SW982,100016,3.947877721573723
UACC-257,UNC0638-navitoclax (1-1 mol-mol),3.0893651600544096
Panc 08.13,107970,2.2427902977668883
A-204,135398744,7.3650683487349236
SU-DHL-1,262093,1.7952973078733698
SEM,241158,3.04470395214072
Ki-JK,5460769,-2.8439091816710707
HuH-28,637858,2.0135028750477275
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037
SaOS-2,644241,2.5011234622868415
OC 314,selumetinib-JQ-1 (4-1 mol-mol),0.4980964574783434
SK-LU-1,sirolimus-bortezomib (250-1 mol-mol),1.1916216925923933
OCI-Ly19,49766530,-0.0820002075595115
MIA PaCa-2,241158,2.0398577340537587
T84,3689413,-1.5299599275494418
GaMG,439501,-0.9687040114702524
GA-10,9903786,1.0626395044563215
EJM,49766530,-0.6352274600767028
HT-1376,selumetinib-JQ-1 (4-1 mol-mol),2.138060477374947
ECC10,12003241,-2.873030940363692
AN3-CA,46907787,4.249089743528786
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407
KP-2,49766530,0.3701885896643133
BT 164,439501,-4.366983118458045
NMC-G1,26596,5.43387943202461
Rh41,49766530,-2.538268095723461
Karpas-422,107970,2.1264000948746555
MOTN-1,439501,-3.3199671011375913
HCC1954,6852167,1.7323424520522626
BT 239,73707398,0.5313402889199192
COLO 741,375860,0.428863043923301
KYSE-150,107970,2.435161948690566
Hs 688(A).T,637858,3.034400874820582
HH [Human lymphoma],44491742,2.6350452695028888
Panc 04.03,168313016,6.087789512449841
PL-21,135999136,3.272294699588802
LN-18,5460769,0.9939611818756712
LMSU,9927531,5.404187778104352
NCI-H1792,107970,2.9959713760395763
RERF-LC-Ad2,tanespimycin-bortezomib (250-1 mol-mol),0.3910876035437155
SW48,637858,1.3097623359774897
Toledo,49766530,2.126888986810566
LP-1,71466445,2.285503887885024
LCLC-103H,6852167,4.45978228332794
IGROV-1,9903786,1.7387584479757865
SW1417,73707398,1.4333921611241789
SW948,637858,1.5262532123254355
OCI-M1,100016,6.862784368685653
NCI-H1792,10231331,1.4633013608252372
JMSU-1,100016,3.921608363156487
KMS-21-BM,3689413,-1.8694843012427496
KE-97,71466445,2.322380108520085
SEM,sirolimus-bortezomib (250-1 mol-mol),-0.6909485025943941
MOR/CPR,10231331,5.9387462777056115
SK-OV-3,12003241,-1.2313805329375749
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766
HCC1171,9927531,5.509897026708257
SNU-387,135421197,2.3985099297623815
UM-UC-3,644241,3.8298846028890745
NCI-H1355,107970,2.284866170992536
TE-6,11455910,0.2232951915413818
MKN74,selumetinib-JQ-1 (4-1 mol-mol),1.7394351663824423
MHH-CALL-3,100016,3.61949081353442
LN-229,selumetinib-JQ-1 (4-1 mol-mol),0.9195048407927706
RCC10RGB,54596490,4.957303932772775
BT 187,46907787,3.607814599945456
COR-L47,439501,-2.8835443741058437
TC-71,6852167,2.7255120299816684
LP-1,637858,1.1984002374597165
NCI-H526,49766530,-2.411772965733929
MIA PaCa-2,46907787,-0.2565491752841508
Hs 611.T,12003241,-4.3632527403619425
SU-DHL-10,selumetinib-JQ-1 (4-1 mol-mol),0.722399176579171
LC-1/sq-SF,44491742,4.404829993178961
Aska-SS,241158,3.805565217473049
TE 441.T,262093,1.5238346929960052
KMS-26,9903786,0.9658613723306017
BICR 22,selumetinib-JQ-1 (4-1 mol-mol),1.538481754600391
NCI-H1105,241158,3.2792765444983036
HEC-108,135999136,4.441314867436916
HT115,5460769,1.7158101929675542
OE21,44491742,3.708692446594154
WM793,6852167,3.317398724097228
HuG1-N,5460769,5.358196013663695
Karpas-299,135421197,1.2662606482255232
MOLP-8,10231331,1.2198029486879254
HOP-92,46907787,2.9516486383279488
TE-9,3689413,4.927394449121957
RL95-2,262093,3.494468986300009
OVSAHO,9903786,3.817356196338304
JJN-3,46907787,-1.5063119607662292
SNU-840,135421197,1.1283252272940862
NU-DUL-1,12003241,-3.7698079605480257
SW1116,6852167,3.995945836747335
OCI-AML-3,selumetinib-JQ-1 (4-1 mol-mol),-2.716692997206964
BT 422,439501,-3.455801521940444
SNU-8,44491742,5.735879763811486
COLO 741,637858,3.389953316236187
SW948,6852167,2.188206161672083
U2OS,71466445,4.273731678378128
TE-10,26596,-0.9876255141372016
SK-MEL-31,44491742,4.695235381351794
BT 147,262093,2.7128872808709414
HCC95,46907787,-0.2787376325383735
PF-382,selumetinib-JQ-1 (4-1 mol-mol),-1.2412031100333754
OCI-AML-3,135999136,4.040843396784286
NB1,135999136,1.5175720637935213
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
SNU-16,9927531,3.2030544942563317
JVM-2,11455910,0.2677947916943763
OE19,sirolimus-bortezomib (250-1 mol-mol),2.347707563651812
DLD-1,26596,0.8453725223634535
23132/87,sirolimus-bortezomib (250-1 mol-mol),0.0673890059049479
U-BLC1,11455910,1.1815633788614182
KMRC-20,49766530,-1.4976923868030616
AM-38,262093,-6.35735494896705
JHH-2,375860,0.4544273736853194
SNU-8,241158,1.5874400033719902
SHP-77,3689413,-2.4730953136867297
TCCSUP,11396600,4.109332889227832
NCI-H1435,637858,1.608648555542635
DU4475,71466445,2.62010200109503
RERF-LC-Ad1,637858,2.9001668968564953
Peer,6852167,1.672414064872
KP-N-YN,tanespimycin-bortezomib (250-1 mol-mol),2.890328599620326
Rh30,3689413,-2.408934939466004
SNU-719,6852167,2.8569668843128606
BICR 22,100016,6.157225392196351
EoL-1,11455910,-0.8638634709362212
BT 164,262093,1.918525006614416
SNU-719,107970,1.9431075169363972
JHH-4,100016,6.356907567320683
SNU-201,6852167,3.1416470109907535
BT 239,sirolimus-bortezomib (250-1 mol-mol),0.5713357079761969
YD-15,9929138,6.969661467519232
DU145,439501,-2.7485794982467637
LAMA-84,644241,-4.93711557474261
Hs 895.T,637858,3.4147376611120186
KYSE-70,262093,3.701785722517592
Ku812,3689413,-1.935767376067546
HuT 78,26596,-1.9929249611117947
A-172,637858,2.4052176402069514
GMS-10,135999136,4.793570328652181
A-253,sirolimus-bortezomib (250-1 mol-mol),0.2141066423714133
BT-474,3689413,-0.6944310513118788
CL-11,73707398,0.832008488362177
PSN1,262093,2.941975220157323
TE-11,44491742,4.693263805058857
MPP 89,9927531,5.277486378374347
Jurkat,selumetinib-JQ-1 (4-1 mol-mol),-1.978152478321326
NCI-H2029,11455910,1.1545705407069018
Panc 05.04,262093,3.3614710639297622
HEC-59,375860,0.0781671745466512
NCI-H1944,sirolimus-bortezomib (250-1 mol-mol),1.314144105484395
JURL-MK1,12003241,-5.793080967465335
KMS-18,9927531,3.9141727382936624
MOLT-13,46907787,-2.224127501302228
NCI-H2106,11396600,2.567316038119924
ONCO-DG-1,12003241,-0.5849918543503058
DEL,9927531,3.262771629290843
PaTu 8988s,tanespimycin-bortezomib (250-1 mol-mol),-2.9825646134003825
HEC-6,107970,2.5203665838349036
HCC95,375860,1.218591942556542
FU-OV-1,262093,2.4810055989466018
OUMS-23,UNC0638-navitoclax (1-1 mol-mol),4.271209740622461
SW1417,135421197,1.3555171655865843
KM12,46907787,3.704464245999132
HCC1171,12003241,-1.936475523579036
Hs 729.T,73707398,0.8195691589926136
CCK-81,107970,2.3373477232254443
JHOM-1,10231331,4.4768538272834375
HCC1419,12003241,0.329008083865116
Lu-65,439501,-2.896459054469027
BxPC-3,10231331,0.6961573218104748
SNU-C4,selumetinib-JQ-1 (4-1 mol-mol),3.2526553861224836
Hs 936.T,3689413,1.174689206695868
NCI-H838,3689413,-2.1672294024388106
Rh41,135421197,0.890799382686484
KYSE-30,tanespimycin-bortezomib (250-1 mol-mol),0.3165609096596899
TE-5,444795,4.827182219857021
MDA-MB-231,11455910,1.414181949063077
BT 139,44491742,4.209444035840443
KMS-12-BM,3689413,-2.359728446736426
Hs 611.T,439501,-3.691204716302381
SUP-HD1,6852167,1.7259381822403246
LC-1/sq-SF,73707398,3.503978721535421
SNU-620,sirolimus-bortezomib (250-1 mol-mol),0.2829661483143316
Karpas-299,439501,-2.5701669510398717
KYSE-410,6852167,1.749610623919313
NCI-H1623,26596,-1.1542368606327895
YH-13,6852167,1.959387815211575
FTC-133,73707398,1.7335394908123083
Hs 746.T,9927531,5.239357337613853
UACC-257,sirolimus-bortezomib (250-1 mol-mol),1.215285215662541
A3/Kawakami,49766530,-0.4479480669957117
CFPAC-1,12003241,-0.6323170147703681
NCI-H2170,6852167,2.6821146878265645
NCI-H1734,9903786,1.4575898804478404
8505C,11455910,-0.1403664208341097
RMG-I,73707398,0.9592777542588656
A-549,168313016,6.463391576466817
NCI-H647,11396600,2.927909062901915
Panc 03.27,12003241,-0.3666669100111787
SNU-61,9903786,2.1391845181717373
Hs 578T,71466445,2.0883073445743574
SK-CO-1,637858,1.8597515079418403
SUIT-2,73707398,2.4448376326021313
OVCAR-5,262093,2.868361777233285
TCCSUP,5460769,3.7572024912117103
SaOS-2,100016,6.565789067704999
TE-1,sirolimus-bortezomib (250-1 mol-mol),1.4536947416119834
NCI-H522,71466445,4.480637973076106
U-937,107970,2.3175497255146804
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784
HPB-ALL,selumetinib-JQ-1 (4-1 mol-mol),1.6760902542091598
SF539,26596,-2.288089999638428
KMRC-1,262093,3.6313310555506817
WM266-4,444795,4.484213962316863
Hs 578T,UNC0638-navitoclax (1-1 mol-mol),0.8451308474744694
ZR-75-1,135421197,1.3077773564492
BV-173,241158,2.5742615925336856
PL-21,sirolimus-bortezomib (250-1 mol-mol),-0.8951196231855002
NCI-H460,107970,2.752075604137296
Calu-1,49766530,-2.4151861357185056
SUIT-2,637858,2.948083302297865
JVM-2,sirolimus-bortezomib (250-1 mol-mol),-7.352032858936448
SNU-1077,107970,2.607215080284504
Kasumi-2,262093,1.7604912977671856
OV7,73707398,1.3742154881695552
U-937,sirolimus-bortezomib (250-1 mol-mol),0.5850227728036819
SYO-1,12003241,-0.4468506697584958
HCC38,100016,6.688694515924342
SW948,73707398,1.7510146080607218
DU4475,11396600,2.471584986754413
ESS-1,46907787,0.8695499024183594
BT 440,49766530,1.1711647007099082
8-MG-BA,135421197,2.5937417683499526
NALM-6,11455910,-0.1269393441174446
SW1710,73707398,0.971226143057924
SNU-410,26596,4.2924060391829935
IM95,100016,6.474511795509729
COLO 678,selumetinib-JQ-1 (4-1 mol-mol),0.2945638397547896
T3M-10,73707398,1.864351117774127
AsPC-1,11396600,3.3240147605355506
HCC1428,6852167,3.9736083121297288
KU-19-19,3689413,0.155027117273248
ME-1 [Human leukemia],262093,1.5767156474221262
NCI-H2106,11455910,1.3355909303164284
HeLa,241158,4.038975399720051
Jurkat,241158,3.2047640771704953
HCC1143,11396600,3.529486359294858
TE 441.T,135999136,1.6397829738151082
JVM-2,49766530,-4.705274253962015
ESS-1,5460769,-0.3251379363550979
SHP-77,9903786,4.085318424686739
COR-L95,241158,4.468160037389037
KMS-21-BM,5460769,1.875881845654493
CAL-78,44491742,4.7670188278775605
OAW28,135421197,1.4901490212875883
Rh18,12003241,-2.237967131461188
HPB-ALL,444795,4.0041475034544325
NCI-H1838,6852167,2.848861882071558
KMRC-3,46907787,3.1191324393866666
AML-193,26596,-1.9434141476174296
Calu-3,73707398,0.8733315682522698
KMS-18,107970,2.023216397694573
IGR-1,12003241,0.2975109917194724
LP-1,49766530,0.7133399832547254
EC-GI-10,168313016,5.76408308969352
BT 179,107970,1.72684325120686
CAL-62,73707398,1.6928009125846106
NCI-H1155,6852167,3.411422238563504
SNU-387,100016,7.682207014450764
NCI-H211,439501,-3.5479428279050955
JURL-MK1,107970,2.4390351360082954
MOLP-2,107970,2.110185420834163
EM-2,375860,-0.8639645436146182
Ri-1,46907787,-1.1077031577889345
U-251MG,11455910,1.7912494784014348
KE-97,439501,-2.4280531684579896
MOLP-8,637858,0.6022882265593398
SF295,5460769,2.0646753609737125
COV434,44491742,4.086933897953946
SW1710,9903786,3.726951851848614
KYSE-180,73707398,1.6922150122396675
Sq-1,3689413,-2.2869880122730755
BT 504,5460769,2.119344247070391
BT 504,10231331,4.750172866148794
P12-Ichikawa,49766530,-2.0130843351151437
NCI-H1838,107970,2.381888048616505
KE-39,46907787,0.5111190203360444
BL-70,6852167,-1.1490016051859089
NCI-H2085,135421197,1.1751521107550191
HEC-251,11396600,4.750561988154587
KMS-21-BM,262093,1.4735879820093536
DB,10231331,4.346778551144196
HEC-59,11396600,4.681293728583163
LS123,44491742,4.080361644542357
HT-1197,637858,1.1987341905705466
NCI-H1944,375860,-0.3513719404528298
NCI-H727,3689413,0.3749801507161196
SIG-M5,71466445,2.546223661997516
BT 232,637858,2.601842990384653
SNU-8,5460769,4.64495536055113
NCI-H2030,100016,6.672614959068411
SNU-869,637858,2.513376946079908
NCI-H1563,136227331,3.8731399869875167
A-375,9903786,2.3118659059614877
PE/CA-PJ34 (clone C12),135421197,2.056271924404355
JeKo-1,168313016,4.381746397495715
HCC1195,9903786,3.7437324544379487
BT-12,3689413,-1.6226385767572318
KMS-18,262093,1.4721662513603355
UM-UC-3,11455910,-0.2189764508549214
Pfeiffer,26596,-3.7585498657816414
GSS,44491742,4.082096433494501
NB4,12003241,-0.9132683604987908
CAS-1,UNC0638-navitoclax (1-1 mol-mol),1.8136943980639495
Capan-2,12003241,-1.76044802004158
NCI-H1355,375860,-0.2835588127763641
BT-12,sirolimus-bortezomib (250-1 mol-mol),1.3345146082799952
TE 441.T,sirolimus-bortezomib (250-1 mol-mol),0.170107693301359
FTC-133,637858,3.731185140297224
KYSE-150,100016,4.009775484830176
SNU-878,46907787,-0.6840421286217908
CJM [Human melanoma],26596,-1.4087486748108544
U2OS,12003241,-1.2814871357228934
SK-N-MC,tanespimycin-bortezomib (250-1 mol-mol),0.3614874661050979
CAL-120,107970,2.6681262489073716
SNU-423,sirolimus-bortezomib (250-1 mol-mol),0.1869702268124788
JHH-2,selumetinib-JQ-1 (4-1 mol-mol),2.106213738968382
HLF,444795,4.996858415004705
IGROV-1,135421197,1.96820638017286
PE/CA-PJ49,11455910,0.6367427486190916
M-07e,26596,-2.7882078019466725
CHP-126,tanespimycin-bortezomib (250-1 mol-mol),1.029486462123943
HEC-6,73707398,1.1585131254296075
L3.3,6852167,2.807934515358382
NCI-H1755,73707398,1.4659899774236258
KCL-22,26596,-1.6030605550543997
KE-37,11396600,2.928108153981295
NH-6,12003241,-1.8219752869317325
SW579,46907787,2.1305561791309273
DMS 79,375860,3.7186272317869102
RL95-2,26596,-0.9803054302492492
NCI-H292,5460769,0.0770188109309223
LNCaP clone FGC,439501,-2.4937134944398176
HuT 78,12003241,-1.0527217193191982
CA46,644241,2.374325583681648
COLO 205,selumetinib-JQ-1 (4-1 mol-mol),-0.3871952665597744
RPMI-6666,3689413,0.7706229516172245
NCI-H1385,12003241,1.7057998630948272
CAL-85-1,11455910,0.9235836598300894
BT 271,107970,1.5328862908650924
SNU-61,241158,3.885428513145571
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588
Hs 940.T,107970,2.2449201121582236
NCI-H2122,3689413,3.5396747143031497
HEC-1-A,49766530,-0.9816829149963144
KMRC-20,6852167,4.09361379982572
A-375,9903786,2.3118659059614877
TE-6,644241,2.3482267869305904
TYK-nu,49766530,-1.9829356479605205
NCI-H2172,11396600,4.171717068415809
DOV13,73707398,1.2640838378303083
DMS 53,46907787,-0.6821606423951819
PC-3,107970,3.1728973881319753
SK-N-SH,26596,-3.7665654883669664
DU145,44491742,3.929497920305024
SNU-C4,439501,-3.0543903815418547
SHP-77,26596,-1.5620029042215733
KO52,10231331,-1.770944789563704
Caov-3,241158,3.40549720249276
KMS-12-BM,selumetinib-JQ-1 (4-1 mol-mol),-0.820838989236415
Hs 683,UNC0638-navitoclax (1-1 mol-mol),1.040409655043311
HEC-1-A,168313016,5.702351892024658
SUP-T1,439501,-1.5599134432816564
KP-4,11455910,-0.3156101411278702
Hs 888.T,9927531,5.625894406785977
SK-N-DZ,168313016,4.271968521443649
CAL-51,73707398,0.7053044464230985
HCT 15,5460769,3.425383237869742
NCI-H1385,46907787,0.0996622150705552
HT-144,439501,-0.7742465567172142
LUDLU-1,637858,2.984571557317574
NCI-H2452,637858,1.8545349692582156
NCI-H2122,107970,2.8025359770355047
GCT,135398744,7.690422491741855
SW1353,12003241,-1.0641088251163675
SW1417,9903786,3.296338786408906
OVISE,262093,2.7343448368987597
LCLC-103H,135999136,4.479345177933151
M-07e,3689413,-2.11596462386005
SNU-738,12003241,0.0747510600230264
HCT 116,tanespimycin-bortezomib (250-1 mol-mol),0.9696018979872172
Daoy,46907787,4.334387972090441
KYSE-70,11455910,0.6771697782379181
NCI-H650,12003241,-0.6460655528270789
TE-4,9903786,1.7247018760374746
KYSE-140,107970,2.5158058197499384
PK-59,selumetinib-JQ-1 (4-1 mol-mol),1.6048028888022474
ME-1 [Human leukemia],10231331,-1.3974711314743906
SNU-899,135999136,4.451212206857688
MOLM-6,444795,3.219828752375847
Daudi,644241,1.4114598324864769
TOV-21G,49766530,-3.499964939979177
SNU-1041,135421197,3.0593389422379293
MKN45,637858,3.657706213668147
HEY A8,10231331,1.7101627370208758
Hs 940.T,46907787,1.3777694831541
NCI-H446,73707398,0.6395483632268802
Hs 888.T,107970,2.2349106200689817
CAL-85-1,107970,1.6693076027868323
RL,375860,-0.2985027186247951
786-O,6852167,3.7190668344591025
EFO-27,637858,1.802850970746332
SK-N-DZ,9903786,2.0344840639265787
HuP-T3,46907787,1.2763139172323097
SNU-182,49766530,-3.329297087517195
SNU-16,11455910,0.0764254411475756
JHOM-1,UNC0638-navitoclax (1-1 mol-mol),-1.7781569058579632
SK-N-DZ,5460769,3.5679680619882617
CML-T1,11455910,-0.3388293365451558
SNU-601,sirolimus-bortezomib (250-1 mol-mol),0.628067282313429
KMS-28BM,11455910,0.2155476441980809
M-07e,262093,1.9323160486424649
HEC-1-A,9903786,5.533982095458378
NCI-H1105,12003241,2.305570238632079
NCI-H520,637858,1.8177885969386705
LS513,135421197,1.126111149798444
Daudi,9929138,3.458684768924583
SNU-886,9903786,2.951492144984292
BICR 18,44491742,4.057400353675569
RCH-ACV,12003241,-2.009657794147886
Hs 944.T,73707398,1.0226628760817618
HEC-251,sirolimus-bortezomib (250-1 mol-mol),1.5826018331734562
A-549,439501,-2.483005959928592
NCI-H28,11455910,-0.4430310622826519
SNU-685,11455910,0.9033032633285248
MHH-CALL-3,26596,-0.8027776235461769
SK-HEP-1,11396600,5.84824704867975
HEC-151,444795,4.8159070538718245
EFE-184,3689413,0.8995807831619225
SW1116,sirolimus-bortezomib (250-1 mol-mol),0.982406512308436
KP-4,100016,6.84348879863886
KMH-2,135421197,1.1476668863331456
SNU-1272,73707398,1.7046938678660917
Hs 746.T,71466445,4.972648672045977
CCF-STTG1,6852167,4.451400297706149
DMS 79,135999136,2.6080032011939953
BHT-101,selumetinib-JQ-1 (4-1 mol-mol),-0.8861655403353532
Ku812,9903786,1.763683139425592
CHP-212,UNC0638-navitoclax (1-1 mol-mol),3.0960304898677973
HL-60,71466445,2.1341422672324732
BT 224,135421197,2.656676342588309
Panc 10.05,107970,2.288044652827366
VMRC-RCW,46907787,1.4182502903454035
RERF-LC-Ad2,262093,2.9385372389092197
NCI-H716,selumetinib-JQ-1 (4-1 mol-mol),-0.1504205000857164
BICR 18,12003241,0.2549770836209779
NCI-H2405,71466445,6.20734018076787
HCC1833,selumetinib-JQ-1 (4-1 mol-mol),2.357049659281798
MDA-MB-453,selumetinib-JQ-1 (4-1 mol-mol),1.824440496752652
OVSAHO,6852167,2.379314950322878
LoVo,375860,-0.1162329718395109
2004,375860,-0.4306769141118115
SNU-1066,tanespimycin-bortezomib (250-1 mol-mol),-0.148232507345562
OVK18,5460769,2.4178106376045516
CAL-54,9903786,1.6300874124823186
KE-39,49766530,-2.0647642539816715
ME-1 [Human leukemia],444795,6.159578889589608
SNU-119,444795,1.2975403527774965
CL-11,107970,1.988288098397546
MOTN-1,107970,1.2324851180704943
RVH-421,135999136,4.306974775879162
KE-39,73707398,1.3252144554958445
HCC1806,107970,2.3006774774871444
NCI-H2030,262093,3.6307250181599215
LMSU,54596490,4.907866417372536
NCI-H1666,11396600,3.2365396547508674
Aska-SS,3689413,-0.2828072846638814
NU-DHL-1,439501,-3.591448694271343
BT 239,439501,-3.505235897057165
TOV-21G,241158,3.758877578075152
JHH-6,73707398,1.7993372824385652
HLF,375860,-0.0399029193144341
MOLM-16,439501,-2.4166934958345476
OPM-2,73707398,-1.391957592490296
ECC12,3689413,0.1011873229267039
HCC44,241158,3.9136091411622345
OC 314,sirolimus-bortezomib (250-1 mol-mol),0.336828605445857
Tm87-16,9903786,3.2568482334104587
PSN1,49766530,-0.1944189543037747
HuH-28,3689413,-1.8867540967033527
DMS 53,26596,-0.0361883728556599
Hs 688(A).T,12003241,-0.4220829795676687
Yamato-SS,644241,4.451249478679348
HCC2279,10231331,5.2502746127917925
VMRC-RCZ,44491742,4.2386816825846285
KMS-26,3689413,-5.054030253725733
Hep 3B2.1-7,135421197,0.863862977673099
NCI-H1793,selumetinib-JQ-1 (4-1 mol-mol),2.732859806890437
UACC-257,644241,2.4588334794775615
NCO2,637858,0.6185034167656125
NCI-H322,375860,-0.2770112078497766
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158
SNU-5,3689413,0.3799296763624849
Raji,12003241,2.533123505917396
SK-MM-2,9903786,2.9629309693480983
LOX-IMVI,375860,0.0693454409370285
HCC4006,644241,2.5673666310720336
AsPC-1,135421197,1.8824248695595285
KMBC-2,11396600,3.805651469243142
DLD-1,9927531,4.358823264887286
Panc 10.05,100016,7.2735240015579645
MDA-MB-361,46907787,1.0050799963168924
NCI-H2081,107970,1.5324597930931985
SR,44491742,4.371664315658822
IGR-37,3689413,2.8374772536506407
ECC10,637858,1.1085550148233343
BT 422,644241,2.356538089518836
PE/CA-PJ49,135421197,1.7245990786454344
JHUEM-3,9927531,4.734556698770441
CAL-54,107970,2.162008035980813
SNU-1033,12003241,-0.6294445516416565
GA-10,9927531,2.891443375149746
G-401,107970,2.0352708529532824
AN3-CA,375860,-0.4575105157706771
SW1353,11455910,2.4581078683414765
DLD-1,241158,4.313425488580076
BT 139,10231331,4.592628649226856
LMSU,262093,3.167641110749879
HCC2935,UNC0638-navitoclax (1-1 mol-mol),1.7958098433458678
JHUEM-3,3689413,-0.6367758327679763
RERF-LC-Ad2,5460769,6.029186520623905
HPAC,637858,2.270663033055596
HD-MY-Z,135999136,4.336889602343054
VMRC-RCW,tanespimycin-bortezomib (250-1 mol-mol),1.6092697528768949
HLF,tanespimycin-bortezomib (250-1 mol-mol),-1.3704475916887384
KMS-18,135999136,4.8693780005592595
Calu-3,637858,1.8527277636987496
G-361,135421197,1.3668023463515628
MHH-ES-1,9903786,1.586022951185602
NUGC-4,26596,-1.113746804335536
AU565,46907787,3.197599854412173
TE-6,262093,4.180478687873399
GaMG,375860,0.0243101951979654
MOLP-8,5460769,1.8843864880791628
Kuramochi,168313016,6.466034723760261
Panc 02.03,100016,6.582809568040202
TUHR10TKB,73707398,1.629534927817398
SNU-489,107970,2.9829628021045975
SUP-HD1,637858,0.8989263915132222
DV-90,11396600,2.8019083313135553
JJN-3,135999136,3.990398552524533
RPMI-8226,71466445,1.9270357841709371
OE33,241158,5.920302917932962
Daoy,439501,-2.3347693323407195
BFTC-909,637858,2.264716830291231
COV434,11396600,2.8403888234500663
LXF 289,12003241,-2.348837864712453
OUMS-23,sirolimus-bortezomib (250-1 mol-mol),1.7172624252600015
Pfeiffer,168313016,4.585441539484118
LN-18,135421197,2.222908154028884
NUGC-4,12003241,-1.4802161759010128
TC-71,439501,-2.5028085406649336
Mel Ho,selumetinib-JQ-1 (4-1 mol-mol),-1.885039449410358
NCI-H647,tanespimycin-bortezomib (250-1 mol-mol),-3.1460893933580727
EM-2,sirolimus-bortezomib (250-1 mol-mol),-5.681511220612078
L-428,12003241,-0.2572573546541544
P31/FUJ,135421197,1.0144502005310674
HPB-ALL,375860,-0.4401336485417012
EHEB,sirolimus-bortezomib (250-1 mol-mol),-0.8631286071127797
MDA-MB-468,71466445,3.782610959631592
MIA PaCa-2,71466445,3.52941204584422
BHY,11455910,2.7739554462043112
P12-Ichikawa,11396600,2.4412876679668165
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671
AGS,5460769,2.317513443937506
OCI-M1,3689413,0.2396810105329112
NCI-H1299,135421197,1.297843636132371
BHY,262093,3.4081401003096548
KYSE-450,637858,3.2826178661178003
SK-N-FI,73707398,-0.4639317195303371
NCO2,107970,0.4926308981227985
TE-14,375860,-0.5133657303817126
SCC-25,3689413,-0.8116745291609476
OC 314,135421197,2.0874935264790646
KMH-2,107970,2.222246268833958
SEM,100016,5.238818929389881
JL-1,375860,-0.015048095510899
KNS-60,375860,-0.5601238085225673
MOLP-2,12003241,0.9753237716846912
T3M-10,262093,3.0314849196691704
FaDu,54596490,4.6794450616255805
OAW28,5460769,4.044755256654475
SW48,11455910,-0.1633281652990052
JHH-6,6852167,4.148791687912657
SK-MEL-5,168313016,6.194351632392148
SNU-308,439501,-2.437759024379206
SNU-5,46907787,-0.3928354111783015
NCI-H838,241158,4.193975575812004
TC-71,135999136,1.4901332353785983
COLO 678,44491742,3.8306560761300696
JeKo-1,tanespimycin-bortezomib (250-1 mol-mol),0.4974732421347879
SW1990,selumetinib-JQ-1 (4-1 mol-mol),1.814683670817831
PE/CA-PJ41 (clone D2),sirolimus-bortezomib (250-1 mol-mol),1.841699935420702
SF295,262093,3.7346493602329462
COV362,444795,4.975026489361351
UACC-812,49766530,0.2629782697340875
Caki-1,241158,5.557951612650369
Hs 729.T,644241,2.251936411171052
A-498,107970,3.0044685679861054
SK-HEP-1,637858,2.866868896175592
LC-1/sq-SF,12003241,1.312627912595186
HuP-T3,637858,1.096014734488476
KMS-18,11396600,2.8169219147606066
BT 245,49766530,0.0902413739193597
LOX-IMVI,637858,1.7619736168396252
SK-MEL-2,439501,1.1166422747690987
NCI-H1105,26596,-1.464012997205303
SUP-T11,107970,0.8330523143812344
Calu-3,262093,2.6683793293156204
SW620,12003241,-2.6864351641930155
HCC1428,3689413,0.0072798037629334
Kasumi-1,135398744,7.461687299190896
KYSE-30,12003241,-0.1095696990749684
WM115,644241,2.021542714802758
WM115,262093,2.5199436905866905
ALL-SIL,439501,-2.349752310116714
SNU-878,9927531,4.662529833906493
RKO,262093,2.7220373961576834
DU4475,444795,4.159357115386211
BT 228,3689413,-1.5659127438457598
COV362,44491742,3.68091331789624
U266B1,26596,-3.1243600455967906
Kasumi-1,444795,4.080394330066641
KE-97,135999136,1.4589784549040783
LP-1,12003241,-0.1215623944522291
HCC15,107970,2.678547076190946
GP2d,UNC0638-navitoclax (1-1 mol-mol),-2.07499994680321
NCI-H1694,100016,6.457618599357896
Panc 03.27,5460769,1.9093660486325057
HuCC-T1,107970,2.387051685262573
SU-DHL-10,107970,2.4723265497575397
CAS-1,46907787,2.098776455360669
OCI-Ly10,3689413,2.738747600587094
HCC1395,5460769,2.101928934987084
KP-2,9903786,4.272294010971456
SW1271,136227331,4.376300443457216
BT 245,241158,3.5873529093746828
LK-2,100016,5.670732740144693
AML-193,168313016,4.844735989269703
BT 131,selumetinib-JQ-1 (4-1 mol-mol),2.4613713362199485
JHUEM-7,168313016,6.3518310954698824
Caki-1,168313016,5.868880738665532
HCC15,11455910,-0.3399110905288865
SNU-466,5460769,0.9969525340042612
CAL-78,selumetinib-JQ-1 (4-1 mol-mol),1.9841734317141573
BT 504,644241,2.5369130082852234
NUGC-3,sirolimus-bortezomib (250-1 mol-mol),0.5062722406192697
Karpas-422,637858,1.0915898497737888
NCI-H2023,73707398,2.6726280968603287
COLO 792,UNC0638-navitoclax (1-1 mol-mol),-0.6661800226482624
Hs 888.T,241158,4.343315425607546
EFO-27,71466445,6.412452895571818
IPC-298,11455910,1.6404749147186584
KMRC-3,sirolimus-bortezomib (250-1 mol-mol),0.4876779746525405
BV-173,6852167,1.2212853775314485
CW-2,11396600,4.1428337021020445
NCO2,71466445,2.6517435517023284
SET-2,168313016,3.716090786123575
Hs 729.T,262093,3.080256577751834
SNU-1,6852167,1.5544290188040613
COR-L51,439501,-3.194299942621501
NCI-H716,11455910,0.5118733249267832
GDM-1,135421197,1.3394592190633656
LN-18,6852167,3.0256445999301045
NCC-StC-K140,5460769,0.9709750837193912
HCC1171,262093,3.491139872179752
NCI-H460,135421197,3.2510260026522233
CCK-81,5460769,-0.0536611992608542
Reh,11396600,3.042988610167451
Hep 3B2.1-7,10231331,1.1707245730964018
Hs 852.T,100016,3.86747930561629
TUHR4TKB,241158,3.690536318141575
AU565,107970,1.9067452119355752
HD-MY-Z,11396600,3.2182854001324768
KMS-27,71466445,4.755423613019404
RCM-1 [Human rectal adenocarcinoma],135999136,4.538916733621322
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
BT 330,44491742,4.367748851083318
NCI-H526,9903786,2.628275304590264
SNU-C2A,135421197,5.231431749442163
UACC-62,44491742,4.3464910230211755
NCI-H23,375860,-0.5313938012128813
MIA PaCa-2,73707398,0.9717738640313962
MOLP-2,262093,2.2971706880531757
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705
SNU-1,73707398,0.9345704256403632
U-118MG,UNC0638-navitoclax (1-1 mol-mol),2.4042669311771747
NCI-H292,9927531,4.942242070848643
MeWo,10231331,1.6242684117210484
SNU-1,10231331,2.0066448846643743
KMS-20,3689413,-1.644811207648459
LK-2,135999136,2.017802061487894
SNU-16,46907787,-1.0299263396915046
KYSE-520,6852167,2.563750102501921
AU565,49766530,1.448288738772077
MDST8,71466445,2.0942740576673593
A-549,9903786,1.8644448309659765
SW1353,6852167,2.5995387617408388
SR,9929138,6.2909687425027405
NCI-H1623,10231331,4.737119210946733
DEL,selumetinib-JQ-1 (4-1 mol-mol),1.5220162631855352
SNU-503,49766530,2.995521329492969
SNU-119,135421197,4.049091304293704
MDA-MB-453,73707398,1.1537227860078607
U2OS,sirolimus-bortezomib (250-1 mol-mol),1.3880787640011472
D283 Med,44491742,3.738153910971064
DU145,6852167,4.203979731076271
HEL 92.1.7,135421197,1.9345150408297491
TC-71,262093,3.008445971803391
NCI-H322,135421197,2.22865477281611
LOU-NH91,439501,-1.197324809082114
SK-N-SH,tanespimycin-bortezomib (250-1 mol-mol),0.2020120787076161
639V,49766530,3.725635459384192
HCC1428,637858,2.210735769602794
DEL,44491742,3.848906849757271
BT 428,sirolimus-bortezomib (250-1 mol-mol),-0.137470191353476
K029AX,3689413,2.968023656376896
BICR 16,375860,0.0398654341652112
BICR 18,26596,-0.934766780366006
SUP-B15,49766530,-0.1643365136132614
RPMI-7951,262093,2.547304876719483
A4/Fukuda,11396600,-8.215434514364686
769-P,107970,2.68737921958017
NCI-H1915,10231331,2.410169333798645
TE-15,3689413,0.9912236496957668
NCI-H1693,135999136,1.5965366802541323
8305C,73707398,0.8416094140918434
MDA-MB-231,135999136,4.393925713686655
Ku812,26596,-2.18380806647072
ES-2,49766530,-3.8492688352561055
NCI-H460,6852167,4.590065962834362
IGR-37,sirolimus-bortezomib (250-1 mol-mol),0.8968777908953848
COLO 699,135421197,0.9619259452362175
TE 617.T,11455910,0.3917461009813664
COR-L105,9903786,2.948812050867326
Calu-3,3689413,-2.218147351051095
WM983B,9927531,5.417064832255327
Sq-1,6852167,2.9289319531621327
NH-6,262093,3.0659860570310995
SNU-601,6852167,2.808936985877374
NCI-H1105,637858,0.7238201865125736
SNU-216,135421197,1.0326096520006542
MEC-1,9903786,1.8402940604427764
THP-1,tanespimycin-bortezomib (250-1 mol-mol),-1.1093068334471472
WM266-4,439501,-0.5871270471596414
LK-2,selumetinib-JQ-1 (4-1 mol-mol),2.330503945113565
NCI-H1944,46907787,2.618124377747688
CCF-STTG1,3689413,0.3028996084806184
NCI-H650,26596,-0.9939630725117288
TE-15,26596,-3.7197158754991615
SNU-119,46907787,2.5271615138386054
KO52,439501,-3.705469726802315
SK-MES-1,9929138,3.12327700271694
HOP-92,selumetinib-JQ-1 (4-1 mol-mol),1.8971159146724967
BT-20,49766530,-3.0336116964226076
HT-1080,26596,-1.5262132269513464
OCI-AML-3,241158,2.768035371877761
MG-63,9927531,4.972527766781062
EM-2,26596,-2.2140652847735027
Reh,9903786,1.595846435725099
EJM,12003241,0.5402616975347148
K-562,135999136,3.657737204061429
639V,107970,2.3280826917079667
A-172,6852167,3.365866392537541
BICR 31,73707398,2.635299985295534
PL-21,71466445,2.5925493312215053
F-36P,11396600,3.0952958144122724
YD-38,10231331,-1.3870760442434895
NCI-H2405,637858,2.527704826903145
UACC-62,tanespimycin-bortezomib (250-1 mol-mol),1.2383620234994217
TUHR14TKB,73707398,1.0008501890108177
ZR-75-30,11455910,1.1218208272028805
VMRC-LCD,107970,1.7842693363117308
SNU-1076,262093,2.995826964829708
HL-60,375860,-0.428675793220051
SK-MES-1,10231331,1.6852843396336314
DU4475,10231331,-4.248158187501236
BxPC-3,71466445,4.819923879864087
CAL-85-1,selumetinib-JQ-1 (4-1 mol-mol),0.6836909669956517
COV644,46907787,2.399255398547224
MKN7,71466445,4.862191582132044
TE 441.T,9903786,2.9236317230426465
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977
HCC78,107970,2.7946806041637933
DU145,241158,4.174318462840133
MM1.S,241158,2.058054746242757
HD-MY-Z,UNC0638-navitoclax (1-1 mol-mol),3.0734625152158688
NCI-H1568,107970,1.680617581032042
Panc 04.03,11396600,3.73844061007523
SNU-201,49766530,0.2558718668414946
GA-10,5460769,2.1295302547958976
SK-MEL-24,46907787,2.494372049313226
OVCAR-8,11455910,1.074074633675783
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188
NCI-H441,439501,1.4166866147967416
B-CPAP,46907787,3.372107688619731
5637,3689413,-0.8929275995994026
SNU-761,10231331,0.4986973787554518
U2OS,UNC0638-navitoclax (1-1 mol-mol),-0.5881639591710891
EC-GI-10,6852167,3.17038059071199
Hs 936.T,637858,2.404158263720436
L-540,71466445,2.156563541822822
HGC-27,136227331,3.820430594188932
RPMI-6666,135421197,1.415232327318222
A3/Kawakami,644241,6.313721804681679
HH [Human lymphoma],49766530,-3.061520130360288
IGROV-1,241158,3.288496474515495
DMS 454,26596,-0.4599730834169373
NCI-H810,262093,0.9896842517721274
UACC-62,135421197,3.0810150127011773
HuT 78,135421197,0.0616295171222303
Namalwa,46907787,-1.1716727326146228
BT 286,49766530,0.4498348011542866
SK-MES-1,375860,-0.2426900588796581
COV434,49766530,-2.1602854851177495
NCI-H2405,100016,6.531050125500204
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249
NCI-H647,10231331,3.723669651517376
OUMS-23,168313016,4.4435991862403155
MDA-MB-453,100016,6.0730906594859215
JVM-2,3689413,-3.874282045367449
TC-71,11396600,3.405164109661843
LP-1,selumetinib-JQ-1 (4-1 mol-mol),-0.0299849732495822
DAN-G,44491742,4.1375495021288
CAL-62,11455910,1.9126970012437423
HOP-92,44491742,4.695490745837731
OPM-2,100016,3.804278037815123
SW1783,73707398,1.417049584359394
COLO 668,107970,1.5128822355273368
NCI-H1869,135999136,1.6552462790975504
SNG-M,439501,-1.900276797941319
JHUEM-1,262093,1.0562191495276867
Calu-3,71466445,2.6015778955315407
NH-6,sirolimus-bortezomib (250-1 mol-mol),1.143169079314691
KYSE-140,11455910,1.0441153824583205
HCC1419,46907787,5.141659597687221
PE/CA-PJ41 (clone D2),135999136,4.2765037519460565
HGC-27,637858,1.3770669368104775
KP-4,11396600,3.580302793635078
THP-1,11396600,3.1299513207633365
ME-1 [Human leukemia],100016,5.540349228215307
Ki-JK,12003241,-1.478318359413444
Caki-1,49766530,-2.8134564290994346
NCI-H1435,9929138,6.22270971673178
LAMA-84,6852167,3.4194645624728257
BT 333,11455910,0.8481846232713552
PLC/PRF/5,12003241,0.8244509806325866
HMC-1-8,73707398,1.3647287690832346
NCI-H2444,644241,2.901364953707021
A-375,selumetinib-JQ-1 (4-1 mol-mol),1.0912668350631578
SK-CO-1,135999136,4.853872243910513
CA46,46907787,-0.8110179268567884
SNU-308,262093,4.9932279379660764
Kasumi-2,49766530,-3.7396811929647513
LS180,9903786,2.2166672873522857
T84,135999136,4.269750359734968
OVTOKO,100016,8.078720974707625
KP-N-SI9s,sirolimus-bortezomib (250-1 mol-mol),0.5710762504018412
2004,11455910,0.701648674397756
COLO 205,375860,-0.9474772906288528
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966
Daoy,9927531,4.407816470136583
HT-1376,46907787,2.915425637626166
KMS-18,46907787,-0.0444535065961487
SNU-213,73707398,1.7452345044805029
MM1.S,11396600,2.9620457472616533
JK-1,10231331,-0.0094076474080567
OAW42,262093,3.645720807716878
AGS,selumetinib-JQ-1 (4-1 mol-mol),0.7685834389081105
A-253,3689413,0.6147211160043753
KE-97,9927531,3.606406667936729
NCI-H1869,11455910,2.924449694106302
KE-37,26596,-2.2525665271951527
CA46,241158,1.6221144264981358
HOP-62,444795,4.062660222672805
BC-3C,73707398,1.995912944947898
DND-41,3689413,-2.0667644412480755
MDST8,73707398,0.930898424190815
BT-20,selumetinib-JQ-1 (4-1 mol-mol),4.7209808702572
YD-38,375860,-0.9666963323879848
HT-1080,tanespimycin-bortezomib (250-1 mol-mol),0.0826003622808549
LK-2,135421197,2.2865264373163487
NCI-H28,439501,-2.3815897212946333
SW48,46907787,-1.5740012638710297
KYSE-450,135421197,2.3081928088852774
A-549,107970,2.6370788506586345
YAPC,71466445,6.285156806731666
COLO 684,262093,1.418781406629004
MCAS,12003241,0.5308085719616568
SNU-8,107970,2.3224728440298814
M-07e,10231331,3.7072976059744134
NCI-H1651,11455910,1.357904809543347
JHH-5,sirolimus-bortezomib (250-1 mol-mol),0.7972150153767945
BT 340,sirolimus-bortezomib (250-1 mol-mol),1.036760644305087
Becker,71466445,4.307879847711241
JJN-3,sirolimus-bortezomib (250-1 mol-mol),0.0133563437119215
T3M-10,49766530,1.7153212560254725
BT 228,637858,2.2538508050873016
KYSE-30,49766530,-1.4671789919373923
U2OS,241158,0.4177230113185624
BT 428,644241,1.7841818020413711
SNU-719,46907787,-0.0717572497015621
NCI-H1703,12003241,-1.7949432370006393
HDLM-2,375860,-0.88724972969489
KMRC-20,100016,7.210629640241846
LN-229,10231331,4.08694802385181
KNS-60,9903786,2.981782520240843
SNU-1033,49766530,-1.347246040659949
KMS-11,6852167,1.1613595325638657
SNU-C1,6852167,0.1423090557165161
GDM-1,sirolimus-bortezomib (250-1 mol-mol),1.1359317053602838
KNS-81,selumetinib-JQ-1 (4-1 mol-mol),7.110946651223067
HT115,44491742,4.056949016282338
NCI-H2087,3689413,-1.4883160931257695
Hs 888.Lu,262093,3.524644323966992
SNU-466,12003241,-1.792822949683991
OUMS-23,71466445,3.24844223945163
SJSA-1,26596,0.7775759099492098
SK-MES-1,44491742,3.681896184622424
Hs 683,44491742,3.840304182439804
SNU-449,135999136,4.264029635041134
PF-382,637858,0.850873658302796
SK-N-DZ,44491742,3.9840069294663025
MDA-MB-453,26596,-1.0726693130426117
OAW42,3689413,0.5201903722679624
FU-OV-1,3689413,-2.180005064661593
BT 286,644241,2.213968846177929
KE-39,107970,2.31854003043047
NCI-H841,UNC0638-navitoclax (1-1 mol-mol),4.479330950981198
HuH-6,26596,0.8914215652548961
MFE-319,375860,0.1651753747878266
HCT 8,11396600,3.8842790603170023
BT 440,tanespimycin-bortezomib (250-1 mol-mol),-2.7167133192176394
TE 441.T,439501,-2.08185324910289
CAS-1,73707398,1.243178259930861
Becker,168313016,4.48609238913996
COLO 678,UNC0638-navitoclax (1-1 mol-mol),1.3905260558490362
Caov-3,44491742,6.286074544034756
HEC-59,3689413,-1.7900495461220194
ChaGo-K-1,135421197,1.864105940411698
KP-N-YN,135999136,4.185097541926131
NCI-H1105,73707398,1.277952733883997
CAL-78,6852167,2.8425857780730936
SK-MEL-2,107970,2.2508906285434143
Raji,11396600,3.2888358336472496
42-MG-BA,135421197,1.023186017239741
OVCAR-5,46907787,2.1714346553006862
VMRC-RCW,selumetinib-JQ-1 (4-1 mol-mol),1.8426593764457728
SNU-245,44491742,4.301989616183203
B-CPAP,6852167,2.612580501807676
HOS,100016,6.425173790511516
HL-60,44491742,3.945358906065035
HCC1395,135999136,4.391261806083376
PC-14,selumetinib-JQ-1 (4-1 mol-mol),0.1857937435498048
SNU-C5,49766530,0.4105480750830131
P-STS,selumetinib-JQ-1 (4-1 mol-mol),1.951618016482338
MHH-NB-11,637858,1.0838908575180757
NCI-H1944,49766530,4.020768643988838
SET-2,46907787,-2.0840425279846553
HD-MY-Z,54596490,4.535330665629844
Li-7,selumetinib-JQ-1 (4-1 mol-mol),-7.070557349165433
MOR/CPR,73707398,1.8563625079342585
A2780,3689413,0.5219259729031659
BHY,10231331,5.244537153432119
SW579,107970,1.6244987565976912
Granta-519,439501,-6.00499370561019
NOMO-1,375860,-0.5184264862355304
NCI-H2052,107970,2.4120996569563253
BT 145,73707398,0.9276611953602932
SNU-8,168313016,4.339041813764209
SNU-410,439501,-1.2001719961376376
Hs 729.T,12003241,-0.5985537077535523
CAL-85-1,9927531,5.462917800107974
TE 617.T,71466445,3.56672644929392
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259
YKG-1,UNC0638-navitoclax (1-1 mol-mol),2.987622235126213
SiMa,tanespimycin-bortezomib (250-1 mol-mol),0.5523677352528538
NCI-H460,46907787,4.3372157131836255
GaMG,241158,4.746833057174428
JVM-3,135421197,0.8439957558117435
NCI-H2196,10231331,5.621753201885216
TE-11,73707398,1.9159507910668552
SNU-685,168313016,6.404851942189217
NCI-H522,444795,5.191031194563041
Toledo,9927531,3.803347409887559
MOLM-16,46907787,-1.411428522933632
OC 314,644241,1.747205449465236
HCC827,3689413,-1.9670372316713456
A-204,44491742,4.019063545989705
NCI-H520,262093,2.5616079053074787
HPAC,135999136,4.37957376504402
MeWo,439501,-2.203137437916754
IGROV-1,11455910,-0.2792640061206097
HuH-6,375860,0.7275713697842162
L-428,3689413,-2.385530955592741
CAL-29,5460769,2.8970816736671416
OCI-Ly19,9903786,1.1452071440663905
CML-T1,168313016,4.15358640853123
NCI-H2029,11396600,2.8760485463291334
Daoy,tanespimycin-bortezomib (250-1 mol-mol),-0.2871492230613796
MOR/CPR,26596,-0.9539590783160214
CAL-85-1,100016,6.683113656599713
TE-9,11396600,5.486103652826923
NU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),-0.7283867124282789
PE/CA-PJ49,135999136,4.298011402376219
NCI-H28,selumetinib-JQ-1 (4-1 mol-mol),-5.691526050173684
F-36P,637858,1.1543782344326252
NCI-H1092,9927531,3.406213307022425
NCI-H446,selumetinib-JQ-1 (4-1 mol-mol),1.746581196190114
GOS-3,sirolimus-bortezomib (250-1 mol-mol),0.3031881482046261
ALL-SIL,168313016,2.945013463521221
NCI-H1623,73707398,1.8898657972875643
AsPC-1,12003241,0.1897400127907629
Caki-2,107970,3.093308869295807
MDA-MB-453,3689413,0.605092083526794
ChaGo-K-1,11455910,-0.3769194241823518
NU-DHL-1,49766530,-4.7275009055236445
Caki-1,UNC0638-navitoclax (1-1 mol-mol),1.2572218654888876
NCI-H2087,73707398,0.8336025649851103
BT 172,11396600,2.88874233952659
SNU-489,241158,3.8247990570864703
BT 179,12003241,-1.00247586074096
OV7,12003241,-1.6318982026296969
A-375,9929138,5.4250105922665375
NCI-H1944,44491742,3.732177387700191
Hs 746.T,6852167,2.617948339328731
SNU-466,73707398,0.902504461291191
KMS-20,sirolimus-bortezomib (250-1 mol-mol),-0.3833823463346493
LUDLU-1,3689413,3.1550499386231325
NCI-H28,241158,2.3012533117747664
KMS-34,selumetinib-JQ-1 (4-1 mol-mol),-0.3341202517618857
Hs 766T,selumetinib-JQ-1 (4-1 mol-mol),-1.1904189535424952
LoVo,262093,2.370412929490009
SNU-423,tanespimycin-bortezomib (250-1 mol-mol),0.0994607736746136
BICR 31,49766530,2.6564815829329236
DMS 273,100016,5.677769516399485
SW1710,3689413,-0.3418925228905715
JM-1,375860,-0.4977027167273706
T24,3689413,-0.672605759999641
Kasumi-2,71466445,1.815897736576068
PC-3,UNC0638-navitoclax (1-1 mol-mol),3.298344799073772
ME-1 [Human leukemia],375860,0.507532063957377
SK-MEL-3,262093,2.386841982025131
SUP-B15,11455910,0.511116887846229
UACC-62,11396600,2.1673340141549886
HCC2279,73707398,1.2685600547710263
ESS-1,3689413,-0.979855371465586
Kasumi-1,637858,0.8254828437519408
MDA-MB-231,12003241,-1.774974219486486
BT 333,12003241,1.72597197998683
COR-L105,44491742,4.003695029376484
JHOS-2,46907787,4.960219995115103
KYSE-150,637858,2.0222292139148887
SUP-B15,9903786,1.6008803071908635
WM983B,11455910,0.7348895690575076
SNU-16,107970,1.3948454573250222
KE-97,26596,-2.711610546447418
SNU-5,10231331,1.1538331312223369
BT 286,444795,5.07961620697437
MCAS,6852167,1.7021529696000626
MDA-MB-415,selumetinib-JQ-1 (4-1 mol-mol),1.6369834680115742
RERF-LC-Ad2,637858,1.7897797033938452
NCI-H1355,9927531,4.199887735428921
OCI-AML-3,439501,-3.711408671836436
MHH-CALL-4,637858,0.6402103133022878
GSU,135421197,3.362120533278017
SF295,100016,6.949657377166824
HCC1588,73707398,1.1440243133842154
SCaBER,135421197,2.9143213088501794
NCI-H1581,selumetinib-JQ-1 (4-1 mol-mol),2.3344397438111404
VMRC-LCD,selumetinib-JQ-1 (4-1 mol-mol),1.7266079975134632
SCC-4,26596,-2.628163319920325
COLO 668,9903786,3.4728233461843745
KYO-1,49766530,-0.7028254429711305
HEC-108,241158,3.683911292843857
MHH-CALL-4,168313016,3.901082293744531
GCT,9903786,3.1531512143319396
WM1799,375860,0.5990452165912616
SUIT-2,3689413,0.4029780891432681
MDA-MB-231,135421197,1.4675791065879262
MDA-MB-231,6852167,3.6519005073230217
SF126,135398744,7.810596319596066
RPMI-7951,sirolimus-bortezomib (250-1 mol-mol),1.5520674857207382
NCI-H1694,637858,0.3995039534325592
22Rv1,5460769,4.1007004291064675
KYSE-180,sirolimus-bortezomib (250-1 mol-mol),1.6916229080787213
JM-1,9903786,1.587415218469425
COV434,73707398,-0.7309489415917809
HCC1588,439501,-0.8839537477169336
AN3-CA,49766530,0.9400447576922468
BT 147,sirolimus-bortezomib (250-1 mol-mol),0.9412516099169256
SK-LMS-1,49766530,-1.7559370930712266
Kelly,26596,-1.7791948075234636
TCCSUP,46907787,2.977323633088547
MCAS,3689413,-1.1400919247426515
NU-DUL-1,49766530,-3.828248490513479
SH-10-TC,100016,6.555483038363527
LS411N,262093,3.2594677855419456
KMS-12-BM,439501,-2.5993845366115016
TTC-709,9903786,2.3304378522453866
HOP-92,637858,1.5659474231121848
5637,107970,2.2197251672380767
PC-3,644241,3.438318735013137
MOLT-3,54596490,4.074964853764077
D283 Med,26596,-3.592310964496019
HuH-6,644241,1.7181445887888465
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894
MDA-MB-231,3689413,-0.2652306492331258
SNU-5,5460769,1.0227075924286728
SNU-1041,selumetinib-JQ-1 (4-1 mol-mol),3.895658717247031
PK-1,tanespimycin-bortezomib (250-1 mol-mol),-1.3417753505365824
BV-173,11396600,2.9579324152439224
HCC1806,9903786,3.5202039340354636
MFE-319,6852167,3.5625471714915395
WM115,46907787,1.8634039559333693
U266B1,262093,2.320136156024279
SK-MEL-1,selumetinib-JQ-1 (4-1 mol-mol),-2.2090163573526653
Mino,11396600,2.601097362695862
MKN74,375860,0.5646140741524153
VMRC-RCZ,439501,0.1982663120150432
KE-37,12003241,-1.2024354482149269
BT 245,262093,2.3897148405812536
23132/87,3689413,0.7778055116853778
KMBC-2,135999136,4.121225006171559
CML-T1,375860,-0.8039918924580166
SK-N-MC,168313016,4.334990427738434
SNU-899,637858,2.6573033243386948
IPC-298,12003241,-0.6695697613758284
SK-N-FI,46907787,0.633002527240528
NCI-H358,9903786,1.2866771615699664
Hs 888.Lu,12003241,-2.029150250693523
HCC202,135421197,1.3435596040644655
SW982,26596,-1.3061424276940652
KE-97,135421197,1.12759931417641
Caov-3,262093,3.252230981856776
L-363,241158,1.721361208612377
253J,637858,2.279095666502017
ONCO-DG-1,sirolimus-bortezomib (250-1 mol-mol),0.4937178485517417
NCI-H929,135421197,1.062377968485951
SK-N-MC,135999136,1.3861351428117616
OVSAHO,sirolimus-bortezomib (250-1 mol-mol),1.2333727480896128
JHUEM-2,11455910,0.0999331855360444
HCC1500,9927531,5.051014893697188
BT 228,12003241,-1.6653206714884845
BT 145,135999136,1.287616200514186
JHH-5,3689413,-2.062402723839909
BT 179,26596,-0.8233770737136159
NCI-H747,selumetinib-JQ-1 (4-1 mol-mol),-2.0784828379342275
CL-34,selumetinib-JQ-1 (4-1 mol-mol),-3.160070646459842
RPMI-8226,444795,2.5324403629836114
NCI-H1694,49766530,-3.246574682514139
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623
SJSA-1,262093,2.9524375383319468
JHUEM-1,9927531,4.870867049217503
NCI-H1755,135421197,1.7196206530846876
ES-2,637858,2.4124737052825975
SNU-C4,73707398,1.213067519189312
M-07e,375860,-0.7306719237293631
RPMI-8226,135398744,6.232374281438443
Kasumi-1,135421197,1.491198054618576
NCI-H2286,135421197,1.3585015224229091
SCC-4,selumetinib-JQ-1 (4-1 mol-mol),0.7097382019229815
T3M-10,12003241,-1.1759997048612671
Lu-99,262093,3.013120554949913
NCI-H522,11455910,0.4156799864056491
SNU-410,49766530,1.0142633339399836
EFE-184,241158,4.6559218833737095
Calu-1,262093,2.8993991941012704
TE-5,9929138,7.538066804414881
FTC-238,375860,-0.2933892047161701
SaOS-2,107970,2.235066344736828
JHH-1,26596,-0.7682069189838904
SNU-1196,439501,-2.3352671282254303
YD-15,11455910,1.434316032947977
BT 504,136227331,4.427068433279088
LOX-IMVI,135421197,1.985626548385356
HCT 116,11455910,1.427750976717415
Panc 05.04,tanespimycin-bortezomib (250-1 mol-mol),-3.230060411523549
JHUEM-3,9903786,2.091612721233031
JJN-3,135398744,6.34309809291168
SK-MEL-5,73707398,1.781035477419176
MOLT-16,637858,0.9912301542753724
NCI-H508,sirolimus-bortezomib (250-1 mol-mol),0.7195278231297386
KO52,3689413,-4.063517257373306
NCI-H1155,444795,4.055241272148919
L3.3,5460769,1.7814582708772182
LCLC-103H,sirolimus-bortezomib (250-1 mol-mol),2.0296751829948683
SNU-1196,12003241,-1.2616769402260497
BC-3C,selumetinib-JQ-1 (4-1 mol-mol),2.3865928246681336
KYSE-180,241158,4.333679160826191
NB1,49766530,-2.158662190283236
MDST8,selumetinib-JQ-1 (4-1 mol-mol),-0.5732607032642526
TE-11,12003241,-1.4991757511197057
AU565,439501,-2.8703859168743384
TUHR14TKB,selumetinib-JQ-1 (4-1 mol-mol),1.836081106756344
SU-DHL-8,375860,-0.3507557955455605
ES-2,262093,2.44906158082759
NCI-H2342,selumetinib-JQ-1 (4-1 mol-mol),2.310038447385045
SNU-475,107970,3.0030316321993484
A-549,73707398,2.11945224002363
697,100016,3.656696343596264
Hs 936.T,439501,-0.3006494435216346
HLF,9903786,4.061487019079308
EC-GI-10,12003241,-1.9756752078564588
CW-2,6852167,3.634155796835429
KE-97,241158,3.4100000813842013
HSC-4,135999136,1.7584955345229645
HCT 15,375860,-0.5583301050627271
NCI-H660,73707398,-0.0968358716112526
SNU-1214,73707398,0.3322136890505088
VM-CUB-1,73707398,0.9598904700080856
HT-144,11455910,1.485095962050077
LOU-NH91,9903786,3.184012464559237
SNU-C5,46907787,2.7707191723433673
HEC-1-B,sirolimus-bortezomib (250-1 mol-mol),1.0526143004361572
SET-2,49766530,-3.130186221857788
DU145,135999136,4.106502655585601
HuH-28,439501,-2.3734651091068693
SET-2,11396600,3.171295781716927
GOS-3,3689413,-2.185831490776692
T98G,73707398,2.1109141148348254
OAW42,6852167,3.327110546741901
WSU-DLCL2,439501,-2.4187850283326933
NCI-H2228,selumetinib-JQ-1 (4-1 mol-mol),0.712413787162595
BT 333,3689413,0.756626575903668
MEC-1,71466445,2.7068349360844675
Hs 578Bst,selumetinib-JQ-1 (4-1 mol-mol),4.806808680835756
KYSE-410,439501,-2.4284024166032365
Hs 729.T,49766530,-0.2266090443337086
BT 359,136227331,5.057853288307873
L-428,49766530,-2.874438748279996
SCC-25,9903786,1.6185741180598072
HCC2108,sirolimus-bortezomib (250-1 mol-mol),3.017488658473148
KE-39,UNC0638-navitoclax (1-1 mol-mol),0.4083822928083427
Detroit 562,375860,-0.8636251834694404
CFPAC-1,3689413,3.8323467943354337
UACC-62,73707398,1.6592602760990676
SNU-1077,637858,2.311785541808234
COLO 699,sirolimus-bortezomib (250-1 mol-mol),-0.458397325764597
NUGC-4,3689413,0.1501840734639977
TC-71,selumetinib-JQ-1 (4-1 mol-mol),4.262945722459713
Yamato-SS,selumetinib-JQ-1 (4-1 mol-mol),-0.2712104381425136
Karpas-620,5460769,3.7991710121936304
SK-N-SH,637858,0.7787528931707683
NCI-H1184,637858,1.2845311841937697
SNU-601,selumetinib-JQ-1 (4-1 mol-mol),0.5711471073512734
COLO 684,11455910,-1.3406228718579627
SR,11455910,-0.2292707717843843
SK-LMS-1,5460769,5.744937264039862
SCC-9,241158,3.962823581088113
NCI-H810,6852167,1.7168081280846608
HLF,135421197,1.600730736912683
NCI-H2009,9903786,1.8298580590992315
BT 164,241158,4.083914381884583
SK-N-BE(2),9927531,3.511797224243287
NCI-H2087,135421197,1.3607762118240936
BT 428,135398744,8.121810698450407
Ri-1,3689413,-2.346816387466721
TCC-Pan2,135421197,1.46026769574307
MDA-MB-468,375860,0.2372575740208442
BT 159,241158,4.193201486638546
SNU-466,46907787,-1.051542172508183
MeWo,12003241,-1.7569732997280945
HCC2279,637858,2.02122620769869
OPM-2,12003241,-2.9738714531294232
639V,135421197,3.226794865257896
DEL,9903786,1.8347897300097875
CHP-126,46907787,-0.1524132064983023
RVH-421,73707398,1.5982063563026574
OVTOKO,selumetinib-JQ-1 (4-1 mol-mol),4.12243300561417
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
SNU-1105,71466445,6.046955371467825
BT 245,135421197,1.3239460835535384
BICR 22,11455910,2.0554057071158303
NCI-H841,637858,1.860990633229084
SH-10-TC,9927531,5.280985634466932
RERF-LC-MS,6852167,1.8897499878184068
SNU-1041,637858,3.0266803479554034
TE 441.T,tanespimycin-bortezomib (250-1 mol-mol),-0.9090621811033658
HEC-251,135421197,1.306349279370071
OVCAR-5,6852167,4.045184483405561
LCLC-97TM1,375860,-0.9613247940016756
HEC-108,439501,-2.3418750446111347
NCI-H2228,46907787,3.0569158272450196
NCI-H1299,637858,2.0159595809429716
COV434,262093,2.1356582362370897
SF126,49766530,-2.4401287268273135
T3M-10,9927531,5.241044178261577
RERF-LC-MS,637858,3.156110522031532
P12-Ichikawa,375860,-0.9657726988428024
OC 314,46907787,-0.3791723220517189
KE-97,3689413,-2.1029735471074225
MKN1,107970,2.535523742229024
PK-45H,12003241,-0.6609061403409452
HCT 8,44491742,4.525976447408572
HuP-T4,375860,-0.2953279197993684
BT 224,3689413,1.7352583151087375
SNU-840,49766530,1.025296962572851
BV-173,135999136,1.7763340204720903
Hs 729.T,107970,2.3122831170597475
GaMG,644241,2.451949741066743
HCC1954,241158,3.120856344806506
LS513,46907787,0.9651727941211948
BT-16,tanespimycin-bortezomib (250-1 mol-mol),-2.3872852877546062
GP2d,135421197,2.1727622250503607
HPAC,5460769,1.6003677750846823
COLO 800,262093,3.3147101233442196
DND-41,11455910,1.0422963026529204
KYSE-140,tanespimycin-bortezomib (250-1 mol-mol),1.07256809549566
BICR 22,73707398,1.4183060149157571
HuNS1,3689413,-2.2730227081216787
NCI-H1915,44491742,3.914803792289667
KYSE-150,3689413,0.7938684230504212
OE21,135421197,1.5054570422138
COV644,5460769,6.215803603541286
SNU-449,11455910,0.8938620280411973
UACC-257,9927531,4.918712273550195
HGC-27,135398744,6.47323705988127
GA-10,168313016,4.160019409093505
SYO-1,11396600,4.152528244885972
MKN1,11396600,3.1092750639740903
TT,3689413,3.828584328493261
SK-MEL-24,11455910,1.6031217504483102
OAW28,3689413,-1.4375749125930504
HT115,9929138,5.341285159279084
SNU-1077,9903786,3.350516769184116
MKN7,44491742,4.213117229463602
NCI-H520,135421197,1.6066426721545042
L-428,46907787,-0.6484055986243037
HSC-4,135421197,2.1482643592466495
G-401,9903786,2.8038927126182327
PaTu 8902,135421197,2.3024316473658004
PaTu 8988s,241158,4.442566432866993
UM-UC-3,3689413,2.922700003558909
Mel JuSo,3689413,1.1230560004280308
TTC-709,26596,-1.3495496110855745
K-562,439501,-2.3563528898814905
OVCAR-5,135421197,1.110544860283993
MDA-MB-157,439501,-3.062684000428755
KMS-12-BM,9929138,5.078790269314151
NCI-H889,sirolimus-bortezomib (250-1 mol-mol),0.2656480378384786
SK-N-BE(2),262093,1.809319637639724
MeWo,49766530,4.570214778123743
Raji,135421197,1.3656726509446273
TE-8,375860,-0.3574304556846926
BT 239,72967,3.6652679956846272
MKN45,135999136,1.8479400978167373
H-STS,49766530,-3.13255748664254
NCI-H2087,tanespimycin-bortezomib (250-1 mol-mol),-5.178784245038985
SNU-466,9903786,3.45397809087946
SK-N-DZ,637858,1.01149631221124
KYSE-410,107970,2.1635571527834676
SK-N-BE(2),375860,-0.3438904708611859
Daudi,11455910,-1.173613913103254
EBC-1,46907787,-0.0936261851935095
TC-71,11455910,0.3179864486303165
U-BLC1,44491742,3.768443657215341
VMRC-LCD,6852167,3.4717019465216037
SBC-5,49766530,2.674414744921775
NU-DUL-1,9903786,0.8090083924855098
Lu-65,73707398,1.7319675343544505
253J,26596,-1.986846221842857
HEC-1-A,375860,1.1545449877423215
L-540,168313016,5.054218548454125
SK-N-BE(2),26596,-1.6881701599106194
KYO-1,168313016,5.709011605678993
Kasumi-1,9903786,0.9129411943023928
SNU-182,644241,1.5546173589165062
NCI-H1869,439501,-1.575584272947446
TE-5,44491742,3.7855362982761194
EJM,100016,6.634092198961092
SW1271,168313016,5.582938604018868
MJ,11455910,1.0370030045754386
NCI-H226,46907787,3.460984679843558
HT-1376,439501,-0.8291876191032579
KYSE-140,9929138,7.103811482735402
Fu97,3689413,-0.2126169445323924
HT-1080,10231331,3.574558984410994
BT 216,54596490,4.353678237582666
Panc 02.03,107970,3.0394503344184214
CAL-54,11455910,0.6457231079325149
HCC15,3689413,0.3467742153458734
HDLM-2,135999136,4.831194178567747
NCI-H2141,UNC0638-navitoclax (1-1 mol-mol),0.371334188919835
SK-LMS-1,262093,2.881429058515633
DoHH2,49766530,-6.954726736729235
SEM,6852167,1.184676073870636
OVTOKO,5460769,2.45887134191899
OCI-AML-3,5460769,2.571994692264208
KYSE-520,637858,3.405755919690514
PF-382,49766530,-3.617209334662046
VMRC-LCD,73707398,0.967348855291882
DU145,11455910,2.077410590950561
RCM-1 [Human rectal adenocarcinoma],6852167,4.10667945313068
NCI-H1869,241158,5.0819681903137806
ChaGo-K-1,10231331,4.797062827822195
AN3-CA,3689413,0.1719288482065274
ONCO-DG-1,135999136,1.5915820066692796
BT 286,9929138,6.547331402872382
VCaP,6852167,2.151866310697208
SNU-182,107970,2.1936630998991262
Lu-99,135421197,1.2736591779946078
IGROV-1,6852167,1.5305143027352028
NCI-H1666,135999136,4.367820960898614
GB-1,11396600,3.609932395636561
CHP-126,3689413,-2.431147866907691
NCI-H838,5460769,0.2411735941540018
NCI-H520,6852167,1.505656389836919
SK-MEL-3,11455910,1.2991192016646154
KP-N-YN,9927531,3.406811023385209
NCI-H2170,444795,4.456748853500419
YD-10B,375860,-0.7327340587593554
TE 617.T,73707398,0.9549107621752264
SNU-685,sirolimus-bortezomib (250-1 mol-mol),0.4201840468382607
OPM-2,UNC0638-navitoclax (1-1 mol-mol),2.0554805477116207
SNU-213,selumetinib-JQ-1 (4-1 mol-mol),1.0193842284675143
OCI-Ly19,73707398,0.0896254246290502
SYO-1,100016,3.831378840669671
OVK18,11396600,3.420105685661315
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236
NCI-H146,49766530,4.81095512251176
HuG1-N,54596490,5.177857055291183
SNU-719,135421197,0.9792842920964928
EFM-192A,241158,4.32002704513449
WM1799,sirolimus-bortezomib (250-1 mol-mol),0.8718810301114039
KMS-11,3689413,-0.1519254071205927
MOLM-6,637858,1.0239222762950713
LXF 289,439501,-1.653941874457911
TT,tanespimycin-bortezomib (250-1 mol-mol),-0.7119220274254645
U-937,12003241,1.6522375422653783
P12-Ichikawa,262093,1.3353925545837786
DEL,135421197,2.352546042439028
NB1,10231331,2.218353261890846
DMS 114,9903786,5.060139909585821
Caki-1,11455910,2.5342429467421144
NALM-6,135421197,0.6704764022840549
HT-144,selumetinib-JQ-1 (4-1 mol-mol),-0.2086141141315494
MOLT-16,5460769,0.1124317409166702
NCI-H2342,3689413,-0.4986291797575011
HD-MY-Z,tanespimycin-bortezomib (250-1 mol-mol),-0.5200948586273125
Hs 294T,107970,1.788602892415094
Hs 852.T,selumetinib-JQ-1 (4-1 mol-mol),1.1151349056672275
JJN-3,637858,0.9088754309056672
ONCO-DG-1,241158,3.197101697830666
PaTu 8988s,262093,3.243938357884203
NCI-H1666,12003241,-2.860788946487449
B-CPAP,375860,-0.8507879875115774
NCI-H2030,73707398,1.6875070689591785
T3M-10,135421197,3.6176522796441546
LAMA-84,107970,2.224975468533932
NCI-H1651,107970,1.540473500145766
MIA PaCa-2,11396600,3.289038329533777
DMS 79,107970,1.6835351033356816
KYSE-410,9927531,5.048506934315496
JK-1,100016,6.141145240463154
Li-7,sirolimus-bortezomib (250-1 mol-mol),1.648845236287691
NCI-H2228,107970,2.8314632132915207
NCI-H2030,6852167,3.664120569274895
BT 416,11396600,2.2118594965797147
KYM-1,9903786,3.7679848907863738
SNU-1105,5460769,2.875284182310896
ONS-76,3689413,-0.2845128895134612
HCC1588,26596,-1.1478060280369464
NU-DUL-1,168313016,3.4848851465403667
SNU-668,tanespimycin-bortezomib (250-1 mol-mol),-0.1123433935372655
SK-MEL-1,10231331,-1.9528897384138784
KYO-1,444795,4.725029182648668
LAMA-84,5460769,3.9784862352409105
IGR-39,241158,5.331256362598503
BV-173,44491742,2.039629297457472
SK-MEL-2,sirolimus-bortezomib (250-1 mol-mol),0.4660061968632925
OVTOKO,12003241,-1.0973416897014734
L-540,439501,-2.6441519340115236
Caki-1,107970,3.065617455859658
BT 245,12003241,-0.4272477548788383
NCI-H1373,46907787,0.3909534501553842
MCF-7,637858,2.2242194755863856
KE-37,168313016,4.401025656704106
KE-97,100016,5.841816758085698
SNU-16,73707398,0.8336482871010481
RL95-2,3689413,-1.8797416437850616
Rh30,49766530,-2.324710777710102
Calu-3,11396600,4.335639453655832
HuP-T4,26596,-2.6464216672474783
ZR-75-30,135421197,0.9431769837232008
IGROV-1,439501,-2.1510551928674557
L-363,71466445,2.316676755012692
MFE-296,12003241,-1.246731028560956
HMCB,241158,3.538321708116031
DMS 454,11455910,1.2938635688773483
HEC-265,UNC0638-navitoclax (1-1 mol-mol),-0.4693446779328366
NCI-H841,135421197,2.4797318977451095
KMS-34,tanespimycin-bortezomib (250-1 mol-mol),0.6300462572492305
NCI-H647,637858,3.278669479288834
BICR 18,9927531,5.5562254884624895
NALM-6,sirolimus-bortezomib (250-1 mol-mol),0.084215684734826
SUP-T1,637858,0.5136167225072658
MHH-CALL-4,439501,-2.5308829551991168
KMRC-1,107970,3.035071998795665
HCC2279,46907787,1.5309207523287058
ZR-75-1,6852167,1.974149453818777
BT 112,375860,-0.4292821848483891
D283 Med,168313016,4.168522701530026
TYK-nu,3689413,-0.8961723591289054
NCI-H1155,selumetinib-JQ-1 (4-1 mol-mol),-0.0960210384523843
NCI-H520,12003241,-2.710304641181941
HT115,selumetinib-JQ-1 (4-1 mol-mol),-0.8127871371839009
SU-DHL-1,46907787,0.92481130470373
NCI-H2087,12003241,-2.8362492565909543
NCI-H2444,44491742,4.369311972266699
SK-MEL-3,9903786,4.6944360721993545
NH-6,9927531,5.219237358239311
NCI-H2291,262093,3.0616783331233197
JJN-3,49766530,0.5555169127000841
GB-1,9927531,4.312258679101311
NCI-H446,644241,3.4620716948259123
G-361,375860,-0.1039366462277599
DND-41,49766530,-2.480417892949832
LMSU,9903786,3.928631993031556
SNU-1076,107970,2.385093319314459
YD-15,46907787,-0.7954794802454365
PE/CA-PJ49,9927531,5.215467759359
IGR-1,375860,-0.2003147634116378
NU-DHL-1,71466445,1.452037118148276
A-549,9929138,6.139762216307962
JURL-MK1,10231331,-1.884478324211451
COLO 699,439501,-0.4708312711011941
HOP-62,5460769,2.443615735481444
SNU-46,439501,-2.258414005891366
OE21,tanespimycin-bortezomib (250-1 mol-mol),-1.6225844369747413
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928
SK-MEL-5,439501,-0.7759362068872153
VM-CUB-1,9903786,3.0676048433352268
Hs 888.T,637858,2.4627454222382235
DB,637858,0.9550301785887676
Aska-SS,73707398,1.256290456128312
NCI-H1339,5460769,-0.265386406275254
SNU-213,9903786,2.2891232968098887
BT 320,sirolimus-bortezomib (250-1 mol-mol),1.2360663463766004
QGP-1,sirolimus-bortezomib (250-1 mol-mol),1.0320237802548329
U-251MG,46907787,3.9064535706541945
MDA-MB-468,11396600,4.2742989673627045
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662
SNU-C1,46907787,0.1536504661582554
PK-59,12003241,-0.8874443449539482
C2BBe1,26596,5.1914595275269795
NCI-H1299,3689413,-0.9598507897960026
EoL-1,73707398,-3.0491075359956508
KMS-28BM,selumetinib-JQ-1 (4-1 mol-mol),-2.4132470490315883
DU4475,49766530,1.1450328858367227
TE-14,11396600,4.264622215416366
SK-CO-1,49766530,2.416603727276247
NCI-H292,49766530,5.348764781206105
RPMI-8402,135421197,0.8834932639167268
NCI-H520,46907787,1.4915843927881316
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576
LNCaP clone FGC,375860,-0.5963987861231773
HGC-27,444795,2.4083732799097395
MeWo,135999136,4.477003311279449
COR-L105,444795,5.02091820523187
HuG1-N,637858,2.4963852514993268
BT 286,46907787,3.635470224586541
Rh41,73707398,0.7299412970985347
LS513,9927531,6.189167828595346
JHUEM-7,73707398,0.8849918098478027
NCI-H2122,5460769,2.4268150631675067
SU-DHL-8,71466445,1.823428220748298
DB,73707398,0.5293823110528094
A2058,sirolimus-bortezomib (250-1 mol-mol),2.018085480755274
SNU-1079,11396600,3.205631918167514
Panc 04.03,241158,4.444137488799797
BT 440,644241,2.739700914223042
Peer,sirolimus-bortezomib (250-1 mol-mol),-1.139363807048106
GaMG,44491742,3.8685046453697383
BICR 6,100016,5.983099357165641
NCI-H1703,3689413,-2.562471575946014
SF295,135999136,4.283449365552917
U-937,135999136,3.69419410967262
Capan-2,73707398,2.506465722260324
Ku812,439501,-2.3195298765386587
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
KMS-26,241158,1.8879300052760837
WM983B,11396600,3.738380516099371
NCI-H889,UNC0638-navitoclax (1-1 mol-mol),-2.669944065758076
HSC-2,tanespimycin-bortezomib (250-1 mol-mol),-0.2988768157355406
OCI-Ly3,49766530,-2.896711539543773
A-549,12003241,-1.903076073453771
OCI-AML-5,439501,-3.3473386459158583
OCI-Ly3,46907787,-0.722061915015215
LS411N,9903786,3.6806866285220017
SK-N-FI,439501,-4.082548455414269
SNB-75,637858,2.6086368841985608
SK-MEL-24,49766530,0.9936370719790436
BT 422,44491742,4.87231922177064
EFE-184,135421197,2.5178551703046277
BT-20,241158,4.666874417516415
OV7,135421197,2.579158372442756
PE/CA-PJ49,3689413,1.6027869787622069
Hs 683,135421197,1.945110581550152
SK-MEL-28,selumetinib-JQ-1 (4-1 mol-mol),-0.6682697886543986
IGR-1,tanespimycin-bortezomib (250-1 mol-mol),1.1267581666470343
PE/CA-PJ15,439501,-2.069757641280327
A-549,44491742,4.437272986024
Namalwa,100016,3.934978584241161
Panc 08.13,sirolimus-bortezomib (250-1 mol-mol),0.500337549713312
HDLM-2,637858,1.3890823822291447
ECC10,10231331,3.4361664003584824
EJM,3689413,-2.394173462666658
OC 314,44491742,4.454392522958538
NCI-H1694,tanespimycin-bortezomib (250-1 mol-mol),-0.386320713281567
253J-BV,107970,2.4409905185132432
COLO 829,5460769,5.712006369948703
SNU-899,6852167,2.8368055986724774
D283 Med,73707398,0.757498039182734
Kelly,11455910,-0.435640272884412
HCC1937,241158,4.91326617468956
OCI-AML-3,73707398,-0.3023697675289024
HCC1143,selumetinib-JQ-1 (4-1 mol-mol),2.450816568945253
IGR-39,439501,-2.7155182926460832
NCI-H1373,11396600,3.5940766248042495
LMSU,439501,-3.1304465735998153
BT 216,tanespimycin-bortezomib (250-1 mol-mol),-1.562937593098705
KNS-60,6852167,2.5006125988541203
JHH-2,10231331,1.680867095557431
T84,11455910,1.5017947925367456
SNU-16,9903786,1.405581496282783
697,9903786,0.9408007056276604
EFO-21,637858,3.247378970072765
Raji,3689413,-1.7827501217470076
NCI-H1703,100016,6.215140096774371
HDQ-P1,439501,-2.3169119812080794
EFO-21,73707398,1.8103187924362223
SF268,135999136,1.9538592313665253
SUP-M2,135421197,0.9814934118096088
NCI-H727,73707398,1.5620380856857303
KMS-20,637858,0.4496747428654858
KMS-20,439501,-3.5751856752548985
YD-10B,46907787,-0.6754469582299863
DMS 454,3689413,-0.1217907891040976
NCI-H146,11455910,-0.4209962248823531
SIG-M5,12003241,-2.3044245068014826
G-402,637858,1.1376865921728858
SCC-25,73707398,0.6106904052422437
OC 314,135999136,1.5511353326033843
NCI-H650,241158,4.216893236896897
WM983B,262093,4.372812176554698
KP-3,9903786,3.3194843074548843
NCI-H2029,262093,2.84677790575948
BDCM,439501,-2.7334853290513497
SNU-601,46907787,1.4332715707381218
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242
WM1799,12003241,-2.735191284404769
TE-8,49766530,-2.1976290152657114
UO-31,9903786,3.174003298065322
SUP-T1,444795,1.0883115007500728
SK-OV-3,107970,2.5604111984812152
HSC-2,6852167,2.0061247190465785
SNU-886,135398744,6.3424886084429435
HCC4006,107970,2.1045056981388246
JIMT-1,26596,-0.816309459972074
NCI-H23,46907787,-0.1743912151849711
MOLT-13,26596,-2.4111257577546565
Ku812,375860,-0.7042833930454624
Fu97,637858,1.7613524415247008
DMS 79,5460769,3.0772238606557623
Hep-G2,10231331,-0.8368419788063003
KMS-18,3689413,0.1282967701093688
WM88,tanespimycin-bortezomib (250-1 mol-mol),-2.8916470647545007
GI-1,637858,2.098296851941244
HSC-4,107970,2.304506496588027
BT 187,6852167,4.060958892704537
SK-MEL-5,135421197,1.8346447693413537
LNCaP clone FGC,46907787,-0.4203114771143783
RERF-LC-A1,135398744,8.259619126952485
ACHN,12003241,-1.5952093864502457
YH-13,241158,3.687700430080618
A-204,11455910,-0.408799298050112
A-673,439501,-3.092013019617277
JURL-MK1,262093,2.648959979850121
VMRC-LCD,12003241,3.8307047822357343
HT-144,46907787,4.841334264393981
SNU-423,135421197,3.0122188559971725
HMCB,46907787,2.4282883374132256
MV4-11,71466445,1.1799710658743192
PK-59,11455910,1.1021180024981292
HT115,46907787,-0.537623842088779
ME-1 [Human leukemia],107970,1.857582457084921
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
RPMI-8402,107970,2.195898791012078
NCI-H929,241158,1.4883272197282302
NCI-H2106,9903786,3.304741679115025
HCC38,637858,1.176311415615167
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
TE-10,sirolimus-bortezomib (250-1 mol-mol),0.6005656385189257
Raji,26596,-2.574302974428465
NALM-6,11396600,2.9362643003919975
BT 239,5460769,-1.3091160600101754
HEC-6,12003241,-1.1839534104512932
HCC1954,637858,1.5173302564464135
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693
COLO 678,73707398,1.0849189454014951
BHY,5460769,2.8101975648917468
NCI-H661,selumetinib-JQ-1 (4-1 mol-mol),2.8735822394027335
COLO 829,241158,5.392571054594158
JHH-5,107970,2.0070201087005457
SW1990,tanespimycin-bortezomib (250-1 mol-mol),-3.036947159692904
NCI-H929,selumetinib-JQ-1 (4-1 mol-mol),-1.4418974567272833
HEC-251,6852167,3.664993078516629
Detroit 562,135421197,1.0926229563125225
KMS-21-BM,6852167,0.4278382768265162
MPP 89,135999136,4.342754015046465
SK-MEL-2,3689413,2.4030655110444767
HLF,73707398,1.1086250249858645
Hs 944.T,262093,3.8646335441234823
HEC-151,selumetinib-JQ-1 (4-1 mol-mol),2.04219566232124
Caki-2,UNC0638-navitoclax (1-1 mol-mol),0.6386694909249623
EC-GI-10,selumetinib-JQ-1 (4-1 mol-mol),4.048995652828291
BICR 18,3689413,0.5803768983412222
BT 340,644241,3.2445197760209505
SJSA-1,12003241,-0.348535560110424
MPP 89,439501,-3.0783668430470574
SK-N-AS,sirolimus-bortezomib (250-1 mol-mol),0.1203472334672894
VMRC-LCD,sirolimus-bortezomib (250-1 mol-mol),2.1405006369000232
Mel JuSo,6852167,2.9551227658662103
CAL-51,107970,2.299284460939792
NCI-H522,12003241,-1.5672925136718587
LXF 289,135421197,2.6553019911408056
NCI-H2228,637858,3.1749317104999673
HCC-56,6852167,3.667817096482301
OV-90,5460769,5.624374105443753
SUP-T1,71466445,1.8491194915279467
Calu-3,5460769,-0.6817561012415637
T84,262093,2.390395114942932
NCI-H1793,100016,7.252403961124031
SUP-HD1,49766530,-3.081720899400098
KMS-21-BM,tanespimycin-bortezomib (250-1 mol-mol),-3.1292569725831796
OCI-Ly3,135999136,1.7797204950280945
NCI-H1092,135421197,1.379439810077043
NCI-H810,11396600,2.3533971168912036
NCI-H2172,73707398,2.7683774259754914
BICR 22,375860,-0.6251605141105395
2004,44491742,4.273676019695118
Kuramochi,107970,2.378071782828113
NCI-H1373,9903786,3.0736149101448893
NCI-H1341,107970,1.14679418621191
SW620,9929138,6.470174413186685
RPMI-7951,135421197,2.3107830834906324
HuT 78,241158,3.345962703014529
KG-1-C,6852167,3.358969778167105
LoVo,12003241,-2.8621949377385465
SNU-46,135421197,1.3377995260402369
PE/CA-PJ34 (clone C12),12003241,-0.6178639171957262
FU-OV-1,10231331,3.398558944555642
HEC-108,375860,-0.0015834583996186
SCC-4,11455910,0.5911512823156414
LN-229,49766530,-2.6497370695255857
MOLT-13,136227331,4.740160343609143
HCC2279,107970,2.1079245815916843
IGR-39,637858,2.3727831768497993
MJ,sirolimus-bortezomib (250-1 mol-mol),-0.1253732166157266
22Rv1,241158,4.118277920202298
PaTu 8902,3689413,3.662647678116459
OCI-AML-3,11396600,2.62511537736271
BT 231,439501,-3.8677572824685913
Mino,375860,-0.5060371680285715
NCI-H2196,375860,-0.2759858226988109
CAL-54,375860,0.076830899239988
SK-UT-1,selumetinib-JQ-1 (4-1 mol-mol),5.500503252581381
K-562,11455910,-0.068399521398108
BL-70,73707398,0.9826136409699476
U-937,637858,1.48880900039916
NU-DHL-1,26596,-3.470221600864271
EBC-1,637858,1.730597013869335
SIG-M5,9927531,4.880658167161108
COV644,107970,1.6396502941518332
639V,5460769,5.247401600018928
LXF 289,3689413,0.4542816941401804
Pfeiffer,44491742,3.3297086723950553
HMCB,sirolimus-bortezomib (250-1 mol-mol),0.2910880989689153
HCC95,tanespimycin-bortezomib (250-1 mol-mol),-0.0613788307173083
J82,3689413,2.7361853242444045
PE/CA-PJ34 (clone C12),54596490,5.097353286236204
BT 498,73707398,4.023335284833002
BT 145,11455910,-0.1698312216802191
KYSE-180,tanespimycin-bortezomib (250-1 mol-mol),-0.8459544412135208
UO-31,262093,2.5027892995722674
HPB-ALL,107970,2.29047871440167
PF-382,444795,3.785413836559396
NCI-H2170,sirolimus-bortezomib (250-1 mol-mol),0.3634507455744757
Daudi,26596,-3.612902475241139
MPP 89,375860,0.3862595177296635
HPAF-II,3689413,1.4854609616797476
Panc 02.03,10231331,3.962628244123872
SK-MEL-31,tanespimycin-bortezomib (250-1 mol-mol),2.560525845699468
SNU-C2A,135999136,5.3185913230589925
BHT-101,637858,2.210357872554675
Daudi,9903786,1.3988461789185107
HSC-3,439501,-2.291291548686292
NCI-H23,71466445,3.4218295182871405
TE 617.T,selumetinib-JQ-1 (4-1 mol-mol),1.4912652874419787
TE-8,selumetinib-JQ-1 (4-1 mol-mol),0.5093233831450799
CAL-27,49766530,0.710892933347092
LC-1F,tanespimycin-bortezomib (250-1 mol-mol),1.261925234920199
SK-MEL-1,UNC0638-navitoclax (1-1 mol-mol),-0.6906136435096342
COLO 829,selumetinib-JQ-1 (4-1 mol-mol),-0.4824383970487524
KMRC-2,selumetinib-JQ-1 (4-1 mol-mol),3.693514223055559
ACC-MESO-1,44491742,5.613898283692527
IGR-1,11455910,1.3265797692921302
NCO2,3689413,-3.837216983883232
NCI-H747,11455910,-0.1344323307423927
LS123,262093,2.2774181206163018
BT 498,6852167,6.0420041098120985
SUP-T11,44491742,3.738526329456195
CML-T1,3689413,-2.671933251411637
BT-474,73707398,1.0474698976362606
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727
Capan-1,11396600,3.9695297031649384
JM-1,107970,1.4704012549786991
HCC1937,11455910,2.342196786755475
PE/CA-PJ34 (clone C12),26596,-1.1037163261022582
KMS-27,sirolimus-bortezomib (250-1 mol-mol),0.0328786954835015
KU-19-19,262093,2.7281718696395303
CCF-STTG1,49766530,2.4939305222304955
WM983B,241158,3.7381276806355537
HCC1806,12003241,-0.1866891199802881
BT 231,637858,1.9874949933256931
CAL-120,6852167,3.8186054907808344
MDA-MB-415,sirolimus-bortezomib (250-1 mol-mol),2.5616194008456916
Hs 822.T,241158,6.131081748082957
TE-15,100016,6.263488161224716
SK-MEL-24,44491742,3.9511074387326337
HEL 92.1.7,262093,2.5840863683898885
SU-DHL-10,9903786,1.7653767834986365
P-STS,375860,0.1612218276357334
Becker,375860,-0.5928207112259023
MOLP-8,107970,1.7976582890286323
NCI-H322,selumetinib-JQ-1 (4-1 mol-mol),1.745335379225679
HuH-1,637858,3.115781360028532
HCC366,637858,2.347165295871174
Ci-1,439501,-2.567904110965142
OVCAR-4,262093,2.934935020789089
GCT,46907787,2.5323439300776873
K-562,26596,-3.6076758496321832
HCC366,100016,6.086233690393214
COR-L88,11455910,2.1470995526848258
OCI-M1,262093,1.0880796533665364
Kelly,9927531,6.376471657693257
BT 328,107970,2.1571810870296333
SNU-1214,3689413,-0.7711373431609502
Mono-Mac-1,637858,0.9949100169924338
NCI-H1092,444795,4.269979452389004
NCI-H661,11396600,4.301216087095742
MHH-CALL-4,71466445,1.6335508440746371
HT-1080,439501,-2.2877487074012026
ONCO-DG-1,107970,2.353407036343958
Hs 729.T,44491742,3.716267531008215
JMSU-1,5460769,-1.1957562952388658
SNU-410,444795,5.209490058147456
HOP-62,135999136,4.132685432378933
YKG-1,9927531,5.706988241233545
SNU-1077,6852167,3.093534637774652
DV-90,444795,4.1768333505010435
A-204,444795,3.9482496369859392
BT 172,6852167,3.7177159373997304
ES-2,selumetinib-JQ-1 (4-1 mol-mol),3.5375386475265116
HCC4006,241158,3.3479342168717694
Capan-1,135999136,4.351414780537385
OCI-Ly10,49766530,5.527943462019326
SCC-4,262093,2.191736984960853
Hs 578T,26596,-0.9561374383661984
MKN74,136227331,4.503917554589063
G-402,375860,-0.0988535878122291
MES-SA,46907787,4.094732434863112
BT 145,107970,1.590370979602365
Hs 888.Lu,637858,3.046602589688793
Mono-Mac-6,168313016,4.302379406609043
BT 145,262093,2.5646715988074917
NOMO-1,135398744,6.340708200805823
SNU-16,44491742,2.438228727906927
NCO2,9929138,5.425530092389558
TE-4,168313016,4.782755227329567
CAL-33,375860,-0.476811057349919
PLC/PRF/5,241158,3.973842744350964
LK-2,10231331,4.441960885168861
KP-3,46907787,2.5590188315760956
SK-MM-2,6852167,1.7319631304035736
NCI-H2141,9903786,2.15851319161548
BT-16,375860,0.1512578525958123
OE19,439501,0.2818425095827352
SNU-1077,135999136,1.6213426965056292
HCC78,100016,6.366939598030235
TE-11,439501,-2.6156568819541435
BT 228,262093,2.371515805144491
TC-71,9903786,2.1601140442915736
Hs 888.T,3689413,-2.4304159299205215
OAW28,439501,-0.9322268226633188
COLO 668,tanespimycin-bortezomib (250-1 mol-mol),-0.9107908194631724
HEC-6,71466445,2.328482360164493
CAL-12T,12003241,-2.021983796416415
EM-2,100016,3.5566389909433913
Detroit 562,46907787,-0.4268141433892927
JHUEM-2,107970,2.1315490396390793
COR-L95,11455910,1.0154509596480157
HPB-ALL,sirolimus-bortezomib (250-1 mol-mol),0.9475176932995892
NCI-H1568,135999136,4.3721543597322405
647V,100016,6.109475002217934
BT 159,637858,2.201222965192923
NCI-H2009,10231331,-1.9302715463885551
Hs 940.T,selumetinib-JQ-1 (4-1 mol-mol),1.6954490088475127
NB4,49766530,-2.04129527445394
OE21,9927531,4.992848693668257
KMS-21-BM,100016,3.297202365361246
NCI-H2170,637858,3.3845898272276016
JHOC-5,73707398,1.509837676483666
NCI-H889,135421197,1.0362826511717604
SF268,644241,2.0955453774449055
Sq-1,11396600,4.017113697276402
BT 216,3689413,-0.8248802266685408
PLC/PRF/5,100016,6.529147023700783
SK-MES-1,5460769,2.678686049759102
HCC1806,375860,-0.04565763318165
NCI-H1299,10231331,4.726273361560379
JHH-5,26596,-1.3669217407356802
GCT,5460769,3.4482432173572644
AN3-CA,sirolimus-bortezomib (250-1 mol-mol),0.0528830702221854
BHY,44491742,4.864491079150181
HT-55,sirolimus-bortezomib (250-1 mol-mol),0.7805175960520967
SK-UT-1,439501,-2.663904937582399
EC-GI-10,49766530,1.479780900637965
BT 359,73707398,1.6798691675714814
LAMA-84,439501,-2.4301107765097525
NUGC-3,6852167,3.3889998350800608
NCI-H2286,73707398,0.5411682012342772
VCaP,selumetinib-JQ-1 (4-1 mol-mol),0.3069804526516825
KMS-21-BM,46907787,-2.184676378105775
Lu-99,439501,-2.3036425217634395
HCC1419,44491742,3.720252057260251
Rh41,375860,-1.1822425747894922
NCI-H841,9927531,4.161760245261401
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
OE33,135421197,1.9963159792783505
BT 224,107970,1.8462444688876551
SNU-182,439501,-3.0072363734756173
BT 271,10231331,3.9566622670383857
Lu-99,12003241,-1.7463019078510122
BICR 6,73707398,1.1329966454047338
Hs 944.T,46907787,2.1367942885767786
MES-SA,262093,3.4311342236601567
M059K,241158,4.804659473259962
SW620,135398744,6.387116600988426
Namalwa,135421197,0.8963594643304925
PE/CA-PJ15,sirolimus-bortezomib (250-1 mol-mol),0.416438105686926
SW982,3689413,-0.7945580289517821
Rh41,selumetinib-JQ-1 (4-1 mol-mol),0.1512506116205909
B-CPAP,73707398,1.14773007898321
COLO 800,5460769,0.4868245753357603
SNU-1076,44491742,5.119632622149795
AML-193,selumetinib-JQ-1 (4-1 mol-mol),-1.0603244627842072
HD-MY-Z,644241,1.5083011664495825
SK-MM-2,73707398,0.3401468259097277
Li-7,107970,2.3347606129628056
Hs 852.T,637858,1.5992596099105147
KM12,3689413,0.1387513220516042
Mono-Mac-1,44491742,3.632264372511232
SNU-201,73707398,1.6082219150055517
NCI-H1435,73707398,1.0591696361842406
NCI-H1944,selumetinib-JQ-1 (4-1 mol-mol),0.9541404535319424
NCI-H2029,tanespimycin-bortezomib (250-1 mol-mol),1.6756703480673036
OV56,11455910,2.728140912842352
AsPC-1,selumetinib-JQ-1 (4-1 mol-mol),1.077922067972621
DMS 53,11455910,0.8364370230272622
OS-RC-2,73707398,1.5913521541277962
KMS-11,44491742,3.7132617808424704
BC-3C,46907787,1.9222116024183311
NCI-H1563,637858,2.0351568858397355
Granta-519,26596,-3.6955660538224784
JHOS-2,12003241,-0.473680569939606
NCI-H2087,UNC0638-navitoclax (1-1 mol-mol),2.07313942878803
KP-3,6852167,3.3293836315268805
LOX-IMVI,439501,-2.207275092585139
SF295,49766530,-1.8796707032595965
BT-20,54596490,5.325824832549944
JHOM-1,6852167,2.88456787030296
Hs 683,49766530,0.8674069188410214
LXF 289,6852167,2.2044562779321635
DB,5460769,1.8834181213891803
RT-4,637858,2.2211102524324717
U-BLC1,71466445,2.8221839412497864
NUGC-3,11396600,3.780901195469807
PE/CA-PJ34 (clone C12),6852167,2.080023831418778
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
MDA-MB-231,107970,2.4334474009984186
Hs 852.T,9903786,1.6008538749226255
Lu-99,107970,2.570142525043538
DMS 454,sirolimus-bortezomib (250-1 mol-mol),0.5194696170938634
ML-1 [Human thyroid carcinoma],375860,0.003862862725961
HCC2108,49766530,-2.150620999142696
ZR-75-30,73707398,1.6198674375550512
NCI-N87,6852167,1.8373876080574163
G-401,73707398,0.5507155331982622
A2780,11455910,-0.8495199814745813
SK-N-FI,168313016,4.337326261772598
Hs 611.T,135421197,0.2639365806220374
Hs 940.T,44491742,4.308619589326881
DMS 454,12003241,-0.401739549188604
BT 498,439501,-2.816531814980934
Yamato-SS,11396600,4.2294198024767145
HCT 116,10231331,2.3806251587463567
5637,tanespimycin-bortezomib (250-1 mol-mol),-0.6809849161541731
WM1799,5460769,2.2209273724490335
TE-8,3689413,-1.695063922582594
MDA-MB-157,selumetinib-JQ-1 (4-1 mol-mol),4.112916907677963
OAW28,135999136,1.5944266420299655
MG-63,71466445,6.092565154113904
BT 428,selumetinib-JQ-1 (4-1 mol-mol),-0.8814562357404941
NCI-H69,10231331,4.414739108436426
COV362,637858,3.021486989132716
OE19,107970,3.0665667847288103
HDLM-2,11396600,2.3384367351946604
L-540,100016,3.9234848652304097
OVISE,49766530,-2.0570642495309004
SK-MEL-31,107970,2.6492337066565033
DOV13,12003241,2.698298225737835
NCI-H1339,9903786,4.835064182647526
HuT 78,9927531,5.1568522769540674
CHP-126,135421197,1.2464718397024956
LS123,49766530,-4.7920009691109
LOX-IMVI,11455910,0.9161498134653596
SNU-719,637858,2.2997289437945487
RKN,375860,0.0559819210079563
HEC-151,241158,3.682505125351082
Rh41,sirolimus-bortezomib (250-1 mol-mol),0.2633406530968948
EPLC-272H,12003241,-2.3102763219954867
KCL-22,241158,3.680884772603812
RS4;11,439501,-2.445140752441031
TE-15,439501,-2.48025284068881
YH-13,439501,-2.216859157731525
Pfeiffer,UNC0638-navitoclax (1-1 mol-mol),1.0211462635075932
TUHR14TKB,644241,2.615417426176258
SK-MEL-1,11455910,2.3970626759922418
NCO2,439501,-2.4046294895536446
HEC-151,46907787,1.109021567995486
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678
BT 440,168313016,5.661072033234367
HeLa,135999136,4.338563749387071
KYSE-30,11455910,0.7960710883386756
GSU,262093,3.0051612017045612
Becker,262093,3.305929946624271
HCC1428,241158,4.858184483095658
JHUEM-7,135398744,6.411220982649173
CAL-54,100016,6.472919480601912
EKVX,6852167,3.4116684246666913
SNU-182,100016,8.076902029611453
HCC38,135999136,4.380203016974773
BT 228,46907787,3.432433507540363
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566
SNU-620,375860,-1.000717785037884
RPMI-8226,9929138,6.391388582144063
697,135421197,-0.0099062080038934
T3M-10,3689413,0.3494943823106689
NCI-H446,46907787,1.4439556704022858
NCI-H1838,9927531,5.140983076545055
GB-1,135999136,1.7433537147277611
JHH-4,44491742,4.756848275600054
NCI-H2452,3689413,1.184555113675537
SF268,tanespimycin-bortezomib (250-1 mol-mol),-0.3321278091609868
RCH-ACV,44491742,3.725167954137364
MEC-1,6852167,1.6745748203448447
TTC-709,9929138,5.828368594409336
KMS-27,44491742,4.7290458888071765
OV56,135421197,2.071998378530058
OCI-Ly3,107970,2.241121524741462
GSS,241158,4.1367730610069975
BT-12,selumetinib-JQ-1 (4-1 mol-mol),3.32378383442081
ST486,6852167,1.0597481979076584
BT 172,selumetinib-JQ-1 (4-1 mol-mol),1.8042299289240984
OS-RC-2,439501,-0.684202622279705
HT-55,11396600,3.0966663667884595
NCI-H526,11396600,3.7053245475874785
EFO-27,107970,2.9901836608736883
Ki-JK,49766530,-2.8034891942597935
MIA PaCa-2,100016,4.223400842588871
HuP-T3,10231331,2.6811135289001236
LK-2,26596,-1.655987263184575
NCI-H716,168313016,4.474917633369443
DK-MG,262093,3.1450288318092596
BICR 31,10231331,3.776464743887352
SET-2,439501,-3.519167585481613
SIG-M5,107970,2.1274244329826417
OPM-2,444795,4.04932788863876
HDLM-2,9929138,7.073059321939057
BT 498,tanespimycin-bortezomib (250-1 mol-mol),2.266327980943949
SNU-61,262093,2.836545473910542
HPAC,selumetinib-JQ-1 (4-1 mol-mol),-0.0816962643206643
OCI-AML-5,241158,3.967364233011896
Ri-1,9927531,3.385054072969868
SNU-407,375860,-0.2735722372490464
SNB-75,73707398,1.9157922187543075
HCC38,3689413,-2.099341250488443
P12-Ichikawa,168313016,4.634165787184027
EPLC-272H,selumetinib-JQ-1 (4-1 mol-mol),-3.103234599645093
TF-1,6852167,3.4840592939536097
Kuramochi,49766530,0.1496678654084536
COLO 699,9929138,6.696462829183714
KNS-62,6852167,4.622267495378103
OCI-AML-3,262093,2.331975538333622
NCI-H520,71466445,4.442767515504577
RPMI-8402,9927531,3.4344708783390856
TE-6,selumetinib-JQ-1 (4-1 mol-mol),2.8882267841059774
A2780,9903786,1.372407357095215
NU-DUL-1,5460769,0.0650786105857349
SUP-B15,44491742,3.782518793178516
SNU-213,12003241,-1.127561281071067
SK-BR-3,tanespimycin-bortezomib (250-1 mol-mol),-1.1582465529639416
Granta-519,selumetinib-JQ-1 (4-1 mol-mol),0.6993639444129659
UACC-62,12003241,-2.2941993438250865
SNU-423,637858,2.0123731637810875
SNU-869,sirolimus-bortezomib (250-1 mol-mol),1.7458276464025495
NCO2,241158,1.6159541696435746
Caov-3,439501,-0.6475406712801833
F-36P,375860,-1.097600146187803
NCI-H2291,46907787,1.4824694863138157
SNU-899,sirolimus-bortezomib (250-1 mol-mol),1.691778664572397
769-P,9903786,3.979605140448373
NCI-H1915,selumetinib-JQ-1 (4-1 mol-mol),1.3677022548996522
HEC-1-A,73707398,1.278227831135503
OCUM-1,sirolimus-bortezomib (250-1 mol-mol),2.078884953433103
P31/FUJ,135999136,4.068676884464422
769-P,3689413,-0.2029622109765157
YD-38,100016,6.21667674155364
LAMA-84,3689413,-1.3009180368872624
NCI-H1155,9927531,3.8709301895195023
DMS 114,73707398,1.0730261578873106
HCC2279,9903786,3.291578502930839
U-937,selumetinib-JQ-1 (4-1 mol-mol),2.241034377001376
BT 444,10231331,2.8828813905739388
DMS 114,46907787,1.0216495137560369
Hs 578Bst,107970,1.8349384981697157
SNU-620,637858,2.5391555167189614
IA-LM,49766530,-3.412847117105243
BT 131,73707398,1.1625406641587088
LCLC-97TM1,9903786,1.8016114643921617
Ki-JK,26596,-2.118639995094933
NCO2,49766530,-4.92824321728858
KG-1-C,sirolimus-bortezomib (250-1 mol-mol),1.4643068357470623
HCC2279,375860,-0.2616514424513608
NH-6,71466445,4.601031445785075
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403
VCaP,241158,4.103874762457962
AsPC-1,637858,2.8111542457272605
EHEB,3689413,-1.930959129148268
BT 112,241158,4.111283984788845
IGROV-1,135398744,6.402844237905131
Panc 02.03,73707398,1.687012904299387
MCF-7,439501,-2.51567390987342
BICR 56,11455910,1.513170236314074
NCI-H23,241158,1.928803930669148
HT115,9927531,5.770411786358663
UACC-62,49766530,1.0622286299463806
SK-N-BE(2),73707398,0.4235514927917171
GA-10,selumetinib-JQ-1 (4-1 mol-mol),-0.1687986372090924
AGS,100016,6.525427767108566
KO52,73707398,0.5433059802196046
BT 271,135999136,1.6268785370862404
OCI-AML-3,444795,-5.04160255125036
KYSE-140,9927531,4.387230999589902
COV644,439501,-3.4357426903027273
Daudi,439501,-2.973914496380735
MDST8,UNC0638-navitoclax (1-1 mol-mol),0.0251885834350385
PF-382,9903786,1.7632578420268197
NUGC-4,71466445,3.986101296043148
U-CH1,12003241,2.634808409336574
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133
SNU-61,100016,6.106397388471953
SUIT-2,107970,2.9350948745745966
KYSE-30,9903786,5.462463083669851
SNU-216,107970,2.273840953303944
T-47D,5460769,6.397053715460356
ME-1 [Human leukemia],46907787,1.000894546616175
JHH-4,6852167,2.8954393352869383
RS4;11,sirolimus-bortezomib (250-1 mol-mol),0.1711857782285224
TC-71,46907787,1.352087076315588
AML-193,107970,1.008310161545622
NCI-H520,444795,5.008670344858
A-375,3689413,-0.7182003405560186
OPM-2,9927531,3.0625153090482757
NCI-H647,UNC0638-navitoclax (1-1 mol-mol),3.07128640317944
KE-39,selumetinib-JQ-1 (4-1 mol-mol),1.3971527695941195
SW579,12003241,-1.7693862144500747
ES-2,tanespimycin-bortezomib (250-1 mol-mol),0.7819342630175604
HCC1937,5460769,4.797106987757637
SNU-503,11455910,1.6883627644278838
SNU-1,444795,5.8199745249535635
M-07e,49766530,-2.4452167818324813
DMS 273,73707398,1.2764695344106731
NCI-H211,11396600,3.088009676720855
SNU-1272,135421197,2.338787330458388
KMH-2,135999136,4.261603598420712
ESS-1,375860,-0.234699059648963
HCC38,241158,4.477022319117719
SW579,9903786,2.7100621017301516
Rh18,UNC0638-navitoclax (1-1 mol-mol),-3.466450646619238
Detroit 562,6852167,2.213470028027015
KMS-34,262093,1.7183791017447037
REC-1,637858,3.5079007609087527
HCC4006,136227331,3.713774396347732
PC-14,11396600,4.745127634228124
OC 314,375860,-0.387180019727141
LCLC-97TM1,5460769,-2.8089441547625067
TF-1,26596,-1.8278178688424689
BV-173,135421197,1.3396067648225152
NCO2,100016,5.1199760357582385
SNU-685,637858,2.5644844019805406
SCC-25,10231331,0.4590527217191406
SNU-398,444795,4.655654873396968
MOLP-2,644241,3.111768413323115
NCI-H1666,UNC0638-navitoclax (1-1 mol-mol),2.2678241552011498
LNCaP clone FGC,44491742,3.7255423914895776
LK-2,12003241,-1.6123297720888603
OAW28,262093,2.853078829548121
TUHR4TKB,sirolimus-bortezomib (250-1 mol-mol),1.666673224601644
Sq-1,644241,2.9163264724433136
HCC1833,11396600,5.135041940263416
Karpas-299,11455910,0.3767083594332863
JHOS-2,107970,2.2743990130812173
HCC202,sirolimus-bortezomib (250-1 mol-mol),0.0889077055626295
LC-1/sq-SF,439501,-1.6562365641481254
KMS-34,637858,0.6996482331075263
IGR-1,54596490,6.338760759181102
SW1783,selumetinib-JQ-1 (4-1 mol-mol),4.8105600035571126
BT 145,9927531,3.3032194302925557
M-07e,73707398,-0.2805329031268003
BT 416,375860,-0.0898603200977126
COLO 684,375860,0.4583693277008406
Mino,44491742,3.5991371763887616
NCI-H2172,9929138,5.835125788077067
YD-10B,12003241,-3.1216797421568847
OC 314,9927531,4.337134005776663
JM-1,12003241,0.2073989775302392
SNU-61,107970,2.0644711824277757
NCI-H1395,73707398,1.4482642438908118
EN,3689413,2.688418705808367
COV362,9927531,5.782280660469085
SNU-182,9927531,4.620682064232075
Hs 888.T,644241,1.6748162418135606
BT 245,135999136,1.3733623937615662
LoVo,444795,4.8141558651213145
MG-63,637858,1.1304564766926708
BT-12,49766530,-0.9440868950031468
BT 340,73707398,1.0135826425077856
639V,selumetinib-JQ-1 (4-1 mol-mol),4.561629835608233
MOLT-16,107970,1.325663053312893
NCI-H2106,262093,0.7594772969687351
SNU-C2A,12003241,-1.200287436461147
G-292 clone A141B1,selumetinib-JQ-1 (4-1 mol-mol),2.4558837946594307
PANC-1,26596,-1.3824156046290312
NCI-H716,10231331,0.9999723434962392
HuH-1,168313016,4.434942531625722
SNU-61,439501,-1.3808373898758073
A-549,439501,-2.483005959928592
OCI-Ly3,selumetinib-JQ-1 (4-1 mol-mol),-0.0066498103237673
OCI-AML-2,73707398,0.2295184114128151
KMS-21-BM,49766530,-1.7820478851785848
8-MG-BA,sirolimus-bortezomib (250-1 mol-mol),0.8530432118926453
NCI-H1793,11455910,0.5323419140009732
8305C,12003241,-1.8647493707838596
IGROV-1,168313016,4.807199318661473
SW1710,135398744,7.400823424142947
ONS-76,73707398,1.7098056225756528
Ki-JK,11455910,1.8601225007707891
NCI-H1299,49766530,-0.517142624612936
HPB-ALL,241158,3.2053071979746344
JM-1,54596490,4.858476490911798
KE-97,tanespimycin-bortezomib (250-1 mol-mol),-0.1953255566925064
SCC-9,262093,3.396257832039873
LNCaP clone FGC,135421197,1.5055395740527522
SaOS-2,73707398,0.8491853151273433
BFTC-909,3689413,0.9841636034152118
FaDu,168313016,4.446637505899028
BT 232,6852167,4.665057754555266
KYSE-140,135999136,5.49785084344862
SK-N-FI,12003241,-1.9986022359494329
SNU-119,11396600,3.5657342992920547
NCI-H661,262093,3.4983141095274126
697,9927531,2.816043229727806
BL-70,tanespimycin-bortezomib (250-1 mol-mol),0.1795536899591847
SBC-5,439501,-2.4874901722547977
ES-2,sirolimus-bortezomib (250-1 mol-mol),1.1433658443254404
G-292 clone A141B1,107970,2.7538669134691895
BV-173,439501,-2.3365000657543415
SYO-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8383808288745799
ST486,selumetinib-JQ-1 (4-1 mol-mol),0.8621591965055626
SiMa,168313016,4.596851957301641
DEL,637858,0.5028649268417138
SW1271,10231331,-0.1974856956768426
SNU-245,6852167,3.4758123608320983
JHH-2,135421197,1.6322230690261417
L-540,tanespimycin-bortezomib (250-1 mol-mol),-0.491280358264631
Calu-6,262093,3.3052566234761116
CHP-126,439501,-0.4236570710914729
JHUEM-7,71466445,4.651705041978002
F-36P,44491742,3.961170859118446
SCC-4,135421197,1.85399046640426
LS123,100016,6.571994849278421
CHP-126,241158,4.488407239110937
MEC-1,44491742,3.700583986314622
NCI-H526,12003241,1.2765702668014436
ALL-SIL,26596,-3.0181503922951674
SK-MM-2,selumetinib-JQ-1 (4-1 mol-mol),-1.4426024400590536
HEC-151,262093,2.667137080366997
KE-97,5460769,-1.2505802220316746
Ku812,10231331,-1.9439726513116764
CAL-51,135999136,4.2132345103647015
SK-N-DZ,135999136,1.9403718347768153
DAN-G,135999136,4.415198368400697
BT-20,262093,3.15256529620894
Li-7,UNC0638-navitoclax (1-1 mol-mol),-0.441208962070896
ChaGo-K-1,637858,1.5063352286209188
GCT,262093,1.5309331416086709
KG-1-C,73707398,3.866855838885212
IGROV-1,375860,0.7731558163124775
JURL-MK1,241158,2.6830481572048255
TALL-1 [Human adult T-ALL],375860,-0.0236557250862759
HT-1376,135421197,1.3113029615588312
OV56,241158,3.916258648740272
SK-ES-1,11396600,3.1511462884170656
HH [Human lymphoma],12003241,0.3736289232405389
SNG-M,71466445,4.540032899995972
SK-N-FI,135421197,0.4390653325388048
A101D,107970,1.67763505646941
SK-N-MC,107970,1.887698358378098
HT-1376,262093,3.325962410010009
Caki-1,135421197,2.421962136106705
Hs 839.T,9927531,5.8565553238540655
OE21,241158,4.080451555980482
SNU-840,6852167,1.1857689341826607
NCI-H460,6852167,4.590065962834362
HuH-28,12003241,-1.746609784805712
GDM-1,637858,1.427006767911647
HDQ-P1,637858,2.3004761888265253
COV362,12003241,-1.5516185540299623
COV362,644241,2.4663572011502457
NCI-H1339,262093,3.4716839644219246
Kasumi-2,46907787,-1.0712711351942366
JVM-2,637858,1.463406475028887
HD-MY-Z,444795,4.361137066373933
NCI-H196,262093,3.244471483790871
NCI-H747,136227331,4.187158203356049
FaDu,12003241,-1.459997114195287
HPB-ALL,6852167,2.8304771744370543
SK-BR-3,12003241,-1.7425302549890949
NCI-H1793,46907787,3.6705160121721736
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023
BICR 16,5460769,4.333999441494942
DU4475,107970,1.5675398019585955
A-253,12003241,0.3953648973902781
SW48,26596,-2.356334812614481
RT-4,selumetinib-JQ-1 (4-1 mol-mol),2.9367807248544233
THP-1,sirolimus-bortezomib (250-1 mol-mol),0.3217250845673337
TCC-Pan2,46907787,2.449998645601034
TE 441.T,637858,0.3313302982061412
COR-L95,100016,6.620829555802918
Ku812,262093,1.3423418533813145
A-204,136227331,3.914790015372966
NCI-H1623,107970,2.966658693868389
DBTRG-05MG,9903786,2.261180783210366
Ri-1,100016,4.838113149785687
CAMA-1,9903786,5.004529624345284
LN-229,637858,1.9749871629178417
OVCAR-4,9929138,6.8802220195172525
CMK,100016,5.771362707779288
Panc 04.03,6852167,3.6951209581653743
K-562,241158,3.183928650435804
NCI-H69,241158,3.5376406535699543
OCI-M1,11455910,0.9199836560966144
OCI-AML-2,135421197,1.0650932399576858
MDST8,9903786,2.958137426904596
PaTu 8988s,44491742,3.6400918872033343
HDQ-P1,sirolimus-bortezomib (250-1 mol-mol),1.8478988823662197
KO52,tanespimycin-bortezomib (250-1 mol-mol),1.3473417684314797
NCI-H2291,12003241,-0.3481975958318299
EB1,107970,1.4399846214228276
TE-9,12003241,-0.5375086976849406
NCI-H1341,12003241,-1.9101542939935303
SNU-1272,168313016,6.45685474572034
GI-1,26596,-0.9174030047278064
NCI-H1341,637858,0.954868585664575
GMS-10,3689413,-2.2812112324373057
BT-16,73707398,1.7491627069246496
SHP-77,49766530,-2.4195879391735216
HL-60,100016,6.415560767920564
NCI-H1155,637858,1.7173682170201705
LXF 289,5460769,3.06478422280727
SUP-HD1,12003241,0.3285815834035863
SK-N-DZ,107970,1.1338188802465183
YD-38,11455910,1.5894943212861383
HeLa,12003241,1.4760559160729645
Hs 766T,6852167,2.9738525518639425
EoL-1,136227331,3.409385468978638
BT 286,3689413,-0.1900658377643967
IGR-37,9927531,5.0345741970674975
BT 159,135421197,3.0775929354078926
MOLM-6,71466445,1.8070039893626304
RL,26596,-2.6100801443617336
GMS-10,241158,3.9645605442022185
SIG-M5,10231331,-4.142163395953805
TE-5,135421197,1.4018767750008558
KMBC-2,637858,2.3795290977842014
WM793,3689413,0.565505634508756
RERF-LC-Ad2,100016,6.703705933143471
LNCaP clone FGC,6852167,3.159871073492599
NUGC-4,5460769,4.378159421113783
BC-3C,5460769,2.335900284678582
ES-2,107970,2.4145055108152262
DBTRG-05MG,135398744,6.409074750923468
Tm87-16,6852167,2.4211748884832813
Hs 766T,5460769,5.317456208461946
G-402,49766530,-4.676070864633351
BT 147,9903786,1.444914560684451
ONCO-DG-1,100016,7.582922943410799
HEC-59,11455910,1.03172730185298
EFO-21,262093,3.250428911213388
Tm87-16,sirolimus-bortezomib (250-1 mol-mol),0.5846669503763354
A3/Kawakami,46907787,-2.1419759395724296
HMC-1-8,10231331,-0.5576269220838886
NCI-H1838,selumetinib-JQ-1 (4-1 mol-mol),-0.1713397125245971
HCC1588,11455910,1.225245370216729
HCC1588,sirolimus-bortezomib (250-1 mol-mol),0.5991119753615496
NCI-H1666,46907787,0.6812473543243156
Panc 08.13,44491742,4.265130925236368
SNU-C5,135999136,4.635904780574041
TE 617.T,26596,-3.5782456619220246
NCI-H1581,3689413,-2.373014481120326
SYO-1,5460769,-0.8579503639796162
EFO-27,49766530,-2.657964166176686
NCO2,6852167,3.0522218001812114
Granta-519,11455910,0.302072347623865
BC-3C,11396600,2.927390282149192
MOR/CPR,3689413,3.3711926349807797
BT 444,73707398,1.807025337873425
ZR-75-1,3689413,2.979171486892431
NCI-H650,637858,2.5210776011499236
NCI-H1581,6852167,2.4363894803566777
SNG-M,135999136,4.445666300574397
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
HuH-1,3689413,3.5538877505923097
MHH-CALL-3,439501,-2.5206189278952325
Ishikawa (Heraklio) 02 ER-,439501,-2.4484029207577347
OCI-Ly19,11396600,4.160001255842617
U-251MG,11396600,2.977650858137137
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
HEC-59,73707398,1.404942401725486
Hs 746.T,sirolimus-bortezomib (250-1 mol-mol),0.2683351273319356
YKG-1,135421197,3.1079510852519343
SK-MEL-5,5460769,5.96903783579764
OS-RC-2,637858,2.270569811724511
LOX-IMVI,107970,2.2116293322990264
RERF-LC-Ad2,439501,-3.088259445062755
NCI-H1693,49766530,-2.9408096951220384
HCC78,439501,-1.472903672264699
BT 482,73707398,1.2920921662182432
NCI-H226,439501,-0.8440362022647064
NCI-H1666,11455910,-0.2695956952552506
CHP-212,107970,1.5459012913024066
Capan-1,637858,2.0066289365913588
OCI-AML-5,262093,2.6389627250166825
MHH-CALL-4,12003241,-1.7117307202040182
MKN74,135421197,1.917095385489804
HT-1080,107970,2.276862612199837
ONS-76,107970,2.339276188405755
Li-7,439501,-2.4815602749889005
JeKo-1,46907787,2.135239462505942
SK-MEL-31,262093,3.561171585686889
DMS 273,135999136,4.8097980755766505
TT2609-C02,5460769,3.053476613598646
FTC-238,49766530,-0.9457086114172378
SUP-HD1,9903786,1.2830576514216323
ES-2,73707398,1.4813259801983545
SNU-878,5460769,2.876812490154217
AM-38,444795,-4.814022989676893
NCI-H1581,637858,1.6649755773360142
RT-112,49766530,0.4682015340120261
SNU-16,26596,-3.716787103027543
NCI-H69,6852167,1.728526971731107
Panc 03.27,107970,2.945998932112281
SW620,6852167,3.2674299159277753
VMRC-RCZ,3689413,-1.2845787687356065
P12-Ichikawa,135421197,0.8700527660051071
HEL,6852167,2.7971477189216207
SNU-626,9903786,4.459436811322819
SUIT-2,262093,4.049104877248936
COLO 792,46907787,1.9326545670415696
SF539,136227331,3.3252279599925085
Capan-1,439501,-1.7438578400457687
T3M-10,107970,2.164377602054981
SW579,73707398,1.013024116730033
HCC1395,444795,5.464087524782881
Capan-2,tanespimycin-bortezomib (250-1 mol-mol),-2.4756483134960385
LS123,444795,4.324297623780839
SNU-1196,sirolimus-bortezomib (250-1 mol-mol),2.2031976803647075
JURL-MK1,26596,-1.965499498470982
COLO 201,5460769,4.015779319815586
KPL-1,262093,3.0634356984830298
JJN-3,135421197,1.2672654970884558
MOLT-3,44491742,3.801093183463652
CCF-STTG1,10231331,5.780092265996196
KE-97,73707398,0.8488233877842626
BHY,9903786,2.1017831140065844
CFPAC-1,sirolimus-bortezomib (250-1 mol-mol),1.733251550284772
OV7,107970,1.7001806684569305
NCI-H1581,73707398,1.105308404191274
AML-193,439501,-3.193215284595587
RL,637858,1.0832577787514124
SNU-620,selumetinib-JQ-1 (4-1 mol-mol),-4.433730050654808
A-253,11396600,3.687595077759593
HOP-62,10231331,1.3709968490270463
SK-CO-1,10231331,-0.7210930575000714
BT 482,11455910,0.8854890707649536
BL-41,3689413,2.890540357567194
Caki-1,sirolimus-bortezomib (250-1 mol-mol),1.904717275884016
OVK18,637858,1.5297854885562336
CCK-81,3689413,0.410216547608945
A-549,9903786,1.8644448309659765
SNU-C5,26596,3.4561899708021175
CA46,439501,-3.521132637790176
KMM-1,11455910,2.3238855811198262
RKN,12003241,-0.3350096455718494
WSU-DLCL2,262093,1.9390116112389448
NCI-H522,UNC0638-navitoclax (1-1 mol-mol),4.115450321285854
CCK-81,12003241,-0.505625792514721
JHH-2,3689413,-2.478608277030538
RT-112,12003241,-0.7712914992257113
IGROV-1,241158,3.288496474515495
TUHR4TKB,UNC0638-navitoclax (1-1 mol-mol),0.4628598930276774
NCI-H28,12003241,-0.6704965456124867
SK-ES-1,26596,-2.5080764618558775
KP-4,135999136,4.290505195277357
NCI-H1339,44491742,4.759108525431012
MOLT-3,selumetinib-JQ-1 (4-1 mol-mol),2.6811661525029904
EFE-184,71466445,4.052816246542502
COR-L95,135999136,4.28146486500778
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106
Aska-SS,107970,1.9510492684161391
HPAF-II,241158,5.361464672847053
8-MG-BA,73707398,1.972925261503962
LMSU,selumetinib-JQ-1 (4-1 mol-mol),3.5274573633732773
CCF-STTG1,73707398,2.079175010578171
DB,44491742,3.5309759894848747
SNU-685,73707398,1.5984502695910892
SNU-620,11396600,4.54842563346304
BT 231,3689413,-1.816097223149399
WM793,5460769,5.840780592325561
MOLT-3,9927531,3.2112573350362372
CMK,262093,3.0450317567550154
Kasumi-2,26596,-3.0246532529835273
JHH-2,tanespimycin-bortezomib (250-1 mol-mol),1.6682234532456457
SNU-478,11396600,3.7061070175674904
JHH-5,9903786,3.1481910076888684
SK-N-FI,11396600,3.485816734238302
MM1.S,107970,1.483055719195773
GI-1,9903786,1.7362048371434178
SNU-878,6852167,1.5277093469935394
HOP-62,11455910,0.5971366632673413
OPM-2,644241,1.6900050339542656
SEM,439501,-3.163159816591066
NCO2,5460769,1.276478801243687
Kelly,444795,2.997154071611722
SF539,135999136,1.70209400272594
SUP-HD1,73707398,0.485799200448075
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
HGC-27,10231331,6.356350936699628
MKN7,9927531,4.538796074024755
NOMO-1,71466445,1.8310961714544176
HEC-50B,241158,5.355916764847489
UM-UC-1,9927531,4.732850009488004
OCI-AML-5,11396600,3.436150065828036
VCaP,107970,2.076938857757041
BT 320,135999136,1.9088296274535188
A3/Kawakami,71466445,1.2297175943082674
NCI-H1666,168313016,4.852809935193056
MOLP-2,439501,-3.1752212130018163
Kelly,6852167,2.334031930420637
Capan-2,5460769,2.6167760530795654
LOX-IMVI,49766530,-3.939815107547984
HMCB,644241,4.490422282614611
NCI-H23,637858,1.0149973634937457
Panc 04.03,135999136,5.549073334475873
NCI-H322,26596,-1.3562395131244265
CAL-85-1,72967,3.75505984138146
SK-N-FI,10231331,0.8741467482588007
NCI-H2126,selumetinib-JQ-1 (4-1 mol-mol),1.9908852314747592
VCaP,135421197,0.8808099569732696
ONCO-DG-1,262093,2.6022952770143197
HuP-T4,262093,3.072428366481475
KO52,100016,6.24417827042609
M-07e,637858,0.673950959080143
KMS-12-BM,444795,2.0247311602920415
SNU-620,26596,-1.49043613544065
IM95,3689413,0.7350625809131119
NCI-H2106,241158,2.9302091646352526
Fu97,9903786,2.3049271395078827
RVH-421,136227331,4.595276173623148
T24,tanespimycin-bortezomib (250-1 mol-mol),0.0189711730076056
NCI-H2029,12003241,2.5373322791001636
HCC366,tanespimycin-bortezomib (250-1 mol-mol),0.9918173547189246
EHEB,100016,6.596024177667571
LK-2,637858,2.9167931054594267
HCC4006,9903786,3.3433056456258585
NCI-H1869,73707398,1.8797199164844864
MPP 89,11396600,3.423222859590498
OVISE,9903786,4.69480560533159
L-1236,6852167,1.1111947927360797
EBC-1,9929138,6.205761956690981
SNU-182,168313016,5.05876054110742
NCI-H1666,sirolimus-bortezomib (250-1 mol-mol),0.7779430535962837
YD-10B,168313016,4.69452362713008
HCC1954,tanespimycin-bortezomib (250-1 mol-mol),-2.182183839668862
Tm87-16,241158,4.326282231261254
JMSU-1,44491742,4.046305015990271
Tm87-16,375860,0.3575465541966368
G-402,54596490,5.430260999889079
RPMI-8226,44491742,4.60819314657813
Ri-1,26596,-3.083821338619051
KMS-12-BM,11455910,-0.5978210432128618
ZR-75-1,262093,2.676837097800324
NCI-H747,12003241,-1.9291719472544329
OAW42,26596,0.2521816339620648
SNU-1033,6852167,3.058956873768391
RCC10RGB,UNC0638-navitoclax (1-1 mol-mol),1.9805139183388023
TE 441.T,375860,0.1054494227896346
SNU-761,UNC0638-navitoclax (1-1 mol-mol),2.3659172139386975
HCC1954,49766530,-2.49359957075404
BT-474,sirolimus-bortezomib (250-1 mol-mol),2.1782836856662136
Hs 895.T,tanespimycin-bortezomib (250-1 mol-mol),2.1359790138247674
NCI-H196,6852167,3.0057734574295765
Hep 3B2.1-7,sirolimus-bortezomib (250-1 mol-mol),1.2691143155253628
UACC-62,3689413,0.3229546491467058
MDA-MB-361,11396600,3.700077553751832
MM1.S,71466445,1.6605389329514368
NCI-H1869,9903786,3.8309501172404734
NCI-H1563,241158,3.759729505660072
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096
SW1353,49766530,-0.8162034464098388
DV-90,sirolimus-bortezomib (250-1 mol-mol),0.1354476911070701
HH [Human lymphoma],644241,1.8294339941253344
OCI-M1,12003241,0.3090538594406519
HCC1588,5460769,0.1168083541927539
TE-9,tanespimycin-bortezomib (250-1 mol-mol),-0.7055515782179059
RT-112,241158,3.714911516167673
OAW28,71466445,4.188405368682896
VMRC-RCW,sirolimus-bortezomib (250-1 mol-mol),0.7357158276025152
SK-CO-1,135421197,1.070123520764916
HCC366,11396600,4.932418286549936
BICR 16,6852167,3.083582887744423
Karpas-299,135999136,1.8576557410346497
SU-DHL-1,10231331,2.149159497852676
JHOM-1,3689413,0.7537035675764964
KYSE-30,135421197,1.7734254693963984
SW1990,73707398,1.200617797087527
JMSU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9678894652146584
AN3-CA,135421197,1.808403236431818
NCI-H2126,168313016,5.941518060923545
ALL-SIL,49766530,-2.347000417785464
RERF-LC-Ad2,3689413,-2.3718681179327143
5637,71466445,3.813254816409256
U-937,46907787,1.778074875045128
LOX-IMVI,44491742,5.895851784959737
MV4-11,73707398,-1.799925362976645
MOLP-8,46907787,-2.434163875600539
KYSE-70,135999136,5.194226724950964
MDA-MB-435S,637858,1.7685528665824608
P31/FUJ,11455910,0.7543092217738059
KMS-18,444795,4.297088429276901
SNU-1105,241158,4.64343596184443
MOLP-8,135398744,7.476327693514706
Mel Ho,6852167,2.564669459332006
697,637858,0.646057758109665
TE 617.T,262093,2.7005370454000004
DOV13,selumetinib-JQ-1 (4-1 mol-mol),5.706841821977817
HEL,375860,-0.4243086466742362
EFO-21,26596,2.967643494346353
KYSE-520,10231331,4.442298950853209
TE-5,46907787,1.9285123682703753
Li-7,46907787,-1.2636759008098706
RKN,262093,2.5285063130840344
KHM-1B,637858,1.18497480261582
NCI-H810,49766530,-1.6477038589154638
A-204,107970,1.8649971930452791
SKM-1,100016,4.336407790429152
BT 416,11455910,-0.2427833720473563
RPMI-8226,375860,-0.5400266159154646
WM115,637858,1.77843641117838
BT 245,375860,-0.1637313030055035
SK-N-SH,selumetinib-JQ-1 (4-1 mol-mol),2.2586391294611974
WM1799,73707398,0.8286664607249193
UO-31,439501,-2.964555924947922
KYSE-410,26596,0.1189340940832646
FTC-133,439501,-1.0725688155870328
CAL-85-1,3689413,-0.0998650254858705
L3.3,135398744,6.452563021638662
BT 239,637858,1.534947650301569
Rh41,5460769,3.320988700800296
COR-L88,135421197,1.3679822518227
A-172,439501,-2.9680565651311723
Becker,46907787,3.975901887649669
NCI-H1869,3689413,-0.7267032921286074
WSU-DLCL2,444795,3.9682152316651496
MG-63,sirolimus-bortezomib (250-1 mol-mol),0.1277203686177557
BICR 18,6852167,2.321701706128057
NCI-H2029,9927531,4.454841105841318
TC-71,73707398,0.9570811163223728
U-937,439501,-2.545607636797326
NCI-H1666,6852167,2.1099138170473384
BT 224,tanespimycin-bortezomib (250-1 mol-mol),-3.111223300831193
BT 179,73707398,1.5883061850934768
SUP-HD1,135999136,4.727855508717699
VMRC-RCZ,12003241,-1.8843773680512867
SNU-5,100016,6.769356825304223
SNU-878,49766530,0.7388609615880275
OVISE,9929138,5.66720682434708
Rh30,136227331,4.257101028878693
Tm87-16,637858,2.3331403787186673
PC-3,11396600,3.5715694520968
T-47D,637858,1.866222886405254
NCI-H292,439501,-2.469830491210978
EFO-27,73707398,1.1269975883077623
IA-LM,262093,2.9896562434219627
HSC-3,135421197,2.8710443540281756
SNU-C5,107970,1.938594575048687
OS-RC-2,9903786,3.8385821896684433
BICR 6,5460769,0.6237785323656337
HCT 8,262093,3.680435821837603
BT-549,107970,2.9169966931039113
LAMA-84,637858,1.7001422847979093
JURL-MK1,73707398,0.1853305147735288
B-CPAP,selumetinib-JQ-1 (4-1 mol-mol),2.8675411473634917
SK-N-BE(2),44491742,3.960613770840922
RERF-LC-Ad2,49766530,0.0972135502095861
SK-MEL-3,135421197,1.515093492040075
UACC-62,6852167,3.6947813963338656
NU-DUL-1,3689413,-2.4087699464815664
SNU-466,tanespimycin-bortezomib (250-1 mol-mol),-4.621211093162312
SW1271,6852167,3.737297660761554
H-STS,sirolimus-bortezomib (250-1 mol-mol),0.1241794019468204
MKN74,71466445,3.93940813882303
HCC1195,11455910,0.2918122154241095
WM983B,10231331,-2.8464070849273755
PF-382,107970,1.4805149558229411
CHP-126,9929138,6.335241995637564
SCC-9,3689413,-0.5284639903905319
UACC-812,selumetinib-JQ-1 (4-1 mol-mol),2.304813012505874
T3M-10,tanespimycin-bortezomib (250-1 mol-mol),-3.2480319159922515
NCI-H1694,26596,-2.376634499212247
NCI-H929,168313016,5.007996140484685
647V,375860,-0.1505103622979239
HT115,12003241,-0.6699503648785873
PLC/PRF/5,375860,-0.0784427755583708
HEC-1-A,262093,2.5793359656763784
HeLa,selumetinib-JQ-1 (4-1 mol-mol),4.321478137399501
HT-1197,168313016,4.3878653913585985
U-251MG,637858,2.3102483718241382
RVH-421,241158,3.9487795616003543
HCC1438,5460769,1.743757679133544
NCI-H1373,6852167,3.4417503249951737
HCC1438,26596,-1.656092804302775
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826
Mino,73707398,0.350796804562992
Hs 895.T,49766530,-0.4019815670420401
ALL-SIL,12003241,-5.746631994241774
YD-38,11396600,4.074151932666014
ChaGo-K-1,439501,-4.217436880778372
HOS,439501,-2.316181578495001
HCC4006,6852167,2.5349173961292206
EC-GI-10,241158,3.603755758520639
SK-N-SH,262093,1.5021437515873324
HCC1588,selumetinib-JQ-1 (4-1 mol-mol),-0.6381739990739388
DMS 114,135421197,1.272483451000873
A101D,73707398,1.1179774459813885
CHP-212,49766530,0.7165809127280346
HMCB,12003241,-2.4987094510650834
ESS-1,26596,-1.5335330182559344
BICR 22,168313016,4.910867780923905
MKN74,71466445,3.93940813882303
SNU-5,107970,2.4514742036829484
EM-2,9903786,1.526711348749508
SK-ES-1,54596490,4.536683455406273
NCI-H1694,9927531,4.024250624925043
CAL-78,10231331,4.497903897116711
KMS-27,5460769,1.7009983096984826
L-363,11455910,-0.1325866927171838
ONS-76,262093,3.354802573562099
HCC44,168313016,4.333593878585594
RT-4,107970,2.3841738823851255
WM115,9903786,3.894434750277636
IGROV-1,439501,-2.1510551928674557
Panc 02.03,439501,0.4668648826805023
BT 131,107970,1.8330733391254264
IA-LM,107970,1.9308025720075177
KMS-27,6852167,1.4833276189220757
LS123,11455910,1.1940798457620236
NCI-H508,49766530,-1.9711369921584831
COR-L51,9903786,2.9541793607693267
Pfeiffer,54596490,2.754630117745776
BT 245,UNC0638-navitoclax (1-1 mol-mol),-0.0358626825022054
MKN74,46907787,3.0385379880903542
KMS-28BM,26596,-2.75100842761318
ECC12,tanespimycin-bortezomib (250-1 mol-mol),-0.7458523006445992
TE-5,637858,0.9454052445962788
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673
MSTO-211H,9903786,1.212702371904443
LCLC-97TM1,44491742,4.237702230509644
MKN74,10231331,5.759039673812496
A-549,11455910,0.2975953497649719
SNU-1105,6852167,2.7622264784385444
OV7,46907787,3.2542167876644466
BT 145,637858,1.269457721746569
L3.3,637858,2.497804094781357
Karpas-299,637858,1.0781855815808754
EM-2,5460769,2.512608661279844
DAN-G,6852167,3.417213289559001
RVH-421,sirolimus-bortezomib (250-1 mol-mol),0.2798149280233217
TF-1,375860,-0.3667631401948379
OE33,100016,6.493432597771833
DBTRG-05MG,135421197,2.57791349467794
HCC1428,44491742,4.031952184974023
KMS-26,12003241,-3.93647753580664
G-361,73707398,0.7623357185652524
KMRC-1,49766530,-0.1675164065777726
SNU-16,136227331,3.664519264936635
HOP-62,3689413,-1.4977119259076146
KMS-21-BM,11396600,-4.473822501630397
SNU-C2A,sirolimus-bortezomib (250-1 mol-mol),0.2009996133577312
SNU-46,9903786,2.745048797484884
NCI-H2452,selumetinib-JQ-1 (4-1 mol-mol),2.500134928300083
KMS-34,9929138,4.716780019482296
KYSE-520,9903786,4.522923988599173
DMS 273,3689413,-1.7704206659692223
NCI-H322,444795,6.421299597347825
NCI-H2106,tanespimycin-bortezomib (250-1 mol-mol),0.3731532829488707
KYSE-410,644241,2.1966590431724
HT,11396600,2.79137838927363
TM-31,sirolimus-bortezomib (250-1 mol-mol),0.5260626662043751
DMS 454,9927531,4.138491843589823
647V,49766530,0.7545140228303677
YD-15,100016,6.01418803247364
BT 145,6852167,3.1517365583575496
M-07e,tanespimycin-bortezomib (250-1 mol-mol),-0.2341108641615783
PaTu 8988s,5460769,4.375147735669684
KALS-1,12003241,-0.678278256964916
BT 179,375860,-0.2104297204099122
KYSE-510,selumetinib-JQ-1 (4-1 mol-mol),4.587608539341743
IGROV-1,11396600,3.99372654279783
RS4;11,9903786,1.046136748247593
DK-MG,44491742,5.623663094967997
OAW28,135999136,1.5944266420299655
JHOM-1,262093,3.378036000941939
SW982,sirolimus-bortezomib (250-1 mol-mol),1.8750003849027723
LCLC-97TM1,136227331,4.3740550996774745
A-549,46907787,5.023259811787708
NCI-H1373,71466445,6.090116254163269
SKM-1,10231331,-2.5704839701228117
Rh30,9929138,6.636453392237079
KYSE-140,sirolimus-bortezomib (250-1 mol-mol),2.1276089770363265
BT-12,107970,2.322047510455146
KYSE-450,tanespimycin-bortezomib (250-1 mol-mol),0.2570143843515884
Caki-1,637858,3.2080656123113713
G-292 clone A141B1,241158,1.9556593894066396
MHH-CALL-3,637858,0.6194049407031013
HuT 78,tanespimycin-bortezomib (250-1 mol-mol),-1.2620001487699233
TE-5,10231331,5.100118375291916
BT-16,262093,3.676362037858863
SNU-423,375860,-0.141425947999252
NUGC-3,12003241,-0.6366922027749422
BT 444,262093,2.9400297132003623
BT 187,12003241,-0.5243066739913107
LNCaP clone FGC,9927531,4.548275216558741
SK-CO-1,6852167,2.111498553552754
A-204,49766530,-2.4739709349642083
NCC-StC-K140,26596,-2.208339007847408
COV434,46907787,1.741111624081942
OS-RC-2,49766530,-2.9436814262452144
TOV-21G,sirolimus-bortezomib (250-1 mol-mol),-0.0646182362217989
A-549,44491742,4.437272986024
MOR/CPR,46907787,3.5743081695315255
A-204,3689413,-1.831192826185156
HT,11455910,-0.2280059787426213
MOLT-3,71466445,1.9485978412010911
KYSE-150,tanespimycin-bortezomib (250-1 mol-mol),-0.0451263891138861
KNS-62,10231331,3.3757174650978534
RVH-421,644241,1.9074274016396804
L3.3,107970,2.7957953106701305
MOLT-3,12003241,0.5652275410160802
BT 416,100016,4.165407662771479
HLF,46907787,6.229944229848937
RD,tanespimycin-bortezomib (250-1 mol-mol),-1.016006094021389
SNU-878,12003241,-0.6657900217683382
A-204,5460769,1.2636887852465275
NCI-H196,11396600,4.033022120096851
TUHR10TKB,136227331,3.9944328984652975
MOLT-16,9903786,1.2441798518109255
Hep 3B2.1-7,selumetinib-JQ-1 (4-1 mol-mol),1.068007517221539
PaTu 8988s,46907787,4.297293150577968
647V,selumetinib-JQ-1 (4-1 mol-mol),1.0952955161444873
MKN1,49766530,-2.302116655830655
SK-ES-1,637858,1.1648710207866575
MOTN-1,135398744,7.842138367791958
Hs 683,12003241,0.8693905406704602
HOP-62,168313016,4.593663167068175
U-251MG,49766530,1.0855724910741882
MKN74,375860,0.5646140741524153
KMS-12-BM,9927531,3.2870919606414963
COV434,5460769,0.4340369587181126
OV-90,439501,-0.6322605477357213
NU-DUL-1,9927531,4.217714200280878
Calu-6,9903786,1.9563383465911224
22Rv1,73707398,1.1279645952785575
WM983B,439501,-2.1469095584384608
NCI-H2081,637858,0.9384843122739523
DU145,9927531,4.922928089289864
SUP-T1,44491742,3.5302085503569782
HEL,26596,-1.8679385890512872
KE-97,UNC0638-navitoclax (1-1 mol-mol),5.143602126758789
SNU-387,10231331,2.753186261724594
SF268,26596,0.6172202345506846
NCI-H1341,11396600,2.1149833327737615
HCC1500,71466445,3.970736335461394
Panc 03.27,11396600,3.3574447393288547
SW579,49766530,0.2032240599458712
KYM-1,375860,-0.0864025501236097
SNU-5,168313016,6.260174128040875
WM266-4,73707398,1.4628063646321043
SBC-5,26596,-2.1907470722084414
DOV13,135421197,2.464750540362873
HD-MY-Z,637858,1.3208525061915146
IGROV-1,10231331,1.9104831176724932
BT 440,3689413,1.7448809021086664
HOP-62,11396600,3.498863261816077
IM95,5460769,5.308865140220459
NCI-H1792,9903786,2.6645651408291227
OCI-Ly19,UNC0638-navitoclax (1-1 mol-mol),0.6251807252163226
Ci-1,107970,1.4916042992052976
A101D,135999136,4.499329757784453
KYM-1,26596,-1.5759790260808906
IGROV-1,71466445,2.3758001916617797
SNU-869,5460769,1.7157786407903552
COV434,375860,-0.1612254056423543
BDCM,11455910,-1.5577309500226444
JK-1,26596,-2.9056009254184247
MDA-MB-468,11455910,1.0367745441510958
NCI-H1339,73707398,1.5517116600994163
LUDLU-1,71466445,4.899023757250514
NCI-H727,10231331,-2.105430518957453
COLO 668,3689413,-2.474838617448709
GCT,644241,2.5275274390262936
B-CPAP,168313016,4.426367892913076
SK-HEP-1,107970,2.7276242080982405
CAS-1,439501,-3.1948113083897223
LS123,135999136,4.314561511385293
KMS-27,135999136,1.9595465875821207
NCI-H2029,73707398,0.5003927400842891
MDA-MB-468,3689413,0.3907824455820104
D283 Med,444795,-3.2845998018022775
TM-31,107970,2.6979475281372944
BHY,sirolimus-bortezomib (250-1 mol-mol),0.9100094711799346
Ki-JK,selumetinib-JQ-1 (4-1 mol-mol),-0.3683128688059284
TYK-nu,UNC0638-navitoclax (1-1 mol-mol),4.545157348775277
NCI-H810,26596,-3.4871956530659927
NCI-H1395,6852167,3.4323108551980748
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402
WM1799,135421197,2.490323876838408
THP-1,168313016,4.49092647714658
HCC95,12003241,-0.8735704800502477
SCC-9,49766530,0.4117706354329887
SNU-1033,375860,2.3566426851273063
JVM-2,26596,-2.43180743148247
Daoy,644241,2.9689041505015603
OCI-Ly10,tanespimycin-bortezomib (250-1 mol-mol),-1.3027926249404789
LUDLU-1,644241,2.818954515130764
CML-T1,44491742,2.876043803936746
HEL 92.1.7,49766530,-2.6866934842186234
BT-549,selumetinib-JQ-1 (4-1 mol-mol),3.8001526734522617
NCI-H2141,439501,-3.4118873833208676
U-CH1,6852167,2.6187781142325823
KMS-21-BM,439501,-2.3809491999533003
CAL-148,168313016,4.8531346041528165
SNG-M,135398744,7.8429611595155055
Lu-65,11455910,0.1308260352372195
CMK,UNC0638-navitoclax (1-1 mol-mol),-0.1141456937981058
HCC38,11455910,0.8868705732454679
Mel Ho,26596,-0.5803801535189402
YH-13,168313016,4.37029301578321
SNU-601,10231331,3.365304175447414
NALM-6,9927531,3.382690661986343
Hs 578Bst,46907787,3.9294981488620366
CAL-51,9929138,6.421072450841616
IMR-32,44491742,3.818890533402266
SNU-475,241158,4.465385444986592
SNU-761,241158,3.6921089683840265
FaDu,49766530,4.291089764816537
SNU-81,26596,-2.2143193215677925
HSC-4,44491742,4.173988284907792
HuH-1,439501,-2.8772683526572496
COV362,11396600,3.1783397213372293
Namalwa,44491742,4.1395858329172235
NCI-H1666,5460769,-0.3925578984877662
TE-6,9903786,2.448917190367821
JVM-3,5460769,-4.534057079586897
KMS-11,12003241,-2.8887213513956147
KMS-28BM,262093,1.4261672899079032
PLC/PRF/5,637858,2.297656828654134
LK-2,439501,-2.6408972828107053
KATO III,selumetinib-JQ-1 (4-1 mol-mol),2.3824011664462117
ES-2,135999136,4.341769517673809
2004,444795,5.087849305555533
C2BBe1,375860,3.403726092342882
SNU-46,3689413,0.3621274861005061
MFE-319,9927531,5.194887870380863
SNU-478,107970,2.28578695983555
Ci-1,sirolimus-bortezomib (250-1 mol-mol),0.4066762870237297
SNU-8,sirolimus-bortezomib (250-1 mol-mol),0.5784576721065883
L3.3,168313016,5.4672449278411595
SBC-5,73707398,1.6541333685248465
BV-173,10231331,4.511463225160437
HOP-62,44491742,4.640090000896823
EKVX,selumetinib-JQ-1 (4-1 mol-mol),2.1173577222029643
IGROV-1,46907787,2.182756719431072
U-251MG,71466445,4.8077443194093705
H-STS,11396600,3.334455384541719
NCI-H446,UNC0638-navitoclax (1-1 mol-mol),2.1887843348128917
PSN1,9903786,4.143013374018909
HEC-265,26596,-1.38176914424549
LoVo,135421197,2.0078610802467307
BT 422,tanespimycin-bortezomib (250-1 mol-mol),0.0760958733861235
Hs 294T,135999136,4.295347676577794
OV-90,375860,0.3915953054415123
HCC366,71466445,5.760220768448806
SiMa,73707398,0.5176109846337434
SNU-626,11455910,1.8288059017639848
JHH-5,262093,2.961551350403051
PLC/PRF/5,3689413,0.4443196233363375
SNU-C5,11455910,0.7223735264442241
HCC1195,3689413,-0.7365828236328352
HCC827,tanespimycin-bortezomib (250-1 mol-mol),-1.554763152633591
M-07e,9927531,3.229988201288456
NCI-H2030,241158,3.7184725002314183
NCI-H520,135421197,1.6066426721545042
KMS-12-BM,10231331,5.965261420703939
NCC-StC-K140,9929138,3.845494861279627
Panc 02.03,637858,2.766769284687194
Kasumi-1,241158,1.872306915049785
LS513,sirolimus-bortezomib (250-1 mol-mol),0.1168577806704952
DB,3689413,-2.3561309099852448
KO52,44491742,3.2759729423779103
PaTu 8988s,168313016,4.471656567537183
MFE-319,sirolimus-bortezomib (250-1 mol-mol),0.3475063070174586
NCI-H1105,375860,-0.1286391946208893
NH-6,6852167,2.540209707487907
KMS-27,9903786,2.0838522642379216
SK-CO-1,26596,-2.200264316257102
WSU-DLCL2,3689413,-4.959446620100962
CJM [Human melanoma],375860,-0.5487520794387316
CHP-212,44491742,3.750067652008212
NCI-H522,6852167,2.4506568165817777
HCC1419,11396600,4.111721753411411
Rh41,46907787,-1.0296946770791056
Hep 3B2.1-7,49766530,-1.5968741678942395
OAW28,11396600,3.5740319462685535
Aska-SS,100016,5.454856815374324
JHUEM-3,135999136,3.851371077820259
ZR-75-30,262093,3.223282782718559
NCC-StC-K140,241158,1.4895187461892925
SNU-398,10231331,-3.488148641094839
CAL-54,439501,-3.2230187997856308
HOP-92,12003241,-2.2936384439521156
NCI-H2196,439501,-1.9043844138508108
SU-DHL-1,9927531,2.969590320438058
SK-UT-1,46907787,3.5849510733980265
DU145,6852167,4.203979731076271
SNU-398,107970,2.587748005247781
NU-DUL-1,9929138,4.2318151055504165
BC-3C,439501,-3.6854661122428896
NCI-H526,444795,4.168802704831755
LCLC-97TM1,439501,-2.367039612081251
LOX-IMVI,5460769,1.2475955137176375
NCI-H1666,439501,-0.7596014001034053
SUP-T11,6852167,1.2603138165512704
HT-55,444795,4.735697190261942
BT 504,11396600,2.364157912442885
COLO 680N,107970,2.2694661867181565
DMS 273,375860,-0.4468381354972334
OV56,46907787,5.709226963672881
NCI-H2342,46907787,2.1286860710526727
BHT-101,107970,2.697716675484313
TE-5,73707398,0.9909489120421338
CHP-212,tanespimycin-bortezomib (250-1 mol-mol),-3.160295416618492
8-MG-BA,selumetinib-JQ-1 (4-1 mol-mol),2.597968943112954
SU-DHL-8,3689413,-0.1983897447219186
HCT 116,439501,-2.291145672790816
PK-45H,11396600,6.037310564900793
MOLM-13,107970,2.204740997332017
MDST8,439501,-2.351670240427255
NCI-H2122,10231331,1.1462222888418094
ST486,UNC0638-navitoclax (1-1 mol-mol),0.2279596514699741
RMG-I,444795,6.5483017268808545
HCC44,10231331,-0.2249435110927301
HEC-108,3689413,1.021712931431184
KYSE-70,12003241,-1.4257688129039825
JURL-MK1,9903786,1.1530539492536125
SF268,5460769,2.7900829317628157
Hs 294T,73707398,0.8837453626165415
Kelly,sirolimus-bortezomib (250-1 mol-mol),0.1077150919065075
ECC12,44491742,5.882219614933299
ACHN,241158,5.588735274561884
LOU-NH91,107970,2.5070848864255093
HOP-92,5460769,4.612763799526671
UACC-62,644241,2.9986317152485307
SNU-387,262093,3.304396146111304
JHH-2,6852167,1.881711410942769
SH-10-TC,sirolimus-bortezomib (250-1 mol-mol),0.4964962482728405
VM-CUB-1,49766530,4.3854090079907015
GSS,107970,2.2178092034727954
Hs 895.T,44491742,4.052136098794782
JHOS-2,439501,-1.7810659698963345
TUHR14TKB,637858,1.156941849061993
F-36P,6852167,2.0711670211251016
MKN7,9903786,5.918197098229428
KLE,73707398,0.4840000511633914
BT 428,135999136,1.4549412998786355
HEL 92.1.7,637858,1.114692071831855
OVK18,selumetinib-JQ-1 (4-1 mol-mol),1.011508135908241
GA-10,12003241,-5.009664542431325
BT 131,sirolimus-bortezomib (250-1 mol-mol),-0.1353843120079282
SK-N-SH,135999136,3.91639066262896
Ci-1,9903786,3.745611899218518
SNU-1076,6852167,1.7947543105192023
Li-7,241158,4.1355969929783045
HCC1588,10231331,-1.6927312799094765
NCI-H1581,11455910,-0.5870511913964108
TE 441.T,5460769,2.227250069350157
RCH-ACV,439501,-2.6930538101979575
SNU-423,9927531,5.196680575825113
NCI-H526,100016,5.298819017471169
OAW42,135421197,2.0874020814941643
HEC-108,135421197,3.884784600125324
SNU-8,637858,2.315225412035183
VM-CUB-1,12003241,-0.6809659848466374
OVSAHO,262093,2.313375156215166
OVCAR-8,262093,3.292567047569706
SNU-423,644241,4.521136945345214
MHH-CALL-3,44491742,4.228181381617403
NCI-H1299,46907787,1.4375849802030871
EHEB,135421197,1.2947733633872678
KYSE-520,135398744,6.453499706252085
NCI-H1650,644241,2.6556304890705618
L-1236,selumetinib-JQ-1 (4-1 mol-mol),2.8513697754529947
HuP-T3,439501,-2.469428626730465
PF-382,241158,3.333523301157689
EKVX,44491742,4.084576713807475
MOLP-8,44491742,4.067907034019371
SNU-878,UNC0638-navitoclax (1-1 mol-mol),-0.9446051430967974
HEY A8,135999136,4.500439967266887
MKN7,637858,1.847380474134536
NCI-H1355,136227331,3.624687432922337
NCI-H2009,selumetinib-JQ-1 (4-1 mol-mol),-2.491953444120814
DLD-1,46907787,1.2209217762946305
MPP 89,UNC0638-navitoclax (1-1 mol-mol),1.0683509046590218
Calu-6,637858,1.7699148310431834
JM-1,UNC0638-navitoclax (1-1 mol-mol),0.2019375485573805
BT 139,selumetinib-JQ-1 (4-1 mol-mol),2.342972128639262
PC-3,46907787,4.432628398195534
SK-MEL-30,262093,2.857601335601776
Hs 683,11396600,3.438921740314131
NCI-H929,11455910,1.7265755247991157
HCC1438,UNC0638-navitoclax (1-1 mol-mol),3.020359062628678
KE-97,375860,-1.25859838989695
HEC-265,10231331,6.423898204800826
HuCC-T1,637858,2.046776139114269
SNB-75,54596490,4.4312268703898825
OAW28,107970,2.4537130721494105
NCI-H2081,tanespimycin-bortezomib (250-1 mol-mol),0.018908734219335
CAS-1,49766530,-0.5285201098219467
UM-UC-1,375860,0.751139865228237
NCI-H211,9929138,5.380776985298909
MKN74,637858,2.2619901111682768
Caov-3,375860,-0.325299744991378
UACC-257,136227331,4.461620315172803
OCI-AML-3,107970,1.3143182352551162
SET-2,selumetinib-JQ-1 (4-1 mol-mol),-0.4291738156644369
HCT 15,12003241,-0.9489590343068364
CFPAC-1,9903786,2.8562781406669653
HCC1833,sirolimus-bortezomib (250-1 mol-mol),1.7413887390149827
TT,sirolimus-bortezomib (250-1 mol-mol),1.7489880165366345
LS513,5460769,-0.3272270852290284
MDA-MB-453,262093,2.6969191096415113
T3M-10,10231331,1.7562968841685376
NCI-H647,644241,2.820722009461978
Hs 888.T,selumetinib-JQ-1 (4-1 mol-mol),4.1803685038079665
BT 504,6852167,5.8705785953298255
Karpas-620,136227331,4.429067996401553
MOR/CPR,12003241,1.56456971518695
Hs 934.T,3689413,-2.375941767618157
Jurkat,375860,-0.5267502714106769
COLO 320,9927531,3.3062100750903594
Mono-Mac-6,71466445,2.7223789510878524
SW1353,637858,2.400898572711613
SNU-398,241158,1.6033958932567285
NCC-StC-K140,selumetinib-JQ-1 (4-1 mol-mol),-0.4329404408477834
EBC-1,26596,-2.071625704215017
KYSE-70,46907787,2.9670215892594793
A-375,71466445,4.407690807388674
SK-MEL-1,46907787,0.0749929399397362
BICR 16,tanespimycin-bortezomib (250-1 mol-mol),-2.3692511571094244
WM266-4,46907787,3.372133923169319
TUHR10TKB,107970,2.500440283566812
TYK-nu,168313016,5.521300034207165
NCI-H1355,6852167,2.860107026969785
AN3-CA,44491742,4.617223070127138
KP-3,73707398,1.3853432761584183
LOU-NH91,selumetinib-JQ-1 (4-1 mol-mol),1.3495947131381103
U-251MG,44491742,4.097928635737581
SK-LU-1,44491742,5.866940990531296
NCI-H508,selumetinib-JQ-1 (4-1 mol-mol),1.3063774876339054
J82,439501,-1.5072353700594
COLO 668,262093,3.0831926825612586
U266B1,6852167,2.66755364409151
SNU-16,444795,3.455599253564167
SBC-5,135398744,6.447254342428179
LP-1,6852167,-0.3749906746995474
HLF,11455910,2.0760137944141355
Jurkat,100016,5.920987823967134
RPMI-8402,sirolimus-bortezomib (250-1 mol-mol),0.331212001560029
DAN-G,5460769,3.6980093078585594
Hs 611.T,5460769,0.2348324565646969
DND-41,26596,-1.3202555430270588
CAL-12T,73707398,1.4913099506647278
SHP-77,439501,-1.6083465101803276
JVM-3,3689413,-1.6537581501619123
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456
RS4;11,26596,-3.6621242440749766
UACC-257,262093,3.003704805776171
Caki-2,6852167,3.1041521694647103
NCI-H2106,444795,4.013902342080577
KE-39,262093,2.516325504276674
NCI-H211,375860,-0.4774994527633157
SW1088,46907787,5.3423839694958595
SJSA-1,selumetinib-JQ-1 (4-1 mol-mol),1.8964351089823623
ACC-MESO-1,tanespimycin-bortezomib (250-1 mol-mol),1.746490159634885
HPAC,sirolimus-bortezomib (250-1 mol-mol),0.9709170992825356
SNU-1076,5460769,2.5468440002865895
FU-OV-1,9929138,5.415072941349914
SNU-216,46907787,3.852045832322763
TE-8,6852167,2.3959021191474448
Pfeiffer,644241,3.575811031828958
SK-UT-1,9903786,5.78516391020833
SNU-216,UNC0638-navitoclax (1-1 mol-mol),2.629430823091792
HCC1428,439501,-1.870619220326862
PaTu 8988s,9927531,5.1297297992623605
BHT-101,3689413,0.1910629182476014
SNU-213,tanespimycin-bortezomib (250-1 mol-mol),-0.03636038337738
Hs 683,100016,6.526692615081327
MV4-11,107970,1.817432876584402
BC-3C,12003241,-1.7584420473179934
UM-UC-3,9903786,3.957731160225435
HCC2935,6852167,2.787674995055815
JHUEM-1,11455910,-0.2565923916493475
NCI-H508,135421197,1.875184072500521
HuP-T3,9927531,4.952379772704904
SUP-HD1,262093,1.1594795274119565
MOLM-6,439501,-2.481235369301624
TCCSUP,73707398,0.9718071298936178
Toledo,444795,4.36576066611392
HEC-59,49766530,-0.0916228108387451
HCC2218,26596,-0.1880453521462128
BT 232,tanespimycin-bortezomib (250-1 mol-mol),-2.012927947463912
KYSE-150,46907787,4.608870266464791
EFO-27,26596,4.577324640946523
HOS,26596,0.4724890056436647
KP-N-YN,241158,4.193334687339578
SNU-601,73707398,0.8838750132106912
COLO 741,241158,1.01148903945962
MFE-296,107970,2.24229394331556
OCI-AML-5,6852167,1.9136367887966896
QGP-1,100016,6.909688760762285
SNU-475,12003241,0.1195420556659512
FU-OV-1,6852167,2.292876265150526
SYO-1,71466445,1.798579929211262
Rh18,241158,3.650001682729563
TE-8,9903786,2.2578315560817432
HuNS1,5460769,0.1719707153677664
NCI-H1915,5460769,1.211615003674484
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176
TT,11396600,4.947180830424627
CAL-12T,3689413,0.6503456712736767
FTC-238,439501,-2.852234724495685
L3.3,73707398,1.2944525096848456
Daudi,12003241,-4.903510386182724
LOU-NH91,3689413,0.742189593443008
Mel Ho,12003241,-1.328246141696159
BT-20,11396600,3.3625164921440884
SW1116,107970,1.8262752967373983
SET-2,sirolimus-bortezomib (250-1 mol-mol),0.175715922868153
SET-2,637858,1.0371530211435662
SK-UT-1,375860,0.2310503192742169
MDST8,26596,-1.25574590011264
JHUEM-1,439501,-3.414887087046791
OVK18,135999136,1.6002328779201676
T-47D,100016,6.980531714745858
MOLT-16,11396600,2.170033155162838
DMS 454,71466445,4.510372203594112
GOS-3,262093,3.1165245547903804
Ri-1,262093,1.5615741003890895
RMG-I,439501,-1.0670769936155349
BT-474,241158,4.261649055387228
SNU-878,26596,-1.9589890224119235
UACC-62,10231331,-1.3900234436911754
MHH-CALL-4,135999136,4.260034737485126
NB1,selumetinib-JQ-1 (4-1 mol-mol),1.785319737848639
PSN1,11455910,0.0826195354078685
SNU-761,3689413,-0.7506907427890448
Kasumi-1,UNC0638-navitoclax (1-1 mol-mol),-1.6460218253730017
CAL-51,26596,-1.4638590943230956
RL95-2,6852167,2.7207432389099395
GA-10,375860,-0.8493314441415308
NCI-H2087,selumetinib-JQ-1 (4-1 mol-mol),-5.600268685370347
HCC4006,3689413,-2.273135078427732
SCC-4,UNC0638-navitoclax (1-1 mol-mol),-2.0380120299925433
SF126,46907787,4.091740890071596
KMS-27,9927531,4.171626738694902
697,selumetinib-JQ-1 (4-1 mol-mol),-0.8612370024069985
NCI-H292,UNC0638-navitoclax (1-1 mol-mol),0.2061924649473525
SF268,44491742,4.062737154124887
A-375,439501,-2.387181275139254
Panc 04.03,439501,0.3022334331499904
SYO-1,11455910,1.1491108391479796
CAL-62,262093,2.299935005581277
HCC1438,9903786,3.876774477069639
PK-59,71466445,3.6462946515492423
ECC10,107970,2.546230477639249
K029AX,12003241,-1.6892437749493532
HCC2279,439501,-2.2925635815610006
K-562,644241,-4.86229706466587
NCI-H889,selumetinib-JQ-1 (4-1 mol-mol),4.19134386436801
SNU-869,9903786,4.230852859752073
GB-1,49766530,-2.426410648312405
Capan-1,sirolimus-bortezomib (250-1 mol-mol),0.7071415431289269
MCAS,135421197,1.955288267695935
BT 228,241158,4.2850908556877405
JHH-2,9927531,4.777538001331337
BT 416,sirolimus-bortezomib (250-1 mol-mol),0.8644266482137087
L3.3,241158,3.9670067644952702
Rh30,135999136,4.27956770229102
MV4-11,100016,3.584878230644963
KU-19-19,637858,2.3404288739792314
SUIT-2,262093,4.049104877248936
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557
KMS-11,26596,-4.4422678730324465
L-363,selumetinib-JQ-1 (4-1 mol-mol),0.5037270825872936
PaTu 8988t,444795,4.288290341819835
NCI-H23,11396600,3.42598990187636
HMC-1-8,11455910,0.6557155975266148
DMS 53,107970,1.762888041904688
NCI-H1395,100016,6.569605836811141
TTC-709,71466445,4.102542258005533
MHH-CALL-3,241158,2.355012632546193
KNS-62,sirolimus-bortezomib (250-1 mol-mol),1.3906693403770916
TALL-1 [Human adult T-ALL],168313016,5.087698576043886
Raji,107970,1.9902567284357284
NCI-H661,444795,4.831383676329662
NUGC-4,6852167,2.041234695282504
RT-4,5460769,0.3645225539442671
SNU-738,241158,6.033903166025284
G-292 clone A141B1,6852167,1.22729598496685
PaTu 8902,136227331,5.567107594748722
Hs 746.T,46907787,3.398269102582514
Hs 578T,107970,1.821405074078983
SK-N-BE(2),444795,4.243523725164084
JM-1,439501,-5.872076466297635
NCI-H510A,26596,-3.9165599075217994
U-937,262093,2.270631541359052
DB,135398744,6.337933152850909
Mono-Mac-6,46907787,6.013710561092881
NCI-H2009,11396600,4.054693544346837
P12-Ichikawa,71466445,1.784342730653087
SNU-1,100016,5.685360721271126
HEY A8,135421197,2.419965019315952
NCI-H1373,5460769,2.0630814106312543
NCI-H1573,637858,2.63768686790808
WM115,100016,7.477930972064711
AU565,444795,4.595530435398324
SCC-9,168313016,4.940700460648117
EB1,6852167,1.278793864374466
WSU-DLCL2,selumetinib-JQ-1 (4-1 mol-mol),-0.1705600284579236
WSU-DLCL2,241158,2.532275707975188
MKN74,444795,4.813746668426388
TT,168313016,4.280600681021949
U-118MG,49766530,0.4314667015324968
NU-DUL-1,71466445,1.0857622618478715
TUHR14TKB,11396600,3.8849450559075343
NCI-H460,46907787,4.3372157131836255
HOP-62,sirolimus-bortezomib (250-1 mol-mol),-1.0582430769109517
5637,73707398,0.9897301208178872
YH-13,49766530,-0.8723369372860722
BT 239,26596,-0.3538471097190154
CFPAC-1,6852167,4.928120613967257
NCI-H1092,135999136,1.996402787689235
SF268,136227331,3.2043124531473945
DU4475,168313016,4.82519717161753
NCI-H2110,107970,2.6685379556569297
KMS-26,6852167,-0.4011200581134632
SH-10-TC,46907787,1.9589503619322264
NCI-H810,71466445,1.829191820836244
KMS-20,262093,1.6065117070445694
NCI-H1734,262093,2.5864421448130632
786-O,tanespimycin-bortezomib (250-1 mol-mol),0.0938204565808633
SNU-61,49766530,-2.178873950286192
HuH-1,12003241,0.2926250163716364
LOX-IMVI,6852167,2.751037556623792
MKN74,168313016,4.440025368788847
RPMI-7951,439501,-2.4869379045692313
Namalwa,tanespimycin-bortezomib (250-1 mol-mol),0.1758913407069346
MOLM-6,44491742,4.372818024610458
MKN1,644241,2.5919310202302532
LC-1/sq-SF,selumetinib-JQ-1 (4-1 mol-mol),1.9783005635841648
SNU-213,sirolimus-bortezomib (250-1 mol-mol),1.705548716075845
UACC-62,UNC0638-navitoclax (1-1 mol-mol),3.345693266997061
JHH-4,375860,-0.101060239455863
KMS-28BM,241158,0.8736847772336357
BT 286,11396600,2.040730461375106
TTC-709,73707398,-0.1314880855632042
SK-LU-1,73707398,2.0384137453818316
BT 224,135999136,1.5656128801524771
BT 232,136227331,4.34663354921091
TE-4,3689413,3.3768605304218036
Panc 03.27,375860,-0.1725632287380341
IGROV-1,73707398,0.8848064516600974
L-540,241158,1.8161298182367036
IGR-37,644241,2.2341406718555814
COLO 792,444795,4.800217468318623
DK-MG,tanespimycin-bortezomib (250-1 mol-mol),0.5926006673391784
MOLM-6,6852167,2.1278340646476654
MDA-MB-157,241158,1.407364121620741
CCF-STTG1,73707398,2.079175010578171
RL,5460769,2.816259716284544
Mino,637858,0.8453968503614813
Ku812,73707398,0.2962870044778456
P3HR-1,241158,4.4514160234357725
OVCAR-8,6852167,4.329418892564513
NCI-H292,6852167,2.409220580223775
OCI-M1,107970,2.5617440742117794
JHH-5,135421197,0.9598662644879212
MDA-MB-415,3689413,0.9318118886316789
MSTO-211H,selumetinib-JQ-1 (4-1 mol-mol),1.9489551392518472
TALL-1 [Human adult T-ALL],107970,1.1259426564073174
NCI-H1693,71466445,4.120869747264166
SF268,11396600,2.843144767793207
LoVo,selumetinib-JQ-1 (4-1 mol-mol),-1.8361098312254576
NCI-H2110,46907787,2.692877404772462
SW1088,107970,2.3943763924537147
COLO 680N,3689413,-1.68743506325492
OV-90,selumetinib-JQ-1 (4-1 mol-mol),-0.755409659671859
SNU-46,11396600,4.157992682582123
VCaP,71466445,2.453363509035087
SF539,49766530,-1.8483208282069583
Hs 683,241158,4.572594529470727
RERF-LC-Ad2,135999136,4.345961129852593
NCI-H1838,135421197,3.0892223680095077
HCC4006,selumetinib-JQ-1 (4-1 mol-mol),2.3344862445657077
RCM-1 [Human rectal adenocarcinoma],262093,3.1357995089449058
JVM-3,9903786,0.2351218463531885
SK-CO-1,44491742,5.1736211152382285
SNU-761,46907787,2.564900222072361
BICR 31,12003241,-1.4237270953299652
NCI-H460,439501,-2.362377537788676
KMS-11,375860,-0.7431294237893198
OVSAHO,375860,3.0148853739241495
BT 330,11455910,-0.0355958099114693
WM115,9927531,5.125567810288171
U2OS,637858,0.295840107326967
P31/FUJ,107970,2.0437014771117425
HEC-6,241158,3.593193456057986
SW1710,375860,-0.2472901912164723
HT-144,sirolimus-bortezomib (250-1 mol-mol),0.2937138425316054
MOLP-2,11396600,3.664107522761926
COV644,637858,1.9905836123238367
NUGC-3,135421197,1.602671962705462
KMS-27,10231331,-2.582639088661463
KO52,11396600,3.051627581840025
KYSE-520,12003241,-1.836986739794001
OVISE,73707398,1.6715872061037895
NCI-H2052,sirolimus-bortezomib (250-1 mol-mol),3.0581569825638417
HT-29,11455910,2.35614963734945
NCI-H526,11455910,1.2336462288733878
NCI-H1755,selumetinib-JQ-1 (4-1 mol-mol),1.244878912686623
Panc 03.27,439501,-1.8758236187541328
DB,12003241,-2.5818700415802107
KNS-62,637858,3.1526441291678737
PK-1,9927531,5.928994406522703
QGP-1,3689413,0.2348303758640308
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
Rh41,241158,2.6802066493092154
BT 248,107970,1.564508535325896
DMS 114,49766530,0.1100604585503799
TALL-1 [Human adult T-ALL],44491742,3.807829450429648
EPLC-272H,49766530,0.3578946183960979
SNU-410,72967,3.703184158128847
EHEB,26596,-2.0876334457911727
SU-DHL-8,107970,1.6318568157956992
NCI-H747,10231331,-2.435318484527335
MIA PaCa-2,6852167,2.446025976555517
KMS-11,9927531,3.9884073246481058
NUGC-4,135421197,0.9656923984345016
Calu-6,241158,1.6946113745445348
KYSE-30,10231331,0.8678234440350742
AML-193,100016,3.9854178308912074
RPMI-7951,46907787,2.690496694685834
TE 441.T,44491742,3.759624787095016
ST486,11455910,-0.3463533308218484
HCT 8,sirolimus-bortezomib (250-1 mol-mol),1.4500182233315906
LS513,107970,2.2797374940944284
HEC-251,selumetinib-JQ-1 (4-1 mol-mol),0.8388140404115119
CW-2,72967,3.734001222623639
HEC-251,100016,6.174926130166858
AsPC-1,135421197,1.8824248695595285
OE21,71466445,1.981156974013709
BICR 16,262093,3.685769886928711
F-36P,selumetinib-JQ-1 (4-1 mol-mol),-1.0872575264771165
EC-GI-10,135421197,2.6554260651885944
NUGC-4,sirolimus-bortezomib (250-1 mol-mol),-0.7003911185233305
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
SNU-C5,644241,2.256907978098841
KYO-1,11455910,-0.2516095405982875
NCI-H841,9903786,1.3953234404083057
HuNS1,135999136,1.7858791194050956
BICR 22,6852167,2.9570859917106533
5637,439501,-2.4129442020826697
HEY A8,11455910,0.7579063331214974
KP-N-SI9s,9903786,1.8487391330719625
SW1573,73707398,2.4757839790774123
DU145,11396600,3.556301760853191
KMH-2,241158,3.3374557271517
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062
MOLT-3,9929138,4.064754061766862
NCI-H2126,6852167,3.4187540293096106
HOP-62,12003241,-2.147728480634193
SNU-620,49766530,-0.1917979569590051
HCC-56,100016,6.404810900486153
KMS-12-BM,168313016,3.5287146199889805
SK-MEL-5,49766530,5.144736864268162
JURL-MK1,44491742,4.045631279535998
SNU-1076,135421197,2.6867393428940107
OV7,439501,-2.8665617033549515
HuP-T4,selumetinib-JQ-1 (4-1 mol-mol),-3.5462201060588714
BT 216,262093,2.591664883123623
BT 482,5460769,4.579365975157546
Caov-3,11396600,3.9486242065815738
HCC827,375860,0.1070945405661363
KALS-1,262093,3.291549071505813
HOP-62,136227331,3.5608481617611165
BT 422,11455910,1.0713128287987654
Peer,11455910,-0.1315414365833526
NCI-H2110,sirolimus-bortezomib (250-1 mol-mol),0.8725557491519701
TTC-709,12003241,-2.491438610606954
SJSA-1,49766530,-1.4703185273344612
HEC-1-A,135421197,1.5855088638754589
NCI-H1581,11396600,3.1540391346849015
SUIT-2,selumetinib-JQ-1 (4-1 mol-mol),3.2290404930384637
MHH-CALL-4,44491742,5.077124852247723
WSU-DLCL2,11396600,2.507675324045039
Becker,637858,2.787561829247156
NCO2,9903786,1.4505958737560818
LNCaP clone FGC,241158,3.9934021722066784
H-STS,375860,-0.6907889018597777
MOLP-8,9927531,5.438833274000949
Ku812,637858,1.0891915977996414
NCI-H146,UNC0638-navitoclax (1-1 mol-mol),-1.9432589760731351
AU565,71466445,4.046585104708946
BT 179,46907787,3.881061843357654
MOR/CPR,100016,6.350482300205422
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308
DMS 53,9903786,1.7776029378286846
RCC10RGB,241158,4.984223152954295
Mono-Mac-1,375860,-0.4295713018664168
BC-3C,26596,-0.2711171382512473
HD-MY-Z,5460769,0.4985347726770217
RKO,241158,4.5302703569847305
T-47D,11396600,3.840733614966456
Calu-1,100016,7.639038839177244
HEL 92.1.7,73707398,1.0106494633423595
MOR/CPR,107970,2.4232948215338355
LOX-IMVI,168313016,4.96467141821942
SNU-216,sirolimus-bortezomib (250-1 mol-mol),0.3912590686829094
TOV-21G,107970,2.735193282025734
BT 147,439501,-3.335486008920962
JHH-5,637858,1.3205642125836328
PaTu 8988s,135421197,1.1460063606701134
MPP 89,46907787,6.057961616888675
OV-90,241158,4.35659665315252
FTC-133,5460769,4.281031552964228
BT 328,262093,2.379096363022233
MHH-ES-1,11396600,3.76498087597508
HCT 15,26596,-1.5306161018190547
MV4-11,sirolimus-bortezomib (250-1 mol-mol),-0.4533727146594301
JMSU-1,3689413,-0.0210585182318067
BT 131,262093,2.390336920502222
SiMa,71466445,2.534593277399028
SK-HEP-1,6852167,5.53454213252302
OVCAR-5,9927531,5.160514110518488
SNU-620,5460769,0.532888566426305
KMRC-1,644241,4.9037113640465035
T-47D,71466445,4.2540654226734596
HT-55,46907787,2.1816340847533824
MKN74,241158,4.664529497930215
Sq-1,135999136,4.253718800618169
HMCB,637858,1.3431818902192771
MFE-296,241158,3.7425746941518327
JHH-2,262093,1.5917989690275902
SUP-B15,637858,1.0348461342218127
639V,73707398,1.241439149904724
YD-15,73707398,0.9589848117776284
SK-N-MC,375860,-0.433233817068978
HCC1143,135421197,0.8918606552263807
ZR-75-30,44491742,3.706511746773907
EC-GI-10,107970,2.2401004276751997
LNCaP clone FGC,262093,3.5120752927452803
NALM-6,135999136,1.471573545820229
SNU-C1,637858,2.363835438412207
MDST8,3689413,-1.6812703512916511
PK-59,tanespimycin-bortezomib (250-1 mol-mol),-0.1370541411444133
RPMI-8226,241158,0.7857834855258714
LMSU,100016,7.332455698517509
PE/CA-PJ49,12003241,-1.496755728928347
RERF-LC-A1,11396600,3.681688949161253
SH-4,9903786,3.356674972156618
Daudi,selumetinib-JQ-1 (4-1 mol-mol),0.1373274073902578
SK-MES-1,26596,-0.6489352140411898
ZR-75-30,439501,0.5523338496996666
NCI-H2196,49766530,-0.5620796478121586
T24,375860,0.4075315384303163
KMS-18,439501,-2.5838956635173287
RVH-421,44491742,4.40169374936578
NCI-H520,selumetinib-JQ-1 (4-1 mol-mol),1.7959695418998267
HeLa,107970,2.289164047292083
Panc 08.13,5460769,-0.1924357520120825
NCI-H2106,49766530,-2.15877326131524
SNU-1,168313016,4.634706136735533
AsPC-1,439501,-1.6009280184427317
SNU-1196,100016,6.169672174830197
SNU-899,9929138,5.051227774447189
EM-2,262093,0.7558915053093321
NB4,637858,1.139031029717768
RKN,107970,2.600341318615175
DMS 454,262093,2.385432279101096
KP-3,100016,6.07483479536675
GB-1,262093,2.1332737171644913
Rh18,10231331,5.000034142038024
NCI-H747,3689413,-2.2954703648292605
NCI-H1395,135421197,1.2810683988074232
KMRC-20,sirolimus-bortezomib (250-1 mol-mol),1.830355580923548
HCT 15,9927531,3.5842922899079173
KG-1-C,3689413,-1.7465014908016088
Kasumi-1,sirolimus-bortezomib (250-1 mol-mol),0.3681691235754297
NCI-H520,9927531,5.647411307076465
SK-MEL-30,135421197,2.8284209456564025
Peer,135999136,0.4527960183796846
HCC1395,sirolimus-bortezomib (250-1 mol-mol),4.6634118808153735
A3/Kawakami,135421197,1.197973904783629
FaDu,11396600,3.202627424323668
SK-MEL-24,3689413,0.3993824056710978
JHH-5,100016,5.964491744827364
CCF-STTG1,637858,3.1960196819129343
CAL-62,46907787,-2.0222332374843
NCI-H226,selumetinib-JQ-1 (4-1 mol-mol),4.20163198876541
HPB-ALL,262093,1.2966531532879173
LoVo,9903786,0.6551100591729495
PE/CA-PJ41 (clone D2),637858,2.8065176462831034
SR,73707398,0.885476765811656
SUP-B15,tanespimycin-bortezomib (250-1 mol-mol),0.1434284566489843
OCUM-1,11455910,0.0490190969024124
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276
NOMO-1,136227331,3.913043208951298
KNS-60,UNC0638-navitoclax (1-1 mol-mol),2.0430869502631475
SNU-61,11455910,1.387165489844305
TCCSUP,135421197,2.510598154952076
NCI-H358,9929138,5.930954019944583
OCI-Ly10,73707398,0.9871539697416232
SU-DHL-1,5460769,-0.475427190707336
WM88,439501,-1.2543537382039465
SF295,107970,2.6813754727325203
NU-DHL-1,10231331,-1.2748802736904843
SNU-478,6852167,1.935755270387292
SW1990,107970,2.5044307368694687
Reh,241158,3.1279755149580213
NCI-H2170,135999136,4.479951445238564
NCI-H1650,107970,2.2663913645375846
CGTH-W-1,sirolimus-bortezomib (250-1 mol-mol),1.647706898870075
CAL-29,46907787,4.132082272537132
WSU-DLCL2,9903786,-0.2732990105431844
23132/87,9929138,5.470109790622619
Kasumi-2,6852167,0.8229890671000598
ACHN,262093,3.108023323173393
TOV-112D,11396600,3.358650381716018
BT 416,49766530,0.2372877169340128
SUP-T11,11455910,1.655670582891713
WM88,71466445,3.914580213276338
NCI-H838,375860,-0.2970078399394082
KYSE-70,5460769,2.831605222646697
PK-1,11455910,1.3401068508197878
OE21,3689413,1.0863405783683666
P-STS,135421197,0.9430476955578664
JL-1,439501,-1.5766228751230973
AsPC-1,selumetinib-JQ-1 (4-1 mol-mol),1.077922067972621
NCI-H838,637858,3.1822824792904467
NCI-H810,73707398,-0.5650291058326256
MG-63,135421197,2.3239487693953627
SUIT-2,439501,0.993663636668041
MSTO-211H,135421197,0.8053711662366769
WSU-DLCL2,9927531,3.1454575318264495
JK-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8712031645935759
MHH-ES-1,3689413,-2.44734032949193
CAL-148,375860,-0.9253661566101976
SCC-9,44491742,4.764074483400304
NCI-H747,444795,5.119508258323706
HCC95,107970,2.8523791542380095
L-428,100016,6.045371287660442
NCI-H2029,439501,-1.7622660866331608
CCF-STTG1,12003241,0.9586959919868534
COLO 668,11455910,0.5026800479718163
NCI-H929,375860,-0.8805079289764249
KMRC-20,637858,2.2731698678706027
NCI-H1944,5460769,2.8815728712933533
SNU-503,6852167,3.0647211041019986
NCI-H1792,26596,-3.036610435257371
HGC-27,107970,1.5990120472762
KCL-22,135421197,1.194260119901322
PE/CA-PJ15,9927531,4.562949408871821
ONCO-DG-1,44491742,4.983213967285157
Lu-99,6852167,2.317139161663513
LK-2,9903786,3.191424869539257
F-36P,71466445,1.2079369849052677
KATO III,44491742,4.678429550063523
SNU-5,9903786,3.415136592873371
HCC44,644241,2.1964993568144244
MKN74,46907787,3.0385379880903542
SET-2,136227331,4.340141921453115
ES-2,71466445,5.483195455605914
Calu-3,375860,3.536505764662041
YD-8,sirolimus-bortezomib (250-1 mol-mol),1.3877197149953842
WM793,tanespimycin-bortezomib (250-1 mol-mol),-1.2734227949577797
Hs 729.T,9903786,3.958862053564968
PK-45H,selumetinib-JQ-1 (4-1 mol-mol),0.8986544638640594
MOLM-6,12003241,-5.9234672860619995
UM-UC-1,6852167,2.5979148138945094
IGR-1,sirolimus-bortezomib (250-1 mol-mol),1.4068933313589211
GB-1,9929138,7.490130865110687
SK-MEL-31,241158,3.7616709028064417
LP-1,5460769,5.634254198515754
SNU-245,sirolimus-bortezomib (250-1 mol-mol),2.143003825797964
U-BLC1,3689413,-0.8991596677439855
Detroit 562,241158,3.684460199981928
Hep 3B2.1-7,9903786,2.792162090587101
SNU-719,12003241,0.0299382028109862
OCI-AML-5,sirolimus-bortezomib (250-1 mol-mol),1.6444241054056523
KMRC-20,262093,3.714553986632731
COLO 792,11396600,4.429975159558261
MOLT-3,46907787,-1.1708174424731892
CAL-78,tanespimycin-bortezomib (250-1 mol-mol),-2.747028808134876
KALS-1,73707398,0.9491392932530416
SNU-601,12003241,-1.174156148938379
KE-39,10231331,4.477976749120646
OVCAR-8,9929138,6.802229697599492
Daudi,46907787,-0.707382985228944
COR-L105,439501,-1.395093001857319
BT 286,tanespimycin-bortezomib (250-1 mol-mol),-2.64428689398821
HCC78,3689413,0.9109498190296136
SNU-201,107970,3.0289309781280287
SNU-1105,637858,3.0144066830582172
COLO 678,100016,6.808142270815235
PE/CA-PJ15,135999136,4.2175976064097265
SNU-1077,100016,6.64200464659652
L-540,444795,4.201661440924783
YD-38,262093,2.9761292729070954
GaMG,135421197,1.593389235572815
253J,9903786,1.7805297403151377
DMS 273,637858,1.5802330029013405
SHP-77,selumetinib-JQ-1 (4-1 mol-mol),1.1256176667196132
SNB-75,11396600,3.7273557083084583
NCI-H1944,444795,4.357606071770019
MOLT-16,9929138,4.3035507183563615
Panc 08.13,375860,1.3164486030027225
Calu-6,selumetinib-JQ-1 (4-1 mol-mol),2.1275623712302454
COLO 668,12003241,0.007541298710802
BT 112,5460769,1.283415330936559
TYK-nu,9927531,4.342224808335168
TE-15,71466445,3.5922640502663077
SU.86.86,46907787,2.7876095981228044
SR,135999136,1.8410476011891763
TOV-21G,6852167,3.9528622196071335
NCI-H1341,11455910,-0.2175400116786661
SEM,11455910,-0.3463344343386808
BT 139,5460769,4.859801196456228
NCI-H1581,9927531,4.312096995742435
Fu97,168313016,4.435663214514425
SNU-C5,selumetinib-JQ-1 (4-1 mol-mol),1.2815948498049754
SNU-620,10231331,-2.4026146003872015
MKN7,12003241,0.0513011107794011
EFE-184,12003241,-0.5797348651994826
CHP-212,375860,-1.8839659810914688
SNU-668,73707398,1.6351221445621116
JIMT-1,44491742,4.195591062798884
BL-70,selumetinib-JQ-1 (4-1 mol-mol),2.011932316177293
ECC12,12003241,-0.4991552447723122
PE/CA-PJ15,46907787,3.628617033804344
NCI-H1373,73707398,1.6821009682995856
WM266-4,49766530,-0.4074764037641682
OAW42,44491742,3.912370337658794
SNU-C5,73707398,0.424759818514952
SK-N-DZ,tanespimycin-bortezomib (250-1 mol-mol),0.4242122917353423
SCC-25,6852167,1.4389858944642788
NCC-StC-K140,3689413,-1.9001520150301452
BT 179,tanespimycin-bortezomib (250-1 mol-mol),-3.1981676947705564
Hs 888.T,6852167,1.984642924657964
HDLM-2,107970,1.9865274855394164
YD-10B,241158,3.886933806831691
KNS-81,6852167,4.651561825132848
YD-38,12003241,-0.5056624439731239
SK-N-BE(2),11455910,1.253525820715845
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
NCI-H446,44491742,5.101744314169451
SK-MEL-24,sirolimus-bortezomib (250-1 mol-mol),0.9554095387328968
F-36P,3689413,-1.7757563129439584
CAL-120,135398744,6.432645448228996
NCI-H522,168313016,4.366007701234683
MDST8,6852167,1.3374988720553735
Ku812,135999136,1.6073024160366625
IGR-37,11396600,3.951317160447081
NCI-H1666,136227331,3.5475542812047873
DMS 114,selumetinib-JQ-1 (4-1 mol-mol),1.888851191317842
SYO-1,6852167,2.5720443571070546
KALS-1,637858,2.4646285747552747
YAPC,12003241,-0.7644111057992425
AM-38,26596,-1.378118107802664
NCI-H2405,11455910,1.6640905380907716
UM-UC-3,262093,2.408651217666756
COR-L88,9929138,3.603535907252336
Ishikawa (Heraklio) 02 ER-,11455910,1.4574745929250947
DOV13,9903786,3.8407513521100975
YKG-1,637858,1.419948249294149
EFO-27,644241,3.241988529302909
UACC-257,12003241,-1.8114895383547025
OCI-AML-2,6852167,0.5738384365467218
SK-N-MC,6852167,1.5726479412597263
HCC1395,262093,3.7391779193808254
NB4,439501,-2.5545682554076805
CML-T1,49766530,-2.849769761760908
NCI-H660,UNC0638-navitoclax (1-1 mol-mol),-2.199385544669957
DU145,11396600,3.556301760853191
KYO-1,637858,1.4266111239318309
BICR 31,9927531,5.661036072082279
VMRC-RCW,44491742,5.061613878025198
HT,12003241,2.790793152125299
HCC1937,sirolimus-bortezomib (250-1 mol-mol),0.6036989015606368
RPMI-6666,444795,4.6852375773815975
SK-BR-3,5460769,4.927732708716518
NMC-G1,107970,2.528467571568031
SNU-489,637858,3.5025780458402784
OV56,5460769,1.208348663787762
LAMA-84,135421197,2.406961444006632
SNU-478,73707398,0.6264771931816725
Li-7,6852167,0.9733642966109146
GOS-3,637858,2.327239346274226
NCI-H1650,sirolimus-bortezomib (250-1 mol-mol),1.0715909350533408
HEC-251,tanespimycin-bortezomib (250-1 mol-mol),0.0186342591611023
SNU-840,73707398,1.0622976409805671
LNCaP clone FGC,26596,-2.187376252798695
BT 330,11396600,1.7759393171748088
SNU-C1,439501,-1.3608922935267702
SK-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.3293932534534852
YD-38,sirolimus-bortezomib (250-1 mol-mol),1.3505427312079858
KO52,9903786,1.3206822748757847
NCI-N87,9903786,2.403456427338335
NCI-H1755,tanespimycin-bortezomib (250-1 mol-mol),-0.7433958922894784
Mono-Mac-1,72967,4.124255908419064
PE/CA-PJ34 (clone C12),439501,-1.4242244228812553
JVM-3,sirolimus-bortezomib (250-1 mol-mol),-5.712232327729444
JHOM-1,100016,6.419236010839144
CJM [Human melanoma],262093,2.9776663734710582
BT 231,26596,-1.8186756145502985
DND-41,107970,1.5227826017057635
IGR-37,107970,2.921312490724966
BT 422,9927531,5.2521428794559
FaDu,tanespimycin-bortezomib (250-1 mol-mol),-2.9915431159716603
COR-L51,tanespimycin-bortezomib (250-1 mol-mol),-1.1077118907846166
HOS,107970,2.981785279093002
NCI-H508,10231331,1.5621495524149538
KCL-22,107970,2.3450086604567195
MKN74,444795,4.813746668426388
DU4475,6852167,2.0552679553733215
NB4,73707398,0.2702647975206608
TOV-21G,UNC0638-navitoclax (1-1 mol-mol),4.683716239269286
BT 286,sirolimus-bortezomib (250-1 mol-mol),0.4309119586946818
BICR 31,637858,2.611871003184785
U-BLC1,107970,1.5582659561874588
OVCAR-4,439501,-2.2754472098367855
SK-ES-1,644241,2.5960462683298067
L-428,sirolimus-bortezomib (250-1 mol-mol),-6.443786074450703
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791
HSC-3,241158,3.419773075540372
A-253,135421197,1.6531350819497892
NCI-H2170,44491742,4.021640872612266
SNU-449,6852167,2.6501635563943977
HCC1195,10231331,1.190047667389913
OAW28,439501,-0.9322268226633188
BT 131,6852167,4.417190549255619
HCC44,12003241,-2.184153343310603
PaTu 8988s,11396600,3.1820503715354276
SW48,3689413,2.066117060158584
Hs 944.T,26596,-1.3336328172357843
WM983B,12003241,-2.729936813041864
FTC-133,6852167,4.78859095347106
BT 359,375860,0.0667828963411476
MEC-1,439501,-3.41979967464108
SNU-886,9927531,4.416743823533711
NCI-H1734,3689413,-2.032752334102639
697,UNC0638-navitoclax (1-1 mol-mol),-1.742714330372107
COLO 680N,5460769,3.8284698218745055
Hs 852.T,262093,1.3766639413412267
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574
NCI-H526,135999136,1.5678365159824872
H-STS,tanespimycin-bortezomib (250-1 mol-mol),0.0434064671940078
DND-41,12003241,-0.2098098510645495
RD,49766530,-0.4768486017330388
JK-1,637858,1.1553498236077802
SK-N-DZ,241158,1.6286594691564176
SNU-423,6852167,2.5596210289916765
D283 Med,9903786,1.479416225891386
Daoy,262093,1.456980228501706
BxPC-3,241158,3.755569293331497
HCC1806,637858,2.071766835745825
SW982,375860,-0.2965947785170124
Karpas-299,73707398,0.3259263898696366
UACC-812,135421197,0.8848266315498433
TOV-112D,9927531,5.049724327124321
GA-10,11396600,1.0536432572837295
CCK-81,73707398,0.5234113847041482
KYSE-410,375860,0.3539761529169563
2004,135999136,4.366970719015835
PK-59,sirolimus-bortezomib (250-1 mol-mol),-0.7779015062858902
SUP-M2,107970,1.4120118261465122
SNU-1105,12003241,-1.0789157776023728
DLD-1,3689413,0.9147561458684622
PSN1,241158,3.850546493000947
LC-1/sq-SF,241158,4.919718305365368
COR-L88,73707398,0.9556404513556984
Mel JuSo,107970,2.345847448694836
NCI-H2029,375860,0.1046660820268347
EoL-1,637858,0.3936490265761631
UM-UC-3,11396600,3.088705801401897
COV644,12003241,0.3541041054737522
SW982,tanespimycin-bortezomib (250-1 mol-mol),-1.8662349479314355
HCC1937,44491742,5.446943100232909
L-428,5460769,3.644532278593977
ECC12,375860,-0.8615166178906869
NU-DUL-1,439501,-2.935576515069395
RPMI-8226,3689413,-0.772061371238599
TE-4,107970,2.372527622902973
8305C,5460769,5.099577444912903
TUHR10TKB,44491742,4.130919607533437
YD-15,6852167,1.5234266215850325
OVK18,73707398,0.6900312181003939
SNU-685,375860,0.2053793820891022
SNU-1076,11396600,4.278437683696295
TE-10,46907787,0.1921390892100071
786-O,9903786,3.782252181935989
ACHN,107970,3.012604712034101
HEC-108,9929138,6.458847770997077
Karpas-422,71466445,2.788648588655379
CGTH-W-1,11455910,1.5970205272466635
SJSA-1,9903786,3.6249544402257863
BT 231,241158,3.4112394985232517
AGS,71466445,4.414686930362743
DB,26596,-3.691509767021521
NCI-H226,637858,2.3908316426717375
MOLP-8,49766530,-0.668776240648524
TE-5,6852167,1.6333591981161106
NCI-H1755,9903786,1.073033240421295
NCI-H1568,11396600,3.496587037401377
SNU-1033,262093,2.351645391909522
LS123,9903786,4.141854621966089
CCK-81,10231331,1.892878749615724
JJN-3,26596,-2.098638975777458
SNU-423,73707398,1.089223560310694
Hs 729.T,46907787,3.916533170347426
KO52,5460769,4.4327211318187745
EB1,9927531,2.850216647233053
WM115,10231331,-3.458943295987183
KMRC-1,12003241,-1.418239320082467
NB1,168313016,4.537464228593661
HPB-ALL,9929138,6.3136934521225445
MDA-MB-468,73707398,0.8500080149823163
JHH-4,73707398,1.0578897556038087
Panc 03.27,100016,6.730276002902577
RERF-LC-Ad2,241158,4.786001291187356
SNU-1272,3689413,0.1489687776606243
LN-18,73707398,1.4834861173786835
SK-UT-1,sirolimus-bortezomib (250-1 mol-mol),0.646773190163625
BT 498,644241,2.2010744744476742
MOLT-3,241158,2.733568382877171
NCI-H1299,3689413,-0.9598507897960026
HuP-T3,241158,3.8412641522091144
CAL-12T,262093,3.257362917097833
SNU-449,12003241,0.2005365129445947
H-STS,selumetinib-JQ-1 (4-1 mol-mol),1.7397587853483405
OE19,10231331,4.637598127525754
RPMI-6666,135999136,3.167235721150589
BFTC-905,6852167,2.9967779321543766
SK-N-SH,135421197,1.303640254483224
HEL 92.1.7,11455910,0.3548529299693889
P31/FUJ,71466445,3.0287439983851225
DND-41,selumetinib-JQ-1 (4-1 mol-mol),-0.0339747112288985
C2BBe1,241158,4.815582884845346
SNU-423,46907787,4.032406628203726
SNU-869,selumetinib-JQ-1 (4-1 mol-mol),2.584496248279929
YD-15,637858,2.2450013527302235
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505
MV4-11,3689413,-0.1876256430889787
TTC-709,selumetinib-JQ-1 (4-1 mol-mol),2.9675969653518948
LoVo,135398744,6.330186357549225
JHUEM-7,3689413,-2.2301251225415255
DU4475,54596490,4.235795189278402
IGR-1,44491742,3.995353370886831
NCI-H1975,11455910,0.0232313677765091
CCF-STTG1,107970,2.063603625316133
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264
CAL-51,444795,5.053001195278548
TT,9903786,2.2571281683889253
SNU-216,5460769,1.6923637113112366
PF-382,3689413,-3.8661032289286488
HCC2108,5460769,1.78766929460534
RCC10RGB,73707398,3.9170227295506304
CAL-148,439501,-2.3789265547219647
BT 482,10231331,-0.950028925069568
LK-2,sirolimus-bortezomib (250-1 mol-mol),0.5771573831788563
CAL-29,tanespimycin-bortezomib (250-1 mol-mol),-0.8282025305629461
HEC-108,637858,2.449708151119433
B-CPAP,3689413,-2.370401360424748
Hs 766T,637858,2.249517442676159
SUP-M2,9903786,1.0371489832457852
Mel Ho,11396600,5.196544531499117
OCI-Ly19,44491742,4.513227413160856
DV-90,9927531,4.273842148602971
HPB-ALL,439501,-2.479146853758179
OCI-Ly3,UNC0638-navitoclax (1-1 mol-mol),-0.8261929635354904
Kuramochi,262093,3.1885659706851026
NCI-H889,439501,-2.793088249368423
MOLT-16,tanespimycin-bortezomib (250-1 mol-mol),0.076704677105394
SCC-9,439501,-2.6581193485563737
LS123,73707398,0.6654924685394674
COR-L95,3689413,-1.01311028513846
ChaGo-K-1,sirolimus-bortezomib (250-1 mol-mol),0.904309234685044
MOLT-13,135421197,0.8546862359015375
Caki-1,439501,-1.3714154371315346
SNU-738,73707398,1.1799424413831334
Caov-3,107970,2.358306338723641
OV-90,3689413,1.0666322744292105
NCI-H520,12003241,-2.710304641181941
Calu-3,444795,4.6155350689818535
FTC-133,135999136,5.800253145127344
MDA-MB-468,44491742,4.175044772115959
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837
SU-DHL-1,9929138,3.6810672504095385
CAL-78,46907787,1.7338019226215953
NCI-H929,6852167,0.2588908385559714
SK-ES-1,UNC0638-navitoclax (1-1 mol-mol),0.7664167233990603
JJN-3,44491742,4.04042701265084
SCaBER,selumetinib-JQ-1 (4-1 mol-mol),-0.5555159454375147
KYO-1,100016,4.086276175586104
L-363,26596,-1.5549208071756957
COR-L105,selumetinib-JQ-1 (4-1 mol-mol),0.4359614379036839
HSC-2,46907787,4.2296699665196344
GA-10,11455910,-1.5757849465302998
BT 416,selumetinib-JQ-1 (4-1 mol-mol),0.8110934532138555
2004,26596,-1.025080107658215
LMSU,107970,2.329788160301069
SUP-HD1,241158,3.1145793783464257
SNU-1272,UNC0638-navitoclax (1-1 mol-mol),1.3009701153803632
NCI-H2029,637858,1.7994577186451293
SNU-119,12003241,-0.7435067493629696
NCI-H838,168313016,5.9902874418125425
Detroit 562,107970,2.26172258664431
NCI-H1581,100016,6.5572943300427795
SNU-1,UNC0638-navitoclax (1-1 mol-mol),2.6940797475374874
Mono-Mac-1,tanespimycin-bortezomib (250-1 mol-mol),-1.759960835446177
HOP-92,UNC0638-navitoclax (1-1 mol-mol),0.3347977995164087
MHH-ES-1,100016,6.165620846351705
KMS-26,135999136,2.070918369097562
OE21,637858,2.675555960290433
Hs 888.T,UNC0638-navitoclax (1-1 mol-mol),0.7614125477011823
BICR 18,71466445,3.286830230491617
CAL-85-1,439501,-2.788056668623063
UO-31,5460769,0.456698735836774
Granta-519,73707398,-0.348610297970246
TUHR14TKB,UNC0638-navitoclax (1-1 mol-mol),-4.287202344436747
TYK-nu,26596,1.1864585547757855
BICR 56,9927531,5.497555124114839
P31/FUJ,439501,-2.3575947617146475
TE-9,135999136,4.639285967377416
SU-DHL-6,439501,-2.4303946334698057
J82,46907787,4.254479025838574
CAL-51,107970,2.299284460939792
Jurkat,3689413,-0.8866590036526504
NCI-H1184,9903786,1.9169497440885477
FaDu,3689413,2.633100488394503
VM-CUB-1,6852167,2.222312161566665
SW620,11396600,3.2226280594878145
HEC-151,439501,-1.7100799573978192
NCI-H1341,375860,-0.4672550537008356
BT 239,44491742,3.7318422225870753
BICR 31,6852167,2.001013365002547
MES-SA,9927531,4.955649444081026
CJM [Human melanoma],637858,2.4545545863502314
SaOS-2,44491742,4.263847553999534
A-375,107970,2.3829956966560664
SNU-1066,3689413,-0.3741974458844401
HEC-1-A,tanespimycin-bortezomib (250-1 mol-mol),-0.4943806740107087
NCI-H2081,12003241,2.480414390654569
C2BBe1,107970,1.6421664588143934
JJN-3,262093,2.0717593866365847
HT-1080,262093,1.0809900576610223
SK-MM-2,3689413,-2.3519138228022367
DK-MG,selumetinib-JQ-1 (4-1 mol-mol),1.540298571322697
YAPC,3689413,3.09003195173071
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
J82,selumetinib-JQ-1 (4-1 mol-mol),4.77504788089244
JHH-4,71466445,3.279742837129593
TCCSUP,12003241,-0.9458347981681208
NCI-H650,selumetinib-JQ-1 (4-1 mol-mol),2.4482139208893674
MOLT-13,71466445,1.1714755088017548
SNU-878,375860,-1.032056104840677
Hs 683,9903786,4.056971165383086
JHOS-2,11396600,4.0221153186085905
Hs 294T,135421197,2.57319967501113
KLE,168313016,5.53335411774071
OE21,375860,-0.7347528974131474
PE/CA-PJ15,3689413,2.6755130574722767
HCC1500,637858,1.1010846881251866
IMR-32,100016,6.43791059275997
EFO-21,241158,5.404342041267148
NCI-H1651,73707398,1.6677013766470885
NCI-H1184,11455910,0.4610574255043957
SH-10-TC,375860,-0.0293228358206677
NB1,241158,3.7390057768995257
SK-N-AS,selumetinib-JQ-1 (4-1 mol-mol),-0.8317042212420149
697,12003241,-3.737782369602395
HuH-6,73707398,0.8885405709685146
769-P,262093,3.4485358488357867
KCL-22,10231331,1.7661201425853783
BICR 22,10231331,2.1949493731732095
SR,100016,4.130694890660373
CAL-54,644241,2.4540588983104628
HCC-56,selumetinib-JQ-1 (4-1 mol-mol),-0.6003400771432926
RPMI-6666,5460769,0.788563204465766
SK-N-SH,107970,2.0186521104376904
UM-UC-3,135421197,1.7291544564806811
VM-CUB-1,100016,6.234028822794693
IMR-32,49766530,-2.845366137118504
EFO-21,168313016,4.418933774560441
TE 441.T,49766530,-1.0459972469347878
K-562,selumetinib-JQ-1 (4-1 mol-mol),0.1487830644360653
HPAC,10231331,1.4659578196353913
KYM-1,262093,2.2176284666013366
DMS 114,26596,-1.464727194464046
LCLC-103H,9903786,3.9967722976793696
HL-60,9927531,5.393037826630499
LoVo,637858,1.5179613366947162
Hs 729.T,3689413,-2.0906347621795076
SNU-601,637858,2.21692805887622
TE 617.T,439501,-4.266247423790402
TE-10,444795,5.4304564593052085
MDA-MB-468,tanespimycin-bortezomib (250-1 mol-mol),0.8210992476411649
Hs 729.T,637858,2.029642877140948
KPL-1,644241,3.1412957180316656
SK-N-AS,375860,-0.8530557147031617
KMS-34,11396600,-3.5704564556839227
RL95-2,11455910,0.9076770125519352
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268
KYO-1,375860,-0.0649576326848778
TE 617.T,168313016,4.349421247778161
OPM-2,26596,-3.75281027154887
OE21,sirolimus-bortezomib (250-1 mol-mol),-0.2095744240897051
M059K,6852167,3.122777995706041
MDST8,12003241,0.3559193403256231
NCI-H322,tanespimycin-bortezomib (250-1 mol-mol),-2.794682738050535
B-CPAP,241158,3.71370211344078
RPMI-6666,sirolimus-bortezomib (250-1 mol-mol),-5.127028405484722
AGS,637858,2.5349975382958294
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
SK-N-DZ,49766530,-5.670578617317044
Hs 611.T,46907787,1.0011001882698198
SW579,3689413,-0.123080329876746
MOLM-13,168313016,3.5509192860421592
UO-31,135999136,3.536527795891914
KYO-1,11396600,3.3836130470467736
HT,168313016,5.111275982915678
CADO-ES1,5460769,-0.4724140531139457
SH-4,44491742,3.636684434382026
MOLT-16,439501,-2.6339721487362775
COLO 320,49766530,-1.8814026432492763
COLO 684,100016,6.373471933627605
TF-1,444795,6.324567376805602
BT-474,44491742,4.780448859314668
BT 216,12003241,2.6409098560740243
YH-13,tanespimycin-bortezomib (250-1 mol-mol),-0.5369599682458667
NH-6,637858,1.1461140723422587
HCC2935,262093,3.2004499429644704
SW1271,11455910,0.4702460968788743
HCC-56,12003241,-1.1028800957118954
DMS 114,107970,2.840444077880968
DoHH2,3689413,-5.86508857802515
NCI-H1105,5460769,2.617523266083722
HCC1143,637858,1.5767538824178036
YD-10B,107970,2.4548970149913187
KMS-12-BM,49766530,-2.33896572420352
SNG-M,26596,-1.5448516753437405
HOP-92,100016,6.879559613863246
SNU-1,107970,2.0495206958344148
LN-229,107970,2.219765317659143
GDM-1,375860,-0.386730724119011
SU-DHL-10,49766530,-0.2943285235939838
BT 359,262093,3.411602907811722
SUP-HD1,sirolimus-bortezomib (250-1 mol-mol),-0.240213465841402
OE21,11455910,0.3483153837156987
RERF-LC-MS,46907787,3.883745984979501
HCC366,sirolimus-bortezomib (250-1 mol-mol),1.704813233293803
CHP-126,6852167,2.3577769718395825
647V,46907787,0.8654746215037775
Hs 578Bst,262093,2.4258150356441277
SK-BR-3,100016,6.79119351825136
BT 416,262093,2.6479795412008937
U266B1,135421197,2.0671733343036247
TE-8,12003241,-1.9101664586501004
NCI-H2444,3689413,-2.223418972852252
JURL-MK1,11455910,-0.1674344407672636
MV4-11,439501,-2.384651174177473
A-172,107970,2.2406967925449854
KG-1-C,11396600,4.230481509625587
MCAS,5460769,1.176961037581758
SW982,49766530,-0.9510465454534272
SYO-1,444795,5.48455213311621
U2OS,73707398,0.2432624867397234
SK-MM-2,12003241,0.4022958113963022
Kasumi-1,439501,-2.487116457098306
LS123,135421197,1.188222873463802
SK-MEL-5,selumetinib-JQ-1 (4-1 mol-mol),2.584301952935506
NCI-H28,11396600,3.4580715977014185
U-CH1,107970,1.9849994578449
HL-60,10231331,-1.6804912174653917
TF-1,73707398,1.4165981550195783
OCI-Ly10,439501,-3.3893615276573783
MV4-11,11396600,-2.6796840852640966
LNCaP clone FGC,10231331,4.305884734347832
KP-2,44491742,3.9373322425213138
ST486,44491742,3.1941323124879393
CAL-27,12003241,-1.271388336497811
SNU-C1,73707398,1.1462047039633347
NCI-H1563,44491742,4.074873654245284
NCI-H2009,637858,2.463099291034241
LOX-IMVI,10231331,1.7536207323976525
253J,71466445,2.845552651770213
RPMI-8226,73707398,0.4792823568542893
SNU-475,637858,3.1810222277694535
Peer,135398744,6.7016638444522325
SNU-8,262093,2.9266150824116877
COLO 678,135999136,4.397967779172533
KMRC-3,375860,-0.2834215688720704
NCI-H1651,168313016,5.365886513418571
MHH-CALL-4,375860,-0.3474081343117626
SW1417,262093,3.3040552673447907
RERF-LC-MS,3689413,0.4263782886644774
CAL-85-1,6852167,1.6238122656389518
Ri-1,444795,2.8789748064532823
L3.3,375860,0.2158630030269858
SW1271,12003241,-1.4062779923685875
BT 139,11455910,0.9756266505311688
NCI-H292,11396600,3.7365966834404225
Mel JuSo,637858,2.3077535969243343
BICR 18,107970,2.433210640100899
MFE-319,107970,2.9739758734328774
5637,49766530,-2.237904920966697
GP2d,9903786,1.6186361299968774
HEL 92.1.7,26596,-1.1995167561269164
BT 482,9903786,3.918124147791562
BT 187,selumetinib-JQ-1 (4-1 mol-mol),2.145503415351022
NCI-H460,262093,3.3627537421549314
DV-90,UNC0638-navitoclax (1-1 mol-mol),1.6997014306077862
Capan-2,135421197,1.2802517101193276
DU4475,12003241,-2.262419788533744
DU4475,375860,-0.8639753216901359
SNU-1076,sirolimus-bortezomib (250-1 mol-mol),0.4980535505825825
DB,375860,-1.6620763038884403
COLO 684,44491742,3.593536773011693
NCI-H1355,5460769,3.1635335423218907
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
A-673,49766530,-3.0139632371957705
SR,9903786,1.863499016732126
ONCO-DG-1,3689413,-1.9285483999998865
BT 159,tanespimycin-bortezomib (250-1 mol-mol),-0.0268795114387354
QGP-1,11455910,1.8508501526124652
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982
NCI-H929,11396600,-1.497885086375298
SNU-1076,375860,-1.1254156508705129
NCI-H2081,439501,-4.570953887500971
SBC-5,644241,3.9213876276885458
FTC-238,9903786,3.4467406025771705
SK-MEL-2,9927531,5.603550958927875
HGC-27,100016,3.78981980973908
Daoy,5460769,2.932419907525853
OCI-AML-3,136227331,4.0355343672890935
RCH-ACV,9927531,3.1896486071629724
A-549,135421197,2.4799819746704075
RMG-I,9903786,4.466562574504816
WM983B,selumetinib-JQ-1 (4-1 mol-mol),-1.7690191358032856
SNU-761,9903786,5.568583080204817
HT-1080,44491742,3.909011022661936
JK-1,135421197,1.447193045378296
NCI-H1105,3689413,0.7120747688732703
EoL-1,100016,3.3783759894754795
NCI-H1915,sirolimus-bortezomib (250-1 mol-mol),0.5181778086955178
MKN74,10231331,5.759039673812496
WM983B,107970,2.073106798570593
GaMG,73707398,1.764890273720185
KMS-34,439501,-2.83193731194203
SW48,11396600,3.829401994456863
P31/FUJ,10231331,0.360402840185862
2004,46907787,0.0998644602240742
DoHH2,sirolimus-bortezomib (250-1 mol-mol),-6.588812122607576
MV4-11,44491742,3.928114355026535
SHP-77,46907787,1.21959073146431
HSC-2,9927531,4.076262005833891
LNCaP clone FGC,5460769,1.4769173176739367
NCI-H1944,168313016,5.996658186309284
YKG-1,439501,-3.197548465236136
A-549,135999136,3.721733527600953
SW1417,11396600,4.42518333755826
JHH-1,168313016,4.409492948023239
NCI-H1838,11396600,3.9087571666656222
BT 333,135999136,1.9230816314921284
Hs 611.T,375860,-0.3365508956402739
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
TE-9,262093,4.268741263772325
BT 440,9903786,3.1498376271679533
Calu-3,11455910,0.8473272312384381
G-361,11396600,3.133964518585525
SUIT-2,11396600,4.33113824085374
BT-549,241158,3.5488750117076484
HCC1833,439501,-1.5774129771640248
SK-MEL-3,46907787,3.879205812014703
SCC-25,241158,3.0649196018080653
SNU-407,11455910,0.0868474536937429
Hs 294T,3689413,-2.200259258980444
BICR 16,46907787,2.015388722243017
RL,11455910,-0.0595035434135363
WM88,637858,1.8355107233516577
HCC44,26596,-2.4855427767458735
BT 330,73707398,1.1643905844402598
IGR-39,44491742,4.786400321878876
LCLC-97TM1,11396600,3.6456493290211425
KMS-20,6852167,1.0361135786452058
SCC-25,tanespimycin-bortezomib (250-1 mol-mol),-2.0789545653070856
CCF-STTG1,49766530,2.4939305222304955
DB,UNC0638-navitoclax (1-1 mol-mol),0.9262699672486184
OCI-AML-2,5460769,1.9036049524164391
HuP-T4,439501,-0.5281906022533748
NCI-H2291,sirolimus-bortezomib (250-1 mol-mol),1.1125015078342035
HSC-2,5460769,0.0073733744403826
SNU-119,637858,2.7399101747630867
PaTu 8988t,9903786,4.140175125497243
JeKo-1,439501,-6.227788271417287
CAL-51,3689413,0.5709426612715743
Hs 688(A).T,107970,2.6275562236634173
HCC827,5460769,2.7975928374001104
SIG-M5,26596,-1.691579811002482
BT 444,644241,3.5221227496629663
SaOS-2,49766530,0.3706728408995327
KE-37,sirolimus-bortezomib (250-1 mol-mol),-5.227534595798211
MDA-MB-361,6852167,1.7520699616345732
HuP-T4,49766530,-2.034879085363831
HCC202,tanespimycin-bortezomib (250-1 mol-mol),-2.788227280084804
SNU-C1,sirolimus-bortezomib (250-1 mol-mol),0.1319095851992196
Panc 05.04,135999136,4.919832850968504
23132/87,9903786,3.7145887754512414
BxPC-3,637858,2.219072546092823
CMK,3689413,0.9967323135888336
SNG-M,5460769,2.9987935080013695
SK-BR-3,73707398,0.4064106830128078
TE-10,49766530,0.4613217391985113
SCC-9,6852167,2.7106856908699255
Hs 294T,439501,-2.312914558527944
BT-549,12003241,-0.9663956127583828
COLO 792,3689413,1.4913457514232935
BT 239,241158,3.9563335392907097
A4/Fukuda,44491742,3.3943913096556444
KYSE-450,11455910,0.6287655004796859
A-172,168313016,5.106297252046059
LCLC-97TM1,135999136,4.356650968290631
MG-63,100016,6.791496028485962
BT 504,135999136,1.8570291523116993
HEC-265,5460769,4.34119097814152
HL-60,73707398,0.8677907289632488
JJN-3,71466445,1.679403169347352
HCC-56,sirolimus-bortezomib (250-1 mol-mol),0.5000391743337353
NCI-H28,375860,-1.018176478830531
RKN,637858,2.0099352926359533
KM12,49766530,-2.0271084274378373
NCI-H211,3689413,-2.259187530744643
A-549,3689413,0.7236603744186211
TALL-1 [Human adult T-ALL],49766530,-2.2368967155466586
GaMG,637858,3.26037697579532
TE-1,73707398,1.1292781016966351
P12-Ichikawa,sirolimus-bortezomib (250-1 mol-mol),0.3718187399928814
HH [Human lymphoma],135999136,4.178944962809741
Hs 729.T,selumetinib-JQ-1 (4-1 mol-mol),4.302811475713859
OCI-Ly19,12003241,-2.2360327877915545
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556
RPMI-8226,49766530,-1.9522692121049856
HCC38,135421197,1.646244202411993
MHH-CALL-3,71466445,3.985305904868944
Toledo,11455910,1.8011509430224568
BT 145,9903786,2.2676133006053965
T-47D,49766530,-0.4213805978343772
KG-1-C,tanespimycin-bortezomib (250-1 mol-mol),1.8442829762863937
YD-38,241158,4.218003156068375
SW1353,9903786,3.629285684044714
UO-31,9927531,3.0316635123485693
ME-1 [Human leukemia],168313016,5.223278335467516
Hs 888.T,26596,-1.257833689984314
NCI-H747,UNC0638-navitoclax (1-1 mol-mol),0.8720524517922084
SNU-886,12003241,-3.694795257520175
Pfeiffer,136227331,3.814394552258677
OAW42,46907787,3.3206761920396164
MFE-319,439501,-2.2775311995949035
C2BBe1,9903786,1.7742124050197758
TE-11,6852167,2.6244902782026966
YD-38,6852167,2.552467124707018
COV362,9903786,6.486394788749974
OV-90,9903786,3.9551127291738424
RD,262093,3.0387065040185264
MOLP-2,637858,1.2784756867176654
SU-DHL-8,637858,1.0038553272764972
EC-GI-10,262093,3.0638768709018795
SNU-213,10231331,0.6074693800366775
KMH-2,46907787,0.3409672144404854
UO-31,49766530,-5.258539330368952
NCI-H1299,100016,6.953805951258825
COV644,11455910,3.873776923883242
DK-MG,637858,2.2775491010161724
RVH-421,135421197,2.7493093312166534
Calu-1,46907787,5.519405311449107
RKO,3689413,3.093382349703003
KYSE-410,73707398,1.149006405026039
Hs 888.T,73707398,2.4412256310996026
EFO-21,tanespimycin-bortezomib (250-1 mol-mol),0.1444768142311704
CHP-126,selumetinib-JQ-1 (4-1 mol-mol),1.2519618903386895
HCT 116,6852167,3.4311504829913213
KYM-1,241158,2.885537975342422
BT 328,136227331,5.061934875267611
UACC-62,9903786,5.03427767143789
NCI-H1869,375860,1.5517292037743613
ST486,135999136,4.078215309645287
TC-71,44491742,3.7748114564226407
FaDu,637858,1.7950412976824095
BT 416,136227331,3.8203373209104425
IGR-39,5460769,4.0932684480850074
HSC-2,26596,0.6802273350911279
JL-1,selumetinib-JQ-1 (4-1 mol-mol),2.2145378518156345
RERF-LC-MS,73707398,2.0319367406190483
NCI-H1299,46907787,1.4375849802030871
8305C,tanespimycin-bortezomib (250-1 mol-mol),1.1491228196694627
NCI-H226,73707398,1.9043471909706144
NCI-H441,107970,2.428065240863963
NOMO-1,9927531,5.049638663441057
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203
Daudi,637858,0.7785119720749748
HDLM-2,135421197,3.3057353966925613
DK-MG,135999136,2.1309073421912075
SNU-1079,71466445,1.115113066325304
MCAS,9903786,3.9207216019302007
SNB-75,9927531,5.402780165726325
K-562,46907787,1.0881737362577
IGR-37,241158,3.741796107382708
DBTRG-05MG,12003241,-1.7775035610862775
8305C,6852167,2.0078484699465884
OVCAR-8,3689413,0.7986129838675038
NCI-H211,6852167,1.2921457601331006
253J,selumetinib-JQ-1 (4-1 mol-mol),1.0702090152450077
SNU-308,5460769,2.0996672061045976
VCaP,12003241,1.0138144203532238
SNU-719,262093,3.356379511241945
A3/Kawakami,44491742,3.8621679307370953
BT 444,selumetinib-JQ-1 (4-1 mol-mol),0.8524514153938803
NCI-H1155,sirolimus-bortezomib (250-1 mol-mol),0.0856236991825952
Jurkat,168313016,4.063506111710871
TT,71466445,5.02784430072311
HOP-92,262093,2.340026978235907
SNU-C1,9927531,4.924275506690927
HD-MY-Z,10231331,1.3407827449085772
Peer,100016,3.808596484759728
EBC-1,135398744,6.3334705093468235
CA46,9903786,1.650432742323398
D283 Med,6852167,1.541783481002512
NCI-H661,375860,0.2037463104187888
TYK-nu,73707398,1.0785188405280586
YH-13,26596,-1.6020780091570677
DB,54596490,5.226833912484438
KMRC-2,9927531,6.175340087469203
NCI-H1395,11455910,1.7673103520073516
Lu-65,375860,-0.0242259972210493
MDA-MB-435S,107970,2.3053857954892742
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
IGROV-1,10231331,1.9104831176724932
Panc 04.03,9903786,4.611047286699123
SR,241158,3.3851919568331765
BT 131,49766530,-1.5740647020909493
CAL-85-1,46907787,0.5241273269532959
Panc 04.03,12003241,0.3752932920389255
HCC38,sirolimus-bortezomib (250-1 mol-mol),0.3307101764486495
TE-14,135398744,6.394251875306054
RL,262093,2.402242412116004
COLO 320,11455910,0.88882946750677
BT-474,107970,2.4195219689765266
RD,107970,2.2653970087336313
BT 248,3689413,-0.3734654016267222
A2780,73707398,0.6651600447827565
MOLT-3,11396600,3.214493659676048
TE-14,5460769,2.4898485363417917
RL95-2,sirolimus-bortezomib (250-1 mol-mol),1.4009445421830615
EC-GI-10,637858,3.0023579305682953
A-498,UNC0638-navitoclax (1-1 mol-mol),0.9874220571731112
SW579,135421197,1.841394745286318
HSC-4,637858,2.398043952194309
KCL-22,444795,4.537075802103081
QGP-1,107970,2.847415715373979
253J,100016,6.267948749211356
SNU-899,3689413,3.063297937380225
NCI-H2087,49766530,-1.9829819346209112
NCI-H23,5460769,-1.0672070635340756
BT-16,439501,-3.235694513476061
NCI-H1155,3689413,-1.8427844176402348
CHP-126,9903786,1.6217083088403044
RT-112,73707398,0.8744160779523937
SK-N-SH,375860,-1.202026834926373
JHUEM-1,49766530,0.8981374764595749
CGTH-W-1,439501,-2.6325140773837012
LS1034,3689413,2.145943189168165
Panc 04.03,637858,2.9634699724220783
DMS 454,439501,-2.8107075635854866
LS411N,107970,2.4864618038552724
Hs 683,136227331,4.5546400151434066
NCI-H2052,439501,-0.5583326091598753
HD-MY-Z,439501,-3.7474534787438714
DEL,375860,-1.0252775108428016
KP-3,10231331,4.79345932538097
RL95-2,5460769,2.3147567331395753
SK-MEL-30,107970,2.928613560405839
NCI-H226,3689413,2.4864282663543302
BT 333,637858,2.533124120863436
BT 245,tanespimycin-bortezomib (250-1 mol-mol),-0.2118058496398642
U-BLC1,241158,3.6969065198741378
SUP-B15,5460769,1.5557801555914603
HuG1-N,tanespimycin-bortezomib (250-1 mol-mol),-2.4884631877439207
JM-1,135999136,3.9281924738089016
BT 440,135999136,2.163125999503531
MHH-NB-11,6852167,2.4645742623243856
A-549,6852167,2.2085984360403663
BT 164,tanespimycin-bortezomib (250-1 mol-mol),-0.668704186369019
IST-Mes1,44491742,4.903550558956352
SW48,439501,-2.266376314928653
SUP-M2,11396600,1.284411602276366
NCI-H1105,107970,2.297291340192952
COLO 684,11396600,2.8933753280460186
WSU-DLCL2,9929138,4.197789309677048
P31/FUJ,26596,-2.2448149587984836
SH-10-TC,5460769,3.8511006484967223
YH-13,637858,2.290172126875016
HCT 8,tanespimycin-bortezomib (250-1 mol-mol),0.9236703838462946
ST486,9903786,1.7386739001111973
CAL-85-1,135421197,1.4377656539975323
AsPC-1,44491742,4.429887143828186
MHH-NB-11,241158,4.0313756433900885
OPM-2,241158,1.7102591321182437
HuH-1,sirolimus-bortezomib (250-1 mol-mol),2.2926354506042497
MOTN-1,46907787,-0.6742316988150437
Hs 944.T,5460769,2.3296902245035995
HDLM-2,12003241,-2.9289857152710344
HEC-6,637858,1.941267423049059
CAL-33,26596,-1.0071366013877838
MM1.S,444795,4.170246109552412
22Rv1,46907787,1.6905939183269825
UO-31,10231331,1.601394393410059
PE/CA-PJ41 (clone D2),168313016,6.324441458081494
SU-DHL-8,44491742,4.1577476289633
EC-GI-10,73707398,1.6298474537045162
Tm87-16,439501,-3.529895077478111
HCC1588,9903786,2.112519242014298
COLO 201,107970,1.868619980747979
KYM-1,135999136,4.4173157173390925
Toledo,sirolimus-bortezomib (250-1 mol-mol),2.5454023047541985
NCI-H2141,73707398,-0.0854879625434804
KYSE-150,73707398,1.088609979945698
PE/CA-PJ34 (clone C12),241158,3.3825380068249276
Rh18,9903786,2.6471801174141625
MDA-MB-453,12003241,-0.9610578830621354
Hs 895.T,9927531,5.651415148698969
NCI-H526,168313016,5.326869674802652
BxPC-3,100016,6.453363473458683
SF126,3689413,-2.3760985230108584
OVCAR-8,107970,2.979884143831386
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638
Hs 936.T,100016,5.806135174623166
HCC1806,selumetinib-JQ-1 (4-1 mol-mol),2.499092919245046
GCT,439501,-2.020397475807145
KCL-22,tanespimycin-bortezomib (250-1 mol-mol),-0.2876767287286612
JHUEM-2,73707398,0.772116909696958
COLO 792,12003241,-1.2493881793514412
HCC1438,135421197,2.9315312537575124
A-673,9903786,1.5948741514342302
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015
SK-N-DZ,439501,-4.085743704417651
NUGC-4,73707398,1.4695211141371651
BT 231,11396600,2.44608853396947
CAL-148,73707398,0.7922411056874308
OCI-Ly3,9927531,4.54855652960748
SNU-1214,26596,-1.0463524319184982
LCLC-97TM1,12003241,-0.8351557307101188
AN3-CA,12003241,-2.637522524679412
253J,9927531,4.121406347708415
BT 216,11455910,0.3541622799052987
KLE,262093,2.3874885119076668
F-36P,12003241,-0.4333234421592413
KMS-11,11455910,-0.6344101562888161
NCI-H1703,439501,-1.5312988936027676
697,444795,4.033454065777357
DK-MG,11455910,0.6874488483397508
MOLT-3,9903786,0.9925932748260368
MOR/CPR,tanespimycin-bortezomib (250-1 mol-mol),-0.9000697563150304
COLO 668,49766530,-2.8242702060305818
MOLT-13,439501,-2.4259548935745348
HCC4006,10231331,2.028448781487259
BT 444,136227331,4.190644654212499
HuP-T4,tanespimycin-bortezomib (250-1 mol-mol),-1.134384257023078
LN-229,6852167,3.506524715278259
SK-LMS-1,selumetinib-JQ-1 (4-1 mol-mol),2.2731779644264645
SK-N-SH,9903786,1.912941590488841
HCC2218,241158,2.2086061733116615
SNU-5,11455910,3.529816425197799
BFTC-909,262093,3.5924629632259792
NCI-H1792,100016,5.097619126157972
NCI-H1838,9903786,2.204739159527363
CFPAC-1,439501,-1.9750103172149232
KALS-1,3689413,-0.2176182562401838
JHOC-5,sirolimus-bortezomib (250-1 mol-mol),1.676278524948005
NCI-H1650,444795,5.080138888321433
MJ,439501,-3.472446137047906
PK-59,6852167,1.7961367286330785
COLO 800,100016,6.663651406564157
CAL-29,26596,-1.7040802846973448
NCI-H1623,9903786,3.0418604220511436
FU-OV-1,107970,2.0514231206369686
BICR 31,168313016,4.3680397842259095
KNS-42,241158,5.1081489530944015
LXF 289,9929138,7.38651684018349
IMR-32,262093,1.1917781979548805
SNU-668,439501,-0.7901558289045547
OCI-AML-2,637858,0.7284581277155234
HT-1376,6852167,4.054024650572562
SW620,sirolimus-bortezomib (250-1 mol-mol),0.6778769985308863
BT 248,73707398,1.2475621750333084
EM-2,3689413,-2.767286284866434
SNU-398,6852167,2.173359087480046
BT 271,3689413,-0.1683301005825848
Mono-Mac-1,9929138,7.711944602530317
Calu-6,12003241,-0.728129558300084
COLO 829,11455910,1.5093587467864735
JHH-4,135999136,4.26368824766702
KE-39,selumetinib-JQ-1 (4-1 mol-mol),1.3971527695941195
A-673,375860,-0.5094320760358009
THP-1,3689413,0.1739337887776562
MG-63,11455910,1.9804853910986304
SNU-C1,135398744,6.35894151615267
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567
SUP-M2,9929138,3.6762665629700177
NCI-H661,6852167,3.3441449371697205
DoHH2,637858,-0.5339503780013348
TM-31,73707398,1.0107205954441807
RERF-LC-Ad1,73707398,2.698751964761458
TE-4,12003241,-0.733911012282654
KMS-26,5460769,1.6781754946124072
A-172,sirolimus-bortezomib (250-1 mol-mol),0.3443286616456003
MDA-MB-468,6852167,2.5398355131679886
NCI-H660,54596490,4.247861500478792
SNU-1214,168313016,6.364459074383153
WM266-4,9927531,4.893127770626654
OUMS-23,6852167,3.800442546300316
SNU-1079,107970,1.8696204302707973
HEL,49766530,-2.395534265113236
BT 131,46907787,3.719666358571709
KLE,444795,4.58251515525995
OCI-AML-5,49766530,0.2957365675241968
Hs 888.T,439501,-5.801037223256167
BFTC-905,107970,2.4913440657651496
KNS-42,3689413,-0.7849742988075888
BT 440,73707398,1.96751487315396
KNS-62,439501,-2.644603626195061
JHOC-5,262093,3.0668349870794542
JHH-2,UNC0638-navitoclax (1-1 mol-mol),-1.9690924025630785
SW982,selumetinib-JQ-1 (4-1 mol-mol),3.3517984322180383
SK-MEL-24,637858,2.0909048277426683
U-BLC1,6852167,1.3413398534081005
CAL-51,44491742,5.152478206660974
SUP-T1,73707398,0.2441086723916535
Pfeiffer,375860,-1.9122388106642976
NCI-H69,439501,-2.497311288560019
SNU-1077,3689413,-1.655364429789056
RD,9903786,3.633793884549444
LUDLU-1,439501,-1.4236131557498473
NCI-H1385,135421197,0.1924120036443515
CAL-33,5460769,2.348968888608987
SF539,439501,-3.28606941940852
OCI-AML-2,12003241,-1.1091047572975106
G-402,26596,-0.4180942485240064
HuH-28,sirolimus-bortezomib (250-1 mol-mol),0.2799415361995808
IGROV-1,12003241,-2.0122972114546904
TCC-Pan2,12003241,-0.2350019856779653
SNU-C1,135421197,0.9147895752646428
PK-59,5460769,5.2141758944681635
KE-39,11396600,3.848773124810753
BT 112,12003241,0.1954695576836523
Daudi,6852167,0.8630196090584432
COLO 201,9903786,2.3732534001710426
RKN,9929138,7.419607622812729
THP-1,107970,2.0442252682761417
RPMI-7951,selumetinib-JQ-1 (4-1 mol-mol),1.1039196671614755
MKN74,44491742,4.321441779997771
MeWo,644241,2.094796596283421
SNU-869,241158,5.826918581124776
BT 328,9903786,4.817171686681598
SU-DHL-1,71466445,3.7763473385017994
KYM-1,72967,3.725186297986206
NCI-H1650,135999136,4.9140472114579365
TE 617.T,46907787,1.8996212852232837
M059K,107970,2.205521615137292
AN3-CA,26596,-3.5868272426759584
SNU-1076,637858,2.268139092050385
GB-1,46907787,3.428923818572933
BT 504,135421197,2.466290644112219
HDLM-2,73707398,0.2540391654131073
DMS 53,12003241,-1.7395700319118894
NCI-H1299,12003241,-0.9760038754339474
SNU-1066,135999136,4.400876966814073
BV-173,637858,1.2819525113051429
Ri-1,135421197,1.0934360104975305
BT 239,6852167,2.2833850419098116
SNU-182,46907787,0.3516168249380413
RPMI-8226,439501,-1.9239295318483216
NCI-H1339,54596490,5.682943703162134
HeLa,100016,5.8653655502295
AML-193,136227331,3.928096776967208
PF-382,sirolimus-bortezomib (250-1 mol-mol),-1.8345993475450983
JHH-5,selumetinib-JQ-1 (4-1 mol-mol),0.6284460578622284
SF268,6852167,2.886787318838284
Karpas-422,9903786,1.5566107707645094
CAL-148,26596,-0.995899107261143
SUP-T11,9927531,4.66163575559017
SNU-387,sirolimus-bortezomib (250-1 mol-mol),0.5952265743447468
COR-L279,135421197,1.2327200147457915
KMS-26,selumetinib-JQ-1 (4-1 mol-mol),-2.213502870233135
HSC-4,241158,3.797905223062241
SNU-216,12003241,-2.3730818081536955
PL-21,9929138,5.81570058531176
Tm87-16,107970,2.1756790823624987
WT2-iPS,3689413,0.8966057482922113
SNU-175,375860,-0.9196869368343216
NCI-H522,selumetinib-JQ-1 (4-1 mol-mol),1.1620563079754236
HuNS1,439501,-3.2381997907918447
NMC-G1,12003241,-0.7597442114064075
NCI-H322,12003241,-0.9727084564838948
KYSE-180,9903786,3.667884143051944
SK-MEL-31,3689413,0.7932345609098049
KMS-20,135999136,4.473937191041351
NCI-H2029,135421197,1.9497380661453336
MSTO-211H,375860,0.0606650448750636
HCC1438,11396600,3.772048320050974
HCC1569,11396600,3.770118441175883
NCI-H1435,10231331,3.7158203392038103
NCI-H1703,9903786,2.5255687748265903
EKVX,262093,3.2676110256725712
ChaGo-K-1,9927531,4.39504142130407
DB,644241,1.3416700671632733
NCI-H716,9903786,1.532038090064473
BT 330,637858,2.906999129152924
EKVX,637858,2.598323376297305
CCK-81,11396600,4.135348832339609
WM115,135999136,1.8466122948256136
SH-10-TC,44491742,3.905889235687173
KMS-21-BM,sirolimus-bortezomib (250-1 mol-mol),-4.769329635088173
NCI-H2087,439501,-1.341118756842812
A-549,12003241,-1.903076073453771
LOU-NH91,375860,-0.2088041582630222
Namalwa,49766530,-1.8902019897608628
NCI-H2405,10231331,-2.5791985337557155
RERF-LC-MS,375860,-0.2896823379882159
SU-DHL-10,262093,2.40427265358065
Peer,439501,-2.3355144214927614
HuG1-N,44491742,3.596787790528333
NCI-H1563,135421197,1.4749525017569085
NCC-StC-K140,sirolimus-bortezomib (250-1 mol-mol),-1.963369351991784
MOLT-3,3689413,-1.814335700031944
SK-HEP-1,135421197,3.339831791709741
WM983B,44491742,4.283339353588083
PLC/PRF/5,107970,2.9757983230893092
KNS-62,73707398,1.7190535741641355
KCL-22,3689413,0.1679864473503304
YD-10B,9903786,0.9692609848682356
JHOS-2,selumetinib-JQ-1 (4-1 mol-mol),3.072081960751537
NCI-H1703,5460769,1.9042192719561193
EFE-184,439501,-0.6930526838136172
NCI-H2170,selumetinib-JQ-1 (4-1 mol-mol),4.249712356863815
SU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),2.388331941434094
Hs 683,46907787,3.0982371748631325
SUP-T1,9929138,6.13855096958909
HMCB,selumetinib-JQ-1 (4-1 mol-mol),1.6185777798994516
42-MG-BA,637858,1.2732883958955747
NCI-H2172,9903786,4.970438346504575
NCI-H358,135421197,3.655226783621308
MEC-1,135999136,1.4630893356395394
SNU-466,selumetinib-JQ-1 (4-1 mol-mol),0.5207583733853219
HSC-2,135999136,5.308021141561782
BT 147,637858,1.9745023824878931
SNB-75,241158,4.443207850412388
REC-1,9903786,4.191167368609226
NCI-H1092,54596490,4.303629834820445
TF-1,9903786,1.2296708534399408
SIG-M5,46907787,-1.5125615192651995
RCH-ACV,71466445,1.275442483005524
MEC-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1834550186065348
DMS 53,11396600,2.5093833662364107
42-MG-BA,375860,1.010061771068955
A-375,46907787,5.129812217042003
SNU-410,262093,2.9879613961382363
SW1990,5460769,2.4608974418371017
SNU-886,26596,-1.4881272997493236
COLO 800,241158,3.8394116886094
YD-15,375860,-0.9866922587532774
HCC1588,6852167,2.2560831218356583
OVCAR-5,439501,-2.798423639950905
COLO 205,9903786,2.133695985637416
KMS-27,11455910,0.2864489394234576
TE 617.T,10231331,2.9787791726298183
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996
JHUEM-3,46907787,-0.2270381387910647
KE-39,11396600,3.848773124810753
SCaBER,10231331,0.960032427399654
SIG-M5,selumetinib-JQ-1 (4-1 mol-mol),-2.937192443891954
Tm87-16,12003241,-0.0978800802816917
SNU-1033,sirolimus-bortezomib (250-1 mol-mol),0.349990621506149
NU-DHL-1,241158,2.9356865238845313
HCC44,46907787,-1.085630650739563
A3/Kawakami,241158,1.613723809197875
SET-2,444795,4.329364706689898
BT 231,107970,1.486990449957834
SNU-475,262093,5.097469804639549
Sq-1,9929138,7.093151024107166
BT-549,73707398,1.468839183930599
SaOS-2,71466445,4.363709574185696
COV434,637858,0.809949930350691
NCI-H1703,241158,3.8145496221130464
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117
A-172,26596,-0.1948539739463346
F-36P,10231331,0.4784045802967716
RMG-I,6852167,3.689813828532847
SYO-1,46907787,-0.8384354430594259
PSN1,637858,1.3005438922518275
HeLa,selumetinib-JQ-1 (4-1 mol-mol),4.321478137399501
NH-6,439501,-1.820365577971014
ZR-75-1,73707398,1.0303983431454184
P3HR-1,241158,4.4514160234357725
TC-71,5460769,1.4458290097671247
P31/FUJ,5460769,2.718083541162644
CAL-120,sirolimus-bortezomib (250-1 mol-mol),1.988882229228272
A-549,6852167,2.2085984360403663
RS4;11,135999136,1.6580439823649238
BT 172,9903786,4.891040343072455
HEC-151,168313016,4.881545929029312
SUP-T1,241158,1.808139416871087
SNB-75,12003241,-1.444419761785008
TUHR14TKB,46907787,0.2152940597768577
TOV-21G,444795,4.92534522275514
BCP-1,11396600,3.181201903061476
SNU-478,262093,2.3459041938371112
SF539,241158,3.806550538894245
AGS,439501,-2.3986338247622148
REC-1,selumetinib-JQ-1 (4-1 mol-mol),5.213062841516755
HT,selumetinib-JQ-1 (4-1 mol-mol),1.0457933075353667
JHH-5,12003241,-2.221894796534897
SK-UT-1,262093,2.998836933826174
CML-T1,12003241,-4.650247315633356
Hs 688(A).T,UNC0638-navitoclax (1-1 mol-mol),1.6674868425364129
IM95,168313016,5.381835335975214
NCI-H1915,444795,4.8987813871468795
ESS-1,262093,3.0427773228942057
SR,71466445,1.8572383863538957
ACC-MESO-1,10231331,6.136184274550163
SNU-119,49766530,-2.6347810345662785
TTC-709,135421197,1.6212603414567397
A4/Fukuda,71466445,1.4546499284121797
786-O,439501,-3.5974319595711832
EHEB,375860,-0.9049347764221136
SJSA-1,73707398,1.3784617669206425
BT 328,selumetinib-JQ-1 (4-1 mol-mol),3.8675980198640465
OVK18,439501,-1.6105511378028463
BT 440,107970,1.846754761569568
HEC-108,46907787,5.113191551513952
GMS-10,12003241,-0.439124949180571
NCI-H841,11396600,2.6632446224517454
TCCSUP,168313016,5.913828803978875
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896
VMRC-RCW,9903786,3.331782716085826
SW1710,49766530,-2.0180793579471183
SF126,73707398,1.606269734820819
BICR 56,6852167,2.49326983244998
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422
KE-39,73707398,1.3252144554958445
SNU-46,UNC0638-navitoclax (1-1 mol-mol),1.5330694735080217
CAL-85-1,637858,1.5106736758760393
DU145,46907787,4.026240658586575
NCI-H810,168313016,3.527700584911011
LN-229,sirolimus-bortezomib (250-1 mol-mol),1.3963325511705935
NCI-H1435,444795,6.033920769526426
MOLT-3,135999136,2.8520154262430144
SW579,tanespimycin-bortezomib (250-1 mol-mol),-2.6338348381850283
EFM-192A,107970,1.699878245077743
RKO,44491742,4.905526099010324
COLO 668,644241,2.1375921936862627
LS1034,44491742,3.738346956467245
SK-CO-1,107970,2.4721550322855843
NCI-H1666,44491742,3.401457772249809
Ki-JK,UNC0638-navitoclax (1-1 mol-mol),0.2574517035947892
T3M-10,5460769,3.3157316369773926
PC-14,107970,3.287444237855521
NCI-H211,107970,1.1174938440677993
NCI-H889,73707398,0.8984121723552707
FU-OV-1,12003241,-1.039273875540509
LS180,135421197,1.2375553911833763
FTC-238,3689413,-2.1600357182012493
HCC4006,439501,-0.4255324495628316
DU145,12003241,-2.0135691280208876
BT 271,sirolimus-bortezomib (250-1 mol-mol),0.1057701535973337
NCI-H522,100016,6.692385014202011
MEC-1,100016,3.995806762220144
THP-1,262093,2.4428888686996237
DBTRG-05MG,135999136,3.6182651515935302
HPAF-II,12003241,0.935672122739968
KG-1-C,49766530,-1.9927650239452297
KMBC-2,12003241,-0.070536665370705
KCL-22,11455910,1.070847957925647
MM1.S,637858,1.1030416488426389
MHH-CALL-4,72967,3.718598415166011
HEC-251,46907787,-0.5109395446508497
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214
SU-DHL-8,444795,3.428161639013317
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398
SNU-182,5460769,4.45196550133433
NCI-H841,73707398,1.141940549320864
WSU-DLCL2,135421197,1.3366887647242718
SUIT-2,10231331,3.5504785260208473
KMS-20,46907787,-1.3444114814530854
BT 187,44491742,4.194091483119568
NCI-H2171,439501,-3.0635131055453924
EM-2,10231331,-1.453053484988338
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
OPM-2,11455910,0.7503761469114726
NCI-H292,262093,2.9868554632365556
L-540,73707398,0.7518551251866028
RKO,46907787,4.104881837237831
SNU-423,71466445,3.7020222675723646
BT 333,44491742,4.348369839159046
SKM-1,439501,-2.678240610691138
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021
RERF-LC-Ad2,135398744,6.529632870190649
NCI-H1573,73707398,1.66643290760046
PF-382,100016,3.957595275699552
NCI-H23,73707398,0.5781793163548435
786-O,11396600,5.6652705596340045
C2BBe1,135421197,0.6239864918667269
HMC-1-8,selumetinib-JQ-1 (4-1 mol-mol),-0.0708976327611117
RL95-2,49766530,-1.414659307229874
NCI-H660,444795,4.054546774998577
TUHR14TKB,9927531,5.242660147082698
MHH-CALL-4,46907787,-0.722309996072336
HT,375860,-1.0285235345603876
Caki-1,135999136,4.348933102663563
RS4;11,12003241,-1.5224166820052676
HCC202,12003241,0.4259304556953664
SNU-182,sirolimus-bortezomib (250-1 mol-mol),0.3656732555283032
MOLP-2,168313016,6.050723195700108
EoL-1,9927531,2.893857253769426
TUHR4TKB,262093,2.707007825366508
KNS-60,262093,2.4239806824503876
LS513,11455910,1.3682876788708345
BT 271,135421197,1.2817550115075582
MDA-MB-435S,6852167,3.3926503317081873
HuG1-N,71466445,4.414199948526064
HCC1438,637858,2.2625996667458974
U-937,444795,3.85111190930368
23132/87,444795,5.5054846626834735
HGC-27,9929138,5.812966492872734
OCI-Ly19,241158,3.0376081259806975
KHM-1B,375860,-0.460638651136882
SK-ES-1,107970,2.2840745570981738
NALM-6,3689413,-1.8173610448442752
U-937,44491742,3.930782705930826
UM-UC-1,sirolimus-bortezomib (250-1 mol-mol),0.2883897871436763
A-673,9927531,4.216692000672551
MM1.S,262093,0.96316485237803
MFE-296,49766530,0.1913665198227111
NU-DHL-1,9903786,2.0090459538270298
T98G,262093,3.081379180281475
Calu-6,444795,4.794697273365938
TE-5,sirolimus-bortezomib (250-1 mol-mol),-0.3603080832286391
MDA-MB-415,168313016,6.365347791419527
Hs 944.T,sirolimus-bortezomib (250-1 mol-mol),1.3396818337224137
NCI-H2405,selumetinib-JQ-1 (4-1 mol-mol),-0.5847662551268008
JHOM-1,135421197,1.641458342897405
CA46,637858,0.8997823848237061
Karpas-299,12003241,-0.4647539333721411
ECC10,100016,5.627610035010204
HCC2218,107970,1.4999859497279118
HMCB,135999136,1.9344485879492248
Sq-1,selumetinib-JQ-1 (4-1 mol-mol),1.2922884384093536
LS1034,9927531,5.052618610074112
NCI-H2452,107970,2.3345640718356364
MKN1,73707398,3.3076884656453283
Mono-Mac-1,73707398,0.6980623217810987
OC 314,6852167,2.8554025378636587
G-361,135999136,4.346430745109726
COLO 792,135999136,4.1263704306141795
ZR-75-30,sirolimus-bortezomib (250-1 mol-mol),1.7584870714322065
IM95,9903786,2.260707421178731
RKO,100016,5.817852214634293
SNU-685,selumetinib-JQ-1 (4-1 mol-mol),2.4989886652623357
KMBC-2,49766530,0.6316468025143787
SBC-5,241158,4.402731015442316
BT 333,selumetinib-JQ-1 (4-1 mol-mol),3.898596298326471
NCI-H1944,135999136,3.9999259167921544
NCI-H1838,tanespimycin-bortezomib (250-1 mol-mol),0.7534040164239657
COV644,262093,3.243932148063393
SK-N-AS,11396600,3.143624411786837
CML-T1,6852167,0.9836314645814764
RPMI-8402,135999136,1.132884235732898
GCT,100016,6.941224948418202
Hs 729.T,sirolimus-bortezomib (250-1 mol-mol),0.5283641874253757
SK-MEL-5,3689413,3.463644790263917
T84,44491742,3.592181787537852
PaTu 8988s,107970,1.550826733385026
NCI-H1355,49766530,-0.7127402307257245
A-253,46907787,4.065025553631924
KYSE-450,12003241,-0.0119879221972118
SH-10-TC,107970,3.078551044723764
LS513,26596,-1.0957721063054122
NCI-H1299,107970,3.021193234232078
NCI-H1092,6852167,4.811360661328789
SNU-475,9903786,5.095134957133182
CAL-85-1,135999136,4.6165811325196735
KATO III,71466445,4.418751574312434
SW579,9927531,5.20286248500357
Pfeiffer,11455910,-1.170722455400671
SK-MEL-28,241158,4.1117452183175445
G-402,107970,2.1842851966179304
NCI-H727,439501,-2.2848783314382133
CML-T1,11396600,3.3654395371867425
SUP-HD1,11455910,0.2376646387177033
KLE,49766530,-2.017018761794788
SET-2,11455910,-0.0425011411311434
BT 216,135398744,6.476974321326381
WM115,49766530,-0.6421157759153451
TE-1,71466445,2.6353487820633847
KYSE-510,100016,5.186546688011686
WT2-iPS,selumetinib-JQ-1 (4-1 mol-mol),-0.2269056443543759
SU-DHL-4,439501,-2.4807393804308777
BT 286,73707398,0.9456567929994184
OCI-AML-2,11455910,0.2624387958343751
BHY,107970,2.2817797633490016
OVTOKO,73707398,1.9090953451864836
SNU-1079,135421197,1.0783376836912564
OV7,11455910,1.3702614621166394
Lu-99,637858,1.7809926728554546
NCI-H650,73707398,1.320339059501373
SW948,9903786,1.6902329933335576
PK-45H,10231331,1.1390548984492337
BT-20,5460769,5.85454688440853
SU-DHL-1,241158,1.6235055790866513
Capan-2,262093,3.612001970240134
GDM-1,107970,1.974801043927804
SNU-5,tanespimycin-bortezomib (250-1 mol-mol),-4.499312047026259
SF295,sirolimus-bortezomib (250-1 mol-mol),1.039702746506238
23132/87,637858,2.155811558126407
K-562,135421197,2.032823128578147
NCI-H522,46907787,0.5375692456309028
SNU-1079,73707398,1.1905051072298996
G-361,26596,-1.652088739985509
EM-2,12003241,-5.8745734353402534
NCI-H2171,71466445,1.378191899492029
A2780,439501,-2.4090624878410316
TYK-nu,439501,-2.468535707905716
AU565,637858,2.0174799842455364
RCH-ACV,100016,4.052738843081589
SW579,selumetinib-JQ-1 (4-1 mol-mol),2.10914043341792
KM12,tanespimycin-bortezomib (250-1 mol-mol),-0.2034233372604618
PE/CA-PJ41 (clone D2),11396600,3.63156445822279
VCaP,9903786,1.7887289169146705
HCT 15,6852167,3.660532698855016
NCI-H196,637858,3.0093076834066923
SNU-668,9927531,6.94205854979306
Caov-3,135398744,6.775001868991772
A-253,375860,1.496704811763376
Toledo,3689413,1.25181961816846
COLO 829,44491742,4.1867442642539725
KMBC-2,71466445,4.930861718344141
PL-21,135421197,1.4240798978799187
UM-UC-3,136227331,3.94021080809034
EM-2,71466445,2.363063257631096
SNU-8,12003241,-0.8120802877527198
Panc 10.05,3689413,0.9531263048130152
FTC-238,selumetinib-JQ-1 (4-1 mol-mol),2.803944259726704
TE-6,375860,0.2137179943255964
KMS-20,73707398,-1.0592725192615595
NCI-H1694,644241,2.0380000680852035
MeWo,11396600,3.146503563655223
VMRC-RCW,12003241,-1.0941298808716429
RPMI-8402,637858,1.581832583062169
COLO 699,168313016,4.7973091734297855
DV-90,375860,-0.9488117357311476
RERF-LC-Ad2,71466445,6.028378172033726
NCI-H1651,sirolimus-bortezomib (250-1 mol-mol),1.0347909654714795
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427
AU565,135421197,1.4743648854968991
AGS,107970,2.300813331206164
HL-60,11396600,3.4352516220498215
SNU-216,11455910,0.3573804688779068
SF539,11396600,2.4945499602014487
CAL-54,sirolimus-bortezomib (250-1 mol-mol),0.5891301092659956
SNU-216,375860,0.5464638688972412
MKN7,49766530,-2.7589304585779493
BT 172,3689413,0.915101391559166
SNU-398,262093,3.8749654719100186
BT 139,12003241,-0.7824976089919207
Mono-Mac-1,3689413,-2.253738856829829
697,54596490,4.316781960045189
HEC-1-B,100016,7.817681002018073
KCL-22,9903786,2.593050827774072
KE-97,637858,1.152191846926287
EJM,6852167,1.8935710220557025
TE-6,135999136,5.897939938855362
HCC2108,637858,1.810315688111992
RL,9903786,3.83184195533614
NCI-H2029,3689413,-0.5548676180878093
Hs 683,375860,-0.6026673211862823
SHP-77,107970,2.2378803555447044
JURL-MK1,3689413,0.8778438710921479
MKN74,11455910,0.5314790476879293
NOMO-1,5460769,4.769752092364765
TE-11,71466445,5.070538866030301
CL-11,44491742,4.051585264115174
SNB-75,tanespimycin-bortezomib (250-1 mol-mol),-1.317235314034222
NCI-H2405,49766530,-0.8537478871049897
NCI-H1568,46907787,2.5747387573296425
VMRC-LCD,375860,-0.2754019641455896
NCI-H2405,262093,3.3162860948220714
Hs 944.T,49766530,-0.7107074816486109
RVH-421,11396600,3.585263708085467
HCT 8,9927531,4.796707314113722
Calu-1,241158,5.139545731518775
NCI-H2081,49766530,1.2305991234309177
SUP-T1,168313016,4.416252700819181
SUP-T11,3689413,-2.394245997939745
CAL-120,73707398,2.482636408608758
PF-382,11396600,2.839145334831077
DMS 79,262093,2.040295424440088
HeLa,3689413,0.6540693787829278
CAL-85-1,44491742,3.820376025852422
NCI-H2023,sirolimus-bortezomib (250-1 mol-mol),2.707809534730406
DOV13,5460769,1.9787074160604587
SNU-899,262093,2.8321925614753116
LCLC-103H,439501,-2.3624899744714956
SNU-899,11396600,4.052340052261649
CAL-33,73707398,0.9500271465517623
KHM-1B,12003241,-0.9345261470540068
NCI-H1435,UNC0638-navitoclax (1-1 mol-mol),3.6159705037693217
Granta-519,444795,4.599812836973149
ECC10,439501,-2.678077063421273
HCC1195,UNC0638-navitoclax (1-1 mol-mol),4.3671706235216465
TOV-112D,tanespimycin-bortezomib (250-1 mol-mol),1.1427039773069572
YKG-1,sirolimus-bortezomib (250-1 mol-mol),0.0311399701967428
OPM-2,6852167,1.7172653102666242
SNU-869,73707398,1.2954231168780477
Kuramochi,selumetinib-JQ-1 (4-1 mol-mol),0.801550139042012
HSC-3,262093,2.860040873457059
NCI-H1385,UNC0638-navitoclax (1-1 mol-mol),-3.5851944113716923
OVCAR-5,100016,6.797399029850292
SUP-HD1,168313016,4.538999743906855
KNS-81,637858,2.7069879492405313
BT 131,tanespimycin-bortezomib (250-1 mol-mol),-1.406336138935124
IMR-32,9927531,3.188320479836116
GSU,12003241,-0.2864311193180854
A-375,71466445,4.407690807388674
OCUM-1,tanespimycin-bortezomib (250-1 mol-mol),-1.6786100630480447
MDA-MB-231,637858,2.969194389696412
HT-144,6852167,3.604976607540464
MES-SA,26596,0.3162950796632606
HuCC-T1,9929138,1.9586255988809151
WM983B,sirolimus-bortezomib (250-1 mol-mol),1.0166833684300536
BICR 16,3689413,1.5183083645706292
CMK,107970,3.0192567609790073
BxPC-3,selumetinib-JQ-1 (4-1 mol-mol),-2.4444526852208206
EFO-27,262093,3.0007323703470896
DV-90,46907787,-0.7207800761519887
KE-37,107970,1.5802988637404825
TE-8,tanespimycin-bortezomib (250-1 mol-mol),1.1915545878263378
COR-L279,5460769,2.2116692629451338
KE-37,439501,-2.40992471859013
OCI-Ly3,135421197,2.144739759882478
HEC-251,135999136,1.694007404717233
Hep 3B2.1-7,3689413,-0.8676280815745859
Hs 683,3689413,-0.4207741938701824
697,644241,1.6492796316111564
LUDLU-1,241158,4.349073004115051
Hs 729.T,11455910,1.0467944276793937
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804
VM-CUB-1,sirolimus-bortezomib (250-1 mol-mol),1.5945782994961089
TCCSUP,241158,3.99107653461265
RL95-2,637858,1.629484037665391
SNU-61,135999136,5.618921387112628
WM88,sirolimus-bortezomib (250-1 mol-mol),-0.0026242391338407
KP-N-YN,9903786,5.5444671223667825
NCI-H727,107970,3.133468251114326
MEC-1,168313016,4.5584742767951125
KLE,11396600,3.656351561000123
AML-193,9927531,3.384669993922374
GP2d,49766530,0.1592380212690584
Mino,135421197,1.5483687621841111
NCI-H889,46907787,3.7493893467815527
HuH-28,44491742,4.601953674704061
JeKo-1,262093,0.8663217724360005
G-402,241158,3.7257491741278512
EJM,637858,1.0127573104049012
PE/CA-PJ41 (clone D2),selumetinib-JQ-1 (4-1 mol-mol),1.3944144559858256
KMRC-2,107970,2.5476750010931446
42-MG-BA,9903786,3.3707760791071184
8505C,6852167,3.356965933736931
Reh,100016,6.483959173055827
NCI-H211,11455910,-0.4390844400246115
SHP-77,135421197,1.1078063098339157
COV362,46907787,3.641146774847172
KNS-42,11455910,1.3943687177837636
SNU-C5,71466445,3.9202067188972616
Hs 888.Lu,439501,-6.314665191885066
NCI-H647,selumetinib-JQ-1 (4-1 mol-mol),1.5451877783992325
RL,168313016,4.727767126002517
RERF-LC-MS,12003241,-0.3897829713203344
ST486,241158,1.6334759620227712
BT 330,135999136,1.458475788495572
JM-1,3689413,-3.612287026066889
RERF-LC-A1,444795,5.084978113439599
BT 232,439501,-1.8419260323239657
SNU-387,11455910,4.584937750024463
CCF-STTG1,107970,2.063603625316133
NCI-H292,9877608,5.923265260718527
HCC1428,9927531,5.49162668491902
T24,12003241,-0.6434481559725229
MOLP-2,selumetinib-JQ-1 (4-1 mol-mol),0.6007356900304069
GCT,44491742,4.460609521265373
JHH-4,10231331,1.1955508274143107
HuP-T4,12003241,-2.8459442311528154
TT,11455910,1.6357775292121417
OPM-2,107970,1.3408908225452507
NCI-H1339,439501,-1.6994812988125017
NCI-H1623,6852167,1.7873387390250663
Yamato-SS,5460769,4.640105648822845
RCH-ACV,262093,0.7174466036111895
MCAS,375860,-0.3499242525784914
BT 440,44491742,6.048012757107985
NCI-H841,262093,3.0633638010395927
DEL,46907787,0.775499404701727
ZR-75-30,107970,2.5357758703425404
NCI-H1693,9903786,3.776760773308461
Ri-1,637858,0.8978114122705031
Aska-SS,5460769,3.7674682150871552
KCL-22,6852167,2.500162547183108
DU4475,11455910,-0.5137096491730787
Hs 852.T,12003241,-1.871479503201469
IA-LM,selumetinib-JQ-1 (4-1 mol-mol),2.5487957947561544
HSC-2,262093,1.000516110359784
MKN1,444795,6.668552685441613
HOS,444795,3.8858541661854775
U266B1,73707398,-0.6379528045224374
SNU-423,12003241,-1.4382544514663564
EJM,9903786,2.5710642236856818
OAW28,3689413,-1.4375749125930504
KMS-21-BM,12003241,-1.038159466289584
QGP-1,6852167,4.211899426816051
SK-N-DZ,9927531,3.3336857807362392
TCC-Pan2,tanespimycin-bortezomib (250-1 mol-mol),-1.7030002887525872
SNU-C1,10231331,-3.0598130215217285
JHUEM-3,73707398,1.3541053482659346
HCT 8,135421197,1.352992198121239
VMRC-RCZ,selumetinib-JQ-1 (4-1 mol-mol),2.1702511953372974
BT 145,12003241,-0.8369227670207208
GSS,9929138,2.058801232137709
HT-1197,44491742,3.769562948559888
DAN-G,262093,4.7024192027781435
BT 147,3689413,1.0613743234478148
NB1,9929138,7.475182637248333
OE33,73707398,1.4892412668396968
Yamato-SS,sirolimus-bortezomib (250-1 mol-mol),1.899815056583121
HD-MY-Z,26596,0.1075810605234112
Raji,9903786,2.8365362494251394
LUDLU-1,136227331,4.9346482061859875
Panc 05.04,5460769,1.7514561399814712
HT-1197,sirolimus-bortezomib (250-1 mol-mol),0.4279936775188873
KHM-1B,44491742,4.066156285625521
DK-MG,26596,-1.5409696775062258
P-STS,46907787,0.2337438016095803
ECC10,135999136,4.34093313955728
MOTN-1,12003241,-0.0935669928398487
OAW42,49766530,2.0594375067340085
NCI-H716,107970,2.192898211455521
Hs 746.T,11396600,2.998642785885706
HCC827,10231331,5.207740808728872
HSC-3,135999136,4.352393936185964
Rh30,11455910,-0.173986116803538
HPAF-II,5460769,4.759612134982938
NCI-H211,tanespimycin-bortezomib (250-1 mol-mol),-2.6494968987318517
GCT,12003241,-2.363961173456096
EFO-21,selumetinib-JQ-1 (4-1 mol-mol),2.934977036652893
Panc 03.27,11455910,0.4781856768651555
Peer,9903786,1.0379810938538272
Ku812,9927531,3.686533687467188
HGC-27,selumetinib-JQ-1 (4-1 mol-mol),2.474282481636993
DOV13,241158,3.7297667131482335
NCI-H1651,5460769,-1.7567427214342684
NCI-H2342,107970,2.0946828835513793
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346
G-401,375860,-0.2910974790080222
NCI-H747,46907787,-0.3397749461210398
BHY,selumetinib-JQ-1 (4-1 mol-mol),0.0066768595340859
OV56,6852167,4.1070527427791585
A2780,375860,-0.912616297645574
K-562,71466445,2.3693775657442373
SNU-16,100016,4.136425652163891
HPAF-II,637858,3.4206935967776135
UM-UC-1,10231331,0.2237903001677945
Mel Ho,9903786,4.6138306230888615
EFO-27,9903786,4.039986452778869
SaOS-2,12003241,-0.699813042979073
COR-L88,12003241,-0.20090693258686
Ishikawa (Heraklio) 02 ER-,135999136,1.8759825202501337
NCI-H23,sirolimus-bortezomib (250-1 mol-mol),0.1265190636772679
GA-10,3689413,-4.87834364200375
Ri-1,UNC0638-navitoclax (1-1 mol-mol),-3.130813752237708
NCI-H727,262093,2.950291125725139
DND-41,11396600,2.425122364939696
MHH-ES-1,107970,2.3247175730314757
PE/CA-PJ15,637858,2.2671736383658985
JHOC-5,5460769,2.0469189795608447
DEL,135999136,3.877926825133574
KE-39,6852167,2.989668764419295
P-STS,3689413,0.8859178339084445
Calu-1,sirolimus-bortezomib (250-1 mol-mol),1.450698493515476
RMG-I,sirolimus-bortezomib (250-1 mol-mol),1.380025279026371
MCAS,100016,6.4909883414165135
OVCAR-5,UNC0638-navitoclax (1-1 mol-mol),0.9443819478994296
AMO1,9903786,2.4699152046705253
Tm87-16,tanespimycin-bortezomib (250-1 mol-mol),-2.1995475163951217
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911
SK-N-BE(2),12003241,-2.145069511983118
NCI-H196,73707398,1.4930546062583872
NCI-H727,637858,2.2360670355510086
YD-10B,135999136,5.8909279281917994
SNU-182,262093,0.4168376562229068
KMRC-20,3689413,-2.0293333018936877
Mono-Mac-6,262093,3.4687299225305535
NCI-H1703,sirolimus-bortezomib (250-1 mol-mol),-0.4256415561025075
HEC-59,107970,2.7080521474876353
AN3-CA,73707398,0.9328233137559012
HSC-4,73707398,0.9895931551524366
NCI-H1793,6852167,3.028337837866536
KYM-1,5460769,0.1657624677468328
SK-CO-1,12003241,-0.9578793579943758
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
SNU-423,10231331,4.762188035854746
MJ,375860,-0.5648982341601144
EoL-1,26596,-3.796383365572035
HCC44,9929138,6.424680472987345
NCI-H1734,107970,2.5124626074074405
MOLM-13,439501,-2.531564352317227
YD-10B,439501,-2.459950710231521
BT 164,6852167,3.560765959786231
KU-19-19,107970,3.004209688555129
Panc 02.03,6852167,4.143336119644561
U-118MG,375860,2.698493959590529
A2058,selumetinib-JQ-1 (4-1 mol-mol),1.8047869257512583
BT 112,73707398,0.9645515230778364
YD-8,12003241,-1.7142863629727714
Hs 852.T,168313016,4.522758676040893
DU4475,46907787,-0.6348556248692606
NCI-H716,637858,1.7981928369747582
COLO 320,sirolimus-bortezomib (250-1 mol-mol),0.8564336763022389
NMC-G1,135421197,2.4402756951086477
NCI-H2126,73707398,1.9031907027928148
TYK-nu,637858,1.7482608253094327
Kelly,135421197,1.3669012525071198
NCI-H1435,71466445,2.4195354882991547
DU4475,73707398,1.2053758533745562
JM-1,262093,0.3077511100871351
SNU-719,49766530,-1.9010790195453584
NCI-H1869,241158,5.0819681903137806
NUGC-3,168313016,5.1272078558334915
HEY A8,241158,5.048056534525615
RERF-LC-MS,26596,-1.2372341703529914
TALL-1 [Human adult T-ALL],tanespimycin-bortezomib (250-1 mol-mol),0.1356817268288457
BxPC-3,9903786,2.126136875029704
LoVo,135999136,5.7154474843469565
RCH-ACV,9903786,1.555646026251057
UM-UC-3,100016,5.625806405184742
BT 428,262093,2.2051737857299547
KMS-20,UNC0638-navitoclax (1-1 mol-mol),1.0394785462110392
HCC1806,46907787,0.9728149371858936
JHUEM-3,637858,1.8218805135289704
NCI-H2452,9903786,2.1501841215173396
OV7,637858,2.6132506339305888
SW1710,44491742,4.487431108260269
KMRC-2,168313016,5.0095238893407315
8305C,26596,-2.120596559409719
JHOC-5,3689413,-2.3603805845843913
NCI-H889,44491742,5.742464384520159
NCI-H2444,135999136,4.625303018501703
NCI-H1915,UNC0638-navitoclax (1-1 mol-mol),1.0243351798341758
NMC-G1,UNC0638-navitoclax (1-1 mol-mol),2.0372459349033716
Ci-1,241158,4.072543777825025
NCI-H1944,54596490,4.385480659852923
DV-90,6852167,0.5997436806483085
U2OS,26596,-1.797685053172872
SET-2,262093,0.9752595476876692
WM115,UNC0638-navitoclax (1-1 mol-mol),2.6292832027586783
NCI-H2228,136227331,3.956978031272767
TE 617.T,637858,1.1275370402381546
COLO 668,444795,5.2717518651707875
BL-70,637858,1.0884199185060726
EB1,439501,-3.6025033052563553
U-BLC1,168313016,5.063255605681815
JHUEM-3,5460769,0.399281620663996
RKO,135421197,1.472175761257966
NCI-H1734,9929138,5.157080013193966
LN-18,selumetinib-JQ-1 (4-1 mol-mol),2.352155313347565
OVCAR-4,135398744,7.790531663529689
GDM-1,49766530,-5.08643578606908
G-361,9903786,2.8296470400432296
MOLT-13,12003241,-0.6419644689091649
KM12,637858,1.7671311825333942
GP2d,sirolimus-bortezomib (250-1 mol-mol),1.47869263930016
HeLa,439501,-2.848382287027866
LXF 289,10231331,2.4249622135671824
MOLP-2,444795,4.339225074199232
T-47D,73707398,1.257680639100872
MKN74,selumetinib-JQ-1 (4-1 mol-mol),1.7394351663824423
Sq-1,135421197,2.584547393194889
JHH-2,241158,1.694333135831791
SK-MEL-28,73707398,1.5724586228934123
NCI-H69,26596,-2.134877782649339
BT 164,107970,1.5974999178888267
HCC15,9903786,1.5576741113339283
KMS-26,11396600,-5.248360616459154
RERF-LC-A1,tanespimycin-bortezomib (250-1 mol-mol),-1.931734288189376
NB1,sirolimus-bortezomib (250-1 mol-mol),-0.0795560213748125
TALL-1 [Human adult T-ALL],135999136,1.718285852306641
CAL-78,637858,1.6758422163434077
SNU-620,9903786,1.530835439194961
NCI-H23,tanespimycin-bortezomib (250-1 mol-mol),-3.070808400033709
HEC-265,135421197,3.07473850340402
MPP 89,26596,0.6612538021834572
MV4-11,168313016,3.2115112435982356
A4/Fukuda,46907787,-1.6446005772830188
GMS-10,444795,4.9652539058226175
HCC1588,tanespimycin-bortezomib (250-1 mol-mol),-0.9414361012739926
SNU-308,168313016,4.41321855315878
PK-59,9929138,7.561658238332544
JHUEM-2,135421197,0.9907591998948792
Rh18,107970,2.2640428199879508
KU-19-19,73707398,1.7453733414385195
SNU-119,9877608,5.864690809801913
KP-3,12003241,-0.3092638329597765
NCI-H2106,107970,2.258654621274229
NOMO-1,3689413,-2.5325178418163174
HCC2935,11396600,3.842906803447669
CAL-33,3689413,0.5447147166063717
KMS-20,selumetinib-JQ-1 (4-1 mol-mol),-2.1329666207384124
DU145,46907787,4.026240658586575
WM88,6852167,1.647257119536929
HD-MY-Z,46907787,2.2677015455494187
SJSA-1,6852167,3.504637342801869
Mel Ho,10231331,-2.0849495719271927
NCI-H2122,637858,2.372515616710106
HOS,135421197,1.1481730372475163
DMS 114,11455910,0.636471074405143
SNU-8,100016,6.375529183181613
UM-UC-3,444795,4.9683698067712365
U-937,135421197,1.66797552132573
NCI-H1395,12003241,1.698262392733821
BT 216,644241,3.0724583671092236
NH-6,selumetinib-JQ-1 (4-1 mol-mol),2.318236461290304
GDM-1,241158,3.4116054847688857
COLO 684,241158,2.662003234974788
SNU-601,375860,0.0670595962305998
G-292 clone A141B1,135999136,4.156911102982334
HCC827,49766530,-2.1224128504974207
BT 145,10231331,0.0541268159574882
OUMS-23,262093,2.6847920209845886
ChaGo-K-1,262093,3.038007559777189
CML-T1,71466445,2.0221424049362033
L-428,135999136,4.19516718985733
2004,3689413,-2.0950734579660417
NCI-H2009,375860,-0.9754800160336818
COR-L95,44491742,4.146782751375218
KE-39,100016,6.665188081944046
253J-BV,tanespimycin-bortezomib (250-1 mol-mol),1.5580913101671798
SIG-M5,tanespimycin-bortezomib (250-1 mol-mol),-0.3458205812117419
Panc 10.05,9927531,5.445272240057394
SNU-61,46907787,2.0753699666277936
LC-1/sq-SF,107970,3.0387693559151754
A-172,44491742,3.879269865010821
Becker,26596,-2.013233579681989
SUP-T11,444795,3.188342205586965
LoVo,46907787,0.5340804086119918
42-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),-2.385025804605588
WT2-iPS,637858,1.311477651994295
KMS-12-BM,sirolimus-bortezomib (250-1 mol-mol),-0.0125868994295277
TE-15,12003241,-1.6215722433150963
NCI-H650,sirolimus-bortezomib (250-1 mol-mol),1.8480757652183293
KP-N-YN,6852167,3.160535826824463
OCUM-1,26596,0.6196247278484265
BT 504,444795,4.894377759650745
HH [Human lymphoma],11455910,0.005551580985779
Hs 839.T,selumetinib-JQ-1 (4-1 mol-mol),2.4784871545769094
Calu-3,6852167,1.946679158570884
PK-59,10231331,3.699323619498394
EFO-27,selumetinib-JQ-1 (4-1 mol-mol),3.927546340306408
TALL-1 [Human adult T-ALL],644241,1.986860911521218
NCI-H810,136227331,3.856341284870196
HCC1500,6852167,3.541859976914812
SNU-16,5460769,1.4244737217539871
SK-N-BE(2),135398744,6.372852995200929
JHUEM-3,44491742,3.947686960056495
NCI-H1355,44491742,3.8267579721093905
Mel Ho,46907787,1.2131777756516886
COLO 668,44491742,3.890577146633183
MHH-ES-1,selumetinib-JQ-1 (4-1 mol-mol),0.1854105188393836
WM88,11455910,0.2100258474381383
YD-8,73707398,1.1339237170250962
BT 340,136227331,4.417429547624524
A3/Kawakami,444795,4.277371495057248
KP-2,73707398,2.475309032034208
BICR 18,sirolimus-bortezomib (250-1 mol-mol),2.192378588292802
5637,9927531,3.46604374571058
THP-1,439501,-2.363264407361294
LS123,439501,-0.5553663251516828
NCI-H747,44491742,4.012258870504445
NCI-H1944,135421197,1.84181744698867
Ishikawa (Heraklio) 02 ER-,selumetinib-JQ-1 (4-1 mol-mol),4.45456930685315
SCC-25,107970,2.0623920721619564
NCI-H1339,241158,4.172701274103716
SNU-1041,3689413,2.0809742429378133
Lu-65,135421197,2.266142941564523
NH-6,9903786,1.6690533510154009
SUP-T1,26596,-4.2216278033342105
NCI-H2196,637858,1.290993907845002
Malme-3M,637858,1.926036953910112
ME-1 [Human leukemia],71466445,4.942504437994406
SNU-16,49766530,-2.8368517260847304
T98G,selumetinib-JQ-1 (4-1 mol-mol),2.813131207617802
KMS-20,49766530,-1.2962307066769267
SKM-1,9903786,0.91314187591027
NCI-H322,11455910,0.5525831103614591
OVCAR-8,12003241,-0.599857829959187
MeWo,11455910,-0.0610908401405663
HCT 15,11455910,-0.2039943057976136
UM-UC-3,46907787,4.913925621865414
TC-71,tanespimycin-bortezomib (250-1 mol-mol),0.107717273209992
KE-39,6852167,2.989668764419295
Hs 729.T,11396600,3.2923365887008966
SW579,637858,2.218521302325827
COV362,73707398,3.674207870915267
SU-DHL-8,26596,-2.3999944738407257
BL-70,168313016,3.7978075808944967
J82,9903786,4.0002373465355054
RPMI-8402,tanespimycin-bortezomib (250-1 mol-mol),0.8651644866846245
HCC1954,262093,2.719302502923702
AsPC-1,12003241,0.1897400127907629
NCI-H1341,6852167,0.0593600612593167
Ki-JK,375860,-1.0279195490213373
F-36P,UNC0638-navitoclax (1-1 mol-mol),0.5889836911302547
EC-GI-10,100016,6.57909581265972
NCI-N87,10231331,4.183605147658756
OE21,100016,6.577886119924336
HuP-T4,5460769,3.995973336692885
NCI-H1299,107970,3.021193234232078
Kasumi-1,73707398,-0.5667763623156434
MFE-296,11455910,1.116173433967265
HT,73707398,0.4062242987529652
LS123,6852167,1.8176468580104257
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291
DV-90,5460769,-1.416729974856236
COV644,44491742,4.3354697105959055
Calu-1,107970,2.841948385775343
VMRC-RCZ,107970,2.285336476499746
SNU-175,100016,4.815284438481943
SW982,9903786,2.8939777098979333
SNU-466,sirolimus-bortezomib (250-1 mol-mol),-0.4040247740859908
ONS-76,44491742,4.314760532803232
GaMG,107970,2.2843601112217535
JHH-1,107970,2.971432436185186
MDA-MB-157,26596,-2.8480155125253623
NCI-H1568,262093,2.8880881470868585
MOLM-6,241158,3.2247883618399444
BV-173,26596,-4.295505465502321
HCC1588,637858,1.5531111300248248
253J,tanespimycin-bortezomib (250-1 mol-mol),-0.9234008422745912
U-BLC1,262093,2.6001367621084306
NALM-6,tanespimycin-bortezomib (250-1 mol-mol),0.0910863571713514
NCI-H1395,241158,4.2689573120798165
MDA-MB-157,168313016,4.249309770188466
Hs 746.T,selumetinib-JQ-1 (4-1 mol-mol),1.3690652535230534
BHT-101,100016,6.007811941047966
SU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-6.722227351020971
HCC366,439501,-0.4382794174763856
CA46,100016,3.773189878640827
Hs 852.T,tanespimycin-bortezomib (250-1 mol-mol),-1.155351108191556
NCI-H810,54596490,5.063126061474121
SK-LMS-1,375860,0.2604054406638652
MIA PaCa-2,107970,1.625165459581556
Jurkat,26596,-2.6358007271857216
Aska-SS,439501,-3.4608963825976686
Mino,11455910,-0.3204403040643599
OPM-2,637858,0.8070227403937857
KMS-27,100016,3.811410813700335
SF268,49766530,0.574843558236966
BT 228,selumetinib-JQ-1 (4-1 mol-mol),2.3416360255070523
OCI-Ly10,135421197,1.9634913874205968
NCI-H23,10231331,0.2640956714926077
KNS-81,sirolimus-bortezomib (250-1 mol-mol),0.8491294280424774
COLO 678,10231331,0.1251543587047796
Hs 729.T,135999136,2.2512921666618166
VM-CUB-1,637858,1.6949759456767477
SNU-410,46907787,3.7701283534171894
U-118MG,637858,2.0304539500460015
Ri-1,5460769,1.1375471412538625
KMS-26,71466445,2.0250779935621868
HuT 78,168313016,3.837657248427472
YD-38,26596,-1.5752818654632963
REC-1,73707398,3.9738319614180666
SNU-761,73707398,0.8313669811057733
KYSE-510,46907787,4.415386026929367
RPMI-8402,5460769,1.919918299685469
Jurkat,UNC0638-navitoclax (1-1 mol-mol),-2.488205497611277
A2780,12003241,-2.743381978251489
KP-4,107970,2.3974989228996586
SNU-46,sirolimus-bortezomib (250-1 mol-mol),2.213576797303729
THP-1,11455910,-0.1573617764654806
KMS-34,135999136,4.609338887069151
PE/CA-PJ15,selumetinib-JQ-1 (4-1 mol-mol),2.840123680248533
ES-2,241158,4.7150295600490235
M059K,49766530,-1.828446567556348
IA-LM,135421197,2.370501142960713
BT 504,637858,1.8465103710961657
NCI-H1341,UNC0638-navitoclax (1-1 mol-mol),-1.6565118719167296
PE/CA-PJ49,73707398,0.9781921467778038
SUIT-2,637858,2.948083302297865
LCLC-103H,262093,3.3068425344063326
SNU-5,11396600,3.811291488960962
GI-1,UNC0638-navitoclax (1-1 mol-mol),1.5277702622089633
HT-1080,selumetinib-JQ-1 (4-1 mol-mol),0.5061126238331859
EKVX,UNC0638-navitoclax (1-1 mol-mol),2.6417819929880126
LAMA-84,sirolimus-bortezomib (250-1 mol-mol),0.5037633346566652
TE-4,6852167,1.583100276013206
DMS 53,135999136,1.9411901601516004
RCH-ACV,3689413,-1.349996625899334
COLO 699,44491742,4.375917041754564
IST-Mes1,262093,3.164571948045499
K-562,637858,1.3097643671251342
NCI-H1703,44491742,4.242219664453596
H-STS,262093,1.3358664140686949
UACC-257,135421197,1.9290983247334992
OV7,135999136,1.588038297711629
SEM,26596,-3.506968001766276
NCI-H727,selumetinib-JQ-1 (4-1 mol-mol),-0.7236905390047186
PF-382,73707398,0.3361294473850881
HCC44,135421197,1.110305691716081
Peer,73707398,-0.5421595453106686
SW1990,168313016,4.40739187693859
JHH-1,sirolimus-bortezomib (250-1 mol-mol),0.3653196480685532
BT 159,644241,4.467530571865769
NCI-H929,107970,2.2964601738289687
BT 422,11396600,2.1657946593546384
NCI-H441,sirolimus-bortezomib (250-1 mol-mol),3.489880905955473
HT-1080,136227331,3.9777239464002223
SiMa,5460769,0.4503719492820418
SUP-B15,sirolimus-bortezomib (250-1 mol-mol),-0.2788872316489693
NCI-H2126,71466445,2.8907750872786404
Rh30,637858,1.50729974182792
NCI-H1105,tanespimycin-bortezomib (250-1 mol-mol),0.6948185089061538
BT-549,100016,6.139281322747303
SK-N-MC,11396600,3.4054376977010485
OCI-AML-3,100016,6.665392900980702
RCC10RGB,71466445,4.397911896340776
SK-MEL-3,6852167,3.696781944889267
RL95-2,241158,2.957107105755342
BT 228,107970,1.7919397546621243
COR-L88,UNC0638-navitoclax (1-1 mol-mol),-2.1535286194834966
GP2d,44491742,5.750365262572418
SNU-1105,439501,-2.4533098010215024
BT-474,637858,2.300118260965066
HuT 78,11455910,0.0216709312460527
PLC/PRF/5,46907787,4.590488786856309
SK-BR-3,3689413,-0.6055139082378386
EM-2,46907787,-1.6373715361565755
MOLT-16,135999136,3.319237148517738
8305C,107970,2.244282047395896
MOLP-2,71466445,3.5509780826004658
HOP-62,tanespimycin-bortezomib (250-1 mol-mol),-2.1315828929129332
HOP-62,UNC0638-navitoclax (1-1 mol-mol),2.4690733929057385
THP-1,644241,1.774267182932786
8305C,9903786,1.7590562865334185
T-47D,44491742,4.391034289015602
BICR 56,5460769,-1.0977162863448868
LS180,107970,2.4480125060803077
P31/FUJ,135398744,5.7727848933678
LS180,11455910,2.088798844266998
KYSE-410,44491742,3.6208474241241473
ECC10,444795,2.5610873462217687
IGR-37,73707398,1.5804639662381832
T24,26596,0.1047033051772514
HEL,9903786,1.206049982415758
GI-1,439501,-2.4273681178364837
DBTRG-05MG,sirolimus-bortezomib (250-1 mol-mol),2.2547470483609637
KYO-1,241158,2.959045378118942
A-498,135421197,2.4500558267656873
Hs 940.T,9903786,1.9949918440372123
PK-59,107970,2.298393992220364
CAL-62,100016,6.567555445612565
SK-BR-3,11396600,4.1222338228644695
COLO 320,tanespimycin-bortezomib (250-1 mol-mol),1.191439437056519
KMRC-2,241158,4.767496150813131
J82,135999136,4.85981653793685
MOLM-6,9903786,1.0024208305438098
CAL-33,6852167,1.8112207544736203
Hs 688(A).T,241158,4.491821627446691
NCI-H2023,135421197,2.5449046355332436
KE-37,375860,-0.9469027157668132
KP-4,439501,-3.618807292682963
Calu-6,100016,6.484915939204548
MHH-CALL-3,73707398,2.0420485735176883
OPM-2,44491742,3.727542800888903
IA-LM,3689413,-4.432004355370191
KM12,12003241,1.1245278791827416
NCI-H929,71466445,3.0733288534415233
COLO 699,107970,2.4218490435577613
SK-MEL-5,46907787,3.947667418966643
BL-70,26596,-3.7588271568583953
KP-3,3689413,-2.21572351958202
SK-CO-1,11455910,1.152685438196598
KE-97,262093,2.317138698505635
HuNS1,375860,-0.6184479016387657
TM-31,637858,2.3445482610973767
BICR 56,71466445,2.0273239202254985
Hs 683,439501,-3.4221859538690467
HuH-28,168313016,4.3836924047698
HCC1500,107970,1.6380228058856745
A-375,135398744,6.486116496095493
NCI-H1703,49766530,-3.0493553752695783
PE/CA-PJ49,selumetinib-JQ-1 (4-1 mol-mol),1.4139822071582016
CFPAC-1,100016,6.545938487461667
COLO 320,26596,0.3070863795461868
IGR-39,UNC0638-navitoclax (1-1 mol-mol),4.155621356761579
UACC-812,439501,-1.4243957864326813
SNU-C2A,107970,2.380782463123486
P3HR-1,107970,3.4553561691501047
LP-1,135999136,4.095278648632366
BICR 6,135999136,4.273525232508699
BT 245,637858,1.8554051464132844
HCC1500,46907787,2.786329845885891
HCC38,12003241,1.828137629090711
EJM,11455910,0.7170091081693915
BL-70,262093,2.9607019791616387
NCI-H2085,11396600,4.2540905152728845
KMS-12-BM,46907787,-3.5146066785265746
ONCO-DG-1,637858,2.0012277986291527
ALL-SIL,71466445,2.2002248480614925
HCT 116,637858,2.500606444102258
KYSE-150,12003241,-0.8115897611031261
ACC-MESO-1,135398744,5.83972457285084
NCI-H2196,44491742,4.104688837740398
SCC-4,73707398,1.0055389356954705
Mono-Mac-1,46907787,-0.5681517995940845
Hs 578Bst,439501,-1.046807547420411
HuH-28,6852167,2.4785220942658137
SNU-213,100016,6.954868306659309
T84,selumetinib-JQ-1 (4-1 mol-mol),0.2360248997526779
KHM-1B,49766530,-2.233986045015649
NCI-H1755,168313016,6.160193768284492
PE/CA-PJ34 (clone C12),11396600,3.27217842552133
GI-1,135999136,4.223499836748494
LMSU,3689413,-0.2257013593388283
NCI-H1792,12003241,-0.2343490439085071
NCI-H322,10231331,3.754211694454943
TC-71,9927531,4.177938465440418
CAL-54,49766530,-3.2730005692653803
NCI-H1355,11396600,3.5209515786022156
SIG-M5,439501,-3.273907668571148
NCI-H716,sirolimus-bortezomib (250-1 mol-mol),0.1986169667929478
HSC-4,71466445,6.061667629347064
TF-1,46907787,0.4244045030022794
OVCAR-8,selumetinib-JQ-1 (4-1 mol-mol),2.9228351858434523
SNU-626,5460769,3.7499472406611334
Hs 944.T,375860,0.0810180917289278
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245
UM-UC-3,12003241,-0.2552051516294621
NCI-H2141,375860,-0.119191761966059
Panc 05.04,selumetinib-JQ-1 (4-1 mol-mol),1.2823810379914613
COR-L95,262093,1.2094317801688714
Caki-1,selumetinib-JQ-1 (4-1 mol-mol),4.356213501153114
JHUEM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0089826234091154
CHP-212,439501,-3.066647647836344
KYSE-520,107970,2.991610825069756
BT 504,107970,1.546603565945837
K029AX,241158,4.250115815507947
Hs 839.T,637858,3.1071442354117473
LN-18,9903786,3.1734737643120696
CHP-212,100016,6.525746829388361
KMH-2,sirolimus-bortezomib (250-1 mol-mol),-3.0653636595991203
SF295,11396600,4.282405011310363
SNU-601,3689413,0.8443240779543064
Karpas-422,439501,-2.968319248514649
CAL-54,5460769,-0.0866419988438866
SU.86.86,3689413,-0.2101757274961018
HEC-6,6852167,2.7812009481164894
SNU-1,135999136,4.2258569764915395
SNU-668,5460769,3.895439916502409
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844
Reh,71466445,1.6116548168850549
SW1088,73707398,1.711259788893634
SCC-9,73707398,1.5896934234406246
SK-BR-3,71466445,3.826803162885657
SK-N-BE(2),49766530,-3.9007408252768503
A-375,107970,2.3829956966560664
SK-ES-1,135999136,1.927716812239529
ChaGo-K-1,46907787,2.3551908782612068
OCI-Ly3,100016,3.877117461004623
NCI-H2110,44491742,4.139827167651669
TE-6,136227331,4.078918341903366
Hs 852.T,UNC0638-navitoclax (1-1 mol-mol),-0.1509084775003549
SH-4,46907787,2.8458594611775947
NCI-H2081,135999136,1.634974352928294
RT-4,73707398,0.8448009736616658
JHH-4,637858,1.967758508296358
SNU-626,12003241,0.7059762795421864
Hs 944.T,tanespimycin-bortezomib (250-1 mol-mol),0.6097209222741542
JHH-5,9927531,4.499670785521202
L-428,11396600,3.243581020285636
JJN-3,73707398,-0.471172401917679
TE-14,9903786,3.4903828938175354
LS1034,10231331,-0.9247771776372667
MeWo,26596,2.4666205413872953
SNB-75,46907787,3.565520882453274
BT 333,241158,4.43002656195282
SUP-HD1,375860,-0.581820779838327
JJN-3,107970,1.9663973240446229
AML-193,3689413,-0.2908308590674514
KE-37,135999136,0.9565366137926632
Hs 940.T,73707398,1.575879149171109
NCI-H1734,26596,-1.406622025931408
TE 617.T,3689413,-0.0312016851133043
NCI-H2405,46907787,0.6159609614456228
MOLP-2,11455910,1.1959894171141363
SF539,tanespimycin-bortezomib (250-1 mol-mol),-1.7404188546520216
RVH-421,637858,2.415713547012104
Ku812,11396600,2.326776145026828
HCC1806,5460769,-0.192100809913994
OCI-AML-5,168313016,4.3654687962480345
T-47D,6852167,3.1829025639617723
CAS-1,644241,2.086999477594296
JIMT-1,107970,2.57313135077594
SYO-1,73707398,0.9065821405188256
SCC-9,107970,3.0149180037966095
DBTRG-05MG,168313016,5.178980190186753
TE 617.T,107970,1.5986795918546095
A3/Kawakami,selumetinib-JQ-1 (4-1 mol-mol),2.7324114698986373
NCI-H889,3689413,1.8557298697874456
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
TCCSUP,107970,2.506866971737107
ES-2,9929138,5.3077403629794
CAL-29,44491742,3.7928020727090392
DB,168313016,4.30064233178
THP-1,241158,2.136965411928187
A4/Fukuda,5460769,3.0365194168079572
AU565,11455910,2.266336610800082
UO-31,135421197,2.4256878664158443
A-204,9927531,4.116017775807866
NCI-H1341,9927531,3.217953728153189
SK-ES-1,100016,7.4795645853927475
UO-31,26596,0.4742942530113579
SK-MES-1,136227331,4.390258592428933
COLO 668,135999136,3.1755303775386654
HT-1376,107970,2.532514719500574
BT 145,selumetinib-JQ-1 (4-1 mol-mol),0.9791242669222224
HT-1197,241158,3.8644992212078617
TC-71,168313016,4.509628867413136
G-361,107970,2.5078993960458917
MKN7,73707398,1.285732603925907
PE/CA-PJ49,439501,-2.9475727314168174
Peer,3689413,-2.558911360370697
OCI-AML-2,135999136,3.9689816560897184
JURL-MK1,135421197,2.4135031491286285
TE-4,439501,-1.5576935303532289
SK-MM-2,107970,2.4881899297299057
NCI-H1373,107970,2.3684164881001584
OVCAR-4,135999136,4.433648895782621
HSC-4,11396600,3.0766488056466104
NCI-H2087,9903786,2.3520196427400717
RKN,49766530,-3.8574490235665584
KP-3,637858,2.0723058540314945
VMRC-RCW,100016,5.733604538717687
ONCO-DG-1,selumetinib-JQ-1 (4-1 mol-mol),1.160528859877599
NCI-H1703,11455910,0.7967317937160228
NCI-H1155,5460769,2.4022459790155413
JHUEM-2,135999136,3.462043848043772
PE/CA-PJ15,107970,2.9199181042545175
UM-UC-1,49766530,3.4095372136602147
NCI-N87,439501,-2.2970478950560715
LS180,375860,-0.0541765269880971
RMG-I,selumetinib-JQ-1 (4-1 mol-mol),0.9170400407627758
BFTC-905,5460769,4.235583914088274
NCI-H196,71466445,5.320372938858583
LOX-IMVI,9903786,2.476339692878584
U-251MG,444795,4.461152799118872
COR-L95,11396600,3.695258257335492
IGR-37,5460769,4.3562687129012625
VM-CUB-1,107970,2.31350526197513
EKVX,73707398,3.029951924279227
OCI-M1,6852167,3.793961103000983
K029AX,11396600,4.390484410073567
HCC2108,tanespimycin-bortezomib (250-1 mol-mol),-0.3667697976747508
BL-70,54596490,5.069667260483249
NCI-H28,6852167,2.1577543799864403
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858
RMG-I,107970,2.2198175714732535
SCC-4,644241,1.8790035097217737
KMS-26,9927531,3.4485802259646703
BT 231,262093,2.1267355779539043
MOLT-16,6852167,0.1209526940764007
HOP-92,9903786,4.828960304549442
KP-N-YN,UNC0638-navitoclax (1-1 mol-mol),0.0470016406930417
MOLM-6,262093,0.6748168893327547
BHY,100016,6.773898116669002
IMR-32,10231331,3.825760806014001
ChaGo-K-1,241158,4.201927221282135
HSC-2,644241,3.1908860621612254
NCI-H1694,107970,1.634233191518056
CAL-54,selumetinib-JQ-1 (4-1 mol-mol),0.710350042212611
U-BLC1,637858,1.4857976283615233
HT-1080,9927531,5.0886456677015595
NU-DUL-1,73707398,0.3699002098172852
SNU-489,46907787,5.700655422231745
Rh41,107970,2.277335866720587
SNU-C1,100016,6.347812039507436
RT-4,6852167,2.0895706527990376
EJM,9929138,6.263891211273599
CAL-85-1,10231331,1.6707948774111965
NCI-H1341,241158,3.623594083926393
HCC95,637858,3.1546972070247667
SK-LU-1,10231331,3.230997250694965
DMS 53,644241,1.4928462905360964
U-118MG,73707398,0.952210463272118
639V,tanespimycin-bortezomib (250-1 mol-mol),0.3038823340698895
CAL-54,3689413,-3.5113381718602756
HCC38,UNC0638-navitoclax (1-1 mol-mol),1.0044709258096385
A-549,135999136,3.721733527600953
Ki-JK,sirolimus-bortezomib (250-1 mol-mol),-5.576010633092176
JHUEM-3,375860,-0.3399174798307714
IMR-32,241158,1.87934561893452
HCC44,selumetinib-JQ-1 (4-1 mol-mol),-1.8271790904045608
TE-4,73707398,1.500912959299055
G-402,5460769,1.138003238352945
OAW28,6852167,2.294169410796982
BT 359,46907787,3.734412578013872
HT-55,6852167,1.7657334784571834
NCI-H1581,439501,-2.58240650687765
MDA-MB-361,49766530,-1.160190626946109
SET-2,UNC0638-navitoclax (1-1 mol-mol),-0.0926361698206657
GCT,tanespimycin-bortezomib (250-1 mol-mol),0.7186181372238337
MeWo,375860,0.0049768320304234
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345
DOV13,637858,2.134745234755602
SNU-46,12003241,-0.9132341104689335
HEC-151,107970,2.3284041079322497
OPM-2,9929138,4.40255967212205
KYSE-520,100016,6.554858217735662
8-MG-BA,439501,-0.5992510337528919
HEY A8,439501,-1.1544595971592837
A2058,26596,-1.435799382276171
NCI-H211,12003241,-0.3344728899219033
TCCSUP,3689413,0.6301346851622357
5637,46907787,-0.5455038235860961
SaOS-2,3689413,0.0712794264513353
Becker,sirolimus-bortezomib (250-1 mol-mol),2.1834069144396393
BT 248,637858,2.256250159493538
SK-N-MC,135421197,1.0109878230238314
Caov-3,135421197,1.5167281474841918
TF-1,9927531,3.351583098746858
BT 328,11396600,3.7528560222461858
SK-ES-1,439501,-3.332679382402903
NCI-H1694,73707398,-0.8924536531071223
KG-1-C,262093,3.4811701682583847
RKO,375860,-0.2095842697906711
HeLa,637858,2.5742998662874035
BT 416,637858,2.044208431747075
KNS-60,136227331,3.7348276766396986
SNG-M,44491742,4.516771250419383
SNU-466,444795,3.973309413484701
Hs 944.T,439501,-0.9410683695438108
COV362,100016,7.994124175315401
JHOC-5,49766530,-2.297129087448997
SNU-449,168313016,5.914877518762689
SW1990,100016,6.759971253936254
CAL-51,5460769,1.3780575552768597
NCI-H524,12003241,-3.023793196266873
SCaBER,375860,-0.5997691554859326
CJM [Human melanoma],44491742,4.278888606986291
GA-10,637858,0.0748434639609226
BT 440,135421197,3.1509992040487074
HeLa,73707398,1.5466980684371698
PaTu 8902,6852167,4.282216220168943
HT-1080,5460769,3.028756475221219
DEL,11455910,-0.2144903394891009
SEM,637858,0.6523373975707702
OUMS-23,135421197,2.711287517534292
HCC2108,73707398,1.1119632364432313
HOP-92,10231331,1.6069626352375108
DMS 53,100016,7.1608088069035185
RL,73707398,0.8668689445518878
NCI-H647,107970,2.33869745071115
L-363,5460769,3.1855297672006087
SNU-407,100016,6.489561303898527
SUP-M2,375860,-1.5256283982593837
VM-CUB-1,375860,-0.8530802496201679
KM12,11455910,1.6759446540932372
BT 428,135421197,1.0281432833092603
NCI-H2452,73707398,1.4673083704761625
NCI-H460,637858,3.384702960830197
VMRC-LCD,44491742,4.573213718781489
BT 328,439501,-3.1360046964577983
639V,6852167,4.510121924990905
Caov-3,26596,-1.3429927330101894
TUHR10TKB,6852167,3.670922279136049
GB-1,444795,4.7060044385424735
RKN,241158,3.8611150596916577
SNU-61,6852167,3.859693430343892
NCI-H1184,12003241,-1.9901297280698445
NCI-H810,12003241,1.7210077749227564
T98G,sirolimus-bortezomib (250-1 mol-mol),0.3680606799164068
HEY A8,100016,6.30003295297675
TE-10,5460769,3.091987508758681
A-375,49766530,-0.2051662663719206
Hs 895.T,5460769,5.961347926985583
NCI-H716,375860,0.0273336501108971
U-937,644241,2.838998182644169
SU-DHL-10,11396600,3.7742694309184297
HCC1143,71466445,2.406598865609875
SK-N-DZ,11396600,2.4748866696759113
WM266-4,644241,2.4444791610838275
EoL-1,262093,0.636688142118246
CMK,44491742,6.009937952525146
TE-15,262093,3.281434334474844
NCI-H446,375860,-1.0573139189688194
YD-10B,637858,1.786914568759276
DB,107970,1.6169184615127037
639V,439501,-2.2821025832606083
HCC95,73707398,2.1605697712261263
SK-N-DZ,12003241,-0.5399118336559388
CAL-33,sirolimus-bortezomib (250-1 mol-mol),0.5156392130456946
GA-10,6852167,0.8612474487872448
NCI-H1869,3689413,-0.7267032921286074
NCI-H2171,3689413,-2.7117222930063867
Yamato-SS,3689413,-0.7026666605397593
IGROV-1,49766530,-0.195540678413639
TOV-112D,637858,1.8542326975791832
GI-1,241158,3.946291763915852
SK-MEL-24,12003241,-2.7585414015303424
C2BBe1,9927531,4.784416538426047
Panc 10.05,selumetinib-JQ-1 (4-1 mol-mol),1.8225918521960305
Jurkat,11455910,1.124658813154621
RKN,439501,-1.5558449248177562
NCI-H1734,135999136,1.9826030882500632
OCI-Ly10,9927531,5.366378866921267
G-402,selumetinib-JQ-1 (4-1 mol-mol),1.4151237701172463
A-375,46907787,5.129812217042003
JIMT-1,12003241,-0.563362100663344
OVK18,tanespimycin-bortezomib (250-1 mol-mol),-0.2590574495112158
ST486,107970,1.035895385995704
NCI-H1155,49766530,-2.3327778818126244
HT-1080,100016,6.676268064255503
IM95,tanespimycin-bortezomib (250-1 mol-mol),-3.0654337981747273
OAW42,71466445,5.313769340389005
NCI-H520,375860,-0.3875820486223135
NCI-H1869,6852167,3.74490947977495
TE 441.T,9927531,5.546705362793043
IGROV-1,3689413,-0.3633634632064185
NCI-H841,sirolimus-bortezomib (250-1 mol-mol),0.0818724348323602
COV434,selumetinib-JQ-1 (4-1 mol-mol),1.350650078825728
NCI-H1792,135398744,6.377997167001959
MOLP-8,241158,1.846975252387852
NOMO-1,11396600,3.3888037624860674
BT 271,tanespimycin-bortezomib (250-1 mol-mol),-3.34346586365967
JHUEM-7,637858,1.2462680133442194
TYK-nu,46907787,2.3666645247212346
BHT-101,10231331,0.5195362214151683
NCI-H1341,439501,-2.6104164072221168
DMS 114,439501,-3.85283118857385
RCH-ACV,tanespimycin-bortezomib (250-1 mol-mol),0.4817586938326316
LN-229,11396600,3.892523581558088
Ci-1,637858,1.188374489474976
ONS-76,5460769,1.8809234095271896
SNU-475,100016,7.606290519099935
A2780,44491742,3.4077888459991774
SUP-HD1,UNC0638-navitoclax (1-1 mol-mol),-1.9382538097314463
Hs 683,9927531,5.316569157291169
SNU-1214,5460769,-0.9519860634538546
G-292 clone A141B1,637858,1.3689975755883457
RPMI-8402,439501,-3.664200727311063
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882
EFO-27,3689413,-2.375877948841856
EHEB,439501,-2.4217048608799097
NCI-H2122,9929138,6.815327786842329
CHP-126,73707398,0.6128353739948191
IGROV-1,9929138,6.483056540257463
TT2609-C02,sirolimus-bortezomib (250-1 mol-mol),1.6449110161663607
MDA-MB-361,637858,1.7828856282424477
HLF,262093,3.0135929063245324
HCC-56,135421197,2.032560895215065
HuG1-N,135421197,1.5338215255875798
HCC44,3689413,2.49151375476088
NCI-H1385,11455910,-0.7459134175942048
SNU-1079,12003241,-2.81102043929997
COLO 699,49766530,0.7999690356188136
COLO 699,selumetinib-JQ-1 (4-1 mol-mol),3.535800123966137
SW1710,637858,1.7303422952388878
PK-45H,262093,3.1651162159981765
SK-MEL-1,637858,2.061096838595509
SU-DHL-10,26596,-1.8221428143230487
SK-N-DZ,71466445,2.103846907376585
NCI-H1694,6852167,2.1606813312691857
EM-2,UNC0638-navitoclax (1-1 mol-mol),-0.3416252714331361
SK-N-BE(2),selumetinib-JQ-1 (4-1 mol-mol),-1.8222666902203384
SNU-119,241158,3.4983662079339295
NCI-H322,54596490,5.659488455835274
Fu97,12003241,-1.5366115434948442
RCM-1 [Human rectal adenocarcinoma],selumetinib-JQ-1 (4-1 mol-mol),0.8519093027045113
Reh,11455910,3.330656455417661
NCI-H2196,sirolimus-bortezomib (250-1 mol-mol),-0.2528324189743298
JIMT-1,262093,3.7926345151691208
KE-39,46907787,0.5111190203360444
HT-1197,selumetinib-JQ-1 (4-1 mol-mol),0.9011980112854324
KMRC-1,73707398,1.5458693028147192
RVH-421,375860,-0.3081604542512128
OVCAR-4,selumetinib-JQ-1 (4-1 mol-mol),2.7898739995965527
HCC1500,73707398,0.9868057798362108
SJSA-1,439501,-2.834147074322405
OPM-2,selumetinib-JQ-1 (4-1 mol-mol),-1.0917216914210384
SH-4,135421197,1.5292272501013058
DND-41,375860,0.0527896767876526
RL,9927531,3.353152417945259
Mel JuSo,10231331,0.9125866595415298
HuH-28,107970,2.16988663827051
Mino,selumetinib-JQ-1 (4-1 mol-mol),-0.0896875125298877
L-428,44491742,3.8287631756244944
NCI-H747,107970,1.6995080105584164
HuP-T4,11455910,2.9391845361778532
SK-MEL-28,sirolimus-bortezomib (250-1 mol-mol),1.3552683647004444
M059K,73707398,1.2235502285517177
NCI-H322,6852167,4.306566159353396
KMS-18,241158,1.5641269542200231
HSC-2,107970,2.953096914146704
Hs 683,444795,5.839973604661916
TTC-709,11396600,2.7906512267667325
MDA-MB-468,637858,1.3196114478937917
OCI-M1,11396600,3.110541819968075
KYSE-180,selumetinib-JQ-1 (4-1 mol-mol),4.706272098527088
CAL-78,49766530,0.682857440978597
NCC-StC-K140,100016,6.431860837963816
IGR-37,tanespimycin-bortezomib (250-1 mol-mol),1.387795726757113
WM266-4,136227331,3.760867873542347
NCI-H446,444795,2.983412688059999
SNU-387,49766530,-0.0337981818562327
MeWo,444795,6.408850279243356
SET-2,644241,4.42349249378709
PC-14,375860,-0.4543940661648492
TE-14,11455910,0.8853432614856256
BxPC-3,439501,-2.27553783948146
KMS-18,644241,1.1242955523524518
A2780,644241,1.9281614760038184
KNS-60,444795,4.769163680647293
NCI-H661,73707398,1.1965083244926786
PSN1,sirolimus-bortezomib (250-1 mol-mol),0.321817101338521
BT 112,107970,1.504371825071881
SW1353,10231331,4.64823511583987
SUP-B15,107970,1.991238175434954
JHUEM-1,168313016,5.6992262147359805
LAMA-84,49766530,-2.2840485371109907
Calu-1,3689413,-2.465191800637427
IPC-298,262093,3.133705488563506
SYO-1,262093,2.864571024942669
F-36P,241158,2.4015613346017113
RL,49766530,-2.7332300451243294
NCI-H2122,439501,-2.460326379579743
NOMO-1,9903786,1.612481289648159
SW48,262093,2.726859331273406
AsPC-1,73707398,2.3690176063372888
RPMI-8226,46907787,-0.7193366635471113
SEM,73707398,-1.1402705015945305
GOS-3,107970,2.255442380434802
SUP-T11,49766530,-4.92791110390187
SNU-1,46907787,-0.7039913444865674
SU-DHL-10,444795,4.65789408600245
SCaBER,sirolimus-bortezomib (250-1 mol-mol),0.2620178296114504
SW948,71466445,3.954398511848749
MOTN-1,11396600,3.137567702451298
SCC-4,71466445,3.670270473572402
KMRC-1,3689413,-1.8207429228817171
KYM-1,73707398,0.8964699426689934
WM115,439501,-0.2667789802830004
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699
LS123,11396600,3.4015234811291246
SUP-T11,375860,-0.2294135177837117
KE-37,135421197,0.0656333668327355
GI-1,12003241,0.5382171766517799
ST486,135398744,6.173673764709001
NCI-H1666,644241,2.338416658672265
NCI-H2286,3689413,-2.1479799329428437
SNU-685,12003241,-1.0976198055590074
HT-55,73707398,1.0598769485898192
SIG-M5,6852167,1.5544573482245505
SK-MES-1,100016,6.467052003541006
MOLT-16,375860,-0.5978036063438881
SHP-77,tanespimycin-bortezomib (250-1 mol-mol),-0.364724393269764
BICR 22,26596,-1.8883514509946957
SET-2,5460769,3.4880653417656022
CJM [Human melanoma],tanespimycin-bortezomib (250-1 mol-mol),0.2668516284110745
NCI-H1693,11396600,3.0020537778987286
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702
SCaBER,26596,-1.7174475471543391
JMSU-1,135999136,1.9983092293214295
TM-31,135999136,1.8138767512848852
CML-T1,5460769,1.000954417912476
KU-19-19,9903786,4.470072542277405
WM266-4,107970,2.3123576759858
NCI-H2023,selumetinib-JQ-1 (4-1 mol-mol),4.204121853439987
JHH-4,168313016,4.720247698392662
CL-11,241158,4.171275148838918
HCT 15,637858,1.0268362607747696
NCI-H1755,12003241,-1.003418586049609
JURL-MK1,5460769,3.622430112813927
LC-1/sq-SF,3689413,0.5159232922556106
SNU-182,11396600,3.6909913141994584
Hs 940.T,UNC0638-navitoclax (1-1 mol-mol),0.3265341030867644
KMBC-2,107970,2.196231544396115
SK-MEL-30,73707398,1.6777957621098678
NCI-H146,5460769,1.8747395178404
TE-5,375860,-0.1603223838203094
A-549,11455910,0.2975953497649719
Karpas-299,71466445,2.2248556118041956
Tm87-16,73707398,1.1462148062827904
OVCAR-5,3689413,-2.1267579766056297
CW-2,12003241,0.1847256343211754
KP-2,644241,4.234611919960947
SNU-398,selumetinib-JQ-1 (4-1 mol-mol),2.57940367072891
SNU-8,73707398,1.2983083910911808
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768
OCI-M1,71466445,1.3804412160808055
697,241158,1.4573107535842036
HEC-108,6852167,3.774395558261256
RT-112,6852167,3.1370975355387825
ZR-75-30,49766530,-1.248821284043819
SW982,637858,1.8179065260330984
Pfeiffer,262093,0.9483544228261476
RL95-2,9903786,1.393609544351605
NCI-H1105,135421197,0.5397494538103206
NCI-H211,135421197,0.3603373283624291
Kasumi-2,9903786,1.7296917357536032
KMRC-2,49766530,0.0425057620545657
SNU-182,12003241,-2.036673656339672
MFE-296,9927531,4.364597960371392
769-P,241158,4.142144552714684
Mino,439501,-5.730054140979018
VMRC-RCZ,54596490,6.225362497613279
KYSE-510,3689413,3.0228627584183565
KMS-20,9929138,5.867169727564362
SJSA-1,11396600,3.615139997245977
NCI-H2141,135421197,1.2037655567537868
SNU-899,12003241,-1.150293591999144
LN-18,100016,6.511039950794577
COLO 668,375860,-0.2552898680870817
HCC1143,135999136,4.602247958833588
HCC1500,135999136,4.086589117257826
TYK-nu,11455910,0.7161463243688381
MG-63,44491742,4.049642181579157
EHEB,selumetinib-JQ-1 (4-1 mol-mol),-0.0163446257701156
SCC-25,26596,-1.8912501387828335
HEC-59,selumetinib-JQ-1 (4-1 mol-mol),2.9499197232125907
OPM-2,10231331,0.6444733525039235
PE/CA-PJ41 (clone D2),12003241,-1.240840898142407
KMS-26,11455910,-0.0860099305648322
NCI-H1573,100016,4.561614919470221
SK-MM-2,168313016,1.868740784996341
OPM-2,136227331,3.7431952210756014
Caki-2,135999136,4.889473783004605
SNU-175,selumetinib-JQ-1 (4-1 mol-mol),-0.1305665077886403
BT 330,46907787,5.374973233157415
DU145,439501,-2.7485794982467637
OVTOKO,262093,5.058822079580486
HPB-ALL,12003241,-0.6872291231969794
SUP-M2,135999136,4.670916241507474
NCI-H838,73707398,1.6319007245831227
HGC-27,241158,3.1465337742819135
U-87MG ATCC,241158,3.8639950646948376
NCI-H1650,9927531,5.159202312794284
KYSE-510,11396600,3.570057014705878
SW1353,sirolimus-bortezomib (250-1 mol-mol),1.598593802144504
TE-9,241158,4.967863865822489
ACC-MESO-1,73707398,1.5001086563583304
BT 333,sirolimus-bortezomib (250-1 mol-mol),0.4281916150518835
JHH-4,444795,4.954557242601277
G-402,439501,-3.32986520483416
NCI-H322,73707398,1.8248083553618009
OE19,3689413,2.2009145574363895
SNG-M,46907787,1.3713068647337556
HEL,100016,4.260371486080393
TT2609-C02,26596,5.442135867718664
LS513,262093,3.104156650593673
NCI-H2444,73707398,1.4354113747623178
DU145,375860,0.0587895300626014
KP-N-SI9s,26596,-1.674008327181718
MSTO-211H,637858,1.3984482263345202
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
CAL-62,26596,-2.09128877077726
COLO 320,439501,-3.5765221681419805
CAMA-1,49766530,0.0581457358273481
SNU-1066,12003241,-0.4993915951512702
NCI-H2171,26596,-1.7584148860978708
TCCSUP,6852167,2.775293027732918
UM-UC-1,73707398,1.4812492573397609
SNU-1272,71466445,5.534293199033029
253J-BV,6852167,2.333510642923989
Mino,5460769,1.2525165030578538
SCC-4,6852167,3.546394346660464
TCCSUP,tanespimycin-bortezomib (250-1 mol-mol),-2.003630452657136
HCC1395,9877608,6.36391605144629
DV-90,73707398,0.6212142210484521
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308
SNU-1041,9903786,3.9190312975923822
EKVX,11396600,3.2965982260380136
HCC4006,sirolimus-bortezomib (250-1 mol-mol),0.6132308595616923
NCI-H1793,11396600,3.5619281448280233
HuT 78,375860,-0.3004561584408421
HCC2935,135999136,4.789223967226289
BT-549,3689413,-0.9397914335397376
T24,241158,4.612211727096444
COLO 792,sirolimus-bortezomib (250-1 mol-mol),0.2253153763681567
Panc 04.03,107970,2.70125557955606
BT 444,135999136,3.658923915607091
SNU-449,5460769,0.9117409452183444
RD,241158,3.681398849246852
Hs 746.T,100016,6.2249168538435
SNU-C5,5460769,3.868586295292914
OVCAR-5,11455910,0.5140465150742446
HCC-56,44491742,4.146730174017219
PC-14,46907787,2.390406251773133
BT 416,tanespimycin-bortezomib (250-1 mol-mol),-2.7176161537390837
DK-MG,73707398,0.9326213981846314
SNU-C4,3689413,0.8564713625003593
SNU-899,444795,6.368100900508937
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629
MOLM-13,5460769,1.2989705913507943
KYSE-520,sirolimus-bortezomib (250-1 mol-mol),0.4067313196424638
U-251MG,9903786,4.913889261363981
PK-45H,6852167,3.230931962142996
SW620,444795,5.00121502031532
BT-16,637858,2.509868277109157
BT 159,73707398,1.1635351268629908
OVSAHO,46907787,1.5644430729796035
SKM-1,11396600,2.556560537938587
L-540,11396600,2.910168116055403
H-STS,135421197,1.21674084203813
SNU-503,107970,2.9918086587664514
BT 422,selumetinib-JQ-1 (4-1 mol-mol),3.270814227900577
MOTN-1,26596,-3.629503770216574
NCI-H1581,375860,-0.5344860443277677
HCC366,107970,2.271123549663536
OS-RC-2,135421197,5.318093622175408
NCI-H2291,100016,7.4079580735543695
SU-DHL-8,49766530,-1.150122303282486
SUP-T1,375860,-0.5976007782888901
LMSU,6852167,2.6209493875982277
EoL-1,375860,-1.005222990918516
22Rv1,12003241,-0.1253815141985464
DMS 454,73707398,0.7615831708776919
Yamato-SS,107970,2.6475909059700284
BFTC-905,46907787,3.862219767298802
RT-112,107970,2.3361930126733785
YD-15,12003241,-1.418070390851184
JVM-3,46907787,-0.7519440596115978
P31/FUJ,12003241,-0.93015536828776
NCI-H2122,9903786,2.7991091527294216
NCI-H358,12003241,-1.009244775405437
NCI-H1573,107970,2.295055793405493
Aska-SS,262093,2.4925778805334975
HEY A8,tanespimycin-bortezomib (250-1 mol-mol),-0.6734038900503383
EBC-1,71466445,3.3244072972986807
TE-1,135999136,5.1786705831528055
SNU-407,44491742,3.765091282887518
SNU-308,12003241,0.0879961923245038
SNU-761,644241,2.361328799023618
JURL-MK1,sirolimus-bortezomib (250-1 mol-mol),0.9558536767512098
DU145,54596490,4.798915584619797
HuH-6,637858,1.0144806827186308
TUHR14TKB,10231331,4.228729010809842
Panc 05.04,9903786,4.601199939689659
BT 248,selumetinib-JQ-1 (4-1 mol-mol),2.943393356661563
EB1,136227331,3.874508283981952
TE-15,135421197,1.6096072932868513
KMS-26,49766530,-5.317731060061128
PC-3,9927531,5.366538449676758
LC-1/sq-SF,9903786,4.361015168836896
EHEB,11396600,3.4241723821303314
DB,241158,2.7771018526302056
LS123,241158,1.4761560714556368
EJM,107970,2.184437882167209
A-549,selumetinib-JQ-1 (4-1 mol-mol),1.5948722522654506
PK-59,3689413,-0.088836641292159
LS1034,46907787,3.4253315978668084
SUP-T11,135999136,4.940178246919182
JHUEM-1,3689413,0.044302486666068
L3.3,135421197,2.5730452840447415
KYSE-150,241158,3.925608446446452
MSTO-211H,71466445,2.2675767772231024
HT,3689413,-1.9551613931391472
OAW28,73707398,1.2451215877479735
NCI-H2085,6852167,3.1183079346322
HCC827,sirolimus-bortezomib (250-1 mol-mol),1.7939037148295924
KMS-11,439501,-0.5953872178744132
WSU-DLCL2,71466445,2.0995254728091304
WM115,444795,4.375682835505768
DU145,637858,2.575359401469111
Hs 940.T,136227331,4.452644003789645
OCI-AML-3,12003241,-2.086986892339566
SF539,73707398,1.0308821565374424
HT-1080,sirolimus-bortezomib (250-1 mol-mol),0.4645124048276262
TT,6852167,2.4660311659605125
HuP-T4,71466445,2.7537575678736452
JHUEM-1,73707398,0.9079210855488236
NCI-H2444,444795,4.943179746981843
COLO 678,262093,3.3030723786800307
BT-20,439501,-1.326762104121763
COLO 800,135421197,2.3295817527143243
PL-21,selumetinib-JQ-1 (4-1 mol-mol),-2.2255955274462287
MFE-296,439501,-3.0642012902552
BT 286,135999136,1.5966853845263294
BT 187,100016,7.76208292164505
PK-1,375860,0.1836341615687206
FTC-238,107970,2.130291511736535
HSC-3,49766530,-2.4571890524447553
U-CH1,262093,3.1428300622202014
OAW28,selumetinib-JQ-1 (4-1 mol-mol),2.156145443592261
HPAC,262093,3.184189581983291
HT-1080,11396600,2.8023964018444176
SK-MM-2,11396600,-5.924315206412897
TALL-1 [Human adult T-ALL],sirolimus-bortezomib (250-1 mol-mol),0.4525392365030144
OV56,tanespimycin-bortezomib (250-1 mol-mol),1.0708573891285402
YKG-1,107970,2.756113266406284
BT 422,444795,5.024437809909507
OVSAHO,107970,2.430589701222164
ESS-1,107970,3.021792385864846
SNU-1,637858,1.0076801628048304
NCI-H1694,439501,-3.146903361549278
NCI-H2087,5460769,-1.5102005910697154
SNU-C5,262093,2.527934317013551
NCI-H322,100016,6.362238943247445
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
ZR-75-30,11396600,3.757449742584293
NCI-H647,100016,4.3873613110575045
BT 340,tanespimycin-bortezomib (250-1 mol-mol),0.797080968963508
Capan-1,12003241,-1.403867722449874
SaOS-2,5460769,2.263492155098724
A-549,439501,-2.483005959928592
DAN-G,3689413,2.9814511815134943
KALS-1,49766530,-2.069599194374988
HCC202,6852167,2.3722949143697076
KMH-2,26596,-2.508510760962814
8505C,9903786,3.4608112423981874
HCC2218,12003241,-0.1021817446699859
KP-4,sirolimus-bortezomib (250-1 mol-mol),1.5699611904925963
BT 359,135421197,1.2544226030548953
IGR-37,UNC0638-navitoclax (1-1 mol-mol),2.547238827516404
KNS-81,49766530,2.7158517560502293
NCI-H2087,10231331,-2.7002323257150636
NCI-H2171,UNC0638-navitoclax (1-1 mol-mol),-0.3565063117120224
DV-90,selumetinib-JQ-1 (4-1 mol-mol),-1.1774042966543188
SK-ES-1,46907787,2.445669024708645
SNU-1079,selumetinib-JQ-1 (4-1 mol-mol),-3.26610855773864
RERF-LC-Ad2,73707398,1.2471079254460122
JVM-3,444795,1.4285696310106424
8505C,49766530,-3.896310533039643
HEC-6,sirolimus-bortezomib (250-1 mol-mol),1.9105485577838577
A-673,637858,0.7164978632133837
DEL,tanespimycin-bortezomib (250-1 mol-mol),-1.3033090305095067
LS123,tanespimycin-bortezomib (250-1 mol-mol),0.0311387625429896
HEC-265,9903786,3.4431873939131536
KNS-60,241158,2.203041444596406
MDST8,135421197,2.23565927197073
KYM-1,637858,0.9207105078433748
NCI-H1666,100016,7.086863626956854
HL-60,637858,1.467320754534128
P3HR-1,135421197,1.4692220072432751
KE-39,71466445,5.518940973386278
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
JHH-2,11455910,2.202317711271985
LUDLU-1,12003241,-0.5957791848083803
COV362,UNC0638-navitoclax (1-1 mol-mol),1.9538248312330373
U-118MG,100016,6.712569444944465
NCI-H1395,49766530,-2.8850236043305792
HT-1197,444795,4.721186439495217
TE-15,tanespimycin-bortezomib (250-1 mol-mol),-0.6249388884216994
HEC-6,9903786,3.848299658438586
CAL-62,12003241,-1.1507806931187785
RVH-421,12003241,-1.8374248826372317
BICR 16,UNC0638-navitoclax (1-1 mol-mol),3.2045768686697684
MOLP-2,9927531,5.358514182418203
SW1116,644241,1.8306415261059923
WM88,107970,2.1698352778486987
CW-2,637858,1.2989979987803284
T84,73707398,0.224073795276098
HCC1833,11455910,1.7776428599570322
OVTOKO,241158,4.780065273335938
HOS,sirolimus-bortezomib (250-1 mol-mol),0.4034549730700768
BICR 18,9903786,1.845690489746328
Mono-Mac-6,100016,3.84240036835353
RS4;11,11455910,-0.9811499604134568
SK-MEL-3,107970,3.0007282894696967
BT 145,tanespimycin-bortezomib (250-1 mol-mol),-2.391322475110553
HuH-6,49766530,0.8339176615571017
TUHR4TKB,375860,-0.0991772019420722
JHH-5,5460769,1.8419810692418657
BT 330,sirolimus-bortezomib (250-1 mol-mol),0.7092263662862476
NCI-H292,107970,2.31632347859771
OE21,46907787,0.1329558963792394
MJ,73707398,1.2722011507797648
TE 441.T,11455910,0.1965703482136005
T3M-10,6852167,3.076618129408845
CW-2,168313016,4.664259792388598
MHH-ES-1,135421197,0.9821303635644922
RERF-LC-MS,44491742,4.380479941679622
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169
OCI-Ly3,9929138,5.257531923381126
769-P,sirolimus-bortezomib (250-1 mol-mol),0.7451378442227841
COR-L51,375860,-0.9911369939793973
Kasumi-1,26596,-2.5055411121240705
MOLT-16,262093,0.3053132271730923
Li-7,11455910,1.362279388286256
JHH-4,439501,-2.8819289141126596
GI-1,selumetinib-JQ-1 (4-1 mol-mol),2.3155507749392137
HCC1143,444795,4.803024181226615
TUHR10TKB,5460769,4.601270489376953
COLO 792,241158,4.646846543778487
L-540,UNC0638-navitoclax (1-1 mol-mol),-0.1391755381050462
BT 159,100016,7.101052412805122
BT 359,tanespimycin-bortezomib (250-1 mol-mol),1.7721099348871308
HCC44,9927531,3.2754168004895328
SU-DHL-8,439501,-2.4804073416438626
MM1.S,9903786,2.841249590923514
UO-31,12003241,-2.005680138773524
MEC-1,11396600,2.4763898883602384
SEM,262093,0.379936046646312
RMG-I,49766530,-2.064948903327457
OE21,107970,2.067715024549662
LOX-IMVI,49766530,-3.939815107547984
TOV-112D,262093,2.6540269134796213
KCL-22,71466445,3.1103858035293235
BICR 56,73707398,1.0454469872982766
QGP-1,135421197,1.134586890713183
BFTC-905,135421197,2.6921264103177
SNU-C5,444795,4.656078466363809
KMS-12-BM,11396600,1.1666466615999174
JeKo-1,49766530,-3.0518255026052454
KP-N-SI9s,11396600,4.554176657358924
L-1236,100016,5.644363792904431
SW1116,12003241,0.0582707461824652
NCI-H2081,241158,4.1289817617864575
SH-10-TC,135421197,2.8631167309091556
NCI-H1623,637858,3.185553411157662
EFE-184,644241,2.502750657538877
OCI-Ly3,444795,3.7741540845121175
EN,637858,2.5142942932116252
A2780,10231331,0.3686619766312378
Daoy,100016,6.878604021612681
U-CH1,5460769,3.546164006563716
NCI-H1339,375860,-0.3541433845632409
RERF-LC-A1,9927531,4.243256542635893
MM1.S,439501,-1.8322200924082088
SW1116,73707398,1.201154114814001
TTC-709,444795,4.010443492718726
HMCB,73707398,1.3368186639169768
UO-31,136227331,3.2031973353809833
TOV-21G,262093,3.1318910470351327
DAN-G,selumetinib-JQ-1 (4-1 mol-mol),2.3069493601380056
NU-DUL-1,46907787,-2.830192384250456
HCC1419,71466445,3.866201948197354
B-CPAP,262093,2.8121848345775784
SNU-489,3689413,0.2649172011332545
HD-MY-Z,262093,3.0364164526237807
M-07e,UNC0638-navitoclax (1-1 mol-mol),-0.772569020368213
EHEB,46907787,0.323033594148826
JJN-3,9903786,1.1978093816271655
A2780,135421197,1.3895584306244824
NCI-H526,73707398,0.1268432403684528
SK-N-AS,10231331,-1.1839301737612744
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
Raji,sirolimus-bortezomib (250-1 mol-mol),0.8276284938593903
KMRC-20,107970,2.3183049291357953
JHH-1,135421197,1.7316230199472116
SNU-8,selumetinib-JQ-1 (4-1 mol-mol),-0.3445187438421354
BT 139,135421197,2.718205377140928
RVH-421,439501,-0.8524727848852272
Granta-519,44491742,4.018752292224149
SW948,135421197,1.7477185084776832
OE21,12003241,-2.4283256435660205
ChaGo-K-1,644241,2.384389937346898
MKN7,439501,-1.6768390868463443
Kasumi-1,10231331,0.7062321842333538
BT 187,107970,1.6658171164192257
TE-8,637858,1.4873668702699938
IGR-39,selumetinib-JQ-1 (4-1 mol-mol),2.11462186606363
HL-60,49766530,1.1453309836966632
HD-MY-Z,sirolimus-bortezomib (250-1 mol-mol),0.1628834192986952
HCT 8,73707398,1.7500112780012191
KYSE-150,10231331,5.9145508836363545
SCC-25,11396600,2.765145835118827
OVCAR-8,241158,4.09430351942766
OE33,44491742,5.719021846419829
HCC1588,3689413,0.6550602760333641
SK-MEL-31,selumetinib-JQ-1 (4-1 mol-mol),2.462947302888872
LUDLU-1,100016,6.796390484470128
ZR-75-30,46907787,5.6188651676565655
MDST8,241158,1.799926141571129
OCI-Ly10,107970,2.8616762132018736
RCH-ACV,637858,0.8093595227428888
COLO 678,9927531,4.922936078042476
OCI-AML-5,135999136,3.783330102557352
OV56,9903786,4.181691762553772
TALL-1 [Human adult T-ALL],26596,-1.974209938729662
NCI-H1339,9927531,5.416434112117517
NCI-H2405,439501,-2.240122833517123
BT 248,262093,2.0571072545208926
OCI-Ly19,3689413,0.0585798733039559
G-401,26596,-1.5666727843222663
HPB-ALL,26596,-2.8269771859665824
WM793,262093,3.640026682877067
HCT 116,135421197,1.1800274219002476
SU-DHL-1,9903786,2.5464454731205777
Li-7,10231331,1.7671950703678494
K029AX,439501,-1.43360047701671
JURL-MK1,UNC0638-navitoclax (1-1 mol-mol),-6.663169619788907
8305C,selumetinib-JQ-1 (4-1 mol-mol),-1.1248005173903517
JeKo-1,637858,1.1914802653668115
SNU-869,11455910,2.0379647800047813
NCI-H2170,10231331,6.00292853605746
MFE-319,selumetinib-JQ-1 (4-1 mol-mol),1.6766813591617562
SNU-878,3689413,0.601904749344492
BT 330,72967,3.756952070615194
SNU-308,637858,3.38776683487698
SNU-761,44491742,4.113182762091863
BT 228,135999136,1.184789757824171
K029AX,262093,3.0004551512416957
SK-N-BE(2),107970,2.0125788242050873
ECC12,100016,5.969737428755433
HEL 92.1.7,44491742,4.540639923778426
NCI-H1299,135421197,1.297843636132371
SW1990,637858,2.6354229615266447
LK-2,241158,4.352486881371655
KATO III,439501,-0.4584208934437059
NCI-H1563,6852167,1.693143094788934
YD-15,26596,-1.9516647022251905
SNU-1041,12003241,-1.3076188477929267
BHT-101,6852167,2.0914160274610616
OVCAR-8,135398744,6.524120777237468
UACC-257,11455910,0.2602701775607313
MDA-MB-361,3689413,-1.8803084883549792
WM983B,3689413,0.8501817874784955
KALS-1,644241,2.759278664699006
HD-MY-Z,375860,-0.2550299270549113
NCI-H2110,9903786,2.318107893964858
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967
Panc 03.27,selumetinib-JQ-1 (4-1 mol-mol),2.6440242769241338
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
ECC10,46907787,-0.2077218323322306
RCH-ACV,UNC0638-navitoclax (1-1 mol-mol),-0.6973432503183749
MKN1,11455910,-0.2869953117882883
NCI-H1869,262093,3.2234761574881485
NCI-H1838,637858,2.13193146153693
KP-N-SI9s,135421197,1.130974840483334
Hs 746.T,73707398,2.6800461507251634
DK-MG,sirolimus-bortezomib (250-1 mol-mol),0.0484701224362502
Hs 294T,9927531,5.24007707651297
U-BLC1,9927531,5.132450103816796
NALM-6,6852167,-0.0864064217105925
SJSA-1,tanespimycin-bortezomib (250-1 mol-mol),0.871032127395642
NCI-H2141,11455910,0.8457435139245203
T-47D,262093,1.970232832851439
KP-4,9903786,1.7495953596701077
CW-2,100016,4.445901991176778
KMS-11,637858,0.3400135149620736
HCC1937,439501,0.0308528134887005
SCC-25,sirolimus-bortezomib (250-1 mol-mol),0.9940787042699578
Namalwa,107970,1.960491610604563
EPLC-272H,73707398,0.7206305777931009
COLO 699,tanespimycin-bortezomib (250-1 mol-mol),0.6482920125737269
TF-1,44491742,3.716758320980523
A101D,selumetinib-JQ-1 (4-1 mol-mol),0.6301447985237953
TTC-709,49766530,-2.0613056502019407
CA46,135421197,1.13174100448049
LMSU,12003241,-1.0531077396215482
HCC15,637858,3.032734575357801
SF539,selumetinib-JQ-1 (4-1 mol-mol),1.3049218182358
SK-MES-1,73707398,1.2846012994899838
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
WM115,54596490,4.400808012137458
HL-60,UNC0638-navitoclax (1-1 mol-mol),1.0635413421585809
NCI-H69,444795,4.095513261024057
EFM-192A,9927531,5.058042989735013
KYO-1,sirolimus-bortezomib (250-1 mol-mol),0.6931512347685437
LS123,12003241,0.0406446748290718
BT-12,135398744,6.373256605371206
Hep-G2,73707398,1.4703050959367814
BT 440,sirolimus-bortezomib (250-1 mol-mol),2.4257327980261936
L-363,tanespimycin-bortezomib (250-1 mol-mol),-2.487698550401284
L-363,9903786,1.2649504106242235
LP-1,73707398,-0.084919728706542
YD-15,tanespimycin-bortezomib (250-1 mol-mol),-1.46921905291906
SW579,136227331,4.609326652979714
SNU-503,135421197,3.1341230661682125
SU-DHL-8,262093,1.173912345187794
Calu-6,3689413,-1.4925549301996452
MDA-MB-157,100016,3.517936084480814
DMS 114,637858,1.7824394886832768
BxPC-3,135421197,1.4419000032460958
KMS-20,168313016,2.502907983030332
HL-60,5460769,4.053430435515514
KYSE-510,135421197,2.241265348212864
TTC-709,135999136,2.269842230246662
KYSE-410,637858,1.774325597801251
NCI-H358,6852167,2.3300376258618294
HEC-151,375860,-0.8046156329798803
BT 131,12003241,0.8855020405936681
SK-N-MC,262093,3.06312964755372
Hs 934.T,UNC0638-navitoclax (1-1 mol-mol),0.9424865340845288
HT-1376,100016,4.270787672820572
AML-193,UNC0638-navitoclax (1-1 mol-mol),1.223470800239613
TE-11,375860,-0.5681056358976869
LOX-IMVI,10231331,1.7536207323976525
LCLC-97TM1,46907787,1.8795083111860824
SNU-1076,3689413,-0.3890418815015654
HMCB,3689413,1.1423939419443525
OAW42,9927531,5.261343543721406
KP-N-SI9s,100016,6.171993249574907
NCI-H2291,5460769,2.25244251110153
COLO 680N,6852167,3.889885977774019
NCI-H1092,3689413,-0.2231155414175143
IM95,sirolimus-bortezomib (250-1 mol-mol),0.6284965219885708
SW1990,11455910,1.2583427289615488
HEL 92.1.7,107970,2.1393634980619622
YD-15,107970,2.3819608381605097
OVCAR-5,644241,1.8863081548750864
SNU-C5,11396600,3.0577499527766316
G-292 clone A141B1,3689413,-2.069808730051662
TUHR4TKB,44491742,4.24148356171105
A-375,444795,4.8572215879040925
SNU-201,12003241,-1.0113776062533857
HCC1171,644241,2.370755588024315
EB1,135421197,0.2915543489276729
Ku812,135421197,1.6654017400601815
U266B1,107970,2.068573563143244
EKVX,49766530,-0.424915470448776
AsPC-1,11396600,3.3240147605355506
Hs 683,10231331,6.307100182412671
CAL-33,11396600,3.937699926815987
MHH-ES-1,UNC0638-navitoclax (1-1 mol-mol),4.348872164293784
CAL-51,3689413,0.5709426612715743
DK-MG,10231331,4.3753601984660175
SNU-719,sirolimus-bortezomib (250-1 mol-mol),2.0194347248370432
HuG1-N,73707398,1.3800802205290363
EJM,44491742,4.208016925641279
BT 216,44491742,5.368329526940575
DU4475,sirolimus-bortezomib (250-1 mol-mol),-1.4046623953130444
SNU-626,73707398,1.6076526777595226
OCI-AML-2,100016,4.069849166636085
SNU-1076,12003241,-1.173823716137647
NCI-H1793,135421197,3.9424142241593145
NCI-H1355,sirolimus-bortezomib (250-1 mol-mol),1.1332482572843785
CAMA-1,6852167,3.8047331998506526
MM1.S,168313016,2.515366642859788
KMS-12-BM,73707398,0.3620923628880652
OUMS-23,107970,1.9293400316395712
WSU-DLCL2,tanespimycin-bortezomib (250-1 mol-mol),-0.4826072076602557
Mel JuSo,439501,-1.0789226024470335
JHOM-1,637858,3.172765266389714
HCC1806,73707398,1.2659800646796615
HCC2218,72967,3.841314233742601
IGR-1,26596,-0.0620943147126713
SK-LU-1,UNC0638-navitoclax (1-1 mol-mol),4.8277080945305375
TCC-Pan2,637858,2.213784354871656
LK-2,9927531,4.895223263990893
COLO 699,637858,1.990442060212899
KMRC-2,44491742,3.971638428490517
NCI-H838,6852167,2.9602564244495713
TYK-nu,12003241,-2.574649573149326
BT 416,241158,3.719071622577502
NCI-H1105,6852167,3.8396171518707023
NCI-H2110,439501,-2.2349143195011583
5637,sirolimus-bortezomib (250-1 mol-mol),0.1813560942007127
HCC827,12003241,-4.000089472829944
Ri-1,241158,1.4314385956610491
LoVo,100016,6.001395250082881
OCI-M1,9903786,1.4970236133945398
SK-HEP-1,262093,3.158620019748703
BT 444,UNC0638-navitoclax (1-1 mol-mol),1.869451456428048
NCI-H2170,UNC0638-navitoclax (1-1 mol-mol),0.9818039893917144
ME-1 [Human leukemia],637858,0.3716421428475518
BL-70,9903786,1.6201088809137068
NH-6,107970,1.549749994663037
NCI-H322,241158,4.940934801994881
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065
DMS 53,135421197,0.687232619284389
KU-19-19,selumetinib-JQ-1 (4-1 mol-mol),-0.4288095691894706
NCI-H1650,9903786,2.8320144189469385
SK-N-MC,241158,3.143336321830594
EFO-21,12003241,-0.6894261883426276
SNU-899,241158,4.245209655205581
23132/87,439501,-2.5239735825770797
RKN,5460769,5.79272629497122
JeKo-1,44491742,3.7422814982420056
L-1236,241158,1.444995384465227
TTC-709,262093,1.587813672786524
MDA-MB-453,UNC0638-navitoclax (1-1 mol-mol),2.401691334113767
HEC-108,168313016,6.1351198054698575
Malme-3M,selumetinib-JQ-1 (4-1 mol-mol),-2.351283247335257
IGR-1,3689413,2.7517007326117957
NALM-6,107970,1.8699252038348184
NCI-H1693,12003241,-2.0700110042259072
EKVX,sirolimus-bortezomib (250-1 mol-mol),1.945724198864232
PC-14,3689413,2.901459905806189
BT 422,637858,1.6662329367795623
KMRC-1,9903786,4.024109374851969
EC-GI-10,26596,-3.5687172078755087
WT2-iPS,11455910,0.3504555455596581
Tm87-16,262093,2.22528250793553
HPAF-II,selumetinib-JQ-1 (4-1 mol-mol),2.1871956092647404
BICR 31,5460769,3.9433617709959696
GP2d,241158,3.714880329185931
NCI-H1869,100016,6.8338343579730285
KMS-21-BM,107970,1.3348974715071786
KMRC-2,6852167,1.9056104142520949
SW1271,107970,2.3235168881670285
HCC1171,439501,-1.4214133435338303
MCAS,49766530,-0.3094916991443784
DU145,3689413,-1.3535401671184424
SiMa,6852167,2.4572377935660037
SK-OV-3,73707398,1.4890038437616029
Reh,3689413,-0.3766335135286286
BT-16,9903786,2.8143760707131347
CAL-54,26596,0.8562356828634801
SNU-1,sirolimus-bortezomib (250-1 mol-mol),0.1110784277529242
IST-Mes1,selumetinib-JQ-1 (4-1 mol-mol),0.7556363714344752
EB1,46907787,0.9817237925855196
U-251MG,135999136,4.081997928047093
OV7,262093,3.0286714339572542
DU145,135999136,4.106502655585601
HCC1428,135421197,1.8247359563067895
D283 Med,241158,3.4452599332241616
HEC-1-B,135421197,1.3262919275478138
EoL-1,135421197,0.8401357676850814
TUHR10TKB,262093,3.638427626686601
BICR 22,637858,2.779101364791116
CAL-54,54596490,6.393585920661526
DMS 79,UNC0638-navitoclax (1-1 mol-mol),4.220125308149289
COLO 829,262093,3.4773152453847715
TUHR4TKB,9927531,4.964100941716243
NCI-H1734,11455910,0.8885636438539928
YD-38,439501,-2.4363640234681347
HEC-59,6852167,2.4613827156801937
VMRC-RCW,73707398,1.1041967608217782
NCI-H1435,12003241,-2.5624704178121274
SUP-T11,selumetinib-JQ-1 (4-1 mol-mol),1.513032323882754
SCC-9,375860,0.1694000381305893
COLO 320,107970,1.828420426524412
WSU-DLCL2,168313016,3.978102745461622
SK-MEL-1,262093,3.2518519489587785
HEL,135421197,2.810551353794614
VMRC-RCZ,46907787,2.9652136995689315
SNU-119,6852167,1.9740525769719148
SK-CO-1,selumetinib-JQ-1 (4-1 mol-mol),-1.696692082912101
SK-N-BE(2),sirolimus-bortezomib (250-1 mol-mol),1.0543507239868668
Hs 852.T,6852167,1.5153309311291714
BT 179,135421197,2.7508543391500875
HuH-1,375860,-0.1259737357610563
KMS-11,100016,4.183673123455152
MOLP-8,9903786,1.299688823902182
Panc 05.04,637858,2.56001931031159
GDM-1,439501,-2.0864895468216846
DB,136227331,5.354479486577142
A-549,9929138,6.139762216307962
BT 231,selumetinib-JQ-1 (4-1 mol-mol),1.4143353306589224
VM-CUB-1,3689413,3.0900699567187013
MOLP-2,26596,-4.180731486004902
HCC44,107970,2.2740758908973766
NCI-H508,12003241,-0.6008293317473488
PE/CA-PJ41 (clone D2),644241,2.3238637219547904
SNU-8,10231331,0.8787847787611084
KMS-27,444795,4.486378633657878
D283 Med,11455910,0.6480749902472364
SK-LU-1,11455910,1.7364253174007704
FaDu,107970,2.22410543491943
NCI-H520,9927531,5.647411307076465
NB1,9903786,2.052998466280315
ECC12,selumetinib-JQ-1 (4-1 mol-mol),2.1210248258767006
HOP-62,439501,-3.0300699988747333
HPAC,100016,6.325474069382135
KM12,100016,6.486077549174115
NOMO-1,11455910,0.2303469505827257
NCI-H510A,46907787,1.6646540248102413
HEC-265,637858,2.1532926189030386
A-172,375860,0.131110300908506
Ishikawa (Heraklio) 02 ER-,73707398,1.818794277396009
PK-1,107970,2.4622131815620834
BICR 22,9927531,5.395078942533075
Hs 611.T,UNC0638-navitoclax (1-1 mol-mol),0.5214150649691321
JMSU-1,sirolimus-bortezomib (250-1 mol-mol),0.8204079064012788
AN3-CA,444795,3.791626271347074
SNU-387,9903786,4.748130611639421
OAW28,71466445,4.188405368682896
NCI-H2126,241158,6.024338101753431
HMCB,tanespimycin-bortezomib (250-1 mol-mol),1.0972296557807748
F-36P,11455910,-0.4221924181382917
NCI-H1184,107970,2.059526895608455
T84,439501,-3.2363484717371964
AML-193,241158,4.142634503453859
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739
Reh,9929138,6.102767885928958
BFTC-909,11455910,1.958059547603208
MDA-MB-231,10231331,2.949013721621845
EoL-1,49766530,-3.8413897802106014
NCI-H1693,241158,5.606232618136794
CJM [Human melanoma],100016,5.681499096329984
PE/CA-PJ15,11396600,3.3444318017760986
MDA-MB-435S,444795,6.789363212656908
NALM-6,73707398,-1.133432091638796
BT-16,100016,4.275534033025709
NCI-H2087,637858,1.5556640998503009
NCI-H2170,135421197,1.5856670633650565
T84,26596,-1.9747226822057509
SK-MEL-28,tanespimycin-bortezomib (250-1 mol-mol),0.8284351953237586
BT 231,135999136,1.241486028701245
SNU-761,6852167,3.092817272087504
COV644,9903786,3.8438435409952456
NUGC-4,100016,6.130178573368833
Hs 746.T,168313016,4.639079207564439
SNU-407,5460769,0.640220508180195
L-428,11455910,-0.1426546871205822
GB-1,9903786,2.9752485766111936
CA46,49766530,-5.499020578204802
SNU-886,135999136,4.094662341834861
A4/Fukuda,72967,3.695839205584607
HH [Human lymphoma],3689413,-2.48685445642347
MSTO-211H,11396600,3.2938939565791765
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981
DAN-G,26596,4.046660448506208
U-118MG,71466445,5.975471047496491
NCI-H1155,tanespimycin-bortezomib (250-1 mol-mol),-1.3476430950240228
NCI-H1693,44491742,3.504045241968317
LS1034,6852167,3.8807120807574784
BT 428,UNC0638-navitoclax (1-1 mol-mol),0.5798906424997637
BT 131,644241,1.8188461332217016
CAL-51,444795,5.053001195278548
HCC1171,selumetinib-JQ-1 (4-1 mol-mol),0.606022356375209
K-562,44491742,3.373435641850853
A-204,73707398,0.8872141377599841
A2780,135999136,1.5930192405329104
A-673,644241,3.265724898737132
OVSAHO,439501,-1.6237946984233838
A-375,637858,2.049731474801189
SNU-1076,selumetinib-JQ-1 (4-1 mol-mol),1.5511529799006534
OCI-Ly3,135398744,6.408015135669225
HCC1438,262093,5.151605944522477
NB1,12003241,1.4891548799263434
Becker,439501,-2.817437349005285
22Rv1,135999136,4.349739635114316
ACC-MESO-1,439501,-2.1177142805540163
IM95,375860,-0.4736196030119515
CAL-148,11396600,3.115756586832573
CHP-212,9927531,5.318398541001747
RKO,11455910,0.1271196393609195
SET-2,12003241,-1.37504024910663
OVCAR-4,241158,4.740656207396031
BT 416,12003241,-2.2907483254938774
BT 286,439501,-3.2145304071914844
COR-L105,6852167,2.71981320036177
TE-9,26596,-1.3406326261923425
WM88,selumetinib-JQ-1 (4-1 mol-mol),-2.6351532870485017
SNU-1214,sirolimus-bortezomib (250-1 mol-mol),0.3499333667052599
A-172,12003241,-1.0086398080644707
MDA-MB-231,9903786,4.774872525437021
MOLT-16,444795,3.4331824193930176
MFE-319,49766530,0.80428041774597
MOLT-3,644241,1.5823178433410596
HMC-1-8,375860,-0.2146762631480129
TUHR4TKB,3689413,-1.6587483895037962
P12-Ichikawa,637858,1.4527984508245164
RS4;11,637858,0.9565366734792956
HuT 78,selumetinib-JQ-1 (4-1 mol-mol),-4.078257117596482
DLD-1,9903786,2.1877560593252343
BT 216,6852167,4.730740612520291
GSS,6852167,1.3969716760302158
IMR-32,UNC0638-navitoclax (1-1 mol-mol),-0.289591590901736
SaOS-2,262093,2.7398792490382244
JM-1,26596,-2.491901301923365
A-549,46907787,5.023259811787708
KMS-21-BM,73707398,-1.1120298197741494
KE-39,49766530,-2.0647642539816715
L-363,46907787,0.1133832024912023
P-STS,107970,1.9935688507494205
KYSE-150,sirolimus-bortezomib (250-1 mol-mol),0.6836910361720296
SU-DHL-10,46907787,-0.8948479430375792
GDM-1,11455910,2.236688406286894
NCI-H2405,5460769,3.951574866457585
SW1710,sirolimus-bortezomib (250-1 mol-mol),0.811654459506224
EB1,73707398,0.2172431300056034
COLO 829,11396600,3.5925898800882856
SNU-620,135421197,2.4250401955395984
BT 333,262093,2.471436519213189
SF268,375860,0.7372350800509891
Namalwa,637858,0.9589719241333216
BT-16,3689413,5.62862969112265
SNU-410,73707398,2.675607708519287
ZR-75-1,11396600,4.04408078338515
Calu-1,54596490,4.459626115799054
KMS-34,107970,1.9427085752985964
DMS 114,100016,6.89872652787532
KP-N-SI9s,12003241,-1.3670670210068214
FU-OV-1,637858,1.762395691671764
Li-7,tanespimycin-bortezomib (250-1 mol-mol),-1.0040061775367006
ST486,375860,-0.5687373512355877
A2780,71466445,2.121500658196736
WSU-DLCL2,sirolimus-bortezomib (250-1 mol-mol),-6.394861252001346
BT 271,11396600,2.12554769286952
OVTOKO,9903786,2.0414174754656544
MM1.S,12003241,-0.8577985614667851
DMS 53,262093,1.90510022371224
BT 172,54596490,4.427470913675516
TE-11,262093,3.7294474830562336
RCH-ACV,sirolimus-bortezomib (250-1 mol-mol),0.6092850769346084
HCC1419,73707398,1.4255015605860972
TALL-1 [Human adult T-ALL],3689413,-2.1948693605087577
AML-193,49766530,-0.6507980760292754
NCI-H747,241158,4.314424044876157
IGR-37,selumetinib-JQ-1 (4-1 mol-mol),0.4307789680425182
WM983B,6852167,3.582375315492635
U-251MG,6852167,3.572430046092572
KP-N-SI9s,135999136,3.2804622409589252
SK-OV-3,selumetinib-JQ-1 (4-1 mol-mol),5.055306733015199
SW1088,44491742,4.15883159123132
RERF-LC-A1,439501,-2.669244370935075
SHP-77,11455910,0.1077676986814373
COLO 800,135398744,6.478150217692287
Ku812,46907787,-1.7178287271779615
SK-HEP-1,49766530,-2.8567737760804324
Kasumi-1,46907787,-2.5065753473574786
MKN74,6852167,3.3368691353125604
CAL-51,49766530,0.4609697007955676
BT 428,11396600,2.03305192481219
Ci-1,49766530,-2.656825005830753
NCI-H889,375860,-0.3028496531572372
SUP-HD1,107970,0.5759861128041995
SNU-C4,49766530,2.185419725240328
NCI-H838,9903786,3.3354692149309124
SK-N-FI,9903786,1.217997719739724
TE-9,73707398,1.6638503318233642
RCC10RGB,135421197,4.393109316582631
KYSE-450,6852167,3.693304163934065
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012
TOV-112D,sirolimus-bortezomib (250-1 mol-mol),0.8859708240687075
BT 330,3689413,-2.329423623315505
MM1.S,selumetinib-JQ-1 (4-1 mol-mol),-0.6106024148084398
COLO 829,135421197,3.0893974148285466
JHUEM-1,11396600,2.4949940260593872
SNU-182,26596,-1.9870021319207585
KMRC-2,262093,3.029643780288338
OVISE,selumetinib-JQ-1 (4-1 mol-mol),1.7685285533186823
BT 440,11455910,0.0350443808128442
Karpas-422,135999136,3.6937273176122294
GSS,sirolimus-bortezomib (250-1 mol-mol),-2.7575012848094147
SNU-81,3689413,1.1974270464491454
MeWo,44491742,4.0764207569550255
Mino,135398744,6.764750512167438
WM266-4,71466445,3.9835521920439625
PK-45H,49766530,-0.0429860028998506
LNCaP clone FGC,54596490,4.35808730811733
639V,sirolimus-bortezomib (250-1 mol-mol),1.801043547803399
SW1088,637858,2.4464344152719817
KLE,9927531,4.8057879583658405
HCC202,439501,-1.9855042257832605
M-07e,44491742,3.818170293843834
SW948,262093,3.1804911198162036
AML-193,44491742,3.5122021187729184
SCC-25,135421197,1.688972609410465
Lu-99,selumetinib-JQ-1 (4-1 mol-mol),1.3184696740871884
DMS 114,5460769,0.4207237171136718
NCI-H1299,241158,3.1343803063940996
Kasumi-2,100016,5.973936097539331
YD-10B,11396600,-4.483822340213775
ESS-1,135999136,4.050088319286221
TF-1,135421197,2.0817745254871216
K029AX,sirolimus-bortezomib (250-1 mol-mol),0.2512522437134671
SUP-T11,262093,-0.249572082043469
5637,12003241,-2.3897344760826775
KYSE-140,10231331,3.095458864415077
Ku812,6852167,2.7508092991832016
EBC-1,262093,3.282088123658991
BT-549,439501,-3.1266914034371567
HuH-6,12003241,-0.3879852820159472
SK-BR-3,11455910,1.4950616471057503
NCI-H2286,439501,-0.7884333546830701
YD-15,3689413,2.243668996765499
EC-GI-10,sirolimus-bortezomib (250-1 mol-mol),2.282726808437879
SNU-398,5460769,0.8679915096242241
SNU-C5,6852167,1.7928485717828972
Karpas-299,375860,-0.8505024577562622
CAL-120,selumetinib-JQ-1 (4-1 mol-mol),1.9222647739332688
KNS-62,3689413,1.1853258222695242
KE-97,49766530,-2.2252000601337456
HuT 78,637858,0.0090449520272635
MOLP-2,tanespimycin-bortezomib (250-1 mol-mol),0.214791737845908
KMBC-2,UNC0638-navitoclax (1-1 mol-mol),-0.2443441372437479
KE-37,100016,3.280443906920473
Calu-6,6852167,4.13886535210474
HPAF-II,135421197,2.4273877762947933
JMSU-1,637858,1.632608270796334
OV56,135398744,6.336681474599488
HCC2935,9927531,5.26637836845999
L-428,241158,3.279588979368862
OCUM-1,439501,-1.255627556410841
G-401,49766530,-2.7444300270308113
GDM-1,6852167,1.5690648286355753
NCI-H2286,241158,1.56895022845318
MES-SA,3689413,1.9720850460136523
AGS,73707398,1.7385666104641533
KMS-18,11455910,-0.1916352786292855
LoVo,439501,-1.7683171506776545
MG-63,241158,3.962785624190749
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263
TE 441.T,107970,1.1503901417213285
DB,11455910,-0.1853401051603744
NCI-H1355,10231331,5.5582513930919255
JHUEM-2,sirolimus-bortezomib (250-1 mol-mol),-3.6728570307591686
EB1,26596,-3.5599614403908264
COLO 201,46907787,3.5696726017009364
5637,9903786,1.5217427141278097
C2BBe1,439501,-3.497031397635042
CHP-212,12003241,-2.3110623292084695
LN-229,73707398,0.9368457509516706
BHT-101,9903786,3.039821260092269
HCC366,5460769,-0.0088365115150554
QGP-1,9903786,2.781324092534045
ChaGo-K-1,3689413,-1.075301905965469
MKN1,6852167,2.386061639562249
REC-1,9929138,7.294165808460384
HCC1419,6852167,1.0857417323628011
Ishikawa (Heraklio) 02 ER-,135421197,3.044962376223266
SNU-245,3689413,-1.9631171858613183
639V,262093,3.248167953384808
Fu97,26596,-2.255904398728495
SiMa,439501,-2.281270120889317
MOLP-8,selumetinib-JQ-1 (4-1 mol-mol),-0.4981022967817401
A-549,100016,7.181380121169662
BT 428,100016,4.306836909333982
WM88,3689413,-2.428480680194512
KYSE-510,71466445,4.893287749594832
KE-97,9903786,1.2492215046339803
JHH-5,44491742,3.8169087988503705
SNU-8,6852167,2.9028412896879856
SU-DHL-10,168313016,3.668325026898756
Lu-65,44491742,4.485926174539046
D283 Med,49766530,-3.2280701678526853
KALS-1,72967,3.838723057282731
NCI-H1703,tanespimycin-bortezomib (250-1 mol-mol),-3.1681297716810692
DND-41,46907787,-0.7130087499349617
CAL-62,tanespimycin-bortezomib (250-1 mol-mol),1.0619884321927937
MDA-MB-361,107970,1.8583499456777055
SU-DHL-1,375860,-0.8487932986720208
DMS 454,49766530,-1.744731880816356
SK-LU-1,selumetinib-JQ-1 (4-1 mol-mol),1.493691888542625
OV7,375860,-0.1349693061548985
NCI-H1184,3689413,-2.309621936722181
HCC2108,6852167,3.7271551469098583
IGR-37,135999136,4.421370905538769
CAL-62,107970,2.231851938620399
KP-3,5460769,4.226589336768475
KCL-22,262093,2.312361441448963
Mono-Mac-1,136227331,4.247854438913471
Lu-99,3689413,0.965763177110082
BT 422,135421197,2.465319301073433
KYSE-520,241158,6.053168866324876
LOX-IMVI,375860,0.0693454409370285
BICR 6,12003241,-1.5069556465481264
BT 248,12003241,-0.5635987052840526
Hs 852.T,11455910,5.310115560593476
HuP-T3,262093,3.018266583248783
KMS-11,107970,1.1628859556901452
HCC366,49766530,-0.9103930727197836
NCI-H526,sirolimus-bortezomib (250-1 mol-mol),1.536405299935234
SHP-77,73707398,1.2877058560034058
HPB-ALL,73707398,0.3017873739761496
SNU-685,241158,4.033832085823602
SK-N-FI,241158,3.5219656608107455
SCaBER,107970,2.2401170615425676
Kuramochi,11396600,4.221456275944083
K029AX,11455910,1.0219454107172774
SNU-182,375860,-0.5806496982631392
NCI-H1573,tanespimycin-bortezomib (250-1 mol-mol),-1.6539350682626517
KMS-28BM,12003241,-1.6881209255451883
Capan-2,11455910,0.6528691404413365
NCI-H1694,71466445,1.7909324236099655
BCP-1,54596490,3.9190164950711313
CAL-27,selumetinib-JQ-1 (4-1 mol-mol),-0.7476694829756971
Ri-1,73707398,0.2154037021026328
NCI-H2405,107970,2.773049051835492
KMBC-2,6852167,2.897354350199853
SK-N-MC,selumetinib-JQ-1 (4-1 mol-mol),1.3987408852467555
BT 416,26596,-1.7367305778393065
LOX-IMVI,262093,3.0192087839524433
G-401,11396600,3.403558125152034
NCI-H446,6852167,1.7003239210515226
Kelly,46907787,1.489260374833201
NCI-H929,9927531,5.740923779315927
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351
SNU-466,71466445,6.314226176026475
T98G,3689413,-0.3099040936553002
BT 145,241158,3.5624759873716685
Caki-1,tanespimycin-bortezomib (250-1 mol-mol),2.360215695891997
CW-2,71466445,2.6360954099135516
IGROV-1,168313016,4.807199318661473
SK-LU-1,46907787,2.3105401780799917
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968
JMSU-1,11396600,3.5882148906168254
Ku812,tanespimycin-bortezomib (250-1 mol-mol),-1.4793309547353497
SNU-466,135421197,3.5326251478471877
DB,135421197,1.3227021747573118
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286
HH [Human lymphoma],11396600,2.7706503807111575
NCI-H647,135398744,6.542739498462596
PE/CA-PJ41 (clone D2),73707398,2.4931970679708972
NB1,71466445,1.9975246726713645
HCC1569,tanespimycin-bortezomib (250-1 mol-mol),-0.2642860947186173
Lu-99,9903786,2.034349953938994
SW620,tanespimycin-bortezomib (250-1 mol-mol),-2.1840810190060287
COLO 684,135999136,3.371101164094913
NCI-H2029,241158,4.340377347526191
NUGC-4,9903786,1.3800210436357438
KE-37,3689413,-1.780022958661614
SK-LMS-1,3689413,-2.0473825870324935
HD-MY-Z,136227331,3.950603619388181
Hs 766T,262093,3.5846417811943514
769-P,46907787,0.4584238337470808
KHM-1B,sirolimus-bortezomib (250-1 mol-mol),0.0402110157809841
J82,12003241,-0.1407716325694316
SK-N-DZ,46907787,1.653220614467886
HGC-27,262093,2.210004437321543
WSU-DLCL2,46907787,-1.3675142639317148
NB4,135999136,1.7804254957800154
TOV-21G,tanespimycin-bortezomib (250-1 mol-mol),-2.720450448840342
CA46,selumetinib-JQ-1 (4-1 mol-mol),0.1147444107016205
GDM-1,11396600,3.1168819453439895
TF-1,5460769,4.30978412133691
LN-18,sirolimus-bortezomib (250-1 mol-mol),1.6485166407126024
SU.86.86,644241,3.4785053193371716
Kuramochi,6852167,3.266960226178628
SUP-T1,11455910,0.2462561508535602
PK-45H,sirolimus-bortezomib (250-1 mol-mol),2.3044458204241014
BC-3C,44491742,3.863176048034213
Hs 944.T,44491742,4.471544496147254
HCC827,44491742,3.1413058075131746
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
769-P,tanespimycin-bortezomib (250-1 mol-mol),0.3785474363326266
GMS-10,135421197,1.564647859858216
KNS-81,46907787,4.401803452784797
LS180,135999136,4.321194581518088
NCI-H2196,11455910,0.991466046593156
SNU-685,107970,1.9143619661744995
CMK,439501,-2.5697505618969547
PK-59,135421197,1.5554330287724354
COLO 792,73707398,0.9576418558919108
Daoy,selumetinib-JQ-1 (4-1 mol-mol),1.1027213311180792
Kelly,107970,2.1359224191736796
HEC-151,5460769,2.7656616945667
WM115,12003241,-3.303596686294694
Ci-1,5460769,3.784060470776022
SK-BR-3,107970,1.6836850193480015
NCI-H2122,375860,-0.2915668084843835
MDST8,375860,-0.0509298762434446
P12-Ichikawa,5460769,2.2031078708702196
MOLT-16,44491742,3.707485326024471
SK-N-FI,375860,-0.8042006203726739
JHOS-2,3689413,-2.497853898445669
BT 245,3689413,-2.318316316051159
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
SNU-668,10231331,2.5432829605574296
GB-1,637858,2.4866943846346072
RPMI-6666,71466445,2.5937687881604106
Caki-2,3689413,-0.1901377653832866
SH-10-TC,9903786,4.254901914328344
KMRC-2,10231331,3.7445529235865895
NCI-H196,3689413,0.3068410473600975
SNU-387,46907787,2.091267871629519
Hs 729.T,5460769,4.220142900655458
SK-LMS-1,tanespimycin-bortezomib (250-1 mol-mol),0.2402445839028043
NCI-H2444,10231331,5.176218450399146
NCI-H226,241158,5.093875853874048
SW48,10231331,-2.95597966611556
KMM-1,107970,3.424252998103548
LNCaP clone FGC,11396600,3.414051330907707
BV-173,selumetinib-JQ-1 (4-1 mol-mol),-6.492404008680617
NCI-H2444,11396600,3.7702875929264312
MFE-319,3689413,0.3953423105508483
DLD-1,6852167,3.5764523935832835
NCI-H647,71466445,5.041902875168557
HSC-2,637858,1.3679707411899185
HCT 116,12003241,-0.2623292503702257
TF-1,637858,1.984492436193965
Hs 746.T,135421197,2.8198811275725206
SEM,168313016,1.967017226052083
OVCAR-5,11396600,3.059623725203541
VMRC-LCD,49766530,-0.8677922390975771
JHH-6,sirolimus-bortezomib (250-1 mol-mol),2.5293285021396277
Ri-1,168313016,3.43203331304281
M059K,sirolimus-bortezomib (250-1 mol-mol),0.4105527890909189
EN,73707398,2.277883684245818
G-402,11396600,2.964823639578594
DAN-G,71466445,4.655647233867882
HEL,12003241,-0.3954740832299299
SNU-119,107970,2.4008728686512617
NCI-H2291,637858,3.0474829746086143
RPMI-6666,44491742,4.997277859824789
MOLM-6,168313016,3.368219114502854
OC 314,11396600,2.739817011792775
IST-Mes1,6852167,3.791716512628995
T24,44491742,4.439042191378119
A101D,sirolimus-bortezomib (250-1 mol-mol),0.247462078551585
NCI-H838,12003241,-1.6819169768090954
SIG-M5,3689413,0.233032105010129
SW48,selumetinib-JQ-1 (4-1 mol-mol),-4.010422232345994
JM-1,241158,1.7269305863155773
SUP-B15,9927531,5.1368052730530955
Rh18,637858,1.8172408807578415
NCI-H647,135421197,2.605948730624533
TE-15,241158,3.84144022719984
WM266-4,241158,3.707551482011516
SNU-8,3689413,-3.353074674655615
COLO 205,10231331,-0.6755418094368107
G-361,637858,1.6464472873206493
RPMI-6666,73707398,1.0548607195564614
JHH-6,107970,3.118262680815441
A4/Fukuda,262093,3.0357368226896178
JHUEM-2,10231331,3.01921809921647
COLO 320,100016,4.196375737127383
NCI-H1155,46907787,-0.1423458632521134
NCI-H2030,135999136,3.784787341236107
EHEB,71466445,3.460498363916868
TUHR14TKB,136227331,4.279193413134127
HEL 92.1.7,9903786,1.7249056875700772
JHUEM-7,241158,3.726297808510672
SNU-466,107970,2.321869103591275
HH [Human lymphoma],375860,-0.7625107237877107
SNB-75,107970,2.331230517757488
HCC2218,11455910,0.1685104412294276
SU-DHL-8,12003241,-0.8632235676270862
SW579,168313016,5.7122133299462945
HLF,UNC0638-navitoclax (1-1 mol-mol),2.5473541790811347
SW1710,26596,-1.5930178898936072
Hep-G2,439501,-0.8010222698535624
OVCAR-5,sirolimus-bortezomib (250-1 mol-mol),0.9753915222823988
HeLa,637858,2.5742998662874035
MHH-CALL-3,135421197,1.4359965769543697
IGR-37,26596,-1.7212662992488197
SK-MES-1,selumetinib-JQ-1 (4-1 mol-mol),1.35020527717367
NCI-H1184,46907787,0.1164433785764037
SK-MEL-3,73707398,1.6754793187128854
HCC2935,54596490,4.468988893625454
TE-8,10231331,3.463708070242339
LCLC-103H,135421197,1.2256317024766628
KMS-12-BM,44491742,3.489197811217823
JHUEM-2,11396600,2.4680372971734372
ONS-76,26596,0.1332187247782509
YD-8,selumetinib-JQ-1 (4-1 mol-mol),3.141432259202229
NCI-H1395,375860,1.7808246881173873
DBTRG-05MG,241158,4.845918295723135
OAW42,107970,2.320375917331678
NCI-H1581,135999136,1.6076711322789656
AM-38,439501,-2.2075146927882177
HH [Human lymphoma],UNC0638-navitoclax (1-1 mol-mol),1.1119627302728434
ES-2,375860,0.1597186252009672
WM983B,637858,2.6617865393922906
JHUEM-2,tanespimycin-bortezomib (250-1 mol-mol),-2.8441025270456097
SCC-4,241158,1.6483761097046987
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
SNU-620,44491742,4.13195678155616
PE/CA-PJ49,262093,3.242343498921695
MKN74,73707398,1.2954691116779045
CGTH-W-1,5460769,2.937857230001596
KP-N-SI9s,46907787,0.1114546179566314
COR-L105,49766530,-0.5480688242609842
NCI-H1395,11396600,4.124168749082167
ONCO-DG-1,73707398,0.7313986398814263
H-STS,439501,-3.713409181758543
PK-45H,135421197,3.006684170238441
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626
NCI-H1155,375860,-1.1401166336200168
SK-N-FI,107970,1.709574109633146
YAPC,5460769,2.316930709954587
NB4,26596,-4.43915063636903
FTC-238,46907787,2.062040520622944
Pfeiffer,9903786,-0.8773679724419216
CJM [Human melanoma],UNC0638-navitoclax (1-1 mol-mol),3.5668679369825074
Karpas-620,selumetinib-JQ-1 (4-1 mol-mol),4.807986755393626
BT 179,9903786,4.337350994333445
RKO,9903786,4.184024439899693
HCC78,71466445,3.2271775960204465
JHUEM-1,12003241,-0.7244634318456832
PK-59,73707398,1.1955784126278513
BV-173,168313016,3.577674079165387
JHUEM-3,49766530,1.26691736539767
HuNS1,tanespimycin-bortezomib (250-1 mol-mol),-0.352087837441777
NCI-H1944,6852167,2.052569965143729
J82,11455910,0.4504251564245444
OUMS-23,44491742,3.6829653315357818
EBC-1,73707398,0.9440582877963352
NCI-H2170,644241,3.042503926939871
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688
JM-1,100016,5.094244415703564
KMS-12-BM,12003241,-2.27657533610394
YD-38,168313016,6.308402556942436
GP2d,selumetinib-JQ-1 (4-1 mol-mol),-0.6768305872482345
SNU-308,9877608,6.965514964870985
KU-19-19,10231331,0.2937024112037242
NCI-H520,26596,-1.7163548151943342
COR-L51,71466445,3.319982023980898
RT-4,439501,-1.136247834932354
BT 216,46907787,3.9063812539976386
SNU-840,tanespimycin-bortezomib (250-1 mol-mol),2.584361399969364
LN-18,9929138,4.994470479876054
MIA PaCa-2,135999136,4.438724153803844
SK-N-SH,241158,3.663182891539546
Li-7,100016,6.9157107863456915
NCI-H841,135999136,1.3609604707232876
DMS 53,375860,0.9049082693788552
SNU-503,tanespimycin-bortezomib (250-1 mol-mol),2.9801728047374527
RVH-421,49766530,0.507430038024508
BHY,UNC0638-navitoclax (1-1 mol-mol),4.480092938546525
LCLC-103H,71466445,3.510295389264131
NCI-H460,100016,5.855223104671776
LoVo,71466445,2.646256567071358
SK-LMS-1,73707398,1.7151608604294482
Hs 746.T,135999136,4.038871397264603
L-1236,46907787,2.216652350556167
647V,439501,-2.3476085577035506
KMS-27,375860,-1.142960082705596
NCI-H1105,sirolimus-bortezomib (250-1 mol-mol),0.3147728445720161
SK-ES-1,135421197,0.934110711885636
FaDu,selumetinib-JQ-1 (4-1 mol-mol),1.1902235075273182
MKN1,3689413,-2.0686117581954537
BC-3C,375860,-0.2868729036934795
TOV-112D,241158,3.7158318737048655
SNU-C4,11455910,3.771721357690206
NOMO-1,6852167,1.234836949550939
SK-LMS-1,sirolimus-bortezomib (250-1 mol-mol),0.2757332914045335
CAL-120,UNC0638-navitoclax (1-1 mol-mol),1.6079379957846396
BT 286,10231331,-1.310629484482038
KMS-11,46907787,-2.444202993147214
CL-11,12003241,-0.9595086367475664
GSU,selumetinib-JQ-1 (4-1 mol-mol),-0.4114270930139164
HMCB,444795,4.365001038195376
SNU-46,73707398,1.3670817300424394
WM115,135421197,2.9135607351561883
CAL-78,241158,3.39668217489539
OV7,tanespimycin-bortezomib (250-1 mol-mol),-1.2936042067435187
CMK,26596,-3.6157989534219497
U-BLC1,sirolimus-bortezomib (250-1 mol-mol),-1.829710592484544
Hep 3B2.1-7,135999136,2.2984722485990567
Detroit 562,49766530,-0.0466351352244022
ESS-1,44491742,4.277473074701454
BT 216,107970,1.6739180929917945
SNU-5,49766530,-2.0910598582068776
KMBC-2,tanespimycin-bortezomib (250-1 mol-mol),0.8255558863308646
OCI-M1,135999136,1.5304010424247585
DMS 114,9927531,5.183306198807951
PL-21,439501,-2.414753232425099
NCI-H2052,262093,2.885672555371676
Fu97,71466445,1.7619679258294287
SCaBER,241158,3.991461020169345
OCI-Ly19,637858,0.9883844033130186
VMRC-RCZ,tanespimycin-bortezomib (250-1 mol-mol),0.3038563935305308
NH-6,49766530,-1.655296315308959
JHUEM-1,135421197,1.216827050882974
BT 228,439501,-2.264868941994625
SNU-626,107970,2.4650135190130817
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719
SK-MES-1,444795,5.062530202812243
NCI-H1915,107970,2.322652332824797
MOLP-8,26596,-2.4791577040777812
OAW28,UNC0638-navitoclax (1-1 mol-mol),1.4894889011779118
SK-BR-3,26596,-2.188814054378237
SU-DHL-1,73707398,0.2992121771474305
CHP-126,sirolimus-bortezomib (250-1 mol-mol),1.5217609730856023
Hs 944.T,9927531,3.41915171718772
Hs 683,644241,2.1182711597047277
MV4-11,11455910,0.2618062537213718
COV362,sirolimus-bortezomib (250-1 mol-mol),0.7278420573421237
SNU-C5,637858,1.288200676644884
BT 232,3689413,-0.4723000491663335
IST-Mes1,637858,2.1376990366589905
COV434,12003241,-2.0451557846060537
NCI-H1869,selumetinib-JQ-1 (4-1 mol-mol),1.6697033595632398
NCI-H1184,71466445,-0.0738213816478361
HLF,637858,2.3340457243469905
LCLC-97TM1,49766530,0.6419783818490065
KMS-34,11455910,-1.0188772923185183
IMR-32,439501,-2.4799025778743884
SW1990,44491742,4.13198674266079
TE-11,241158,4.108940957136676
FTC-238,tanespimycin-bortezomib (250-1 mol-mol),0.0088820138944574
CAL-12T,107970,2.601314081604761
SNU-761,107970,2.2170986122907177
SBC-5,3689413,-0.1482568941323282
NCI-H841,54596490,4.447927326498449
PE/CA-PJ34 (clone C12),49766530,5.059286998332617
KYSE-70,71466445,4.079477869375345
EBC-1,tanespimycin-bortezomib (250-1 mol-mol),-3.429772106953884
HCC2108,107970,2.525568270617478
SNU-1077,73707398,1.6899308948113645
BT 482,3689413,0.1224003168777627
UACC-62,9927531,5.07743176976165
C2BBe1,11455910,0.6579710467185694
JVM-3,107970,1.9172884284374956
HeLa,241158,4.038975399720051
MIA PaCa-2,tanespimycin-bortezomib (250-1 mol-mol),-3.0154822613403898
MOTN-1,444795,4.717239973457594
U-BLC1,73707398,0.5348084909882532
KE-39,54596490,4.684539429557116
DU145,44491742,3.929497920305024
DV-90,49766530,1.92724859659278
HEC-59,262093,2.7698106992927007
PK-1,6852167,3.144204149712558
U2OS,9903786,2.225601394928473
Rh41,135999136,4.307553129612744
RPMI-6666,6852167,1.0949232019863977
HT-55,selumetinib-JQ-1 (4-1 mol-mol),0.079312954019081
IST-Mes1,241158,4.374014389295604
NCI-H1869,12003241,-1.5114527115730307
L-428,9927531,4.649182566177492
KMS-34,644241,0.6843791574877399
L-428,637858,0.9506850141037074
VMRC-RCW,107970,2.4523848142824924
EFM-192A,26596,-0.8945052736311969
Reh,73707398,0.2688632485358125
JHH-6,11455910,3.965766048623887
Yamato-SS,262093,2.7505818299570897
KP-2,107970,2.7210126732046995
IGROV-1,26596,2.910298792762654
BICR 22,107970,2.71438120007047
AGS,262093,2.7795414492690953
Detroit 562,73707398,1.0205294862246352
NCI-H2085,73707398,1.0923484245076107
JHOS-2,49766530,-2.972328777920352
MHH-NB-11,375860,-1.167115758317035
BT 172,644241,2.6400684779055448
KG-1-C,11455910,4.990169857060823
U-BLC1,tanespimycin-bortezomib (250-1 mol-mol),-2.071210678838922
MOR/CPR,71466445,4.247289487065976
MSTO-211H,135999136,4.2061059176098645
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
K029AX,135398744,6.420759462552213
PSN1,11396600,2.760096793353625
NCI-H520,444795,5.008670344858
ST486,439501,-3.700540877794945
SNU-201,3689413,-1.5340531054377644
PSN1,tanespimycin-bortezomib (250-1 mol-mol),-1.4884042212108968
8-MG-BA,44491742,6.487107858540147
KMS-21-BM,241158,1.877362835227471
JHUEM-1,10231331,4.962562844927884
JL-1,262093,4.749807355253156
BT 504,375860,-0.0376175483747626
HLF,26596,-1.3271956114296155
KNS-81,107970,3.224010672626954
SYO-1,135999136,1.963149298158808
GI-1,107970,1.763597971813926
MDA-MB-468,262093,2.5828402827919064
IPC-298,637858,2.0731770893558954
NCI-H2126,135421197,2.0437497253057137
MDA-MB-468,100016,5.725845417349072
Hs 940.T,11396600,4.001977527096724
NALM-6,375860,-0.5746489324982738
Mino,6852167,1.220926429953778
HEC-59,12003241,-0.4049011737939335
J82,262093,3.090491521434039
NCI-H1623,5460769,3.63452416726077
RL95-2,375860,-0.928474794655752
LoVo,107970,2.0597080136849795
Panc 04.03,9927531,5.313421559596226
RCH-ACV,107970,1.9405981464406723
MOR/CPR,11455910,1.2367157670420523
IMR-32,3689413,-3.464498060379514
NCI-H322,9903786,4.921113869322727
MKN45,107970,3.2436851115973035
JVM-3,135999136,1.5770128380468875
HT115,444795,4.63817892392484
SK-MEL-5,107970,3.0501102581579977
HEC-59,241158,3.2385648758912904
SR,637858,1.3694084425594049
SNU-398,46907787,3.965707936652475
IGR-39,375860,-0.5520797955328177
KYSE-150,selumetinib-JQ-1 (4-1 mol-mol),3.5614174256580187
MM1.S,73707398,0.3713750235386087
Granta-519,46907787,0.1510211143130647
Hs 822.T,49766530,-2.239699786404697
KNS-60,135999136,4.651096577413856
RPMI-6666,100016,5.822007631719843
MHH-CALL-4,107970,1.5226905124680885
SUIT-2,73707398,2.4448376326021313
SU-DHL-4,9903786,1.90197998733756
SNU-1041,439501,-2.4187407213181085
JHH-1,439501,-0.896844817014076
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711
COLO 678,241158,4.15604357395598
WT2-iPS,10231331,-2.6099308614640417
LXF 289,73707398,1.5723760999376108
NCI-H1944,UNC0638-navitoclax (1-1 mol-mol),0.8826171881767358
MG-63,73707398,1.4753017703355924
COLO 792,9903786,2.6845883070851277
ECC10,136227331,5.843658104512461
YD-10B,26596,-1.4003119054370567
KMS-27,46907787,-0.4980850656291734
786-O,49766530,-1.7436393019266725
LN-229,9927531,7.375456166440614
BT-12,262093,3.0128893223100333
Hs 746.T,107970,2.1679941354436196
Caki-1,6852167,4.352231289432342
SK-CO-1,11396600,4.255124433433546
KMS-28BM,637858,-0.0987535237113853
Detroit 562,5460769,3.1492937743842724
HSC-4,12003241,-0.0373048915881231
A-549,135999136,3.721733527600953
RPMI-6666,11455910,2.3485395047161783
MHH-CALL-3,UNC0638-navitoclax (1-1 mol-mol),0.1946854000145928
SK-ES-1,5460769,0.8929417744322142
Hs 578Bst,9927531,5.122326242765859
KMS-11,tanespimycin-bortezomib (250-1 mol-mol),-4.691870791647551
TE-15,sirolimus-bortezomib (250-1 mol-mol),0.9127775689721958
TTC-709,11455910,-0.0853911997786654
TALL-1 [Human adult T-ALL],9903786,1.5190576712457438
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478
NCI-H810,375860,0.3770517333677842
CML-T1,9903786,2.526700219209825
BT 422,241158,4.557316478619076
SNU-489,11455910,3.799785050507332
LCLC-103H,5460769,4.406822689547097
TE-8,26596,-1.186583847807299
IGR-37,439501,-2.841973609481132
SK-N-AS,26596,-3.589406361417691
HCC1143,11455910,1.411815978618001
NU-DHL-1,262093,0.667372891927881
Lu-65,sirolimus-bortezomib (250-1 mol-mol),1.2427816713041802
NCI-H2286,100016,5.552985583261177
NCI-H2087,44491742,3.6695473170739583
Ki-JK,73707398,-1.0738345642120612
MHH-CALL-4,UNC0638-navitoclax (1-1 mol-mol),-1.5087642797213563
NCI-H1563,100016,6.550294719377214
LUDLU-1,262093,4.588998578428556
OE21,9903786,3.8183922804943298
JHH-5,136227331,4.11271540989167
Hs 729.T,439501,-2.5302940667967695
KNS-62,tanespimycin-bortezomib (250-1 mol-mol),-0.0918486546852887
HCC1500,262093,2.85046563878574
SUIT-2,10231331,3.5504785260208473
TE-6,26596,0.4120128768036302
SW1990,71466445,5.525497338974383
HCC95,439501,-2.2206191561813537
Mel Ho,107970,2.382821676365672
TF-1,168313016,4.574809025929095
DV-90,439501,-2.858386639088026
SUP-B15,26596,-1.8657043517312688
42-MG-BA,selumetinib-JQ-1 (4-1 mol-mol),2.1771764634536734
PC-3,73707398,4.033617880786533
SW1088,3689413,0.8885196557801914
Capan-1,71466445,6.280411506729028
OV7,5460769,0.8621725528933663
A-172,71466445,4.063203501420166
PaTu 8988s,3689413,2.020164099747706
AGS,tanespimycin-bortezomib (250-1 mol-mol),-1.1617791040203864
HSC-2,44491742,4.345443441235533
CAL-33,107970,2.1111978025436797
HEL,168313016,4.358661125075543
NCI-H1869,637858,2.4827908237252183
SNG-M,168313016,5.345031475904297
OVISE,107970,3.0608588072726444
Ki-JK,71466445,2.2114493223689693
MOTN-1,100016,6.2802968176710445
PF-382,439501,-2.5741395884768377
SNU-1079,439501,-2.542024376307003
TE-4,72967,3.69473331553554
SIG-M5,73707398,0.4222046163414817
MDA-MB-415,107970,1.9761217126753423
F-36P,tanespimycin-bortezomib (250-1 mol-mol),-0.3225177069442169
NCI-H292,241158,3.585722962787503
RERF-LC-Ad2,selumetinib-JQ-1 (4-1 mol-mol),5.304471125852225
KATO III,135999136,4.4010537882468785
WM983B,tanespimycin-bortezomib (250-1 mol-mol),0.7695231376052774
MOLM-13,46907787,-1.536709398859376
PaTu 8902,selumetinib-JQ-1 (4-1 mol-mol),5.2969208566894075
OS-RC-2,3689413,-2.40669101710066
CAL-12T,selumetinib-JQ-1 (4-1 mol-mol),6.071710843361034
OV7,44491742,4.062871601608624
SCC-25,439501,-2.292727593069412
RKO,6852167,3.601912647929868
RCH-ACV,11396600,2.874378489903408
SCaBER,3689413,-2.276836963642964
OE21,73707398,1.45276102032063
JHUEM-3,12003241,-2.0090653802187197
RERF-LC-A1,6852167,3.5109914497052928
IST-Mes1,439501,-2.4971864822052767
NB4,46907787,-0.9478840081863982
HCC366,44491742,5.047439553601353
SNU-449,135421197,1.7191553190938056
NCI-H2087,135999136,4.85845906429525
SF268,444795,4.01418198594817
HT-1080,637858,1.7356668622045788
Hs 294T,6852167,2.030444131876515
SNU-761,tanespimycin-bortezomib (250-1 mol-mol),1.2423836146793283
MeWo,107970,1.9752107373732688
BxPC-3,5460769,-0.1362128387149436
CGTH-W-1,107970,2.906028593305823
IGROV-1,135421197,1.96820638017286
LN-18,9927531,5.697950654725697
COR-L51,5460769,2.8872461015254913
JJN-3,9929138,7.196831688264381
SUP-T11,637858,1.0076857486222597
SK-N-BE(2),46907787,-0.3861436275691191
LS180,100016,6.005443229591697
KMS-12-BM,6852167,1.232935409292076
HT-1197,107970,2.1985623382097574
IPC-298,73707398,0.9731823872438464
G-292 clone A141B1,12003241,-1.351842997684689
DMS 454,637858,1.6809233286791794
COLO 800,11396600,4.874134738718471
THP-1,9903786,3.0926145703043852
Yamato-SS,637858,2.139067108128219
NCI-H647,9929138,4.265521593960728
U2OS,439501,-2.693554795919347
NCI-H841,26596,-2.5240216748283393
HOP-62,135421197,0.8812919220198131
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393
HCC1171,3689413,-1.743559773321706
Lu-99,26596,-1.1176086778994336
DU145,5460769,5.167808415466422
SNU-81,73707398,1.1294477244846828
Ishikawa (Heraklio) 02 ER-,262093,3.584751515027739
NCI-H2444,439501,-0.8074653551260249
SKM-1,selumetinib-JQ-1 (4-1 mol-mol),-3.5716961442559496
Mono-Mac-6,5460769,2.7333685745073457
KM12,375860,-0.5085253136640141
BT 440,46907787,5.667511206840828
KHM-1B,tanespimycin-bortezomib (250-1 mol-mol),-0.3010055650508828
HuP-T3,5460769,4.291069487745317
KMRC-3,637858,0.9671022653811864
NCI-H526,3689413,-2.6230284067277725
BT 216,11396600,1.9603911758569217
SH-4,11396600,5.060968167282413
NCI-H508,3689413,-2.320337530403156
NCI-H1105,135999136,3.2946052044715737
DOV13,71466445,6.3474763334075615
MDA-MB-157,9927531,5.35009923211275
T84,tanespimycin-bortezomib (250-1 mol-mol),-1.3994092588399578
RL95-2,46907787,0.5712988396817201
SNU-119,3689413,-2.887862499697321
HCC-56,135999136,4.45483812083689
COR-L279,439501,-3.5163381606181243
HCC1438,9927531,4.9957520851932955
T98G,6852167,2.9321470861606533
SW579,262093,3.2995610578191683
GDM-1,9929138,5.504057309727688
NB4,5460769,1.5499271806248969
TOV-112D,439501,-4.317689883213593
SK-MEL-1,12003241,-1.7363712573149035
SET-2,73707398,0.747643412090769
KMBC-2,44491742,4.484748547607026
Karpas-422,262093,3.033308575813637
Hs 578Bst,11455910,1.5492426268686
SK-MEL-30,sirolimus-bortezomib (250-1 mol-mol),1.4325338004264097
OAW28,135421197,1.4901490212875883
JVM-3,439501,-2.5078633176007803
RPMI-8226,168313016,3.4366235502594007
YKG-1,49766530,1.555111020821771
EFM-192A,44491742,3.8805374650465905
SNU-213,135421197,2.2792835673188687
COLO 668,26596,-1.2429093822877924
5637,135421197,1.1694761088255747
CAMA-1,439501,-1.1821357093397586
MV4-11,46907787,-2.893360076838023
PE/CA-PJ34 (clone C12),637858,1.319722583622998
Ri-1,11396600,2.305014362827753
NCI-H520,644241,4.472644159305388
ST486,168313016,3.7452740241785847
JM-1,44491742,3.590859136704876
SU-DHL-1,168313016,5.361416197440646
BHY,6852167,2.688170131060443
GA-10,107970,0.8863840463858195
GI-1,262093,2.614529868805307
KYM-1,100016,6.934049900113359
KALS-1,sirolimus-bortezomib (250-1 mol-mol),0.8201349521844062
NCI-H2106,12003241,4.508121614525734
P12-Ichikawa,46907787,-0.81199339168832
DBTRG-05MG,5460769,5.967153987898797
RPMI-7951,100016,4.945357769827656
BT 416,5460769,1.3706696040691966
NCI-H2228,9903786,2.418550241736446
KCL-22,12003241,-4.05956124354109
ST486,49766530,-3.0199322417978065
HCC44,tanespimycin-bortezomib (250-1 mol-mol),-2.3281487607595515
WT2-iPS,sirolimus-bortezomib (250-1 mol-mol),0.4538341173925034
KMS-28BM,44491742,3.645458914971546
EB1,9903786,1.1512361945239595
SK-MEL-1,107970,2.4240588929392715
Lu-65,49766530,1.0861089243329392
RPMI-8402,100016,6.7779334067701145
SF126,439501,-2.7774123769651315
A-253,262093,2.9926889319530736
SK-MM-2,26596,0.072150738405161
SNU-1196,9903786,3.851159965091799
FTC-133,44491742,4.538470926749077
A101D,12003241,-1.0986495828587448
HSC-3,637858,2.0652307033731097
SNU-398,439501,-1.0670786880866563
TM-31,26596,-0.9336571735173056
KYM-1,9927531,4.58392682790106
SUP-T1,6852167,1.0606596994017583
YAPC,135421197,1.6415717791988456
NCI-H1944,262093,3.0559716202604834
AGS,12003241,-0.4936842382500208
BT 320,375860,4.032556785404055
D283 Med,439501,-4.70695325279779
NCI-H446,439501,-2.615106266936583
HCC2108,241158,3.0824386157377197
Hs 611.T,26596,-1.6290206215335707
SNU-886,637858,1.4418078006770565
TE-9,9903786,2.6320007696302894
Kasumi-2,135398744,8.02054113805855
OPM-2,375860,-0.7230228450862618
WM983B,375860,0.0821681125114241
SK-N-FI,637858,1.275762804618504
SiMa,375860,-1.5020105505925594
HCC-56,5460769,4.347795399558133
KMRC-2,sirolimus-bortezomib (250-1 mol-mol),0.567306978247713
NH-6,136227331,4.3480381735805365
NCI-H1693,26596,0.3286565515580511
FTC-238,637858,1.114636329944604
OVCAR-8,439501,-0.7603560285089889
NCI-H441,3689413,0.4936421850915237
EM-2,11396600,2.356094145041023
COLO 699,262093,2.601705972340985
253J-BV,135421197,3.2645583108657217
TF-1,12003241,-0.8942649772523563
NCI-H1915,439501,-4.1452565317565995
OCI-Ly10,54596490,5.381670584410645
Pfeiffer,241158,3.156782665894997
DU4475,241158,3.034259728320883
NCI-H660,637858,0.9020207680443736
BHT-101,sirolimus-bortezomib (250-1 mol-mol),1.6700358071481498
A-549,73707398,2.11945224002363
SU-DHL-1,11396600,2.533401176626175
EHEB,107970,2.1350318268920776
Malme-3M,135421197,3.050817856383808
DMS 454,136227331,4.3527556098556275
2004,439501,-3.526370090236184
DMS 454,375860,-1.1674942929403889
HEL,9929138,6.278460484472286
HCC4006,73707398,1.5270479808510071
Kasumi-2,selumetinib-JQ-1 (4-1 mol-mol),-0.370012591860846
MSTO-211H,5460769,-2.0887143253822615
NB4,241158,1.760612084671808
KP-N-SI9s,107970,2.3206029022874404
M-07e,71466445,0.4211698315737406
SW620,44491742,4.4130085164157125
SNU-620,11455910,2.08443042552151
K-562,12003241,-5.632155645383806
CAS-1,tanespimycin-bortezomib (250-1 mol-mol),1.4677187949031796
NCI-H810,selumetinib-JQ-1 (4-1 mol-mol),1.3010994394801945
G-292 clone A141B1,135398744,6.65861915049708
KP-N-SI9s,375860,-0.3225844332082871
SH-10-TC,49766530,2.645691737420763
Li-7,73707398,1.3993074762120628
JHOS-2,9903786,4.753698085205414
KYSE-410,71466445,4.5751159315788055
NCI-H211,241158,5.257469500310299
COR-L95,637858,1.3348673917451612
IGR-37,375860,-0.4375644933586405
C2BBe1,262093,2.5609927987470753
JHUEM-7,107970,1.950560118304485
SU-DHL-1,12003241,0.0778318253848937
COLO 678,6852167,2.6711614029982265
NCI-H1373,sirolimus-bortezomib (250-1 mol-mol),1.9040141833310924
SW1990,11396600,4.084870548965884
ST486,73707398,-1.0150997686400067
697,26596,-3.738264049294864
Hs 888.Lu,tanespimycin-bortezomib (250-1 mol-mol),0.5097438432490347
NCI-H1734,241158,4.904474400938833
NCI-H2196,3689413,-2.371911217935783
Capan-2,selumetinib-JQ-1 (4-1 mol-mol),1.8393844312735137
NCI-H810,UNC0638-navitoclax (1-1 mol-mol),1.050373409146072
NCI-H2081,9927531,2.933726437844289
GDM-1,100016,5.649529454604957
GMS-10,439501,-2.5226384823579404
NCI-H1341,49766530,-3.266288365391744
HLF,241158,4.258193705032094
Panc 03.27,44491742,4.225898186806888
RERF-LC-A1,100016,6.9126876628990885
RKO,11396600,3.504834935214814
NCI-H1915,6852167,2.88069410899598
CW-2,selumetinib-JQ-1 (4-1 mol-mol),1.016238653425278
EPLC-272H,262093,2.6585734964122576
MCAS,sirolimus-bortezomib (250-1 mol-mol),0.8032325328072784
NCI-H28,26596,-2.2516218144459508
UM-UC-1,12003241,-2.5301689860244534
SIG-M5,5460769,1.4726407580947376
KMS-11,71466445,1.8143007153609576
SIG-M5,135421197,1.947558909075972
BT 228,11396600,1.874591390979962
NCI-H727,49766530,1.5110740555461553
COLO 205,tanespimycin-bortezomib (250-1 mol-mol),-2.2778936602109483
MFE-296,71466445,6.167390306969204
Sq-1,sirolimus-bortezomib (250-1 mol-mol),0.8750306611034651
Li-7,26596,-1.7379173085827686
NCI-H1838,3689413,1.1347617687317235
MM1.S,100016,6.180279624553647
KMBC-2,73707398,1.4795418187244096
BT 239,107970,0.200195118514019
C2BBe1,sirolimus-bortezomib (250-1 mol-mol),0.281617007338844
639V,12003241,3.941533367074586
HCC1171,11455910,2.1800393678946395
SNU-620,3689413,0.413852643898191
SK-N-SH,12003241,-0.1782836435040178
TC-71,107970,2.798539733238077
CAL-51,135421197,1.6266864976107616
KMS-26,637858,-0.2587644829981909
NCI-H226,sirolimus-bortezomib (250-1 mol-mol),1.5737469522318486
VM-CUB-1,439501,-2.2859816602677077
IMR-32,12003241,0.5902035807991148
NCI-H508,375860,-0.1999863020255136
NCI-H146,71466445,0.6815814889300492
SF539,135421197,1.037431947377599
NB4,71466445,1.5990398825459642
JHUEM-1,6852167,1.554254101027855
COR-L47,46907787,1.5571447931043088
JHH-5,135999136,1.8373103914697355
NCI-H1793,637858,3.697458536286102
CMK,selumetinib-JQ-1 (4-1 mol-mol),0.226926842733127
Lu-99,11396600,3.614830317436624
NCI-H1184,444795,4.437911221112586
MSTO-211H,10231331,1.7809441814393978
NCI-H810,439501,-2.873270400537551
RPMI-6666,262093,3.187153978804494
MIA PaCa-2,49766530,-2.3545367349028097
OAW28,5460769,4.044755256654475
UO-31,UNC0638-navitoclax (1-1 mol-mol),1.0830521696478217
YD-10B,10231331,-3.2666005565013183
A-375,135421197,1.9818816716343688
NCI-H2228,11455910,0.4514463057977056
OCI-Ly19,262093,1.0490468502028176
NB1,100016,5.984902151942781
DV-90,9929138,3.266607070409867
OVCAR-4,444795,5.182703743158894
A2780,637858,1.382423379201008
B-CPAP,26596,-2.034534215785694
NCI-H1105,644241,5.119219602350766
NCI-H146,644241,1.2089846023639548
SK-N-BE(2),6852167,2.849776055810666
HEL,46907787,-1.2802643066913908
EFO-27,46907787,4.067144836646944
SCaBER,262093,3.0352387860556824
RL95-2,100016,4.898266673475204
HCC2935,637858,2.581193307800251
LoVo,3689413,-0.0015328635235731
NCI-H929,73707398,-1.1294071073635834
COLO 680N,100016,6.604594090356929
ST486,tanespimycin-bortezomib (250-1 mol-mol),-0.6822883440168558
KM12,107970,2.55431308296488
Hs 888.Lu,168313016,5.717641132644131
NCI-H209,9927531,3.5477571143466156
JHH-1,100016,6.434861287132587
KYSE-410,46907787,2.6604064739007804
HCC4006,444795,4.934994268877888
WSU-DLCL2,107970,2.0978783908634537
Panc 03.27,tanespimycin-bortezomib (250-1 mol-mol),-1.5321411216647824
NCI-H1299,637858,2.0159595809429716
NALM-6,9903786,0.8985317533889718
KNS-42,439501,-0.277437282797495
HeLa,135999136,4.338563749387071
JHH-2,100016,7.043022520962564
F-36P,73707398,-0.2227517759229556
SNU-407,49766530,0.1037791929989153
NCI-H1792,9929138,7.3864021797267485
LN-18,11396600,4.155710167267898
NCI-H1339,107970,3.0174891180051793
SK-MES-1,439501,-3.0675595474826194
BL-70,11455910,0.0297014164053517
KYSE-450,sirolimus-bortezomib (250-1 mol-mol),1.472196995185456
HCC2935,73707398,1.6520031559057071
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733
647V,26596,-2.3148144516989184
MOLT-3,637858,0.8565038735884491
HeLa,375860,-0.2411971223696274
A-673,136227331,4.241984110268528
CAL-33,UNC0638-navitoclax (1-1 mol-mol),2.6190479668064284
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
MOLT-3,49766530,-1.2433717650560063
SW1353,71466445,3.3058354165580712
MDA-MB-453,6852167,1.219966928776707
BT 482,644241,2.486810185249483
NCI-H1435,46907787,2.0566854807716317
EFO-27,136227331,4.702115323060179
NCI-H446,241158,2.8273295901889273
NCI-H1944,10231331,3.941339928718522
HPB-ALL,100016,7.357554409535215
COLO 800,6852167,3.2462624682071493
SK-MEL-3,selumetinib-JQ-1 (4-1 mol-mol),1.624169736782825
SU-DHL-4,46907787,-0.3916382463419708
BHY,11396600,4.25848737272748
Hs 822.T,selumetinib-JQ-1 (4-1 mol-mol),3.901287400786403
Mino,sirolimus-bortezomib (250-1 mol-mol),-0.0680495630332059
NCI-H1563,3689413,0.532874202175122
IGR-1,262093,3.048494446765652
JK-1,sirolimus-bortezomib (250-1 mol-mol),0.507486963529962
SEM,135999136,1.8493753189775255
DMS 454,6852167,4.1609541401682755
NU-DHL-1,11396600,1.7686570539993816
KCL-22,sirolimus-bortezomib (250-1 mol-mol),-0.943153613452708
Karpas-620,100016,5.312019885835398
EBC-1,44491742,3.57682955784604
NCI-H2172,11455910,3.487096997214958
Detroit 562,637858,1.8443507539386277
KMS-20,10231331,-0.0376220922185321
LAMA-84,71466445,3.0064862485124073
5637,26596,-2.698358850803536
SNU-719,439501,-0.6056911297010781
A-549,11455910,0.2975953497649719
MKN1,135421197,0.9793646210495068
TE-4,26596,-1.4080950714953673
D283 Med,11396600,2.9109671183024983
NCI-H196,49766530,0.4460348160421952
BICR 22,46907787,3.4905986586009843
A-204,637858,1.2825280617215151
SNU-407,135421197,1.3307309137808745
PK-1,73707398,1.4410973874230182
SNB-75,5460769,5.271808255832039
NALM-6,46907787,-2.3948812362942964
NCI-H526,46907787,-0.1511584481957571
MKN7,11455910,1.138632994153518
RL95-2,10231331,-1.47553780419568
BICR 31,selumetinib-JQ-1 (4-1 mol-mol),1.6620620003816966
OVISE,3689413,-2.3316050545360136
L-1236,9903786,-0.7492109399697982
NCI-H661,49766530,1.1318827683023138
BT 271,241158,5.625981584697921
NCI-H1703,135421197,2.2444093773538043
NCI-H2228,12003241,-0.7511130172017173
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024
SK-N-MC,73707398,0.55519642478783
A3/Kawakami,tanespimycin-bortezomib (250-1 mol-mol),-0.2399210374743367
YD-8,10231331,5.266552071230695
RCC10RGB,439501,-2.548266242367821
BT 228,5460769,3.1734234469755775
NCI-H292,9903786,2.498172259524573
M059K,3689413,-2.3612434015729336
TUHR4TKB,46907787,4.198282991293648
MFE-296,5460769,1.1407160363759563
EoL-1,241158,0.7802478350206956
HCT 15,73707398,1.1959193392458622
SNU-1041,73707398,1.6372848153968225
SK-N-AS,644241,2.0495505337377393
KHM-1B,5460769,1.8331932839616616
AGS,3689413,2.90749290772993
NCI-H1694,UNC0638-navitoclax (1-1 mol-mol),-1.417470888611864
M059K,9903786,3.785857349201863
A-549,73707398,2.11945224002363
VMRC-RCZ,262093,3.1107535398689747
A101D,262093,3.196770029367663
HCC2218,46907787,2.570368749578335
Mino,49766530,-3.2030154452064696
SNU-761,49766530,-1.6667197408090684
Daudi,444795,4.05018196872557
NCI-H1155,73707398,0.8186433878121172
SNU-878,262093,4.410693672921156
Peer,10231331,5.411125162137865
NCI-H810,10231331,4.27940972162908
HT,tanespimycin-bortezomib (250-1 mol-mol),-0.5308149065627191
EJM,135421197,1.4211538659692204
SNU-899,135421197,3.636870006524017
MHH-ES-1,6852167,1.3235332252332372
KP-N-SI9s,71466445,1.8589750237088865
YD-10B,11455910,1.0221520098708106
U-87MG ATCC,selumetinib-JQ-1 (4-1 mol-mol),4.879492377756021
NCI-H2029,sirolimus-bortezomib (250-1 mol-mol),0.2827623623245045
LXF 289,168313016,5.746715572468322
OE19,5460769,4.447133624333207
SNU-245,49766530,-2.046420200198333
SK-ES-1,262093,1.8712503240297784
SK-MEL-31,73707398,1.4524538881276303
Karpas-299,sirolimus-bortezomib (250-1 mol-mol),-3.935889732903339
Namalwa,71466445,4.063090897069234
UM-UC-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8990264790704343
BT-549,49766530,-1.005486623843658
CHP-212,3689413,0.1952243777291655
MCAS,107970,2.3689234635005274
PL-21,26596,-4.324956328818882
KYO-1,135999136,1.771053497047969
TE-10,tanespimycin-bortezomib (250-1 mol-mol),0.6297749244951121
NCI-H1650,selumetinib-JQ-1 (4-1 mol-mol),2.519916667602708
OC 314,71466445,3.8450252260882105
SW1271,262093,2.7991981503454495
NCI-H1623,135421197,3.7764453326534855
HEC-1-A,11455910,0.0025723571677065
SK-N-AS,135421197,2.9463042299637645
BICR 6,107970,2.2230750476194676
YD-38,46907787,-0.5393505828045682
COLO 668,135421197,1.2477515484477224
LoVo,73707398,0.5951327141059009
SUP-T1,46907787,-1.0799760028641845
22Rv1,262093,2.6846165954285386
YD-38,5460769,0.587016845611175
NB1,3689413,-0.0909545830460423
DK-MG,49766530,-2.542495237652574
COLO 684,49766530,-2.0010350026906787
SNU-899,9877608,7.308498444418231
MHH-NB-11,9903786,1.7813974868905205
YD-15,241158,3.805397573173429
Rh18,46907787,2.4292480291627214
HCC1954,9903786,3.647576872659031
IPC-298,tanespimycin-bortezomib (250-1 mol-mol),1.4855938894276637
SNU-840,637858,2.902104601766375
P31/FUJ,375860,-1.2092771030706315
SK-N-AS,241158,4.128008478186768
KMRC-2,9903786,3.847767222952075
KP-4,262093,2.717667187094357
Hs 578T,selumetinib-JQ-1 (4-1 mol-mol),1.8752949809426225
WSU-DLCL2,44491742,3.7672171779194983
HeLa,107970,2.289164047292083
LK-2,11396600,3.577744596051322
HCC44,71466445,3.444849178593719
EM-2,49766530,-1.2569750425961423
T-47D,107970,2.340422447326511
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
SW48,49766530,3.606492941369466
TM-31,241158,3.6501345239800216
JHUEM-1,9903786,2.799765938694702
Calu-3,107970,1.816322424399714
YKG-1,3689413,0.6324676509110861
697,44491742,3.706087965098128
TE 617.T,49766530,0.7219936029633269
T84,11396600,3.8176066701556097
NCI-H441,71466445,4.182727047603201
NCI-H2110,selumetinib-JQ-1 (4-1 mol-mol),2.5540188828609907
LS1034,73707398,1.4627229109682227
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573
786-O,241158,3.701389818055655
ALL-SIL,644241,-6.056766449232899
EHEB,44491742,5.293750317448726
NCI-H2405,9903786,2.53791171783736
NB4,11396600,3.2499354212792646
NCI-H460,9903786,4.057661845653794
DMS 79,6852167,4.014161600338899
EB1,11455910,-1.5299168268702652
SNU-1033,637858,1.4383513056323138
HCC1195,241158,3.21939431238571
JHH-5,241158,1.8373368397822012
HuH-1,44491742,4.9230469745960255
Kasumi-2,73707398,-0.974822208153436
JHOM-1,241158,3.6386964384932137
GB-1,73707398,1.1867709251238034
OPM-2,54596490,4.128803973627264
Hs 294T,46907787,3.712635526652043
TALL-1 [Human adult T-ALL],444795,3.2400868280054995
BT 328,3689413,2.3836323832860673
IM95,107970,1.6852534939866826
MOR/CPR,selumetinib-JQ-1 (4-1 mol-mol),2.7739348806287945
HEY A8,262093,2.6286127201317835
NCI-H747,49766530,-2.525329800647816
BT 286,UNC0638-navitoclax (1-1 mol-mol),1.4427957482860168
MM1.S,5460769,2.129502129742311
SW620,135999136,4.224661895270989
SNU-423,44491742,3.863177146863686
Caov-3,46907787,0.9279743097720166
NCI-H716,26596,0.0248584598201427
KNS-60,44491742,4.18434599527296
HCC15,selumetinib-JQ-1 (4-1 mol-mol),1.0945511889039805
FaDu,439501,-1.5866164776842138
BxPC-3,262093,3.443903516481154
SNU-119,selumetinib-JQ-1 (4-1 mol-mol),2.003564395289463
MM1.S,135999136,4.602725766791159
SaOS-2,9903786,2.3206358959344264
MOLT-13,73707398,0.4538955993003755
TE-14,107970,2.304242218577071
HCC95,241158,6.17490433758637
IMR-32,5460769,-1.03513215878617
FTC-133,262093,3.024825063724614
GI-1,3689413,-2.447824191080865
VM-CUB-1,10231331,1.4888918847331971
CAL-148,637858,1.8040983358368403
CAL-54,12003241,-2.3491200847554103
NCI-H1299,241158,3.1343803063940996
THP-1,100016,3.892329450898836
Calu-1,44491742,5.4818200754646
NCI-H1568,44491742,3.692908194165655
SW1783,9903786,4.362374850125049
NCI-H1703,selumetinib-JQ-1 (4-1 mol-mol),2.399515856711348
MV4-11,135999136,3.817952088116468
NCI-H1975,11396600,3.468451084221391
NCI-H1105,262093,1.4948338370067744
VMRC-LCD,9903786,1.8330708335593808
TE-5,136227331,4.141551967030233
NCI-H1703,6852167,1.7470383195809174
A-549,100016,7.181380121169662
PK-1,10231331,4.583437812683764
Hs 852.T,107970,1.793411000541102
KMS-28BM,9903786,-0.1585542654155638
CGTH-W-1,9903786,1.99445591465905
SK-HEP-1,46907787,5.1061569205326505
NCI-H520,26596,-1.7163548151943342
KNS-42,49766530,0.1123105929795226
COV362,11455910,3.2611382384479186
YD-8,637858,2.173572899934862
SNU-1105,3689413,0.7210916116253745
LNCaP clone FGC,49766530,1.5259250948267933
YD-10B,71466445,5.667780405427701
TE-15,11455910,-0.076849872958893
PK-1,241158,4.411269356882099
COV644,73707398,1.004277448975642
TYK-nu,44491742,3.839739340970965
IM95,UNC0638-navitoclax (1-1 mol-mol),1.2778255958828686
NCI-H2452,6852167,1.5258165813873172
KNS-60,11455910,1.2653119972070106
G-401,135999136,2.1711954992798987
NCI-H1155,12003241,0.5053452290511842
T98G,11455910,0.2544044244043033
NCI-H211,49766530,-2.3844555763934707
WT2-iPS,241158,3.6908045312751145
SEM,9929138,6.8273209917060145
G-361,49766530,-1.5432487194919586
Hs 934.T,644241,1.8848101536179052
RL,sirolimus-bortezomib (250-1 mol-mol),-0.1936565509728958
KMS-12-BM,tanespimycin-bortezomib (250-1 mol-mol),-0.6230177375781689
Hs 822.T,444795,5.019849007849625
Hs 688(A).T,439501,-2.959985011333181
NCI-H2009,26596,-1.5885219134108934
NCI-H2085,637858,1.2687999057722932
HCT 15,100016,6.694419225032017
SF268,3689413,-1.0049822928368335
DB,100016,4.066938426663746
RT-4,3689413,0.3652230576391069
COV434,3689413,-2.336562516768729
Fu97,262093,3.1812015946879924
KNS-62,136227331,4.203841276745653
J82,sirolimus-bortezomib (250-1 mol-mol),0.3485441031707259
RERF-LC-A1,12003241,-0.839480669213789
NCI-H1155,UNC0638-navitoclax (1-1 mol-mol),0.5053861350195396
YD-10B,262093,3.599984263013195
GSS,9903786,1.9234294660474929
MEC-1,selumetinib-JQ-1 (4-1 mol-mol),0.0562917055128989
SNU-5,241158,4.938861844841369
PE/CA-PJ49,11396600,3.5050583522874637
OVCAR-4,46907787,-0.5848382539691691
BT-16,sirolimus-bortezomib (250-1 mol-mol),3.18518711060972
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825
NCI-H1339,49766530,0.922676999768476
BHT-101,26596,-0.678699585519716
Hs 944.T,135421197,1.7444427011785306
AN3-CA,71466445,5.096273299698095
Calu-6,168313016,6.238498419183306
SF126,637858,2.685608756713638
SNU-886,46907787,3.408086497020091
BT 444,11455910,1.1196809594429316
SK-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.5276941672655032
KO52,444795,3.710694398794004
HCC1954,73707398,0.7920047045443592
BT 112,tanespimycin-bortezomib (250-1 mol-mol),-0.1012397521650829
SNU-C1,262093,1.2400206335619155
NCI-H810,135999136,1.8085550154613508
HuH-28,262093,3.3718876693981175
TE-10,3689413,-0.6087813624831553
SUP-T1,sirolimus-bortezomib (250-1 mol-mol),-0.9944486722205774
HLF,107970,2.1682422311433123
CGTH-W-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1580124006071881
G-402,135999136,4.750055175062071
COV644,135421197,2.2912269565469936
SEM,444795,1.9334021981472231
DU145,3689413,-1.3535401671184424
COR-L88,72967,3.68051960609927
NCI-H2141,241158,3.8240614308547327
VMRC-LCD,135421197,1.103585656826272
C2BBe1,5460769,5.889347981048802
KYSE-30,9929138,6.4382239569963255
SNB-75,selumetinib-JQ-1 (4-1 mol-mol),2.6228425444296004
NCI-H2291,71466445,5.58813492621218
NCI-H1355,637858,2.3984786151718773
NCI-H524,sirolimus-bortezomib (250-1 mol-mol),0.5181816489165546
OVCAR-8,135421197,1.5864277094483568
Li-7,637858,2.0676196467006447
ONCO-DG-1,9903786,3.737117521186133
BICR 56,UNC0638-navitoclax (1-1 mol-mol),2.815412644303643
Hep-G2,6852167,3.060489701170588
SNU-449,selumetinib-JQ-1 (4-1 mol-mol),3.9590560352886457
JHUEM-7,135421197,2.2083604774336973
MFE-319,262093,3.9047520178061856
Lu-65,46907787,3.3131734896161444
U-87MG ATCC,135421197,3.5274943050860874
TE-8,439501,-2.6420993562145925
PaTu 8902,73707398,2.5949502925816397
NCI-H2009,3689413,0.5343246791806224
PE/CA-PJ34 (clone C12),11455910,0.5657744918990928
RERF-LC-A1,10231331,6.3240202906005045
Raji,241158,1.7953871388242486
SNU-869,439501,0.8866471334792935
TE-5,26596,-0.6674646083378311
BT 172,439501,-3.021522386524776
TF-1,49766530,-3.109454480053962
OCI-Ly19,71466445,3.5959031231902663
HOP-62,71466445,1.9622269092656943
NCI-H810,9903786,3.328850282444774
HCC1937,selumetinib-JQ-1 (4-1 mol-mol),2.308102509236992
YAPC,439501,-1.3344819600707327
SaOS-2,135999136,4.306712196094447
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386
HEC-251,12003241,0.0135079560064688
SIG-M5,444795,-5.244515717974557
HEC-265,375860,-0.1308592558386561
LOX-IMVI,5460769,1.2475955137176375
U-937,3689413,0.9938277330138956
Hs 578Bst,54596490,4.55589845145933
253J-BV,26596,-1.8629561826944263
RERF-LC-A1,107970,2.429814394867771
BT 131,637858,1.8330567448634565
SNU-16,UNC0638-navitoclax (1-1 mol-mol),1.1266318716416923
NCI-H28,637858,1.7357637542615616
SNB-75,6852167,3.854897598564988
CGTH-W-1,100016,5.226111530095554
NU-DHL-1,54596490,5.416894183216897
TE-14,6852167,2.6176714040781977
COV434,135421197,0.3873638415100381
NCI-H2141,46907787,2.646319689052489
HCC1438,sirolimus-bortezomib (250-1 mol-mol),0.8076549533300275
Hs 822.T,11396600,4.268177594859087
EB1,444795,3.792865279889192
A-204,tanespimycin-bortezomib (250-1 mol-mol),-2.803355347845335
SK-N-DZ,444795,-2.5083972815041577
OV-90,71466445,5.236644798872222
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179
DMS 454,241158,4.171276603162088
HT-144,9903786,5.3539912005761705
CMK,9903786,0.6507335736439642
KYM-1,71466445,1.4464310394768298
U266B1,5460769,3.751565438771286
SNU-886,73707398,1.147330182406101
BT 286,262093,2.2473217807206916
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911
CL-11,9929138,5.374540786580353
FTC-133,49766530,-1.1381086002707512
ESS-1,71466445,5.77037971840281
HT-1197,73707398,1.1241151390025674
OCI-AML-2,46907787,-1.6680050924308902
ALL-SIL,100016,4.099229681419155
SNG-M,9903786,2.9432381601198427
EM-2,6852167,0.9842346287991872
SNU-601,241158,4.328788935254692
BT 416,439501,-5.114778373309692
Hs 729.T,241158,3.68166010418192
EFE-184,selumetinib-JQ-1 (4-1 mol-mol),1.6324969446710622
EBC-1,135999136,4.328547073399329
SNG-M,241158,3.0909058026203144
SUP-M2,46907787,-1.6457394871000364
HCC1438,6852167,3.7274636692401297
WM115,9929138,6.7694003006369226
OVISE,12003241,-0.8183931153803442
FTC-238,12003241,-0.6060695245587711
MDA-MB-468,241158,2.89506441485498
NCI-H1341,73707398,0.4714728014883233
MOLP-2,135421197,1.9402190230236491
HuH-28,9903786,2.984330186348554
Hs 729.T,26596,0.627655143965394
NU-DUL-1,100016,4.060799847781438
HCC2218,6852167,2.7413890151562543
ALL-SIL,9927531,4.600523700119875
SW1573,107970,2.0608182724975266
NCI-H838,49766530,-0.8492681792296649
NUGC-4,637858,2.002597662326331
NCI-H522,9903786,3.9217135447784783
BT 498,46907787,4.416353779526344
KMRC-1,241158,4.823138037217212
Peer,637858,0.987077054262488
SNU-C4,46907787,3.840379213773751
SK-MES-1,tanespimycin-bortezomib (250-1 mol-mol),-2.706649698692507
THP-1,444795,2.529502673160271
UACC-62,sirolimus-bortezomib (250-1 mol-mol),1.7829668045842757
DMS 454,tanespimycin-bortezomib (250-1 mol-mol),2.8093099362578746
BT 271,UNC0638-navitoclax (1-1 mol-mol),2.04696764004419
SW1353,135421197,2.4746920364366813
NCI-H1694,375860,-0.3230504534344686
CAL-78,5460769,3.8399978594136193
OC 314,49766530,-1.543055424188454
TCC-Pan2,9903786,4.661219913833123
HCC2279,tanespimycin-bortezomib (250-1 mol-mol),0.9868379448514812
HuP-T4,46907787,-0.6151499250248685
Calu-1,135999136,4.366294064672552
MCAS,71466445,2.5533694020857163
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386
HCC366,selumetinib-JQ-1 (4-1 mol-mol),1.3799022063370607
BT 340,6852167,4.842070078129686
WM88,44491742,3.817934383194013
GP2d,26596,-1.9076944219866043
TYK-nu,644241,2.6049212423400907
NCI-H2171,46907787,0.7633638606493435
ESS-1,100016,6.502595194480242
D283 Med,71466445,1.8844109066317911
KPL-1,9927531,4.948797048783531
Hs 766T,46907787,-0.1882915719944492
HCT 8,6852167,4.092945222972044
NCI-H1563,11455910,-0.3468172057796411
NCI-H1568,49766530,-3.205306991379519
SNU-503,UNC0638-navitoclax (1-1 mol-mol),1.8536750772324864
OCI-AML-5,637858,1.7330578787515938
TE-5,11455910,0.4645654676747968
NCI-H522,49766530,-2.92412408259348
DoHH2,444795,2.4065428115339005
SNU-1214,439501,-2.3459859921965793
HEC-1-B,49766530,0.5619128655889829
LC-1/sq-SF,262093,5.279467675468132
AN3-CA,637858,1.3761527435149865
NCI-H2009,100016,6.24887408197215
KG-1-C,UNC0638-navitoclax (1-1 mol-mol),0.3093766679731706
8505C,73707398,1.096799488168713
MDA-MB-453,444795,4.759998515464953
GCT,49766530,-2.994788722122755
DND-41,73707398,-1.2139974872607189
SUIT-2,439501,0.993663636668041
BFTC-909,439501,-2.4866456286351095
UM-UC-1,9903786,1.5514700820318568
RVH-421,9927531,5.089842816937553
Rh41,6852167,0.2858028091905864
Malme-3M,46907787,0.0437822426845402
MDA-MB-231,selumetinib-JQ-1 (4-1 mol-mol),1.533786837540601
L3.3,3689413,1.7908878640591075
KP-3,375860,0.992773842660452
Ki-JK,11396600,1.9069544068718032
P12-Ichikawa,100016,6.391056060940552
786-O,5460769,2.250547826623791
WM266-4,262093,1.7934582046103504
COLO 205,135999136,4.470292461600089
OCI-Ly10,12003241,1.0181729921478868
PC-3,49766530,-1.3415324716004575
HCC2935,selumetinib-JQ-1 (4-1 mol-mol),3.5585346140363483
OCI-AML-5,tanespimycin-bortezomib (250-1 mol-mol),-0.6942997118623143
G-402,135421197,2.1545147661375275
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
BT 428,5460769,2.5146871392563845
KNS-62,11396600,3.6666207328470217
IGROV-1,12003241,-2.0122972114546904
HEC-50B,439501,-2.0612919893622084
KM12,selumetinib-JQ-1 (4-1 mol-mol),2.4684544152911334
JHOS-2,sirolimus-bortezomib (250-1 mol-mol),0.7378509581797704
NCI-H69,46907787,1.1887394251634753
SNU-449,44491742,3.9284370838515903
LS513,637858,1.4546571063620808
TE-1,3689413,2.462483014763608
HCC15,9927531,3.758901572486559
Calu-3,9929138,6.17100330774615
HCT 15,9903786,1.9585182501172609
KMS-28BM,168313016,3.3868967811757313
NCI-H2141,sirolimus-bortezomib (250-1 mol-mol),-0.1693402780002957
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667
BxPC-3,49766530,0.5943123243750338
SNU-475,73707398,2.6554640747961664
A-673,135421197,0.3124298336996849
NCI-H1944,3689413,3.2556823925737395
BT 147,11396600,2.435185258634128
CAL-120,44491742,4.283004570772673
RKO,439501,-1.8401322759847645
Panc 05.04,12003241,-1.2094626899686458
OVCAR-8,tanespimycin-bortezomib (250-1 mol-mol),0.6249256155417496
AM-38,11455910,0.8170455923888418
G-401,selumetinib-JQ-1 (4-1 mol-mol),0.629673615073819
Daudi,135421197,0.2989842149032058
Kuramochi,46907787,0.743649036621638
KO52,26596,-3.758446698642679
HCC1500,5460769,5.1304942195737935
MHH-CALL-4,tanespimycin-bortezomib (250-1 mol-mol),0.3224433500782956
NH-6,UNC0638-navitoclax (1-1 mol-mol),0.3961901525390363
HuP-T3,selumetinib-JQ-1 (4-1 mol-mol),1.2883856318712232
KP-2,439501,-0.3502086047975351
SF539,262093,2.0596515913386786
OCI-AML-2,135398744,6.3440072866172965
Calu-3,10231331,2.145606244915116
T24,135999136,5.239460804430351
MOLT-16,26596,-3.5703441979693245
RS4;11,444795,3.789506011302555
HDLM-2,9903786,0.9941602221273084
SK-N-AS,637858,1.2070263661617462
JURL-MK1,71466445,3.07345032592258
SNU-182,6852167,1.4866247167817654
P-STS,262093,0.957741648186898
Hs 578Bst,644241,1.8272145958520527
NH-6,tanespimycin-bortezomib (250-1 mol-mol),0.3512808047097303
HuCC-T1,9927531,3.6522633748640487
CAL-62,9927531,5.042893811802322
K-562,6852167,3.2696177089982807
MHH-ES-1,135999136,1.7507962768732164
NCI-H2110,71466445,4.525976755285506
ALL-SIL,6852167,2.025737624061405
U-118MG,6852167,2.9671585976275385
Tm87-16,3689413,-0.2220957395853978
GMS-10,262093,2.9524447590849063
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392
RCC10RGB,637858,2.3286326267725084
SNU-308,73707398,3.5686803185694327
CMK,46907787,-1.0002189336263791
MDA-MB-361,262093,2.430209495289511
BT 239,11455910,0.8577205226551546
Namalwa,11455910,-0.4529585092669797
SNU-C5,9903786,3.1730161972997517
HDLM-2,262093,2.5590696667733908
MHH-NB-11,439501,-2.5352340677709404
DAN-G,241158,3.8198495824160736
EoL-1,46907787,-4.038494248120017
TE-14,100016,6.976624848230786
HCT 15,10231331,5.105409369900083
Hs 683,5460769,1.3545224877290158
COLO 699,3689413,3.029151035827229
U-937,241158,3.3313730449185113
NCI-H520,3689413,0.9100551461140616
MHH-ES-1,26596,-2.3851189142163176
SK-N-AS,11455910,1.0183707360563456
P12-Ichikawa,11455910,-0.4653341655184377
A3/Kawakami,375860,-0.4676935312596571
SNU-1066,73707398,1.51937832388092
KMRC-1,637858,3.0556928718558707
CJM [Human melanoma],12003241,-0.9609981142913676
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452
HCC78,135421197,2.5201678114483683
SNU-869,107970,2.357589135817321
KATO III,3689413,2.9835896213027673
SaOS-2,11455910,0.8777485884783317
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167
Reh,46907787,0.6071639421711836
JeKo-1,135421197,1.3904667144592064
MHH-CALL-4,49766530,-1.9452729400457551
NCI-H2196,100016,7.101599749729703
G-292 clone A141B1,49766530,-1.892767942202222
A-549,10231331,2.044831055629592
EJM,sirolimus-bortezomib (250-1 mol-mol),0.0278018018083393
PaTu 8988t,73707398,1.170719580837983
LCLC-103H,3689413,1.9966381223526644
OC 314,5460769,0.7455149919957782
SK-MES-1,12003241,-1.463616091527542
EFM-192A,11396600,3.5001558011372045
HCC1195,73707398,1.556886983624434
NCI-H1666,10231331,-2.5582241272853667
Rh30,71466445,3.123064034579754
HLF,100016,6.001250521147636
8-MG-BA,444795,4.950662878119513
Daoy,135999136,1.8625758220326087
RCM-1 [Human rectal adenocarcinoma],46907787,1.929794927586623
ZR-75-1,selumetinib-JQ-1 (4-1 mol-mol),3.094728167218718
SU-DHL-1,135421197,1.1384736779813156
TE-14,12003241,-0.291419040743519
SNU-201,637858,3.034279619559701
GA-10,262093,-0.1751219833238948
MDA-MB-361,71466445,3.6959978776465414
NCI-H1299,262093,2.920458315101783
BT 187,637858,2.7601807501956337
JL-1,10231331,6.305660182558998
GCT,136227331,4.154263248782668
NCI-H2030,107970,3.119598892281485
COLO 800,439501,-0.358926557493619
SNU-886,3689413,-0.3695618539773043
8505C,107970,2.375571587180646
SNU-410,644241,3.406569838152794
NOMO-1,12003241,-0.5951695723430065
MKN74,135421197,1.917095385489804
NCI-H1651,135999136,5.817346187949403
KYSE-410,49766530,0.2031131423748078
KP-4,135421197,2.59268452027494
TTC-709,439501,-6.296451607950602
DU4475,135999136,4.276034607772466
UM-UC-3,439501,-1.7316159115926524
CAL-27,637858,1.966992675721693
NCI-H2030,tanespimycin-bortezomib (250-1 mol-mol),1.0255259856925616
LAMA-84,11455910,0.4620694061975223
NCI-H1650,46907787,2.274323665886221
LP-1,3689413,0.1149626145640583
Kasumi-2,44491742,3.800345149395397
KYM-1,107970,2.300725596971748
L-540,49766530,-0.200470626398811
A3/Kawakami,11455910,-1.104878748608077
BT 498,11396600,3.4855943403203704
RPMI-7951,6852167,2.0077345898162675
MDA-MB-361,168313016,4.301877723932002
SNU-626,sirolimus-bortezomib (250-1 mol-mol),0.2861431467696579
KP-N-YN,44491742,4.254136072994776
IMR-32,46907787,-0.8465098966903165
PSN1,12003241,-0.8593243794123258
SET-2,54596490,4.331118205930631
SK-UT-1,135421197,2.4956722116312813
MOLT-3,375860,-0.9337740552924476
C2BBe1,46907787,2.8691428959141296
NCI-H522,44491742,4.766943404170333
PC-14,tanespimycin-bortezomib (250-1 mol-mol),-0.4303356181915626
FaDu,6852167,4.667127824779662
Aska-SS,selumetinib-JQ-1 (4-1 mol-mol),-0.4940381618393021
Panc 02.03,49766530,0.9655059796360064
BT 248,46907787,3.027762940742573
BT 131,11455910,0.493476636285018
SW1271,9927531,4.558020454092029
KMS-34,73707398,0.3733285965494264
769-P,439501,-0.7998429700142536
KE-37,73707398,-1.1916852271114504
LCLC-97TM1,9929138,5.774162864206733
BxPC-3,46907787,0.03250860780982
IM95,46907787,1.2487466118215294
SF268,selumetinib-JQ-1 (4-1 mol-mol),3.3872094498347063
SNU-475,sirolimus-bortezomib (250-1 mol-mol),1.5218514057883192
Hs 895.T,439501,-3.8668511324468664
SNU-1196,5460769,1.0482928300242556
NCI-H446,3689413,-2.437056347343706
CHP-212,10231331,-5.947772300553975
BT 504,sirolimus-bortezomib (250-1 mol-mol),1.7161873277095432
DV-90,26596,-3.568331067432308
YD-15,11396600,3.950136388858035
B-CPAP,100016,6.506572981316216
BT 444,12003241,-0.4351069615199688
MOLM-6,9929138,4.00608246192175
DB,6852167,1.6575256705815002
AN3-CA,241158,3.592519055568355
BT 216,73707398,1.0265344986941225
EPLC-272H,9929138,6.961893442416843
G-292 clone A141B1,262093,2.200248075467667
WSU-DLCL2,637858,0.5051604368629126
NCI-H841,12003241,-1.6250883775981226
KP-4,selumetinib-JQ-1 (4-1 mol-mol),2.1555803314083635
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578
IMR-32,135421197,0.1202799185207932
DB,71466445,1.8837270144082423
SNU-1079,sirolimus-bortezomib (250-1 mol-mol),-1.4435273189765718
Panc 10.05,5460769,2.1730903163441444
RCM-1 [Human rectal adenocarcinoma],71466445,2.906568419759945
BT 231,100016,7.4946101776766385
OCI-Ly19,selumetinib-JQ-1 (4-1 mol-mol),-1.2560093436498458
SUP-T11,241158,1.0042355726441765
LS180,10231331,0.7625893939503741
JVM-3,11396600,3.007140156358036
WSU-DLCL2,6852167,0.3992644477087519
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175
HuH-28,UNC0638-navitoclax (1-1 mol-mol),-0.7244825162600496
PaTu 8988t,107970,2.530920724052233
BICR 31,241158,4.31214680273537
NCI-H810,3689413,-2.3374294855019566
BT 245,6852167,3.061843713920685
T84,49766530,-0.5596671678676561
YD-10B,9929138,5.087034787927538
SW620,637858,2.50208407243828
OCI-M1,73707398,0.9723798314394978
CA46,44491742,3.801952242992866
KMRC-2,3689413,-1.0505298927618916
HPB-ALL,637858,1.3214508999864645
KHM-1B,11396600,1.492899305921399
NCI-H747,644241,2.028132169133259
NCI-H1694,9903786,3.3065111756665564
Hs 746.T,262093,3.2071255403244097
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117
HSC-3,3689413,-2.2600837113951497
COR-L105,135421197,1.9442341701951136
LP-1,tanespimycin-bortezomib (250-1 mol-mol),0.6048283757885538
SCC-4,3689413,-0.212283545233458
COLO 792,262093,2.2000430142721736
SK-MM-2,9927531,3.423086236737343
BV-173,73707398,0.4212435272473835
DV-90,644241,1.9963801342029477
SBC-5,375860,-0.6399303579455221
Sq-1,262093,2.8908130105513856
KYSE-510,12003241,-0.1961434673469709
Hs 934.T,44491742,4.305764247310721
MHH-ES-1,241158,2.9486895199136876
SU.86.86,73707398,1.5768997133892455
NCI-H2085,262093,2.713548107137237
DV-90,168313016,4.073202068254718
LMSU,11455910,2.490355648913592
OAW42,241158,4.137379643985406
UM-UC-1,439501,-2.7541191906970224
IST-Mes1,3689413,0.9013533734229402
TT2609-C02,73707398,3.611682023187072
P12-Ichikawa,135999136,0.868328937682989
SK-MEL-30,selumetinib-JQ-1 (4-1 mol-mol),-2.43528576724259
SK-N-BE(2),439501,-3.274978008142144
DEL,444795,4.321957786836183
MDA-MB-415,49766530,3.102282172182342
H-STS,5460769,1.2422964505231244
BT 228,sirolimus-bortezomib (250-1 mol-mol),-0.6325726268478239
HPAF-II,73707398,1.96583699059278
KP-3,439501,-2.4441073658124837
SNU-1076,9903786,2.0917140595670585
DMS 114,241158,3.5080412405177195
HT,sirolimus-bortezomib (250-1 mol-mol),-1.783381881062306
NCI-H1944,11455910,-0.1007611933414571
NCI-H650,5460769,3.805855578074832
SUP-B15,262093,1.7420921581554918
SKM-1,3689413,-2.418262014134033
SR,5460769,1.487017062685354
SK-CO-1,5460769,-0.7722931098274061
OAW28,UNC0638-navitoclax (1-1 mol-mol),1.4894889011779118
HEC-50B,9903786,4.880358665703779
Calu-3,12003241,-0.8682368391192625
IMR-32,11396600,2.686072598374917
SCaBER,tanespimycin-bortezomib (250-1 mol-mol),-1.0690096997886145
Lu-65,135999136,6.05207061737822
ONS-76,46907787,2.0367347893242247
Hs 766T,sirolimus-bortezomib (250-1 mol-mol),-1.9217809600428275
GMS-10,49766530,-2.0823399026837888
BT 224,241158,4.18453017300662
PLC/PRF/5,135999136,4.161588438871366
786-O,12003241,0.5866804436375384
HT-55,107970,2.0894496787312313
LOU-NH91,49766530,0.361985362717411
YD-8,135999136,6.481795126986557
JHUEM-2,46907787,-0.0354976865727375
SCLC-21H,selumetinib-JQ-1 (4-1 mol-mol),-0.3063993577138266
SNU-410,44491742,4.2778322604140815
Detroit 562,439501,-2.3410897293820003
SCaBER,100016,6.423492154596734
KE-39,9927531,6.019185228760376
M-07e,46907787,-1.2673876445941157
OCUM-1,12003241,-0.8918432074998596
HT-1080,135421197,1.6974023477762936
UACC-62,439501,-0.4240195200695472
LOX-IMVI,100016,4.319089113839007
COLO 201,100016,6.515418099212221
HOP-62,644241,3.1135369440994767
HuP-T3,3689413,-1.422602865458103
TM-31,3689413,-2.3957166593643104
TE-6,6852167,1.7770458307223695
NCI-H841,444795,4.067288283451541
SNU-503,241158,4.23502512903834
OC 314,439501,-2.7228413581115105
LCLC-97TM1,26596,-2.266692800551727
SNU-407,selumetinib-JQ-1 (4-1 mol-mol),-1.4031529042241262
BT 164,12003241,-0.888203268787868
FTC-238,100016,6.441740826290021
MDA-MB-435S,selumetinib-JQ-1 (4-1 mol-mol),-0.9058827313834622
RERF-LC-Ad1,12003241,-0.821513059069255
ACC-MESO-1,107970,3.0129300087399744
769-P,selumetinib-JQ-1 (4-1 mol-mol),2.569867947443669
BT 482,637858,2.0886989886626335
SUIT-2,selumetinib-JQ-1 (4-1 mol-mol),3.2290404930384637
SK-MM-2,46907787,-2.970047454600876
NCI-H1703,11396600,3.3181128171686254
KPL-1,44491742,4.061678740812618
CAL-85-1,262093,2.917494988411318
SUP-T11,9903786,1.3476542683573176
KMS-18,12003241,-1.9143210957947092
KYSE-520,selumetinib-JQ-1 (4-1 mol-mol),3.0817543061531434
SIG-M5,11455910,0.7552766623437589
A-549,49766530,0.1688758689952186
IGR-1,439501,-2.7516642734120307
MHH-ES-1,49766530,-2.35946817477404
MOTN-1,73707398,-0.2089189057600323
Hs 294T,11455910,1.2626812839087918
MOLP-8,100016,7.090961588333011
Ki-JK,135421197,1.017420564830507
SK-MEL-31,637858,2.2737617331848807
SNU-449,9927531,4.924705078398161
TE-10,107970,2.363675844497519
DMS 53,selumetinib-JQ-1 (4-1 mol-mol),0.0293599246560963
HT-55,5460769,6.100853443002961
LK-2,49766530,3.215264234500344
LCLC-103H,241158,3.440238106244061
MDA-MB-157,9903786,1.458865596348786
A-549,3689413,0.7236603744186211
HCC2279,selumetinib-JQ-1 (4-1 mol-mol),2.0805029001286517
RPMI-8402,12003241,-0.4088888603650127
GMS-10,sirolimus-bortezomib (250-1 mol-mol),0.908148060868429
P12-Ichikawa,12003241,0.1281153302005317
647V,241158,4.253529022731219
NCI-H838,10231331,6.376756175674043
22Rv1,637858,2.0333625515444353
MDA-MB-157,73707398,-0.5856522541525173
U2OS,100016,5.485609538675787
HPB-ALL,135999136,1.8548730425081073
SR,12003241,1.5749280257994038
CAL-27,tanespimycin-bortezomib (250-1 mol-mol),-0.409380186496711
MOLM-13,9903786,0.7109980532390177
HCC1419,439501,-1.0086934548500974
Ci-1,9927531,4.406404304601132
BT 224,6852167,4.53858021347583
JHOM-1,375860,0.4553478964552023
SNU-216,135999136,4.192311948123392
EPLC-272H,107970,2.2048649006361623
HT-1197,9927531,4.678863685283018
KYSE-140,11396600,4.836880334492914
MKN74,3689413,0.9993219534405752
BT 330,644241,2.044782133454181
LOX-IMVI,100016,4.319089113839007
HCT 15,selumetinib-JQ-1 (4-1 mol-mol),1.4588191826561598
NCI-H650,439501,-2.431498086573591
Aska-SS,6852167,0.8511531756898867
BT 159,135999136,1.5002095290775506
LCLC-103H,107970,2.8448254128571224
SCC-4,49766530,-0.2029842802375615
HT115,11396600,3.748253613191512
KE-39,135999136,4.6219900849735325
OCUM-1,10231331,-2.6467056337525183
NCI-H1155,11455910,-0.6780769977748015
CML-T1,26596,-2.14043660837674
PE/CA-PJ15,375860,-0.3600146700827705
TOV-21G,73707398,1.040399662883959
PK-1,selumetinib-JQ-1 (4-1 mol-mol),1.9861622648896295
SNU-16,10231331,4.660588677927323
BICR 18,135421197,2.040633770246715
SW1116,selumetinib-JQ-1 (4-1 mol-mol),-1.5718709944273437
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764
BT 231,135421197,1.0763175924586934
UM-UC-3,26596,-0.252554246147762
Hs 936.T,sirolimus-bortezomib (250-1 mol-mol),1.4470879407729986
BT 498,9927531,5.612738328284819
SF539,644241,2.736795870753983
MeWo,3689413,1.920191181250088
MDA-MB-468,46907787,3.086871495075205
BICR 16,439501,-3.169207556484136
KYSE-30,selumetinib-JQ-1 (4-1 mol-mol),3.305713321992504
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
L-1236,444795,2.729490341854986
GB-1,10231331,4.4589377550912745
B-CPAP,637858,2.2733284631239044
NCI-H1092,5460769,5.922318384562557
SNU-308,UNC0638-navitoclax (1-1 mol-mol),1.6647275742348495
42-MG-BA,3689413,-1.7117650747651572
NCI-H716,3689413,0.3516381459827891
EBC-1,11396600,3.453174926041772
KMS-12-BM,262093,1.1865999929989532
IM95,selumetinib-JQ-1 (4-1 mol-mol),0.2831662508837702
8305C,241158,3.792534780111898
RERF-LC-MS,5460769,5.094680634820597
G-361,100016,5.501390716782531
SNU-1214,9929138,6.834852342367116
JHH-1,11455910,0.6944106748858588
NCI-H2052,9903786,2.0027287626066297
SCC-9,54596490,5.620994411748341
HuNS1,46907787,1.7038689762215966
CW-2,sirolimus-bortezomib (250-1 mol-mol),1.6646573064439074
MOLM-13,71466445,2.28410988708537
EKVX,241158,5.164302158965644
BT 359,12003241,0.8363622600991807
CAL-51,135999136,4.2132345103647015
MES-SA,135421197,2.6547553279335543
NCI-H2029,135999136,4.497237183301633
SK-N-MC,26596,-3.660625750775288
SK-N-MC,100016,6.319948334432407
JHOM-1,11455910,0.6774290111714439
Calu-3,9927531,4.58448758255864
Kuramochi,tanespimycin-bortezomib (250-1 mol-mol),2.338671099156103
JHH-5,439501,-1.654650544214748
EJM,375860,-0.4454409247993169
NCI-H1869,6852167,3.74490947977495
AML-193,71466445,1.808334525963911
TE-5,107970,1.5256811386739602
LCLC-97TM1,6852167,1.822160840349085
OCI-AML-2,3689413,-0.7025216224577658
8305C,sirolimus-bortezomib (250-1 mol-mol),0.6983572372591207
COLO 792,10231331,-1.289578148322008
OCI-Ly19,107970,1.7406149998809803
NCI-H322,439501,-2.585087913028924
YD-10B,sirolimus-bortezomib (250-1 mol-mol),0.8194985120964778
SNU-119,262093,2.598697839644185
NCI-H1573,9927531,4.21902889327973
SNU-626,6852167,3.646098015968206
EFM-192A,6852167,1.4625394744980325
KE-39,100016,6.665188081944046
KMRC-3,439501,-3.150982817952844
NCI-H2122,selumetinib-JQ-1 (4-1 mol-mol),1.880665568287093
JHH-2,49766530,-3.049401978968413
HEL 92.1.7,135999136,1.6323653290095597
LOX-IMVI,262093,3.0192087839524433
EJM,135999136,1.6782155584907743
NCI-H69,375860,-0.9936844149430912
HPB-ALL,11396600,3.1053872858307225
LNCaP clone FGC,selumetinib-JQ-1 (4-1 mol-mol),0.1140146745231702
BV-173,71466445,1.7673516880901483
GB-1,sirolimus-bortezomib (250-1 mol-mol),0.3465048040128788
MV4-11,9929138,5.135177780047251
NU-DUL-1,637858,0.2470687054795695
SK-MM-2,439501,-1.9347764023362728
Capan-2,3689413,2.633842483871067
G-402,73707398,1.1492190990464957
ST486,54596490,5.2508906493958625
BT 320,136227331,4.5584663350036605
HuP-T4,10231331,-2.2405949766532935
BT-549,135999136,1.9798336492119424
OPM-2,168313016,3.5498730155612863
BT 330,UNC0638-navitoclax (1-1 mol-mol),2.829713529856627
K029AX,5460769,3.760325914422788
HCC1806,241158,4.195325698193969
Lu-65,168313016,6.388486365629365
NCI-H716,11396600,4.406293438661701
MEC-1,46907787,-0.7601525986896981
ChaGo-K-1,5460769,6.469611673758945
SNU-668,107970,2.4249439647555264
NCI-H1650,241158,3.702855511233096
NCI-H1435,9903786,1.8372314189682823
T84,107970,1.2920542062005194
KMS-20,12003241,-1.6984779188581272
RPMI-8226,637858,0.6587174282897974
ONS-76,135421197,2.4329108516652775
BT 139,11396600,2.700615833267889
MDST8,46907787,1.4338285439483007
Hep-G2,selumetinib-JQ-1 (4-1 mol-mol),-0.7772498513580158
NCI-H1755,107970,2.3148125135378548
KHM-1B,46907787,-1.0017805456317357
NCI-H2170,12003241,-0.7011198558518746
JeKo-1,107970,1.751754163116744
A101D,6852167,3.582205934028784
SNU-886,11455910,-0.4283095081187237
MV4-11,5460769,0.4038466040082859
HeLa,12003241,1.4760559160729645
Caki-1,9927531,5.587911994434885
A-253,444795,4.639406715254548
Ku812,644241,-5.729959790836442
NCI-H211,sirolimus-bortezomib (250-1 mol-mol),1.3707117645726492
SW1783,107970,3.037635999927972
ONCO-DG-1,10231331,3.502059620603748
LMSU,375860,0.9440264058556476
COR-L105,73707398,2.56355231698926
TE-8,sirolimus-bortezomib (250-1 mol-mol),1.0878251503851162
IA-LM,637858,2.795809218533269
HEL 92.1.7,375860,-0.1874438560569251
NALM-6,selumetinib-JQ-1 (4-1 mol-mol),-2.6623327843481035
MDA-MB-415,73707398,1.5258742521817483
HCC1143,6852167,2.667487538311212
BT 164,135421197,1.9530013508190165
PC-14,100016,6.551425062945198
OCI-Ly19,sirolimus-bortezomib (250-1 mol-mol),0.0855079956722299
MOTN-1,3689413,-2.530735206047899
L-363,439501,-2.2383513664350394
SK-N-DZ,135421197,1.275457172430967
VMRC-RCW,6852167,3.4570004694788965
SK-BR-3,49766530,-0.361082625264213
SU.86.86,selumetinib-JQ-1 (4-1 mol-mol),2.491154829564457
OCI-Ly19,11455910,0.6096382769703742
NCI-H292,135421197,1.1571557888211337
CAL-85-1,12003241,-1.401340141763049
PSN1,selumetinib-JQ-1 (4-1 mol-mol),0.8634237269595101
HuG1-N,9927531,4.775383733857977
SBC-5,9927531,4.452264212548339
ESS-1,637858,1.315760041448024
MSTO-211H,3689413,-2.1873545800685865
MES-SA,444795,5.074827680340431
RVH-421,71466445,5.483453670429095
NCI-H520,3689413,0.9100551461140616
SNU-1076,49766530,1.189560796158491
PC-14,12003241,-2.6584563263219203
CHP-126,444795,3.714617722830771
OCI-AML-2,136227331,6.356124272356354
CAL-62,241158,3.704320848974484
KG-1-C,12003241,-2.4512871070373476
KP-N-YN,262093,1.320292146111092
SNU-668,12003241,-0.9113554646183494
NCI-H2141,135999136,2.014096560063098
TCCSUP,135999136,4.392620213932673
NCI-H1184,262093,1.9402045938209425
L-363,107970,2.3182024739752123
LOX-IMVI,6852167,2.751037556623792
SUP-T1,12003241,-2.125139255884817
RL95-2,107970,2.164613856567184
RS4;11,UNC0638-navitoclax (1-1 mol-mol),-2.225017135965684
ACHN,637858,2.369370305211161
BT-12,tanespimycin-bortezomib (250-1 mol-mol),0.4298883528890555
HT-1197,71466445,4.752167556586409
MCAS,11396600,3.718076439368648
KU-19-19,241158,4.34083218708613
MKN7,3689413,-1.1623045029840038
SK-MEL-3,135999136,4.927599963416982
WM983B,UNC0638-navitoclax (1-1 mol-mol),4.930439890956027
LP-1,46907787,-2.0895710134477063
NH-6,44491742,4.075747370877145
COLO 201,6852167,3.5682572601097116
CHP-212,637858,1.7500511895355555
G-401,241158,1.9889661714459972
MDA-MB-415,9927531,4.701582574311918
DAN-G,tanespimycin-bortezomib (250-1 mol-mol),-0.938511355699207
A2780,168313016,3.896841135664639
TT2609-C02,135421197,3.994443505891966
CMK,135999136,1.26133129608494
Lu-99,73707398,0.9944479975381392
BT 444,107970,2.33891923497999
BT 482,selumetinib-JQ-1 (4-1 mol-mol),0.6843473878763143
Kelly,11396600,2.808288398090548
SH-4,73707398,0.8791045664416594
NCI-H2122,26596,-0.3703174924227287
NCI-H1184,5460769,-0.2786372914944621
MOLP-2,9903786,4.729359936369518
OCI-M1,9927531,4.777784518044042
SNU-899,selumetinib-JQ-1 (4-1 mol-mol),2.409462633962382
CA46,9927531,3.0223750820915978
OE19,selumetinib-JQ-1 (4-1 mol-mol),4.339166063556634
BT 428,107970,1.3396670576098808
COLO 680N,sirolimus-bortezomib (250-1 mol-mol),1.5905576307574611
TOV-21G,71466445,4.3182150687628695
KYSE-140,73707398,1.695660009720789
COR-L105,46907787,0.7742744471044445
U-118MG,262093,3.0545033004696203
KMBC-2,262093,2.431705852322835
NCI-H1568,11455910,-0.0792581795853734
TOV-112D,168313016,5.522653694343065
CAL-51,12003241,-1.2189714227076325
JHUEM-3,6852167,2.2177056670449105
KNS-60,10231331,6.3329537184020674
SF268,12003241,-2.0418893916572243
TUHR14TKB,12003241,-2.6792741920200815
Capan-2,9903786,4.9592857340128385
ESS-1,sirolimus-bortezomib (250-1 mol-mol),0.3261097694928553
A-673,241158,1.6738540084680422
GaMG,11455910,1.9778197277547145
KNS-62,262093,2.8892264309510014
SCC-9,selumetinib-JQ-1 (4-1 mol-mol),2.082538789678548
MEC-1,UNC0638-navitoclax (1-1 mol-mol),3.101091843102834
SK-MM-2,sirolimus-bortezomib (250-1 mol-mol),1.09289711908984
KMS-27,637858,1.2889744461011985
HCC1195,49766530,-2.234197173599504
Karpas-620,49766530,-1.8063473095000468
VMRC-LCD,439501,-2.2001056287042715
SK-MES-1,262093,3.241171035364572
SK-N-BE(2),168313016,5.114415680164609
HuH-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8646931377295993
NCI-H2452,262093,3.2163720661137942
NCI-H1623,12003241,-0.4868602659209724
HGC-27,375860,-1.0398325430166302
COLO 678,439501,-1.1365168855313783
KMS-12-BM,241158,1.5195082823857844
NOMO-1,26596,-2.074766602044621
ChaGo-K-1,444795,4.90712509154543
Kuramochi,5460769,4.70110979591698
MHH-CALL-4,6852167,1.516764811863356
NCI-H2081,262093,2.026605801788383
NCI-H146,44491742,2.6808030102351323
SW948,46907787,2.3709287142369555
EPLC-272H,135421197,1.5481264659951517
NCI-H524,11455910,0.6737102909376176
SNU-16,135999136,4.1641097715500495
KP-2,3689413,-1.979504715969029
AsPC-1,107970,2.236934549480267
D283 Med,tanespimycin-bortezomib (250-1 mol-mol),-0.3446270457541043
SNU-738,637858,2.247136359045344
JHUEM-1,54596490,4.836153565936757
Sq-1,71466445,3.0659362414230795
SNU-668,sirolimus-bortezomib (250-1 mol-mol),1.8089907805416063
BT-12,439501,-3.217940129826054
SHP-77,262093,3.3265672360163374
A-172,9903786,3.6235991814079545
SNU-245,selumetinib-JQ-1 (4-1 mol-mol),-1.0935434340518932
SNU-8,26596,-0.6710039843025739
SNU-878,100016,5.516104284834857
YD-38,selumetinib-JQ-1 (4-1 mol-mol),-0.3338451182587707
BT 139,135999136,1.5889963250911243
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334
IGR-1,168313016,4.4632549660929195
MCF-7,selumetinib-JQ-1 (4-1 mol-mol),2.4423640678398413
EoL-1,439501,-3.7702491221703145
HEC-251,26596,-1.8718311463988424
EBC-1,sirolimus-bortezomib (250-1 mol-mol),-3.1620626490759633
NCI-H441,9903786,3.5452366409305887
VCaP,3689413,-1.1358537127375183
BT 112,262093,1.8523945417932268
JHOC-5,9903786,4.996792602991681
BICR 56,100016,6.239283130221144
HEL 92.1.7,11396600,3.6147449573871735
Capan-1,26596,-0.6895285509385911
CAL-33,46907787,3.1182368809636487
BT 145,46907787,3.740968952451874
NMC-G1,9927531,6.6210082677754984
MOLP-8,11455910,0.4759456923848041
COLO 792,selumetinib-JQ-1 (4-1 mol-mol),-0.9796050035167326
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208
KMS-21-BM,168313016,1.80428760603686
HT-29,107970,2.4408786211606226
NCI-H2052,241158,4.256087222388137
DAN-G,9927531,4.82875872277198
TF-1,262093,2.2730814154629573
OCI-AML-5,10231331,3.33754223031549
NCI-H650,262093,2.723348041118166
AU565,375860,-0.7785666069738753
SUP-B15,135398744,6.752582090660733
OVSAHO,selumetinib-JQ-1 (4-1 mol-mol),3.5066947205839236
MFE-296,sirolimus-bortezomib (250-1 mol-mol),-4.372432753750482
AML-193,375860,-0.9246349933126312
DK-MG,11396600,4.342648785841818
Sq-1,5460769,2.958314651359677
NCI-H1694,selumetinib-JQ-1 (4-1 mol-mol),0.438004270294335
SF126,9903786,3.79320485000813
SNU-478,439501,-2.527106469117114
OCUM-1,107970,1.812300160781112
L-540,262093,1.75189061264014
NCI-H446,tanespimycin-bortezomib (250-1 mol-mol),0.8775659669348672
SNU-C2A,637858,2.233207186626609
IGROV-1,11396600,3.99372654279783
K029AX,375860,0.6414495398180249
L-363,135421197,1.89182184034138
NCI-H2106,selumetinib-JQ-1 (4-1 mol-mol),-0.56613539512018
NCI-H810,107970,1.4646038858189545
ME-1 [Human leukemia],11396600,3.0194011260213824
MOLM-6,11396600,2.3493263787787244
SNU-626,3689413,-0.5930983813401607
IGR-37,136227331,4.32939216676153
A-549,10231331,2.044831055629592
CL-11,11455910,1.292205129341028
LUDLU-1,sirolimus-bortezomib (250-1 mol-mol),0.877597095580597
GA-10,444795,3.886732538639244
NCI-H929,5460769,1.81013287796662
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
OPM-2,11396600,1.8817984525619431
A-253,9903786,4.10726286628635
HL-60,107970,1.8158418564078016
U266B1,tanespimycin-bortezomib (250-1 mol-mol),-0.8017004823688043
LP-1,100016,3.986438392754067
C2BBe1,tanespimycin-bortezomib (250-1 mol-mol),0.2943844142837441
KMRC-20,11396600,4.3348303945761835
Li-7,135421197,2.8637872744317763
CMK,73707398,1.0162249456833987
G-401,71466445,3.182548969694367
HuP-T4,3689413,-0.6711491165828569
BT 422,sirolimus-bortezomib (250-1 mol-mol),0.5835017840972496
CAL-51,241158,3.781489879449518
CAL-29,135421197,2.48018015495381
SW1088,sirolimus-bortezomib (250-1 mol-mol),0.8011613247197977
HT-1080,6852167,3.24608706290334
SF539,6852167,2.369096859709367
NCI-H1299,439501,-2.475221299124019
Hs 746.T,UNC0638-navitoclax (1-1 mol-mol),1.0511790307872622
HCC2279,241158,5.839446783664071
NCI-H2122,11455910,1.0821419204732732
Ku812,11455910,-0.1088527514294285
SHP-77,sirolimus-bortezomib (250-1 mol-mol),1.6844110283136058
G-361,262093,2.334861127155717
DMS 53,73707398,0.3652360376283804
BT 340,9927531,6.379921104021661
Rh41,168313016,3.825560105528655
NCI-H524,135421197,1.1654489956873584
NCI-H1395,46907787,2.4653160178838354
TCC-Pan2,6852167,2.8611295471217533
IPC-298,10231331,-2.263642508285418
CML-T1,637858,1.454745710944211
PE/CA-PJ41 (clone D2),136227331,5.555158250699494
EFO-27,444795,5.488221670965637
SNU-1066,5460769,2.0075693464583817
KYSE-70,73707398,2.029692143461395
QGP-1,439501,-1.697500396570699
KMBC-2,9903786,2.1846129600819353
OE21,6852167,2.0185127581228763
LMSU,168313016,4.430377140485892
KPL-1,135421197,3.0565693123686617
SU-DHL-10,tanespimycin-bortezomib (250-1 mol-mol),0.050214335602148
MHH-CALL-3,375860,-0.1586420227897289
DV-90,tanespimycin-bortezomib (250-1 mol-mol),-3.2159049827612356
PaTu 8988s,73707398,1.72539191163247
Kasumi-1,11455910,3.359505919978685
TE-10,135999136,5.59737351740663
PL-21,11455910,0.5383649206422021
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691
MJ,5460769,-0.0196671860810318
SNU-503,100016,6.601678520618542
COLO 668,UNC0638-navitoclax (1-1 mol-mol),1.041904598510707
GOS-3,439501,-3.404828566068769
SNU-449,73707398,1.8238531786702632
HPB-ALL,9903786,2.3044154759834847
Panc 05.04,3689413,-0.0862100916213441
HCC1806,3689413,2.70275971282259
BT 228,135421197,1.0231801193279042
BICR 18,49766530,0.9372744186265172
PK-59,11396600,3.5699719356694573
SNU-216,tanespimycin-bortezomib (250-1 mol-mol),0.2069315895115227
P3HR-1,selumetinib-JQ-1 (4-1 mol-mol),3.656805781248008
OCI-AML-3,9903786,2.1236549190588097
Panc 05.04,6852167,2.4950969519348685
CAL-51,71466445,4.7818956768695715
FTC-238,73707398,0.967863994452516
YH-13,262093,3.0071094341497826
GaMG,12003241,-1.1621616673389346
NCI-H647,49766530,1.518533488741799
BT 231,49766530,0.2532028472914431
PC-3,262093,3.07605084151026
SNU-869,9927531,5.42388661469149
P-STS,9903786,4.008586814147432
NCI-H1650,UNC0638-navitoclax (1-1 mol-mol),1.4354883086402157
DoHH2,6852167,2.322695414326351
SU.86.86,439501,-1.025939576051134
Calu-1,73707398,1.2133176360224152
HSC-2,3689413,-2.0236874476208353
HPAF-II,tanespimycin-bortezomib (250-1 mol-mol),0.3261912422307886
NALM-6,71466445,2.5967465437674537
HT-55,10231331,1.030153906918628
SF539,11455910,0.0331728686867912
NCI-H1869,637858,2.4827908237252183
ZR-75-30,9927531,5.796828878545894
OCI-Ly3,637858,0.9478393577089198
HGC-27,11396600,2.081101267240524
VMRC-RCW,49766530,-1.510963658016383
HGC-27,135421197,0.8927042884556606
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528
MKN45,135421197,1.3599393151619537
P12-Ichikawa,9903786,1.487769039842012
OAW28,selumetinib-JQ-1 (4-1 mol-mol),2.156145443592261
Karpas-422,11455910,0.7211757450052372
GP2d,3689413,0.2049378471192219
OCI-Ly10,375860,0.5230976360665899
KYSE-520,439501,-3.151478653175136
Aska-SS,11455910,2.343634234167196
A-204,100016,6.602223097366851
EoL-1,54596490,3.971496787644092
NCI-H929,135999136,4.255812797167961
JK-1,262093,1.0085892511994845
BT 359,selumetinib-JQ-1 (4-1 mol-mol),3.6581943862007416
LAMA-84,10231331,-0.5336947695557159
SNU-387,3689413,-0.310852459101112
NCI-H1339,6852167,2.7157240163412206
TF-1,107970,2.495705780879279
SK-N-AS,135999136,3.841880719801881
NCI-H1838,UNC0638-navitoclax (1-1 mol-mol),0.5563197288031422
U-937,26596,-4.272350751013951
CW-2,tanespimycin-bortezomib (250-1 mol-mol),2.6313334952159844
NB1,11455910,-0.1636183381201439
G-402,168313016,4.5360377997320915
SU-DHL-1,49766530,-4.824875359994143
SNU-308,sirolimus-bortezomib (250-1 mol-mol),1.6825510481181765
KMH-2,637858,0.9367437449814346
NU-DHL-1,73707398,-1.134131669743868
NCI-H1563,262093,2.947853268609805
HCC1569,sirolimus-bortezomib (250-1 mol-mol),0.3856699137888855
NCI-H1435,107970,2.287499744924415
SK-BR-3,168313016,5.907534707953531
42-MG-BA,6852167,2.433379256165192
BT 330,5460769,2.587250000288721
MCF-7,262093,3.511527860265079
NCI-H2444,UNC0638-navitoclax (1-1 mol-mol),3.249927198416822
A-253,135999136,4.704597459303478
A-204,9903786,2.6800363782821517
MOLM-13,241158,1.7093626682651633
SNU-466,168313016,4.749596387848816
HEC-1-B,439501,-2.327113074925545
HCC15,6852167,3.485797740848402
CAMA-1,135999136,1.755447111331727
SUP-T1,3689413,-3.2638224504497195
HT-144,375860,0.9202284793115426
ES-2,100016,6.579379467241575
Hs 944.T,6852167,2.6502457950936837
DAN-G,73707398,1.7178798930780177
BT 112,11455910,0.2027348347828513
SBC-5,6852167,3.965917526242172
NCI-H2452,11455910,0.7111396076654327
HSC-3,46907787,0.9324024386936162
PC-14,10231331,0.5461377223152567
CAL-62,135999136,-5.204307291938572
HSC-4,5460769,1.9290612526481368
HuG1-N,26596,-1.6967804623376053
Karpas-620,9903786,4.2683089971609265
KMH-2,439501,-2.384989575251817
SW579,26596,-1.623870534815972
BT 164,sirolimus-bortezomib (250-1 mol-mol),-0.1632601406357518
NUGC-3,5460769,1.9333841225118369
Hs 294T,637858,1.3922470268743958
NCI-H1373,9929138,7.584401812075051
NCI-H2196,UNC0638-navitoclax (1-1 mol-mol),0.6687398915022545
L-1236,637858,0.7270189908659739
Panc 03.27,241158,4.5818896655025165
NCI-H661,26596,-0.5563822784391794
WT2-iPS,6852167,4.7114285575150765
BT 232,11455910,0.0350412788633053
GA-10,26596,-3.772659675473913
HCC1143,10231331,3.1675049490504943
BT 428,71466445,5.17114192317244
KHM-1B,selumetinib-JQ-1 (4-1 mol-mol),-1.6661106827496956
SNU-1214,12003241,-2.886982661469118
MCAS,439501,-1.7764971276715424
SNU-626,tanespimycin-bortezomib (250-1 mol-mol),0.974779826853052
PE/CA-PJ49,5460769,0.8323029326456293
NCI-H358,439501,-0.5524451893811123
U-87MG ATCC,262093,2.7764008714475317
JURL-MK1,6852167,2.5656057202015923
IM95,241158,4.0998965911685605
OCI-Ly19,375860,-0.4899216845678457
UO-31,644241,1.6075210452191253
KYSE-450,3689413,-0.3124621453247139
BC-3C,9903786,3.0556905946174537
PE/CA-PJ34 (clone C12),5460769,-0.2838566207500756
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218
HT-144,135421197,3.272729024645835
G-402,6852167,2.090716330092647
MKN7,107970,2.1860197697313595
JMSU-1,73707398,1.0584772481895266
NCI-H650,tanespimycin-bortezomib (250-1 mol-mol),0.4769050892801147
ZR-75-1,107970,2.995397749509407
HuNS1,26596,-3.648585672469648
UACC-257,637858,2.517971043881924
NCI-H2126,46907787,2.1585150171474794
NCI-H1581,9903786,1.8918310652044057
Lu-65,12003241,0.1595843887204832
L-363,3689413,0.386026439105166
VMRC-RCZ,6852167,4.45250121529264
BICR 16,107970,2.422420093451505
NCI-H2342,637858,2.6043516467539662
Karpas-422,12003241,0.4573968210074843
OCI-M1,241158,3.69055500632508
KYSE-450,107970,3.4899067291718717
COLO 684,439501,-2.1381820034562944
HT,5460769,1.55908415219926
G-401,6852167,1.9492633511801831
OAW42,sirolimus-bortezomib (250-1 mol-mol),1.527275498618008
G-401,46907787,-0.0293884143124787
TE 441.T,11396600,2.898111820402536
HMC-1-8,262093,2.6952463235362414
TE 441.T,UNC0638-navitoclax (1-1 mol-mol),1.000062005612718
L-540,46907787,-0.1213280736644094
TE-4,selumetinib-JQ-1 (4-1 mol-mol),-0.2694684145255028
NCI-H2228,11396600,3.725847437407865
PC-14,9903786,1.3474672632704163
BT-12,135999136,1.8612722925490397
CCK-81,46907787,-0.7254087381657865
HuNS1,71466445,2.129403545309997
SK-MEL-2,10231331,1.800532200590708
SK-LMS-1,107970,3.0105847397664403
SNU-407,10231331,0.088671458998178
COLO 680N,168313016,5.234421894550309
CAL-29,12003241,-0.9586511485623302
NCI-H23,44491742,4.066691621644064
NCI-H1666,637858,1.967161556580531
MOLT-16,168313016,3.9383617008767295
OCI-Ly19,135421197,1.1485789152916004
RKN,11396600,3.670395083293249
K-562,375860,-0.3542925626582329
Hs 729.T,6852167,2.694469174782692
ZR-75-1,135999136,4.466274366376033
HCC1428,107970,1.710707773894572
KP-2,71466445,5.055512681465278
Peer,241158,2.2186450937544664
NCI-H1651,26596,-1.4213694669265446
GSS,100016,3.718199006522657
SCC-25,46907787,-0.5502677293335551
BT 416,644241,2.228775392817017
BT-16,5460769,2.094030868827637
COLO 829,6852167,4.832673025771979
MV4-11,26596,-2.2629821538239576
M059K,135421197,3.1464794228942488
RKO,135999136,6.045591123054076
PLC/PRF/5,11455910,0.2914890015755099
SUP-B15,12003241,-3.8836552178144848
CFPAC-1,107970,2.8345957706781544
BT 131,11396600,1.7130676585109468
HEC-265,100016,5.251492285111922
RD,44491742,4.422595956491757
SKM-1,73707398,0.3700517012219515
Daoy,637858,2.1279349928795455
NCI-H1869,71466445,5.354012834432668
Lu-99,375860,-0.8428045335797242
NCI-H1105,UNC0638-navitoclax (1-1 mol-mol),-2.607743956042822
OCI-AML-5,73707398,0.4979905922815086
HT,135421197,1.8590236680580152
BT 333,107970,2.568042136344133
A-375,100016,6.005492870785018
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885
AsPC-1,262093,3.2992304028365926
RERF-LC-Ad2,444795,4.5594337932678455
HuCC-T1,241158,4.215812511929855
ECC10,9929138,5.792605196564901
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
HMCB,135421197,2.011360494635396
DEL,26596,-2.2766928538396916
BT 286,375860,0.1606437193581575
MKN7,241158,3.770372619506397
CAL-78,12003241,-1.8526248382085972
THP-1,26596,-4.239434805167959
KMS-34,12003241,-3.0064029669480528
OVCAR-4,sirolimus-bortezomib (250-1 mol-mol),0.1609764343460656
SW1353,26596,-1.2000741302841849
TYK-nu,selumetinib-JQ-1 (4-1 mol-mol),1.2226400408293931
SK-N-FI,26596,-3.6176410664455374
NCI-H1568,73707398,1.0000031751048108
GDM-1,5460769,2.283984174479844
EJM,168313016,4.883313185195125
SK-CO-1,73707398,0.894037962240185
A2058,12003241,1.9511247747481215
CHP-126,637858,1.208684782865996
SW48,73707398,0.6331221198690845
PaTu 8988s,637858,2.70031319298971
WT2-iPS,100016,6.129452507999119
SNU-620,tanespimycin-bortezomib (250-1 mol-mol),-1.6605884966990527
SK-MEL-24,selumetinib-JQ-1 (4-1 mol-mol),-1.505467160134209
OE19,375860,0.3956315927623631
MHH-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.6292839894036704
NCI-H460,135421197,3.2510260026522233
SUIT-2,6852167,4.156327087057675
LUDLU-1,375860,-0.1285972370265223
RPMI-8402,44491742,5.171904167752256
UO-31,73707398,1.1940255314517427
Ki-JK,100016,3.514869011895543
NCI-H661,241158,4.406370209729512
PK-59,444795,4.575943921838248
LOX-IMVI,637858,1.7619736168396252
G-401,12003241,-2.103305079214356
T98G,135999136,1.5843327150060262
GSS,12003241,-1.231369265985878
NCI-H2110,3689413,0.5131338822863976
U-BLC1,12003241,-2.3919609664555543
SW48,375860,-0.9823609780883206
OCI-Ly3,71466445,3.621772786062987
NCI-H838,100016,5.521581837907123
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245
PSN1,100016,3.987578982943132
EKVX,46907787,3.5587951033471112
KYSE-150,135421197,2.7515172040532687
Hs 746.T,644241,2.8412475305578786
RERF-LC-MS,107970,3.001301355490032
MDA-MB-157,136227331,3.870321503168366
Mino,135999136,1.739858930997736
NCI-H2052,10231331,0.0369259699577181
OCI-AML-3,10231331,-4.326304119674098
BT-549,9903786,2.513972936103366
A-172,135999136,2.07127965150468
Ri-1,sirolimus-bortezomib (250-1 mol-mol),-9.474135938791196
LCLC-103H,637858,2.882745745429834
TOV-21G,375860,1.331316468880544
A-549,selumetinib-JQ-1 (4-1 mol-mol),1.5948722522654506
HT-1080,71466445,2.000268821259553
T3M-10,439501,-3.538112606826756
SNU-5,26596,-1.206984929364511
RS4;11,6852167,0.8313885928837619
SF268,637858,2.030315050805783
SNU-46,11455910,2.77319640879208
MFE-296,3689413,0.1325691008190123
LNCaP clone FGC,9903786,4.486079979714403
NB1,11396600,3.5328020412692376
KMRC-3,44491742,3.892317452433475
NB1,6852167,1.7522276332147415
CHP-212,135421197,1.019713131092093
Karpas-422,168313016,4.1332698119868265
OV7,3689413,-5.087599218712134
HT-1080,49766530,-3.575770083541022
BT 359,637858,2.5273498695616627
KCL-22,637858,1.7963655240899727
HCT 15,11396600,4.026693260912133
TE-9,168313016,6.046508255391066
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841
SNU-601,262093,2.665583006952994
YD-10B,9927531,6.486218545334236
KMS-28BM,49766530,-3.0196417815888124
SiMa,3689413,-0.4508724532834644
LN-18,241158,4.2473346445945594
CL-11,sirolimus-bortezomib (250-1 mol-mol),0.3846215058454166
SW1088,selumetinib-JQ-1 (4-1 mol-mol),2.946061724217482
BT 231,44491742,3.9496827176131384
KNS-62,9927531,5.413841173671558
Hs 852.T,46907787,1.758090813443025
WM88,100016,6.2407728308576
Mel Ho,sirolimus-bortezomib (250-1 mol-mol),-0.1905502812400849
COR-L88,5460769,4.328731747643338
NCI-H28,44491742,4.1731257553412116
GCT,375860,-0.0653979815404537
SNU-620,46907787,-0.9958322433999224
BT-16,168313016,4.373316472356694
MES-SA,6852167,3.4530557014146024
EN,sirolimus-bortezomib (250-1 mol-mol),1.0494581662942
Ci-1,44491742,4.040597879597693
BICR 6,637858,2.1920881342545773
RT-112,10231331,2.3318477678961367
HCC1438,46907787,4.671733521099006
TYK-nu,135999136,4.524317210504986
253J,44491742,4.062821625609178
HCC1395,3689413,-0.620515875859175
PE/CA-PJ41 (clone D2),3689413,2.5059514962832536
HCC1171,73707398,1.2245906470205266
LS180,73707398,1.191690395470446
SW1271,3689413,-1.2412691685690602
MIA PaCa-2,375860,-0.6403278633855397
RT-112,selumetinib-JQ-1 (4-1 mol-mol),2.905178034325965
RS4;11,46907787,0.1973276065334859
HT-144,107970,1.7664193063263929
SNU-16,tanespimycin-bortezomib (250-1 mol-mol),-3.234515138053412
HCC827,73707398,1.1622787671814725
HT-1197,46907787,2.8838222010198975
NCI-H810,644241,1.7813212984436453
42-MG-BA,439501,-2.6369598322141967
SNU-398,71466445,4.422743395241771
OVCAR-4,73707398,0.9342396451955234
BT 248,9927531,4.7076279917818225
SCC-9,11455910,1.869884665357408
HEL,439501,-2.350875236844296
Panc 03.27,73707398,1.02648838548017
5637,10231331,4.7519859123848285
Kelly,241158,3.0916607727606333
MSTO-211H,UNC0638-navitoclax (1-1 mol-mol),-1.567850255531391
EB1,5460769,0.545957183213574
MOLM-6,10231331,-0.5102428611078511
BT 172,73707398,1.3761444311807098
T3M-10,11455910,0.8263435212921274
NCI-H810,444795,3.9825694306913086
CW-2,135421197,1.1852786816312322
SCC-4,12003241,-1.1287847624263156
PE/CA-PJ34 (clone C12),9927531,5.274687585125943
COV644,3689413,-1.4992872949818017
NCI-H1341,selumetinib-JQ-1 (4-1 mol-mol),2.3331984343698045
SK-MM-2,100016,6.381158442456996
M059K,tanespimycin-bortezomib (250-1 mol-mol),0.2006380895510879
GCT,71466445,3.865548826740254
JVM-3,9929138,5.001902882551054
HCC1395,9927531,6.948950349672662
GP2d,100016,6.428285689025714
Ci-1,26596,-1.6175201482887698
KMRC-1,439501,-2.7889227637684773
NCI-H520,439501,-2.5978412941351405
MOTN-1,UNC0638-navitoclax (1-1 mol-mol),1.0336260327177484
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961
PL-21,11396600,2.4757103369664084
A-253,241158,3.928835071598182
PaTu 8988s,sirolimus-bortezomib (250-1 mol-mol),0.5300595749454592
MFE-296,262093,2.4223872491935077
AU565,135999136,4.178255303593246
SK-MES-1,3689413,0.2897315368024132
COLO 680N,selumetinib-JQ-1 (4-1 mol-mol),3.283056644335128
G-401,5460769,-1.872739736028161
TE-4,11396600,3.940884116586543
COV644,6852167,1.9451043894831948
Ci-1,12003241,-0.8991759784993727
Mono-Mac-6,49766530,-0.8039148598736047
KP-2,637858,3.1748941243834103
TE-1,12003241,-0.9529252226933594
HMC-1-8,135999136,4.399756896007318
Panc 04.03,262093,3.918875507815306
HEC-1-B,11396600,5.535370939543194
BT 359,44491742,4.570849750938812
LOX-IMVI,3689413,-4.023880524547255
RERF-LC-A1,644241,2.932089965738435
DU145,135421197,3.2080942542888056
NCI-H1666,3689413,1.2654271755000104
DK-MG,135398744,6.3715043377255665
KO52,241158,3.6727095918533
HCC1438,12003241,-0.2782249625748692
HT-1197,135999136,4.533058673840764
JHUEM-3,439501,-2.1632963006772075
HT115,262093,2.8442241689305123
YAPC,262093,3.6115167721531343
TE-15,107970,2.289738953976788
MOLT-16,71466445,1.8215054764803564
MOR/CPR,375860,-0.6619931812165856
NCI-H2087,11396600,3.1581134421925
SH-10-TC,439501,0.97642019578469
LUDLU-1,73707398,1.875547807805639
NCI-H196,9927531,5.55374615852481
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
T24,5460769,2.1302621758873435
NCI-H292,637858,2.5198155256882813
SF295,241158,3.864746766488878
BT 112,135421197,2.023572470173789
BHY,135421197,2.210170489791885
MOLP-8,3689413,-2.303477592076259
BT 231,375860,-0.0580384195874913
SW982,73707398,0.9471359795057472
CAL-51,71466445,4.7818956768695715
OS-RC-2,44491742,4.539389041576503
Daoy,6852167,2.893676835078427
OVCAR-4,11396600,4.545943819655395
A4/Fukuda,selumetinib-JQ-1 (4-1 mol-mol),-0.1942413967070371
C2BBe1,selumetinib-JQ-1 (4-1 mol-mol),1.7438038372946627
PE/CA-PJ49,26596,-2.486533753867605
LP-1,11396600,4.222971690174634
TF-1,135999136,1.260535287279569
Kelly,135999136,1.6211634256627956
F-36P,26596,-3.451633292118186
SK-LU-1,12003241,-2.6616586719339725
BT 333,73707398,2.80004003661401
MDA-MB-157,12003241,-1.4339892472843776
RPMI-8402,9903786,1.556072952295762
HCT 116,5460769,4.292752734346336
CCK-81,241158,4.130700497746359
OUMS-23,11455910,4.2280456550760235
UO-31,46907787,1.771308845530738
NCI-H2106,3689413,-2.547861084772001
SK-LMS-1,135999136,4.540087324054403
MFE-296,6852167,3.968241432358567
GSS,selumetinib-JQ-1 (4-1 mol-mol),-3.114554328810234
NCI-H2009,135421197,1.5480281661357902
A-204,135421197,1.5277781833550137
Hs 683,107970,1.9317129294379751
NCI-H1341,262093,2.9706231896058823
COLO 678,11455910,2.071395728825759
MDA-MB-453,71466445,1.9167870178623896
NCI-H1105,11455910,0.5219957952901316
MDA-MB-157,107970,2.1200224507121868
OCI-AML-2,9903786,1.7653976313293729
BT 440,10231331,0.8389226179977666
KE-37,241158,2.42379613610841
KMS-26,73707398,0.2889997068369305
GaMG,168313016,5.769923785934136
GCT,sirolimus-bortezomib (250-1 mol-mol),1.1354554226801
KCL-22,9929138,6.476952108797493
CAL-33,44491742,3.945687581773722
TF-1,sirolimus-bortezomib (250-1 mol-mol),0.3198417316245446
Karpas-422,135421197,2.168063446429243
MDST8,637858,1.7716899628344815
Pfeiffer,5460769,3.50798965945468
CML-T1,100016,5.302267949835527
CL-11,135421197,1.4144894380219903
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
U-937,9903786,1.2748798795403693
K029AX,168313016,6.147743390869082
SUP-M2,UNC0638-navitoclax (1-1 mol-mol),0.3542006408694472
Lu-65,241158,4.2277525357675705
NCI-H69,11455910,1.576050849827518
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
42-MG-BA,11396600,3.992983938802259
HSC-3,5460769,0.5796773846600773
Hs 688(A).T,73707398,3.3637618147673276
HCC1195,100016,5.060252338886612
CML-T1,46907787,-0.5465083296094366
NCI-H716,135398744,6.457168364956761
HL-60,168313016,4.321395169470036
MDA-MB-415,135999136,4.973861835319697
BT 147,selumetinib-JQ-1 (4-1 mol-mol),1.3824985900887286
TCC-Pan2,262093,3.1215793064839903
NCI-H460,637858,3.384702960830197
HCC1954,375860,-0.3791480952403591
Karpas-422,46907787,-1.7872558374884018
BL-70,9927531,3.241092589782463
SF268,9927531,3.0957828421568396
A-204,54596490,4.718810668338487
CJM [Human melanoma],49766530,-0.5091083947600985
EPLC-272H,3689413,0.721701872436853
KP-4,12003241,-0.2003950722684058
WM88,375860,-0.1387933856952615
GSS,5460769,0.9437954326098514
PE/CA-PJ49,107970,2.309472784516984
CCF-STTG1,637858,3.1960196819129343
IMR-32,6852167,1.9156173636084908
BHY,439501,-2.5036111867595823
HuNS1,168313016,5.986857407824858
COV434,tanespimycin-bortezomib (250-1 mol-mol),-0.6221104075249205
HMC-1-8,9929138,7.281868070980933
Rh41,26596,-2.117854193038536
MHH-NB-11,12003241,-1.5354599516868075
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225
TUHR10TKB,46907787,3.6384939383070662
SUP-M2,71466445,2.643802810982145
COR-L51,9929138,5.641097380037884
MPP 89,3689413,-2.191379674666751
NCI-H2291,10231331,0.770730162794698
GB-1,selumetinib-JQ-1 (4-1 mol-mol),4.142934403640131
HT-1080,UNC0638-navitoclax (1-1 mol-mol),3.1453657978309937
HCC1195,46907787,3.546738673188822
Rh18,44491742,3.876019031257375
REC-1,3689413,1.860618150322578
SEM,3689413,-0.1393923728957227
MKN45,3689413,3.361842209441358
CAS-1,637858,2.6727632637471848
NCI-H1792,6852167,3.9268827346397264
Ri-1,44491742,3.935960320926185
KP-N-SI9s,49766530,-2.2767545360017407
SR,sirolimus-bortezomib (250-1 mol-mol),-4.8079752577906625
COLO 205,12003241,-1.1256209046349093
NCI-H1650,3689413,-2.359636469082647
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566
OPM-2,46907787,-3.368300500627006
P31/FUJ,6852167,1.016015239887951
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
SK-N-AS,9927531,4.866192814831014
HT-29,10231331,3.491390747008782
MIA PaCa-2,262093,3.1147038686055812
LAMA-84,262093,2.21531989487936
HT-29,262093,3.4460135622894263
253J-BV,73707398,1.865307102666125
TCCSUP,9927531,4.77726983491798
SNU-478,9903786,1.906264308135136
Hs 766T,71466445,5.502653015711173
RVH-421,26596,1.0810327973270226
TUHR14TKB,241158,1.8223582935360012
Mono-Mac-1,644241,2.275828690099689
MCF-7,71466445,4.436792389060464
OCI-Ly19,10231331,0.2879784016430623
SUIT-2,12003241,-0.3419407469483631
SNU-407,11396600,4.026955307306754
NCI-H1341,168313016,4.195064479213196
PLC/PRF/5,11396600,2.8035721911913645
COLO 678,46907787,3.489005746708635
ST486,26596,-3.6953345637142063
YD-8,11455910,2.3608003231552717
RD-ES,12003241,-1.2305184687153958
BC-3C,637858,3.302055844369792
Daudi,54596490,4.948926549609605
NCI-H2110,100016,6.079052375839209
SNU-387,241158,4.027101114870974
MKN1,UNC0638-navitoclax (1-1 mol-mol),3.1350259693808926
COV362,439501,-2.4929175140704443
ACHN,3689413,-2.388175172833965
SUP-M2,100016,3.7473632933772394
Hs 578Bst,11396600,3.7098372009722262
KLE,9903786,3.130074514321622
KYSE-70,107970,2.5727619321994353
SNU-1214,135421197,1.3172671598461234
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904
KMS-12-BM,107970,1.2280769647153718
PE/CA-PJ34 (clone C12),44491742,3.733326745267952
HT-144,100016,6.638904024373049
VMRC-RCZ,644241,2.9068882426131313
Li-7,12003241,-1.919504874807884
JURL-MK1,375860,-0.9544947155395412
SEM,49766530,0.1216347460182048
SF126,12003241,-0.8562047407383144
SK-MEL-24,241158,4.25425778982335
TE 441.T,644241,1.5282801612003003
SNU-1196,262093,3.697852439265109
SNU-761,11455910,-0.2070657020305296
YAPC,135398744,6.484368053683043
KMM-1,71466445,4.780709751917369
NALM-6,100016,5.173644166821544
MDA-MB-361,selumetinib-JQ-1 (4-1 mol-mol),0.7975844110985498
BICR 18,72967,3.609620563730147
NCI-H2291,UNC0638-navitoclax (1-1 mol-mol),0.0684358892424717
BT 224,11455910,0.6330255553599808
NB4,100016,6.294523599868374
697,tanespimycin-bortezomib (250-1 mol-mol),0.0075427877175817
Mel Ho,tanespimycin-bortezomib (250-1 mol-mol),0.3102733441080628
SW1271,49766530,-1.8216621121390524
BT 482,241158,4.269412013532964
TF-1,439501,-2.265040568492349
HSC-3,375860,-0.7997603409835673
NCI-H1693,439501,-5.586339578501797
KYSE-70,375860,-0.042936769343065
Daudi,375860,-0.7416229308895455
SNU-16,375860,-0.954947659547355
WM266-4,11455910,-0.4355783836702207
HCC1195,107970,3.035088271235786
COLO 201,12003241,-1.3508897145637075
SNU-626,49766530,-0.2308457798178905
SNU-16,sirolimus-bortezomib (250-1 mol-mol),-0.2778167709338917
TE 441.T,26596,-1.4712296697044354
PaTu 8988s,10231331,2.3383323035983787
NCI-H1915,tanespimycin-bortezomib (250-1 mol-mol),-3.029490834381303
UACC-257,439501,-1.398087538451765
SH-4,12003241,-2.3432697923698083
MDST8,262093,2.389063867163299
JHH-5,644241,1.6912278541244328
DMS 273,46907787,0.4735517334159472
OVTOKO,168313016,5.682190141491144
NB1,73707398,0.8206064026989972
RMG-I,262093,2.363268635735914
IST-Mes1,46907787,2.643041583848796
M-07e,439501,-3.111960923766982
BICR 56,135421197,3.0441014153106893
IGROV-1,9929138,6.483056540257463
Caov-3,5460769,3.7832431235533903
COLO 201,10231331,-1.1140410692145708
HeLa,6852167,3.9174873228525353
EFO-21,6852167,4.52142922121983
BT 172,UNC0638-navitoclax (1-1 mol-mol),1.816912544797352
EFM-192A,46907787,2.276348372522029
KMRC-1,44491742,6.09620831621162
ST486,262093,0.8785422298451224
SUP-B15,11396600,3.1558477769861892
KLE,637858,1.7560393431403896
HGC-27,9927531,3.8749849093672744
G-292 clone A141B1,sirolimus-bortezomib (250-1 mol-mol),-0.3022581749422651
TUHR14TKB,262093,2.19350220661364
TE-15,637858,1.9944393508197875
NCI-H1650,73707398,0.7010144240165336
HCC15,12003241,-1.0460858766179792
NCI-H1155,107970,2.2957080194510437
HuT 78,sirolimus-bortezomib (250-1 mol-mol),-0.0760803060705267
Hs 578T,73707398,0.3948619170486216
RL,44491742,3.724190928980732
BT 164,selumetinib-JQ-1 (4-1 mol-mol),2.475873893186851
Calu-3,26596,0.6204289833771246
G-292 clone A141B1,26596,-0.9634124714344006
Fu97,46907787,-0.7019075543696672
NCI-H446,26596,-3.841011502431018
MDST8,10231331,0.2022855962524302
F-36P,100016,3.924028764616067
COLO 678,107970,1.689165488290766
A-375,135421197,1.9818816716343688
CAL-51,262093,2.862241975448649
Jurkat,637858,1.7578033949234262
KYSE-450,9903786,5.350068255808832
DV-90,54596490,6.2895799434326
SKM-1,71466445,1.6319589215508703
KO52,46907787,0.3317813334576328
DK-MG,46907787,1.3821864850113783
HuG1-N,9903786,2.6577848330965
NCI-H1666,71466445,3.492343929395081
NCI-H1155,262093,2.304592796713043
Hs 578T,sirolimus-bortezomib (250-1 mol-mol),0.4812309444002518
HEC-151,12003241,-1.83751972949174
COLO 680N,262093,3.064075924679912
8-MG-BA,637858,3.771770795308391
NCI-H716,12003241,-5.132639925352329
NCI-H460,100016,5.855223104671776
HCC1588,49766530,2.4669861757295832
AML-193,11396600,2.463856517722703
HT,9929138,4.348342572684797
DoHH2,5460769,1.245270036002789
EFE-184,49766530,0.8289691461992541
SNU-16,selumetinib-JQ-1 (4-1 mol-mol),-0.036968234082151
NCI-H2023,11455910,0.9302760696412364
A2780,241158,1.61479428578643
CAL-12T,11396600,4.498308812674723
HuG1-N,46907787,3.257301518744958
KMRC-1,100016,6.458679548763862
CAL-148,71466445,3.5849271130179448
Raji,73707398,0.7917635742848352
L-540,5460769,1.6720211707369994
TOV-112D,444795,5.198010345063251
NCI-H526,135421197,1.27710242642961
U266B1,100016,6.458228016262307
697,375860,-1.6013192541839316
CJM [Human melanoma],5460769,2.7678000793867077
Kelly,439501,-0.837700217244781
KYSE-150,6852167,4.365388047600905
AML-193,9903786,0.8964959082150169
KYSE-450,241158,4.285328470501583
KNS-81,3689413,2.13740937168454
JHH-2,71466445,6.302834522641025
NCI-H1975,9903786,1.3990648437170825
HDLM-2,49766530,-0.915068926729708
COLO 829,tanespimycin-bortezomib (250-1 mol-mol),-0.6009535916354974
NCI-H1651,11396600,5.109965211899371
SNU-761,262093,1.8734688668170425
NCI-H661,10231331,4.850159308010921
NCI-H1869,selumetinib-JQ-1 (4-1 mol-mol),1.6697033595632398
G-401,10231331,2.894718734978725
SK-MES-1,sirolimus-bortezomib (250-1 mol-mol),0.6700738424680361
BT 147,12003241,0.4037100837513208
HCC2279,49766530,-1.2949504069495965
SNU-C1,49766530,0.3403545416536475
IA-LM,73707398,1.4255919606814562
LN-229,168313016,5.156674307088484
IGROV-1,5460769,1.6083174601829917
SF268,100016,6.377468220379779
EN,selumetinib-JQ-1 (4-1 mol-mol),5.845147422589704
RPMI-8226,sirolimus-bortezomib (250-1 mol-mol),-1.8682631606171884
NCI-H1568,6852167,2.376266672184036
BT 245,5460769,4.174087021944073
TE-10,selumetinib-JQ-1 (4-1 mol-mol),1.1375794894339473
MOR/CPR,9903786,3.5279183844640305
KP-N-YN,3689413,-0.8084843339395943
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636
SW982,107970,2.5555367756868153
P-STS,11455910,1.4406039312157646
NCI-H647,5460769,0.6003032928308929
SNU-1077,262093,2.74279505858148
CAL-33,135398744,6.573384587063474
L-428,439501,-3.0695670825388848
BFTC-909,12003241,-0.8371396827795129
NCO2,10231331,-0.4964087143893907
SNU-308,tanespimycin-bortezomib (250-1 mol-mol),-1.0172716653448413
OCI-Ly3,11396600,1.20620750211381
NCI-H841,11455910,0.3569598695245802
HuP-T3,49766530,1.2218451996302029
JK-1,9903786,1.7060026782988165
JHUEM-2,3689413,-0.0908621852790934
HCC44,11396600,3.8855375571171846
CL-11,100016,6.945803371228119
DU145,241158,4.174318462840133
A-204,sirolimus-bortezomib (250-1 mol-mol),0.1160777276351835
JJN-3,12003241,-0.0138977078234466
NCI-H1651,135421197,1.3042680543887686
PL-21,10231331,-1.2621716252501856
KYSE-180,637858,2.310022745659766
BT 444,135421197,2.634348679178173
HuH-1,135421197,1.8778683670700504
COLO 201,sirolimus-bortezomib (250-1 mol-mol),2.3709690887392516
YD-8,UNC0638-navitoclax (1-1 mol-mol),2.814214671394628
YH-13,46907787,2.497821160225489
KP-N-SI9s,73707398,0.6857954039664277
BICR 56,sirolimus-bortezomib (250-1 mol-mol),1.89463967365671
JHUEM-2,375860,-1.6699040750668208
JIMT-1,11396600,4.3251237501633675
SK-N-AS,tanespimycin-bortezomib (250-1 mol-mol),0.7232551135734744
DOV13,49766530,-2.036556412816105
KYSE-510,262093,2.791157701495768
SU-DHL-8,9903786,1.70511202729143
Becker,tanespimycin-bortezomib (250-1 mol-mol),-0.8898597294862367
MDA-MB-361,241158,4.008394347858686
MDA-MB-453,46907787,-0.524764523127372
NCI-H929,26596,-1.2167182000669836
JMSU-1,10231331,2.1189745433064515
T84,UNC0638-navitoclax (1-1 mol-mol),2.4353508898299245
NCI-H522,26596,-2.5500947066960276
KMS-34,9927531,3.5487000216351277
SNU-685,49766530,-2.1503606591822364
DoHH2,12003241,-3.729445034849217
PK-1,262093,3.4724760266373087
PE/CA-PJ15,26596,-1.1054075726167758
KNS-60,73707398,0.4331789831099927
SK-MEL-24,107970,1.5448155256300662
COLO 792,637858,1.0332594159439463
T24,100016,6.183675550900896
SNU-C1,168313016,4.005521663397634
TOV-112D,107970,2.816191825989141
GDM-1,73707398,0.4445585345149614
SNU-761,439501,-2.8080514994136
8305C,637858,1.993620328425992
SNU-16,241158,3.7925495758268286
WM1799,3689413,0.6160914431487012
JHUEM-1,107970,2.1854656376588415
NCI-H524,6852167,2.748516407102372
KYSE-450,49766530,0.7642756518369849
MKN74,262093,3.405035629450505
JURL-MK1,644241,-5.066770527926198
HCC95,44491742,3.8054910800445994
LS1034,135421197,0.962643417558857
WSU-DLCL2,5460769,0.924781789272552
KYO-1,262093,2.3511585107741286
TOV-112D,135999136,5.136012887417667
CAS-1,3689413,-1.7594128574941137
NCI-H2030,3689413,1.2400324738328432
HuG1-N,6852167,2.3066185552914593
SNU-387,44491742,4.132370196510326
Calu-1,11396600,3.740782908411944
HEC-1-A,11396600,3.204796240985317
FaDu,262093,2.775295689369596
SiMa,9903786,1.5237540856212457
JHOC-5,107970,2.549485059999082
NCI-H1838,5460769,4.113464535509182
EM-2,11455910,-0.237589126916505
Panc 03.27,9903786,3.06546007586267
KNS-42,107970,2.850114382105987
A3/Kawakami,12003241,0.0304416634107028
WM115,11455910,0.9860510612095932
BT 416,71466445,4.968371844164254
ACC-MESO-1,11455910,1.4227308564953651
COR-L105,12003241,-1.8759508779616432
LK-2,44491742,3.8692951916642353
NCI-H889,26596,-2.687353168028847
MOLT-13,5460769,4.221123357906427
SNU-761,9927531,4.19360542314586
COLO 668,241158,2.3162244242092815
NCI-H1568,135421197,1.29303587511011
MV4-11,375860,-1.038594146310439
T-47D,241158,4.377516241825195
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
GaMG,26596,-1.3647461579215698
FaDu,9927531,4.819445610620238
BT 147,6852167,3.4749398701378515
SNU-840,107970,2.850093670381666
BT 340,5460769,6.248142012309782
U-87MG ATCC,439501,-1.3147544227486891
COLO 741,6852167,4.031174198198206
EFO-27,44491742,4.311239061696844
TTC-709,375860,-0.1104220027434393
NCI-H2171,9927531,3.1501077196413783
COR-L279,UNC0638-navitoclax (1-1 mol-mol),-2.0129718005483785
COR-L51,3689413,-2.4511139859333526
CA46,375860,-0.5712781411665353
D283 Med,100016,3.728925578699804
Kuramochi,44491742,6.028956148879381
PE/CA-PJ49,168313016,4.508662039314565
U-937,168313016,5.149453664972447
DU4475,9927531,3.2558531780718507
Hs 578T,241158,4.135038700144079
YAPC,637858,2.16601707981449
Mino,tanespimycin-bortezomib (250-1 mol-mol),-0.3113346740290634
HEC-1-A,100016,7.347183870003149
MFE-319,tanespimycin-bortezomib (250-1 mol-mol),0.5813484013187771
OVK18,444795,4.809227288639882
COR-L95,selumetinib-JQ-1 (4-1 mol-mol),4.793493423716469
NCI-H2029,selumetinib-JQ-1 (4-1 mol-mol),2.795337882414602
SF295,6852167,3.343016827643526
OC 314,637858,1.1559909710813434
SNU-869,49766530,0.4790816119449209
SW579,44491742,3.723441369263322
BT 187,5460769,4.174601592946769
HCC2108,12003241,-1.7779849182593923
DOV13,tanespimycin-bortezomib (250-1 mol-mol),0.5750258227871521
Mel Ho,262093,2.800747953988144
SNU-668,11396600,4.182067548365165
OAW28,262093,2.853078829548121
SNU-387,637858,3.1289218700109696
ZR-75-30,selumetinib-JQ-1 (4-1 mol-mol),4.4940949952945575
HCC1438,44491742,5.362050315054713
BT-474,439501,-3.058225040966164
JHUEM-2,262093,2.369625461390079
SW579,5460769,2.5889118142562197
Hs 895.T,12003241,-1.2157135831587602
DU4475,644241,1.8384373512088976
LNCaP clone FGC,637858,2.004669804836901
GMS-10,tanespimycin-bortezomib (250-1 mol-mol),0.0800415609138278
ECC10,241158,1.496418149137826
NCI-H1373,136227331,6.256455591315265
BT 286,5460769,1.8515527065353563
NCI-H2405,135421197,1.0087242199460646
A-673,26596,-3.820628112159822
SNU-245,10231331,1.5636115973451816
C2BBe1,73707398,1.453704181016527
Daudi,10231331,6.134507235467236
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853
KYO-1,12003241,-5.7976599099380595
DLD-1,sirolimus-bortezomib (250-1 mol-mol),1.5948066539629249
Caov-3,73707398,0.8005567181272054
Mel JuSo,selumetinib-JQ-1 (4-1 mol-mol),0.9282438421968175
MDA-MB-157,UNC0638-navitoclax (1-1 mol-mol),-2.9600993667864275
NCI-H2196,135999136,3.7154561762942353
M-07e,selumetinib-JQ-1 (4-1 mol-mol),-0.078699162510743
HCC2279,11396600,5.494062372014229
NCI-H1563,9903786,2.6215320097996684
ECC10,262093,1.4663563613449744
AM-38,46907787,2.780926012910743
JHUEM-2,9929138,6.79897920922461
BFTC-909,9927531,5.31835549136936
SW1417,107970,2.060618552310012
A101D,49766530,0.6153321218578233
Hs 611.T,637858,0.871054087636222
JHUEM-7,sirolimus-bortezomib (250-1 mol-mol),-6.320695454237984
NCI-H446,262093,1.6387081415954237
NCI-H1341,44491742,2.77003350871112
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
UACC-257,107970,2.211425151239531
BHT-101,375860,-0.7386088763195126
MOTN-1,11455910,0.7749413706396605
PaTu 8988t,6852167,4.186106645973286
SUP-M2,3689413,-3.139623723794694
DMS 53,54596490,4.264908888356617
LOX-IMVI,3689413,-4.023880524547255
Malme-3M,10231331,-2.99024616185617
IGROV-1,26596,2.910298792762654
HCC4006,tanespimycin-bortezomib (250-1 mol-mol),1.0336276508061957
NCI-H1355,135999136,1.691805478061882
PC-3,135999136,1.552966926323613
BC-3C,6852167,1.631200387252669
HCC-56,9927531,5.667739973718857
NCI-H660,375860,0.3780778676190657
Lu-65,6852167,2.6497392225444103
A3/Kawakami,26596,-1.4802505010126563
SEM,44491742,3.581981402307046
SK-CO-1,444795,5.109688629113172
TE-5,selumetinib-JQ-1 (4-1 mol-mol),1.7443513942912756
GSS,439501,-2.3619517329640782
SNU-216,6852167,2.5800071539870846
SUP-T1,selumetinib-JQ-1 (4-1 mol-mol),-0.508172798980745
MOLP-8,54596490,4.413151323823571
NCI-H2122,46907787,2.248014576758407
GCT,107970,1.7083698024056695
SK-N-AS,44491742,3.868464169325176
HuCC-T1,10231331,4.5361574010300805
NCI-H889,135999136,4.223038519760353
FaDu,644241,3.1108112382917814
OE19,100016,6.21408400033578
CAL-85-1,73707398,2.240426052352089
HuH-28,73707398,0.8791610389008363
NCI-H28,3689413,-1.886606090231827
NCI-N87,26596,-0.8687464208841552
NOMO-1,100016,4.546215242968586
HCC1500,26596,-0.8174609850015592
SK-MEL-30,439501,-0.2056245952948021
CML-T1,135999136,1.353337094400064
SNU-719,9903786,2.245774395512323
CL-11,637858,1.4070270256293935
NCI-H520,644241,4.472644159305388
SK-MM-2,tanespimycin-bortezomib (250-1 mol-mol),1.2255908255092252
KMS-18,637858,1.2526171470027732
Ci-1,71466445,4.362793002044996
TE-11,sirolimus-bortezomib (250-1 mol-mol),1.0808686364833595
TOV-21G,3689413,-2.863324096900296
SF295,9929138,4.960030945136907
Hs 611.T,107970,1.3823074139293197
BHT-101,168313016,4.350384619812103
KMS-34,26596,-3.9045844155365304
RD,26596,-1.141843302094684
NCI-H2110,73707398,1.6375647309525496
MOTN-1,241158,2.7455766578845564
HCC1171,10231331,1.1298251907359
LK-2,6852167,3.0492440780711605
NCI-H520,selumetinib-JQ-1 (4-1 mol-mol),1.7959695418998267
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
DBTRG-05MG,selumetinib-JQ-1 (4-1 mol-mol),1.400104516992479
M-07e,168313016,3.928570731388112
NCI-H1755,46907787,1.530837440029527
EoL-1,3689413,-2.5778346492897266
YH-13,selumetinib-JQ-1 (4-1 mol-mol),2.881387318518872
HSC-2,135421197,2.289170573267479
KMS-34,241158,1.191579890053919
DB,11396600,2.484814775765491
KMBC-2,241158,4.749872704815576
SKM-1,11455910,-0.0252675410510007
NCI-H508,439501,-0.5256588079382335
NCI-H2444,sirolimus-bortezomib (250-1 mol-mol),0.8470480091874228
G-401,168313016,4.483065775660181
YKG-1,selumetinib-JQ-1 (4-1 mol-mol),2.6528510984038864
Rh30,12003241,-2.0054573943466876
JVM-3,375860,-1.2196327473464486
MEC-1,3689413,-2.5144055984412903
OVCAR-4,6852167,3.1722254779927757
COLO 699,9903786,3.444453349709646
VM-CUB-1,selumetinib-JQ-1 (4-1 mol-mol),0.0299329512793566
NB1,26596,-1.7417489155233454
KYSE-70,11396600,3.829938839575827
SUP-HD1,444795,4.9983836585041015
DU4475,tanespimycin-bortezomib (250-1 mol-mol),-2.7587555584503853
BT 248,6852167,2.795606288509473
TCCSUP,11455910,2.681471740921846
UACC-62,46907787,5.687092610783554
Namalwa,sirolimus-bortezomib (250-1 mol-mol),-0.1415528846199467
SNU-175,12003241,-1.252002444372071
A-253,49766530,4.327253973822055
SNU-475,5460769,3.649857099977848
OCI-AML-5,12003241,0.3941324977706439
SW579,6852167,1.90487015320506
SKM-1,107970,2.3266449159028735
OCI-Ly19,9927531,5.466722325400782
SK-MM-2,9929138,0.5464010335439101
HuP-T4,9903786,1.2000554865922293
Hs 746.T,49766530,-0.4715984788298692
WM88,26596,-3.3679469356752465
SUIT-2,135421197,1.9421505415119584
JHH-1,selumetinib-JQ-1 (4-1 mol-mol),2.2841827224917206
NCI-H23,11455910,0.0561940780927377
NCI-H2106,439501,-2.192418172555811
NCI-H1793,9927531,3.368036257397712
COLO 201,73707398,0.9936334998071072
SNU-C5,3689413,0.7822461761518839
HCC2218,11396600,2.588416382808436
JHUEM-7,46907787,-0.7019339701280191
HT-144,241158,4.021482220995618
ChaGo-K-1,11396600,3.1968353669128637
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957
LOX-IMVI,135398744,6.429324407359154
COLO 829,3689413,0.7694296944480054
L-428,26596,-3.3648892390526144
PC-14,439501,-2.395737625467809
Calu-3,49766530,-1.5198016619838384
HSC-2,9929138,4.82243538291714
HT-144,9927531,5.124270234210206
CAL-62,439501,-2.324492116544492
MKN74,136227331,4.503917554589063
GaMG,tanespimycin-bortezomib (250-1 mol-mol),-0.9299125293643992
OCI-AML-5,selumetinib-JQ-1 (4-1 mol-mol),-0.0288655863231173
SW1353,439501,-2.4341280198681248
MHH-CALL-4,241158,1.661305159450415
BT 224,selumetinib-JQ-1 (4-1 mol-mol),4.743283040381324
BT 286,12003241,-0.6969940125697452
Panc 08.13,262093,2.9271884425048404
Hs 766T,100016,6.453782329995662
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731
K029AX,6852167,3.6050393182388225
HCT 8,71466445,2.03705487664743
Capan-2,107970,2.6741892032296875
RT-4,tanespimycin-bortezomib (250-1 mol-mol),-1.2603421044397636
JHOC-5,439501,-1.8314674512872349
NCI-H2342,6852167,3.4879830506373817
Hep-G2,12003241,-0.7040118985216451
Granta-519,9927531,4.885085469625254
ACC-MESO-1,5460769,5.633127442709169
HH [Human lymphoma],71466445,1.7610041408250423
SNU-478,100016,6.124719500368946
VMRC-RCZ,637858,2.5558948315535757
HCC95,selumetinib-JQ-1 (4-1 mol-mol),0.4273461795026718
SK-N-MC,439501,-1.9559444468392349
HOS,44491742,4.672695647178855
KMRC-3,UNC0638-navitoclax (1-1 mol-mol),2.633297765474324
TE-6,3689413,3.2359405444130473
RD,168313016,5.51438068712699
NCI-H2291,6852167,4.73681316056411
COLO 829,439501,-1.3241633043003287
Karpas-299,46907787,-0.0391332663516403
NB4,11455910,0.3286835470988328
JHOS-2,262093,3.1807395255548463
HLF,6852167,3.9661239452653088
TE-11,107970,2.9500167329306692
RT-4,135421197,2.4643711937197756
A-253,11455910,0.0705993826212342
BICR 22,12003241,-0.4808187565312439
HEC-1-A,3689413,-1.724337097738872
SK-ES-1,241158,2.8136344339249275
SW1271,46907787,1.639327018501732
TE-1,439501,-0.5334953492440002
HCC1833,10231331,4.172766842331065
JK-1,5460769,-2.680332547756694
NCI-H1299,100016,6.953805951258825
639V,9903786,3.738179934930431
KYSE-70,135398744,6.338938630156892
K029AX,637858,2.158003562439808
CGTH-W-1,49766530,-0.0096054874021786
KE-97,46907787,-0.8205560600274511
A-204,168313016,4.364596621658886
NCI-H1395,5460769,5.87662281780079
647V,tanespimycin-bortezomib (250-1 mol-mol),0.053073240777135
EB1,375860,-1.1817069193066
COLO 320,262093,2.003306505705094
Aska-SS,49766530,-1.4586728518943333
SNG-M,selumetinib-JQ-1 (4-1 mol-mol),1.4036596659631748
SET-2,100016,6.077577626399248
HCC4006,UNC0638-navitoclax (1-1 mol-mol),-1.371581476675196
G-361,12003241,-2.5867066735550623
IGROV-1,135398744,6.402844237905131
IGROV-1,11455910,-0.2792640061206097
NCI-H1944,71466445,5.389376015988457
KLE,sirolimus-bortezomib (250-1 mol-mol),2.0698040575432572
Calu-3,241158,5.835885626166657
NCI-H1581,26596,-0.8859288398475073
SaOS-2,selumetinib-JQ-1 (4-1 mol-mol),2.075892545487755
Rh30,168313016,5.331123133929558
HuG1-N,UNC0638-navitoclax (1-1 mol-mol),1.1274185196104751
WM115,107970,1.780812210779262
Lu-65,107970,1.8814184481987688
KO52,375860,-1.0348961069797258
GP2d,71466445,4.352014639159245
8505C,637858,1.946970263384462
DK-MG,6852167,2.7662965247819056
PC-14,26596,-1.584314299248499
JHH-5,46907787,2.46563567325675
COLO 201,3689413,0.7393302797479664
SCC-9,100016,6.423023301160456
MDA-MB-415,tanespimycin-bortezomib (250-1 mol-mol),-3.006075352171784
Hs 936.T,262093,3.786495505346027
SK-N-SH,10231331,6.160386015509348
CAL-85-1,54596490,4.44350849938878
Hs 888.T,444795,4.182213673682921
Granta-519,5460769,2.1422187145203897
NCI-H520,44491742,3.7897459257936057
Panc 08.13,6852167,2.816659852155705
RVH-421,107970,3.187164130309253
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
KYSE-510,sirolimus-bortezomib (250-1 mol-mol),0.7044078807643728
EJM,439501,-2.5591027297640565
Mono-Mac-1,241158,3.016187818443372
COLO 684,6852167,1.7245441218599669
IM95,11455910,0.766351703140193
Hs 895.T,135999136,4.261728173473695
T24,9927531,4.8353414036700615
NCI-H2172,107970,2.7119922666869276
TE-8,11455910,0.8822945282493246
COLO 205,6852167,3.347119164765525
MOLT-13,10231331,-1.0231086705106536
NCI-H929,sirolimus-bortezomib (250-1 mol-mol),-3.8848205267511817
Ku812,5460769,3.1615206717567608
NCI-H2444,selumetinib-JQ-1 (4-1 mol-mol),1.4268472301227464
LP-1,241158,2.0926541088677055
HEC-108,262093,2.510970460452122
J82,100016,6.509431143115434
IGR-39,12003241,-1.2962824425712205
HCC2935,tanespimycin-bortezomib (250-1 mol-mol),-2.9372994580333947
SNU-387,6852167,2.3914256143726433
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
WM88,135421197,2.6537583925781054
KYSE-410,135999136,4.574182902915764
QGP-1,49766530,0.3270238560259029
A-673,107970,1.5652885370840817
Sq-1,637858,1.6916403508982327
SW579,375860,-0.3689240744334486
Rh30,10231331,3.76900481174906
KMM-1,selumetinib-JQ-1 (4-1 mol-mol),2.602303806396768
JHH-1,10231331,4.365919080349219
Daudi,168313016,3.9002026806644734
ST486,46907787,-1.2194061813967136
NCI-H716,71466445,4.25396332421541
RKO,12003241,-0.2410566552434749
COV362,135999136,4.490973640630612
KYM-1,tanespimycin-bortezomib (250-1 mol-mol),-2.3069485733891155
DK-MG,241158,3.78846931925535
TE-11,637858,3.1102345821229673
C2BBe1,11396600,3.438018426982882
G-402,12003241,-1.3833657940583168
BT 112,sirolimus-bortezomib (250-1 mol-mol),0.0905666857071608
SW1990,241158,4.5746267223156085
BT 482,135421197,2.625315115733885
KO52,12003241,-1.0632598943321483
MEC-1,241158,2.7058988737419787
U-251MG,9927531,5.06166571476347
PE/CA-PJ34 (clone C12),tanespimycin-bortezomib (250-1 mol-mol),-1.982258316980141
YH-13,9903786,3.849279075978848
LK-2,11455910,-0.0454664251663307
8505C,9927531,4.3206227244137745
AGS,6852167,3.2110227906181876
SNU-423,selumetinib-JQ-1 (4-1 mol-mol),2.511686996120453
SNU-C5,241158,1.6968578329684194
BT 328,sirolimus-bortezomib (250-1 mol-mol),2.117607620911863
OV7,26596,0.3804702126499801
PL-21,107970,1.3819465807660944
786-O,71466445,4.288313305391022
SW1990,6852167,2.6280721153803843
SBC-5,637858,3.033148612268187
Hs 852.T,3689413,-1.1635573957116976
DMS 454,44491742,3.21829880696891
DoHH2,tanespimycin-bortezomib (250-1 mol-mol),-0.3609676807954009
NCI-H1155,135999136,2.1142509404842147
Hs 888.Lu,3689413,-2.4401760719127092
SK-CO-1,9903786,1.8148473241522671
COR-L105,637858,2.3247583240908405
Hs 611.T,44491742,3.458740390209698
MHH-CALL-3,sirolimus-bortezomib (250-1 mol-mol),2.0420007480682925
Capan-1,3689413,0.3362458713829924
A-375,135398744,6.486116496095493
MOLP-8,439501,-2.9296652389863267
NCI-H2087,644241,1.6454264321046088
OV7,selumetinib-JQ-1 (4-1 mol-mol),3.65742971657535
SW982,6852167,2.04801894672205
SCC-25,168313016,4.190269075253486
NCI-H647,3689413,0.6953623673111984
HEC-251,375860,-0.1403385126276384
Capan-2,UNC0638-navitoclax (1-1 mol-mol),2.1905592054300764
TE-1,637858,2.0624451168659657
PaTu 8988s,9929138,5.293231117903689
Ci-1,135421197,1.276790754576014
RL,241158,3.0936457450366057
HCC1171,135999136,4.43426569810154
Hs 822.T,439501,-2.4556830232378712
WM793,135999136,5.309745002054086
BT 333,46907787,6.1383675954590835
T24,637858,2.492000159283808
HCT 8,637858,2.1347621147598206
HMC-1-8,637858,2.1501243127898064
NCI-H1694,44491742,4.026754305354829
Raji,11455910,3.338513112420112
COLO 680N,12003241,-0.3137141462022448
TCCSUP,644241,2.2463977673648823
SBC-5,107970,3.247043743319875
Panc 03.27,sirolimus-bortezomib (250-1 mol-mol),0.6121410442614872
KP-2,9927531,5.1844073401368735
Calu-3,selumetinib-JQ-1 (4-1 mol-mol),-2.481326472415344
BICR 16,241158,4.494291631912356
NCI-H209,439501,-3.220511958386942
OV56,107970,2.635438984490241
Hs 746.T,241158,3.344811066724749
J82,6852167,3.3420386373293685
NCI-H1869,11396600,4.813854369313605
SH-10-TC,selumetinib-JQ-1 (4-1 mol-mol),1.9837436435885376
CAL-33,11455910,1.2995904735860209
Mel JuSo,241158,4.124736524200029
SNU-216,44491742,4.347867819055225
KMS-28BM,6852167,0.671457321927331
OCI-Ly10,sirolimus-bortezomib (250-1 mol-mol),-9.44158843717878
PLC/PRF/5,9903786,4.947267974127204
OVCAR-8,49766530,-0.1649030183556315
MCF-7,73707398,1.774214442125948
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561
HCC-56,439501,0.1637931010538502
Panc 10.05,tanespimycin-bortezomib (250-1 mol-mol),-0.5396853932122618
SNU-685,6852167,3.0753896768893028
SW579,135999136,4.040780810793802
WM266-4,12003241,-2.6604387870862745
Hs 294T,sirolimus-bortezomib (250-1 mol-mol),0.1024720435012197
SW982,12003241,-0.7831418604360746
BL-70,3689413,-1.0284037004933524
NCI-H2110,241158,3.1912359933366465
TOV-112D,644241,3.1066083987990445
LS513,439501,-0.8485123993452164
COLO 668,439501,-2.739607891151669
NCI-H1755,439501,-3.104182815210806
FTC-238,262093,2.848255562611525
P12-Ichikawa,26596,-2.168612597742571
NCC-StC-K140,10231331,-1.373872117719025
SCC-4,9903786,2.916722616299938
SNU-503,10231331,4.23088232579893
ChaGo-K-1,107970,1.9284648709268049
RCM-1 [Human rectal adenocarcinoma],107970,2.147130016699997
HEY A8,444795,4.655736917004839
KU-19-19,439501,-2.2192304341921205
NCI-H2291,168313016,6.023429526313328
HOS,6852167,3.572559775208279
Becker,73707398,1.456292128842472
Hs 944.T,100016,5.802201252997301
JHH-1,5460769,4.810019702724217
KP-2,selumetinib-JQ-1 (4-1 mol-mol),2.520383276264048
KYSE-150,49766530,2.5375392775981913
SNU-1041,tanespimycin-bortezomib (250-1 mol-mol),1.783117356671438
Karpas-422,375860,-0.2340212994929422
Karpas-299,6852167,2.12917908692066
AsPC-1,10231331,1.7826677656602696
NCI-H1573,439501,-2.416114223913521
SUIT-2,135421197,1.9421505415119584
LUDLU-1,46907787,0.7163750513556869
NCI-H2405,12003241,-1.91851712943585
BT-20,3689413,-3.3374276278199972
M-07e,5460769,1.3910333770062682
SK-LU-1,439501,-0.3728808637534341
TE-14,26596,-1.531582993203474
Granta-519,241158,3.1692083740262373
HCC827,262093,3.007487219518493
UM-UC-1,262093,3.285353873808155
GB-1,6852167,3.2720023248760293
BT 147,11455910,0.0190221125535866
Fu97,selumetinib-JQ-1 (4-1 mol-mol),0.2124672849949502
ES-2,3689413,-2.830682661734752
BT 172,11455910,0.4137780640071803
RPMI-8226,6852167,1.5516188067482786
SHP-77,637858,1.6869536628628743
Hs 294T,71466445,3.938194222071139
K029AX,100016,6.8355789955685395
Hs 888.Lu,73707398,1.7025083015610414
KMH-2,3689413,-1.7619354335242607
BC-3C,107970,3.022957216824654
KMBC-2,selumetinib-JQ-1 (4-1 mol-mol),1.4650712581947256
SET-2,9903786,0.1058309934713531
HL-60,sirolimus-bortezomib (250-1 mol-mol),-0.1037456225306153
SU-DHL-1,11455910,0.1271925880707346
CAL-33,9927531,3.2885061744461273
NCI-H524,439501,-1.5131923813940935
IST-Mes1,375860,0.4088289358172842
OVCAR-4,107970,2.404125658896095
Mono-Mac-1,12003241,-3.167077714646063
BT 271,9927531,5.398706995408204
PLC/PRF/5,sirolimus-bortezomib (250-1 mol-mol),0.3197220965800605
SK-N-AS,3689413,-1.598597846908754
NCI-H1650,44491742,4.220144565804619
HOP-92,135999136,4.381843912128879
KYSE-510,107970,2.515593278152379
PLC/PRF/5,135421197,1.8500736721187756
CCK-81,9903786,2.4008516567284848
DK-MG,9903786,4.148261806293546
SNU-46,100016,6.6556000707540095
BT 248,UNC0638-navitoclax (1-1 mol-mol),1.1596436088492943
NCI-H1693,135421197,1.2995160865472135
HEC-1-A,selumetinib-JQ-1 (4-1 mol-mol),1.220922111320793
Lu-65,9927531,5.027796470849251
8505C,100016,6.577733697234268
JMSU-1,9903786,1.2487858864951975
U-118MG,11455910,0.7446076183130194
JHOC-5,71466445,4.945491447820873
NCI-H1694,11455910,0.2193513858726209
ECC12,444795,5.615613038326261
COLO 678,12003241,-1.07618054300688
SK-UT-1,637858,2.463996188946881
SNU-216,26596,-1.178501170162628
Lu-65,5460769,3.7972822070130494
NCI-N87,12003241,-2.470820657410725
NCI-H841,tanespimycin-bortezomib (250-1 mol-mol),-1.639550345576176
Hs 294T,375860,-0.214003047287039
HMCB,375860,-0.2087542288186852
Pfeiffer,9929138,4.431024289942506
SK-N-BE(2),11396600,3.067666885131691
JHOM-1,49766530,1.1391722298569036
COLO 800,3689413,2.0885075938315576
PE/CA-PJ49,44491742,3.950119634705539
Hs 822.T,262093,2.2664804620168693
COR-L88,44491742,3.2658502599700188
NCI-H838,107970,3.016331313127053
NCI-H838,46907787,4.142158924634486
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
DLD-1,73707398,0.9462775715159254
Panc 10.05,135421197,2.5618075811816277
NCI-H647,73707398,1.965831350411136
CAL-85-1,UNC0638-navitoclax (1-1 mol-mol),1.0364537191058536
D283 Med,107970,1.5899675113879286
SW1990,12003241,-1.6004272332343192
Caki-1,3689413,-2.406735628687606
MFE-319,5460769,5.093824644165235
KMS-21-BM,375860,-1.2608056103151717
HCC827,9903786,1.5312362888468285
OE33,71466445,3.9319707229949703
DoHH2,73707398,-1.1852671026116226
PE/CA-PJ41 (clone D2),439501,-0.7748943226504631
SR,11396600,3.1743105813803085
BT 164,637858,1.0928281047696768
L-428,262093,2.197551267633171
BT 482,49766530,0.6927956114386422
CW-2,107970,2.3483421716877393
ONS-76,selumetinib-JQ-1 (4-1 mol-mol),-2.481078216030984
NCI-H211,73707398,0.5175001919026392
KP-N-SI9s,637858,1.6021781453279658
SNU-878,135999136,4.61740204433434
EBC-1,10231331,-0.5164847757495455
HEC-59,71466445,5.0373269237544465
SU-DHL-1,26596,-2.3613305357908625
M059K,selumetinib-JQ-1 (4-1 mol-mol),1.7015071354964328
TE-6,9927531,3.995869764794834
KE-39,10231331,4.477976749120646
RS4;11,107970,1.6679413535699257
SNU-449,100016,6.350050439021361
DND-41,241158,3.5371394102308646
BT 504,49766530,1.1284892746391262
SNU-216,11396600,3.905215698607568
Hs 729.T,9927531,5.3265551472820425
NALM-6,26596,-2.8659414702792128
KYSE-30,439501,-2.11333824600192
BICR 31,3689413,0.760898743899782
SU-DHL-10,100016,5.73425222116556
G-361,135398744,6.4148171061967645
KO52,49766530,-2.9689315906411413
22Rv1,439501,-2.2106497946316175
U-937,tanespimycin-bortezomib (250-1 mol-mol),-0.8253884714136634
LN-18,46907787,1.895990025484258
CCF-STTG1,selumetinib-JQ-1 (4-1 mol-mol),4.9623301985248265
NCI-H2444,107970,2.840600883147425
SNU-449,9903786,3.696408358539977
PaTu 8902,44491742,4.263402068757711
L-428,71466445,2.253432696874775
COLO 684,tanespimycin-bortezomib (250-1 mol-mol),-1.1171395210873645
Granta-519,UNC0638-navitoclax (1-1 mol-mol),-1.1089217343766455
NCI-H522,241158,3.3210308536521156
U266B1,168313016,4.103374457520469
ALL-SIL,selumetinib-JQ-1 (4-1 mol-mol),0.7996490760807272
KMS-34,44491742,2.8856017326933965
Granta-519,107970,1.5911312599666134
WT2-iPS,262093,1.0416118497469489
NCI-H1755,10231331,3.436279502262436
OCI-M1,44491742,3.801673396413645
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
EFO-21,11455910,1.6034546526861042
ACHN,sirolimus-bortezomib (250-1 mol-mol),2.4619171301455736
SUP-M2,12003241,0.982076040273681
HOP-92,73707398,1.019832404417608
KHM-1B,135421197,0.982032972009238
FaDu,135999136,4.400675161067026
SW1353,168313016,6.218366310793427
MDA-MB-361,11455910,0.4388713413004988
NCI-H1694,135999136,3.5133999051844795
HD-MY-Z,9927531,4.2813620085195625
DAN-G,135421197,3.0058015912267475
MOLT-13,3689413,-2.356450494712317
U-937,100016,4.26159584690163
HPAF-II,sirolimus-bortezomib (250-1 mol-mol),1.6842797227364328
NCI-H810,11455910,-0.6368425988840776
BT 440,637858,2.6000641094082635
YD-38,135421197,2.8276318584619022
CML-T1,selumetinib-JQ-1 (4-1 mol-mol),0.8733678884698052
8505C,12003241,-1.423942083306862
NCI-H292,12003241,-1.027467238096921
LP-1,9903786,3.180613462551036
GP2d,tanespimycin-bortezomib (250-1 mol-mol),-3.105115465971025
VMRC-RCZ,136227331,4.757387304339598
SK-CO-1,262093,3.1807391377127376
HCC1195,262093,3.0706321230019635
HCC44,135999136,4.053989707945556
Hs 578T,12003241,-1.9219753364875385
HCC366,46907787,0.88765268675736
PE/CA-PJ41 (clone D2),135421197,1.2532047663272594
DMS 79,tanespimycin-bortezomib (250-1 mol-mol),0.386728913048693
SNU-1077,241158,4.367473186933375
OVCAR-5,444795,4.301907976555397
BT 147,241158,3.953049776749466
U-87MG ATCC,tanespimycin-bortezomib (250-1 mol-mol),0.7593284831518214
C2BBe1,12003241,-0.6014753337621667
SNU-213,5460769,1.7717518807864931
NCI-H838,135999136,4.446245852167806
TE-1,6852167,3.8311272087264814
SK-N-MC,9903786,1.1605258193445984
HD-MY-Z,3689413,-2.31640912661536
OAW28,637858,2.2776250733597085
KMRC-2,54596490,5.045398582154487
NCI-H23,439501,-3.080706529891667
LNCaP clone FGC,3689413,0.5325071990753445
COR-L47,tanespimycin-bortezomib (250-1 mol-mol),1.2425942007865165
NCI-H929,262093,-0.1267697569252451
Hs 888.Lu,selumetinib-JQ-1 (4-1 mol-mol),2.5380306208890744
HuP-T3,107970,2.2315719384591133
MDA-MB-361,135421197,1.0665899538152213
KMM-1,6852167,5.031362845213915
BT 428,9903786,3.72207082245763
KYSE-180,12003241,-0.805265861116592
SNU-601,135421197,1.035367817666236
AU565,selumetinib-JQ-1 (4-1 mol-mol),3.812986745391109
SW1353,241158,3.9499039254187105
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094
HuT 78,439501,-3.2848313932186315
A-375,241158,3.5865598480759413
DB,262093,1.243928535741269
HCC1428,46907787,1.8840160820417653
VMRC-LCD,135398744,6.4569642970049
COR-L95,5460769,3.3963309413836815
SW1463,10231331,-1.1566445252598772
HEC-1-A,135999136,4.326266563149784
SKM-1,9929138,6.747336348801134
SNU-213,107970,2.2765725167688045
L-1236,73707398,0.6462128656528482
Hs 934.T,262093,2.035260189129304
DMS 79,11396600,3.318439325862458
PF-382,12003241,-3.7051147214471114
SNG-M,11455910,-0.2567139520485192
Detroit 562,12003241,-1.0092858141729106
TOV-21G,135999136,2.1034760470617138
SW48,12003241,-0.9746028071684796
ZR-75-1,637858,1.8695576554878648
LN-229,241158,4.166915058651339
COR-L279,72967,3.602139194156965
SF539,46907787,0.2074640579250286
KALS-1,375860,0.6178760797597267
PF-382,6852167,1.6136489506938916
MOLM-16,26596,-3.9817084754511782
SK-MEL-24,11396600,3.3796631473976135
TE-5,tanespimycin-bortezomib (250-1 mol-mol),-0.0271595153409523
BT 147,136227331,3.829920256470893
Granta-519,637858,1.0013506713179747
VMRC-RCW,135421197,2.019130008458573
EB1,44491742,3.4704982889402545
HD-MY-Z,11455910,0.2534017769980389
NCI-H810,sirolimus-bortezomib (250-1 mol-mol),0.258624131959815
42-MG-BA,73707398,0.9751037110279231
SK-MEL-2,selumetinib-JQ-1 (4-1 mol-mol),0.1209546449517723
NCI-H2106,135421197,0.6471538236638695
HEL,71466445,1.5745300131733593
NCC-StC-K140,73707398,0.6748262049833047
CML-T1,439501,-2.361432010025089
Hs 611.T,6852167,0.4305744814723918
JK-1,73707398,0.3515563744907511
MIA PaCa-2,selumetinib-JQ-1 (4-1 mol-mol),-0.019734255481758
PK-59,262093,2.249881918634125
RT-112,9903786,2.0638797497197237
HT-1376,11455910,0.3601219062444335
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678
RVH-421,tanespimycin-bortezomib (250-1 mol-mol),-0.2539281679768233
SK-MEL-30,3689413,3.4376299216272685
NCI-H2110,375860,0.2017557628381111
A2058,637858,3.1141521678001114
KMS-27,107970,2.0805071505254107
IST-Mes1,135999136,4.360333625305844
HCC2108,10231331,3.026437227257123
BT 239,46907787,1.748010103728736
UM-UC-1,3689413,0.3078714826369425
SNU-1214,107970,2.341829699130604
BICR 56,3689413,1.5922116280396923
SNU-601,107970,2.326433259827754
JHUEM-7,6852167,1.350724801432494
HEC-108,sirolimus-bortezomib (250-1 mol-mol),0.3537850835558722
TF-1,11455910,-0.5944245496950694
GSU,73707398,1.504061003792855
8-MG-BA,262093,2.906826185305208
SCC-9,5460769,4.655053652221148
NCI-H661,71466445,2.1620252686029646
SNU-C4,262093,3.503220082312251
SK-N-BE(2),241158,2.5701082208436477
NCI-H526,6852167,2.93402855712139
Capan-1,9927531,5.621022347820903
NCI-H2023,262093,3.744435284140356
Hs 888.Lu,9927531,5.408720252144841
Rh18,439501,-2.3237711161162102
HCC-56,73707398,1.6052927593856017
BT 340,262093,2.384282781054805
Ku812,71466445,2.9617943038056858
SU.86.86,262093,3.327893877156399
NCI-H28,262093,2.707398146289125
NCI-H508,136227331,4.38758043299591
Lu-65,selumetinib-JQ-1 (4-1 mol-mol),-0.4610963672816198
EM-2,241158,2.6622179540907283
RL,UNC0638-navitoclax (1-1 mol-mol),0.9240725003614388
HT115,6852167,3.3430367149018596
COR-L95,439501,-1.1523844892623298
HCC1954,107970,2.2705367149515543
MCAS,637858,2.160945503625874
Daudi,9927531,3.2507934675389447
NCI-H522,644241,2.1349742590503427
BICR 31,11455910,2.0785566961581186
RCH-ACV,135421197,1.024054023197644
UM-UC-1,135421197,1.1725143747551234
BHY,73707398,1.0886291662008367
Pfeiffer,46907787,-2.4243616059921864
MDA-MB-157,262093,2.565616950913742
NCI-H1869,107970,2.0096354902950178
GP2d,637858,1.5344934743402423
BT-20,9927531,4.105614320548644
Ishikawa (Heraklio) 02 ER-,tanespimycin-bortezomib (250-1 mol-mol),-0.660556469573982
AML-193,5460769,4.1891717596196205
SK-MEL-24,tanespimycin-bortezomib (250-1 mol-mol),-0.1831765254782449
IGR-1,107970,1.916732154292642
NCI-H841,375860,-0.3820365701601304
CAMA-1,3689413,0.0263776901636627
Ku812,168313016,4.091505378923506
MSTO-211H,73707398,0.6990065379334892
TCCSUP,selumetinib-JQ-1 (4-1 mol-mol),2.2207378270123725
HSC-3,6852167,3.108712764007485
SU-DHL-8,selumetinib-JQ-1 (4-1 mol-mol),0.9864241326692214
KATO III,9903786,1.8271137188030744
SK-ES-1,selumetinib-JQ-1 (4-1 mol-mol),3.2551720376366022
SNU-1077,10231331,3.484337251970082
SW1417,46907787,1.724855594045881
AsPC-1,439501,-1.6009280184427317
RPMI-7951,3689413,-1.832371720912868
JHOM-1,selumetinib-JQ-1 (4-1 mol-mol),4.373142511310138
HPAF-II,107970,2.753042652639578
OS-RC-2,selumetinib-JQ-1 (4-1 mol-mol),3.295482739639699
KPL-1,11396600,3.5604078040671796
OAW28,12003241,-0.542287488877267
COLO 668,54596490,5.118300220706665
BT 328,241158,5.267624320159163
NCI-H23,12003241,-0.7384604538146603
HEC-6,5460769,3.976458521596205
MFE-319,637858,3.461230658478568
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331
Hs 729.T,tanespimycin-bortezomib (250-1 mol-mol),1.0644356767516514
BT-474,262093,2.736655857570439
SKM-1,168313016,3.949913306453134
Kasumi-1,107970,1.9349338275651868
KMS-20,5460769,-0.4034471516809727
639V,241158,4.254110598517854
OCI-AML-3,sirolimus-bortezomib (250-1 mol-mol),0.125209205535959
NCI-H2110,26596,-0.8689069076907829
NCI-H2452,100016,6.6405878618594985
NCI-H716,tanespimycin-bortezomib (250-1 mol-mol),-2.992165698836288
MOLP-2,3689413,-0.0389139812968664
HCC-56,tanespimycin-bortezomib (250-1 mol-mol),1.6383234075963011
A2780,107970,2.1177540249197246
JHUEM-7,tanespimycin-bortezomib (250-1 mol-mol),-0.0825179950707132
TCC-Pan2,11396600,4.21456785581041
SNU-182,135999136,4.249172509573539
Peer,49766530,-3.815848082576589
NCI-H522,637858,0.9732265340904396
NCI-H1092,439501,-3.60207444945155
BT 131,241158,3.979093045578545
DMS 114,UNC0638-navitoclax (1-1 mol-mol),2.3153747752746834
SaOS-2,26596,-1.8442798913702467
CAL-85-1,644241,2.606352757440632
NCI-H2087,71466445,4.206842460124275
MG-63,375860,-0.4723696527252595
KMRC-3,6852167,2.76779483892737
ONS-76,11396600,3.887590392789339
RL95-2,439501,-2.2732011177914586
EFO-21,10231331,4.759276702825322
NCI-H650,3689413,-2.023136862594463
Ki-JK,46907787,-0.7224055491880652
HCC1937,6852167,3.606828986673197
TE 441.T,135421197,0.4096443090762519
RERF-LC-MS,100016,6.56071523320666
OC 314,241158,3.741404759579216
ONCO-DG-1,5460769,1.9256836095204335
ACHN,5460769,0.8804471145118281
HCC38,375860,-0.35863164801815
A-549,12003241,-1.903076073453771
ESS-1,54596490,4.349195883265103
WSU-DLCL2,26596,-2.173424611684264
SR,135398744,6.424256669199728
HEC-1-A,136227331,4.058497716463453
23132/87,44491742,4.505625737535984
COLO 829,637858,2.2097100379550936
L-363,637858,1.4329368390332162
BV-173,5460769,1.1539249163538905
HD-MY-Z,9903786,3.5223384929798187
TYK-nu,71466445,3.026483876560308
NCI-H1105,9903786,2.2828684981562013
SYO-1,3689413,0.2165411688819273
SK-ES-1,12003241,-1.52997414629941
HOP-92,9927531,4.8467416959319625
Hs 746.T,tanespimycin-bortezomib (250-1 mol-mol),-0.2857851889987055
MG-63,135398744,6.808455799902383
KMS-27,selumetinib-JQ-1 (4-1 mol-mol),-2.808360563321437
COV362,5460769,5.303432014507575
NCI-H522,11396600,3.374818989992459
MeWo,637858,1.1064250861176543
K-562,9903786,3.6050720376028105
LoVo,241158,4.012317425862525
SHP-77,100016,6.499498313563913
EHEB,262093,2.39806678929768
Kelly,9903786,1.651293069080272
MKN74,73707398,1.2954691116779045
ACHN,73707398,1.6311925065880293
HLF,135999136,5.433599477864868
JHUEM-7,262093,2.8461427698978197
NCI-H2228,6852167,4.0498001150674225
NALM-6,9929138,5.239590555889495
2004,637858,1.3330020321957723
NCI-H1944,11396600,2.88322672555981
Hs 683,selumetinib-JQ-1 (4-1 mol-mol),3.498842094614085
SK-N-BE(2),71466445,2.4935058531452414
Hs 729.T,54596490,5.7619879899039095
DAN-G,12003241,-0.4522104330137063
LCLC-97TM1,637858,1.4157632634757724
SNU-1079,262093,2.756274169770221
TE 617.T,UNC0638-navitoclax (1-1 mol-mol),1.3072146472034474
BT 422,6852167,4.1385741646892145
BICR 31,46907787,2.190433361645711
KATO III,tanespimycin-bortezomib (250-1 mol-mol),0.4150623185921985
SIG-M5,637858,1.0348469848357038
HCC1833,135999136,4.219025793158123
BICR 16,sirolimus-bortezomib (250-1 mol-mol),-4.146745756723436
WM266-4,3689413,-0.1379446477721048
K029AX,107970,2.970679690534556
WM793,10231331,2.277080944837622
YKG-1,241158,4.094206621053088
ChaGo-K-1,73707398,1.0973603524165894
OE33,9927531,5.791665708309609
OCUM-1,UNC0638-navitoclax (1-1 mol-mol),0.1567632695939746
A3/Kawakami,9927531,2.786138883968946
MHH-NB-11,107970,2.4568673024890604
Calu-6,136227331,4.4599645259954555
Hs 766T,439501,-3.031090708237588
BL-70,44491742,3.343909693711406
Panc 10.05,637858,1.877223323246833
NCI-H1869,9927531,5.985290716685452
COLO 668,sirolimus-bortezomib (250-1 mol-mol),1.0327595793559854
EoL-1,tanespimycin-bortezomib (250-1 mol-mol),-1.822520413880902
MeWo,sirolimus-bortezomib (250-1 mol-mol),0.5468033899342802
NCI-H520,71466445,4.442767515504577
OS-RC-2,12003241,-1.2099466565873536
NCI-H1339,tanespimycin-bortezomib (250-1 mol-mol),-2.1721885896548514
HT-144,71466445,4.558955973709899
SK-LMS-1,10231331,6.028475115684305
BT-20,135999136,4.456503311518702
SK-N-DZ,selumetinib-JQ-1 (4-1 mol-mol),1.491892256324692
A-204,UNC0638-navitoclax (1-1 mol-mol),2.407510176104919
GCT,9927531,4.599543435598106
EKVX,10231331,2.2534490436168766
RT-4,444795,5.14749831666829
P12-Ichikawa,107970,2.3007298588505702
KO52,135999136,3.8823895578085743
TE-6,UNC0638-navitoclax (1-1 mol-mol),3.0125565049053487
SU-DHL-10,241158,3.096931304704652
BT 145,44491742,4.062519071433911
RKN,3689413,-4.085525957083088
BFTC-909,100016,5.8134150302243865
HT-144,44491742,3.9121735247647127
TE 441.T,241158,4.026754207652904
BT-549,5460769,6.35928800843138
Caov-3,11455910,2.963871199363813
SW1353,tanespimycin-bortezomib (250-1 mol-mol),-0.2663421154423994
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
NCI-H2126,439501,-1.6048735298353825
HEC-1-B,9903786,3.578370658582295
Ki-JK,107970,0.4876893584938715
TE 617.T,241158,3.7218678617090046
SNU-407,107970,2.3692041371322494
GSS,168313016,4.309710891894579
HD-MY-Z,12003241,-2.342795911905131
IM95,6852167,1.9087565501375077
KALS-1,44491742,4.207872917974877
TT2609-C02,54596490,5.109876516053897
BHT-101,11396600,4.367853211267109
SNU-5,selumetinib-JQ-1 (4-1 mol-mol),-0.3965065242719394
NCI-H1395,637858,2.3715473340173774
HCC827,selumetinib-JQ-1 (4-1 mol-mol),3.0068650568734396
U-CH1,3689413,0.3133886953072482
RPMI-6666,439501,-2.7068928395348935
Calu-1,selumetinib-JQ-1 (4-1 mol-mol),6.8446491124721085
Hs 852.T,439501,-1.3990443453800825
HEL,135999136,1.6019096984193502
KMS-20,tanespimycin-bortezomib (250-1 mol-mol),-0.2140039466554119
OCI-Ly3,73707398,0.607106430835092
SJSA-1,375860,-0.2161052387707686
P3HR-1,5460769,3.3454995233869957
MOLP-8,262093,0.615798330418347
LXF 289,9903786,1.8485652979864533
SK-MEL-24,644241,2.0343401267094925
OVSAHO,135999136,4.44889825660089
JHH-1,71466445,1.5476660922212682
CA46,11455910,-0.2967360934235351
HT,9903786,3.804202680432086
SNU-16,12003241,-4.948615651726049
KMS-20,44491742,3.719914001289463
SKM-1,375860,-0.6747488513339966
COLO 668,135398744,8.327897360354253
SNG-M,637858,1.5780139874200845
LNCaP clone FGC,135999136,2.023158565172241
WM266-4,10231331,-1.2915436879792983
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
NCI-H2126,11455910,1.7285212021483076
COLO 741,73707398,1.4336068172676
FTC-238,sirolimus-bortezomib (250-1 mol-mol),0.2541232172189812
BT 159,11396600,2.8148026318928054
P12-Ichikawa,439501,-2.449202945881867
AU565,262093,2.3992948308197093
GOS-3,6852167,4.136996914293619
SF539,100016,5.965471494853995
MIA PaCa-2,9903786,3.251255785633491
SW579,11396600,3.356641244231253
NUGC-3,241158,4.199647797705153
NCI-H69,135421197,1.0126694729048382
BT 286,135421197,2.331823163871174
KMS-18,selumetinib-JQ-1 (4-1 mol-mol),0.4000748221734009
SBC-5,135999136,5.333154079184271
SK-OV-3,49766530,0.1985460846164677
NCI-H358,46907787,0.0932722717709755
WM88,73707398,1.223752817996938
BT 239,12003241,-1.4894008844853184
Peer,5460769,2.3155061508829107
NCI-H520,439501,-2.5978412941351405
HEC-251,107970,2.646140813822107
MCF-7,135421197,1.272552449753212
U-BLC1,46907787,2.215172875838617
SNU-5,262093,3.3115328447566723
NCI-H524,637858,1.0517398150644477
NCI-H747,135421197,1.1053174645352293
SKM-1,12003241,-1.1629643414911237
CJM [Human melanoma],selumetinib-JQ-1 (4-1 mol-mol),3.328512112066071
NCI-H1341,9903786,1.643545486774536
PaTu 8902,9903786,4.041497343746548
HCC1588,12003241,-0.4884151161938169
HL-60,3689413,0.2723590351268871
BT 239,375860,0.789468692413804
H-STS,637858,1.1585331861261023
CAS-1,262093,2.1849008326659636
JVM-3,100016,3.63486720200834
SNU-119,9903786,3.393165032525661
SNU-685,100016,6.855109756647912
LOX-IMVI,241158,3.680686115975284
SNU-869,12003241,1.357086277670327
Ku812,sirolimus-bortezomib (250-1 mol-mol),-4.706863759104448
SiMa,10231331,3.4625935909833583
KMS-12-BM,9903786,0.6537757100604409
5637,135999136,4.088875596610543
SET-2,71466445,1.5490156865471134
IM95,73707398,0.9480066923155336
SF268,135421197,1.2829440642017702
NCI-H1703,107970,2.219056559870104
VMRC-RCZ,11455910,2.4109500553955487
Hs 888.Lu,107970,3.001005642322468
RL,439501,-3.24492764026673
SNU-119,439501,-2.3303537311085143
HCC1143,168313016,5.718985268806146
647V,262093,3.044497646509944
P3HR-1,107970,3.4553561691501047
Hs 934.T,375860,3.709125028692515
CML-T1,10231331,3.71504818577299
BT 422,262093,2.50169329189886
GDM-1,46907787,1.561453615533633
LP-1,439501,-3.639573627473922
647V,107970,1.6847508381936895
Karpas-299,9927531,5.423795277339213
SW1417,44491742,4.02538714893742
U-118MG,11396600,3.770930746611021
KP-4,tanespimycin-bortezomib (250-1 mol-mol),-2.4280197504959107
OV7,49766530,-5.15064199643512
SNU-1033,44491742,3.84113608449774
JHH-6,selumetinib-JQ-1 (4-1 mol-mol),5.125843437299189
NCI-H889,11396600,3.5135706355172016
SNB-75,135999136,4.820409920697815
RCH-ACV,73707398,0.2793180424503238
647V,637858,1.2035591572726518
SNU-719,tanespimycin-bortezomib (250-1 mol-mol),-1.2568282299836298
NCC-StC-K140,49766530,-0.6974859837361669
T98G,12003241,-0.2247982599387034
JHUEM-1,selumetinib-JQ-1 (4-1 mol-mol),1.9844934160703236
MOLM-6,644241,-6.412510011256156
HCC44,sirolimus-bortezomib (250-1 mol-mol),1.406227075762608
MOLT-13,135999136,1.6862554581464335
5637,11455910,0.64521724418638
NCI-H2081,11455910,0.9023670010212674
OVK18,10231331,2.741626907853192
MDA-MB-468,49766530,0.7158760984187301
SNU-407,12003241,-0.5168922712641052
COLO 699,73707398,0.3893821784676728
MIA PaCa-2,UNC0638-navitoclax (1-1 mol-mol),2.8894676156365
HT-144,3689413,-0.1147563319413739
KMS-28BM,sirolimus-bortezomib (250-1 mol-mol),0.5815431662005854
JHH-4,241158,4.032336391203072
NCI-H2087,136227331,3.603331893484652
NCI-H1373,439501,-1.5059395530242756
LK-2,107970,2.4057924006239317
Daudi,136227331,3.813653547789358
RERF-LC-A1,375860,-0.507812876154058
U-251MG,644241,3.0245187520411694
RVH-421,46907787,3.7950027413321306
VCaP,26596,0.7732068358688922
BICR 31,262093,3.397835562493394
BT 482,11396600,2.553396780600671
HOS,selumetinib-JQ-1 (4-1 mol-mol),3.1878483028080673
NUGC-4,10231331,-2.888773769193711
RT-4,sirolimus-bortezomib (250-1 mol-mol),0.9499468705615456
BICR 6,241158,3.789279687880277
Mel JuSo,sirolimus-bortezomib (250-1 mol-mol),1.422716190739553
IM95,44491742,3.8617516807929873
HCC78,637858,2.2955589210250773
NCI-H2141,26596,-3.569863113976208
SHP-77,135999136,1.876778796417732
Li-7,168313016,4.344664847370071
SW48,5460769,-0.8804369809799648
HEC-1-B,444795,4.914613662514923
KNS-42,135421197,1.7884636185596865
SNU-1,11396600,2.945712911704453
NCI-H1568,637858,1.7833024505225796
U2OS,tanespimycin-bortezomib (250-1 mol-mol),-0.4956813125549447
KYSE-180,439501,-1.6605779697575254
JVM-3,73707398,-0.2600677123452043
Hs 611.T,168313016,4.489282789911296
Kasumi-1,168313016,3.058088325309781
A-172,73707398,0.9336261150356991
OVK18,135421197,1.6539511410681966
SR,3689413,0.3714575249004426
BFTC-909,73707398,1.325657316242966
CAL-78,sirolimus-bortezomib (250-1 mol-mol),0.4097773819170223
NCI-H1155,241158,3.784258278156689
OC 314,9903786,3.545915763256713
KPL-1,selumetinib-JQ-1 (4-1 mol-mol),4.46971279886646
BT 504,241158,4.311533589367548
HCC1954,12003241,-0.7991546925756471
HuP-T4,sirolimus-bortezomib (250-1 mol-mol),1.161558608864497
LOX-IMVI,11455910,0.9161498134653596
OCI-AML-3,135421197,1.1151677608997974
NCI-H650,100016,5.632760623979546
Hep 3B2.1-7,12003241,-1.3373877223864783
NCI-H28,107970,2.518066551188869
LCLC-97TM1,selumetinib-JQ-1 (4-1 mol-mol),1.553276046289172
WM793,637858,1.8553013176450457
HCC1954,11396600,4.077392960060392
CAL-78,3689413,1.0903536033822472
CML-T1,73707398,-0.0310412376393591
KMH-2,9929138,5.036636108742583
FTC-238,26596,-1.757502878688391
COV434,439501,-6.307025719899454
MDA-MB-231,49766530,-1.3973718691388817
Capan-2,44491742,5.038963412977017
KE-37,637858,0.6902429951487689
TE-15,9903786,2.5325936452806723
23132/87,241158,3.5006717835026713
HCC1438,375860,-0.6408911339583222
GMS-10,107970,2.1682911780966245
EPLC-272H,439501,-1.68247015094151
VCaP,11396600,5.246887519153865
Calu-6,10231331,0.6339980155000304
HCT 116,3689413,3.301731662910047
MOLT-3,tanespimycin-bortezomib (250-1 mol-mol),0.0214957708571904
JHOC-5,selumetinib-JQ-1 (4-1 mol-mol),2.141197390405602
NCI-H1299,49766530,-0.517142624612936
SR,9927531,3.5947665035551113
CAL-51,9929138,6.421072450841616
SW1088,11455910,0.1121601149091921
IA-LM,241158,3.7495123409873528
NCI-H2196,168313016,5.854117563388439
SUP-T1,100016,6.229647258472745
DU4475,3689413,0.1265439413603304
SR,selumetinib-JQ-1 (4-1 mol-mol),2.1481021926688695
SEM,107970,1.646444978651256
IM95,135421197,1.82803770659542
DU145,375860,0.0587895300626014
EM-2,168313016,4.389317398313489
HOP-92,3689413,-2.4488363425715076
BT 340,637858,3.4610486275881147
SNU-C4,107970,2.5216503815906375
TE 617.T,9903786,3.301651498076641
647V,73707398,0.9172695307391888
DMS 273,selumetinib-JQ-1 (4-1 mol-mol),2.4189081702185096
HOS,3689413,-0.1573622709293647
MES-SA,637858,2.6624965870315505
HL-60,tanespimycin-bortezomib (250-1 mol-mol),0.1959762790136793
LUDLU-1,selumetinib-JQ-1 (4-1 mol-mol),1.0606041855234352
NCI-H727,5460769,4.510942150258337
MDA-MB-157,11396600,3.7386973485738424
TE-5,439501,-3.2949389532726867
HCC1500,375860,0.1348683063529126
NCI-H28,9903786,3.2913179081195776
MHH-CALL-3,6852167,2.761241961167472
GDM-1,9903786,1.637599474321908
MDA-MB-453,9903786,4.505035222499518
SNU-601,11455910,0.7913610206716569
HCC78,73707398,1.3403643878686862
K-562,100016,4.034095210213227
Hs 895.T,107970,2.9764537428543516
BT 328,637858,2.786285777963434
KYSE-510,637858,3.0396411206635516
SIG-M5,100016,4.056618507771364
BT 428,136227331,3.9646009077151456
U-118MG,5460769,3.4252823056372845
Panc 10.05,46907787,2.9074392738010384
BT 145,26596,-1.6561784022945174
KYSE-180,26596,-0.879665743021705
MFE-296,135999136,2.110993721878467
NCI-H2081,71466445,4.38598643785932
MOLM-6,107970,1.5916207881460709
DND-41,100016,5.882204784714585
NCI-H460,11455910,1.4134750909778395
HCC1438,tanespimycin-bortezomib (250-1 mol-mol),-1.8197339175047005
NCI-H2052,tanespimycin-bortezomib (250-1 mol-mol),2.581253190791589
SaOS-2,375860,-0.2844076074043694
MEC-1,9927531,3.3122365402427816
JHUEM-1,241158,3.61852207918387
EPLC-272H,6852167,1.3585565195030245
HeLa,375860,-0.2411971223696274
KYSE-70,6852167,2.2981101713941814
SU-DHL-6,26596,-1.882707371112463
EC-GI-10,135999136,4.467618898798576
SW1783,5460769,4.078393209152703
EoL-1,selumetinib-JQ-1 (4-1 mol-mol),-1.4243084091722091
NCI-H2052,3689413,-1.081433417665549
BEN,107970,2.561102930550366
SK-MEL-5,241158,4.170979949638567
Daoy,107970,2.72954505874123
HuNS1,12003241,-0.810335190638815
HOS,241158,3.8448261010276674
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433
SNU-478,selumetinib-JQ-1 (4-1 mol-mol),-1.2725800627795898
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
NCI-H1755,135398744,6.361982871837632
Fu97,241158,4.729687986093483
RL,11396600,2.7344364548427413
BT 330,135421197,3.0606427160011433
SU-DHL-10,12003241,2.591682900303347
KYSE-140,12003241,-0.6057431237522657
SK-N-MC,12003241,-1.5670005679110546
HT115,3689413,1.0252939168322983
CW-2,439501,-2.020246340202773
NCI-H727,6852167,3.356078560596427
Becker,6852167,2.488549626227047
JHH-4,26596,-1.5147419870530787
DEL,49766530,-2.519225091580242
SNU-387,tanespimycin-bortezomib (250-1 mol-mol),0.93646564215711
GDM-1,71466445,4.505903550249394
KYSE-180,262093,4.394400122480356
DOV13,6852167,1.6285837488742436
EHEB,241158,3.817598938948392
DND-41,6852167,1.828834613140458
KNS-62,107970,2.9855005311621623
OVK18,11455910,-0.0430501401536957
NCI-H661,107970,2.2398777867932473
NCI-H2444,9927531,4.993346804303282
CAL-148,107970,2.288238614109801
NU-DUL-1,444795,2.712125699604821
NCI-H1568,71466445,4.632148673172368
DU145,11455910,2.077410590950561
BT 416,135999136,1.7385922508955245
SW1710,107970,2.8501029800719744
NCI-H1975,44491742,4.016351620338357
HEY A8,sirolimus-bortezomib (250-1 mol-mol),1.5777182717045015
HEC-251,49766530,-1.4787018176624072
MDA-MB-468,26596,-0.798846302362186
M059K,375860,0.2487548899979027
BCP-1,135999136,4.224263765271161
T24,54596490,5.93576817753399
NCI-H520,73707398,1.1778124455658596
COLO 741,selumetinib-JQ-1 (4-1 mol-mol),-0.2608627934385684
NCI-H446,9927531,3.935868593657491
NCI-H2081,375860,-0.0986689884250349
NCI-H1573,3689413,-0.5514389876644209
NCI-H1299,73707398,1.237381568912588
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457
HCC1171,49766530,-2.294988687179399
BICR 18,637858,3.015698204447704
HMC-1-8,439501,-2.9619639493833247
OCI-Ly3,241158,1.7687975312544326
COLO 800,637858,1.9254657398660469
NCI-H522,3689413,-4.273368850016072
Ri-1,375860,-0.316355066244252
OE19,637858,2.3590283739366145
KMS-12-BM,644241,2.605305599492216
SUIT-2,12003241,-0.3419407469483631
NCI-H810,46907787,-0.1951086170067281
HT-1197,136227331,4.1686832896523685
DMS 273,262093,2.141936221481062
PSN1,9927531,4.910271279543014
CAL-62,UNC0638-navitoclax (1-1 mol-mol),2.629188723486929
HPAF-II,262093,2.839576376925405
A4/Fukuda,168313016,2.0147776130358253
OUMS-23,73707398,1.567830139530049
NCI-H2052,135421197,2.7850999570051003
SNU-182,637858,1.6708222949269376
LUDLU-1,26596,-1.0531529741547596
Kuramochi,3689413,-0.3905926620288846
KNS-60,3689413,0.5613903891454114
KNS-62,selumetinib-JQ-1 (4-1 mol-mol),1.6160613728913362
MeWo,73707398,1.0654051497037464
KP-N-YN,46907787,4.256466884181242
BT 286,107970,1.9511501669936515
MFE-296,11396600,3.78613722040272
TE-5,UNC0638-navitoclax (1-1 mol-mol),2.6531859620297373
22Rv1,tanespimycin-bortezomib (250-1 mol-mol),0.2637398344293039
SNU-C5,12003241,-1.9279387541899935
HEL,262093,2.3252232523203995
LOX-IMVI,46907787,-0.948054839108756
SW1783,sirolimus-bortezomib (250-1 mol-mol),2.8566656968780313
LMSU,49766530,-0.1291663690745916
Mono-Mac-6,444795,2.051246828353319
BT 320,644241,3.936570500455286
2004,100016,6.70935199674954
TUHR10TKB,49766530,-0.1624329738440981
COLO 668,11396600,3.0895910074964856
BT 239,UNC0638-navitoclax (1-1 mol-mol),-3.437137028059637
U-BLC1,644241,1.7323634588350438
BT 248,439501,-2.3411963573363104
Hs 294T,49766530,-1.3950088307868331
NCI-H647,241158,5.626860272324237
NCI-H2228,UNC0638-navitoclax (1-1 mol-mol),2.5874541495767933
